Citrus Sinensis ID: 008238
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 573 | 2.2.26 [Sep-21-2011] | |||||||
| Q9M0X5 | 675 | Cysteine-rich receptor-li | yes | no | 0.947 | 0.804 | 0.570 | 0.0 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.909 | 0.778 | 0.614 | 0.0 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.923 | 0.782 | 0.538 | 1e-165 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.895 | 0.818 | 0.554 | 1e-164 | |
| O65482 | 830 | Putative cysteine-rich re | no | no | 0.923 | 0.637 | 0.521 | 1e-162 | |
| Q9C5S8 | 659 | Cysteine-rich receptor-li | no | no | 0.898 | 0.781 | 0.551 | 1e-161 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.919 | 0.781 | 0.534 | 1e-158 | |
| O65479 | 666 | Putative cysteine-rich re | no | no | 0.907 | 0.780 | 0.527 | 1e-156 | |
| Q9LZU4 | 676 | Cysteine-rich receptor-li | no | no | 0.947 | 0.803 | 0.520 | 1e-155 | |
| Q8L7G3 | 659 | Cysteine-rich receptor-li | no | no | 0.916 | 0.796 | 0.533 | 1e-155 |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 640 bits (1650), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/566 (57%), Positives = 405/566 (71%), Gaps = 23/566 (4%)
Query: 11 FFMLFLFVIYLSISFQSSFTAAADPTYAYHVC--SANFTGNSTYQTNRNLLLSSLPTNAS 68
F +FLF+I +++ +DPTY YH+C + ++ NS+Y TN +LSSL +S
Sbjct: 11 LFSVFLFMILKTVT--------SDPTYLYHICPNTTTYSRNSSYLTNLRTVLSSL---SS 59
Query: 69 RGNGYSSGFYNETTGQ--DPNKVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTI 126
Y+S F N G+ D N+VYG+FLCRGD +A C+DCV FA + +QRCP K +
Sbjct: 60 PNAAYASLFDNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAV 119
Query: 127 IWYDQCLLRYSNRSIFSTMDTVPYVSLLNTQNVTDR--GRFNQILASLMSQVVNQAVNNS 184
IWYD+C++RYSN+SI M P V L N QN+T+ RFN+ L +L+ V +A +S
Sbjct: 120 IWYDECMVRYSNQSIVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSS 179
Query: 185 RKFATRTANFTALQTLYSLAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCI 244
RKFAT ANFT QT+YSL QCTPDL++ DC CL+ I LP CC G +V+ PSC
Sbjct: 180 RKFATEKANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCS 239
Query: 245 VRYEFYPFYNLS----ATSPPPPAPVLLPPPPPGSARGKSGISSSTIIAIVAPIAVTAVL 300
RYE YPFYN + +PPP + V PP S +GK + + AI P++V VL
Sbjct: 240 FRYELYPFYNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSV-CVL 298
Query: 301 FIVGLCYFI-RKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGF 359
+ +C+ + R+ NK +A E ++ IT+ E+LQF F IE ATN FS NKLG GGF
Sbjct: 299 LLGAMCWLLARRRNNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGF 358
Query: 360 GEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419
GEVYKG L +G+ +A+KRLS+ S QG +EFKNEV +VAKLQHRNL +LLG+CL+GEEKIL
Sbjct: 359 GEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKIL 418
Query: 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479
VYEFVPNKSLDYFL++ EK++ LDW RRYKII GIARGILYLH DSRL IIHRDLKASNI
Sbjct: 419 VYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNI 478
Query: 480 LLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 539
LLDA+M+PKISDFGMA+IFGVDQTQ NT RIVGTYGYM+PEYA+HG++SVKSDVYSFGVL
Sbjct: 479 LLDADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVL 538
Query: 540 VLEIITGKKNSSFYQTDGAADLLSYV 565
VLE+ITGKKNSSFY+ DG DL++YV
Sbjct: 539 VLELITGKKNSSFYEEDGLGDLVTYV 564
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 639 bits (1648), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/545 (61%), Positives = 412/545 (75%), Gaps = 24/545 (4%)
Query: 31 AAADPTYAYHVC--SANFTGNSTYQTNRNLLLSSLPTNASRGNGYSSGFYNETTGQDPNK 88
+A DPTY YH C +AN+T NSTY N LL+SL +SR YS+GF N T GQ P++
Sbjct: 33 SAQDPTYVYHTCQNTANYTSNSTYNNNLKTLLASL---SSRNASYSTGFQNATVGQAPDR 89
Query: 89 VYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCLLRYSNRSIFSTMDTV 148
V GLF CRGD + C+ CV+FA D + RCP+ K+ ++YD+C+LRYSN++I ST+ T
Sbjct: 90 VTGLFNCRGDVSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQNILSTLITT 149
Query: 149 PYVSLLNTQNVTDRGRFNQI--LASLMSQVVNQA----VNNSRKFATRTANFTALQTLYS 202
V L+NT+NVT NQ+ L+ L+ +NQA +N+S+KF TR NFTALQ+ Y
Sbjct: 150 GGVILVNTRNVTS----NQLDLLSDLVLPTLNQAATVALNSSKKFGTRKNNFTALQSFYG 205
Query: 203 LAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYPFYNLSATSPPP 262
L QCTPDL+ DC+ CLQ I ++P + + GA+++ PSC RYE Y FY SA PPP
Sbjct: 206 LVQCTPDLTRQDCSRCLQLVINQIP---TDRIGARIINPSCTSRYEIYAFYTESAVPPPP 262
Query: 263 PAPVLLPP---PPPGSARGKSGISSSTIIAIVAPIAVTAVLFIVGLCYFIRKAKNKYNAV 319
P P + P PP S GK G S +IAIV PI V +LFI G C+ R+A+ Y
Sbjct: 263 PPPSISTPPVSAPPRS--GKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRARKSY-YT 319
Query: 320 PEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLS 379
P A +DITT +SLQ D+ TI+ AT++F NK+G+GGFGEVYKG L G E+AVKRLS
Sbjct: 320 PSAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLS 379
Query: 380 RSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ 439
+SSGQG EFKNEVVLVAKLQHRNLVRLLGFCL+GEE++LVYE+VPNKSLDYFL++P K+
Sbjct: 380 KSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKK 439
Query: 440 QQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499
QLDW+RRYKIIGG+ARGILYLH+DSRL IIHRDLKASNILLDA+MNPKI+DFGMA+IFG
Sbjct: 440 GQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFG 499
Query: 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAA 559
+DQT+ NT+RIVGTYGYM+PEYAMHGQ+S+KSDVYSFGVLVLEII+GKKNSSFYQTDGA
Sbjct: 500 LDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAH 559
Query: 560 DLLSY 564
DL+SY
Sbjct: 560 DLVSY 564
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 581 bits (1497), Expect = e-165, Method: Compositional matrix adjust.
Identities = 293/544 (53%), Positives = 384/544 (70%), Gaps = 15/544 (2%)
Query: 31 AAADPTYAYHVC--SANFTGNSTYQTNRNLLLSSLPTNASRGNGYSSGFYNETTGQDPNK 88
+A +P Y H C ++ NSTY TN LLSS ASR YS+GF N GQ P++
Sbjct: 33 SAQNPFYLNHDCPNRTTYSSNSTYSTNLKTLLSSF---ASRNASYSTGFQNIRAGQTPDR 89
Query: 89 VYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCLLRYSNRSIFSTMDTV 148
V GLFLCRGD + C +CV F+ + + RCP+ ++ + +Y++C+LRYS+++ ST+
Sbjct: 90 VTGLFLCRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYEECILRYSHKNFLSTVTYE 149
Query: 149 PYVSLLNTQNVT----DRGRFNQILASLMSQVVNQAVNNSRKFATRTANFTALQTLYSLA 204
+ + N N++ R +F ++ S M+Q N+A N+SRKF+T T+LQTLY L
Sbjct: 150 GELIMRNPNNISSIQNQRDQFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLV 209
Query: 205 QCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYPFYNLSAT---SPP 261
QCTPDL+ DC CL ++I + + GA+ PSC RYE Y FYN +A SPP
Sbjct: 210 QCTPDLARQDCFSCLTSSINRMMPLF--RIGARQFWPSCNSRYELYAFYNETAIGTPSPP 267
Query: 262 PPAPVLLPPPPPGSARGKSGISSSTIIAIVAPIAVTAVLFIVGLCYFIRKAKNKYNAVPE 321
P P PP S GKSG +S+ ++ + +AV + +VG C+ ++ K ++
Sbjct: 268 PLFPGSTPPLTSPSIPGKSG-NSTVLVVAIVVLAVLLFIALVGYCFLAQRTKKTFDTASA 326
Query: 322 VNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRS 381
+D+ T +SLQ D+ TI+ ATN+F+ NK+G GGFGEVYKG +G+E+AVKRLS++
Sbjct: 327 SEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKN 386
Query: 382 SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ 441
S QG EFK EVV+VAKLQHRNLVRLLGF L+GEE+ILVYE++PNKSLD L++P KQ Q
Sbjct: 387 SRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQ 446
Query: 442 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501
LDW +RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA++NPKI+DFGMA+IFG+D
Sbjct: 447 LDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLD 506
Query: 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADL 561
QTQ NT+RIVGTYGYMAPEYAMHGQFS+KSDVYSFGVLVLEII+G+KNSSF ++DGA DL
Sbjct: 507 QTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDL 566
Query: 562 LSYV 565
L++
Sbjct: 567 LTHT 570
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 579 bits (1492), Expect = e-164, Method: Compositional matrix adjust.
Identities = 301/543 (55%), Positives = 384/543 (70%), Gaps = 30/543 (5%)
Query: 37 YAYHVC--SANFTGNSTYQTNRNLLLSSLPT-NASRGNGYSSGFYNETTGQDPNKVYGLF 93
Y H+C + ++ NS Y TN LLSSL NAS YS+GF + GQ P++V GLF
Sbjct: 26 YIKHICPNTTTYSRNSPYLTNLRTLLSSLSAPNAS----YSTGFQSARAGQAPDRVTGLF 81
Query: 94 LCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCLLRYSNRSIFSTMDTVPYVSL 153
LCRGD + + C++CV F+ D + +CP ++++ +YD+C+LRYS+++I ST+
Sbjct: 82 LCRGDVSPAVCRNCVAFSINDTLVQCPSERKSVFYYDECMLRYSDQNILSTLAYDGAWIR 141
Query: 154 LNTQNVTDRG---RFNQILASLMSQVVNQAVNNSRKFATRTANFTALQTLYSLAQCTPDL 210
+N D+ RF ++S M+Q +A ++ RKF T A +TALQTLY L QCTPDL
Sbjct: 142 MNGNISIDQNQMNRFKDFVSSTMNQAAVKAASSPRKFYTVKATWTALQTLYGLVQCTPDL 201
Query: 211 SSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYPFYNLSATSPPPPAP----- 265
+ DC CL+++I +P KTG + L SC RYE + FYN + P
Sbjct: 202 TRQDCFSCLESSIKLMP---LYKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLPPS 258
Query: 266 ----VLLPPPPPGSARGKSGISSSTIIAIVAPIAVTAVLFIVGLCYFIRKAKNKYNAVPE 321
V P P GKS S+ ++AIV I V A+L I G C F ++ KN + P
Sbjct: 259 STPLVTSPSLP-----GKSWNSNVLVVAIVLTILVAALLLIAGYC-FAKRVKNSSDNAPA 312
Query: 322 VNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRS 381
+ D DITT ESLQ D+ I ATN FS +NK+G+GGFGEVYKG +G E+AVKRLS+S
Sbjct: 313 FDGD-DITT-ESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSKS 370
Query: 382 SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ 441
SGQG EFKNEVV+VAKLQHRNLVRLLGF + G E+ILVYE++PNKSLDYFL++P KQ Q
Sbjct: 371 SGQGDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQNQ 430
Query: 442 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501
LDW+RRYK+IGGIARGILYLH+DSRL IIHRDLKASNILLDA+MNPK++DFG+A+IFG+D
Sbjct: 431 LDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGMD 490
Query: 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADL 561
QTQ NT+RIVGT+GYMAPEYA+HGQFSVKSDVYSFGVLVLEII+GKKN+SFY+TDGA DL
Sbjct: 491 QTQENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAHDL 550
Query: 562 LSY 564
+++
Sbjct: 551 VTH 553
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65482|CRK23_ARATH Putative cysteine-rich receptor-like protein kinase 23 OS=Arabidopsis thaliana GN=CRK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 571 bits (1471), Expect = e-162, Method: Compositional matrix adjust.
Identities = 312/598 (52%), Positives = 391/598 (65%), Gaps = 69/598 (11%)
Query: 30 TAAADPTYAYHVCS--ANFTGNSTYQTNRNLLLSSLPTNASRGNGYSSGFYNETTGQDPN 87
T+A DPTY YHVC A F +STY TN LLS+L +S YS+GF N T G+ P+
Sbjct: 134 TSALDPTYVYHVCPSWATFPRSSTYMTNLITLLSTL---SSPSASYSTGFQNATAGKHPD 190
Query: 88 KVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCLLRYSNRSIFSTMDT 147
+V GLF CRGD + C+ CV+FA + RCP K+ ++YDQC LRYSNR+I ST +T
Sbjct: 191 RVTGLFNCRGDVSPEVCRRCVSFAVNETSTRCPIEKEVTLYYDQCTLRYSNRNILSTSNT 250
Query: 148 VPYVSLLNTQNVT--DRGRFNQILASLMSQVVNQAVNNSRKFATRTANFTALQTLYSLAQ 205
+ L N+QN+T ++ RF ++ + M+Q A N+S++F R+ANFT L +LY+L Q
Sbjct: 251 NGGIILANSQNMTSNEQARFKDLVLTTMNQATIAAANSSKRFDARSANFTTLHSLYTLVQ 310
Query: 206 CTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYPFYNLSATSPPPPA- 264
CT DL+ DC CLQ I +LP + K G Q ++PSC R+E FYN SA + P P
Sbjct: 311 CTHDLTRQDCLSCLQQIINQLP---TEKIGGQFIVPSCSSRFELCLFYNQSAVTTPQPQQ 367
Query: 265 ----------------------PV--------------LLPP-------PPPGSARGKSG 281
P+ LL P GK G
Sbjct: 368 NSAPPPPPTSIPSPRPGLNSRFPLITCLSAVSFEKFKDLLKPGFICILIKIVSENTGKGG 427
Query: 282 ISSSTIIAIVAPIAVTAVLFIVGLCYFIRKAKNKYNAVPEVNAD--------------ND 327
SS IIA+V I +LF+ ++ K A+P +N +
Sbjct: 428 NSSVIIIAVVVSITALLLLFVAVFSVRTKRRKKMIGAIPLLNVKRKDTEVTEPLAENGDS 487
Query: 328 ITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQ 387
ITT SLQFDF+ I ATNNF NKLG+GGFGEVYKG PSG ++AVKRLS++SGQG +
Sbjct: 488 ITTAGSLQFDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKTSGQGER 547
Query: 388 EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRR 447
EF+NEVV+VAKLQHRNLVRLLG+CLEGEEKILVYEFV NKSLDYFL++ ++QLDW+RR
Sbjct: 548 EFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTMKRQLDWTRR 607
Query: 448 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT 507
YKIIGGIARGILYLH+DSRL IIHRDLKA NILLDA+MNPK++DFGMA+IFG+DQT+ NT
Sbjct: 608 YKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANT 667
Query: 508 NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGA-ADLLSY 564
R+VGTYGYMAPEYAM+GQFS+KSDVYSFGVLV EII+G KNSS YQ D + ++L++Y
Sbjct: 668 RRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSLYQMDDSVSNLVTY 725
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 567 bits (1462), Expect = e-161, Method: Compositional matrix adjust.
Identities = 301/546 (55%), Positives = 385/546 (70%), Gaps = 31/546 (5%)
Query: 34 DPTYAYHVCSANFTGNSTYQTNRNLLLSSLPTNASRGNGY-SSGFYNETTGQDPNKVYGL 92
DPTY HVC+ + NS Y +N LL+SL +N N Y S G ++ T GQ+ + V+GL
Sbjct: 28 DPTYVGHVCTNRISRNSIYFSNLQTLLTSLSSN----NAYFSLGSHSLTKGQNSDMVFGL 83
Query: 93 FLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCLLRYSNRSIFSTMDTVPYVS 152
+LC+GD + SC++CV FA +D RCP GK+ +I YD+C+L YS+R+IF T +
Sbjct: 84 YLCKGDLSPESCRECVIFAAKDTRSRCPGGKEFLIQYDECMLGYSDRNIFMDTVTTTTII 143
Query: 153 LLNTQNVT--DRGRFNQILASLMSQVVNQAVNN-SRKFATRTANFTALQTLYSLAQCTPD 209
NTQ VT RFN + SLM + +A N+ S+KFA + ++F++ Q+LY+ QC PD
Sbjct: 144 TWNTQKVTADQSDRFNDAVLSLMKKSAEEAANSTSKKFAVKKSDFSSSQSLYASVQCIPD 203
Query: 210 LSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYPFYNLS--------ATSPP 261
L+S DC +CLQ +I EL K G + L+PSC RYE YPFY + S P
Sbjct: 204 LTSEDCVMCLQQSIKEL---YFNKVGGRFLVPSCNSRYEVYPFYKETIEGTVLPPPVSAP 260
Query: 262 PPAPVLLPPPPPGSARGKSGISSSTIIAIVAPIAVTAVLFIVGLCYF--IRKAKNKYNAV 319
P V P PPG G +S+ II + +VL V + F ++AK Y+
Sbjct: 261 PLPLVSTPSFPPG-----KGKNSTVIIIAIVVPVAISVLICVAVFSFHASKRAKKTYD-T 314
Query: 320 PEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLS 379
PE ++DITT SLQFDF+ IE AT+ FS NKLG+GGFG+VYKG LP+G ++AVKRLS
Sbjct: 315 PE---EDDITTAGSLQFDFKVIEAATDKFSMCNKLGQGGFGQVYKGTLPNGVQVAVKRLS 371
Query: 380 RSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ 439
++SGQG +EFKNEVV+VAKLQHRNLV+LLGFCLE EEKILVYEFV NKSLDYFL++ Q
Sbjct: 372 KTSGQGEKEFKNEVVVVAKLQHRNLVKLLGFCLEREEKILVYEFVSNKSLDYFLFDSRMQ 431
Query: 440 QQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499
QLDW+ RYKIIGGIARGILYLH+DSRL IIHRDLKA NILLDA+MNPK++DFGMA+IF
Sbjct: 432 SQLDWTTRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFE 491
Query: 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGA- 558
+DQT+ +T R+VGTYGYM+PEYAM+GQFS+KSDVYSFGVLVLEII+G+KNSS YQ D +
Sbjct: 492 IDQTEAHTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGRKNSSLYQMDASF 551
Query: 559 ADLLSY 564
+L++Y
Sbjct: 552 GNLVTY 557
|
Involved in multiple distinct defense responses. May function as a disease resistance (R) protein. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 558 bits (1439), Expect = e-158, Method: Compositional matrix adjust.
Identities = 296/554 (53%), Positives = 382/554 (68%), Gaps = 27/554 (4%)
Query: 31 AAADPTYAYHVC--SANFTGNSTYQTNRNLLLSSLPT-NASRGNGYSSGFYNETTGQDPN 87
+A DP Y H C + ++ NSTY TN LLSSL + NAS YS+GF N T G+ P+
Sbjct: 23 SAQDPFYLNHYCPNTTTYSSNSTYSTNLRTLLSSLSSRNAS----YSTGFQNATAGKAPD 78
Query: 88 KVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCLLRYSNRSIFSTMDT 147
+V GLFLCRGD + C++CV F+ + CP ++ + +Y+QC+LRYS+++I ST T
Sbjct: 79 RVTGLFLCRGDVSPEVCRNCVAFSVNQTLNLCPKVREAVFYYEQCILRYSHKNILSTAIT 138
Query: 148 VPYVSLLNTQNVTDRGR-----FNQILASLMSQVVNQAVNNSRKFATRTANFTALQTLYS 202
+L+ N + F ++S MS+ +A N+SRK T TA Q LY
Sbjct: 139 NEGEFILSNTNTISPNQKQIDGFTSFVSSTMSEAAGKAANSSRKLYTVNTELTAYQNLYG 198
Query: 203 LAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYPFYNLSATSPPP 262
L QCTPDL+ +DC CLQ++I + + GA++ PSC RYE YPFYN SA PP
Sbjct: 199 LLQCTPDLTRADCLSCLQSSINGM---ALSRIGARLYWPSCTARYELYPFYNESAIETPP 255
Query: 263 -----------PAPVLLPPPPPGSARGKSGISSSTIIAIVAPIAVTAVLFIVGLCYFIRK 311
+ V PP S GKSG +S+ ++ V +AV + +VG C+ +K
Sbjct: 256 LPPPPPPPPPRESLVSTPPISSSSLPGKSG-NSTVLVVAVVVLAVLLFIALVGYCFLAKK 314
Query: 312 AKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQ 371
K ++ +D+ T +SLQ D+ TI+ ATN+F+ NK+G GGFGEVYKG +G+
Sbjct: 315 KKKTFDTASASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGK 374
Query: 372 EIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDY 431
E+AVKRLS++S QG EFK EVV+VAKLQHRNLVRLLGF L+GEE+ILVYE++PNKSLD
Sbjct: 375 EVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDC 434
Query: 432 FLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 491
L++P KQ QLDW +RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA++NPKI+D
Sbjct: 435 LLFDPTKQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIAD 494
Query: 492 FGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551
FGMA+IFG+DQTQ NT+RIVGTYGYMAPEYAMHGQFS+KSDVYSFGVLVLEII+G+KNSS
Sbjct: 495 FGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSS 554
Query: 552 FYQTDGAADLLSYV 565
F ++DGA DLL++
Sbjct: 555 FGESDGAQDLLTHA 568
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 552 bits (1422), Expect = e-156, Method: Compositional matrix adjust.
Identities = 297/563 (52%), Positives = 388/563 (68%), Gaps = 43/563 (7%)
Query: 27 SSFTAAA-DPTYAYHVCS--ANFTGNSTYQTNRNLLLSSLPTNASRGNGYSSGFYNETTG 83
+SFTA+A +P Y YH CS ++ NSTY TN L + L + +SR YS+GF N T G
Sbjct: 17 TSFTASAQNPFYLYHNCSITTTYSSNSTYSTN---LKTLLSSLSSRNASYSTGFQNATAG 73
Query: 84 QDPNKVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCLLRYSNRSIFS 143
Q P+ V GLFLCRG+ + C+ C+ + + + RCP+ ++ + +Y+QC+LRYSNR+I S
Sbjct: 74 QAPDMVTGLFLCRGNVSPEVCRSCIALSVNESLSRCPNEREAVFYYEQCMLRYSNRNILS 133
Query: 144 TMDTVPYVSLLNTQN--VTDRGRFNQILASLMSQVVNQAVNNSRKFATRTANFTALQTLY 201
T++T V + N +N + RF ++ + M+ +A + ++FA + ALQ+LY
Sbjct: 134 TLNTDGGVFMQNARNPISVKQDRFRDLVLNPMNLAAIEAARSIKRFAVTKFDLNALQSLY 193
Query: 202 SLAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYPFYNLSATSPP 261
+ QCTPDL+ DC CLQ +I ++ K G + +PSC RY+ Y FYN P
Sbjct: 194 GMVQCTPDLTEQDCLDCLQQSINQV---TYDKIGGRTFLPSCTSRYDNYEFYNEFNVGTP 250
Query: 262 PPAPVLLPPPPPGSARGKSGISSSTIIAIVAPIAVTAVLFIVGLCYF-IRKAKNK--YNA 318
+ P PG K G SS +IA+V VLF++ + +F +R+AK K A
Sbjct: 251 QDSS-----PRPG----KGGNSSVIVIAVVV---PITVLFLLFVAFFSVRRAKRKKTIGA 298
Query: 319 VP----------------EVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEV 362
+P E +DITT SLQFDF+ I AT+ F NKLG+GGFGEV
Sbjct: 299 IPLFKVKRKETEVTEPPAETTDGDDITTAGSLQFDFKAIVAATDIFLPINKLGQGGFGEV 358
Query: 363 YKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422
YKG PSG ++AVKRLS++SGQG +EF+NEVV+VAKLQHRNLV+LLG+CLEGEEKILVYE
Sbjct: 359 YKGTFPSGVQVAVKRLSKNSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYE 418
Query: 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 482
FVPNKSLDYFL++P Q QLDWSRRYKIIGGIARGILYLH+DSRL IIHRDLKA NILLD
Sbjct: 419 FVPNKSLDYFLFDPTMQGQLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLD 478
Query: 483 AEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE 542
A+MNPK++DFGMA+IFG+DQT+ NT R+VGTYGYMAPEYAM+G+FS+KSDVYSFGVLVLE
Sbjct: 479 ADMNPKVADFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGKFSMKSDVYSFGVLVLE 538
Query: 543 IITGKKNSSFYQTDGA-ADLLSY 564
I++G KNSS Q DG+ ++L++Y
Sbjct: 539 IVSGMKNSSLDQMDGSISNLVTY 561
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LZU4|CRK4_ARATH Cysteine-rich receptor-like protein kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 550 bits (1416), Expect = e-155, Method: Compositional matrix adjust.
Identities = 301/578 (52%), Positives = 388/578 (67%), Gaps = 35/578 (6%)
Query: 11 FFMLFLFVIYLSISFQSSFTAAADPTYAY----HVCSAN---FTGNSTYQTNRNLLLSSL 63
FF LF F+++LS F S + + P + H C ++ ++ NSTY TN L + L
Sbjct: 3 FFWLFPFLLHLS--FADSLSPLSAPVQNFIHLNHSCPSSILTYSRNSTYFTN---LKTLL 57
Query: 64 PTNASRGNGYSSGFYNETTGQDPNKVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGK 123
+ +SR YS+GF T GQ P++V GLFLCRGD + C++CV F+ ++ + CP K
Sbjct: 58 SSLSSRNASYSTGFQTATAGQAPDRVTGLFLCRGDVSQEVCRNCVAFSVKETLYWCPYNK 117
Query: 124 QTIIWYDQCLLRYSNRSIFSTMDTVPYVSLLNTQNVTDRGR-----FNQILASLMSQVVN 178
+ +++YD+C+LRYS+R+I ST+ LLN N++ + F +++S ++
Sbjct: 118 EVVLYYDECMLRYSHRNILSTVTYDGSAILLNGANISSSNQNQVDEFRDLVSSTLNLAAV 177
Query: 179 QAVNNSRKFATRTANFTALQTLYSLAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQV 238
+A N+S+KF TR Q LY L QCTPDL+ DC CLQ +I + + G +
Sbjct: 178 EAANSSKKFYTRKV--ITPQPLYLLVQCTPDLTRQDCLRCLQKSIKGMS---LYRIGGRF 232
Query: 239 LIPSCIVRYEFYPFYNLSATSPPPPA----------PVLLPPPPPGSARGKSGISSSTII 288
PSC RYE Y FYN +AT P + L PPP S RGK G +SS II
Sbjct: 233 FYPSCNSRYENYSFYNETATRSSSPPSLPPRSTPQQQLKLAPPPLISERGK-GRNSSVII 291
Query: 289 AIVAPIAVTAVLFIVGLCYFIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNF 348
+V PI +LF+ +K + Y P +DITT SLQFDF+ IE ATN F
Sbjct: 292 VVVVPIIALLLLFVAFFSLRAKKTRTNYEREPLTEESDDITTAGSLQFDFKAIEAATNKF 351
Query: 349 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLL 408
NKLG+GGFGEVYKG+ PSG ++AVKRLS++SGQG +EF NEV++VAKLQHRNLVRLL
Sbjct: 352 CETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLL 411
Query: 409 GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLR 468
GFCLE +E+ILVYEFVPNKSLDYF+++ Q LDW+RRYKIIGGIARGILYLH+DSRL
Sbjct: 412 GFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLT 471
Query: 469 IIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFS 528
IIHRDLKA NILL +MN KI+DFGMA+IFG+DQT+ NT RIVGTYGYM+PEYAM+GQFS
Sbjct: 472 IIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFS 531
Query: 529 VKSDVYSFGVLVLEIITGKKNSSFYQTDG--AADLLSY 564
+KSDVYSFGVLVLEII+GKKNS+ YQ DG A +L++Y
Sbjct: 532 MKSDVYSFGVLVLEIISGKKNSNVYQMDGTSAGNLVTY 569
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 547 bits (1410), Expect = e-155, Method: Compositional matrix adjust.
Identities = 289/542 (53%), Positives = 381/542 (70%), Gaps = 17/542 (3%)
Query: 31 AAADPTYAYHVC--SANFTGNSTYQTNRNLLLSSLPTNASRGNGYSSGFYNETTGQDPNK 88
+A DP + + C + ++ NSTY TN L + L + +SR YS+GF N T GQ ++
Sbjct: 22 SAQDPRFLAYYCPNATTYSSNSTYLTN---LKTLLSSLSSRNASYSTGFQNATVGQALDR 78
Query: 89 VYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCLLRYSNRSIFSTMDTV 148
V GLFLCRGD + C++CVTFA + RCP+ ++ + +Y++C+LRYS+++I ST T
Sbjct: 79 VTGLFLCRGDVSPEVCRNCVTFAVNNTFSRCPNQREAVFYYEECILRYSHKNILSTAITN 138
Query: 149 PYVSLLNTQN-----VTDRGRFNQILASLMSQVVNQAVNNSRKFATRTANFTALQTLYSL 203
+L N +F ++ S M+Q+ +A +N RKF+T TALQT Y L
Sbjct: 139 EGEFILRNPNHISPIQNQINQFTNLVLSNMNQIAIEAADNPRKFSTIKTELTALQTFYGL 198
Query: 204 AQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYPFYNLSATSPPPP 263
QCTPDLS +C CL ++I +P + GA+ PSC RYE Y FYN +A PPP
Sbjct: 199 VQCTPDLSRQNCMNCLTSSINRMP---FSRIGARQFWPSCNSRYELYDFYNETAIGTPPP 255
Query: 264 APVLLPPPPPGSARGKSGISSSTIIAIVAPIAVTAVLFIVGLCYFIRKAKNKYNAVPEVN 323
L S KSG S+ ++A+V PI V ++FI G C+F ++AK Y P ++
Sbjct: 256 PLPPLAS---PSLSDKSGNSNVVVVAVVVPIIVAVLIFIAGYCFFAKRAKKTYGTTPALD 312
Query: 324 ADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSG 383
D D TT+ESLQ D+ I+ ATN+FS +NK+G GGFG+VYKG +G E+AVKRLS++S
Sbjct: 313 ED-DKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSE 371
Query: 384 QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLD 443
QG EFKNEVV+VA L+H+NLVR+LGF +E EE+ILVYE+V NKSLD FL++P K+ QL
Sbjct: 372 QGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLY 431
Query: 444 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503
W++RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA+MNPKI+DFGMA+IFG+DQT
Sbjct: 432 WTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQT 491
Query: 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLS 563
Q NT+RIVGTYGYM+PEYAM GQFS+KSDVYSFGVLVLEII+G+KN+SF +TD A DL++
Sbjct: 492 QQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDLVT 551
Query: 564 YV 565
+
Sbjct: 552 HA 553
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 573 | ||||||
| 255555033 | 579 | ATP binding protein, putative [Ricinus c | 0.907 | 0.898 | 0.671 | 0.0 | |
| 255555031 | 674 | ATP binding protein, putative [Ricinus c | 0.928 | 0.789 | 0.659 | 0.0 | |
| 255555035 | 671 | ATP binding protein, putative [Ricinus c | 0.951 | 0.812 | 0.639 | 0.0 | |
| 359474715 | 684 | PREDICTED: cysteine-rich receptor-like p | 0.949 | 0.795 | 0.635 | 0.0 | |
| 351721533 | 667 | cysteine-rich protein precursor [Glycine | 0.921 | 0.791 | 0.633 | 0.0 | |
| 359474717 | 663 | PREDICTED: cysteine-rich receptor-like p | 0.909 | 0.785 | 0.643 | 0.0 | |
| 224113935 | 674 | predicted protein [Populus trichocarpa] | 0.930 | 0.790 | 0.628 | 0.0 | |
| 356575777 | 671 | PREDICTED: cysteine-rich receptor-like p | 0.961 | 0.821 | 0.587 | 0.0 | |
| 359496581 | 666 | PREDICTED: cysteine-rich receptor-like p | 0.917 | 0.789 | 0.606 | 0.0 | |
| 356575779 | 666 | PREDICTED: cysteine-rich receptor-like p | 0.956 | 0.822 | 0.591 | 0.0 |
| >gi|255555033|ref|XP_002518554.1| ATP binding protein, putative [Ricinus communis] gi|223542399|gb|EEF43941.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1830), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/545 (67%), Positives = 420/545 (77%), Gaps = 25/545 (4%)
Query: 39 YHVCS--ANFTGNSTYQTNRNLLLSSLPTNASRGNGYSSGFYNETTGQDPNKVYGLFLCR 96
Y+VCS FT NSTYQTN L+ L ++ S S GF+N +GQ P+ VYG FLCR
Sbjct: 31 YYVCSNTTAFTPNSTYQTN----LNKLLSSLSNNANNSIGFFNIPSGQQPDDVYGSFLCR 86
Query: 97 GDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCLLRYSNRSIFSTMDTVPYVSLLNT 156
GD + CQDCVTFAT+D+V+RCP K I+WYD+CLLRY N+S STMD P + + NT
Sbjct: 87 GDVSTDVCQDCVTFATQDIVKRCPIEKVAIVWYDECLLRYENQSFISTMDQTPGLYMWNT 146
Query: 157 QNVT--DRGRFNQILASLMSQVVNQA---VNNSRKFATRTANFTALQTLYSLAQCTPDLS 211
QN++ D+ RFN +LAS M+ + +A + +KFA + +FT+ Q LYSL QCTPDLS
Sbjct: 147 QNISTSDQVRFNALLASTMNNLATEASTAASGEKKFAVKEDSFTSFQKLYSLVQCTPDLS 206
Query: 212 SSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYPFYNLSATSPPPPAPVL---- 267
+SDC CLQ AI+ LP+CC GK G +VL PSC +RYE Y F+N +A PPPPAP
Sbjct: 207 TSDCGQCLQTAISNLPSCCGGKQGGRVLYPSCNIRYEVYLFFNATALEPPPPAPSPVVPL 266
Query: 268 ------LPPPPPGSARGKSGISSSTIIAIVAPIAVTAVLFIVGLCYFIRKAKNKYNAVPE 321
L P GK GIS+ TIIAIVAPIAV VLF +G CY R+ KY AV E
Sbjct: 267 PPPPTGLGAKP--QIEGKRGISTVTIIAIVAPIAVATVLFSLGCCYLRRR--KKYEAVQE 322
Query: 322 VNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRS 381
+A N+ITT ESLQ D TIEVATN FS DNKLGEGGFGEVYKG LP+GQEIAVK+LSRS
Sbjct: 323 DDARNEITTAESLQIDLNTIEVATNKFSADNKLGEGGFGEVYKGTLPNGQEIAVKKLSRS 382
Query: 382 SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ 441
SGQG +EFKNEV L+AKLQHRNLVRLLGFCLEG EKILVYEFVPNKSLDYFL++PEKQ Q
Sbjct: 383 SGQGAEEFKNEVALLAKLQHRNLVRLLGFCLEGAEKILVYEFVPNKSLDYFLFDPEKQAQ 442
Query: 442 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501
LDWSRRYKIIGGIARGI+YLHEDSRLRIIHRDLKASNILLD MN KISDFGMA+IFGVD
Sbjct: 443 LDWSRRYKIIGGIARGIVYLHEDSRLRIIHRDLKASNILLDRNMNSKISDFGMARIFGVD 502
Query: 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADL 561
QTQGNT+RIVGTYGYM+PEYAMHGQFSVKSD+YSFG+LVLEII+GKKNSSFYQ DG DL
Sbjct: 503 QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDMYSFGILVLEIISGKKNSSFYQIDGVDDL 562
Query: 562 LSYVS 566
+SYVS
Sbjct: 563 VSYVS 567
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555031|ref|XP_002518553.1| ATP binding protein, putative [Ricinus communis] gi|223542398|gb|EEF43940.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1822), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/547 (65%), Positives = 431/547 (78%), Gaps = 15/547 (2%)
Query: 30 TAAADPTYAYHVCS--ANFTGNSTYQTNRNLLLSSLPTNASRGNGYSSGFYNETTGQDPN 87
+ + +P Y YHVCS F NSTYQTN N L SL NA+ S GFYN ++GQDP+
Sbjct: 23 SQSPEPVYLYHVCSNTTTFAPNSTYQTNLNQLFPSLSNNANN----SIGFYNRSSGQDPD 78
Query: 88 KVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCLLRYSNRSIFSTMDT 147
+YGLFLCRGD + CQDCVTFA++D+V+RCP K I+WYD+CLL Y+NRS++S M
Sbjct: 79 DIYGLFLCRGDVSTDVCQDCVTFASQDIVKRCPIEKVAIVWYDECLLHYANRSLYSIMAQ 138
Query: 148 VPYVSLLNTQNVTDRGRFNQILASLMSQVVNQAVN---NSRKFATRTANFTALQTLYSLA 204
P V LLN QN+ D+ RFN +LA+ M ++ +A + +KFA + NFTA + LYSL
Sbjct: 139 EPGVFLLNVQNIADQDRFNNLLATTMGKLATEAASAASGEKKFAVKIDNFTAFEKLYSLV 198
Query: 205 QCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYPFYNLSATSPPPPA 264
QCTPDLS+ DC CLQAAI+ LP CC GK G +VL PSC +RYE YPF+N++A PPPP+
Sbjct: 199 QCTPDLSNLDCGRCLQAAISNLPTCCDGKRGGRVLYPSCNIRYEVYPFFNVTALEPPPPS 258
Query: 265 PVLLPPPPPGSA------RGKSGISSSTIIAIVAPIAVTAVLFIVGLCYFIRKAKNKYNA 318
P + PPPP S+ +GKSG+S+ TI+AIVAP+AV V F +G CY R+A+ KY+A
Sbjct: 259 PSPVVPPPPTSSGTRPETKGKSGLSTVTIVAIVAPVAVAIVFFFLGCCYLRRRARKKYDA 318
Query: 319 VPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL 378
E +A N+ITT+ESLQ D TIE AT+ FS NKLGEGGFG+VYKG LP+GQEIAVK+L
Sbjct: 319 GQEDDAGNEITTVESLQIDLNTIEAATDKFSAANKLGEGGFGKVYKGTLPNGQEIAVKKL 378
Query: 379 SRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEK 438
SRSS QG QEFKNEVVL+AKLQHRNLVRLLGFCLEG EKILVYEFVPNKSLDYFL++ +K
Sbjct: 379 SRSSVQGAQEFKNEVVLLAKLQHRNLVRLLGFCLEGAEKILVYEFVPNKSLDYFLFDAKK 438
Query: 439 QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498
Q QLDW RYKI+GGIARGI+YLHEDS+L+IIHRDLK SNILLD +MNPKISDFGMA+IF
Sbjct: 439 QGQLDWQTRYKIVGGIARGIIYLHEDSQLKIIHRDLKVSNILLDKDMNPKISDFGMARIF 498
Query: 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGA 558
GVDQTQGNTNRIVGTYGYM+PEYAMHG FSVKSD+YSFGVLVLEII GKKNSSFY+ GA
Sbjct: 499 GVDQTQGNTNRIVGTYGYMSPEYAMHGHFSVKSDIYSFGVLVLEIICGKKNSSFYEIHGA 558
Query: 559 ADLLSYV 565
+DL+SYV
Sbjct: 559 SDLVSYV 565
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555035|ref|XP_002518555.1| ATP binding protein, putative [Ricinus communis] gi|223542400|gb|EEF43942.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 705 bits (1819), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/568 (63%), Positives = 429/568 (75%), Gaps = 23/568 (4%)
Query: 10 KFFMLFLFVIYLSISFQSSFTAAADPTYAYHVCS--ANFTGNSTYQTNRNLLLSSLPTNA 67
+F ++ LF++ L+I A P Y YH CS FT NSTYQTN L+ + ++
Sbjct: 6 RFPIILLFLLRLAI-----IVKAESPEYRYHFCSNTTTFTPNSTYQTN----LNQVLSSL 56
Query: 68 SRGNGYSSGFYNETTGQDPNKVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTII 127
S S GF+N +GQ P+ VYG FLCRGD + CQDCVTFAT+D+V+RCP K I+
Sbjct: 57 SNNANNSIGFFNIPSGQQPDDVYGSFLCRGDVSTDVCQDCVTFATQDIVKRCPIEKVAIV 116
Query: 128 WYDQCLLRYSNRSIFSTMDTVPYVSLLNTQNVTDRGRFNQILASLMSQVV---NQAVNNS 184
WYDQCLLRY N+S STMD P V L NTQ+++D RF+ +LA+ M + + A +
Sbjct: 117 WYDQCLLRYENQSFISTMDQTPGVFLSNTQDISDPDRFDNLLATTMENLATDASSAASGE 176
Query: 185 RKFATRTANFTALQTLYSLAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCI 244
+KFA NFTA Q LYSL QCTPDLS+ C CL+ AI+ LP+CC GK GA VL PSC
Sbjct: 177 KKFAATDDNFTAFQKLYSLVQCTPDLSNPGCRQCLRGAISNLPSCCGGKRGANVLYPSCN 236
Query: 245 VRYEFYPFYNLSATSPPPPAPVLLPPPPPGSA-------RGKSGISSSTIIAIVAPIAVT 297
VRYE YPF+N +A PPPP+P PPPP + G+SGIS+ I+AIVAP+A+
Sbjct: 237 VRYEVYPFFNATAVEPPPPSPSPAVPPPPPTGSGTRPETEGQSGISTVIIVAIVAPVAIA 296
Query: 298 AVLFIVGLCYFIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEG 357
VLF + CY R+ + KY+AV E N+ITT+ESLQ D T+E ATN FS DNKLGEG
Sbjct: 297 IVLFSLAYCYLRRRPRKKYDAVQE--DGNEITTVESLQIDLNTVEAATNKFSADNKLGEG 354
Query: 358 GFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 417
GFGEVYKG+LP+GQEIAVK+LSRSSGQG QEFKNEVVL+AKLQHRNLVRLLGFCLEG EK
Sbjct: 355 GFGEVYKGILPNGQEIAVKKLSRSSGQGAQEFKNEVVLLAKLQHRNLVRLLGFCLEGAEK 414
Query: 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 477
ILVYEFV NKSLDYFL++PEKQ+QLDWS RYKI+GGIARGILYLHEDS+LRI+HRDLK S
Sbjct: 415 ILVYEFVSNKSLDYFLFDPEKQRQLDWSTRYKIVGGIARGILYLHEDSQLRIVHRDLKVS 474
Query: 478 NILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFG 537
NILLD MNPKISDFG A+IFGVDQ+QGNT RIVGTYGYM+PEYAMHGQFSVKSD+YSFG
Sbjct: 475 NILLDRNMNPKISDFGTARIFGVDQSQGNTKRIVGTYGYMSPEYAMHGQFSVKSDMYSFG 534
Query: 538 VLVLEIITGKKNSSFYQTDGAADLLSYV 565
VL+LEII GKKNSSFY+ DGA DL+SYV
Sbjct: 535 VLILEIICGKKNSSFYEIDGAGDLVSYV 562
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474715|ref|XP_003631522.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1773), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/574 (63%), Positives = 427/574 (74%), Gaps = 30/574 (5%)
Query: 13 MLFLFVIYLSISFQSSFTAAADPTYAYHVCSANFT--GNSTYQTNRNLLLSSLPTNASRG 70
+LFL + L+IS A P Y +HVCS T NSTYQTN N LLSSL +NA+R
Sbjct: 9 LLFLCALGLAIS---CLAIQAAPDYIHHVCSNTTTIQPNSTYQTNLNSLLSSLSSNATRA 65
Query: 71 NGYSSGFYNETTGQDPNKVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYD 130
NG FYN T GQ P+ YGLFLCRGD C+DCV A+ +++Q+C K+ IIWYD
Sbjct: 66 NG----FYNATAGQSPDVAYGLFLCRGDVAIDDCRDCVANASAEILQQCSGVKKAIIWYD 121
Query: 131 QCLLRYSNRSIFSTMDTVPYVSLLNTQNVTDRGRFNQILASLMSQVVNQAVNNS--RKFA 188
QC+L YSNRSIFS ++ P + L N QNVTD G FNQ++ M+ A N+ +KFA
Sbjct: 122 QCMLHYSNRSIFSRVEENPMLQLYNLQNVTDPGPFNQLVVDTMNATATLAANDESGKKFA 181
Query: 189 TRTANFTALQTLYSLAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYE 248
T+ NFT QTLYSL QCTPDLS +DC+ CL+ AI L CCSGK GA+ L PSC RYE
Sbjct: 182 TKEENFTGSQTLYSLVQCTPDLSIADCSKCLEGAIGALSLCCSGKQGARTLTPSCNARYE 241
Query: 249 FYPFYNLSA-------TSPPPPAPVLLPPPPPG---------SARGKSGISSSTIIAIVA 292
YPFY L A P A VLLPPPP S GK GISS TI+ IV
Sbjct: 242 LYPFYQLEAGPLAPALAPAPTSATVLLPPPPAPSSKSSATEPSTEGKGGISSKTIVIIVV 301
Query: 293 PIAVTAVLFIVGLCY-FIRK-AKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFST 350
P V+ V+F + LCY FIR+ AK +Y+ + N + +ITT +SLQFD TI+ ATNNFS
Sbjct: 302 PTFVSVVIFSI-LCYCFIRRCAKKRYDTLEAENVEFNITTEQSLQFDLATIQAATNNFSD 360
Query: 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGF 410
NK+GEGGFG VYKG L SGQEIA+KRLS+SSGQG EFKNEVVLVAKLQHRNLVRLLGF
Sbjct: 361 HNKIGEGGFGAVYKGTLSSGQEIAIKRLSKSSGQGAVEFKNEVVLVAKLQHRNLVRLLGF 420
Query: 411 CLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRII 470
CLEGEEKILVYE+VPNKSLDYFL++P+K+ QLDWSRRYKIIGGIARGILYLHEDSRLR+I
Sbjct: 421 CLEGEEKILVYEYVPNKSLDYFLFDPDKRGQLDWSRRYKIIGGIARGILYLHEDSRLRVI 480
Query: 471 HRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVK 530
HRDLKASN+LLD +MNPKISDFGMA+IFGVDQTQGNTNR+VGTYGYM+PEYAMHG+FSVK
Sbjct: 481 HRDLKASNVLLDGDMNPKISDFGMARIFGVDQTQGNTNRVVGTYGYMSPEYAMHGRFSVK 540
Query: 531 SDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSY 564
SDVYSFGVLVLEII+GK+++ F+++D A DLLSY
Sbjct: 541 SDVYSFGVLVLEIISGKRSNCFHESDQAEDLLSY 574
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721533|ref|NP_001238492.1| cysteine-rich protein precursor [Glycine max] gi|223452302|gb|ACM89479.1| cysteine-rich protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 684 bits (1764), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/543 (63%), Positives = 412/543 (75%), Gaps = 15/543 (2%)
Query: 32 AADPTYAYHVCSA-NFTGNSTYQTNRNLLLSSLPTNASRGNGYSSGFYNETTG---QDPN 87
++ P Y YH CS N T NS YQ N LL+SL +NA+ ++ F N T G +
Sbjct: 25 SSTPVYLYHNCSGGNTTANSAYQLNLRTLLTSLSSNAT-----TTEFSNNTVGLGTSPSD 79
Query: 88 KVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCLLRYSNRSIFSTMDT 147
+VYGLF+CRGD ++ CQ CV AT L +C KQ +IWYD+C +RYSNRS FST+DT
Sbjct: 80 RVYGLFMCRGDVPSALCQQCVVNATGRLRSQCSLAKQAVIWYDECTVRYSNRSFFSTVDT 139
Query: 148 VPYVSLLNTQNVTDRGRFNQILASLMSQVVNQAVNNS---RKFATRTANFTALQTLYSLA 204
P V LLNT N++++ F ++L +++ ++A N S +K+A AN + Q+LY LA
Sbjct: 140 RPRVGLLNTANISNQDSFMRLLFQTINRTADEAANFSVGLKKYAVNQANISGFQSLYCLA 199
Query: 205 QCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYPFYNLSATSPPPPA 264
QCTPDLS +C CL I +LP CC GK G +VL PSC VRYE YPFY ++A+ P
Sbjct: 200 QCTPDLSQENCRSCLSGVIGDLPWCCQGKQGGRVLYPSCNVRYELYPFYRVTASPPSSSP 259
Query: 265 PVLLPPPPPGS--ARGKSGISSSTIIAIVAPIAVTAVLFIVGLCYFIRKAKNKYN-AVPE 321
PPP S + G SGIS+ TI+AIV PI V ++FIVG+C+ R+A+ K +V E
Sbjct: 260 SPPTLLPPPTSPISPGSSGISAGTIVAIVVPITVAVLIFIVGICFLSRRARKKQQGSVKE 319
Query: 322 VNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRS 381
DI T++SLQFDF TIE ATN FS DNKLGEGGFGEVYKG L SGQ +AVKRLS+S
Sbjct: 320 GKTAYDIPTVDSLQFDFSTIEAATNKFSADNKLGEGGFGEVYKGTLSSGQVVAVKRLSKS 379
Query: 382 SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ 441
SGQGG+EFKNEVV+VAKLQHRNLVRLLGFCL+GEEKILVYE+VPNKSLDY L++PEKQ++
Sbjct: 380 SGQGGEEFKNEVVVVAKLQHRNLVRLLGFCLQGEEKILVYEYVPNKSLDYILFDPEKQRE 439
Query: 442 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501
LDW RRYKIIGGIARGI YLHEDSRLRIIHRDLKASNILLD +MNPKISDFGMA+IFGVD
Sbjct: 440 LDWGRRYKIIGGIARGIQYLHEDSRLRIIHRDLKASNILLDGDMNPKISDFGMARIFGVD 499
Query: 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADL 561
QTQGNT+RIVGTYGYMAPEYAMHG+FSVKSDVYSFGVL++EI++GKKNSSFYQTDGA DL
Sbjct: 500 QTQGNTSRIVGTYGYMAPEYAMHGEFSVKSDVYSFGVLLMEILSGKKNSSFYQTDGAEDL 559
Query: 562 LSY 564
LSY
Sbjct: 560 LSY 562
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474717|ref|XP_002267916.2| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/541 (64%), Positives = 408/541 (75%), Gaps = 20/541 (3%)
Query: 35 PTYAYHVC--SANFTGNSTYQTNRNLLLSSLPTNASRGNGYSSGFYNETTGQDPNKV-YG 91
P Y YH+C + F NS+Y+TN N LSSL +NA+R +GFYN T G+ P V YG
Sbjct: 22 PGYLYHICPNTTTFNPNSSYETNLNFALSSLSSNATR----DTGFYNVTAGRTPPDVAYG 77
Query: 92 LFLCRGDQTASSCQDCVTFATRDLV-QRCPDGKQTIIWYDQCLLRYSNRSIFSTMDTVPY 150
LFLCRGD T+ CQDCV A + V QRC KQ IIWYD+C+LRYSN S FS + P
Sbjct: 78 LFLCRGDVTSQVCQDCVATAVNETVRQRCRGFKQAIIWYDECMLRYSNESFFSQVSESPR 137
Query: 151 VSLLNTQNVTDRGRFNQILASLMSQVVNQAVNNS--RKFATRTANFTALQTLYSLAQCTP 208
VS+ NTQN+T+ +FNQ+L + + QAVN+ +KFAT+ NFT Q +YSL QCTP
Sbjct: 138 VSMWNTQNITEPDQFNQVLGDTLDSIRTQAVNDQSGKKFATKEENFTGFQRVYSLVQCTP 197
Query: 209 DLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYPFYNLSATSPPPPAPVLL 268
DLS C+ CL IA LP+CC GK GA+VL PSC VRYE YPFY S P
Sbjct: 198 DLSPDQCDRCLIGTIAILPDCCGGKQGARVLFPSCNVRYELYPFYQ----SVAAPPSPPP 253
Query: 269 PPPPPGSARGKSGISSSTIIAIVAPIAVTAVLFIVGLCY-FIRK-AKNKYNAVPEVNADN 326
P S GK GISS TI+ IV P V+ V+F + LCY FIR+ AK +Y+ + N +
Sbjct: 254 ARPSEPSTEGKGGISSKTIVIIVVPTFVSVVIFSI-LCYCFIRRCAKKRYDTLEAENVEF 312
Query: 327 DITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGG 386
+ITT +SLQFD TI+ ATNNFS NK+GEGGFG VYKG L SGQEIA+KRLS+SSGQG
Sbjct: 313 NITTEQSLQFDLATIQAATNNFSDHNKIGEGGFGAVYKGTLSSGQEIAIKRLSKSSGQGA 372
Query: 387 QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY---EPEKQQQLD 443
EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE+VPNKSLDYFL+ +P K+ QLD
Sbjct: 373 VEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDYFLFGLAQPTKRGQLD 432
Query: 444 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503
WSRRYKIIGGIARGILYLHEDSRLR+IHRDLKASN+LLD +MNPKISDFGMA+IFGVDQT
Sbjct: 433 WSRRYKIIGGIARGILYLHEDSRLRVIHRDLKASNVLLDGDMNPKISDFGMARIFGVDQT 492
Query: 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLS 563
QGNTNR+VGTYGYM+PEYAMHG+FSVKSDVYSFGVLVLEII+GK+++ F+++D A DLLS
Sbjct: 493 QGNTNRVVGTYGYMSPEYAMHGRFSVKSDVYSFGVLVLEIISGKRSNCFHESDQAEDLLS 552
Query: 564 Y 564
Y
Sbjct: 553 Y 553
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113935|ref|XP_002316618.1| predicted protein [Populus trichocarpa] gi|222859683|gb|EEE97230.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 675 bits (1742), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/546 (62%), Positives = 423/546 (77%), Gaps = 13/546 (2%)
Query: 30 TAAADPTYAYHVC--SANFTGNSTYQTNRNLLLSSLPTNASRGNGYSSGFYNETTGQDPN 87
T A DPT+ Y C + FT NSTYQ N NLLLSSL +NA+R N +GFYN + GQDP+
Sbjct: 20 TQAQDPTFLYPYCPNTTTFTRNSTYQANLNLLLSSLSSNATRNN--INGFYNVSAGQDPD 77
Query: 88 KVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCLLRYSNRSIFSTMDT 147
VYG+FLCRGD + S C++CV FA +D+++RCP K +IW+D+C LRYSNR+IFST+D
Sbjct: 78 AVYGMFLCRGDVSNSVCRNCVNFAAKDVLERCPIEKVAMIWFDECELRYSNRNIFSTVDQ 137
Query: 148 VPYVSLLNTQNVTDR-GRFNQILASLMSQVVNQAVN---NSRKFATRTANFTALQTLYSL 203
+ +++ NVT + RFNQ++ + ++ + +A + ++KFA + N+T +Q LY+L
Sbjct: 138 DFTLFMMSPNNVTVQPDRFNQLVETTINDIAARAASAPSGAKKFAVQQVNYTGIQKLYTL 197
Query: 204 AQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYPFYNLSATSPPPP 263
QCTPDLS+ DC+ CLQ AI++L NCC+ K G +VL SC RYE Y FYN +A + P
Sbjct: 198 VQCTPDLSTPDCSRCLQGAISKLGNCCNRKQGGRVLFASCNFRYELYEFYNATAAAEAAP 257
Query: 264 APVLLP-----PPPPGSARGKSGISSSTIIAIVAPIAVTAVLFIVGLCYFIRKAKNKYNA 318
P + P + +GK G+S+ IIAI+ P+ V+ VLF +G C+ R+AK+ N+
Sbjct: 258 PPPPVALSPPPTSGPETRKGKGGVSTVLIIAILIPVTVSLVLFCLGFCFLSRRAKSNKNS 317
Query: 319 VPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL 378
E + N+IT +ESLQFD +I+ ATN+FS DNKLGEGGFGEVYKG LP+GQ IAVKRL
Sbjct: 318 AQENDVGNEITNVESLQFDLSSIQDATNHFSADNKLGEGGFGEVYKGTLPNGQAIAVKRL 377
Query: 379 SRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEK 438
S+ SGQG EFKNEV+LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF+++PEK
Sbjct: 378 SKGSGQGAAEFKNEVILVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFVFDPEK 437
Query: 439 QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498
Q LDWS+RYKIIGGIARGILYLHEDSRLR+IHRDLKASNILLD +MN K+SDFGMA+IF
Sbjct: 438 QGLLDWSKRYKIIGGIARGILYLHEDSRLRVIHRDLKASNILLDGDMNAKVSDFGMARIF 497
Query: 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGA 558
GVDQTQG TNRIVGTYGYM+PEYAMHGQFSVKSD YSFGVL+LEII+GKKNSSFYQT GA
Sbjct: 498 GVDQTQGCTNRIVGTYGYMSPEYAMHGQFSVKSDAYSFGVLILEIISGKKNSSFYQTGGA 557
Query: 559 ADLLSY 564
ADL SY
Sbjct: 558 ADLASY 563
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575777|ref|XP_003556013.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1721), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/563 (58%), Positives = 413/563 (73%), Gaps = 12/563 (2%)
Query: 9 SKFFMLFLFVIYLSISFQSSFTAAADPTYAYHVCSAN-FTGNSTYQTNRNLLLSSLPTNA 67
S F ++FLFV+ +SF + A PT+ C +N T NST+Q N L SSL +NA
Sbjct: 5 SSFKLIFLFVLVNFLSFATP-KAQQVPTFLAQDCPSNGTTANSTFQINIRTLFSSLSSNA 63
Query: 68 SRGNGYSSGFYNETT-GQDP-NKVYGLFLCRGDQTASSCQDCVTFATRDLVQ--RCPDGK 123
+ N FYN T G +P + VYGLF+CRGD C CV AT+ L +C K
Sbjct: 64 TANNV----FYNSTVAGANPSDTVYGLFMCRGDVPFQLCGQCVINATQKLSSDLQCSLSK 119
Query: 124 QTIIWYDQCLLRYSNRSIFSTMDTVPYVSLLNTQNVTDRGRFNQILASLMSQVVNQAVNN 183
Q +IWYD+C++RYSNRS FST+DT P + LLN+ N++++ F +++ M++ ++A
Sbjct: 120 QAVIWYDECMVRYSNRSFFSTVDTRPAIGLLNSANISNQANFMRLMFDTMNETADEAAIG 179
Query: 184 SRKFATRTANFTALQTLYSLAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSC 243
++K+AT+ AN + QTLY L QCTPDLS+ C CL AI LP CC GK G ++L PSC
Sbjct: 180 AKKYATKQANISGFQTLYCLVQCTPDLSTQGCRSCLSDAIGLLPWCCEGKQGGRILNPSC 239
Query: 244 IVRYEFYPFYNLSATSPPPPAPVLLPPPPPGS--ARGKSGISSSTIIAIVAPIAVTAVLF 301
VRY+ YPFY + ++PP P G+ + G S IS TI+AIV PI V +LF
Sbjct: 240 NVRYDLYPFYRTNVSAPPASVPPTDSSNSGGNIISYGGSEISPGTIVAIVVPITVAVLLF 299
Query: 302 IVGLCYFIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGE 361
IVG+ ++A K N+ + + +I+ +ESL+FDF TIE AT+ FS NKLGEGGFGE
Sbjct: 300 IVGIWLLSKRAAKKRNSAQDPKTETEISAVESLRFDFSTIEAATDKFSDANKLGEGGFGE 359
Query: 362 VYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421
VYKG+LPSGQE+AVKRLS++SGQGG EFKNEV +VAKLQH+NLVRLLGFCLEGEEKILVY
Sbjct: 360 VYKGLLPSGQEVAVKRLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVY 419
Query: 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 481
EFV NKSLDY L++PEKQ+ LDW+RRYKI+ GIARGI YLHEDSRL+IIHRDLKASN+LL
Sbjct: 420 EFVANKSLDYILFDPEKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLL 479
Query: 482 DAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVL 541
D +MNPKISDFGMA+IFGVDQTQ NTNRIVGTYGYM+PEYAMHG++S KSDVYSFGVL+L
Sbjct: 480 DGDMNPKISDFGMARIFGVDQTQANTNRIVGTYGYMSPEYAMHGEYSAKSDVYSFGVLIL 539
Query: 542 EIITGKKNSSFYQTDGAADLLSY 564
EII+GK+NSSFY+TD A DLLSY
Sbjct: 540 EIISGKRNSSFYETDVAEDLLSY 562
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496581|ref|XP_002270035.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 665 bits (1715), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/536 (60%), Positives = 407/536 (75%), Gaps = 10/536 (1%)
Query: 35 PTYAYHVCS--ANFTGNSTYQTNRNLLLSSLPTNASRGNGYSSGFYNETTGQDPNKVYGL 92
PT Y C+ +N+ NSTYQ++ N+LL+SL ++A+ NG F+N T GQ P+ VYGL
Sbjct: 26 PTLLYSFCTENSNYVPNSTYQSSLNVLLTSLSSDATILNGRK--FHNTTAGQAPDMVYGL 83
Query: 93 FLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCLLRYSNRSIFSTMDTVPYVS 152
+LCRGD T + CQDCV A+++++ +CP+ K+ + WYDQC+LRYSNRSIFS M+ P ++
Sbjct: 84 YLCRGDVTDAVCQDCVQTASQEILTKCPNRKEALSWYDQCMLRYSNRSIFSIMEERPMLT 143
Query: 153 LLNTQNVTDRGRFNQILASLMSQVVNQAVNNSRK---FATRTANFTALQTLYSLAQCTPD 209
+ N+ ++ D RF+QI+ M ++ +A +NS + F T ANF A +Y L QCTPD
Sbjct: 144 MSNSLDMDDPDRFDQIVNKTMVGLIEKATHNSSERDMFETGEANFNASTKIYGLVQCTPD 203
Query: 210 LSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYPFYNLSATSPPPPAPVLLP 269
LS S+C+ CL+ + + NCC GK GA++L+PSC RYE YPFY + P
Sbjct: 204 LSGSNCSTCLENIFSRITNCCLGKQGARILVPSCNFRYELYPFYG--DLAAATPPAPAPS 261
Query: 270 PPPPGSARGKSGISSSTIIAIVAPIAVTAVLF-IVGLCYFIRKAKNKYNAVPEVNADNDI 328
P S GK G SS +IAI+ P+AV+ V+F I+ C+ RKAK KY++ E +NDI
Sbjct: 262 PLSLLSPPGKKGNSSQLLIAIIVPVAVSVVIFSILCYCFICRKAKKKYSSTEEEKVENDI 321
Query: 329 TTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQE 388
TT++SLQFDF T+E ATNNFS DNK+GEGGFG+VYKG L SG+EIA+KRLSRSS QG E
Sbjct: 322 TTVQSLQFDFGTLEAATNNFSDDNKIGEGGFGDVYKGTLSSGKEIAIKRLSRSSAQGAVE 381
Query: 389 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRY 448
FKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE+VPNKSLD FL++P+KQ QLDWSRRY
Sbjct: 382 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDCFLFDPDKQGQLDWSRRY 441
Query: 449 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTN 508
KIIGGIARGILYLHEDS+L++IHRDLKASN+LLD +MNPKISDFGMA+IFG DQT+G+T
Sbjct: 442 KIIGGIARGILYLHEDSQLKVIHRDLKASNVLLDGDMNPKISDFGMARIFGGDQTRGSTK 501
Query: 509 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSY 564
R+VGTYGYM+PEYAM G FS KSDVYSFGVLVLEII+GKK S FY++D DLL Y
Sbjct: 502 RVVGTYGYMSPEYAMRGHFSAKSDVYSFGVLVLEIISGKKISHFYESDQTEDLLGY 557
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575779|ref|XP_003556014.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1709), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/561 (59%), Positives = 412/561 (73%), Gaps = 13/561 (2%)
Query: 9 SKFFMLFLFVIYLSISFQSSFTAAADPTYAYHVCSAN-FTGNSTYQTNRNLLLSSLPTNA 67
S F ++FLFV+ +SF + A PT+ C +N T NST+Q N L SSL +NA
Sbjct: 5 SSFKLIFLFVLVNFLSFATP-KAQQVPTFLAQDCPSNGTTANSTFQINIRTLFSSLSSNA 63
Query: 68 SRGNGYSSGFYNETT-GQDP-NKVYGLFLCRGDQTASSCQDCVTFATRDLVQ--RCPDGK 123
+ N FYN T G +P + VYGLF+CRGD C CV AT+ L +C K
Sbjct: 64 TANNV----FYNSTVAGANPSDTVYGLFMCRGDVPFQLCGQCVINATQKLSSDLQCSLSK 119
Query: 124 QTIIWYDQCLLRYSNRSIFSTMDTVPYVSLLNTQNVTDRGRFNQILASLMSQVVNQAVNN 183
Q +IWYD+C++RYSNRS FST+DT P + LLN+ N++++ F +++ M++ ++A
Sbjct: 120 QAVIWYDECMVRYSNRSFFSTVDTRPAIGLLNSANISNQANFMRLMFDTMNETADEAAIG 179
Query: 184 SRKFATRTANFTALQTLYSLAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSC 243
++K+AT+ AN + QTLY L QCTPDLS+ C CL AI LP CC GK G ++L PSC
Sbjct: 180 AKKYATKQANISGFQTLYCLVQCTPDLSTQGCRSCLSDAIGLLPWCCEGKQGGRILNPSC 239
Query: 244 IVRYEFYPFYNLSATSPPPPAPVLLPPPPPGSARGKSGISSSTIIAIVAPIAVTAVLFIV 303
VRY+ YPFY + ++PP P P S G S IS TI+AIV PI V +LFIV
Sbjct: 240 NVRYDLYPFYRTNVSAPPASVP---PTDSSNSGGGGSEISPGTIVAIVVPITVAVLLFIV 296
Query: 304 GLCYFIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVY 363
G+ ++A K N+ + + +I+ +ESL+FDF TIE AT+ FS NKLGEGGFGEVY
Sbjct: 297 GIWLLSKRAAKKRNSAQDPKTETEISAVESLRFDFSTIEAATDKFSDANKLGEGGFGEVY 356
Query: 364 KGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423
KG+LPSGQE+AVKRLS++SGQGG EFKNEV +VAKLQH+NLVRLLGFCLEGEEKILVYEF
Sbjct: 357 KGLLPSGQEVAVKRLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEF 416
Query: 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 483
V NKSLDY L++PEKQ+ LDW+RRYKI+ GIARGI YLHEDSRL+IIHRDLKASN+LLD
Sbjct: 417 VANKSLDYILFDPEKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLLDG 476
Query: 484 EMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 543
+MNPKISDFGMA+IFGVDQTQ NTNRIVGTYGYM+PEYAMHG++S KSDVYSFGVL+LEI
Sbjct: 477 DMNPKISDFGMARIFGVDQTQANTNRIVGTYGYMSPEYAMHGEYSAKSDVYSFGVLILEI 536
Query: 544 ITGKKNSSFYQTDGAADLLSY 564
I+GK+NSSFY+TD A DLLSY
Sbjct: 537 ISGKRNSSFYETDVAEDLLSY 557
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 573 | ||||||
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.947 | 0.811 | 0.574 | 6e-167 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.947 | 0.804 | 0.556 | 3.6e-160 | |
| TAIR|locus:2121626 | 830 | CRK23 "cysteine-rich RLK (RECE | 0.439 | 0.303 | 0.733 | 4.6e-150 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.952 | 0.807 | 0.514 | 8.1e-147 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.944 | 0.820 | 0.515 | 5.1e-145 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.923 | 0.820 | 0.522 | 5.5e-141 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.949 | 0.804 | 0.506 | 7.2e-139 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.438 | 0.375 | 0.742 | 6.5e-138 | |
| TAIR|locus:2121691 | 667 | CRK11 "cysteine-rich RLK (RECE | 0.460 | 0.395 | 0.711 | 1.9e-136 | |
| TAIR|locus:2141762 | 665 | CRK26 "cysteine-rich RLK (RECE | 0.954 | 0.822 | 0.477 | 1.2e-131 |
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1624 (576.7 bits), Expect = 6.0e-167, P = 6.0e-167
Identities = 323/562 (57%), Positives = 399/562 (70%)
Query: 9 SKFFMLFLFVIYLSISFQSSFTAAA-DPTYAYHVC--SANFTGNSTYQTNRNLLLSSLPT 65
S FF LFLF SF +SF +A DPTY YH C +AN+T NSTY N LL+SL
Sbjct: 16 SSFFFLFLF------SFLTSFRVSAQDPTYVYHTCQNTANYTSNSTYNNNLKTLLASL-- 67
Query: 66 NASRGNGYSSGFYNETTGQDPNKVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQT 125
+SR YS+GF N T GQ P++V GLF CRGD + C+ CV+FA D + RCP+ K+
Sbjct: 68 -SSRNASYSTGFQNATVGQAPDRVTGLFNCRGDVSTEVCRRCVSFAVNDTLTRCPNQKEA 126
Query: 126 IIWYDQCLLRYSNRSIFSTMDTVPYVSLLNTQNVTDR--GRFNQILASLMSQVVNQAVNN 183
++YD+C+LRYSN++I ST+ T V L+NT+NVT + ++ ++Q A+N+
Sbjct: 127 TLYYDECVLRYSNQNILSTLITTGGVILVNTRNVTSNQLDLLSDLVLPTLNQAATVALNS 186
Query: 184 SRKFATRTANFTALQTLYSLAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSC 243
S+KF TR NFTALQ+ Y L QCTPDL+ DC+ CLQ I ++P + + GA+++ PSC
Sbjct: 187 SKKFGTRKNNFTALQSFYGLVQCTPDLTRQDCSRCLQLVINQIP---TDRIGARIINPSC 243
Query: 244 IVRYEFYPFYNXXXXXXXXXXXXXXXXXXXXXXR-GKSGXXXXXXXXXXXXXXXXXXLFI 302
RYE Y FY R GK G LFI
Sbjct: 244 TSRYEIYAFYTESAVPPPPPPPSISTPPVSAPPRSGKDGNSKVLVIAIVVPIIVAVLLFI 303
Query: 303 VGLCYFIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEV 362
G C+ R+A+ Y P A +DITT +SLQ D+ TI+ AT++F NK+G+GGFGEV
Sbjct: 304 AGYCFLTRRARKSYYT-PSAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEV 362
Query: 363 YKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422
YKG L G E+AVKRLS+SSGQG EFKNEVVLVAKLQHRNLVRLLGFCL+GEE++LVYE
Sbjct: 363 YKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYE 422
Query: 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 482
+VPNKSLDYFL++P K+ QLDW+RRYKIIGG+ARGILYLH+DSRL IIHRDLKASNILLD
Sbjct: 423 YVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLD 482
Query: 483 AEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE 542
A+MNPKI+DFGMA+IFG+DQT+ NT+RIVGTYGYM+PEYAMHGQ+S+KSDVYSFGVLVLE
Sbjct: 483 ADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLE 542
Query: 543 IITGKKNSSFYQTDGAADLLSY 564
II+GKKNSSFYQTDGA DL+SY
Sbjct: 543 IISGKKNSSFYQTDGAHDLVSY 564
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1560 (554.2 bits), Expect = 3.6e-160, P = 3.6e-160
Identities = 312/561 (55%), Positives = 384/561 (68%)
Query: 16 LFVIYLSISFQSSFTAAADPTYAYHVC--SANFTGNSTYQTNRNLLLSSLPTNASRGNGY 73
LF ++L F T +DPTY YH+C + ++ NS+Y TN +LSSL +S Y
Sbjct: 11 LFSVFL---FMILKTVTSDPTYLYHICPNTTTYSRNSSYLTNLRTVLSSL---SSPNAAY 64
Query: 74 SSGFYNETTGQ--DPNKVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQ 131
+S F N G+ D N+VYG+FLCRGD +A C+DCV FA + +QRCP K +IWYD+
Sbjct: 65 ASLFDNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWYDE 124
Query: 132 CLLRYSNRSIFSTMDTVPYVSLLNTQNVTDR--GRFNQILASLMSQVVNQAVNNSRKFAT 189
C++RYSN+SI M P V L N QN+T+ RFN+ L +L+ V +A +SRKFAT
Sbjct: 125 CMVRYSNQSIVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRKFAT 184
Query: 190 RTANFTALQTLYSLAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEF 249
ANFT QT+YSL QCTPDL++ DC CL+ I LP CC G +V+ PSC RYE
Sbjct: 185 EKANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYEL 244
Query: 250 YPFYNXXXXXXXXXXXXXXXXXX----XXXXRGKSGXXXXXXXXXXXXXXXXXXLFIVGL 305
YPFYN +GK G L + +
Sbjct: 245 YPFYNETIAAAPMAPPPSSTVTAPPLNIPSEKGK-GKNLTVIVTAIAVPVSVCVLLLGAM 303
Query: 306 CYFI-RKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYK 364
C+ + R+ NK +A E ++ IT+ E+LQF F IE ATN FS NKLG GGFGEVYK
Sbjct: 304 CWLLARRRNNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYK 363
Query: 365 GVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424
G L +G+ +A+KRLS+ S QG +EFKNEV +VAKLQHRNL +LLG+CL+GEEKILVYEFV
Sbjct: 364 GQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFV 423
Query: 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE 484
PNKSLDYFL++ EK++ LDW RRYKII GIARGILYLH DSRL IIHRDLKASNILLDA+
Sbjct: 424 PNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDAD 483
Query: 485 MNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 544
M+PKISDFGMA+IFGVDQTQ NT RIVGTYGYM+PEYA+HG++SVKSDVYSFGVLVLE+I
Sbjct: 484 MHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELI 543
Query: 545 TGKKNSSFYQTDGAADLLSYV 565
TGKKNSSFY+ DG DL++YV
Sbjct: 544 TGKKNSSFYEEDGLGDLVTYV 564
|
|
| TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 965 (344.8 bits), Expect = 4.6e-150, Sum P(2) = 4.6e-150
Identities = 187/255 (73%), Positives = 219/255 (85%)
Query: 313 KNKYNAVPEVNADN--DITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSG 370
K K V E A+N ITT SLQFDF+ I ATNNF NKLG+GGFGEVYKG PSG
Sbjct: 471 KRKDTEVTEPLAENGDSITTAGSLQFDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSG 530
Query: 371 QEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 430
++AVKRLS++SGQG +EF+NEVV+VAKLQHRNLVRLLG+CLEGEEKILVYEFV NKSLD
Sbjct: 531 VQVAVKRLSKTSGQGEREFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLD 590
Query: 431 YFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 490
YFL++ ++QLDW+RRYKIIGGIARGILYLH+DSRL IIHRDLKA NILLDA+MNPK++
Sbjct: 591 YFLFDTTMKRQLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVA 650
Query: 491 DFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550
DFGMA+IFG+DQT+ NT R+VGTYGYMAPEYAM+GQFS+KSDVYSFGVLV EII+G KNS
Sbjct: 651 DFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNS 710
Query: 551 SFYQTDGA-ADLLSY 564
S YQ D + ++L++Y
Sbjct: 711 SLYQMDDSVSNLVTY 725
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1434 (509.9 bits), Expect = 8.1e-147, P = 8.1e-147
Identities = 288/560 (51%), Positives = 372/560 (66%)
Query: 14 LFLFVIYLSISFQSSFTAAA-DPTYAYHVCS--ANFTGNSTYQTNRNLLLSSLPTNASRG 70
L F+ SF +SF A+A +P Y H C ++ NSTY TN LLSS ASR
Sbjct: 15 LICFIFLFLFSFLTSFKASAQNPFYLNHDCPNRTTYSSNSTYSTNLKTLLSSF---ASRN 71
Query: 71 NGYSSGFYNETTGQDPNKVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYD 130
YS+GF N GQ P++V GLFLCRGD + C +CV F+ + + RCP+ ++ + +Y+
Sbjct: 72 ASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYE 131
Query: 131 QCLLRYSNRSIFSTMDTVPYVSLLNTQNVTD----RGRFNQILASLMSQVVNQAVNNSRK 186
+C+LRYS+++ ST+ + + N N++ R +F ++ S M+Q N+A N+SRK
Sbjct: 132 ECILRYSHKNFLSTVTYEGELIMRNPNNISSIQNQRDQFIDLVQSNMNQAANEAANSSRK 191
Query: 187 FATRTANFTALQTLYSLAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVR 246
F+T T+LQTLY L QCTPDL+ DC CL ++I + + GA+ PSC R
Sbjct: 192 FSTIKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSINRMMPLF--RIGARQFWPSCNSR 249
Query: 247 YEFYPFYNXXXXXXXXXXXXXXXXXXXXXXRGKSGXXXXXXXXXXXXXXXXXXLFI--VG 304
YE Y FYN G LFI VG
Sbjct: 250 YELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPGKSGNSTVLVVAIVVLAVLLFIALVG 309
Query: 305 LCYFIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYK 364
C+ ++ K ++ +D+ T +SLQ D+ TI+ ATN+F+ NK+G GGFGEVYK
Sbjct: 310 YCFLAQRTKKTFDTASASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYK 369
Query: 365 GVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424
G +G+E+AVKRLS++S QG EFK EVV+VAKLQHRNLVRLLGF L+GEE+ILVYE++
Sbjct: 370 GTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYM 429
Query: 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE 484
PNKSLD L++P KQ QLDW +RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA+
Sbjct: 430 PNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDAD 489
Query: 485 MNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 544
+NPKI+DFGMA+IFG+DQTQ NT+RIVGTYGYMAPEYAMHGQFS+KSDVYSFGVLVLEII
Sbjct: 490 INPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEII 549
Query: 545 TGKKNSSFYQTDGAADLLSY 564
+G+KNSSF ++DGA DLL++
Sbjct: 550 SGRKNSSFDESDGAQDLLTH 569
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1417 (503.9 bits), Expect = 5.1e-145, P = 5.1e-145
Identities = 288/559 (51%), Positives = 377/559 (67%)
Query: 14 LFLFVIYLSISFQSSFTAAA-DPTYAYHVC--SANFTGNSTYQTNRNLLLSSLPTNASRG 70
LF F+ SF +SF A+A DP + + C + ++ NSTY TN LLSSL +SR
Sbjct: 4 LFPFIFLFLFSFLTSFRASAQDPRFLAYYCPNATTYSSNSTYLTNLKTLLSSL---SSRN 60
Query: 71 NGYSSGFYNETTGQDPNKVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYD 130
YS+GF N T GQ ++V GLFLCRGD + C++CVTFA + RCP+ ++ + +Y+
Sbjct: 61 ASYSTGFQNATVGQALDRVTGLFLCRGDVSPEVCRNCVTFAVNNTFSRCPNQREAVFYYE 120
Query: 131 QCLLRYSNRSIFSTMDTVPYVSLLNTQN----VTDR-GRFNQILASLMSQVVNQAVNNSR 185
+C+LRYS+++I ST T +L N + ++ +F ++ S M+Q+ +A +N R
Sbjct: 121 ECILRYSHKNILSTAITNEGEFILRNPNHISPIQNQINQFTNLVLSNMNQIAIEAADNPR 180
Query: 186 KFATRTANFTALQTLYSLAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIV 245
KF+T TALQT Y L QCTPDLS +C CL ++I +P + GA+ PSC
Sbjct: 181 KFSTIKTELTALQTFYGLVQCTPDLSRQNCMNCLTSSINRMP---FSRIGARQFWPSCNS 237
Query: 246 RYEFYPFYNXXXXXXXXXXXXXXXXXXXXXXRGKSGXXXXXXXXXXXXXXXXXXLFIVGL 305
RYE Y FYN KSG +FI G
Sbjct: 238 RYELYDFYNETAIGTPPPPLPPLASPSLSD---KSGNSNVVVVAVVVPIIVAVLIFIAGY 294
Query: 306 CYFIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKG 365
C+F ++AK Y P ++ D D TT+ESLQ D+ I+ ATN+FS +NK+G GGFG+VYKG
Sbjct: 295 CFFAKRAKKTYGTTPALDED-DKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKG 353
Query: 366 VLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425
+G E+AVKRLS++S QG EFKNEVV+VA L+H+NLVR+LGF +E EE+ILVYE+V
Sbjct: 354 TFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVE 413
Query: 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 485
NKSLD FL++P K+ QL W++RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA+M
Sbjct: 414 NKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADM 473
Query: 486 NPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
NPKI+DFGMA+IFG+DQTQ NT+RIVGTYGYM+PEYAM GQFS+KSDVYSFGVLVLEII+
Sbjct: 474 NPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIIS 533
Query: 546 GKKNSSFYQTDGAADLLSY 564
G+KN+SF +TD A DL+++
Sbjct: 534 GRKNNSFIETDDAQDLVTH 552
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1379 (490.5 bits), Expect = 5.5e-141, P = 5.5e-141
Identities = 291/557 (52%), Positives = 374/557 (67%)
Query: 18 VIYLSISFQSSFTAAADPT-YAYHVCSAN--FTGNSTYQTNRNLLLSSLPT-NASRGNGY 73
+ ++ + SS TA+A T Y YH CS F+ NSTY TN LLSSL + NAS Y
Sbjct: 5 ISFIFLFLFSSITASAQNTFYLYHNCSVTTTFSSNSTYSTNLKTLLSSLSSLNAS---SY 61
Query: 74 SSGFYNETTGQDPNKVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCL 133
S+GF T GQ P++V GLFLCR D ++ C+ CVTFA + + RCP K+ + +Y+QCL
Sbjct: 62 STGFQTATAGQAPDRVTGLFLCRVDVSSEVCRSCVTFAVNETLTRCPKDKEGVFYYEQCL 121
Query: 134 LRYSNRSIFSTMDTVPYVSLLNTQNVTD--RGRFNQILASLMSQVVNQAVNNSRKFATRT 191
LRYSNR+I +T++T + + + +N + +F ++ + M+ +A + +K+A R
Sbjct: 122 LRYSNRNIVATLNTDGGMFMQSARNPLSVKQDQFRDLVLTPMNLAAVEAARSFKKWAVRK 181
Query: 192 ANFTALQTLYSLAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYP 251
+ A Q+LY + +CTPDL DC CL+ I ++ K G ++L+PSC RY+ Y
Sbjct: 182 IDLNASQSLYGMVRCTPDLREQDCLDCLKIGINQVTY---DKIGGRILLPSCASRYDNYA 238
Query: 252 FYNXXXXXXXXXXXXXXXXXXXXXXRGKSGXXXXXXXXXXXXXXXXXXLFIVGLCYFIRK 311
FYN GK G LF++ + F +
Sbjct: 239 FYNESNVGTPQDSSPRP---------GKGGNSSVIIIAVVVPITV---LFLLLVAVFSVR 286
Query: 312 AKNK--YNAVPEVNAD-NDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLP 368
AKNK N V D NDITT SLQFDF+ IE ATN F NKLG+GGFGEVYKG L
Sbjct: 287 AKNKRTLNEKEPVAEDGNDITTAGSLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLS 346
Query: 369 SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS 428
SG ++AVKRLS++SGQG +EF+NEVV+VAKLQHRNLV+LLG+CLEGEEKILVYEFVPNKS
Sbjct: 347 SGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKS 406
Query: 429 LDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 488
LD+FL++ + +LDW+RRYKIIGGIARGILYLH+DSRL IIHRDLKA NILLD +MNPK
Sbjct: 407 LDHFLFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPK 466
Query: 489 ISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548
I+DFGMA+IFG+DQT+ T R+VGTYGYM+PEYAM+GQFS+KSDVYSFGVLVLEII+G K
Sbjct: 467 IADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMK 526
Query: 549 NSSFYQTD-GAADLLSY 564
NSS YQ D +L++Y
Sbjct: 527 NSSLYQMDESVGNLVTY 543
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1359 (483.5 bits), Expect = 7.2e-139, P = 7.2e-139
Identities = 292/577 (50%), Positives = 371/577 (64%)
Query: 11 FFMLFLFVIYLSISFQSSFTAAADPTYAY--HVCSAN---FTGNSTYQTNRNLLLSSLPT 65
FF LF F+++LS + S +A + + H C ++ ++ NSTY TN LLSSL
Sbjct: 3 FFWLFPFLLHLSFADSLSPLSAPVQNFIHLNHSCPSSILTYSRNSTYFTNLKTLLSSL-- 60
Query: 66 NASRGNGYSSGFYNETTGQDPNKVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQT 125
+SR YS+GF T GQ P++V GLFLCRGD + C++CV F+ ++ + CP K+
Sbjct: 61 -SSRNASYSTGFQTATAGQAPDRVTGLFLCRGDVSQEVCRNCVAFSVKETLYWCPYNKEV 119
Query: 126 IIWYDQCLLRYSNRSIFSTMDTVPYVSLLNTQNVTDRGRFNQI--LASLMSQVVN----Q 179
+++YD+C+LRYS+R+I ST+ LLN N++ + NQ+ L+S +N +
Sbjct: 120 VLYYDECMLRYSHRNILSTVTYDGSAILLNGANISSSNQ-NQVDEFRDLVSSTLNLAAVE 178
Query: 180 AVNNSRKFATRTANFTALQTLYSLAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVL 239
A N+S+KF TR T Q LY L QCTPDL+ DC CLQ +I + + G +
Sbjct: 179 AANSSKKFYTRKV-ITP-QPLYLLVQCTPDLTRQDCLRCLQKSIKGMSLY---RIGGRFF 233
Query: 240 IPSCIVRYEFYPFYNXXXXXXXXXXXXXXXXXXXX----------XXRGKSGXXXXXXXX 289
PSC RYE Y FYN RGK G
Sbjct: 234 YPSCNSRYENYSFYNETATRSSSPPSLPPRSTPQQQLKLAPPPLISERGK-GRNSSVIIV 292
Query: 290 XXXXXXXXXXLFIVGLCYFIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFS 349
LF+ +K + Y P +DITT SLQFDF+ IE ATN F
Sbjct: 293 VVVPIIALLLLFVAFFSLRAKKTRTNYEREPLTEESDDITTAGSLQFDFKAIEAATNKFC 352
Query: 350 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLG 409
NKLG+GGFGEVYKG+ PSG ++AVKRLS++SGQG +EF NEV++VAKLQHRNLVRLLG
Sbjct: 353 ETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLG 412
Query: 410 FCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRI 469
FCLE +E+ILVYEFVPNKSLDYF+++ Q LDW+RRYKIIGGIARGILYLH+DSRL I
Sbjct: 413 FCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTI 472
Query: 470 IHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSV 529
IHRDLKA NILL +MN KI+DFGMA+IFG+DQT+ NT RIVGTYGYM+PEYAM+GQFS+
Sbjct: 473 IHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSM 532
Query: 530 KSDVYSFGVLVLEIITGKKNSSFYQTDG--AADLLSY 564
KSDVYSFGVLVLEII+GKKNS+ YQ DG A +L++Y
Sbjct: 533 KSDVYSFGVLVLEIISGKKNSNVYQMDGTSAGNLVTY 569
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 6.5e-138, Sum P(2) = 6.5e-138
Identities = 187/252 (74%), Positives = 214/252 (84%)
Query: 311 KAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSG 370
+ K Y EV A ++ITT SLQF F+TIE AT+ FS N +G GGFGEVY+G L SG
Sbjct: 309 RRKKSYKTT-EVQATDEITTTHSLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSG 367
Query: 371 QEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 430
E+AVKRLS++SGQG +EFKNE VLV+KLQH+NLVRLLGFCLEGEEKILVYEFVPNKSLD
Sbjct: 368 PEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLD 427
Query: 431 YFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 490
YFL++P KQ +LDW+RRY IIGGIARGILYLH+DSRL IIHRDLKASNILLDA+MNPKI+
Sbjct: 428 YFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIA 487
Query: 491 DFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550
DFGMA+IFGVDQ+Q NT RI GT+GYM+PEYAM G FS+KSDVYSFGVLVLEII+GKKNS
Sbjct: 488 DFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNS 547
Query: 551 SFYQTDGAADLL 562
SFY D + L
Sbjct: 548 SFYNIDDSGSNL 559
|
|
| TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 995 (355.3 bits), Expect = 1.9e-136, Sum P(2) = 1.9e-136
Identities = 192/270 (71%), Positives = 229/270 (84%)
Query: 300 LFIVGLCYFIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGF 359
L ++G F R+ K+ Y + +++DI+T +SL +DF+TIE ATN FST NKLGEGGF
Sbjct: 305 LLVLGFVLF-RRRKS-YQRT-KTESESDISTTDSLVYDFKTIEAATNKFSTSNKLGEGGF 361
Query: 360 GEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419
G VYKG L +G ++AVKRLS+ SGQG +EF+NE VLV KLQHRNLVRLLGFCLE EE+IL
Sbjct: 362 GAVYKGKLSNGTDVAVKRLSKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQIL 421
Query: 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479
+YEFV NKSLDYFL++PEKQ QLDW+RRYKIIGGIARGILYLH+DSRL+IIHRDLKASNI
Sbjct: 422 IYEFVHNKSLDYFLFDPEKQSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNI 481
Query: 480 LLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 539
LLDA+MNPKI+DFG+A IFGV+QTQGNTNRI GTY YM+PEYAMHGQ+S+KSD+YSFGVL
Sbjct: 482 LLDADMNPKIADFGLATIFGVEQTQGNTNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGVL 541
Query: 540 VLEIITGKKNSSFYQTDG---AADLLSYVS 566
VLEII+GKKNS YQ D A +L++Y S
Sbjct: 542 VLEIISGKKNSGVYQMDETSTAGNLVTYAS 571
|
|
| TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1291 (459.5 bits), Expect = 1.2e-131, P = 1.2e-131
Identities = 270/566 (47%), Positives = 359/566 (63%)
Query: 13 MLFLFVIYLSISFQ-SSFTAAADPTYAYHVCS---ANFTGNSTYQTNRNLLLSSLPTNAS 68
ML L + +S+ FQ FT + P +CS NFT N+ Y N + L+SSL ++
Sbjct: 1 MLSLLLPLISLLFQIQCFTVKSQPVPLNQICSNVTGNFTVNTPYAVNLDRLISSL--SSL 58
Query: 69 RGNGYSSGFYNETTGQDPNKVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIW 128
R N +GFYN + G KV + CRGD C +C+ A + LV CP K+ IIW
Sbjct: 59 RRN--VNGFYNISVGDSDEKVNSISQCRGDVKLEVCINCIAMAGKRLVTLCPVQKEAIIW 116
Query: 129 YDQCLLRYSNRSIFSTMDTVPYVSLLNTQNVT-DRGRFNQILASLMSQVVNQA--VNNSR 185
YD+C RYSNR+IF+ ++ P+ S+ T+N T DR + + L L+ + N+A + S+
Sbjct: 117 YDKCTFRYSNRTIFNRLEISPHTSITGTRNFTGDRDSWEKSLRGLLEGLKNRASVIGRSK 176
Query: 186 K-FATRTANFTALQTLYSLAQCTPDLSSSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCI 244
K F + + QTL+ L QCTPD+S DC+ CL IA++P+CC K G+ V+ PSC+
Sbjct: 177 KNFVVGETSGPSFQTLFGLVQCTPDISEEDCSYCLSQGIAKIPSCCDMKMGSYVMSPSCM 236
Query: 245 VRYEFYPFYNXXXXXXXXXXXXXXXXXXXXXXR----GKSGXXXXXXXXXXXXXXXXXXL 300
+ Y + FY+ R G L
Sbjct: 237 LAYAPWRFYDPVDTDDPSSVPATPSRPPKNETRSVTQGDKNRGVPKALIFASASVAIVVL 296
Query: 301 FIVGLCYFIRKAKNKYNAVPEVNA-DNDITTLESLQFDFETIEVATNNFSTDNKLGEGGF 359
FIV L F+ K + K N N +N+ + +S++FDF ++ AT++FS +NKLGEGGF
Sbjct: 297 FIVLLVVFL-KLRRKENIRNSENKHENENISTDSMKFDFSVLQDATSHFSLENKLGEGGF 355
Query: 360 GEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419
G VYKGVL GQ+IAVKRLS+++ QG EFKNE +LVAKLQHRNLV+LLG+ +EG E++L
Sbjct: 356 GAVYKGVLSDGQKIAVKRLSKNAQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLL 415
Query: 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479
VYEF+P+ SLD F+++P + +L+W RYKIIGG+ARG+LYLH+DSRLRIIHRDLKASNI
Sbjct: 416 VYEFLPHTSLDKFIFDPIQGNELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNI 475
Query: 480 LLDAEMNPKISDFGMAKIFGVDQT-QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGV 538
LLD EM PKI+DFGMA++F +D T Q TNRIVGT+GYMAPEY MHGQFS K+DVYSFGV
Sbjct: 476 LLDEEMTPKIADFGMARLFDIDHTTQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGV 535
Query: 539 LVLEIITGKKNSSFYQTDGAADLLSY 564
LVLEII+GKKNS F D DL+S+
Sbjct: 536 LVLEIISGKKNSGFSSEDSMGDLISF 561
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9M0X5 | CRK25_ARATH | 2, ., 7, ., 1, 1, ., - | 0.5706 | 0.9476 | 0.8044 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00001153001 | SubName- Full=Chromosome chr2 scaffold_113, whole genome shotgun sequence; (663 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 573 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-42 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-39 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-38 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-36 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-33 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 2e-33 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-32 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-32 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-30 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-29 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-29 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-29 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-29 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-27 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-26 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-26 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-26 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-26 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 1e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-25 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-25 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-24 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-23 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-23 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-21 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-20 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-18 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 1e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 5e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| pfam01163 | 186 | pfam01163, RIO1, RIO1 family | 0.002 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 9e-54
Identities = 81/204 (39%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 351 DNKLGEGGFGEVYKGVL-----PSGQEIAVKRL-SRSSGQGGQEFKNEVVLVAKLQHRNL 404
KLGEG FGEVYKG L E+AVK L +S Q +EF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 405 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED 464
V+LLG C E E +V E++ L +L + + L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE-- 119
Query: 465 SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT---YGYMAPEY 521
IHRDL A N L+ + KISDFG+++ D + R G +MAPE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174
Query: 522 AMHGQFSVKSDVYSFGVLVLEIIT 545
G+F+ KSDV+SFGVL+ EI T
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 3e-53
Identities = 81/204 (39%), Positives = 110/204 (53%), Gaps = 17/204 (8%)
Query: 351 DNKLGEGGFGEVYKGVL-----PSGQEIAVKRL-SRSSGQGGQEFKNEVVLVAKLQHRNL 404
KLGEG FGEVYKG L E+AVK L +S Q +EF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 405 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED 464
V+LLG C E E ++V E++P L +L + ++ L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE-- 120
Query: 465 SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT---YGYMAPEY 521
IHRDL A N L+ + KISDFG+++ D + ++ G +MAPE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPES 175
Query: 522 AMHGQFSVKSDVYSFGVLVLEIIT 545
G+F+ KSDV+SFGVL+ EI T
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 8e-53
Identities = 72/194 (37%), Positives = 107/194 (55%), Gaps = 11/194 (5%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG-QEFKNEVVLVAKLQHRNLVRLLGFC 411
LGEGGFG VY +G+++A+K + + +E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 412 LEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 471
+ LV E+ SL L E + +L +I+ I G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 472 RDLKASNILLDA-EMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSV 529
RDLK NILLD+ K++DFG++K+ D++ T IVGT YMAPE + G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 530 KSDVYSFGVLVLEI 543
KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 3e-51
Identities = 80/221 (36%), Positives = 113/221 (51%), Gaps = 30/221 (13%)
Query: 353 KLGEGGFGEVYKGVL-----PSGQEIAVKRLSRSSGQGG-QEFKNEVVLVAKLQHRNLVR 406
KLGEG FGEVYKG L + ++AVK L + + +EF E ++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 407 LLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSR 466
LLG C +GE +V E++P L FL + ++L ++ IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES--- 120
Query: 467 LRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQGNTNRIVGTYGY-----MAPE 520
+HRDL A N L+ + KISDFG+++ I+ D + G MAPE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR------KRGGGKLPIKWMAPE 174
Query: 521 YAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSSFYQ 554
G+F+ KSDV+SFGVL+ EI T G N +
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE 215
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 5e-50
Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE-FKNEVVLVAKLQHRNLV 405
+ KLGEG FG+VY +G+ +A+K + + + +E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
RL + ++ LV E+ L L + + D +R Y + I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFY--LRQILSALEYLHS-- 115
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG 525
I+HRDLK NILLD + + K++DFG+A+ VGT YMAPE +
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGK 171
Query: 526 QFSVKSDVYSFGVLVLEIITGK 547
+ D++S GV++ E++TGK
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-49
Identities = 74/199 (37%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 353 KLGEGGFGEVYKGVLPS-GQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLG 409
KLG G FG VYK G+ +AVK L + S + Q + E+ ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 410 FCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRI 469
+ + LV E+ L +L + L KI I RG+ YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 470 IHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE-YAMHGQFS 528
IHRDLK NILLD KI+DFG+AK + + VGT YMAPE +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 529 VKSDVYSFGVLVLEIITGK 547
K DV+S GV++ E++TGK
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 3e-49
Identities = 77/206 (37%), Positives = 108/206 (52%), Gaps = 16/206 (7%)
Query: 352 NKLGEGGFGEVYKGVL--PSGQEI--AVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVR 406
KLGEG FGEVYKG L G+ AVK L S + ++F E ++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 407 LLGFCLEGEEKILVYEFVPNKSLDYFL------YEPEKQQQLDWSRRYKIIGGIARGILY 460
LLG C E E LV E++ L +L + ++ L IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQGNTNRIVGTYGYMAP 519
L + +HRDL A N L+ ++ KISDFG+++ ++ D + T + +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 520 EYAMHGQFSVKSDVYSFGVLVLEIIT 545
E G F+ KSDV+SFGVL+ EI T
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 8e-42
Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 352 NKLGEGGFGEVYKGVLP-SGQEIAVK--RLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLL 408
LG G FG VY + +G+ +AVK LS S + + + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 409 GFCLEGEEK-ILVY-EFVPNKSLDYFLYEPEKQQQLDWS--RRYKIIGGIARGILYLHED 464
G + E+ + ++ E+V SL L +K +L R+Y I G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKY--TRQILEGLAYLH-- 118
Query: 465 SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH 524
I+HRD+K +NIL+D++ K++DFG AK G +T T + GT +MAPE
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 525 GQFSVKSDVYSFGVLVLEIITGK 547
++ +D++S G V+E+ TGK
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 7e-39
Identities = 73/198 (36%), Positives = 111/198 (56%), Gaps = 6/198 (3%)
Query: 348 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRL 407
F+ + KLG G FGEV++G+ + +A+K L Q+F+ EV + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRL 467
C GE ++ E + SL FL PE Q L + + +A G+ YL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF 527
IHRDL A NIL+ ++ K++DFG+A++ D + +I Y + APE A HG F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 528 SVKSDVYSFGVLVLEIIT 545
S KSDV+SFG+L+ E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 4e-38
Identities = 71/206 (34%), Positives = 114/206 (55%), Gaps = 21/206 (10%)
Query: 354 LGEGGFGEVYKGV-LPSGQ----EIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRL 407
LG G FG VYKGV +P G+ +A+K L + + +E +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPE----KQQQLDWSRRYKIIGGIARGILYLHE 463
LG CL + L+ + +P L ++ + Q L+W + IA+G+ YL E
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM 523
R++HRDL A N+L+ + KI+DFG+AK+ VD+ + + +MA E +
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 524 HGQFSVKSDVYSFGVLVLEIIT-GKK 548
H ++ KSDV+S+GV V E++T G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 7e-37
Identities = 75/212 (35%), Positives = 110/212 (51%), Gaps = 22/212 (10%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
E+ + + KLG G FGEV+ G ++AVK L + + F E ++ KL+H
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRH 60
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEK-----QQQLDWSRRYKIIGGIAR 456
LV+L C E E +V E++ SL FL E Q +D + + IA
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQ------IAE 114
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ---TQGNTNRIVGT 513
G+ YL IHRDL A NIL+ + KI+DFG+A++ D+ +G I T
Sbjct: 115 GMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT 171
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
APE A +G+F++KSDV+SFG+L+ EI+T
Sbjct: 172 ----APEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 70/212 (33%), Positives = 107/212 (50%), Gaps = 31/212 (14%)
Query: 348 FSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVR 406
F K+G+GGFGEVYK +G+E+A+K + S + ++ NE+ ++ K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 407 LLGFCLEGEEKILVYEFVPNKSLDYFLYE-----PEKQQQLDWSRRYKIIGGIARGIL-- 459
G L+ +E +V EF SL L E Q I + + +L
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----------IAYVCKELLKG 110
Query: 460 --YLHEDSRLRIIHRDLKASNILL--DAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG 515
YLH IIHRD+KA+NILL D E+ K+ DFG++ N +VGT
Sbjct: 111 LEYLHS---NGIIHRDIKAANILLTSDGEV--KLIDFGLSAQL---SDTKARNTMVGTPY 162
Query: 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
+MAPE + K+D++S G+ +E+ GK
Sbjct: 163 WMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 70/211 (33%), Positives = 110/211 (52%), Gaps = 17/211 (8%)
Query: 352 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSRSSGQGGQ-EFKNEVVLVAKLQHRNLV 405
+LGEG FG+V +G+++AVK L+ S + + +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 406 RLLGFCLEGEEKI--LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
+ G C + + L+ E++P+ SL +L + Q++ R I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT--QGNTNRIVGTYGYMAPEY 521
R IHRDL A NIL+++E KISDFG+AK+ D+ + Y APE
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 522 AMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551
+FS SDV+SFGV + E+ T G + S
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 69/195 (35%), Positives = 99/195 (50%), Gaps = 21/195 (10%)
Query: 354 LGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE 413
+G+G FG+V G GQ++AVK L S Q F E ++ L+H NLV+LLG L+
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 414 GEEKILVYEFVPNKSLDYFLYEP-----EKQQQLDWSRRYKIIGGIARGILYLHEDSRLR 468
G +V E++ SL +L QQL ++ + G+ YL E
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD------VCEGMEYLEEK---N 122
Query: 469 IIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFS 528
+HRDL A N+L+ ++ K+SDFG+AK Q G + APE +FS
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL-----PVKWTAPEALREKKFS 177
Query: 529 VKSDVYSFGVLVLEI 543
KSDV+SFG+L+ EI
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 69/219 (31%), Positives = 112/219 (51%), Gaps = 32/219 (14%)
Query: 354 LGEGGFGEVYKGVLPSGQE------IAVKRLSRSSGQGGQE-FKNEVVLVAKLQHRNLVR 406
LGEG FG+V+ G + +AVK L ++ ++ F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 407 LLGFCLEGEEKILVYEFVPNKSLDYFL-----------YEPEKQQQLDWSRRYKIIGGIA 455
G C EG+ I+V+E++ + L+ FL +L S+ +I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 456 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQGNTNRIVGT- 513
G++YL + +HRDL N L+ ++ KI DFGM++ ++ D R+ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY-----RVGGHT 184
Query: 514 ---YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 548
+M PE M+ +F+ +SDV+SFGV++ EI T GK+
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 35/216 (16%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQ--EFKNEVVLVAKLQHRN 403
N+ + +G G FG VYKG+ L +G +A+K++S + E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGG---------- 453
+V+ +G + ++ E+ N SL + K G
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSL---------------RQIIKKFGPFPESLVAVYV 105
Query: 454 --IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
+ +G+ YLHE +IHRD+KA+NIL + K++DFG+A ++ + +V
Sbjct: 106 YQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVV 160
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
GT +MAPE S SD++S G V+E++TG
Sbjct: 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 48/108 (44%), Positives = 67/108 (62%), Gaps = 7/108 (6%)
Query: 39 YHVCSANFTG-----NSTYQTNRNLLLSSLPTNASRGNGYSSGFYNETTGQDPNKVYGLF 93
+H+CS+N +G NST+++N N LLSSL +NA+ +G GF T+G P+ VYGL
Sbjct: 1 FHLCSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSG--KGFAAGTSGAAPDTVYGLA 58
Query: 94 LCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCLLRYSNRSI 141
CRGD +AS C+ C+ A +L + CP+ K IWYD C LRY +
Sbjct: 59 QCRGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 9e-33
Identities = 74/207 (35%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 352 NKLGEGGFGEVYKGV--LPSGQEI--AVKRLSRSSGQGG-QEFKNEVVLVAKLQHRNLVR 406
+LG G FG V KGV + SG+E+ AVK L + G +EF E ++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 407 LLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLD---WSRRYKIIGGIARGILYLHE 463
L+G C GE +LV E P L +L + + D + + +A G+ YL
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG-----YMA 518
+HRDL A N+LL KISDFGM++ G G+ T G + A
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGA----GSDYYRATTAGRWPLKWYA 166
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIIT 545
PE +G+FS KSDV+S+GV + E +
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 19/202 (9%)
Query: 353 KLGEGGFGEVYKGVL-PSGQEIAVKRL-SRSSGQGGQEFKNEVVLVAKLQHRNLVRLLG- 409
LG+G G VYK P+G+ A+K++ + ++ E+ + + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 410 FCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL----YLHEDS 465
F EGE I V E++ SL L + K ++ IAR IL YLH +
Sbjct: 68 FYKEGEISI-VLEYMDGGSLADLLKKVGK-----IPEP--VLAYIARQILKGLDYLH--T 117
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG 525
+ IIHRD+K SN+L++++ KI+DFG++K+ ++ T N VGT YM+PE
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTYMSPERIQGE 175
Query: 526 QFSVKSDVYSFGVLVLEIITGK 547
+S +D++S G+ +LE GK
Sbjct: 176 SYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 70/211 (33%), Positives = 113/211 (53%), Gaps = 25/211 (11%)
Query: 354 LGEGGFGEVYKG--VLPSGQE----IAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVR 406
LGEG FG+VYKG P+ + +A+K L + + QEF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 407 LLGFCLEGEEKILVYEFVPNKSLDYFL-------------YEPEKQQQLDWSRRYKIIGG 453
LLG C + + +++E++ + L FL + + LD S I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQGNTNRIVG 512
IA G+ YL S +HRDL A N L+ + KISDFG+++ I+ D + + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 513 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 543
+M PE ++G+F+ +SD++SFGV++ EI
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 66/209 (31%), Positives = 114/209 (54%), Gaps = 18/209 (8%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL-SRSSGQGGQEFKNEVVLVAKLQ 400
+ + + +G G FGEV +G L P +EI A+K L + SS + +F E ++ +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
H N++RL G + +++ E++ N SLD FL E + + + ++ GIA G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKY 121
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF----GVDQTQGNTNRIVGTYGY 516
L S + +HRDL A NIL+++ + K+SDFG+++ T+G I T
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT--- 175
Query: 517 MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
APE + +F+ SDV+SFG+++ E+++
Sbjct: 176 -APEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 2e-31
Identities = 71/213 (33%), Positives = 107/213 (50%), Gaps = 17/213 (7%)
Query: 347 NFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSR---SSGQGGQEFKNEVVLVAKLQH-R 402
++ KLGEG FGEVY + +A+K L++ S + + F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 403 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLH 462
N+V+L F + LV E+V SL+ L + ++ L S I+ I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 463 EDSRLRIIHRDLKASNILLDAEMN-PKISDFGMAKIFGVDQT----QGNTNRIVGTYGYM 517
IIHRD+K NILLD + K+ DFG+AK+ + + VGT GYM
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 518 APEYAMH---GQFSVKSDVYSFGVLVLEIITGK 547
APE + S SD++S G+ + E++TG
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 70/211 (33%), Positives = 110/211 (52%), Gaps = 22/211 (10%)
Query: 354 LGEGGFGEVY----KGVLPSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVR 406
LG+G FG+V K +G+ A+K L + + + E +++++ H +V+
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 407 LLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
L + + EEK+ LV E+ P L L + E + + +R Y I + YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSK-EGRFSEERARFY--AAEIVLALEYLH--- 110
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG 525
L II+RDLK NILLDA+ + K++DFG+AK + ++ NT GT Y+APE +
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGK 168
Query: 526 QFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
+ D +S GVL+ E++TGK FY D
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK--PPFYAED 197
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 73/218 (33%), Positives = 109/218 (50%), Gaps = 21/218 (9%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SRSSGQGGQEFKNEVV 394
EV ++ + LG G FGEVY+G+ ++AVK L S Q +F E +
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE----PEKQQQLDWSRRYKI 450
+++K H+N+VRL+G E + ++ E + L FL E PE+ L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 451 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMAK-IFGVDQTQG 505
+A+G YL E+ IHRD+ A N LL + P KI+DFGMA+ I+ +
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRK 177
Query: 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 543
R + +M PE + G F+ K+DV+SFGVL+ EI
Sbjct: 178 G-GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 75/205 (36%), Positives = 107/205 (52%), Gaps = 24/205 (11%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLS-RSSGQGGQE----FKNEVVLVAKLQHRNLVRL 407
LG G FG VY+G+ L G AVK +S GQ GQE + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYFLYE----PEKQQQLDWSRRYKIIGGIARGILYLHE 463
LG E + + E VP SL L + PE +L ++R+ I G+ YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL-YTRQ------ILLGLEYLHD 120
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM 523
+HRD+K +NIL+D K++DFGMAK G+ +MAPE
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 524 H-GQFSVKSDVYSFGVLVLEIITGK 547
G + + +D++S G VLE+ TGK
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 64/196 (32%), Positives = 104/196 (53%), Gaps = 12/196 (6%)
Query: 353 KLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412
KLG G FGEV++G+ + +AVK L + ++F E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 413 EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 472
E +V E + SL +L + + L + + +A G+ YL + IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 473 DLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT---YGYMAPEYAMHGQFSV 529
DL A N+L+ K++DFG+A++ D + G + APE A++ +FS+
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSI 183
Query: 530 KSDVYSFGVLVLEIIT 545
KSDV+SFG+L+ EI+T
Sbjct: 184 KSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 74/208 (35%), Positives = 114/208 (54%), Gaps = 15/208 (7%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
EV KLG G FGEV+ G ++A+K L + S + F E L+ +LQH
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQH 60
Query: 402 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
LVRL + + +E I ++ E++ N SL FL PE + L ++ + IA G+ +
Sbjct: 61 PRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAF 117
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ---TQGNTNRIVGTYGYM 517
+ R IHRDL+A+NIL+ + KI+DFG+A++ ++ +G I T
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT---- 170
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEIIT 545
APE +G F++KSDV+SFG+L+ EI+T
Sbjct: 171 APEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 352 NKLGEGGFGEVYKGV-LPSGQEIAVKR--LSRSSGQGGQEFKNEVVLVAKLQHRNLVRLL 408
++G+G FG+VY G+ +K LS S + ++ NEV ++ KL H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 409 GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ-------LDWSRRYKIIGGIARGILYL 461
E + +V E+ L + + +K+ + LDW + + + YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKYL 119
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY 521
H +I+HRD+K NI L + K+ DFG++K+ T +VGT Y++PE
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPEL 174
Query: 522 AMHGQFSVKSDVYSFGVLVLEIITGKK 548
+ ++ KSD++S G ++ E+ T K
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 59/195 (30%), Positives = 108/195 (55%), Gaps = 9/195 (4%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFC 411
K+GEG GEVYK +G+E+A+K++ R Q + NE++++ +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 412 LEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 471
L G+E +V E++ SL + + + ++ + + + +G+ YLH +IH
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIITQNFVR--MNEPQIAYVCREVLQGLEYLH---SQNVIH 139
Query: 472 RDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKS 531
RD+K+ NILL + + K++DFG A ++++ N+ +VGT +MAPE + K
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKV 197
Query: 532 DVYSFGVLVLEIITG 546
D++S G++ +E+ G
Sbjct: 198 DIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 73/210 (34%), Positives = 113/210 (53%), Gaps = 22/210 (10%)
Query: 354 LGEGGFGEVYKG----VLPSG---QEIAVKRLSR-SSGQGGQEFKNEVVLVAKLQHRNLV 405
LG G FGEVY+G +L G +AVK L + ++ Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ----LDWSRRYKIIGGIARGILYL 461
+LLG CL E + ++ E + L +L + ++ L I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 462 HEDSRLRIIHRDLKASNILL-----DAEMNPKISDFGMAK-IFGVDQTQGNTNRIVGTYG 515
++ IHRDL A N L+ DA+ KI DFG+A+ I+ D + ++
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+MAPE + G+F+ +SDV+SFGVL+ EI+T
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 76/220 (34%), Positives = 127/220 (57%), Gaps = 21/220 (9%)
Query: 354 LGEGGFGEVYKGV-LPSGQEI----AVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRL 407
LG G FG VYKG+ +P G+ + A+K L+ ++G + EF +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPE----KQQQLDWSRRYKIIGGIARGILYLHE 463
LG CL + LV + +P+ L +++E + Q L+W + IA+G++YL E
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM 523
R++HRDL A N+L+ + + KI+DFG+A++ D+ + N + +MA E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 524 HGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLL 562
+ +F+ +SDV+S+GV + E++T G K T DLL
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-28
Identities = 74/222 (33%), Positives = 121/222 (54%), Gaps = 26/222 (11%)
Query: 353 KLGEGGFGEVY----KGVLPSGQE--IAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVR 406
+LGEG FG+V+ +LP + +AVK L +S Q+F+ E L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 407 LLGFCLEGEEKILVYEFVPNKSLDYFL--YEPEKQ----------QQLDWSRRYKIIGGI 454
G C EG ++V+E++ + L+ FL + P+ + QL + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 455 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQGNTNRIVGT 513
A G++YL + L +HRDL N L+ + KI DFGM++ I+ D + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG-GRTMLP 187
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQ 554
+M PE ++ +F+ +SD++SFGV++ EI T GK+ +YQ
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ--PWYQ 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 353 KLGEGGFGEVYKGVLPSGQEIAVK--RLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGF 410
K+G+G FG+VYKGVL E+AVK R + ++F E ++ + H N+V+L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIGV 60
Query: 411 CLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRII 470
C++ + +V E VP SL FL + + +L + ++ A G+ YL +S+ I
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYL--ESK-NCI 115
Query: 471 HRDLKASNILLDAEMNPKISDFGMAK--IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFS 528
HRDL A N L+ KISDFGM++ G+ +I + APE +G+++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYT 173
Query: 529 VKSDVYSFGVLVLEIITG 546
+SDV+S+G+L+ E +
Sbjct: 174 SESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 19/219 (8%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGV---LPSGQ---EIAVKRLS-RSSGQGGQEFKNEVV 394
E+ + +LG+G FG VY+G+ + G+ +A+K ++ +S + EF NE
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS 61
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE--PEKQQQ-----LDWSRR 447
++ + ++VRLLG G+ ++V E + L +L PE + +
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 448 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQGN 506
++ IA G+ YL + +HRDL A N ++ ++ KI DFGM + I+ D +
Sbjct: 122 IQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
++ +MAPE G F+ KSDV+SFGV++ E+ T
Sbjct: 179 GKGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 71/212 (33%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 347 NFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSRSSGQGGQ-EFKNEVVLVAKL 399
N LG G FGEV+ KG+ G E + VK L ++ + Q EF+ E+ + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 400 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL------YEPEKQQQLDWSRRYKIIGG 453
H+N+VRLLG C E E ++ E+ L FL E K L ++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
IA G+ +L S R +HRDL A N L+ ++ K+S ++K + N ++
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-P 181
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
++APE FS KSDV+SFGVL+ E+ T
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 32/212 (15%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVR 406
F KLGEG +G VYK + +GQ +A+K + + QE E+ ++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 407 LLGFCLEGEEKILVYEF-----------VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIA 455
G + + +V E+ + NK+L E++ I+
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT------EEEIAA-------ILYQTL 109
Query: 456 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG 515
+G+ YLH + IHRD+KA NILL+ E K++DFG++ T N ++GT
Sbjct: 110 KGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT--DTMAKRNTVIGTPF 164
Query: 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
+MAPE ++ K+D++S G+ +E+ GK
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 67/209 (32%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 353 KLGEGGFGEVYKG--VLPSGQEI--AVKRLSRSSGQGG-QEFKNEVVLVAKLQHRNLVRL 407
KLG+G FG V +G G+ I AVK L +F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQL---------DWSRRYKIIGGIARGI 458
G L +V E P SL + ++ L D++ + IA G+
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQ------IANGM 110
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV--DQTQGNTNRIVGTYGY 516
YL R IHRDL A NILL ++ KI DFG+ + D + V + +
Sbjct: 111 RYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAW 166
Query: 517 MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
APE FS SDV+ FGV + E+ T
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-27
Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 354 LGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE 413
LG G FG V+ G ++A+K + R +F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 414 GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD 473
+V E++ N L +L E + + +W + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 474 LKASNILLDAEMNPKISDFGMAKIFGVDQ---TQGNTNRIVGTYGYMAPEYAMHGQFSVK 530
L A N L+ + K+SDFG+A+ DQ +QG + + PE + +FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV----KWAPPEVFDYSRFSSK 181
Query: 531 SDVYSFGVLVLEIITGKK 548
SDV+SFGVL+ E+ + K
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 69/220 (31%), Positives = 109/220 (49%), Gaps = 16/220 (7%)
Query: 352 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN---EVVLVAKLQHRNLVRL 407
+LG G G V K + P+G+ +AVK + + K E+ ++ K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGF 64
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRL 467
G + + E++ SLD L E Q ++ KI + +G+ YLHE
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEK--H 120
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF 527
+IIHRD+K SNIL+++ K+ DFG++ V+ + T VGT YMAPE +
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VN-SLAKTF--VGTSSYMAPERIQGNDY 176
Query: 528 SVKSDVYSFGVLVLEIITGKKNSSFYQT--DGAADLLSYV 565
SVKSD++S G+ ++E+ TG+ DG +LL Y+
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 70/211 (33%), Positives = 113/211 (53%), Gaps = 22/211 (10%)
Query: 354 LGEGGFGEV----YKGVLPS-GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLL 408
LG+G FG V Y + + G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 409 GFCLE-GEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSR 466
G C G + LV E++P SL +L + +++LD + I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYL---GS 126
Query: 467 LRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ-----TQGNTNRIVGTYGYMAPEY 521
R +HRDL NIL+++E KI DFG+ K+ D+ + + I + APE
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WYAPES 182
Query: 522 AMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551
+FSV SDV+SFGV++ E+ T K+ S
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFTYSDKSCS 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 71/241 (29%), Positives = 110/241 (45%), Gaps = 42/241 (17%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL----- 399
++F +GEG F V + +E A+K L + Q +E K + V + K
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58
Query: 400 -QHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLD--WSRRYKIIGGIA 455
H +++L + + EE + V E+ PN L ++ K LD +R Y I
Sbjct: 59 NGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFY--AAEIL 112
Query: 456 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ------------- 502
+ YLH IIHRDLK NILLD +M+ KI+DFG AK+ +
Sbjct: 113 LALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 503 TQGNTNRI-----VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK---KNSSFYQ 554
+Q NR VGT Y++PE SD+++ G ++ +++TGK + S+ Y
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 555 T 555
T
Sbjct: 230 T 230
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 67/212 (31%), Positives = 105/212 (49%), Gaps = 14/212 (6%)
Query: 352 NKLGEGGFGEVYKGV-LPSGQEIAVK--RLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLL 408
NK+G G FG+VY V L +G+ +AVK R+ + + +E +E+ ++ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 409 GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLR 468
G + E+ + E+ +L+ L E + R Y + + G+ YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTL--QLLEGLAYLHSH---G 119
Query: 469 IIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ--GNTNRIVGTYGYMAPEYAMHGQ 526
I+HRD+K +NI LD K+ DFG A + T + GT YMAPE G+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 527 FSVK---SDVYSFGVLVLEIITGKKNSSFYQT 555
+D++S G +VLE+ TGK+ S
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 71/208 (34%), Positives = 115/208 (55%), Gaps = 15/208 (7%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
E+ + KLG G FGEV+ G ++AVK L + + F E ++ KL+H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRH 60
Query: 402 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
LV+L + + EE I +V E++ SL FL + E + L + +A G+ Y
Sbjct: 61 DKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAY 117
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ---TQGNTNRIVGTYGYM 517
+ R+ IHRDL+++NIL+ + KI+DFG+A++ ++ QG I T
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT---- 170
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEIIT 545
APE A++G+F++KSDV+SFG+L+ E++T
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 69/208 (33%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRLSR-SSGQGGQEFKNEVVLVAKLQH 401
F LG G FG VYKG+ +P G+++ A+K L +S + +E +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYEPEK---QQQLDWSRRYKIIGGIARG 457
++ RLLG CL + L+ + +P L DY + Q L+W + IA+G
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYM 517
+ YL E R++HRDL A N+L+ + KI+DFG+AK+ G D+ + + +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEIIT 545
A E +H ++ +SDV+S+GV V E++T
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 65/232 (28%), Positives = 111/232 (47%), Gaps = 33/232 (14%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYK----GVLPSGQE---IAVKRLSR-SSGQGGQEFKNEV 393
E NN +G+G FG V++ G+LP + +AVK L +S +F+ E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQADFQREA 59
Query: 394 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------------Y 434
L+A+ H N+V+LLG C G+ L++E++ L+ FL
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 435 EPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494
L + + I +A G+ YL E + +HRDL N L+ M KI+DFG+
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL 176
Query: 495 A-KIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ I+ D + + N + +M PE + +++ +SDV+++GV++ EI +
Sbjct: 177 SRNIYSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 66/204 (32%), Positives = 112/204 (54%), Gaps = 9/204 (4%)
Query: 347 NFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKR--LSRSSGQGGQEFKNEVVLVAKLQHRN 403
+F NK+G+G FG V+K V + + A+K+ LS+ + + +E +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
++R L+ + +V E+ N L L + ++ + L + ++ I G+ +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM 523
+I+HRD+K+ N+ LDA N KI D G+AK+ + NT IVGT Y++PE
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCE 174
Query: 524 HGQFSVKSDVYSFGVLVLEIITGK 547
++ KSDV++ GV++ E TGK
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 73/208 (35%), Positives = 117/208 (56%), Gaps = 15/208 (7%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
E+ + D KLG+G FGEV+ G ++A+K L + + F E ++ KL+H
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRH 60
Query: 402 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
LV L + + EE I +V EF+ SL FL E + + L + + IA G+ Y
Sbjct: 61 DKLVPL--YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAY 117
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ---TQGNTNRIVGTYGYM 517
+ R+ IHRDL+A+NIL+ + KI+DFG+A++ ++ QG I +
Sbjct: 118 IE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI----KWT 170
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEIIT 545
APE A++G+F++KSDV+SFG+L+ E++T
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-26
Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 19/202 (9%)
Query: 353 KLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412
++G G FG V+ G +++A+K + R ++F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 413 EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIG---GIARGILYLHEDSRLRI 469
E LV+EF+ + L +L + Q+ +S+ ++G + G+ YL + +
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL----RAQRGKFSQE-TLLGMCLDVCEGMAYLESSN---V 121
Query: 470 IHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT---YGYMAPEYAMHGQ 526
IHRDL A N L+ K+SDFGM + DQ +T GT + +PE +
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSK 177
Query: 527 FSVKSDVYSFGVLVLEIITGKK 548
+S KSDV+SFGVL+ E+ + K
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 59/212 (27%), Positives = 107/212 (50%), Gaps = 33/212 (15%)
Query: 352 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG--QEFKNEVVLVAKLQHRNLVRLL 408
++GEG +G+VYK +G+ +A+K++ + + G E+ L+ KL+H N+VRL
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 409 GFCLEGEEK--ILVYEFVPNKSLDYFLYEPEKQ----------QQLDWSRRYKIIGGIAR 456
+ +V+E++ + L L PE + +QL
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQL------------LE 111
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY 516
G+ YLH + I+HRD+K SNIL++ + K++DFG+A+ + + TNR++ T Y
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWY 167
Query: 517 MAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 547
PE + ++ + D++S G ++ E+ GK
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-25
Identities = 43/101 (42%), Positives = 57/101 (56%), Gaps = 4/101 (3%)
Query: 155 NTQNV--TDRGRFNQILASLMSQVVNQAVNNSRK-FATRTANFTALQTLYSLAQCTPDLS 211
NT T F L +L+S + + A ++S K FA T+ A T+Y LAQC DLS
Sbjct: 7 NTSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSG-AAPDTVYGLAQCRGDLS 65
Query: 212 SSDCNVCLQAAIAELPNCCSGKTGAQVLIPSCIVRYEFYPF 252
+SDC CL A++EL CC K G ++ SC +RYE YPF
Sbjct: 66 ASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 71/211 (33%), Positives = 109/211 (51%), Gaps = 20/211 (9%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
E+ + KLG G FGEV+ G + ++AVK L + Q F E L+ LQH
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQH 60
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ-----QQLDWSRRYKIIGGIAR 456
LVRL + E ++ E++ SL FL E + +D+S + IA
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAE 114
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTY-- 514
G+ Y+ R IHRDL+A+N+L+ + KI+DFG+A++ ++ T R +
Sbjct: 115 GMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPI 168
Query: 515 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ APE G F++KSDV+SFG+L+ EI+T
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 74/220 (33%), Positives = 121/220 (55%), Gaps = 21/220 (9%)
Query: 354 LGEGGFGEVYKGV-LPSGQEI----AVKRL-SRSSGQGGQEFKNEVVLVAKLQHRNLVRL 407
LG G FG VYKG+ +P G+ + A+K L +S + +E +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 408 LGFCLEGEEKILVYEFVPNKSL-DYFLYEPEK---QQQLDWSRRYKIIGGIARGILYLHE 463
LG CL + LV + +P L DY ++ Q L+W + IA+G+ YL E
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM 523
+R++HRDL A N+L+ + + KI+DFG+A++ +D+T+ + + +MA E +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 524 HGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLL 562
H +F+ +SDV+S+GV V E++T G K DLL
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 71/229 (31%), Positives = 119/229 (51%), Gaps = 22/229 (9%)
Query: 343 VATNNFSTDNKLGEGGFGEVY----KGVLPSGQEI--AVKRLSRSSGQGGQEFKNEVVLV 396
+ +N +LGEG FG+V+ + P +I AVK L +S ++F E L+
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 397 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY----------EPEKQQQLDWSR 446
LQH ++V+ G C+EG+ I+V+E++ + L+ FL E + +L S+
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 447 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQG 505
I IA G++YL + +HRDL N L+ + KI DFGM++ ++ D +
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178
Query: 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 554
+ ++ +M PE M+ +F+ +SDV+S GV++ EI T K +YQ
Sbjct: 179 GGHTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ-PWYQ 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-25
Identities = 70/208 (33%), Positives = 116/208 (55%), Gaps = 15/208 (7%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
E+ + + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 60
Query: 402 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
LV+L + + EE I +V E++ SL FL + E + L + + IA G+ Y
Sbjct: 61 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 117
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ---TQGNTNRIVGTYGYM 517
+ R+ +HRDL+A+NIL+ + K++DFG+A++ ++ QG I T
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---- 170
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEIIT 545
APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 68/211 (32%), Positives = 112/211 (53%), Gaps = 26/211 (12%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFK----NEVVLVAKLQHR 402
+ KLGEG +G VYK +G+ +A+K++ + + G E+ L+ +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG--IPSTALREISLLKELKHP 58
Query: 403 NLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRY--KIIGGIARGIL 459
N+V+LL E K+ LV+E+ + L +L ++ S I+ + RG+
Sbjct: 59 NIVKLLDVIH-TERKLYLVFEYC-DMDLKKYL----DKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAP 519
Y H S RI+HRDLK NIL++ + K++DFG+A+ FG+ T+ +V T Y AP
Sbjct: 113 YCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLWYRAP 167
Query: 520 EYAMHGQF---SVKSDVYSFGVLVLEIITGK 547
E + + +V D++S G + E+ITGK
Sbjct: 168 EILLGSKHYSTAV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 67/214 (31%), Positives = 117/214 (54%), Gaps = 31/214 (14%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRL---SRSSGQGGQE-------FKNEVVLVAKLQHR 402
+G+G +G VY + + +G+ +AVK++ + +G+ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 403 NLVRLLGFCLEGEEKILVY-EFVPNKSLDYFLYEPEK-QQQLDWSRRYKIIGGIARGILY 460
N+V+ LGF EE + ++ E+VP S+ L + ++QL +++ G+A Y
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA----Y 123
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK----IFGVDQTQGNTNRIVGTYGY 516
LH I+HRDLKA N+L+DA+ KISDFG++K I+ DQ + G+ +
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ----NMSMQGSVFW 176
Query: 517 MAPE--YAMHGQFSVKSDVYSFGVLVLEIITGKK 548
MAPE ++ +S K D++S G +VLE+ G++
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ 400
E+ + + +KLG G +GEVY+GV +AVK L + +EF E ++ +++
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIK 60
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
H NLV+LLG C ++ EF+ +L +L E +Q+ ++ + I+ + Y
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEY 119
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTY------ 514
L + + IHRDL A N L+ K++DFG++++ D TY
Sbjct: 120 LEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----------TYTAHAGA 165
Query: 515 ----GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ APE + +FS+KSDV++FGVL+ EI T
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 66/217 (30%), Positives = 122/217 (56%), Gaps = 25/217 (11%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSRSSG---QGGQEFKNEVVLV 396
E+ ++ + +G G FGEV++G+L P +E+AV + G + Q+F +E ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 397 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIG---G 453
+ H N++RL G + + +++ E++ N +LD +L + ++S Y+++G G
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL----RDHDGEFSS-YQLVGMLRG 115
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF-----GVDQTQGNTN 508
IA G+ YL S + +HRDL A NIL+++ + K+SDFG++++ G T G
Sbjct: 116 IAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 509 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
I T APE + +F+ SDV+SFG+++ E+++
Sbjct: 173 PIRWT----APEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 70/222 (31%), Positives = 119/222 (53%), Gaps = 28/222 (12%)
Query: 353 KLGEGGFGEVY----KGVLPSGQE--IAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVR 406
+LGEG FG+V+ + P+ + +AVK L + ++F+ E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 407 LLGFCLEGEEKILVYEFVPNKSLDYFLY------------EPEKQQ-QLDWSRRYKIIGG 453
G C +G+ I+V+E++ + L+ FL +P + + +L S+ I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVD--QTQGNTNRI 510
IA G++YL + +HRDL N L+ A + KI DFGM++ ++ D + G+T
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 511 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552
+ +M PE M+ +F+ +SDV+SFGV++ EI T K F
Sbjct: 189 I---RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 69/215 (32%), Positives = 112/215 (52%), Gaps = 20/215 (9%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG--QEFKNEV 393
D+ IE K+GEG +G VYKG +GQ +A+K++ S + G E+
Sbjct: 1 DYTKIE----------KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI 50
Query: 394 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGG 453
L+ +LQH N+V L ++ L++EF+ + L +L K Q +D +
Sbjct: 51 SLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQ 109
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
I +GIL+ H R++HRDLK N+L+D + K++DFG+A+ FG+ + T+ +V T
Sbjct: 110 ILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-T 164
Query: 514 YGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 547
Y APE + +S D++S G + E+ T K
Sbjct: 165 LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 71/200 (35%), Positives = 104/200 (52%), Gaps = 27/200 (13%)
Query: 353 KLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412
+GEG FG V +G +GQ++AVK + Q F E ++ KL H+NLVRLLG L
Sbjct: 13 IIGEGEFGAVLQGEY-TGQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 413 EGEEKILVYEFVPNKSLDYFLYEPEKQ-----QQLDWSRRYKIIGGIARGILYLHEDSRL 467
I V E + +L FL + Q L +S +A G+ YL
Sbjct: 70 HNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLD------VAEGMEYLESK--- 119
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKI--FGVDQTQGNTNRIVGTYGYMAPEYAMHG 525
+++HRDL A NIL+ + K+SDFG+A++ GVD ++ + APE H
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKHK 172
Query: 526 QFSVKSDVYSFGVLVLEIIT 545
+FS KSDV+S+GVL+ E+ +
Sbjct: 173 KFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 19/212 (8%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKR-----LSRSSGQGGQEFKNEVVLVAKL 399
N+ LG+G FG VY + +G+E+AVK+ S + + + E+ L+ L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 400 QHRNLVRLLGFCLEGEEKILVY-EFVPNKSL-DYF-LYEPEKQQQLDWSRRYKIIGGIAR 456
QH +V+ G CL +E + ++ E++P S+ D Y L + K I
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGA-----LTETVTRKYTRQILE 115
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV-GTYG 515
G+ YLH + I+HRD+K +NIL D+ N K+ DFG +K + G + V GT
Sbjct: 116 GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
+M+PE + K+DV+S G V+E++T K
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 69/215 (32%), Positives = 109/215 (50%), Gaps = 29/215 (13%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
E+ + + KLG G FGEV+ ++AVK + S + F E ++ LQH
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH 60
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ-----LDWSRRYKIIGGIAR 456
LV+L + E ++ EF+ SL FL E +Q +D+S + IA
Sbjct: 61 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAE 113
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG- 515
G+ ++ + + IHRDL+A+NIL+ A + KI+DFG+A++ N G
Sbjct: 114 GMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI-------EDNEYTAREGA 163
Query: 516 -----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ APE G F++KSDV+SFG+L++EI+T
Sbjct: 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 68/208 (32%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE---------FKNEVVLVAKLQHRN 403
+G G FG VY G+ SG+ +AVK++ S + E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
+V+ LG L+ + + E+VP S+ L + + + I +G+ YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG--NTNR--IVGTYGYMAP 519
+R IIHRD+K +NIL+D + KISDFG++K + N R + G+ +MAP
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 520 EYAMHGQFSVKSDVYSFGVLVLEIITGK 547
E ++ K+D++S G LV+E++TGK
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 352 NKLGEGGFGEVYKGVLPSGQEIAVKRLS------RSSGQGGQEFKNEVVLVAKLQHRNLV 405
LG+G +G VY G+ GQ IAVK++ ++ + ++ + EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFL--YEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
+ LG CL+ + EFVP S+ L + P + +Y I G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF---CKYT--KQILDGVAYLHN 120
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAK---IFGVDQTQGNTNRIV-GTYGYMAP 519
+ ++HRD+K +N++L K+ DFG A+ G+ T N + + GT +MAP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 520 EYAMHGQFSVKSDVYSFGVLVLEIITGK 547
E + KSD++S G V E+ TGK
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 347 NFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKR--LSRSSGQGGQEFKNEVVLVAKLQHRN 403
+F KLG+G +G VYK L Q A+K L S + ++ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ-----QQLDWSRRYKIIGGIARGI 458
++ L+G + +V E+ P L + + +K+ +Q W R I + RG+
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW--RIFI--QLLRGL 116
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMA 518
LHE +I+HRDLK++NILL A KI D G++K+ + +GT YMA
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMA 169
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
PE +S KSD++S G L+ E+ T
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 354 LGEGGFGEVYKGVLPSGQ-EIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412
LG+G +G VY S Q IA+K + + Q E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 413 EGEEKILVYEFVPNKSLDYFLYE-----PEKQQQLDWSRRYKIIGGIARGILYLHEDSRL 467
E + E VP SL L + +Q + + + I G+ YLH+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-----ILEGLKYLHD---N 127
Query: 468 RIIHRDLKASNILLDAEMNP-KISDFGMAK-IFGVDQTQGNTNRIVGTYGYMAPEYAMHG 525
+I+HRD+K N+L++ KISDFG +K + G++ T GT YMAPE G
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKG 184
Query: 526 Q--FSVKSDVYSFGVLVLEIITGK 547
+ +D++S G ++E+ TGK
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 20/202 (9%)
Query: 354 LGEGGFGEVYKGV-LPSGQEI----AVKRL-SRSSGQGGQEFKNEVVLVAKLQHRNLVRL 407
LG G FG V+KG+ +P G I A+K + RS Q QE + ++ + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPE----KQQQLDWSRRYKIIGGIARGILYLHE 463
LG C G LV + P SL + + Q+ L+W + IA+G+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM 523
R++HR+L A NILL ++ +I+DFG+A + D + + +MA E +
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 524 HGQFSVKSDVYSFGVLVLEIIT 545
G+++ +SDV+S+GV V E+++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 64/214 (29%), Positives = 116/214 (54%), Gaps = 25/214 (11%)
Query: 353 KLGEGGFGEVYKGVL------PSGQEIAVKRLS-RSSGQGGQEFKNEVVLVAKLQHRNLV 405
+LGE FG+VYKG L Q +A+K L ++ G +EFK+E ++ ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLY--EPEK-----------QQQLDWSRRYKIIG 452
LLG + + +++ + + L FL P + L+ + I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 453 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQGNTNRIV 511
IA G+ +L S ++H+DL N+L+ ++N KISD G+ + ++ D + N ++
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+M+PE M+G+FS+ SD++S+GV++ E+ +
Sbjct: 189 PIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 69/241 (28%), Positives = 103/241 (42%), Gaps = 40/241 (16%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQ-EFKNEVVLVAKLQHRN 403
++LGEG G V K L + I A+K ++ Q + E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 404 LVRLLG-FCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRY--KIIGGIARGIL 459
+V+ G F E I + E+ SLD + +K+ R K++G IA +L
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVL 115
Query: 460 ----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG--------MAKIFGVDQTQGNT 507
YLH +IIHRD+K SNILL + K+ DFG +A F
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF--------- 163
Query: 508 NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK--KNSSFYQTDGAADLLSYV 565
GT YMAPE +S+ SDV+S G+ +LE+ + G +LLSY+
Sbjct: 164 ---TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI 220
Query: 566 S 566
Sbjct: 221 V 221
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-23
Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 29/225 (12%)
Query: 354 LGEGGFGEVYKGVL----PSGQEIAVK--RLSRSSGQGGQEFKNEVVLVAKLQHRNLVRL 407
LGEG FG V +G L S ++AVK +L + +EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 408 LGFCLEGEEK------ILVYEFVPNKSLDYFLYEP---EKQQQLDWSRRYKIIGGIARGI 458
+G C E +++ F+ + L FL ++L K + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA-KIFGVD-QTQGNTNRIVGTYGY 516
YL S IHRDL A N +L +M ++DFG++ KI+ D QG ++ +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181
Query: 517 MAPEYAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSSFYQ 554
+A E ++ KSDV++FGV + EI T G +N Y
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD 226
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 70/214 (32%), Positives = 111/214 (51%), Gaps = 25/214 (11%)
Query: 353 KLGEGGFGEVYKG--VLPS---GQEIAVKRLSR-SSGQGGQEFKNEVVLVAKLQHRNLVR 406
+LGE FG++YKG LP Q +A+K L ++ Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 407 LLGFCLEGEEKILVYEFVPNKSLDYFLY--EPEK------------QQQLDWSRRYKIIG 452
LLG + + +++E++ L FL P + LD I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 453 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQGNTNRIV 511
IA G+ YL S +H+DL A NIL+ +++ KISD G+++ I+ D + ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+M PE M+G+FS SD++SFGV++ EI +
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-23
Identities = 73/208 (35%), Positives = 103/208 (49%), Gaps = 30/208 (14%)
Query: 354 LGEGGFGEV----YKGVLP----SGQEIAVKRLSRSSGQGGQE-FKNEVVLVAKLQHRNL 404
LGEG FG+V Y P +G+ +AVK L R GQ +K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVSLYCYD---PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 405 VRLLGFCLEGEEKI--LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLH 462
V+ G C E K L+ E+VP SL +L + +L+ ++ I G+ YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG-----YM 517
IHRDL A N+LLD + KI DFG+AK +G+ V G +
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWY 177
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEIIT 545
A E +FS SDV+SFGV + E++T
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 6e-23
Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 26/209 (12%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG------QEFKNEVVLVAKLQHRNLVR 406
LG G F Y+ + +G +AVK+++ + + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 407 LLGFCLEGEEKILVYEFVPNKSLDYFL--YEPEKQQQLDWSRRYKIIGGIARGILYLHED 464
+LG E L E++ S+ + L Y K+ + + RG+ YLHE+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLHEN 122
Query: 465 SRLRIIHRDLKASNILLDAE-MNPKISDFGMA-----KIFGVDQTQGNTNRIVGTYGYMA 518
+IIHRD+K +N+L+D+ +I+DFG A K G + QG +++GT +MA
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
PE Q+ DV+S G +++E+ T K
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 7e-23
Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 14/216 (6%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---RSSGQGGQEFKNEVVLVAKLQ 400
NF + K+G+G F VYK + L G+ +A+K++ + Q+ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRR-YKIIGGIARGIL 459
H N+++ L +E E +V E L + +KQ++L R +K + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAP 519
++H RI+HRD+K +N+ + A K+ D G+ + F T ++ +VGT YM+P
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 175
Query: 520 EYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSFYQ 554
E +H ++ KSD++S G L+ E+ + S FY
Sbjct: 176 E-RIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-23
Identities = 59/203 (29%), Positives = 107/203 (52%), Gaps = 23/203 (11%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG-QEFKNEVVLVAKLQH---RNLVRLL 408
+G G +G VY+G +P+G+ +A+K ++ + + + EV L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 409 GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL----YLHED 464
G L+G ++ E+ S+ + K + +Y I I R +L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIA--EKY--ISVIIREVLVALKYIHKV 120
Query: 465 SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH 524
+IHRD+KA+NIL+ N K+ DFG+A + +Q + VGT +MAPE
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITE 175
Query: 525 GQ-FSVKSDVYSFGVLVLEIITG 546
G+ + K+D++S G+ + E+ TG
Sbjct: 176 GKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN--EVVLVAKLQHRNLVRLLG 409
K+GEG +G VYK +G+ +A+K++ G E+ L+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 410 FCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ--LDWSRRYKIIGGIARGILYLHEDSRL 467
+ LV+EF +D LY+ K +Q L S + + +G+ + H
Sbjct: 66 VFRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SH 117
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE--YAMHG 525
I+HRDLK N+L++ E K++DFG+A+ FG V T Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGD-K 174
Query: 526 QFSVKSDVYSFGVLVLEIITGK 547
+S D++S G + E+++ +
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS-RSSGQGGQEFKNEVVLVAKLQHRNLV 405
F+ +G+G FGEVYK + + Q +A+K + + ++ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKI----IGGIARGIL-- 459
+ G L+G + ++ E+ S LD + K+ I I R +L
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC------------LDLLKPGKLDETYIAFILREVLLG 110
Query: 460 --YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG-VDQTQGNTNRIVGTYGY 516
YLHE+ IHRD+KA+NILL E + K++DFG++ G + T N VGT +
Sbjct: 111 LEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS---GQLTSTMSKRNTFVGTPFW 164
Query: 517 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
MAPE + K+D++S G+ +E+ G+
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 18/200 (9%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFC 411
K+G+G G VY + + +GQE+A+K+++ + NE++++ + +H N+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 412 LEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL----YLHEDSRL 467
L G+E +V E++ SL + E + I + R L +LH +
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDE--------GQIAAVCRECLQALEFLHSN--- 134
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF 527
++IHRD+K+ NILL + + K++DFG +Q++ +T +VGT +MAPE +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAY 192
Query: 528 SVKSDVYSFGVLVLEIITGK 547
K D++S G++ +E++ G+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG--QEFKNEVVLVAKLQHRNLVRLLG 409
K+GEG +G VYK +G+ +A+K++ + G E+ L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 410 FCLEGEEKILVYEFVPNKSLDYFLY-EPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLR 468
+ LV+EF+ LD Y + LD + + +GI Y H S R
Sbjct: 66 VVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH-R 119
Query: 469 IIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-QF 527
++HRDLK N+L+D E K++DFG+A+ FGV + T+ +V T Y APE + Q+
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILLGSRQY 177
Query: 528 SVKSDVYSFGVLVLEIITGK 547
S D++S G + E++ +
Sbjct: 178 STPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 70/207 (33%), Positives = 111/207 (53%), Gaps = 26/207 (12%)
Query: 354 LGEGGFGEV----YKGVLP----SGQEIAVKRLS-RSSGQGGQEFKNEVVLVAKLQHRNL 404
LGEG FG+V Y P +G+++AVK L S G + K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 405 VRLLGFCLEGEEK--ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLH 462
V+ G C E L+ EF+P+ SL +L P + +++ ++ K I +G+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL- 125
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ----TQGNTNRIVGTYGYMA 518
SR + +HRDL A N+L+++E KI DFG+ K D+ + + + V Y A
Sbjct: 126 -GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY---A 180
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIIT 545
PE + +F + SDV+SFGV + E++T
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 63/214 (29%), Positives = 114/214 (53%), Gaps = 27/214 (12%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQ 400
+ + +G G FGEV G L P +EI V + +G + ++F +E ++ +
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIG---GIARG 457
H N++ L G + + ++V E++ N SLD FL + + Q + +++G GIA G
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV-----IQLVGMLRGIASG 118
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG-- 515
+ YL S + +HRDL A NIL+++ + K+SDFG++++ D T R G
Sbjct: 119 MKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGK 170
Query: 516 ----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ APE + +F+ SDV+S+G+++ E+++
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 5e-22
Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 353 KLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412
+LG G FG V+ G + ++A+K + ++F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 413 EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 472
+ + +V EF+ N L +L + +Q +L + + G+ YL +S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 473 DLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG------YMAPEYAMHGQ 526
DL A N L+ + K+SDFGM + D+ + G + PE +
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE-------YTSSSGAKFPVKWSPPEVFNFSK 177
Query: 527 FSVKSDVYSFGVLVLEIIT-GK---KNSSFYQ 554
+S KSDV+SFGVL+ E+ T GK + S Y+
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 37/223 (16%)
Query: 353 KLGEGGFGEVY------------KGVLPSGQE-----IAVKRLSRSSGQGG-QEFKNEVV 394
KLGEG FGEV+ K + +AVK L + ++F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE--------PEKQQQLDWSR 446
++++L N+ RLLG C ++ E++ N L+ FL + + L +S
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 447 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506
+ IA G+ YL L +HRDL N L+ KI+DFGM++ + +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSD 184
Query: 507 TNRIVGT----YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
R+ G +MA E + G+F+ KSDV++FGV + EI+T
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 8e-22
Identities = 62/202 (30%), Positives = 106/202 (52%), Gaps = 10/202 (4%)
Query: 352 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG-QEFKNEVVLVAKLQHRNLVRLLG 409
+G G VY + LP+ +++A+KR+ Q E + EV +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 410 FCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRI 469
+ G+E LV ++ SL + + LD + ++ + +G+ YLH + +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 470 IHRDLKASNILLDAEMNPKISDFGMAKIF--GVDQTQGNTNRIVGTYGYMAPEYAMHGQ- 526
IHRD+KA NILL + + KI+DFG++ G D+T+ VGT +MAPE M
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVH 182
Query: 527 -FSVKSDVYSFGVLVLEIITGK 547
+ K+D++SFG+ +E+ TG
Sbjct: 183 GYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 8e-22
Identities = 63/195 (32%), Positives = 102/195 (52%), Gaps = 11/195 (5%)
Query: 354 LGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQ-EFKNEVVLVAKLQHRNLVRLLGFCL 412
LG+G FGEV+KG L +AVK Q + +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 413 EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 472
+ + +V E VP D+ + +K+ +L + K A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 473 DLKASNILLDAEMNPKISDFGMAKIF--GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVK 530
DL A N L+ KISDFGM++ G+ + G + + APE +G++S +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI---KWTAPEALNYGRYSSE 174
Query: 531 SDVYSFGVLVLEIIT 545
SDV+S+G+L+ E +
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 57/199 (28%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 353 KLGEGGFGEVYK-GVLPSGQEIAVKR--LSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLG 409
++GEG G V+K +G+ +A+K+ L R G + E+ + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 410 FCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRI 469
G +LV E++P+ L L + E+ + Y + + +G+ Y+H I
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMHA---NGI 120
Query: 470 IHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ--F 527
+HRDLK +N+L+ A+ KI+DFG+A++F ++ + +++ V T Y APE ++G +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPEL-LYGARKY 178
Query: 528 SVKSDVYSFGVLVLEIITG 546
D+++ G + E++ G
Sbjct: 179 DPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 66/232 (28%), Positives = 110/232 (47%), Gaps = 34/232 (14%)
Query: 342 EVATNNFSTDNKLGEGGFGEV----------YKGVLPSGQE-----IAVKRL-SRSSGQG 385
E KLGEG FGEV + G + +AVK L + +
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 386 GQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWS 445
+F E+ ++++L++ N++RLLG C+ + ++ E++ N L+ FL + E + +
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 446 RRYKIIG---------GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496
+ IA G+ YL + L +HRDL N L+ KI+DFGM++
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 497 -IFGVD--QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
++ D + QG R V +MA E + G+F+ SDV++FGV + E+ T
Sbjct: 178 NLYSGDYYRIQG---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 352 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLL 408
+G+G FG V K G+ + K + + + Q+ +EV ++ +L+H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 409 G-FCLEGEEKI-LVYEF--------VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGI 458
+ + +V E+ + K Y E+ W +I+ + +
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI---W----RILTQLLLAL 118
Query: 459 LYLH--EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY 516
H D ++HRDLK +NI LDA N K+ DFG+AKI G D + T VGT Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYY 176
Query: 517 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
M+PE H + KSD++S G L+ E+
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-21
Identities = 62/207 (29%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 348 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGG-QEFKNEVVLVAKLQHRNLV 405
F+ ++G+G FGEVYKG+ +E+ A+K + + ++ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 406 RLLGFCLEGEEKILVYEFVPNKS-LDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED 464
R G L+G + ++ E++ S LD K L+ + I+ I +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHSE 120
Query: 465 SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH 524
R IHRD+KA+N+LL + + K++DFG+A + TQ N VGT +MAPE
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 525 GQFSVKSDVYSFGVLVLEIITGKKNSS 551
+ K+D++S G+ +E+ G+ +S
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 354 LGEGGFGEVYK-GVLPSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLG 409
LG+GGFGEV V +G+ A K+L + +G Q NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 410 FCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLR 468
+ E ++ + LV + L Y +Y + +R I G+ +LH + R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFPEARAIFYAAQIICGLEHLH---QRR 115
Query: 469 IIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFS 528
I++RDLK N+LLD N +ISD G+A + GT GYMAPE +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYD 172
Query: 529 VKSDVYSFGVLVLEIITGK 547
D ++ G + E+I G+
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 62/201 (30%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 354 LGEGGFGEVYKGVL--PSGQE--IAVKRLSRSSGQGGQE--FKNEVVLVAKLQHRNLVRL 407
LG G FGE+ +G L PS +E +A+ L R+ Q F E + + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRL 467
G G ++V E++ N +LD FL + E QL + ++ G+A G+ YL E +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSE---M 126
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMA---KIFGVDQTQGNTNRIVGTYGYMAPEYAMH 524
+H+ L A +L+++++ KIS F K + T + ++ + APE +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL----WAAPEAIQY 182
Query: 525 GQFSVKSDVYSFGVLVLEIIT 545
FS SDV+SFG+++ E+++
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 63/203 (31%), Positives = 112/203 (55%), Gaps = 19/203 (9%)
Query: 354 LGEGGFGEVYKGVL--PSGQEI--AVKRL-SRSSGQGGQEFKNEVVLVAKLQHRNLVRLL 408
+G G FGEV +G L P +EI A+K L S + + ++F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 409 GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ---QQLDWSRRYKIIGGIARGILYLHEDS 465
G + +++ EF+ N +LD FL + + Q QL ++ GIA G+ YL E
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYLSE-- 124
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVG---TYGYMAPEYA 522
+ +HRDL A NIL+++ + K+SDFG+++ D + +G + APE
Sbjct: 125 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 523 MHGQFSVKSDVYSFGVLVLEIIT 545
+ +F+ SDV+S+G+++ E+++
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 4e-21
Identities = 67/199 (33%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 353 KLGEGGFGEVYKGVL---PSGQEIAVKRLSRSSGQGG--QEFKNEVVLVAKLQHRNLVRL 407
+LG G FG V KG+ S + +AVK L + E E ++ +L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRL 467
+G C E E +LV E L+ FL +K + + +++ ++ G+ YL E +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD----QTQGNTNRIVGTYGYMAPEYAM 523
+HRDL A N+LL + KISDFG++K G D + + + V Y APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APECMN 171
Query: 524 HGQFSVKSDVYSFGVLVLE 542
+ +FS KSDV+SFGVL+ E
Sbjct: 172 YYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-21
Identities = 66/219 (30%), Positives = 112/219 (51%), Gaps = 19/219 (8%)
Query: 342 EVATNNFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLSRSSGQGGQ-EFKNEVV 394
EVA + +LG+G FG VY KGV+ E +A+K ++ ++ + EF NE
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL--YEPEKQQQL-----DWSRR 447
++ + ++VRLLG +G+ +++ E + L +L PE + +
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 448 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQGN 506
++ G IA G+ YL+ + + +HRDL A N ++ + KI DFGM + I+ D +
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
++ +M+PE G F+ SDV+SFGV++ EI T
Sbjct: 179 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 5e-21
Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 353 KLGEGGFGEVYKGV--LPSGQ-EIAVKRLSRSSGQG-GQEFKNEVVLVAKLQHRNLVRLL 408
+LG G FG V KGV + Q ++A+K L + + E E ++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 409 GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLR 468
G C E E +LV E L+ FL K+ ++ S +++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 469 IIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTY--GYMAPEYAMHGQ 526
+HRDL A N+LL + KISDFG++K G D + R G + + APE +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAPECINFRK 174
Query: 527 FSVKSDVYSFGVLVLEIIT-GKK 548
FS +SDV+S+G+ + E + G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-21
Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 347 NFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSRSSGQGG-QEFKNEVVLVAKL 399
N LGEG FG+V K +AVK L ++ ++ +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 400 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQ----QLDWSRRYKIIGG-- 453
H ++++L G C + +L+ E+ SL FL E K D +R +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 454 ---------------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498
I+RG+ YL E ++++HRDL A N+L+ KISDFG+++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ + ++ +MA E ++ +SDV+SFGVL+ EI+T
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 347 NFSTDNKLGEGGFGEVYKGV--LPSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQH 401
+F +G+G FG+V V + + A+K +++ + NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCI-VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH 59
Query: 402 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
LV L + + EE + LV + + L Y L ++ + + I I + Y
Sbjct: 60 PFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICEIVLALEY 115
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520
LH IIHRD+K NILLD + + I+DF +A T GT GYMAPE
Sbjct: 116 LHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPE 169
Query: 521 YAMHGQFSVKSDVYSFGVLVLEIITGKK 548
+SV D +S GV E + GK+
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 353 KLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412
+LG G FG V G ++A+K + S EF E ++ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 413 EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 472
+ +V E++ N L +L E K+ Q S+ ++ + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 473 DLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT---YGYMAPEYAMHGQFSV 529
DL A N L+D + K+SDFG+++ D+ + VG+ + PE ++ +FS
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSS 180
Query: 530 KSDVYSFGVLVLEIIT-GK 547
KSDV++FGVL+ E+ + GK
Sbjct: 181 KSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 13/214 (6%)
Query: 341 IEVATNNFSTDNKLGEGGFGEVYKGV--LPSGQEI--AVKRLSR-SSGQGGQEFKNEVVL 395
E+ + + +GEG FG+VY+GV P ++I AVK +S ++F E +
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 396 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIA 455
+ + H ++V+L+G E +V E P L +L + LD + ++
Sbjct: 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLS 117
Query: 456 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG 515
+ YL R +HRD+ A N+L+ + K+ DFG+++ D++ ++
Sbjct: 118 TALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIK 173
Query: 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 548
+MAPE +F+ SDV+ FGV + EI+ G K
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 58/207 (28%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 348 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGG-QEFKNEVVLVAKLQHRNLV 405
F+ ++G+G FGEV+KG+ Q++ A+K + + ++ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 406 RLLGFCLEGEEKILVYEFVPNKS-LDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED 464
+ G L+G + ++ E++ S LD P + Q+ ++ I +G+ YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHSE 120
Query: 465 SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH 524
+ IHRD+KA+N+LL + + K++DFG+A + TQ N VGT +MAPE
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 525 GQFSVKSDVYSFGVLVLEIITGKKNSS 551
+ K+D++S G+ +E+ G+ +S
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 352 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGF 410
++G G +G+VYK + +G+ +A+K + G + + E+ ++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 411 CLEGEEKILVYEFVPNKSLD---YFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRL 467
L ++ +V E+ SL P + Q+ + R + +G+ YLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE---T 120
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA---MH 524
IHRD+K +NILL + + K++DFG++ + T +GT +MAPE A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQ--LTATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 525 GQFSVKSDVYSFGVLVLE 542
G + K D+++ G+ +E
Sbjct: 179 GGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 72/223 (32%), Positives = 111/223 (49%), Gaps = 28/223 (12%)
Query: 354 LGEGGFGEVYKGVLPSGQEI---AVK--RLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLL 408
LGEG FG V +G L I AVK +++ + ++F +E V + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 409 GFCLEGEEK------ILVYEFVPNKSL-DYFLYEP--EKQQQLDWSRRYKIIGGIARGIL 459
G CL+ E +++ F+ + L + LY + Q L K + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA-KIFGVD-QTQGNTNRIVGTYGYM 517
YL S IHRDL A N +L+ MN ++DFG++ KI+ D QG ++ ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWI 181
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSSFY 553
A E ++ KSDV+SFGV + EI T G +NS Y
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 61/203 (30%), Positives = 110/203 (54%), Gaps = 13/203 (6%)
Query: 348 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGG-QEFKNEVVLVAKLQHRNLV 405
F+ K+G+G FGEV+KG+ Q++ A+K + + ++ + E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 406 RLLGFCLEGEEKILVYEFVPNKS-LDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED 464
+ G L+ + ++ E++ S LD L EP LD ++ I+ I +G+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 120
Query: 465 SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH 524
+ IHRD+KA+N+LL K++DFG+A + TQ N VGT +MAPE
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 525 GQFSVKSDVYSFGVLVLEIITGK 547
+ K+D++S G+ +E+ G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 6e-20
Identities = 71/231 (30%), Positives = 117/231 (50%), Gaps = 35/231 (15%)
Query: 353 KLGEGGFGEVY----KGVL----------PSGQE---IAVKRLSRSSGQGGQ-EFKNEVV 394
KLGEG FGEV+ +G+ SG + +AVK L + + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGG- 453
++++L+ N++RLL C+ + ++ E++ N L+ FL E Q+ + + I
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 454 -------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVD--QT 503
IA G+ YL S L +HRDL N L+ KI+DFGM++ ++ D +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 554
QG R V +M+ E + G+F+ SDV++FGV + EI+T K + Q
Sbjct: 189 QG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 6e-20
Identities = 54/196 (27%), Positives = 111/196 (56%), Gaps = 10/196 (5%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFC 411
K+G+G G V+ + + +GQE+A+K+++ + NE++++ +L++ N+V L
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 412 LEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 471
L G+E +V E++ SL + E +D ++ + + + +LH + ++IH
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHAN---QVIH 138
Query: 472 RDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKS 531
RD+K+ N+LL + + K++DFG +Q++ +T +VGT +MAPE + K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196
Query: 532 DVYSFGVLVLEIITGK 547
D++S G++ +E++ G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-20
Identities = 61/201 (30%), Positives = 105/201 (52%), Gaps = 23/201 (11%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLL-GFC 411
LG+G FG+VYK +G A K + S + ++F E+ ++++ +H N+V L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 412 LEGEEKILVYEFVPNKSLDYFLYEPEK---QQQLDWSRRYKIIGGIARGILYLHEDSRLR 468
E + IL+ EF +LD + E E+ + Q+ + R + + +LH +
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQ-----MLEALNFLHSH---K 123
Query: 469 IIHRDLKASNILLDAEMNPKISDFGM-AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF 527
+IHRDLKA NILL + + K++DFG+ AK Q + + +GT +MAPE F
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFIGTPYWMAPEVVACETF 180
Query: 528 S-----VKSDVYSFGVLVLEI 543
K+D++S G+ ++E+
Sbjct: 181 KDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-20
Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 33/201 (16%)
Query: 354 LGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE 413
+G+G FG+V G G ++AVK + + Q F E ++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 414 GEEKI-LVYEFVPNKSL-DYFLYEPEKQQQLDWSRRYKIIGG---------IARGILYLH 462
+ + +V E++ SL DY SR ++GG + + YL
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLR-----------SRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA 522
++ +HRDL A N+L+ + K+SDFG+ K TQ V + APE
Sbjct: 120 ANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPV---KWTAPEAL 171
Query: 523 MHGQFSVKSDVYSFGVLVLEI 543
+FS KSDV+SFG+L+ EI
Sbjct: 172 REKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 68/232 (29%), Positives = 114/232 (49%), Gaps = 38/232 (16%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSSGQGGQEFKNEVVL 395
E+ + + LGEG FG+V K +AVK L + + ++ + L
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSD---L 62
Query: 396 VAKL-------QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE---PEKQQQLDWS 445
V+++ +H+N++ LLG C + +V E+ + +L FL P + D
Sbjct: 63 VSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDP 122
Query: 446 R-------RYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495
R + ++ +ARG+ +L S+ + IHRDL A N+L+ + KI+DFG+A
Sbjct: 123 RPPEETLTQKDLVSFAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLA 179
Query: 496 K-IFGVDQTQGNTN-RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ I +D + TN R+ +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 180 RDIHHIDYYRKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 12/212 (5%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---RSSGQGGQEFKNEVVLVAKLQHR 402
NF + K+G G F EVY+ L + +A+K++ + Q+ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 403 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRR-YKIIGGIARGILYL 461
N+++ L +E E +V E L + +KQ++L R +K + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY 521
H SR R++HRD+K +N+ + A K+ D G+ + F T ++ +VGT YM+PE
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 522 AMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553
++ KSD++S G L+ E+ S FY
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM--AALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN---EVVLVAKLQHRN 403
FS ++G G FG VY + + + +A+K++S S Q +++++ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
++ G L LV E+ + D + Q+++ + + G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AVTHGALQGLAYLHS 133
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM 523
+ +IHRD+KA NILL K+ DFG A I N VGT +MAPE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 524 ---HGQFSVKSDVYSFGVLVLEI 543
GQ+ K DV+S G+ +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 354 LGEGGFGEVYKGVL--PSGQEI--AVKRLSR-SSGQGGQEFKNEVVLVAKLQHRNLVRLL 408
+G+G FG VY G L GQ+I AVK L+R + + ++F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 409 GFCLEGE-EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIG---GIARGILYLHED 464
G CL E ++V ++ + L F+ + +IG +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK-----DLIGFGLQVAKGMEYLASK 117
Query: 465 SRLRIIHRDLKASNILLDAEMNPKISDFGMAK------IFGVDQTQGNTNRIVGTYGYMA 518
+ +HRDL A N +LD K++DFG+A+ + V G + +MA
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV----KWMA 170
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIIT 545
E +F+ KSDV+SFGVL+ E++T
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 35/209 (16%)
Query: 354 LGEGGFGEVYK-GVLPSGQEIAVKRLSRSS-GQGGQE--FKNEVVLVAKLQHRNLVRLLG 409
LG GGFG V V + A+K + + + GQ+ +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 410 FCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQL-----------DWSRRYKIIGGIARGI 458
F K + Y L E +L +++ R+ I +
Sbjct: 59 ----------YRTFKDKKYI-YMLMEYCLGGELWTILRDRGLFDEYTARF-YIACVVLAF 106
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMA 518
YLH II+RDLK N+LLD+ K+ DFG AK Q T GT Y+A
Sbjct: 107 EYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVA 160
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
PE ++ + D +S G+L+ E++TG+
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 65/210 (30%), Positives = 115/210 (54%), Gaps = 21/210 (10%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL---SRSSGQGGQEFKNEVVLVAKLQHR 402
NF K+GEG +G VYK +G+ +A+K++ + + G + E+ L+ +L H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 59
Query: 403 NLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQ---QLDWSRRYKIIGGIARGI 458
N+V+LL + E K+ LV+EF+ ++ L F+ L S ++++ G+A
Sbjct: 60 NIVKLLD-VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA--- 114
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMA 518
+ H R++HRDLK N+L++ E K++DFG+A+ FGV + T+ +V T Y A
Sbjct: 115 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRA 168
Query: 519 PEYAMHGQF-SVKSDVYSFGVLVLEIITGK 547
PE + ++ S D++S G + E++T +
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 25/203 (12%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLG-F 410
+LG+G FG+VYK +G A K + S + +++ E+ ++A H +V+LLG F
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 411 CLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL----YLHEDSR 466
+G+ I++ EF P ++D + E LD I I R +L YLH
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIMLE------LDRGLTEPQIQVICRQMLEALQYLHS--- 128
Query: 467 LRIIHRDLKASNILLDAEMNPKISDFGM-AKIFGVDQTQGNTNRIVGTYGYMAPEYAM-- 523
++IIHRDLKA N+LL + + K++DFG+ AK +T + +GT +MAPE M
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV---KTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 524 ---HGQFSVKSDVYSFGVLVLEI 543
+ K+D++S G+ ++E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 54/202 (26%), Positives = 102/202 (50%), Gaps = 10/202 (4%)
Query: 347 NFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLV 405
K+GEG G V +G+++AVK++ Q + NEVV++ QH N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
+ L G+E +V EF+ +L + +++ + + + + + +LH
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALSFLHAQ- 134
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG 525
+IHRD+K+ +ILL ++ K+SDFG + + + +VGT +MAPE
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISRL 190
Query: 526 QFSVKSDVYSFGVLVLEIITGK 547
+ + D++S G++V+E++ G+
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 5e-19
Identities = 55/196 (28%), Positives = 109/196 (55%), Gaps = 10/196 (5%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFC 411
K+G+G G VY + + +GQE+A+K+++ + NE++++ + ++ N+V L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 412 LEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 471
L G+E +V E++ SL + E +D + + + + +LH + ++IH
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSN---QVIH 138
Query: 472 RDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKS 531
RD+K+ NILL + + K++DFG +Q++ +T +VGT +MAPE + K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196
Query: 532 DVYSFGVLVLEIITGK 547
D++S G++ +E++ G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 5e-19
Identities = 71/276 (25%), Positives = 127/276 (46%), Gaps = 35/276 (12%)
Query: 282 ISSSTIIAIVAPIAVTAVLFIVGLCYFIRKAKNKYNAVPEVN-ADNDITTLESLQFDFE- 339
+ T+ A + +A+ A F+ FIR N E+ +N+ T E FD +
Sbjct: 631 YITCTLGAFLV-LALVAFGFV-----FIRGRNNL-----ELKRVENEDGTWELQFFDSKV 679
Query: 340 ----TIEVATNNFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSRSSGQGGQEFKNEVV 394
TI ++ +N + G G YKG + +G + VK ++ + E +
Sbjct: 680 SKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD--- 736
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGI 454
+ KLQH N+V+L+G C + L++E++ K+L L + L W RR KI GI
Sbjct: 737 -MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGI 789
Query: 455 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTY 514
A+ + +LH ++ +L I++D + P + + + D ++
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------ 842
Query: 515 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550
Y+APE + KSD+Y FG++++E++TGK +
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA 878
|
Length = 968 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 5e-19
Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 352 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE------FKNEVVLVAKLQHRNL 404
N++G G G VYK + P+G+ A+K + G E E+ ++ + H N+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVI-----YGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 405 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED 464
V+ E ++ EF+ SL+ E Q D +R +I+ GIA YLH
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE-QFLADVAR--QILSGIA----YLH-- 185
Query: 465 SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA-- 522
R I+HRD+K SN+L+++ N KI+DFG+++I + QT N VGT YM+PE
Sbjct: 186 -RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAYMSPERINT 242
Query: 523 --MHGQFS-VKSDVYSFGVLVLEIITGK 547
HG + D++S GV +LE G+
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 19/199 (9%)
Query: 352 NKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQEFKN---EVVLVAKLQHRNLVRL 407
+++G G FG VY E+ AVK++S S Q +++++ EV + +L+H N +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRL 467
G L+ LV E+ + D + Q+++ + I G +G+ YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLHSHN-- 141
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM---H 524
+IHRD+KA NILL K++DFG A N VGT +MAPE +
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPEVILAMDE 194
Query: 525 GQFSVKSDVYSFGVLVLEI 543
GQ+ K DV+S G+ +E+
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 44/217 (20%)
Query: 354 LGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQ-EFKNEVVLVAKLQH-RNLVRLLG- 409
+G G FG V K + PSG +AVKR+ + + Q ++ +V + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 410 --------FCLEGEEKIL--VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIA---- 455
C+E + L Y++V PE+ I+G IA
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVI---PEE-----------ILGKIAVATV 117
Query: 456 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK--IFGVDQTQGNTNRIVGT 513
+ + YL E+ L+IIHRD+K SNILLD N K+ DFG++ + + +T R G
Sbjct: 118 KALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT-----RDAGC 170
Query: 514 YGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGK 547
YMAPE + V+SDV+S G+ + E+ TGK
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 33/210 (15%)
Query: 352 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG--QEFKNEVVLVAKLQ---HRNLV 405
++GEG +G VYK L +G+ +A+K++ + G E+ L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 406 RLLGFC----LEGEEKI-LVYEFVPNKSLDYFL-------YEPEKQQQLDWSRRYKIIGG 453
RLL C + E K+ LV+E V ++ L +L PE + L +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDL--------MRQ 115
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
+ RG+ +LH RI+HRDLK NIL+ ++ KI+DFG+A+I+ + +V T
Sbjct: 116 LLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVT 169
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 543
Y APE + ++ D++S G + E+
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 31/227 (13%)
Query: 344 ATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFK----NEVVLVAK 398
++ KLGEG FGEVYK + +G+ +A+K++ + + G F E+ ++ K
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG--FPITALREIKILKK 63
Query: 399 LQHRNLVRLLGFCLE-----GEEKILVYEFVP--NKSLDYFLYEPEKQQQLDWSRRYKII 451
L+H N+V L+ +E ++ VY P + L L P +L S+ +
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP--SVKLTESQIKCYM 121
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN----- 506
+ GI YLHE+ I+HRD+KA+NIL+D + KI+DFG+A+ +
Sbjct: 122 LQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 507 -----TNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 547
TN +V T Y PE + +++ D++ G + E+ T +
Sbjct: 179 GTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 8e-19
Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 43/229 (18%)
Query: 353 KLGEGGFGEVYKGVLPSGQE-----------------IAVKRLSRSSGQGGQ-EFKNEVV 394
KLGEG FGEV+ + + Q+ +AVK L + + + +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL--------------YEPEKQQ 440
++++L+ N++RLLG C++ + ++ E++ N L+ FL P
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 441 QL--DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-I 497
+S + IA G+ YL S L +HRDL N L+ + KI+DFGM++ +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 498 FGVD--QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 544
+ D + QG R V +MA E + G+F+ SDV++FGV + EI+
Sbjct: 189 YAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 8e-19
Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 29/208 (13%)
Query: 354 LGEGGFGE--VYK----GVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRL 407
LG+G FGE +Y+ L +E+ + RLS + NE+V+++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL---NEIVILSLLQHPNIIAY 64
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYF----LYEP-EKQQQLDWSRRYKI--IGGIARGILY 460
++ + L+ E ++Y LY+ +Q+ + + + I + Y
Sbjct: 65 YNHFMD--DNTLLIE------MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520
+H+ I+HRD+K NI L K+ DFG++KI G + + T +VGT YM+PE
Sbjct: 117 IHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPE 171
Query: 521 YAMHGQFSVKSDVYSFGVLVLEIITGKK 548
+++ KSD+++ G ++ E++T K+
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 1e-18
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN---EVVLVAKLQHRN 403
F+ ++G G FG VY + + + +A+K++S S Q +++++ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
+ G L LV E+ + D + Q+++ + I G +G+ YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLHS 143
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM 523
+ +IHRD+KA NILL K++DFG A I N VGT +MAPE +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194
Query: 524 ---HGQFSVKSDVYSFGVLVLEI 543
GQ+ K DV+S G+ +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 54/196 (27%), Positives = 108/196 (55%), Gaps = 10/196 (5%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFC 411
K+G+G G VY + + +GQE+A+++++ + NE++++ + ++ N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 412 LEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 471
L G+E +V E++ SL + E +D + + + + +LH + ++IH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 472 RDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKS 531
RD+K+ NILL + + K++DFG +Q++ + +VGT +MAPE + K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 532 DVYSFGVLVLEIITGK 547
D++S G++ +E+I G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 68/207 (32%), Positives = 114/207 (55%), Gaps = 15/207 (7%)
Query: 347 NFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQEFK-NEVVLVAKLQHRNL 404
NF KLGEG + VYKG + EI A+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 405 VRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
VRL + E K+ LV+E++ +K L ++ + LD + + +GI + HE
Sbjct: 61 VRLHD-VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT--NRIVGTYGYMAPEY 521
+ R++HRDLK N+L++ K++DFG+A+ FG+ NT N +V T Y AP+
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVV-TLWYRAPDV 171
Query: 522 AMHGQ-FSVKSDVYSFGVLVLEIITGK 547
+ + +S D++S G ++ E+ITG+
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 346 NNFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSRSSGQGGQEFKN----EVVLVAKLQ 400
N + +GEG +G V K +G+ +A+K+ S + ++ K EV ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES--EDDEDVKKTALREVKVLRQLR 58
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
H N+V L LV+E+V L+ L I + + I Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR----IVGTYGY 516
H IIHRD+K NIL+ K+ DFG A+ + V T Y
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYVATRWY 167
Query: 517 MAPE----YAMHGQFSVKSDVYSFGVLVLEIITG 546
APE +G V DV++ G ++ E++ G
Sbjct: 168 RAPELLVGDTNYG-KPV--DVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 59/196 (30%), Positives = 102/196 (52%), Gaps = 10/196 (5%)
Query: 353 KLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFC 411
K+GEG G V SG+++AVK + Q + NEVV++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 412 LEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 471
L GEE ++ EF+ +L + Q +L+ + + + + + YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 472 RDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKS 531
RD+K+ +ILL + K+SDFG D + + +VGT +MAPE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEV 198
Query: 532 DVYSFGVLVLEIITGK 547
D++S G++V+E++ G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 353 KLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFC 411
K+GEG G V +G+++AVK++ Q + NEVV++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 412 LEGEEKILVYEFVPNKSL-DYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRII 470
L G+E +V EF+ +L D + ++Q+ + + R + YLH +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQG---VI 140
Query: 471 HRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVK 530
HRD+K+ +ILL ++ K+SDFG V + +VGT +MAPE + +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 531 SDVYSFGVLVLEIITGK 547
D++S G++V+E+I G+
Sbjct: 199 VDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 68/205 (33%), Positives = 108/205 (52%), Gaps = 22/205 (10%)
Query: 353 KLGEGGFGEVYKGVLPSGQE-IAVK--RLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLG 409
K+GEG +G VYK E IA+K RL + E+ L+ ++QH N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 410 FCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGG----IARGILYLHED 464
+ E+++ LV+E+ LD L + D+++ ++I I RGI Y H
Sbjct: 69 -VVHSEKRLYLVFEY-----LDLDL-KKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH-- 119
Query: 465 SRLRIIHRDLKASNILLDAEMNP-KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM 523
S R++HRDLK N+L+D N K++DFG+A+ FG+ + T+ +V T Y APE +
Sbjct: 120 SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLWYRAPEILL 176
Query: 524 HG-QFSVKSDVYSFGVLVLEIITGK 547
+S D++S G + E++ K
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 61/194 (31%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 353 KLGEGGFGEVYKGVLPSGQE-IAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGF 410
++G G FGEV+ G L + +AVK + +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 411 CLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRII 470
C + + +V E V + D+ + + +L +++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 471 HRDLKASNILLDAEMNPKISDFGMAK--IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFS 528
HRDL A N L+ + KISDFGM++ GV + G +I + APE +G++S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 529 VKSDVYSFGVLVLE 542
+SDV+SFG+L+ E
Sbjct: 175 SESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 12/212 (5%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---RSSGQGGQEFKNEVVLVAKLQHR 402
NF + K+G G F EVY+ L G +A+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 403 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRR-YKIIGGIARGILYL 461
N+++ +E E +V E L + +KQ++L + +K + + ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY 521
H SR R++HRD+K +N+ + A K+ D G+ + F T ++ +VGT YM+PE
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 522 AMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553
++ KSD++S G L+ E+ S FY
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM--AALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 344 ATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QH 401
T F +GEG +G+VYK +GQ +A+K + +E K E ++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNH 62
Query: 402 RNLVRLLGFCL------EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYK------ 449
N+ G + ++ LV E S+ + + +R K
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAY 117
Query: 450 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR 509
I+ RG+ YLHE+ ++IHRD+K NILL K+ DFG++ +D T G N
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNT 172
Query: 510 IVGTYGYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITGK 547
+GT +MAPE + +SDV+S G+ +E+ GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 356 EGGFGEVYKGVL-----PSGQEIAVKRLSRSSGQGGQE-FKNEVVLVAKLQHRNLVRLLG 409
EG FG ++ G+L +E+ VK + + + E L+ L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 410 FCLEGEEKILVYEFVPNKS-LDYFLYEP---EKQQQLDWSRRYKIIGG--IARGILYLHE 463
C+E E V N L FL + E S + + IA G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVD-QTQG-NTNRIVGTYGYMAPE 520
+ +IH+D+ A N ++D E+ KI+D +++ +F +D G N NR V +MA E
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---WMALE 189
Query: 521 YAMHGQFSVKSDVYSFGVLVLEIIT 545
++ ++S SDV+SFGVL+ E++T
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 67/217 (30%), Positives = 114/217 (52%), Gaps = 30/217 (13%)
Query: 354 LGEGGFGEVYK----GVLPSGQE----IAVKRLS-RSSGQGGQEFKNEVVLVAKL-QHRN 403
LGEG FG+V + G+ S + +AVK L ++ + + +E+ L+ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFL---------YEPE----KQQQLDWSRRYKI 450
++ LLG C + ++ E+ +L FL Y + ++QL +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 451 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQGNTN- 508
+ARG+ YL +SR R IHRDL A N+L+ + KI+DFG+A+ + +D + +N
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 509 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
R+ +MAPE ++ +SDV+SFG+L+ EI T
Sbjct: 197 RL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 41/221 (18%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL---SRSSGQGGQEFK--NEVVLVAKLQ 400
+ KLGEG + VYK +G+ +A+K++ R + G F E+ L+ +L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVP--------NKSLDYFLYEPEKQQQLDWSRRYKIIG 452
H N++ LL LV+EF+ +KS+ L + + +
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI--VLTPADIKS---------YML 109
Query: 453 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRI-- 510
RG+ YLH I+HRDLK +N+L+ ++ K++DFG+A+ F G+ NR
Sbjct: 110 MTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF------GSPNRKMT 160
Query: 511 --VGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGK 547
V T Y APE G + V D++S G + E++
Sbjct: 161 HQVVTRWYRAPELLF-GARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 353 KLGEGGFGEV-YKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFC 411
K+GEG G V V SG+ +AVK++ Q + NEVV++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 412 LEGEEKILVYEFVPNKSL-DYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRII 470
L G+E +V EF+ +L D + ++Q+ + + + + LH +I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQG---VI 138
Query: 471 HRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVK 530
HRD+K+ +ILL + K+SDFG V + +VGT +MAPE + +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 531 SDVYSFGVLVLEIITGK 547
D++S G++V+E++ G+
Sbjct: 197 VDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 39/101 (38%), Positives = 60/101 (59%), Gaps = 10/101 (9%)
Query: 449 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK--IFGVDQTQGN 506
KI + G+ YL+ RI+HRD+K SNIL+++ K+ DFG++ I + T
Sbjct: 107 KIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT--- 161
Query: 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
VGT YM+PE G+++VKSDV+S G+ ++E+ GK
Sbjct: 162 ---FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 19/219 (8%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGV---LPSGQ---EIAVKRLSRSSGQGGQ-EFKNEVV 394
EV+ + +LG+G FG VY+G + G+ +AVK ++ S+ + EF NE
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSR-------R 447
++ ++VRLLG +G+ ++V E + + L +L + + + R
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 448 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQGN 506
++ IA G+ YL+ + +HRDL A N ++ + KI DFGM + I+ D +
Sbjct: 122 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
++ MAPE G F+ SD++SFGV++ EI +
Sbjct: 179 GKGLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 357 GGFGEVY---KGVLPSGQEIAVKRLSRSSGQGG---QEFKNEVVLVAKLQHRNLVRLLGF 410
G +G V+ K +G A+K + ++ + E ++++ Q +V+L +
Sbjct: 4 GAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-Y 60
Query: 411 CLEGEEKI-LVYEFVPN---KS-LDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
+G++ + LV E++P S L+ E D +R Y I I + YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDE-----DVARIY--IAEIVLALEYLH--- 110
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN-------TNRIVGTYGYMA 518
IIHRDLK NIL+D+ + K++DFG++K G+ + Q N RIVGT Y+A
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIITG 546
PE + S D +S G ++ E + G
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 354 LGEGGFGEVYK-------GVLPSGQEIAVKRLS-----RSSGQGGQEFKNEVVLVAK-LQ 400
LG G FG VYK L + +EI V + R + + +EV ++ + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYEPEKQQQLDWSRRYKIIGGIARGIL 459
H N+VR LE + +V + + L ++F EK+Q+ R + I + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT--NRIVGTYGYM 517
YLH++ R I+HRDL +NI+L + I+DFG+AK Q Q + +VGT Y
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGTILYS 180
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
PE + + K+DV++FG ++ ++ T FY T+
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTN 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 68/221 (30%), Positives = 112/221 (50%), Gaps = 15/221 (6%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL-----SRSSGQGGQEFKNEVVLVAKLQ 400
N+ LG G FGEVY +G+E+AVK++ S+ + + + E+ L+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 401 HRNLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGI 458
H +V+ G + EEK L E++P S+ L + + +RRY I +G+
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE-NVTRRYT--RQILQGV 119
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQGNTNRIVGTYGYM 517
YLH + I+HRD+K +NIL D+ N K+ DFG +K I + + + GT +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGA 558
+PE + K+DV+S V+E++T K + Y+ A
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 354 LGEGGFGEV------YKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRL 407
LG+GGFGEV G + + +++ KRL + SG+ + E++ + + +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL---EKVNSPFIVN 57
Query: 408 LGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSR 466
L + E + + LV + L Y +Y ++ L+ R I GIL+LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNV-GERGLEMERVIHYSAQITCGILHLHS--- 113
Query: 467 LRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT-NRIVGTYGYMAPEYAMHG 525
+ I++RD+K N+LLD + N ++SD G+A V+ G T + GT GYMAPE
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA----VELKDGKTITQRAGTNGYMAPEILKEE 169
Query: 526 QFSVKSDVYSFGVLVLEIITGK 547
+S D ++ G + E++ G+
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 17/215 (7%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRL-----SRSSGQGGQEFKNEVVLVAKLQHRNLVRL 407
LG+G FG VY + +G+E+A K++ S + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 408 LGFCLE--GEEKILVY-EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED 464
G CL E+ + ++ E++P S+ L + L S K I G+ YLH +
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 465 SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR-IVGTYGYMAPEYAM 523
I+HRD+K +NIL D+ N K+ DFG +K G R + GT +M+PE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 524 HGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGA 558
+ K+DV+S G V+E++T K + Y+ A
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 67/204 (32%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN----EVVLVAKLQHRNLVRL 407
+GEG +G V K +GQ +A+K+ S + K E+ ++ +L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ-LDWSRRYKIIGGIARGILYLHEDSR 466
+ + LV+EFV + LD + EK LD SR K + I RGI + H +
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN- 120
Query: 467 LRIIHRDLKASNILLDAEMNPKISDFGMAKIF---GVDQTQGNTNRIVGTYGYMAPEYAM 523
IIHRD+K NIL+ K+ DFG A+ G T V T Y APE +
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD-----YVATRWYRAPELLV 173
Query: 524 -HGQFSVKSDVYSFGVLVLEIITG 546
++ D+++ G LV E++TG
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN---EVVLVAKLQHRN 403
F+ ++G G FG VY + + + +A+K++S S Q +++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
+ G L LV E+ + D + Q+++ + I G +G+ YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIA---AICHGALQGLAYLHS 133
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE--Y 521
R IHRD+KA NILL K++DFG A + N VGT +MAPE
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYWMAPEVIL 184
Query: 522 AM-HGQFSVKSDVYSFGVLVLEI 543
AM GQ+ K DV+S G+ +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 354 LGEGGFGEVYK-GVLPSGQEIAVKRLS--RSSGQGGQEFK-NEVVLVAKLQHRNLVRLLG 409
LG+GGFGEV V +G+ A K+L R + G+ NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 410 FCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLR 468
+ E ++ + LV + L + +Y + + R I G+ LH++ R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYH-MGEAGFEEGRAVFYAAEICCGLEDLHQE---R 122
Query: 469 IIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT-QGNTNRIVGTYGYMAPEYAMHGQF 527
I++RDLK NILLD + +ISD G+A QT +G VGT GYMAPE + ++
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNERY 178
Query: 528 SVKSDVYSFGVLVLEIITGKKNSSFYQ 554
+ D ++ G L+ E+I G+ S F Q
Sbjct: 179 TFSPDWWALGCLLYEMIAGQ--SPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 70/239 (29%), Positives = 114/239 (47%), Gaps = 19/239 (7%)
Query: 319 VPEVNADNDITTLESLQFDF-ETIEVATNNFSTDNKLGEGGFGEVYK----GVLPSGQ-- 371
V E N+ ++ Q + E NN S LG G FG+V + G+ S
Sbjct: 7 VIESINGNEYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVM 66
Query: 372 EIAVKRLSRSSGQGGQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSL 429
++AVK L ++ +E +E+ +++ L H N+V LLG C G +++ E+ L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 430 DYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 489
FL +++ L +A+G+ +L + IHRDL A N+LL KI
Sbjct: 127 LNFLRR-KRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182
Query: 490 SDFGMAKIFGVDQ---TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
DFG+A+ D +GN V +MAPE + ++ +SDV+S+G+L+ EI +
Sbjct: 183 CDFGLARDIMNDSNYVVKGNARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 38/218 (17%)
Query: 353 KLGEGGFGEVYKGVL---PSGQEIAVKRLSRSSGQG---GQEFKNEVVLVAKLQHRNLVR 406
+G G +G VYK G+E A+K+ Q Q E+ L+ +L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 407 LLGFCLEGEEKI--LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYK-----------IIGG 453
L+ LE +K L++++ ++ L+ Q + + R+ K ++
Sbjct: 67 LVEVFLEHADKSVYLLFDYA-----EHDLW-----QIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMAKIFGVD-QTQGNTN 508
I G+ YLH + ++HRDLK +NIL+ E KI D G+A++F + + +
Sbjct: 117 ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 509 RIVGTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIIT 545
+V T Y APE + + K+ D+++ G + E++T
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 64/203 (31%), Positives = 105/203 (51%), Gaps = 25/203 (12%)
Query: 353 KLGEGGFGEVYK------GVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVR 406
+LG+G FG+VYK GVL + + I K S + +++ E+ ++A H N+V+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVK 66
Query: 407 LL-GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
LL F E IL+ EF ++D + E E+ L + + + YLHE+
Sbjct: 67 LLDAFYYENNLWILI-EFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN- 122
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM-- 523
+IIHRDLKA NIL + + K++DFG++ +T + +GT +MAPE M
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 524 ---HGQFSVKSDVYSFGVLVLEI 543
+ K+DV+S G+ ++E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 353 KLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKN--EVVLVAKLQ---HRNLVR 406
++G G +G VYK P SG +A+K + + + G EV L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 407 LLGFC----LEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYL 461
L+ C + E K+ LV+E V Y P + + ++ RG+ +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDFL 124
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY 521
H + I+HRDLK NIL+ + K++DFG+A+I+ Q +V T Y APE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 522 AMHGQFSVKSDVYSFGVLVLEIITGK 547
+ ++ D++S G + E+ K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 72/207 (34%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 354 LGEGGFGEVYK-GVLPSGQEIAVKRLS--RSSGQGGQEFK-NEVVLVAKLQHRNLVRLLG 409
LG+GGFGEV V +G+ A K+L R + G+ NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 410 FCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLR 468
+ E ++ + LV + L + +Y D R I G+ LH R R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYN-MGNPGFDEERAVFYAAEITCGLEDLH---RER 122
Query: 469 IIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR-IVGTYGYMAPEYAMHGQF 527
I++RDLK NILLD + +ISD G+A V+ +G T R VGT GYMAPE + ++
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAPEVVKNERY 178
Query: 528 SVKSDVYSFGVLVLEIITGKKNSSFYQ 554
+ D + G L+ E+I GK S F Q
Sbjct: 179 TFSPDWWGLGCLIYEMIEGK--SPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFC 411
+G G +G+VYKG + +GQ A+K + +G +E K E+ ++ K HRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 412 LE------GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
++ ++ LV EF S+ L + K L I I RG+ +LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH- 130
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM-- 523
++IHRD+K N+LL K+ DFG++ +D+T G N +GT +MAPE
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 524 ---HGQFSVKSDVYSFGVLVLEIITG 546
+ KSD++S G+ +E+ G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL-----SRSSGQGGQEFKNEVVLVAKLQ 400
N+ LG+G FG VY +G+E+AVK++ S + + + E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 401 HRNLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGI 458
H +V+ G + E+ L E +P S+ L + + +R+Y I G+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-NVTRKYT--RQILEGV 119
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN-TNRIVGTYGYM 517
YLH + I+HRD+K +NIL D+ N K+ DFG +K G + GT +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
+PE + K+D++S G V+E++T K
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 48/231 (20%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVL 395
D E IE +LG G +G V K +P+G +AVKR+ + QE K +++
Sbjct: 2 DLEVIE----------ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQK-RLLM 48
Query: 396 VAKLQHR-----NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEP--EKQQQLDWSRRY 448
+ R V G L E + + V + SLD F Y+ +K +
Sbjct: 49 DLDISMRSVDCPYTVTFYG-ALFREGDVWICMEVMDTSLDKF-YKKVYDKGLTIPEDILG 106
Query: 449 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG--------MAKIFGV 500
KI I + + YLH +L +IHRD+K SN+L++ K+ DFG +AK +
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT--I 162
Query: 501 DQTQGNTNRIVGTYGYMAPEY---AMHGQ-FSVKSDVYSFGVLVLEIITGK 547
D G YMAPE ++ + + VKSDV+S G+ ++E+ TG+
Sbjct: 163 D---------AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 354 LGEGGFGEVY------KGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRL 407
LG+GGFGEV G L + +++ KRL + G G + ++ AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRIL--AKVHSRFIVSL 58
Query: 408 LGFCLEGEEKI-LVYEFVPNKSLDYFLYE-PEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
+ + + + LV + L Y +Y E+ R I G+ +LH+
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR- 116
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG 525
RII+RDLK N+LLD + N +ISD G+A + Q T GT G+MAPE
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGE 172
Query: 526 QFSVKSDVYSFGVLVLEIITGK 547
++ D ++ GV + E+I +
Sbjct: 173 EYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 69/222 (31%), Positives = 103/222 (46%), Gaps = 41/222 (18%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSRS----SGQGGQE 388
DFE I+ LG G FG V +K SG+ A+K LS++ Q +
Sbjct: 2 DFEFIKT----------LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQV-EH 47
Query: 389 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE----PEKQQQLDW 444
NE ++ ++H LV L G + LV E+VP L L + PE
Sbjct: 48 VLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPE-----PV 102
Query: 445 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504
+R Y + + YLH L I++RDLK N+LLD++ KI+DFG AK +
Sbjct: 103 ARFY--AAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-----VK 152
Query: 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 546
G T + GT Y+APE + + D ++ G+L+ E++ G
Sbjct: 153 GRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 68/231 (29%), Positives = 108/231 (46%), Gaps = 29/231 (12%)
Query: 348 FSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQH 401
F+ LG+G FG V + L S Q++AVK L S +EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 402 RNLVRLLGFCLEGEEK------ILVYEFVPNKSLDYFLYEP---EKQQQLDWSRRYKIIG 452
N+++L+G L K +++ F+ + L FL E+ L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 453 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA-KIFGVD-QTQGNTNRI 510
IA G+ YL S IHRDL A N +L+ M ++DFG++ KI+ D QG +++
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 511 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-------GKKNSSFYQ 554
++A E ++ SDV++FGV + EI+T G +NS Y
Sbjct: 178 --PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 335 QFDFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEV 393
Q D+E I+ ++G G +G+VYK L +G+ AVK + G + E+
Sbjct: 8 QHDYELIQ----------RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEI 57
Query: 394 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD--YFLYEPEKQQQLDWSRRYKII 451
+V + +H N+V G L E+ + E+ SL Y + P + Q+ + R +
Sbjct: 58 FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL- 116
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
+G+ YLH ++ HRD+K +NILL + K++DFG+A + T +
Sbjct: 117 ----QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFI 167
Query: 512 GTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEI 543
GT +MAPE A +G ++ D+++ G+ +E+
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 41/229 (17%)
Query: 338 FETIEVATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSR--SSGQGGQEFKNEVV 394
+T+ + + + +G G +G+V +G+++A+K+LSR S + E+
Sbjct: 7 NKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR 66
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------------LYEPEKQQQ 441
L+ + H N++ LL F P SL+ F L K Q+
Sbjct: 67 LLKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQK 114
Query: 442 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501
L ++ I RG+ Y+H IIHRDLK SNI ++ + KI DFG+A+ +
Sbjct: 115 LSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171
Query: 502 QTQGNTNRIVGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGK 547
T V T Y APE MH +V D++S G ++ E++TGK
Sbjct: 172 MTG-----YVATRWYRAPEIMLNWMHYNQTV--DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 354 LGEGGFGEVYKGVLPSGQ------EIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRL 407
+G G FG V+ + Q +I V+++++ Q NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRL 467
LE + ++V E+ P +L ++ +++ I+ + +L LH
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYI----QKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 468 RIIHRDLKASNILLDA-EMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ 526
I+HRDLK NILLD +M KI DFG++KI ++ +VGT Y++PE
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKP 177
Query: 527 FSVKSDVYSFGVLVLEIITGKK 548
++ KSD+++ G ++ E+ + K+
Sbjct: 178 YNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 46/229 (20%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSG---QEIAVKRLSRSSGQGG-QEFKNEVVLVAKL-Q 400
N+ + +GEG FG+V K + + A+KR+ + + ++F E+ ++ KL
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPE-------------------KQQQ 441
H N++ LLG C L E+ P+ +L FL + QQ
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 442 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501
L ++ +ARG+ YL S+ + IHRDL A NIL+ KI+DFG+++
Sbjct: 127 LHFA------ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----- 172
Query: 502 QTQGNTNRIVGTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
G + T G +MA E + ++ SDV+S+GVL+ EI++
Sbjct: 173 ---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 353 KLGEGGFGEVYKG--VLPSGQEIAVKRLSRSSGQGGQEFKN--EVVLVAKLQ---HRNLV 405
++GEG +G+V+K + G+ +A+KR+ +G+ G EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 406 RLLGFCL----EGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
RL C + E K+ LV+E V Y PE + + ++ + RG+ +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLDF 125
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520
LH R++HRDLK NIL+ + K++DFG+A+I+ Q +V T Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 179
Query: 521 YAMHGQFSVKSDVYSFGVLVLEI 543
+ ++ D++S G + E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 68/229 (29%), Positives = 114/229 (49%), Gaps = 30/229 (13%)
Query: 342 EVATNNFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SRSSGQGGQEFKNE 392
EV + LGEG FG+V K ++AVK L S ++ + + +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 393 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-----------YEPEK-- 438
+ ++ + +H+N++ LLG C + ++ E+ +L +L Y P +
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 439 QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-I 497
++QL + +ARG+ YL + + IHRDL A N+L+ + KI+DFG+A+ I
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 498 FGVDQTQGNTN-RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+D + TN R+ +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 191 HHIDYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 335 QFDFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEV 393
Q DFE I+ ++G G +G+VYK + +G+ A+K + G+ + E+
Sbjct: 8 QEDFELIQ----------RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI 57
Query: 394 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD--YFLYEPEKQQQLDWSRRYKII 451
+++ +H N+V G L ++ + EF SL Y + P + Q+ + R +
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL- 116
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
+G+ YLH + +HRD+K +NILL + K++DFG++ + T +
Sbjct: 117 ----QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFI 167
Query: 512 GTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEI 543
GT +MAPE A G ++ D+++ G+ +E+
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 6e-16
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN--------EVVLVAKLQ-HR 402
+LG+G FG VY +G+ +A+K++ ++F + EV + KL H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHP 58
Query: 403 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLH 462
N+V+L E +E V+E++ +L Y L + K + S II I +G+ ++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA 522
+ HRDLK N+L+ KI+DFG+A+ + T+ V T Y APE
Sbjct: 117 ---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTD-YVSTRWYRAPEIL 170
Query: 523 MHGQF-SVKSDVYSFGVLVLEIITGK 547
+ S D+++ G ++ E+ T +
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 66/200 (33%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 354 LGEGGFGEVYK-GVLPSGQEIAVKRLS--RSSGQGGQEFK-NEVVLVAKLQHRNLVRLLG 409
LG+GGFGEV V +G+ A K+L R + G+ NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 410 FCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLR 468
+ E ++ + LV + L + +Y D R + G+ L R R
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQ---RER 122
Query: 469 IIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR-IVGTYGYMAPEYAMHGQF 527
I++RDLK NILLD + +ISD G+A V +G T R VGT GYMAPE + ++
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 528 SVKSDVYSFGVLVLEIITGK 547
+ D + G L+ E+I G+
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 354 LGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFK----NEVVLVAKLQHRNLVRLL 408
LG+G FG+V+ L + Q A+K L + + + + VL +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 409 GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLR 468
E V E++ L ++ + + D R I G+ +LH
Sbjct: 63 CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--- 116
Query: 469 IIHRDLKASNILLDAEMNPKISDFGMAK--IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ 526
I++RDLK NILLD + + KI+DFGM K + G T GT Y+APE + +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLGQK 172
Query: 527 FSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
++ D +SFGVL+ E++ G+ S F+ D
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ--SPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 347 NFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSRSS----GQGGQEFKNEVVLVAK 398
NF LG G +G+V+ G +G+ A+K L +++ + + + E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 399 LQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARG 457
++ + L + + + K+ L+ ++V L LY+ E S I I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLA 117
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYM 517
+ +LH+ L II+RD+K NILLD+E + ++DFG++K F ++ + GT YM
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 518 APEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVS 566
APE G D +S GVL E++TG +S + DG + S +S
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG---ASPFTVDGEQNSQSEIS 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 71/240 (29%), Positives = 108/240 (45%), Gaps = 57/240 (23%)
Query: 338 FETIEVATNNFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSRSSGQGGQE 388
F ++EV + F+ + +G G G V Y V GQ +A+K+LSR
Sbjct: 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRP------- 52
Query: 389 FKN---------EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--LYEPE 437
F+N E+VL+ + H+N++ LL F P KSL+ F +Y
Sbjct: 53 FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVM 100
Query: 438 K----------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 487
+ Q LD R ++ + GI +LH IIHRDLK SNI++ ++
Sbjct: 101 ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 157
Query: 488 KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
KI DFG+A+ G T +V Y Y APE + + D++S G ++ E+I G
Sbjct: 158 KILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQEFK---NEVVLVAKLQH 401
+F ++G+GG+G+V+ EI A+KR+ +S E + E ++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 402 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
LV+LL + + +E + L E+VP L + D +R Y +A
Sbjct: 61 EWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSE-DHARFY-----MAEMFEA 113
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520
+ L IHRDLK N L+DA + K++DFG++K N +VG+ YMAPE
Sbjct: 114 VDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPE 168
Query: 521 YAMHGQFSVKSDVYSFGVLVLEIITG 546
+ D +S G ++ E + G
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 51/239 (21%)
Query: 334 LQFDFETIEVATNNFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSRSSGQGGQEFKN- 391
L D + N+ ++G G G+VYK +G +AVK++ R+ + +E K
Sbjct: 3 LTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRI 60
Query: 392 ----EVVL---------------VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF 432
+VVL + + L+ CL+ + + +P L
Sbjct: 61 LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLD-KLLKRIQGPIPEDILG-- 117
Query: 433 LYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492
K+ I + + YL E +IHRD+K SNILLDA N K+ DF
Sbjct: 118 ----------------KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDF 159
Query: 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEY----AMHGQFSVKSDVYSFGVLVLEIITGK 547
G++ VD ++ T R G YMAPE + ++ +++DV+S G+ ++E+ TG+
Sbjct: 160 GISG-RLVD-SKAKT-RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 47/216 (21%)
Query: 354 LGEGGFGEV----YKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVL-------------V 396
LG+G FG+V KG + + AVK L K +V+L V
Sbjct: 3 LGKGSFGKVLLAELKG---TDELYAVKVL-----------KKDVILQDDDVECTMTEKRV 48
Query: 397 AKLQHRN--LVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGG 453
L ++ L +L C + ++++ V E+V L ++ ++ + D R
Sbjct: 49 LALAGKHPFLTQLHS-CFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAE 104
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK--IFGVDQTQGNTNRIV 511
I G+ +LHE II+RDLK N+LLD+E + KI+DFGM K I G T+
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFC 157
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
GT Y+APE + + D ++ GVL+ E++ G+
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 70/237 (29%), Positives = 113/237 (47%), Gaps = 34/237 (14%)
Query: 325 DNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSG 383
D D++ L FE +EV +G G +G+VYKG + +GQ A+K + +
Sbjct: 5 DIDLSALRDPAGIFELVEV----------VGNGTYGQVYKGRHVKTGQLAAIKVMDVTED 54
Query: 384 QGGQEFKNEVVLVAKL-QHRNLVRLLGFCLE------GEEKILVYEFVPNKSLDYFLYEP 436
+ +E K E+ ++ K HRN+ G ++ ++ LV EF S+ L +
Sbjct: 55 EE-EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKN 112
Query: 437 EKQQQL--DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494
K L DW I I RG+ +LH ++IHRD+K N+LL K+ DFG+
Sbjct: 113 TKGNALKEDWIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGV 167
Query: 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITG 546
+ +D+T G N +GT +MAPE + +SD++S G+ +E+ G
Sbjct: 168 SA--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 63/200 (31%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 354 LGEGGFGEVY--KGVLP--SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRL 407
LG+G FG+V+ + + +GQ A+K L +++ + K E ++A++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 408 LGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSR 466
+ + E K+ L+ +F+ L L + + D + Y + +A + +LH
Sbjct: 64 -HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-VKFY--LAELALALDHLH---S 116
Query: 467 LRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ 526
L II+RDLK NILLD E + K++DFG++K +D + GT YMAPE
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEK-KAYSFCGTVEYMAPEVVNRRG 174
Query: 527 FSVKSDVYSFGVLVLEIITG 546
+ +D +SFGVL+ E++TG
Sbjct: 175 HTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 66/233 (28%), Positives = 110/233 (47%), Gaps = 38/233 (16%)
Query: 342 EVATNNFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRLSRSSGQGGQEFKNEV 393
E + + + LGEG FG+V K +AVK L + + K+
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-----KDLS 65
Query: 394 VLVAKLQ-------HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE---PEKQQQLD 443
LV++++ H+N++ LLG C + ++ E+ +L +L P + D
Sbjct: 66 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 444 WSR------RYKIIGG----IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493
+R +K + +ARG+ YL + + IHRDL A N+L+ KI+DFG
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFG 182
Query: 494 MAK-IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+A+ + +D + TN + +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 183 LARDVNNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 69/230 (30%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN---------EVVLVAKLQHRN 403
+G G +G V V +G+++A+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 404 LVRLL---------GFCLEGEEKILVYEFVP---------NKSLD-----YFLYEPEKQQ 440
++ LL F + +V E + + L YFLY+
Sbjct: 61 IIGLLDILRPPSPEDF----NDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQ----- 111
Query: 441 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500
I RG+ YLH + +IHRDLK SNIL+++ + KI DFG+A+
Sbjct: 112 -------------ILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155
Query: 501 DQTQGN--TNRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 547
D+ + T +V T Y APE + ++ D++S G + E++T K
Sbjct: 156 DEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 347 NFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR---LSRSSGQGGQEFKNEVVLVAKLQHRN 403
+ K+GEG FG++Y S E V + L++ + + K EV+L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEP-----EKQQQLDWSRRYKIIGGIARGI 458
+V E +V E+ L + + Q L W + I+ G+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLGL 114
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYM 517
++H+ +I+HRD+K+ NI L M K+ DFG+A+ ++ + VGT Y+
Sbjct: 115 KHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYL 169
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
+PE + ++ K+D++S G ++ E+ T K
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 65/228 (28%), Positives = 102/228 (44%), Gaps = 48/228 (21%)
Query: 338 FETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSR--SSGQGGQEFKNEVV 394
FE TN + +G G FG V +GQ +A+K++ + S+ + E+
Sbjct: 6 FEI----TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKI-LVYEF-------------VPNKSLDYFLYEPEKQQ 440
L+ L+H N++ L + E I V E + + + YFLY+
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQ----- 116
Query: 441 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500
I RG+ Y+H ++HRDLK SNIL++ + KI DFG+A+I
Sbjct: 117 -------------ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI--- 157
Query: 501 DQTQGNTNRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 547
Q T V T Y APE + Q + V+ D++S G + E++ GK
Sbjct: 158 -QDPQMTG-YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 58/216 (26%), Positives = 112/216 (51%), Gaps = 25/216 (11%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFK--NEVVLVAKLQHRNL 404
F ++GEG +G+VYK +G+ +A+K++ + + G E+ ++ +L HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 405 VRL----------LGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRY--KIIG 452
V L L F + LV+E++ D+ L + + +S + +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 453 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVG 512
+ G+ Y H+ + L HRD+K SNILL+ + K++DFG+A+++ ++++ TN+++
Sbjct: 124 QLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179
Query: 513 TYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 547
T Y PE + ++ DV+S G ++ E+ T K
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 354 LGEGGFGEVYK-GVLPSGQEIAVKRLS--RSSGQGGQEFK-NEVVLVAKLQHRNLVRLLG 409
LG+GGFGEV V +G+ A KRL R + G+ NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 410 FCLEGEEKI-LVYEFVPNKSLDYFLYE---PEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
+ E ++ + LV + L + +Y P +++ R I G+ LH ++
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE----RALFYAAEILCGLEDLHREN 122
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMA-KIFGVDQTQGNTNRIVGTYGYMAPEYAMH 524
++RDLK NILLD + +ISD G+A KI + +G VGT GYMAPE +
Sbjct: 123 ---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNN 175
Query: 525 GQFSVKSDVYSFGVLVLEIITGK 547
++++ D + G L+ E+I G+
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 49/226 (21%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQG-GQEFKNEVVLVAKLQHRNL 404
+ + +GEG +G V P+G ++A+K++S Q Q E+ ++ + +H N+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 405 VRLL------GFCLEGEEKILVYEFVP-------------NKSLDYFLYEPEKQQQLDWS 445
+ +L F + +V E + N + YFLY+
Sbjct: 66 IGILDIIRPPSFE-SFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ---------- 114
Query: 446 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505
I RG+ Y+H + ++HRDLK SN+LL+ + KI DFG+A+I D
Sbjct: 115 --------ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHD 161
Query: 506 NTNRI---VGTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGK 547
+T + V T Y APE ++ + K+ D++S G ++ E+++ +
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 34/218 (15%)
Query: 351 DNKLGEGGFGEVYKGVLPSG---QEIAVKRLSR-SSGQGGQEFKNEVVLVAKL-QHRNLV 405
++ +GEG FG+V + ++ A+K L +S ++F E+ ++ KL H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLY-------------EPEKQQQLDWSRRYKIIG 452
LLG C + E+ P +L FL E L + +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 453 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVG 512
+A G+ YL E + IHRDL A N+L+ + KI+DFG+++ G +
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--------GEEVYVKK 175
Query: 513 TYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
T G +MA E + ++ KSDV+SFGVL+ EI++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 33/208 (15%)
Query: 353 KLGEGGFGEVY-----KGV----LPSGQEIAVKRLS-RSSGQGGQEFKNEVVLVAKLQHR 402
+LG+G FG VY K V L +EI V L+ + Q QE + L++KL H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ----LLSKLDHP 62
Query: 403 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEK-------QQQLDWSRRYKIIGGIA 455
+V+ LE + ++ E+ + LD L E + Q +W + +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117
Query: 456 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG 515
G+ Y+H+ RI+HRDLKA NI L + KI DFG++++ T GT
Sbjct: 118 -GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPY 170
Query: 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEI 543
YM+PE H + KSD++S G ++ E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 63/214 (29%), Positives = 108/214 (50%), Gaps = 28/214 (13%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFK----NEVVLVAKLQH 401
+ N++ EG +G VY+ +G+ +A+K+L + G F E+ ++ KLQH
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG--FPITSLREINILLKLQH 63
Query: 402 RNLVRL----LGFCLEGEEKI-LVYEFVPN--KSLDYFLYEPEKQQQLDWSRRYKIIGGI 454
N+V + +G +KI +V E+V + KSL +Q S ++ +
Sbjct: 64 PNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSL-----METMKQPFLQSEVKCLMLQL 115
Query: 455 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTY 514
G+ +LH++ I+HRDLK SN+LL+ KI DFG+A+ +G ++V T
Sbjct: 116 LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS--PLKPYTQLVVTL 170
Query: 515 GYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 547
Y APE + ++S D++S G + E++T K
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 37/205 (18%)
Query: 357 GGFGEVY--KGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNL---------V 405
G FG VY K +G A+K L +S KN+V V K + +
Sbjct: 7 GAFGSVYLAKKRS-TGDYFAIKVLKKSD----MIAKNQVTNV-KAERAIMMIQGESPYVA 60
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFL----YEPEKQQQLDWSRRYKIIGGIARGILYL 461
+L + LV E++ + PE DW+++Y I + G+ L
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE-----DWAKQY--IAEVVLGVEDL 113
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY 521
H+ IIHRD+K N+L+D + K++DFG+++ ++ + VGT Y+APE
Sbjct: 114 HQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPET 164
Query: 522 AMHGQFSVKSDVYSFGVLVLEIITG 546
+ SD +S G ++ E + G
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 18/235 (7%)
Query: 352 NKLGEGGFGEVYKGVLPSGQEIA---VKRLSRSSGQGGQ-EFKNEVVLVAKLQHRNLVRL 407
+++G G FG+V G G A VK L S+ Q F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRY--KIIGGIARGILYLHEDS 465
LG C+E +LV EF P L +L + ++ +A G+L+LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG 525
+ IH DL N L A+++ KI D+G+A + + ++APE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 526 QFSV-------KSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSINRVINL 573
+ KS+++S GV + E+ T Y +L V + I L
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQP--YPDLSDEQVLKQVVREQDIKL 230
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 69/236 (29%), Positives = 111/236 (47%), Gaps = 38/236 (16%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN--EVVLVAKLQHRN 403
F N++GEG +G VY+ SG+ +A+K++ + + G + E+ L+ L+H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLD-YFLYEPEKQQQL-----DWSRRYK------II 451
+V L E V K LD FL +Q L + + ++
Sbjct: 68 IVELK-------------EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLM 114
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
+ RG+ YLHE+ IIHRDLK SN+LL + KI+DFG+A+ +G+ T ++V
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-MTPKVV 170
Query: 512 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGKK----NSSFYQTDGAADLL 562
T Y APE + + D+++ G ++ E++ K S Q D LL
Sbjct: 171 -TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLL 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 34/215 (15%)
Query: 354 LGEGGFGEVYKGVLPSG---QEIAVKRLSR-SSGQGGQEFKNEVVLVAKL-QHRNLVRLL 408
+GEG FG+V K + + A+KR+ +S ++F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 409 GFCLEGEEKILVYEFVPNKSL-DY------------FLYEPEKQQQLDWSRRYKIIGGIA 455
G C L E+ P+ +L D+ F L + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 456 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG 515
RG+ YL + + IHRDL A NIL+ KI+DFG+++ G + T G
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMG 171
Query: 516 -----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+MA E + ++ SDV+S+GVL+ EI++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 353 KLGEGGFGEVYKGVLPSG---QEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLL 408
++G G FG+V G + SG ++ VK L S+ Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 409 GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQL--DWSRRYKIIGGIARGILYLHEDSR 466
G C E +LV EF P L +L K + + D + ++ IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 467 LRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA--MH 524
IH DL N LL A++ KI D+G++ + +++ ++APE +H
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 525 GQFSV-----KSDVYSFGVLVLEI 543
G V +S+V+S GV + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 25/185 (13%)
Query: 352 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFK----NEVVLVAKLQHRNLVR 406
K+G+G FGEV+K + Q +A+K++ + + G F E+ ++ L+H N+V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG--FPITALREIKILQLLKHENVVN 75
Query: 407 LLGFCLEGEEK--------ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGI 458
L+ C LV+EF + L L + S K++ + G+
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGL 132
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV---DQTQGNTNRIVGTYG 515
Y+H R +I+HRD+KA+NIL+ + K++DFG+A+ F + + TNR+V T
Sbjct: 133 YYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLW 188
Query: 516 YMAPE 520
Y PE
Sbjct: 189 YRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 354 LGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAK------LQHRNLVR 406
LG+G FG+V L SG+ AVK L + Q+ E + K H L +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVIL--QDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 407 LLGFCLEGEEKIL-VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
L C + +++ V EFV L ++ +K ++ D +R I +++LH+
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAK--IF-GVDQTQGNTNRIVGTYGYMAPEYA 522
II+RDLK N+LLD E + K++DFGM K IF G T+ GT Y+APE
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-----TTSTFCGTPDYIAPEIL 168
Query: 523 MHGQFSVKSDVYSFGVLVLEIITG 546
+ D ++ GVL+ E++ G
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 34/205 (16%)
Query: 354 LGEGGFGEVYKG-VLPSGQEIAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLG-F 410
LG G G VYK L + + +AVK + + + ++ +E+ ++ K ++ G F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 411 CLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIA----RGILYLHEDSR 466
+E I EF+ SLD + PE ++G IA +G+ YL
Sbjct: 69 FVENRISICT-EFMDGGSLDVYRKIPEH-----------VLGRIAVAVVKGLTYLWS--- 113
Query: 467 LRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRI----VGTYGYMAPEYA 522
L+I+HRD+K SN+L++ K+ DFG++ N I VGT YMAPE
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--------VNSIAKTYVGTNAYMAPERI 165
Query: 523 MHGQFSVKSDVYSFGVLVLEIITGK 547
Q+ + SDV+S G+ +E+ G+
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 41/221 (18%)
Query: 354 LGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLV--RLLGF 410
LG+G FG+V L G+ AVK L K +VVL+ +V R+L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKAL-----------KKDVVLIDDDVECTMVEKRVLAL 51
Query: 411 CLEG-------------EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARG 457
E E V EF+ L ++ + + + D R I G
Sbjct: 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVCG 108
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK--IFGVDQTQGNTNRIVGTYG 515
+ +LH II+RDLK N++LD + + KI+DFGM K +FG + GT
Sbjct: 109 LQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPD 161
Query: 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
Y+APE +++ D +SFGVL+ E++ G+ S F+ D
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ--SPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 63/233 (27%), Positives = 109/233 (46%), Gaps = 38/233 (16%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVV------L 395
E++ + LGEG FG+V V+ I + ++ + K++ L
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64
Query: 396 VAKLQ-------HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE------------- 435
V++++ H+N++ LLG C + ++ E+ +L +L
Sbjct: 65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 436 --PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493
PE +QL + +ARG+ YL + + IHRDL A N+L+ + KI+DFG
Sbjct: 125 KLPE--EQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFG 179
Query: 494 MAK-IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+A+ + +D + TN + +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 180 LARDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 40/96 (41%), Positives = 57/96 (59%), Gaps = 9/96 (9%)
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK--IFGVDQTQGNTNRIV 511
IA G+ +LH II+RDLK N++LDAE + KI+DFGM K IFG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR----TFC 162
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
GT Y+APE + + D ++FGVL+ E++ G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 65/245 (26%), Positives = 104/245 (42%), Gaps = 55/245 (22%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRS----SGQGGQEFKN 391
DFE I+V +G G FGEV+ ++ A+K L +S Q +
Sbjct: 2 DFEVIKV----------IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQI-AHVRA 50
Query: 392 EVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLD--WSRRY 448
E ++A +V+L + + EE + LV E++P L L ++ +R Y
Sbjct: 51 ERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLI---RKDVFPEETARFY 106
Query: 449 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK------------ 496
IA +L L +L IHRD+K NIL+DA+ + K++DFG+ K
Sbjct: 107 -----IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161
Query: 497 -------------IFGVDQTQGNTNR--IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVL 541
+ D Q VGT Y+APE + ++ D +S GV++
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221
Query: 542 EIITG 546
E++ G
Sbjct: 222 EMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 36/99 (36%), Positives = 60/99 (60%), Gaps = 6/99 (6%)
Query: 449 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTN 508
KI + RG+ YL E + +I+HRD+K SNIL+++ K+ DFG++ +D N
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---AN 156
Query: 509 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
VGT YM+PE ++V+SD++S G+ ++E+ G+
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 14/196 (7%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG--QEFKNEVVLVAKLQHRNLVRLLG 409
K+GEG +G V+K + + +A+KR+ G E+ L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 410 FCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLR 468
L ++K+ LV+E+ YF +D + + +G+ + H
Sbjct: 67 -VLHSDKKLTLVFEYCDQDLKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 469 IIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ-F 527
++HRDLK N+L++ K++DFG+A+ FG+ + V T Y P+ + +
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE--VVTLWYRPPDVLFGAKLY 177
Query: 528 SVKSDVYSFGVLVLEI 543
S D++S G + E+
Sbjct: 178 STSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 7e-14
Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 24/194 (12%)
Query: 369 SGQEIAVKRLSRSSGQGGQE---FKNEVVLVAKLQHRNLVRLLGFCLEGEEK----ILVY 421
+G E+A+K L + + + F+ E L A+L H N+V LL GE V+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD---SGEAPPGLLFAVF 58
Query: 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 481
E+VP ++L L L +++ + + H I+HRDLK NI++
Sbjct: 59 EYVPGRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMV 112
Query: 482 ---DAEMNPKISDFGMAKIF-GVD----QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDV 533
+ K+ DFG+ + GV T T ++GT Y APE + SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 534 YSFGVLVLEIITGK 547
Y++G++ LE +TG+
Sbjct: 173 YAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 39/212 (18%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412
+G G +G V + +G ++A+K+L R F++E L AK +R L RLL +
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRP-------FQSE--LFAKRAYREL-RLLKH-M 71
Query: 413 EGEEKI-LVYEFVPNKSLD----YFLYEP---------EKQQQLDWSRRYKIIGGIARGI 458
+ E I L+ F P+ SLD ++L P K ++L R ++ + +G+
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMA 518
Y+H IIHRDLK N+ ++ + KI DFG+A+ QT V T Y A
Sbjct: 132 KYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRA 183
Query: 519 PEYA---MHGQFSVKSDVYSFGVLVLEIITGK 547
PE MH ++ D++S G ++ E++TGK
Sbjct: 184 PEVILNWMH--YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 339 ETIEVATN-NFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVA 397
+ EV + ++ L G G V+ P + V ++ GQ G E +L+
Sbjct: 58 KAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI----GQKGTTLI-EAMLLQ 112
Query: 398 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARG 457
+ H +++R+ + G +V +P+ S D + Y ++ + L + I I G
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEG 169
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYM 517
+ YLH RIIHRD+K NI ++ I D G A+ F V + GT
Sbjct: 170 LRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAP--AFLGLAGTVETN 223
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEII 544
APE +++ K+D++S G+++ E++
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 56/214 (26%), Positives = 109/214 (50%), Gaps = 41/214 (19%)
Query: 353 KLGEGGFGEVYKGVL----PSGQEIAVKRL--SRSSGQGGQEFKNEVVLVAKLQHRNLVR 406
K+GEG FG K +L G++ +K + S+ S + +E + EV +++ ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 407 -------------LLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGG 453
++ +C G+ +Y+ + + F PE Q LDW +
Sbjct: 64 YQESFEENGNLYIVMDYCEGGD----LYKKINAQRGVLF---PE-DQILDWFVQ------ 109
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
I + ++H+ +I+HRD+K+ NI L + K+ DFG+A++ ++ T +GT
Sbjct: 110 ICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGT 164
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
Y++PE + ++ KSD+++ G ++ E+ T K
Sbjct: 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 28/207 (13%)
Query: 354 LGEGGFGEV----YKGVLPSGQEIAVKRLS--RSSGQGGQEFKNEVVLVAKLQHRNLVRL 407
+G+G +GEV ++ G++ +K+L+ +S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-A 63
Query: 408 LGFCLEGEEKIL--VYEFVPNKSLDYFLYEPEKQ-----QQLDWSRRYKIIGGIARGILY 460
EGE+ +L V F L + L E + + Q ++W + IA + Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQY 117
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520
LHE I+HRDLK N+ L K+ D G+A++ +T ++GT YM+PE
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPE 172
Query: 521 YAMHGQFSVKSDVYSFGVLVLEIITGK 547
+ ++ KSDV++ G V E+ T K
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 27/216 (12%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYK-GVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ 400
E+ ++F ++LG G G V K PSG +A K + +N+++ ++
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPA---IRNQIIRELQVL 57
Query: 401 HR-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIA 455
H N ++GF +GE I + E + SLD L E ++ + +I+G ++
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPE-------EILGKVS 109
Query: 456 ----RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
RG+ YL E + +I+HRD+K SNIL+++ K+ DFG++ +D N V
Sbjct: 110 IAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFV 163
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
GT YM+PE +SV+SD++S G+ ++E+ G+
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHR 402
+ +G G FG V+ S A+K ++ + Q NE ++ ++ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 403 NLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGG------I 454
++RL F E +++ L + E+VP L F Y L S R+ G I
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGEL--FSY-------LRNSGRFSNSTGLFYASEI 110
Query: 455 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTY 514
+ YLH I++RDLK NILLD E + K++DFG AK D+T + GT
Sbjct: 111 VCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTW----TLCGTP 162
Query: 515 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
Y+APE + D ++ G+L+ E++ G
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 32/208 (15%)
Query: 354 LGEGGFGEV----YKGVLPSGQEIAVKRLSRSSGQGGQEF------KNEVVLVAKLQHRN 403
LG G FG+V YK +G+ A+K L + E K +H
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 404 LVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYE---PEKQQQLDWSRRYKIIGGIARGIL 459
LV L C + E+ + V E+ L ++ E + Y + G+
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-----Y--AACVVLGLQ 115
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI-FGVDQTQGNTNRIVGTYGYMA 518
YLHE+ +I++RDLK N+LLD E KI+DFG+ K G T+ GT ++A
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLA 169
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIITG 546
PE ++ D + GVL+ E++ G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 41/213 (19%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSR--SSGQGGQEFKNEVVLVAKLQHRNLVRLLGF 410
+G G +G V +G +AVK+LSR S + E+ L+ ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 411 CLEGEEKILVYEFVPNKSLDYF-------------LYEPEKQQQLDWSRRYKIIGGIARG 457
F P +SL+ F L K Q+L +I I RG
Sbjct: 85 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYM 517
+ Y+H IIHRDLK SN+ ++ + KI DFG+A+ T V T Y
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 184
Query: 518 APEYA---MHGQFSVKSDVYSFGVLVLEIITGK 547
APE MH ++ D++S G ++ E++TG+
Sbjct: 185 APEIMLNWMH--YNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 66/234 (28%), Positives = 109/234 (46%), Gaps = 43/234 (18%)
Query: 337 DFETIEVATNNFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSR--SSGQG 385
+F ++E+ + F+ + +G G G V Y +L + +A+K+LSR +
Sbjct: 9 NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTH 66
Query: 386 GQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--LYEPEK----- 438
+ E+VL+ + H+N++ LL F P KSL+ F +Y +
Sbjct: 67 AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 439 -----QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493
Q +LD R ++ + GI +LH IIHRDLK SNI++ ++ KI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
+A+ G T +V Y Y APE + + D++S G ++ E+I G
Sbjct: 172 LARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 26/210 (12%)
Query: 352 NKLGEGGFGEVYKGVL--PSGQEIAVK--RLSRSSGQGGQEFKNEVVLVAKLQHRNLVRL 407
++LG+G +G VYK VL P+G +A+K RL + Q E+ ++ K +V
Sbjct: 7 DELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDILHKAVSPYIVDF 64
Query: 408 LG-FCLEGEEKILVY---EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
G F +EG VY E++ SLD + + +I + +G+ +L E
Sbjct: 65 YGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY-- 521
+ IIHRD+K +N+L++ K+ DFG++ + + TN +G YMAPE
Sbjct: 121 E--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTN--IGCQSYMAPERIK 174
Query: 522 ----AMHGQFSVKSDVYSFGVLVLEIITGK 547
+ ++V+SDV+S G+ +LE+ G+
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 40/105 (38%), Positives = 61/105 (58%), Gaps = 11/105 (10%)
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK--IFGVDQTQGNTNRIV 511
I G+ +LH+ II+RDLK N+LLD + + KI+DFGM K + G +G +
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFC 157
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
GT Y+APE +++ D +SFGVL+ E++ G+ S F+ D
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ--SPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 332 ESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFK 390
S E++ T+ + +G+G +G+VYK G AVK L S +E +
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIE 66
Query: 391 NEVVLVAKL-QHRNLVRLLGFCLEGEEKI-----LVYEFVPNKSLDYFLYEPEKQ-QQLD 443
E ++ L H N+V+ G + ++ + LV E S+ + Q+LD
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126
Query: 444 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503
+ I+ G G+ +LH + RIIHRD+K +NILL E K+ DFG++ +
Sbjct: 127 EAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 504 QGNTNRIVGTYGYMAPEYAMHGQ-----FSVKSDVYSFGVLVLEIITG 546
+ NT+ VGT +MAPE Q + + DV+S G+ +E+ G
Sbjct: 184 RRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 354 LGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQEF------KNEVVLVAKLQHRNLVR 406
LG+G FG+V L E+ A+K L + + K + L AK H L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTA 60
Query: 407 LLGFCLEGEEKIL-VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
L C + ++++ V E+V L +++ ++ ++ D R + +++LH
Sbjct: 61 LHC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN-TNRIVGTYGYMAPEYAMH 524
+I+RDLK NILLDAE + K++DFGM K G T GT Y+APE
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 525 GQFSVKSDVYSFGVLVLEIITGK 547
++ D ++ GVL+ E++ G+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 352 NKLGEGGFGEVYKGVLP-SGQEIAVK--RLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLL 408
+KLGEG + VYKG + +A+K RL G + EV L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 409 GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLR 468
+ LV+E++ +K L +L + + + + + + RG+ Y H R +
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRK 124
Query: 469 IIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-QF 527
++HRDLK N+L++ K++DFG+A+ + T+ +N +V T Y P+ + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGSTDY 182
Query: 528 SVKSDVYSFGVLVLEIITGK 547
S + D++ G + E+ TG+
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 40/212 (18%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSR--SSGQGGQEFKNEVVLVAKLQHRNLVRLLGF 410
+G G +G V + +G+++A+K+LSR S + E+ L+ +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 411 CLEGEEKILVYEFVPNKSL----DYFLYEPEKQQQLDWSRRYK--------IIGGIARGI 458
F S D++L P Q L + ++ + G+
Sbjct: 83 ------------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMA 518
Y+H IIHRDLK N+ ++ + KI DFG+A+ + T V T Y A
Sbjct: 131 KYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVTRWYRA 182
Query: 519 PEYA---MHGQFSVKSDVYSFGVLVLEIITGK 547
PE MH +V D++S G ++ E++TGK
Sbjct: 183 PEVILNWMHYNQTV--DIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 67/232 (28%), Positives = 108/232 (46%), Gaps = 43/232 (18%)
Query: 338 FETIEVATNNFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSR--SSGQGG 386
F +++VA + F+ + +G G G V + VL G +AVK+LSR +
Sbjct: 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHA 64
Query: 387 QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF--------LYEPEK 438
+ E+VL+ + H+N++ LL F P KSL+ F L +
Sbjct: 65 KRAYRELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANL 112
Query: 439 QQ----QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494
Q +LD R ++ + GI +LH IIHRDLK SNI++ ++ KI DFG+
Sbjct: 113 CQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169
Query: 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 546
A+ + T +V Y Y APE + + D++S G ++ E++ G
Sbjct: 170 ARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN----EVVLVAKLQHRNLVRL 407
K+GEG +G V+K +GQ +A+K+ S + K E+ ++ +L+H NLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVES--EDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ-LDWSRRYKIIGGIARGILYLHEDSR 466
+ + LV+E+ + L+ E EK + + KII + + + H +
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLN----ELEKNPRGVPEHLIKKIIWQTLQAVNFCH---K 118
Query: 467 LRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM-HG 525
IHRD+K NIL+ + K+ DFG A+I + + V T Y APE +
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 526 QFSVKSDVYSFGVLVLEIITG 546
Q+ DV++ G + E++TG
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 62/236 (26%), Positives = 113/236 (47%), Gaps = 23/236 (9%)
Query: 347 NFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSRSS----GQGGQEFKNEVVLVAK 398
NF LG G +G+V+ SG + A+K L +++ + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 399 LQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARG 457
++ + L + + + K+ L+ +++ L L + E+ ++ + G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQ---IYSGEIVLA 117
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYM 517
+ +LH +L II+RD+K NILLD+ + ++DFG++K F D+ + GT YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 518 APEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSINRVI 571
AP+ G D +S GVL+ E++TG +S + DG + S I+R I
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG---ASPFTVDGEKN--SQAEISRRI 224
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 354 LGEGGFGEVYKGVL---------PSGQEIAVKR-LSRSSGQGGQEFKNEVVLVAKLQHRN 403
LG+G F +YKGVL GQE++V + S + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
LV+L G C+ +E I+V E+V LD FL+ + L W + + +A + YL +
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 464 DSRLRIIHRDLKASNILL----DAEMNP---KISDFGMAKIFGVDQTQGNTNRIVGTYGY 516
+++H ++ NIL+ E K+SD G+ T + V +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI------TVLSREERVERIPW 170
Query: 517 MAPEYAMHGQFSVKS--DVYSFGVLVLEI 543
+APE +GQ S+ D +SFG +LEI
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 354 LGEGGFGEVYKG----VLPSGQ----EIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLV 405
LG+G F +++KG V G+ E+ +K L +S + F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
G C+ G+E I+V E+V SLD +L + + + W + ++ +A + +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 466 RLRIIHRDLKASNILL-----DAEMNP---KISDFGMAKIFGVDQTQGNTNRIVGTYGYM 517
+ H ++ A N+LL NP K+SD G++ V + RI ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERI----PWV 171
Query: 518 APEYAMHGQ-FSVKSDVYSFGVLVLEIITG 546
PE + Q S+ +D +SFG + EI +G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 352 NKLGEGGFGEVYKGVLPSGQE-IAVK--RLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLL 408
KLGEG + V+KG + +A+K RL G + EV L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 409 GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLR 468
+ LV+E++ +K L ++ + + + + + I RG+ Y H R +
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRK 124
Query: 469 IIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM-HGQF 527
++HRDLK N+L++ K++DFG+A+ V T+ +N +V T Y P+ + ++
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSSEY 182
Query: 528 SVKSDVYSFGVLVLEIITGK 547
S + D++ G + E+ +G+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 43/233 (18%)
Query: 338 FETIEVATNNFSTDNK------LGEGGFGEV---YKGVLPSGQEIAVKRLSR--SSGQGG 386
F ++EV + F+ + +G G G V Y VL + +A+K+LSR +
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 60
Query: 387 QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD-----YFLYEPEK--- 438
+ E+VL+ + H+N++ LL F P KSL+ Y + E
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANL 108
Query: 439 ----QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494
Q +LD R ++ + GI +LH IIHRDLK SNI++ ++ KI DFG+
Sbjct: 109 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165
Query: 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
A+ G T +V Y Y APE + + D++S G ++ E++ K
Sbjct: 166 ARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 62/216 (28%), Positives = 111/216 (51%), Gaps = 27/216 (12%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ 400
E+ ++F ++LG G G V+K PSG +A K + +N+++ ++
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA---IRNQIIRELQVL 57
Query: 401 HR-NLVRLLGFC----LEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIA 455
H N ++GF +GE I + E + SLD L + + + +I+G ++
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPE-------QILGKVS 109
Query: 456 ----RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
+G+ YL E + +I+HRD+K SNIL+++ K+ DFG++ +D N V
Sbjct: 110 IAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFV 163
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
GT YM+PE +SV+SD++S G+ ++E+ G+
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFK--NEVVLVAKLQHRN 403
+++ KLGEG + VYKG ++ ++ R + G F E L+ L+H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
+V L E LV+E+V Y P L + + RG+ Y+H+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM 523
I+HRDLK N+L+ K++DFG+A+ V + +N +V T Y P+ +
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV-TLWYRPPDVLL 176
Query: 524 HG-QFSVKSDVYSFGVLVLEIITG 546
++S D++ G + +E+I G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 353 KLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFK--NEVVLVAKLQHRNLVRLLG 409
KLGEG + VYKG+ +GQ +A+K +S + +G F E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHD 70
Query: 410 FCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRI 469
E V+E++ Y + P L + + RG+ Y+H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIH---GQHI 124
Query: 470 IHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-QFS 528
+HRDLK N+L+ K++DFG+A+ + +Q ++ +V T Y P+ + +S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVV-TLWYRPPDVLLGATDYS 182
Query: 529 VKSDVYSFGVLVLEIITGK 547
D++ G + +E++ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 4e-12
Identities = 62/221 (28%), Positives = 110/221 (49%), Gaps = 48/221 (21%)
Query: 352 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN---------EVVLVAKL-Q 400
KLG+G +G V+K + + + +A+K++ F+N E++ + +L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIF-------DAFRNATDAQRTFREIMFLQELGD 65
Query: 401 HRNLVRLLG-FCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQL-DWSRRYKIIGGIARG 457
H N+V+LL E ++ I LV+E+ ++ L+ + L D +RY I+ + +
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEY-----METDLHAVIRANILEDVHKRY-IMYQLLKA 119
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRI----VGT 513
+ Y+H S +IHRDLK SNILL+++ K++DFG+A+ + + N + V T
Sbjct: 120 LKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLS-ELEENPENPVLTDYVAT 175
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGV-------LVLEIITGK 547
Y APE + S Y+ GV ++ E++ GK
Sbjct: 176 RWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 38/95 (40%), Positives = 57/95 (60%), Gaps = 7/95 (7%)
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR-IVG 512
I+ G+ +LH II+RDLK N++LD+E + KI+DFGM K VD G T R G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---GVTTRTFCG 163
Query: 513 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
T Y+APE + + D +++GVL+ E++ G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-12
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 33/222 (14%)
Query: 353 KLGEGGFGEVYKGVLPS-GQEIAVKRLSRSSGQGGQEFKN----EVVLVAKLQHRNLVRL 407
+G+GG GEVY P + +A+K++ R K E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYK--------IIGGIARGIL 459
C +G+ ++ +L L +++ L K I I I
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK--------IFGVDQTQGNT---- 507
Y+H S+ ++HRDLK NILL I D+G A + +D + N
Sbjct: 128 YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 508 ----NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+IVGT YMAPE + S +D+Y+ GV++ +++T
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG--QEFKNEVVLVAKLQHRN-LVRLL 408
K+GEG +G+VYK +G+ +A+K+ + G E+ L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 409 GFCLEG-EEKI------LVYEFVPNKSLDYFL--YEPEKQQQLDWSRRYKIIGGIARGIL 459
+E EEK LV+E++ + L F+ + L + + +G+
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMAKIFGVDQTQGNTNRIVGTYGYMA 518
+ H + ++HRDLK N+L+D + KI+D G+ + F + + T+ IV T Y A
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV-TLWYRA 179
Query: 519 PEYAMHG-QFSVKSDVYSFGVLVLEIITG 546
PE + +S D++S G + E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 351 DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLG 409
D +G G FG V+ P G+ +A+K++ F+N V K R L ++L
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-------FQNLVS--CKRVFREL-KMLC 54
Query: 410 FCLEGEEKIL-VYEFVPNKSLDYF--LYEPEKQQQLDWSRRYKIIGG------------- 453
F + +L + + +D F +Y + Q D +KII
Sbjct: 55 FF--KHDNVLSALDILQPPHIDPFEEIYVVTELMQSDL---HKIIVSPQPLSSDHVKVFL 109
Query: 454 --IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
I RG+ YLH I+HRD+K N+L+++ KI DFG+A++ D+++ T +V
Sbjct: 110 YQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 512 GTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK----KNSSFYQTDGAADLL 562
Y Y APE M + ++ D++S G + E++ + S Q D DLL
Sbjct: 167 TQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLL 221
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 352 NKLGEGGFGEVYKGVLP-SGQEIAVK--RLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLL 408
+KLGEG + V+KG + +A+K RL G + EV L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 409 GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKI-IGGIARGILYLHEDSRL 467
LV+E++ + Y + L KI + + RG+ Y H +
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYL----DNCGNLMSMHNVKIFMFQLLRGLSYCH---KR 122
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-Q 526
+I+HRDLK N+L++ + K++DFG+A+ V T+ +N +V T Y P+ + +
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSTE 180
Query: 527 FSVKSDVYSFGVLVLEIITGK 547
+S D++ G ++ E+ TG+
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 36/210 (17%)
Query: 354 LGEGGFGEVYKGVL----PSGQEIAVK--RLSRSSGQGGQEFKNEVVLVAKLQHRNLVRL 407
+GEG FG + +L S Q+ A+K RL +SS ++ + E VL+AK++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 408 L-GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ---------LDWSRRYKIIGGIARG 457
F +G I V E+ L + K Q+ L W + + G
Sbjct: 64 KESFEADGHLYI-VMEYCDGGDL----MQKIKLQRGKLFPEDTILQWFVQ------MCLG 112
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYM 517
+ ++HE R++HRD+K+ NI L K+ DFG A++ T VGT Y+
Sbjct: 113 VQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYV 167
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
PE + ++ KSD++S G ++ E+ T K
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 354 LGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQEFKNEV----VLVAKLQHRNLVRLL 408
+G+G FG+V + + AVK L + + +E K+ + VL+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 409 GFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRL 467
+ + +K+ V ++V L + L ++++ R IA + YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---L 115
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF 527
II+RDLK NILLD++ + ++DFG+ K G+ + T+ GT Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGI-EHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 528 SVKSDVYSFGVLVLEIITGKKNSSFYQTDGA 558
D + G ++ E++ G FY D A
Sbjct: 174 DRTVDWWCLGAVLYEMLYGL--PPFYSRDTA 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 34/209 (16%)
Query: 352 NKLGEGGFGEVYKG-VLPSGQEIAVKRLSRSSGQGGQEFK--------NEVVLVAKLQ-H 401
K+GEG F EV K +G+ A+K + + FK E+ + +L H
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMK-------KHFKSLEQVNNLREIQALRRLSPH 57
Query: 402 RNLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFLYEPEK--QQQLDWSRRYKIIGGIARG 457
N++RL+ + + LV+E +D LYE K ++ L R + + +
Sbjct: 58 PNILRLIEVLFDRKTGRLALVFEL-----MDMNLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYM 517
+ ++H R I HRD+K NIL+ + K++DFG + G+ T I T Y
Sbjct: 113 LDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYR 165
Query: 518 APEYAM-HGQFSVKSDVYSFGVLVLEIIT 545
APE + G + K D+++ G + EI++
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 64/233 (27%), Positives = 116/233 (49%), Gaps = 26/233 (11%)
Query: 347 NFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSRSS----GQGGQEFKNEVVLVAK 398
NF LG G +G+V+ +G+ A+K L +++ + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 399 LQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARG 457
++ + L + + E K+ L+ ++V + LY+ + + D R Y G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-DEVRFY--SGEIILA 117
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYM 517
+ +LH +L I++RD+K NILLD+E + ++DFG++K F + + + T GT YM
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYM 173
Query: 518 APEY----AMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVS 566
APE HG+ D +S G+L+ E++TG +S + +G + S VS
Sbjct: 174 APEIIRGKGGHGK---AVDWWSLGILIFELLTG---ASPFTLEGERNTQSEVS 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
IA G+ +LH II+RDLK N++LD+E + KI+DFGM K D T GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
Y+APE + + D ++FGVL+ E++ G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 41/213 (19%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSR--SSGQGGQEFKNEVVLVAKLQHRNLVRLLGF 410
+G G +G V Q++AVK+LSR S + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 411 CLEGEEKILVYEFVPNKSLDYF-------------LYEPEKQQQLDWSRRYKIIGGIARG 457
F P S++ F L K Q+L +I + RG
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYM 517
+ Y+H IIHRDLK SN+ ++ + +I DFG+A+ Q V T Y
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYR 182
Query: 518 APEYA---MHGQFSVKSDVYSFGVLVLEIITGK 547
APE MH +V D++S G ++ E++ GK
Sbjct: 183 APEIMLNWMHYNQTV--DIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 58/228 (25%), Positives = 107/228 (46%), Gaps = 41/228 (17%)
Query: 351 DNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSS------------GQGGQEFK--NEVVL 395
LGEG +G+V K +G+ +A+K++ G G F E+ +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 396 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGI 454
+ +++H N++ L+ +EG+ LV + + L + +++ +L S+ I+ I
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDI-----MASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 455 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRI---- 510
G+ LH+ +HRDL +NI ++++ KI+DFG+A+ +G ++
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 511 --------VGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGK 547
V T Y APE M + F+V D++S G + E++TGK
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 353 KLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQG-GQEFKNEVVLVAKLQHRNLVRLLG-F 410
K+G G +G VYK G++ L + G G E+ L+ +L+H N++ L F
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 411 CLEGEEKI-LVYEFVPNKSLDYFLYE-----PEKQQQLDWSRRYKIIGGIARGILYLHED 464
+ K+ L++++ + + +K QL S ++ I GI YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 465 SRLRIIHRDLKASNILLDAEMNP-----KISDFGMAKIFGVD-QTQGNTNRIVGTYGYMA 518
++HRDLK +NIL+ E P KI+D G A++F + + + +V T+ Y A
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 519 PEYAMHGQFSVKS-DVYSFGVLVLEIITGK 547
PE + + K+ D+++ G + E++T +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 46/140 (32%), Positives = 77/140 (55%), Gaps = 13/140 (9%)
Query: 411 CLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQL--DWSRRYKIIGGIARGILYLHEDSRL 467
C + E ++ V EFV L ++ ++Q++L + +R Y I+ + +LHE
Sbjct: 64 CFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYS--AEISLALNFLHERG-- 116
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF 527
II+RDLK N+LLDAE + K++D+GM K G+ + T+ GT Y+APE +
Sbjct: 117 -IIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGI-RPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 528 SVKSDVYSFGVLVLEIITGK 547
D ++ GVL+ E++ G+
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 52/243 (21%), Positives = 98/243 (40%), Gaps = 71/243 (29%)
Query: 336 FDFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVV 394
FD + + +G G +G V + SG+++A+K++ + +V
Sbjct: 1 FDVGS------RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------DVP 45
Query: 395 LVAK-----------LQHRNLVRLLG-FCLEGEEKILVY-----------------EFVP 425
+AK +H N++ + G + VY + +
Sbjct: 46 TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLT 105
Query: 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 485
+ + YFLY+ + RG+ Y+H + +IHRDLK SN+L++ +
Sbjct: 106 EEHIRYFLYQ------------------LLRGLKYIHSAN---VIHRDLKPSNLLVNEDC 144
Query: 486 NPKISDFGMAKIFGVDQT--QGNTNRIVGTYGYMAPE--YAMHGQFSVKSDVYSFGVLVL 541
+I DFGMA+ T + V T Y APE ++ +++ D++S G +
Sbjct: 145 ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP-EYTTAIDMWSVGCIFA 203
Query: 542 EII 544
E++
Sbjct: 204 EML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLL---- 408
LG G G V+ V + +AVK++ + Q + E+ ++ +L H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 409 --GFCLEGEEKILVY---EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
G L + L ++ + ++ L +Q L + + RG+ Y+H
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS 132
Query: 464 DSRLRIIHRDLKASNILLDAE-MNPKISDFGMAKIFGVDQT---QGNTNRIVGTYGYMAP 519
+ ++HRDLK +N+ ++ E + KI DFG+A+I VD +G + + T Y +P
Sbjct: 133 AN---VLHRDLKPANVFINTEDLVLKIGDFGLARI--VDPHYSHKGYLSEGLVTKWYRSP 187
Query: 520 EYAMHGQFSVKS-DVYSFGVLVLEIITGK 547
+ K+ D+++ G + E++TGK
Sbjct: 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 353 KLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQG-GQEFKNEVVLVAKLQHRNLVRLLG-F 410
K+G G +G VYK G++ L + G G E+ L+ +L+H N++ L F
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 411 CLEGEEKI-LVYEFVPNKSLDYFLYE-----PEKQQQLDWSRRYKIIGGIARGILYLHED 464
+ K+ L++++ + + +K QL ++ I GI YLH +
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 465 SRLRIIHRDLKASNILLDAEMNP-----KISDFGMAKIFGVD-QTQGNTNRIVGTYGYMA 518
++HRDLK +NIL+ E P KI+D G A++F + + + +V T+ Y A
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 519 PEYAMHGQFSVKS-DVYSFGVLVLEIITGK 547
PE + + K+ D+++ G + E++T +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 28/213 (13%)
Query: 354 LGEGGFGEVYK-GVLPSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRN--LVRL 407
+G GGFGEVY +G+ A+K L + QG NE ++++ + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 408 LGFCLEGEEKI-LVYEFVPNKSLDYFLYE----PEKQQQLDWSRRYKIIGGIARGILYLH 462
+ + +K+ + + + L Y L + EK+ + + +II G+ H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYAT---EIILGLE------H 112
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA 522
+R +++RDLK +NILLD + +ISD G+A D ++ + VGT+GYMAPE
Sbjct: 113 MHNRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVL 167
Query: 523 MHGQ-FSVKSDVYSFGVLVLEIITGKKNSSFYQ 554
G + +D +S G ++ +++ G +S F Q
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRG--HSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 68/245 (27%), Positives = 114/245 (46%), Gaps = 30/245 (12%)
Query: 323 NADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRS 381
N DN + E + +++ ++ +G G FGEV S Q++ A+K LS+
Sbjct: 20 NIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF 79
Query: 382 SGQGGQE---FKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFL--Y 434
+ F E ++A +V+L FC ++K L V E++P L + Y
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNY 137
Query: 435 E-PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493
+ PEK W++ Y A +L L + +IHRD+K N+LLD + K++DFG
Sbjct: 138 DVPEK-----WAKFYT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187
Query: 494 MAKIFGVDQT-QGNTNRIVGTYGYMAPEY----AMHGQFSVKSDVYSFGVLVLEIITGKK 548
+D+T + VGT Y++PE G + + D +S GV + E++ G
Sbjct: 188 TC--MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG-- 243
Query: 549 NSSFY 553
++ FY
Sbjct: 244 DTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 14/198 (7%)
Query: 354 LGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQEFKN---EVVLVAKLQHRNLVRLLG 409
+G+G FG+V + Q I A+K + ++ E + E ++A++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 410 FCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLR 468
F + EK+ LV F+ L + L +++ + D SR + + LH+
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCALENLHK---FN 113
Query: 469 IIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFS 528
+I+RDLK NILLD + + + DFG+ K+ D + TN GT Y+APE + ++
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGYT 171
Query: 529 VKSDVYSFGVLVLEIITG 546
D ++ GVL+ E++TG
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 354 LGEGGFGEVYKGVLPS-GQEIAVKRLSRSSGQGGQEFKNEV----VLVAKLQHRNLVRLL 408
+G+G FG+V S G AVK L + + +E + + VL+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 409 GFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRL 467
+ + EK+ V ++V L +F + E+ +R Y +A I YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL-FFHLQRERCFLEPRARFYA--AEVASAIGYLHS---L 115
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF 527
II+RDLK NILLD++ + ++DFG+ K GV+ + T+ GT Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEP-EETTSTFCGTPEYLAPEVLRKEPY 173
Query: 528 SVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
D + G ++ E++ G FY D
Sbjct: 174 DRTVDWWCLGAVLYEMLYGL--PPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 73/264 (27%), Positives = 114/264 (43%), Gaps = 49/264 (18%)
Query: 309 IRKAKN------KYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEV 362
+RK KN +Y E IT L DF+ I+V +G G FGEV
Sbjct: 15 LRKNKNIDNFLSRYEKAAE-----KITKLRMKAEDFDVIKV----------IGRGAFGEV 59
Query: 363 YKGVLPSGQEI-AVKRLSRSSGQGGQE---FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418
S +++ A+K LS+ + F E ++A +V+L ++K
Sbjct: 60 QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL--HYAFQDDKY 117
Query: 419 L--VYEFVPNKSLDYFL--YE-PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD 473
L V E++P L + Y+ PEK W+R Y A +L L + IHRD
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYDIPEK-----WARFY-----TAEVVLALDAIHSMGFIHRD 167
Query: 474 LKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM----HGQFSV 529
+K N+LLD + K++DFG + + VGT Y++PE G +
Sbjct: 168 VKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226
Query: 530 KSDVYSFGVLVLEIITGKKNSSFY 553
+ D +S GV + E++ G ++ FY
Sbjct: 227 ECDWWSVGVFLYEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 9e-11
Identities = 45/140 (32%), Positives = 77/140 (55%), Gaps = 13/140 (9%)
Query: 411 CLEGEEKIL-VYEFVPNKSLDYFLYEPEKQQQL--DWSRRYKIIGGIARGILYLHEDSRL 467
C + E ++ V E+V L ++ ++Q++L + +R Y I+ + YLHE
Sbjct: 64 CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYS--AEISLALNYLHERG-- 116
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF 527
II+RDLK N+LLD+E + K++D+GM K G+ + T+ GT Y+APE +
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGL-RPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 528 SVKSDVYSFGVLVLEIITGK 547
D ++ GVL+ E++ G+
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 39/94 (41%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IF-GVDQTQGNTNRIV 511
+ARG+ +L SR + IHRDL A NILL KI DFG+A+ I+ D + R+
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+MAPE ++ +SDV+SFGVL+ EI +
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 354 LGEGGFGEVYKGVLPSGQE----IAVKRLSRSSGQGGQE----FKNEVVLVAKLQHRNLV 405
LG+GG+G+V++ +G + A+K L +++ Q+ K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
L+ G + L+ E++ L L E E D + Y + I+ + +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIFMEDTACFY--LSEISLALEHLH--- 117
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN--TNRIVGTYGYMAPEYAM 523
+ II+RDLK NILLDA+ + K++DFG+ K + T+ GT YMAPE M
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 524 HGQFSVKSDVYSFGVLVLEIITG 546
D +S G L+ +++TG
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 344 ATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN-EVVLVAKLQH 401
++ N +G G FG VY+ + + + +++A+K++ + ++KN E++++ L H
Sbjct: 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNH 118
Query: 402 RNLVRLLGF----CLEGEEKIL----VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGG 453
N++ L + C + EK + V EF+P Y + L
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ 178
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMAKIFGVDQTQGNTNRIVG 512
+ R + Y+H I HRDLK N+L+D + K+ DFG AK + Q + + I
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQRSVSYICS 233
Query: 513 TYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITG 546
+ Y APE + ++ D++S G ++ E+I G
Sbjct: 234 RF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 347 NFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKL 399
+F LG G FG V +KG +G+ A+K L + + Q E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 400 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL 459
H +V ++ + + EFV L L + + D ++ Y A +L
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN-DVAKFYH-----AELVL 129
Query: 460 ---YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY 516
YLH II+RDLK N+LLD + + K++DFG AK + T + GT Y
Sbjct: 130 AFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEY 181
Query: 517 MAPEYAMHGQFSVKSDVYSFGVLVLEIITG 546
+APE D ++ GVL+ E I G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 35/93 (37%), Positives = 55/93 (59%), Gaps = 4/93 (4%)
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG--VDQTQGNTNRIVGTYG 515
+L +H +IHRD+K++NILL + K+ DFG +K++ V G T GT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT--FCGTPY 210
Query: 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548
Y+APE +S K+D++S GVL+ E++T K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 64/230 (27%), Positives = 108/230 (46%), Gaps = 35/230 (15%)
Query: 338 FETIEVATNNFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSRSSGQGGQEFKNEV-V 394
F++ ++ + +G+G +G+V+K VL +G + AVK L +E + E +
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILD-PIHDIDEEIEAEYNI 67
Query: 395 LVAKLQHRNLVRLLGFCLE-----GEEKILVYEFVPNKSL----DYFLYEPEKQQQLDWS 445
L A H N+V+ G + G++ LV E S+ FL E+ ++
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP--- 124
Query: 446 RRYKIIGGIAR----GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501
II I G+ +LH + + IHRD+K +NILL E K+ DFG++
Sbjct: 125 ----IIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177
Query: 502 QTQGNTNRIVGTYGYMAPEY-----AMHGQFSVKSDVYSFGVLVLEIITG 546
+ + NT+ VGT +MAPE + + + DV+S G+ +E+ G
Sbjct: 178 RLRRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 10/166 (6%)
Query: 392 EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKII 451
E ++ + H ++++L G + L+ +P D + Y K+ + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRN-IAICDILAIE 188
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
+ R I YLHE+ RIIHRD+KA NI ++ + + DFG A F VD
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDG 557
GT APE + D++S G+++ E+ T S ++ DG
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH--DSLFEKDG 288
|
Length = 391 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQEFKN----EVVLVAKLQ 400
N F +GEG +G V K +EI A+K+ S + +E K E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLK 58
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
N+V L + LV+E+V L+ L E + R Y I + + I +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSY--IYQLIKAIHW 115
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520
H++ I+HRD+K N+L+ K+ DFG A+ + + N V T Y +PE
Sbjct: 116 CHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPE 171
Query: 521 YAMHGQFSVKSDVYSFGVLVLEIITGK 547
+ + D++S G ++ E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 42/138 (30%), Positives = 72/138 (52%), Gaps = 9/138 (6%)
Query: 411 CLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRI 469
C + ++ LV E+V L ++ ++Q++L I + +LHE I
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---I 117
Query: 470 IHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSV 529
I+RDLK N+LLDA+ + K++D+GM K G+ T+ GT Y+APE ++
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCK-EGL-GPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 530 KSDVYSFGVLVLEIITGK 547
D ++ GVL+ E++ G+
Sbjct: 176 SVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-10
Identities = 66/257 (25%), Positives = 117/257 (45%), Gaps = 46/257 (17%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKN---EVVLVAK 398
E N + K+G G FGEV+ QE + G +E EV ++ +
Sbjct: 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68
Query: 399 LQHRNLVRLLG-FCLEGEEKI-LVYEFVPNKSLD------YFLY-EPEKQQQLDWSRRYK 449
L+H+N+VR + F + +K+ ++ EF L Y ++ + E+ +D +R+
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ-- 126
Query: 450 IIGGIARGILYLHE----DSRLRIIHRDLKASNILLD----------AEMN-------PK 488
+ + Y H + R++HRDLK NI L A+ N K
Sbjct: 127 ----LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 489 ISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITG 546
I DFG++K G++ + VGT Y +PE +H + KSD+++ G ++ E+ +G
Sbjct: 183 IGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 547 KKNSSFYQTDGAADLLS 563
K + F++ + + L+S
Sbjct: 240 K--TPFHKANNFSQLIS 254
|
Length = 1021 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 35/209 (16%)
Query: 353 KLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFK--NEVVLVAKLQHRNLVRLLG 409
KLGEG + VYKG +GQ +A+K + R + G F E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 410 FCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRR-----------YKIIGGIARGI 458
+ LV+E++ + + +Q +D ++++ RG+
Sbjct: 71 IIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLL----RGL 116
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMA 518
Y H + R++HRDLK N+L+ K++DFG+A+ V ++ +N +V T Y
Sbjct: 117 AYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVV-TLWYRP 171
Query: 519 PEYAMHG-QFSVKSDVYSFGVLVLEIITG 546
P+ + ++S D++ G + E+ TG
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQE----FKNEVVLVAKLQ 400
+F + +G G FGEV + +I A+K + +S QE F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV-LLAQETVSFFEEERDILSISN 59
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
+ +L + + LV E+ P L L E Q D ++ Y +A +L
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----LAELVLA 114
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520
+H ++ +HRD+K N+L+D + K++DFG A ++ N+ VGT Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPE 173
Query: 521 Y--AMHG----QFSVKSDVYSFGVLVLEIITGK 547
M+G + V+ D +S GV+ E+I G+
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 28/213 (13%)
Query: 354 LGEGGFGEVY---KGVLPSGQEIAVKRL--SRSSGQGGQEFK-NEVVLVAKLQHRN--LV 405
+G GGFGEVY K +G+ A+K L R + G+ NE ++++ + + +
Sbjct: 2 IGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 406 RLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRY--KIIGGIARGILYLH 462
+ + +K+ + + + L Y L + + + R Y +II G+ H
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAE-MRFYAAEIILGLE------H 112
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA 522
+R +++RDLK +NILLD + +ISD G+A D ++ + VGT+GYMAPE
Sbjct: 113 MHNRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVL 167
Query: 523 MHG-QFSVKSDVYSFGVLVLEIITGKKNSSFYQ 554
G + +D +S G ++ +++ G +S F Q
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRG--HSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 40/105 (38%), Positives = 56/105 (53%), Gaps = 7/105 (6%)
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN-TNRIVG 512
IA +L L + I++RDLK NILLDA + + DFG++K + T TN G
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCG 158
Query: 513 TYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
T Y+APE + + ++ D +S GVLV E+ G S FY D
Sbjct: 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGW--SPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 65/258 (25%), Positives = 108/258 (41%), Gaps = 72/258 (27%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSRSS----GQGGQE 388
DFE+I+V +G G FGEV K +G A+K+L +S Q
Sbjct: 2 DFESIKV----------IGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAH- 47
Query: 389 FKNEVVLVAKLQHRNLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFLYEPEKQQQL--DW 444
+ E ++A+ + +V+L + +E L+ E++P + L K+ +
Sbjct: 48 VRAERDILAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTEEE 102
Query: 445 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG----- 499
+R Y IA IL + +L IHRD+K N+LLDA+ + K+SDFG+
Sbjct: 103 TRFY-----IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157
Query: 500 -----VDQTQGNT--------------------NRI------VGTYGYMAPEYAMHGQFS 528
+ + NR VGT Y+APE + ++
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN 217
Query: 529 VKSDVYSFGVLVLEIITG 546
+ D +S GV++ E++ G
Sbjct: 218 KECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 354 LGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEV----VLVAKLQHRNLVRLL 408
+G+G FG+V G+ AVK L + +E K+ + VL+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 409 GFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRL 467
+ + EK+ V +FV L + L ++++ R IA + YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---I 115
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF 527
I++RDLK NILLD++ + ++DFG+ K G+ Q+ T GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSD-TTTTFCGTPEYLAPEVIRKQPY 173
Query: 528 SVKSDVYSFGVLVLEIITGKKNSSFYQTDGA 558
D + G ++ E++ G FY D A
Sbjct: 174 DNTVDWWCLGAVLYEMLYGL--PPFYCRDVA 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 39/94 (41%), Positives = 56/94 (59%), Gaps = 7/94 (7%)
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IF-GVDQTQGNTNRIV 511
+ARG+ +L SR + IHRDL A NILL KI DFG+A+ I+ D + + R+
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+MAPE ++ +SDV+SFGVL+ EI +
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQE---FKNE 392
DFE I+V +G G FGEV + + I A+K L++ E F+ E
Sbjct: 2 DFEIIKV----------IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE 51
Query: 393 --VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYK 449
V++ Q + L + + E + LV ++ L L + E + D +R Y
Sbjct: 52 RNVLVNGDCQ---WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY- 107
Query: 450 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR 509
IA +L +H +L +HRD+K N+LLD + +++DFG D T ++
Sbjct: 108 ----IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSV 162
Query: 510 IVGTYGYMAPEY--AMH---GQFSVKSDVYSFGVLVLEIITGKKNSSFY 553
VGT Y++PE AM G++ + D +S GV + E++ G+ + FY
Sbjct: 163 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 6/97 (6%)
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD--QTQGNTNRIV 511
I G+ Y+H + ++HRDLK N+L++A+ KI DFG+A+ F + + G V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 512 GTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGK 547
T Y APE + Q K+ DV+S G ++ E++ K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
+A+G+ +L SR + IHRDL A NILL KI DFG+A+ D
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+MAPE ++++SDV+SFGVL+ EI +
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 45/128 (35%), Positives = 66/128 (51%), Gaps = 15/128 (11%)
Query: 456 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI-FGVDQTQGNTNRIVGTY 514
R + Y+H + + HRDLK NIL +A+ KI DFG+A++ F T V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 515 GYMAPEY--AMHGQFSVKSDVYSFGVLVLEIITGK-----KNSSFYQTDGAADLL---SY 564
Y APE + +++ D++S G + E++TGK KN +Q D DLL S
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLITDLLGTPSP 229
Query: 565 VSINRVIN 572
+I+RV N
Sbjct: 230 ETISRVRN 237
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 58/206 (28%), Positives = 87/206 (42%), Gaps = 18/206 (8%)
Query: 347 NFSTDNKLGEGGFGEVYKGVLPSGQ--EIAVKRLSRS----SGQGGQEFKNEVVLVAKLQ 400
+F+ LG G FG V + +A+KR +S Q F +L +
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL-NYIN 89
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
H V L G + LV EFV FL K+ D Y A+ +L
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYA-----AQIVLI 143
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520
L I++RDLK N+LLD + K++DFG AK+ T + GT Y+APE
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPE 198
Query: 521 YAMHGQFSVKSDVYSFGVLVLEIITG 546
++ +D ++ G+ + EI+ G
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 354 LGEGGFGEVYKGVL----PSGQEIAVKRLSRSSGQGGQEFKNEVV--LVAKLQHRNLVRL 407
LG+G FG+V +L SG+ A+K L + E + + V K +
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 408 LGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSR 466
L + + ++++ V E+V L +F E+ D +R Y I + YLH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL-FFHLSRERVFSEDRTRFYG--AEIVSALDYLHSG-- 114
Query: 467 LRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ 526
+I++RDLK N++LD + + KI+DFG+ K D T GT Y+APE
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDND 171
Query: 527 FSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
+ D + GV++ E++ G+ FY D
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 62/225 (27%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN---------EVVLVAKLQHRN 403
+G G +G V + +++A+K+++ + F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 404 LVRLLGFCLEGEEK------ILVYEFV---------PNKSL-----DYFLYEPEKQQQLD 443
++ + + + +VYE + +++L YFLY+
Sbjct: 66 VIAIKD-IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ-------- 116
Query: 444 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503
+ RG+ Y+H + ++HRDLK SN+LL+A + KI DFG+A+ +
Sbjct: 117 ----------LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEK 161
Query: 504 QGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGK 547
V T Y APE ++ +++ DV+S G + E++ K
Sbjct: 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 353 KLGEGGFGEVYKGVL---PSGQEIAVKRLSRSSGQGGQ-EFKNEVVLVAKLQHRNLVRLL 408
++G G FG+V + + VK L ++ Q EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 409 GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRR-------YKIIGGIARGILYL 461
G C+E +LV+E+ L +L Q W RR ++ IA G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494
H + +H DL N L +++ K+ D+G+
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 354 LGEGGFGEVYKGVL-----------PSGQEIAV--KRLSRSSGQGGQEFKNEVVLVAKLQ 400
LG G ++Y G+L +EI V K L S F ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
H+++V L G C+ E I+V EFV LD F++ W ++K+ +A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 461 LHEDSRLRIIHRDLKASNILL-----DAEMNP--KISDFGMAKIFGVDQTQGNTNRIVGT 513
L ED L +H ++ NILL D E P K+SD G+ V Q RI
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERI--- 172
Query: 514 YGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEI 543
++APE + S+ +D +SFG + EI
Sbjct: 173 -PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 37/96 (38%), Positives = 52/96 (54%), Gaps = 14/96 (14%)
Query: 470 IHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT---QGNTNRIVGTYGYMAPEYAMHGQ 526
IHRD+ A N+LL KI DFG+A+ D +GN V +MAPE
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK---WMAPESIFDCV 290
Query: 527 FSVKSDVYSFGVLVLEIIT-GKK-------NSSFYQ 554
++V+SDV+S+G+L+ EI + GK NS FY+
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 354 LGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQEFKNEV----VLVAKLQHRNLVRLL 408
+G+G FG+V + ++ AVK L + + +E K+ + VL+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 409 GFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRL 467
F + +K+ V +++ L Y L ++++ R IA + YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLHS---L 115
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF 527
I++RDLK NILLD++ + ++DFG+ K + G T+ GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 528 SVKSDVYSFGVLVLEIITG 546
D + G ++ E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 66/247 (26%), Positives = 106/247 (42%), Gaps = 69/247 (27%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLV 396
DFE ++V +G G FGEV AV ++ +++GQ V
Sbjct: 2 DFEILKV----------IGRGAFGEV-----------AVVKM-KNTGQ---------VYA 30
Query: 397 AKLQHR--NLVRLLGFCLEGEEKILV-----------YEFVPNKSL----DYF------- 432
K+ ++ L R C E +LV Y F +L DY+
Sbjct: 31 MKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLT 90
Query: 433 -LYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 491
L + E + D +R Y +A +L + +L +HRD+K N+LLD + +++D
Sbjct: 91 LLSKFEDRLPEDMARFY-----LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLAD 145
Query: 492 FGMAKIFGVDQTQGNTNRIVGTYGYMAPEY--AMH---GQFSVKSDVYSFGVLVLEIITG 546
FG D T +N VGT Y++PE AM G++ + D +S GV + E++ G
Sbjct: 146 FGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
Query: 547 KKNSSFY 553
+ + FY
Sbjct: 205 E--TPFY 209
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT---QGNTNRI 510
+A+G+ +L + IHRDL A NILL KI DFG+A+ D +GN
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 511 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
V +MAPE + ++ +SDV+S+G+L+ EI +
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 30/88 (34%), Positives = 51/88 (57%)
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYM 517
+L L E +++HRDLK++NI L K+ DFG +K + + + GT Y+
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEIIT 545
APE ++S K+D++S GV++ E++T
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR-IVG 512
I + YLH +++RDLK N++LD + + KI+DFG+ K + G T + G
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCG 157
Query: 513 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
T Y+APE + D + GV++ E++ G+ FY D
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 27/199 (13%)
Query: 358 GFGEVYKGVLPSGQEIA--VKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 415
G +G + IA VK SR++ Q +NE++ + +L H N++++
Sbjct: 181 GVNSTNQGKPKCERLIAKRVKAGSRAAIQ----LENEILALGRLNHENILKI-------- 228
Query: 416 EKILVYE---FVPNKSLDYFLYEPEKQQQLDWSRR------YKIIGGIARGILYLHEDSR 466
E+IL E ++ + D+ LY + DW R I+ + + Y+H+
Sbjct: 229 EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-- 286
Query: 467 LRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ 526
++IHRD+K NI L+ + + DFG A F ++ + VGT +PE
Sbjct: 287 -KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYG-WVGTVATNSPEILAGDG 344
Query: 527 FSVKSDVYSFGVLVLEIIT 545
+ +D++S G+++L++++
Sbjct: 345 YCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 38/220 (17%)
Query: 332 ESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKN 391
E + + E V NN + ++ V K + PS ++IA+ +S
Sbjct: 25 EEDEMEDEDPLVEGNNNGRELRV-------VLKVLDPSHRDIALAFFETAS--------- 68
Query: 392 EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKII 451
L++++ H +L + G C+ G E I+V EFV + LD L + + + + W + +
Sbjct: 69 ---LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVA 123
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNIL-----LDAEMNP--KISDFGMAKIFGVDQTQ 504
+A + YL ED L +H ++ A NIL L +P K+SD G++ F +
Sbjct: 124 QQLASALSYL-EDKNL--VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSRE 178
Query: 505 GNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEI 543
RI ++APE G S +D +SFG +LEI
Sbjct: 179 ERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
+A G+ +L + +HRDL A N+L+ KI DFG+A+ D +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+MAPE + ++ SDV+SFG+L+ EI T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 354 LGEGGFGEVYKGVL----PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN--LVRL 407
LG+G FG+V +L +G+ A+K L + E + V LQ+ +
Sbjct: 3 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 408 LGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSR 466
L + + +++ V E+ L +F E+ + +R Y I + YLH
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEIVSALEYLHSRD- 115
Query: 467 LRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR-IVGTYGYMAPEYAMHG 525
+++RD+K N++LD + + KI+DFG+ K G+ + G T + GT Y+APE
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCK-EGI--SDGATMKTFCGTPEYLAPEVLEDN 170
Query: 526 QFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
+ D + GV++ E++ G+ FY D
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
+ARG+ +L + +HRDL A N+LL KI DFG+A+ D +
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+MAPE ++ SDV+S+G+L+ EI +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 43/172 (25%), Positives = 71/172 (41%), Gaps = 9/172 (5%)
Query: 382 SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ 441
+ GG+ E+ ++ + HR ++ L+ K V +P D F Y ++
Sbjct: 126 AVTGGKTPGREIDILKTISHRAIINLIH---AYRWKSTVCMVMPKYKCDLFTY-VDRSGP 181
Query: 442 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501
L + I + + YLH IIHRD+K NI LD N + DFG A
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553
GT +PE + K+D++S G+++ E+ KN + +
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV--KNVTLF 288
|
Length = 392 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 45/222 (20%), Positives = 85/222 (38%), Gaps = 40/222 (18%)
Query: 349 STDNKLGE----GGFGEVYKGVLPSGQEIAVKR--LSRSSGQGGQEFKNEVVLVAKLQHR 402
+G+ + K P+ +AVK+ L S + + + E++ +LQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 403 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE------PEKQQQLDWSRRYKIIGGIAR 456
N++ + + E +V + S + L PE I+ +
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-------ILKDVLN 112
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF---------GMAKIFGVDQTQGNT 507
+ Y+H IHR +KAS+ILL + +S G + D + +
Sbjct: 113 ALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169
Query: 508 NRIVGTYGYMAPEY---AMHGQFSVKSDVYSFGVLVLEIITG 546
+ +++PE + G ++ KSD+YS G+ E+ G
Sbjct: 170 KNL----PWLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 6/103 (5%)
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
I + YLH S +++RDLK N++LD + + KI+DFG+ K D T GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGT 159
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
Y+APE + D + GV++ E++ G+ FY D
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 62/251 (24%), Positives = 104/251 (41%), Gaps = 57/251 (22%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV--LPSGQEIAVKRLSRSSGQGGQEF---KNEVVLVAKLQ 400
+F T +G+G FGEV + V +G+ A+K L +S + K E ++A+
Sbjct: 1 EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
+V L + + L+ EF+P L L + + + D +R Y +A +L
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE-DVTRFY-----MAECVLA 113
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF---------------------- 498
+ +L IHRD+K NIL+D + K+SDFG++ F
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 499 ------GVDQ---TQGNTNRI--------------VGTYGYMAPEYAMHGQFSVKSDVYS 535
VD T + ++I VGT Y+APE + + + D +S
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233
Query: 536 FGVLVLEIITG 546
G ++ E + G
Sbjct: 234 LGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 68/257 (26%), Positives = 111/257 (43%), Gaps = 35/257 (13%)
Query: 309 IRKAKNKYNAVPEVNAD-NDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVL 367
+RK KN N + N I L D+E ++V +G G FGEV
Sbjct: 15 LRKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKV----------IGRGAFGEVQLVRH 64
Query: 368 PSGQEI-AVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEF 423
S +++ A+K LS+ + F E + + V L + + + + +V E+
Sbjct: 65 KSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 124
Query: 424 VPNKSLDYFL--YE-PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 480
+P L + Y+ PEK W+R Y A +L L + IHRD+K N+L
Sbjct: 125 MPGGDLVNLMSNYDVPEK-----WARFYT-----AEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 481 LDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY----AMHGQFSVKSDVYSF 536
LD + K++DFG + + VGT Y++PE G + + D +S
Sbjct: 175 LDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 537 GVLVLEIITGKKNSSFY 553
GV + E++ G ++ FY
Sbjct: 234 GVFLYEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 59/227 (25%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQE---FKNE 392
DFE ++V +G G FGEV L + ++ A+K L++ E F+ E
Sbjct: 2 DFEILKV----------IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 51
Query: 393 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKII 451
++ ++ + L + + E + LV ++ L L + E + D +R Y
Sbjct: 52 RDVLVNGDNQ-WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--- 107
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
+A ++ + +L +HRD+K NIL+D + +++DFG D T ++ V
Sbjct: 108 --LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAV 164
Query: 512 GTYGYMAPEY--AMH---GQFSVKSDVYSFGVLVLEIITGKKNSSFY 553
GT Y++PE AM G++ + D +S GV + E++ G+ + FY
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 10/100 (10%)
Query: 449 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMAKIFGVDQTQGNT 507
KII + + LH + IIH D+K N+L D + + D+G+ KI G
Sbjct: 113 KIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-- 167
Query: 508 NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
GT Y +PE + V D ++ GVL E++TGK
Sbjct: 168 ----GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 35/200 (17%)
Query: 368 PSGQEIAVK--RLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425
P+G + V+ L + + + +NEVVL +H N++ G ++ F+
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 426 NKSLDYFL--YEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 483
S + L Y PE + + I+ G RG+ YLH++ IHR++KAS+IL
Sbjct: 83 YGSANSLLKTYFPEGMSE---ALIGNILFGALRGLNYLHQNG---YIHRNIKASHIL--- 133
Query: 484 EMNPKISDFGMAKIFGVDQ-----TQGNTNRIVGTYG--------YMAPEYA---MHGQF 527
IS G+ + G+ G ++V + +++PE ++G +
Sbjct: 134 -----ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG-Y 187
Query: 528 SVKSDVYSFGVLVLEIITGK 547
+VKSD+YS G+ E+ TG+
Sbjct: 188 NVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 28/100 (28%), Positives = 49/100 (49%), Gaps = 16/100 (16%)
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI-------------FGVDQTQGN 506
YLH I+HRDLK N+L+ + + K++DFG++KI D +
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 546
++ GT Y+APE + + D ++ G+++ E + G
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 42/161 (26%), Positives = 69/161 (42%), Gaps = 39/161 (24%)
Query: 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 478
L+ EF+P + L + + + + ++ Y IA +L + +L IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTE-EETQFY-----IAETVLAIDSIHQLGFIHRDIKPDN 131
Query: 479 ILLDAEMNPKISDFGMAK----------------IFGVDQTQGNTN-------------- 508
+LLD++ + K+SDFG+ D T N N
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 509 ---RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 546
VGT Y+APE M ++ D +S GV++ E++ G
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 35/166 (21%), Positives = 79/166 (47%), Gaps = 18/166 (10%)
Query: 389 FKNEVVLVAKLQHRNLVRLLGFCLEGEEK----ILVYEFVPNKSLDYFLYEPEKQQQLDW 444
+NE+ + ++ N++++ GF ++ + L+ E+ L L K++ L +
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD---KEKDLSF 121
Query: 445 SRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503
+ + +G+ L++ ++ +++L + + L+ KI G+ KI
Sbjct: 122 KTKLDMAIDCCKGLYNLYKYTNK---PYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF 178
Query: 504 QGNTNRIVGTYGYMAPEYA--MHGQFSVKSDVYSFGVLVLEIITGK 547
+ N N +V Y + + + ++++K D+YS GV++ EI TGK
Sbjct: 179 K-NVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 57/249 (22%), Positives = 102/249 (40%), Gaps = 57/249 (22%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQE----FKNE 392
DFE+++V +G G FGEV I ++ R + +E + E
Sbjct: 2 DFESLKV----------IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAE 51
Query: 393 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIG 452
++ + +V++ + L+ EF+P + L + + + + ++ Y
Sbjct: 52 RDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSE-EATQFY---- 106
Query: 453 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG------- 505
IA +L + +L IHRD+K N+LLDA+ + K+SDFG+ G+ +
Sbjct: 107 -IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCT--GLKKAHRTEFYRNL 163
Query: 506 -------------NTNR---------------IVGTYGYMAPEYAMHGQFSVKSDVYSFG 537
N+ R VGT Y+APE M ++ D +S G
Sbjct: 164 THNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223
Query: 538 VLVLEIITG 546
V++ E++ G
Sbjct: 224 VIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 8e-06
Identities = 33/148 (22%), Positives = 56/148 (37%), Gaps = 17/148 (11%)
Query: 353 KLGEGGFGEVYKGVLPSGQE-IAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLV--RLLG 409
L G VY L + E +K S + G + + EV ++ L + L ++L
Sbjct: 5 LLKGGLTNRVYL--LGTKDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLA 60
Query: 410 FCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRI 469
L+ E++ ++LD E ++ +A + LH+ L +
Sbjct: 61 SGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ----------LAELLAKLHQLPLLVL 110
Query: 470 IHRDLKASNILLDAEMNPKISDFGMAKI 497
H DL NIL+D I D+ A
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 57/235 (24%), Positives = 102/235 (43%), Gaps = 40/235 (17%)
Query: 339 ETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAK 398
E I+V+T F + LGEG FG+V + +E ++ R+ + ++ K E+ + K
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEK 181
Query: 399 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQ-QLDW-------SRRY-- 448
++ + F L + + + N++ + P+ LDW S R+
Sbjct: 182 VRQADPADR--FPL-----MKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLA 234
Query: 449 KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNP-------------KISDF 492
+II + Y H + L ++H DLK NIL+ D ++P +I D
Sbjct: 235 QIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
G G + + IV T Y +PE + + +D++S G ++ E+ TGK
Sbjct: 293 G-----GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 62/235 (26%), Positives = 93/235 (39%), Gaps = 55/235 (23%)
Query: 353 KLGEGGFGEVY----KGVLPSGQEIAVKRLSRSSGQGGQEFKN---EVVLVAKLQHRNLV 405
LG+G G V+ KG +G+ A+K L + + K E ++A L H L
Sbjct: 8 LLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLYE-PEKQQQLDWSRRYKIIGGIARGIL---YL 461
L LV ++ P L L P K + +R Y A +L YL
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY-----AAEVLLALEYL 119
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI------------------------ 497
H L I++RDLK NILL + +SDF ++K
Sbjct: 120 H---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 498 ---FGVDQTQGNTNRIVGTYGYMAPEY---AMHGQFSVKSDVYSFGVLVLEIITG 546
++ +N VGT Y+APE HG +V D ++ G+L+ E++ G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAV--DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 54/177 (30%), Positives = 73/177 (41%), Gaps = 34/177 (19%)
Query: 347 NFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR--LSRSSGQGGQE-FKNEVVL------VA 397
+F KLGEG FG VYK L + Q + L +++ G E + NE V A
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCA 192
Query: 398 KLQHRNLVRL---------LGFCLEGEEKILVYEFVPNKSLDYFLYEP---EKQQQL--D 443
+ L + L + EGE + + + +K Y + EP K Q L
Sbjct: 193 DFVYGFLEPVSSKKEDEYWLVWRYEGESTL--ADLMQSKEFPYNV-EPYLLGKVQDLPKG 249
Query: 444 WSRRYKIIGGIARGILY----LHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMA 495
R KII I R IL+ LH I+HRD+K NI+ KI D G A
Sbjct: 250 LERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 21/49 (42%), Positives = 31/49 (63%), Gaps = 3/49 (6%)
Query: 449 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497
K I +A + YLH IIHRDLK N+L+ E + K++DFG++K+
Sbjct: 108 KYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 33/146 (22%), Positives = 60/146 (41%), Gaps = 46/146 (31%)
Query: 443 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM-------- 494
D +R Y I + I +H ++ IHRD+K NIL+D + + K++DFG+
Sbjct: 101 DLARFY--IAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155
Query: 495 -AKIFGV--------------------------------DQTQGNTNRIVGTYGYMAPEY 521
+K + + + +VGT Y+APE
Sbjct: 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEV 215
Query: 522 AMHGQFSVKSDVYSFGVLVLEIITGK 547
+ ++ D +S GV++ E++ G+
Sbjct: 216 LLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 26/124 (20%), Positives = 46/124 (37%), Gaps = 32/124 (25%)
Query: 390 KNEVVLVAKLQHRNLVRLLGFC------LEGEEKILVYEFVPNKSLDYFLYEPEKQQQLD 443
+ E ++AK R G ++ + ++V E++ + L L
Sbjct: 47 RREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL---------- 90
Query: 444 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI------ 497
R ++ + R + LH+ I+H DL SNI+L DFG+ +
Sbjct: 91 EEARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVED 146
Query: 498 FGVD 501
VD
Sbjct: 147 KAVD 150
|
Length = 204 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 36/163 (22%), Positives = 64/163 (39%), Gaps = 35/163 (21%)
Query: 352 NKLGEGGFGEVYKGVLPSGQEIAVK--RLSRSSGQGGQEFKNEV------------VLVA 397
K+G G +VY + P G+++AVK RL R+S + + ++ + L A
Sbjct: 97 TKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAA 156
Query: 398 KLQHRNLVRLLGFC------LEGEEKILVYEFVPNKSLDYF-LYE-PEKQQQLDWSRRYK 449
+ + L RL + +V E++ + LY + D K
Sbjct: 157 EREFEALQRLYPEGVKVPKPIAWNRHAVVMEYI-----EGVELYRLRLDVENPD-EILDK 210
Query: 450 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492
I+ + Y R I+H DL NIL+ + + + D+
Sbjct: 211 ILEEVR--KAY-----RRGIVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 391 NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKI 450
+E L+ +L H ++ LL + G LV +P D + Y + + L ++
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 451 IGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506
+ +AR +L Y+H + IIHRD+K N+L++ + + DFG A +
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE 542
I GT APE ++ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 29/79 (36%), Positives = 42/79 (53%), Gaps = 9/79 (11%)
Query: 446 RRYKIIGGIARGILY-LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504
R +I G+ R +L L + R+ I+HRD+K N+L+ + KI DFG A VD
Sbjct: 306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA----VDMCT 361
Query: 505 G-NTNRIVGTYGYMAPEYA 522
G N N + YG + P Y+
Sbjct: 362 GINFNPL---YGMLDPRYS 377
|
Length = 507 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 54/247 (21%), Positives = 95/247 (38%), Gaps = 63/247 (25%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEF---KNEVVLVAKLQHRNLVRLLG 409
LG G FGEV + + A+K L + + K E ++A+ + +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 410 FCLEGEEKILVYEFVPNKSLDYFLYE----PEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
+ + V +++P + L PE +R Y IA L +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEV-----LARFY-----IAELTLAIESVH 118
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT-----QGNTNR----------- 509
++ IHRD+K NIL+D + + K++DFG+ F +G+ R
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 510 -----------------------------IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 540
+VGT Y+APE + ++ D +S GV++
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 541 LEIITGK 547
E++ G+
Sbjct: 239 FEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|201633 pfam01163, RIO1, RIO1 family | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.002
Identities = 38/158 (24%), Positives = 61/158 (38%), Gaps = 33/158 (20%)
Query: 362 VYKGVLPSGQEIAVK--RLSRSS-------GQGGQEFKNE-------VVLVAKLQHRNLV 405
VY G+++AVK R +S G F++ V L A+ + RNL
Sbjct: 2 VYHAYSEDGKKVAVKIYRTGTTSFKKRKRYRDGDFRFRDSKTSWRYLVRLWAEKEFRNLK 61
Query: 406 RLLGFCL------EGEEKILVYEFVPNKSLDYFLYE-PEKQQQLDWSRRY-KIIGGIARG 457
RL + +LV EF+ + + + + + Y +II + R
Sbjct: 62 RLYEAGVPVPKPIAVNRHVLVMEFIGDD--GVPAPRLKDVELEEEAEEIYDEIIREMRR- 118
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495
LY ++H DL N+L+D + P I D A
Sbjct: 119 -LYQEA----GLVHGDLSEYNVLVDDD-KPVIIDVPQA 150
|
This is a family of atypical serine kinases which are found in archaea, bacteria and eukaryotes. Activity of Rio1 is vital in Saccharomyces cerevisiae for the processing of ribosomal RNA, as well as for proper cell cycle progression and chromosome maintenance. The structure of RIO1 has been determined. Length = 186 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 573 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.98 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.98 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.98 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.98 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.98 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.98 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.98 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.98 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.98 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.98 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.86 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.11 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.08 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.94 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.93 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.88 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.66 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.62 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.58 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.47 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.37 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.36 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.33 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.24 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.22 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.17 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.13 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.13 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.06 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.01 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.99 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.99 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.95 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.88 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.87 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.83 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.64 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.56 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.43 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.25 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.23 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.22 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.22 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.18 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.06 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.05 | |
| PLN02236 | 344 | choline kinase | 96.97 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.76 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.59 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.39 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.32 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.16 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.09 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.97 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.9 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.88 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.78 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.68 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.67 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.55 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.39 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.99 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.6 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=387.74 Aligned_cols=234 Identities=50% Similarity=0.856 Sum_probs=205.1
Q ss_pred cccccchhHHHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEE
Q 008238 332 ESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFC 411 (573)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 411 (573)
....|.+.++..++++|...+.||+|+||.||+|.+++++.||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34568999999999999999999999999999999989999999988765433156699999999999999999999999
Q ss_pred EcCC-eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEe
Q 008238 412 LEGE-EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 490 (573)
Q Consensus 412 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~ 490 (573)
.+.+ +.+||||||++|+|+++|+..... +++|.+|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875544 89999999999999999999999988899999999999999999999999
Q ss_pred ccCCcccccCCCCccccccc-cccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhh
Q 008238 491 DFGMAKIFGVDQTQGNTNRI-VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSIN 568 (573)
Q Consensus 491 DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~ 568 (573)
|||+++..... ....... .||.+|+|||++..+..+.|+|||||||+++||+||+++.+.........+++|++..
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 99999654321 1111122 7999999999999999999999999999999999999988765555666689988653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=354.72 Aligned_cols=210 Identities=30% Similarity=0.524 Sum_probs=184.7
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.+|.+.++||+|+||+||+|++ +++.+||||.+.+. .....+.+..|+++|+.++|||||.+++++..++..+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 4688889999999999999995 46899999999766 45556778899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC------CCeEEeccCCcc
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE------MNPKISDFGMAK 496 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~------~~vkl~DfGla~ 496 (573)
||.+|+|.++++. .+.+++..+..++.||+.||++||+++ ||||||||.||||+.. -.+||+|||+++
T Consensus 90 yC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999964 347999999999999999999999998 9999999999999764 458999999999
Q ss_pred cccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
.+.. .......+|++-|||||++...+|+.|+|+||+|+++||+++|+.||+- ....+|+.|+.+
T Consensus 164 ~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a---~t~~eL~~~~~k 228 (429)
T KOG0595|consen 164 FLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA---ETPKELLLYIKK 228 (429)
T ss_pred hCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc---cCHHHHHHHHhc
Confidence 8763 2344568999999999999999999999999999999999999999762 345556655544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=339.22 Aligned_cols=214 Identities=28% Similarity=0.423 Sum_probs=185.8
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.++|++.+.||+|+||+||.++. +.++.+|+|.+++.. ....+..+.|..+|.+++||.||+++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45799999999999999999995 468889999998653 23356678899999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
+||+.||.|..+|. ++..+++..+.-++.+|+.||.|||+++ ||||||||+|||||++|+++|+||||++..-.
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999994 4567999999999999999999999998 99999999999999999999999999985432
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhhc
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSINR 569 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~~ 569 (573)
. ...+...+||+.|||||++.+..++..+|+||||+++|||++|.+||.. ++...+.+-+...+
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~---~~~~~~~~~I~~~k 241 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA---EDVKKMYDKILKGK 241 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC---ccHHHHHHHHhcCc
Confidence 2 2344558999999999999999999999999999999999999999854 33444555555444
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=349.81 Aligned_cols=201 Identities=36% Similarity=0.615 Sum_probs=174.5
Q ss_pred CCcccccccccceeEEEEecCCCCeeEEEEeccCCccc--hHHHHHHHHHHHhcCCCccceEEEEEEcCC-eeEEEEEcc
Q 008238 348 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQG--GQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-EKILVYEFV 424 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 424 (573)
+.+.+.||+|+||+||+|.+.....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ...+||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 44556699999999999999555559999997643222 568999999999999999999999999988 789999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC-CeEEeccCCcccccCCCC
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~~~~~~ 503 (573)
++|+|.++++.. ....+++..+++++.|||+||+|||++++ ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999764 45789999999999999999999999863 99999999999999997 99999999998654322
Q ss_pred ccccccccccCCccchhccc--cCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAM--HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
.......||..|||||++. ...++.|+||||||+++|||+||+.||...
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~ 249 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL 249 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC
Confidence 2223368999999999999 568999999999999999999999998643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=334.04 Aligned_cols=215 Identities=29% Similarity=0.390 Sum_probs=187.7
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccC-CccchHHHHHHHHHHHhcCCCccceEEEEEEcCC-eeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-EKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 423 (573)
+++..+.||+|..|+|||++++ +++.+|+|.+... .....+++.+|++++++.+|||||+++|.|.... ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4566789999999999999964 6888999999543 4455678999999999999999999999999988 59999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
|++|+|++++.. .+.+++...-+|+.+|++||.|||+. ++||||||||+|||++..|+|||+|||.++.+-..
T Consensus 160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999953 36699999999999999999999963 24999999999999999999999999999876433
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC--CCCCcccHHHHHHhhcc
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY--QTDGAADLLSYVSINRV 570 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~--~~~~~~~ll~~~~~~~~ 570 (573)
..+..+||..|||||.+.+..|+.++||||||+.++|+.+|+-|+... ......+|+.+|-..-+
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP 299 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC
Confidence 445678999999999999999999999999999999999999998753 24577888888876544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=346.62 Aligned_cols=199 Identities=29% Similarity=0.491 Sum_probs=182.7
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
.+|...+.||+|||+.+|+++. ..|+.||+|++.+. .....+.+.+||+|.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4689999999999999999996 88999999999764 3445677899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
|+|++++|..+++ +..++++.+++.++.||+.||.|||+++ |+|||||-.|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999985 4578999999999999999999999987 999999999999999999999999999887544
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. .+..+++||+.|+|||++....++..+||||+||++|-||.|++||+-
T Consensus 172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet 220 (592)
T KOG0575|consen 172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET 220 (592)
T ss_pred c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence 3 345578999999999999999999999999999999999999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=361.49 Aligned_cols=226 Identities=31% Similarity=0.526 Sum_probs=192.9
Q ss_pred hHHHHHhCCCCcccccccccceeEEEEecC------CCCeeEEEEeccCCcc-chHHHHHHHHHHHhcCCCccceEEEEE
Q 008238 339 ETIEVATNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSSGQ-GGQEFKNEVVLVAKLQHRNLVRLLGFC 411 (573)
Q Consensus 339 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~ 411 (573)
...+....+.+..++||+|.||+||+|+.. +...||||.++..... ...+|++|++++..++|||||+|+|+|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 334556667888999999999999999853 3456999999877655 778999999999999999999999999
Q ss_pred EcCCeeEEEEEccCCCChhhhccCcC-------c----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEE
Q 008238 412 LEGEEKILVYEFVPNKSLDYFLYEPE-------K----QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 480 (573)
Q Consensus 412 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIL 480 (573)
.+++..++|+|||..|+|.+||+... . ..+++..+.+.|+.|||.||+||-++. +|||||..+|+|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCL 635 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCL 635 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhce
Confidence 99999999999999999999996421 1 234899999999999999999999876 999999999999
Q ss_pred eCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 008238 481 LDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAA 559 (573)
Q Consensus 481 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~ 559 (573)
|.++..|||+||||+|.....+.........-+.+||+||.|+.++||.+||||||||+|||++| |+.|+. .-..+
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~---glSn~ 712 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY---GLSNQ 712 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc---ccchH
Confidence 99999999999999997655544433334455789999999999999999999999999999998 888864 23456
Q ss_pred cHHHHHHhhcc
Q 008238 560 DLLSYVSINRV 570 (573)
Q Consensus 560 ~ll~~~~~~~~ 570 (573)
+++++|+..++
T Consensus 713 EVIe~i~~g~l 723 (774)
T KOG1026|consen 713 EVIECIRAGQL 723 (774)
T ss_pred HHHHHHHcCCc
Confidence 78888887765
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=345.29 Aligned_cols=203 Identities=35% Similarity=0.552 Sum_probs=176.2
Q ss_pred HhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
..+.+...++||+|.||+||.|.++....||+|.++.. ....+.|.+|+.+|++++|+|||+++|+|..++.++|||||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 33445677899999999999999977779999999754 34457888999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
|+.|+|.++|+. ..+..++..+.+.++.||++||+||++++ +|||||.++||||+++..+||+||||++....+..
T Consensus 283 m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 999999999976 34567899999999999999999999987 99999999999999999999999999996544333
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.... ...-+..|.|||.+..+.++.|||||||||+||||+| |+.|+..
T Consensus 359 ~~~~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 359 TASE-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred eecC-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 2222 2233678999999999999999999999999999999 7777543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=319.39 Aligned_cols=202 Identities=27% Similarity=0.465 Sum_probs=175.3
Q ss_pred CCCcccccccccceeEEEEe-cCCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEE-EEcCCe-eEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGF-CLEGEE-KILVY 421 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~-~~lv~ 421 (573)
+|++.++||+|.||+|||++ +.+|+.+|.|.+.-. +....+....|+.+|++++|||||+++++ +.++.+ ..|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 58889999999999999999 679999999998743 33445678889999999999999999984 333344 78999
Q ss_pred EccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 422 EFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLR--IIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 422 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~--ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
|++..|+|...++.. ...+.++++.+++++.|++.||..+|++. ++ |+||||||.||+|+.+|.+||+||||++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999998653 34567899999999999999999999853 33 999999999999999999999999999987
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.... ......+||+.||+||.+.+..|+.||||||+||++|||..-+.||.
T Consensus 179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~ 229 (375)
T KOG0591|consen 179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY 229 (375)
T ss_pred cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc
Confidence 5443 34456899999999999999999999999999999999999999975
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=310.64 Aligned_cols=211 Identities=29% Similarity=0.398 Sum_probs=185.7
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||.|+||.|.+++. .+|..+|+|++++... ...+...+|..+|+.+.||+++++.+.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4688899999999999999995 4688899999986543 23345678999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||.+||.|..+|+ +.+.++++.++-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||.++...
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 9999999999995 4567999999999999999999999987 9999999999999999999999999998753
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhhcc
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSINRV 570 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~~~ 570 (573)
..+-+++||+.|+|||++....+..++|+|||||++|||+.|.+||... ...++.+-|....+
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~---~~~~iY~KI~~~~v 258 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD---NPIQIYEKILEGKV 258 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC---ChHHHHHHHHhCcc
Confidence 3466789999999999999999999999999999999999999997543 33556666655544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=326.16 Aligned_cols=200 Identities=28% Similarity=0.446 Sum_probs=173.8
Q ss_pred HhCCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCCcc-------chHHHHHHHHHHHhcCCCccceEEEEEEcCC
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQ-------GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 415 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 415 (573)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++++.... ....+.+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678899999999999999998 568999999999764221 2234679999999999999999999999999
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC---CCeEEecc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDF 492 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~---~~vkl~Df 492 (573)
..|+||||++||.|.+++- .+..+.+.....++.|++.|+.|||+++ |+||||||+|||+..+ -.+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999884 3456788888999999999999999998 9999999999999765 67999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccccCCC---CccchhHHHHHHHHHHHhCCCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF---SVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|+++..+ ......+.+||+.|.|||++.+... ..+.|+||+||+||-+++|.+||+-
T Consensus 324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~ 383 (475)
T KOG0615|consen 324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE 383 (475)
T ss_pred chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence 9999765 3345667899999999999977643 4588999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=325.13 Aligned_cols=194 Identities=35% Similarity=0.550 Sum_probs=168.9
Q ss_pred CCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHh--cCCCccceEEEEEEcCC----eeEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAK--LQHRNLVRLLGFCLEGE----EKIL 419 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~l 419 (573)
...++.+.||+|+||.||||++ +++.||||++.. +..+.|++|-+|.+. ++|+||++++++-..++ +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3456678999999999999999 569999999964 445677888777665 58999999999887666 8899
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEeecCCCCCEEeCCCCCeEEeccC
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED------SRLRIIHRDLKASNILLDAEMNPKISDFG 493 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~------~~~~ivH~Dlkp~NILl~~~~~vkl~DfG 493 (573)
|++|.++|+|.++| +...++|....+|+..+++||+|||+. .|++|+|||||++||||..|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 567899999999999999999999964 46789999999999999999999999999
Q ss_pred CcccccCCCCccccccccccCCccchhccccCCC-C-----ccchhHHHHHHHHHHHhCC
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF-S-----VKSDVYSFGVLVLEIITGK 547 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s-----~~~DvwslGvll~elltG~ 547 (573)
++.++...........-+||.+|||||++.+... . .+.||||+|.+||||++.-
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 9999887777776667899999999999976532 2 4689999999999999854
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.24 Aligned_cols=199 Identities=27% Similarity=0.461 Sum_probs=172.5
Q ss_pred CCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcC--CeeEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILV 420 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 420 (573)
+.|+.+++||+|.||.||+++ ..+|+.||+|++.... +.......+||.||++++||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457778899999999999999 5689999999987654 44456678999999999999999999998876 688999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
+|||++ +|.-++.. ..-.|++.++..++.|++.||+|+|+++ |+|||||.+|||||.+|.+||+||||++++..
T Consensus 197 FeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999976 45555533 3357999999999999999999999988 99999999999999999999999999998876
Q ss_pred CCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......+++ +-|++|.|||.+.+. .|+.+.|+||.||||.||+.|++.+.
T Consensus 271 ~~~~~~T~r-VvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~ 321 (560)
T KOG0600|consen 271 SGSAPYTSR-VVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ 321 (560)
T ss_pred CCCcccccc-eEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence 655554444 459999999999875 69999999999999999999999865
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=321.75 Aligned_cols=216 Identities=24% Similarity=0.353 Sum_probs=182.8
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
..++|++++.||+|+||.||+++. .+|+.+|+|+++++.- ...+.++.|-.+|...++|+||+|+..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 456899999999999999999994 5799999999988753 334567889999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||++||++..+|. +...|++..+..++.+++-|++-||+.+ +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999995 4568999999999999999999999988 9999999999999999999999999985331
Q ss_pred CC----------------------CCc-----cc------------------cccccccCCccchhccccCCCCccchhH
Q 008238 500 VD----------------------QTQ-----GN------------------TNRIVGTYGYMAPEYAMHGQFSVKSDVY 534 (573)
Q Consensus 500 ~~----------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~s~~~Dvw 534 (573)
.. ... .. ....+||+.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 000 00 0125899999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCC-CCcccHHHHH
Q 008238 535 SFGVLVLEIITGKKNSSFYQT-DGAADLLSYV 565 (573)
Q Consensus 535 slGvll~elltG~~p~~~~~~-~~~~~ll~~~ 565 (573)
|||||+||||.|.+||....+ +....++.|.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr 404 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWR 404 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999999999999875443 2334444444
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=326.18 Aligned_cols=199 Identities=29% Similarity=0.515 Sum_probs=182.2
Q ss_pred hCCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
...|...++||+|+.|.||.+. ...++.||||++........+-+.+|+.+|+..+|+|||++++.+..++++|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3468889999999999999998 567889999999887777778889999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
|++|+|.+.+ ....+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999998 4456999999999999999999999998 99999999999999999999999999987754433
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....+||+.|||||++....|..|.||||||++++||+-|++||-.
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 45568999999999999999999999999999999999999999744
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=321.89 Aligned_cols=201 Identities=30% Similarity=0.448 Sum_probs=176.8
Q ss_pred hCCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCC---ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 419 (573)
..+|...+.||+|+|++|++++ ...+++||||++.+.- +...+-+..|-+.|.+| .||.|++|+..|++...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 4578999999999999999999 5579999999987542 22234467788899999 79999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
|+||+++|+|.++|. +.+.+++.....++.||+.+|+|||+++ ||||||||+|||||+|+++||+|||.++.+.
T Consensus 152 vLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999995 4567999999999999999999999988 9999999999999999999999999999875
Q ss_pred CCCCc---------ccc--ccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 500 VDQTQ---------GNT--NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 500 ~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
..... ... ...+||..|.+||++.++..+..+|||+|||++|+|+.|++||.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr 288 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR 288 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc
Confidence 43221 111 34799999999999999999999999999999999999999984
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=292.22 Aligned_cols=209 Identities=28% Similarity=0.466 Sum_probs=177.0
Q ss_pred CCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++|...++||+|.||.||+|+ .++|+.||||+++.... .......+||+.|+.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467788999999999999999 56899999999975432 224567899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
||+ .+|+..+++ +...++..++..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+++.+....
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 578888865 5568999999999999999999999998 9999999999999999999999999999887554
Q ss_pred CccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYV 565 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~ 565 (573)
..... .+-|.+|.|||.+.+. .|+...||||.|||+.||+-|.+-+ ..+...|.+..|
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f---pG~sDidQL~~I 214 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF---PGDSDIDQLSKI 214 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC---CCCchHHHHHHH
Confidence 43322 2679999999999876 5899999999999999999987643 234444444444
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=302.13 Aligned_cols=210 Identities=26% Similarity=0.383 Sum_probs=177.3
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++|+...++|+|+||.|||++.+ +|+.||||++..+.+ ...+-..+||++|++++|+|+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35778889999999999999964 699999999976543 233456799999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|++..-|+++-+. ...++...+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||.|+.+..+
T Consensus 82 ~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 9999888766532 346889999999999999999999988 999999999999999999999999999977532
Q ss_pred CccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVS 566 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~ 566 (573)
....+..+.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+-| ..+...|.+..|+
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~---PG~SDiDQLy~I~ 215 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW---PGRSDIDQLYLIR 215 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC---CCcchHHHHHHHH
Confidence 222344577999999999987 68999999999999999999999854 3444555554443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.19 Aligned_cols=208 Identities=33% Similarity=0.550 Sum_probs=178.9
Q ss_pred hhHHHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCC
Q 008238 338 FETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 415 (573)
Q Consensus 338 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 415 (573)
.+.+++..+.+.+.+.||+|.||+||+|.|.. .||||+++.. ..+..+.|++|+..+++-+|.||+-+.|+|....
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 35666777778899999999999999999853 6999998755 3445688999999999999999999999999877
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
. .||..||+|.+|..+++..+ ..|+..+.+.|++||++||.|||.++ |||||||++||+|.++++|||+||||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred e-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 6 99999999999999998644 57899999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCCCccccccccccCCccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
..-..-..........|...|||||++.. .+|+..+||||||+++|||++|..||...
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~ 596 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ 596 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC
Confidence 64332222222334567889999999954 46899999999999999999999998743
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=318.92 Aligned_cols=196 Identities=29% Similarity=0.466 Sum_probs=176.1
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++|.+.+.||+|.||.||||+. .+.+.||+|.+.+.. +...+.+.+|++|+++++|||||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4688889999999999999995 467889999987653 3445678999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+.+ +|..+|. ....++++.+..|+.++..||.|||+.+ |+|||+||+|||++..+.+|++|||+++......
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 9999984 3457999999999999999999999987 9999999999999999999999999999775433
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
.....+.||+-|||||...+.+|+..+|+||+||++||+++|++||
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF 200 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPF 200 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCc
Confidence 2345678999999999999999999999999999999999999997
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.70 Aligned_cols=216 Identities=26% Similarity=0.396 Sum_probs=185.7
Q ss_pred HHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCee
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 417 (573)
..-++|.+.+.||+|.||+|+++..+ +++.+|||.+++.. .+..+..+.|..++.... ||.+++++..++..++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34568999999999999999999964 67889999998764 344566777888887775 99999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
+.||||+.||++..+. ..+.+++..+.-++..|+.||+|||+++ ||+||||-+|||||.+|++||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999955444 3467999999999999999999999998 99999999999999999999999999985
Q ss_pred ccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhhcc
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSINRV 570 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~~~ 570 (573)
-- .....+.+.+||+.|||||++.+..|+..+|+|||||+||||+.|..||. .|+++++.+-|....+
T Consensus 518 ~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~---gddEee~FdsI~~d~~ 585 (694)
T KOG0694|consen 518 GM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP---GDDEEEVFDSIVNDEV 585 (694)
T ss_pred cC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC---CCCHHHHHHHHhcCCC
Confidence 32 12346778999999999999999999999999999999999999999975 3566667666655443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.05 Aligned_cols=193 Identities=33% Similarity=0.492 Sum_probs=170.7
Q ss_pred HHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++..+....++.||.|+.|.||+|++ .++.||||+++.-. +.+|+-|++|+||||+.+.|+|.....++|||
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 33444455678999999999999999 67899999986322 35899999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
|||..|-|...|+ ..+++.......|..+||.||.|||.+. |||||||+-||||..+..|||+|||-++.....
T Consensus 192 EfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 192 EFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred eccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 9999999999995 4567888999999999999999999987 999999999999999999999999999876433
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.......||..|||||+|.+.+.+.|+|||||||+|||||||..||.
T Consensus 266 ---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYk 312 (904)
T KOG4721|consen 266 ---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYK 312 (904)
T ss_pred ---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcc
Confidence 22345689999999999999999999999999999999999999974
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=307.96 Aligned_cols=202 Identities=32% Similarity=0.504 Sum_probs=171.8
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCC--eeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 422 (573)
.++...+.||+|+||+||++... +|+..|||.+........+.+.+|+.+|++++|||||+.+|.....+ ...++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777899999999999999964 48999999987654333667899999999999999999999855444 5889999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC-CCCeEEeccCCcccccC-
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMAKIFGV- 500 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~~~~- 500 (573)
|+++|+|.+++..... .+++..+.++..||++||+|||+++ |+|+||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999965322 6999999999999999999999988 999999999999999 79999999999987653
Q ss_pred CCCccccccccccCCccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
...........||+.|||||++.++. ...++|||||||++.||+||++||..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 11122334578999999999998643 34599999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=314.06 Aligned_cols=214 Identities=27% Similarity=0.453 Sum_probs=182.4
Q ss_pred HHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC----Cc-cchHHHHHHHHHHHhcC-CCccceEEEEEEcCC
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS----SG-QGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGE 415 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 415 (573)
...++|.+.+.||+|+||+|+.+.. .+++.||+|.+.+. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456799999999999999999984 57899999977653 12 23456778999999999 999999999999999
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC-CCeEEeccCC
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGM 494 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~DfGl 494 (573)
..++||||+.+|+|.+++.. ...+.+.++.++++|++.|++|+|+++ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999954 467888999999999999999999988 9999999999999999 9999999999
Q ss_pred cccccCCCCccccccccccCCccchhccccCC-CC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ-FS-VKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+. +....+...+..
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~~~~~l~~ki~~ 237 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD---SNVPNLYRKIRK 237 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC---ccHHHHHHHHhc
Confidence 98763 2233455679999999999998877 75 789999999999999999999865 334444444443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=301.59 Aligned_cols=207 Identities=27% Similarity=0.405 Sum_probs=179.1
Q ss_pred HhCCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
..+.|++.+.||.|..++||+|+ .+.++.||||++.-... .....+.+|+..++.++||||++++..|..++.+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 34679999999999999999999 66789999999975433 33588999999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
+||.+|++.++++..-. ..+++..+..|.+++++||.|||.++ -||||||+.||||+++|.|||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999965433 34899999999999999999999998 999999999999999999999999987644322
Q ss_pred CC-cc-ccccccccCCccchhccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008238 502 QT-QG-NTNRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSSFYQ 554 (573)
Q Consensus 502 ~~-~~-~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwslGvll~elltG~~p~~~~~ 554 (573)
.. .. +.+..+||+.|||||+++.. .|+.|+||||||+...||.+|..||..+.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 21 11 12667999999999997554 58999999999999999999999998655
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=300.70 Aligned_cols=201 Identities=28% Similarity=0.431 Sum_probs=167.8
Q ss_pred chhHHHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHh--cCCCccceEEEEEEcC
Q 008238 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAK--LQHRNLVRLLGFCLEG 414 (573)
Q Consensus 337 ~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~ 414 (573)
.+-......+...+.+.||+|.||+||+|.| .|+.||||++.... .+.+.+|.++.+. ++|+||+.+++.-..+
T Consensus 202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKD 277 (513)
T ss_pred hhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence 3344566778899999999999999999999 78999999996433 3456667777665 5999999999876544
Q ss_pred C----eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEeecCCCCCEEeCCCC
Q 008238 415 E----EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE-----DSRLRIIHRDLKASNILLDAEM 485 (573)
Q Consensus 415 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-----~~~~~ivH~Dlkp~NILl~~~~ 485 (573)
+ ++|||.+|.+.|||.|+| +...++....++++..+|.||++||. +++|.|.|||||++|||+..++
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 3 679999999999999999 44789999999999999999999994 5889999999999999999999
Q ss_pred CeEEeccCCcccccCCCC--ccccccccccCCccchhccccCC----C--CccchhHHHHHHHHHHHh
Q 008238 486 NPKISDFGMAKIFGVDQT--QGNTNRIVGTYGYMAPEYAMHGQ----F--SVKSDVYSFGVLVLEIIT 545 (573)
Q Consensus 486 ~vkl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--s~~~DvwslGvll~ellt 545 (573)
.+.|+|+||+........ ....+..+||.+|||||++...- + -..+||||||+++||+..
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 999999999987654422 23456679999999999985532 1 246899999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=309.55 Aligned_cols=198 Identities=26% Similarity=0.402 Sum_probs=170.9
Q ss_pred HhCCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCCccchHH-HHHHHHHHHhcC-CCccceEEEEEEcCC-eeEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE-FKNEVVLVAKLQ-HRNLVRLLGFCLEGE-EKIL 419 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~-~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~l 419 (573)
..++|.+.++||.|.||.||+|+ ...++.||||++++.-....+- -.+|++.|++++ ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 44678999999999999999999 5678999999998654433222 357999999999 999999999999988 8999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
|||||+ .+|.++++++ +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||...
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999995 5788888653 679999999999999999999999998 9999999999999988899999999999764
Q ss_pred CCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
... ..+..+.|.+|.|||++.. +-|+.+.||||+|||++|+.+-++-|
T Consensus 162 Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF 210 (538)
T KOG0661|consen 162 SKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF 210 (538)
T ss_pred cCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence 332 2334578999999999865 56899999999999999999988754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=309.10 Aligned_cols=209 Identities=31% Similarity=0.491 Sum_probs=183.3
Q ss_pred HHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCcc-chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQ-GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
.+.+.+...+.++||+|.||.|.+++...+..||||+++..... ..++|..|+++|.+++||||++++|+|..++.+++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 34566778899999999999999999978899999999876544 45899999999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
|+|||++|+|.+|+....... +......+|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||+++-+.
T Consensus 613 I~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999997643322 455667889999999999999877 9999999999999999999999999999776
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh--CCCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT--GKKNSSFY 553 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt--G~~p~~~~ 553 (573)
..+......+.+-+.+|||||.+..++++.++|+|+||+.+||+++ ..+||+..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l 744 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL 744 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh
Confidence 6655555556677899999999999999999999999999999854 67787643
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.86 Aligned_cols=221 Identities=33% Similarity=0.531 Sum_probs=183.1
Q ss_pred HHhCCCCcccccccccceeEEEEecCC--CC----eeEEEEeccC-CccchHHHHHHHHHHHhcCCCccceEEEEEEcCC
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPS--GQ----EIAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 415 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 415 (573)
...++.+..+.||+|.||.||+|...+ +. .||||.+++. +.+...+|.+|..+|++++|||||+++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 345667788999999999999999642 33 4899999865 4455678999999999999999999999999999
Q ss_pred eeEEEEEccCCCChhhhccCcC----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEec
Q 008238 416 EKILVYEFVPNKSLDYFLYEPE----KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 491 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~D 491 (573)
..+|++|||++|+|..||++.+ ....++..+++.++.|||+|+.||+++. +|||||..+|+||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999998642 2467899999999999999999999987 99999999999999999999999
Q ss_pred cCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcccHHH-HHHhhc
Q 008238 492 FGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLLS-YVSINR 569 (573)
Q Consensus 492 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~~ll~-~~~~~~ 569 (573)
||+|+.+.............-+.+|||||.+.++.++.|+|||||||++||++| |..||.. ....+++. +....|
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~---~~n~~v~~~~~~ggR 922 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS---RSNFEVLLDVLEGGR 922 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC---cchHHHHHHHHhCCc
Confidence 999995543333333333344679999999999999999999999999999999 6677643 33444555 444333
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.94 Aligned_cols=201 Identities=25% Similarity=0.357 Sum_probs=173.5
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||+||+++. .+++.||||++.+.. ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688999999999999999985 468899999987532 223456788999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999853 357899999999999999999999987 999999999999999999999999998754321
Q ss_pred CCc---------------------------------cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCC
Q 008238 502 QTQ---------------------------------GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548 (573)
Q Consensus 502 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~ 548 (573)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCC
Q 008238 549 NSSF 552 (573)
Q Consensus 549 p~~~ 552 (573)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=309.68 Aligned_cols=207 Identities=29% Similarity=0.434 Sum_probs=171.3
Q ss_pred HHhCCCCcccccccccceeEEEEec------CCCCeeEEEEeccCCc-cchHHHHHHHHHHHhc-CCCccceEEEEEEcC
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEG 414 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 414 (573)
...++|++.++||+|+||.||++.+ ..++.||||++..... .....+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4556899999999999999999973 2356899999875432 3345788999999999 899999999988764
Q ss_pred C-eeEEEEEccCCCChhhhccCcCc-------------------------------------------------------
Q 008238 415 E-EKILVYEFVPNKSLDYFLYEPEK------------------------------------------------------- 438 (573)
Q Consensus 415 ~-~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 438 (573)
+ ..+++|||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 57899999999999998864211
Q ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccC
Q 008238 439 ----QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTY 514 (573)
Q Consensus 439 ----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~ 514 (573)
...+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...............++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 235888999999999999999999987 9999999999999999999999999998653322222222345677
Q ss_pred CccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 515 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 515 ~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~ 279 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCC
Confidence 8999999999999999999999999999997 9999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=295.99 Aligned_cols=198 Identities=24% Similarity=0.448 Sum_probs=178.5
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
.+|++.+.||+|.||.|-++.. ..|+.||||.+++.. +++.-.+.+||+||+.++||||+.++.+|.+.+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4688899999999999999984 789999999987654 344456889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||..+|.|.+++. ..+.+++.+...+++||..++.|+|.+. ++|||||.+|||||+++++||+||||+..+...
T Consensus 133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999995 4567999999999999999999999887 999999999999999999999999999876433
Q ss_pred CCccccccccccCCccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslGvll~elltG~~p~~~ 552 (573)
...++.+|++-|.+||++.+.+| .+..|-|||||+||-|+.|..||+-
T Consensus 207 ---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 207 ---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred ---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 34567899999999999999888 5899999999999999999999864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=297.91 Aligned_cols=199 Identities=29% Similarity=0.436 Sum_probs=172.4
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367889999999999999995 578999999986432 2233467889999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998887532 2346899999999999999999999987 9999999999999999999999999997653221
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 203 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCC
Confidence 12345789999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=285.18 Aligned_cols=208 Identities=27% Similarity=0.413 Sum_probs=172.8
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccc--hHHHHHHHHHHHhcCCCccceEEEEEEcC--CeeEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQG--GQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILVY 421 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 421 (573)
.|+.++.|++|.||.||+|+. ++++.||+|+++...+.. --.-.+||.+|.+.+|||||.+-.+.... +..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 478889999999999999995 468899999997554322 23457899999999999999999987654 5789999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||++. +|..++..- .+++...++..++.|+++|++|||.+. |+|||||++|+|+++.|.+||+|||+||.++.+
T Consensus 157 e~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99975 677777542 368999999999999999999999998 999999999999999999999999999988755
Q ss_pred CCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYV 565 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~ 565 (573)
.. ..+..+-|.+|.|||.+.+. .|+...|+||+|||+.||+++++-|. ...+.|.++-|
T Consensus 231 ~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~---G~sE~dQl~~I 290 (419)
T KOG0663|consen 231 LK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP---GKSEIDQLDKI 290 (419)
T ss_pred cc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC---CCchHHHHHHH
Confidence 32 23456779999999999886 58999999999999999999998653 23444444443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=288.36 Aligned_cols=199 Identities=29% Similarity=0.470 Sum_probs=168.2
Q ss_pred CCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCCcc--chHHHHHHHHHHHhcCCCc-cceEEEEEEcCC------
Q 008238 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQ--GGQEFKNEVVLVAKLQHRN-LVRLLGFCLEGE------ 415 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------ 415 (573)
..|+..++||+|.||+||+|+ ..+|+.||+|++.....+ .-....+|+.++++++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 346677889999999999999 457899999998755432 2345688999999999999 999999999877
Q ss_pred eeEEEEEccCCCChhhhccCcCcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQ-QQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
..++||||++ .+|..++....+. +.++...+..++.||++||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7889999994 5788887553322 45777889999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~ 550 (573)
++.+..+... ....++|.+|.|||++.+. .|+...||||+|||+.||++++.-|
T Consensus 167 Ara~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF 221 (323)
T KOG0594|consen 167 ARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF 221 (323)
T ss_pred HHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC
Confidence 9976544322 3445789999999999987 6899999999999999999977644
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=312.84 Aligned_cols=200 Identities=25% Similarity=0.363 Sum_probs=171.8
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.|++.+.||+|+||+||+++. .+++.||||++.+.. ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999985 568899999986532 2334568899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999853 346889999999999999999999987 9999999999999999999999999976432110
Q ss_pred Cc---------------------------------------------cccccccccCCccchhccccCCCCccchhHHHH
Q 008238 503 TQ---------------------------------------------GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFG 537 (573)
Q Consensus 503 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG 537 (573)
.. ......+||+.|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 001235799999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 008238 538 VLVLEIITGKKNSSF 552 (573)
Q Consensus 538 vll~elltG~~p~~~ 552 (573)
|++|||++|+.||..
T Consensus 236 ~il~elltG~~Pf~~ 250 (381)
T cd05626 236 VILFEMLVGQPPFLA 250 (381)
T ss_pred hHHHHHHhCCCCCcC
Confidence 999999999999854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=313.17 Aligned_cols=201 Identities=26% Similarity=0.346 Sum_probs=171.9
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.++||+|+||+||+++. .+++.||||++.+.. ....+.+++|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688999999999999999985 578899999986432 233456888999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999853 356889999999999999999999987 999999999999999999999999998643211
Q ss_pred CCc------------c---------------------------------ccccccccCCccchhccccCCCCccchhHHH
Q 008238 502 QTQ------------G---------------------------------NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSF 536 (573)
Q Consensus 502 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dvwsl 536 (573)
... . .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCC
Q 008238 537 GVLVLEIITGKKNSSF 552 (573)
Q Consensus 537 Gvll~elltG~~p~~~ 552 (573)
||++|||++|+.||..
T Consensus 235 Gvil~elltG~~Pf~~ 250 (377)
T cd05629 235 GAIMFECLIGWPPFCS 250 (377)
T ss_pred chhhhhhhcCCCCCCC
Confidence 9999999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=300.18 Aligned_cols=196 Identities=27% Similarity=0.352 Sum_probs=172.7
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.++||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999964 68899999986432 223456889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~- 153 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD- 153 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC-
Confidence 99999999999853 356899999999999999999999987 99999999999999999999999999876532
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~ 200 (291)
T cd05612 154 ----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200 (291)
T ss_pred ----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12235789999999999988999999999999999999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=314.22 Aligned_cols=215 Identities=33% Similarity=0.457 Sum_probs=177.5
Q ss_pred HHHHhCCCCcccccccccceeEEEEecCC--C--Ce-eEEEEecc---CCccchHHHHHHHHHHHhcCCCccceEEEEEE
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVLPS--G--QE-IAVKRLSR---SSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 412 (573)
++..-++..+.++||+|+||.||+|++.. + .. ||||..+. .......+|.+|..++++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34445566677999999999999999642 2 23 89999875 23556788999999999999999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEecc
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df 492 (573)
....+++|||++.||+|+++|.... ..++..++++++.+.|.||+|||+++ +|||||.++|+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence 9999999999999999999996532 36999999999999999999999988 999999999999999999999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHH
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLLSYV 565 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~~ll~~~ 565 (573)
|+++.-.. .........-+.+|+|||.+..+.++.++|||||||++||+++ |..|+.- -...++..+|
T Consensus 307 GLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g---~~~~~v~~kI 375 (474)
T KOG0194|consen 307 GLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG---MKNYEVKAKI 375 (474)
T ss_pred ccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC---CCHHHHHHHH
Confidence 99875421 1111111134679999999999999999999999999999999 7887642 3344555555
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=311.04 Aligned_cols=201 Identities=25% Similarity=0.372 Sum_probs=173.3
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||+||+++. .+++.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3688999999999999999995 468899999987532 233456788999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999853 346899999999999999999999987 999999999999999999999999998754321
Q ss_pred CCcc------------------------------------ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh
Q 008238 502 QTQG------------------------------------NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545 (573)
Q Consensus 502 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt 545 (573)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112469999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 008238 546 GKKNSSF 552 (573)
Q Consensus 546 G~~p~~~ 552 (573)
|+.||..
T Consensus 235 G~~Pf~~ 241 (364)
T cd05599 235 GYPPFCS 241 (364)
T ss_pred CCCCCCC
Confidence 9999853
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=276.71 Aligned_cols=212 Identities=28% Similarity=0.434 Sum_probs=183.4
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|-||.||.++. +++-.||+|++.++. .....++.+|+++-+.++||||+++++++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 4789999999999999999994 567789999987653 334567899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||..+|++...|++. +...+++.....++.|+|.||.|+|..+ +|||||||+|+|++.++.+||+|||.+..-.
T Consensus 102 Eya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999642 3456889999999999999999999887 9999999999999999999999999986421
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhh
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSIN 568 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~ 568 (573)
.......+||..|.+||...+..++...|+|++|++.||++.|.+||+... ..+..+-|.+.
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~ 237 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKV 237 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHc
Confidence 334556899999999999999999999999999999999999999987543 34444444443
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=311.98 Aligned_cols=200 Identities=25% Similarity=0.358 Sum_probs=171.3
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.|++.++||+|+||+||+++. .+++.||+|++.+.. ......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999995 468899999987542 2334568899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998853 346889999999999999999999987 9999999999999999999999999975331100
Q ss_pred C---------------------------------------------ccccccccccCCccchhccccCCCCccchhHHHH
Q 008238 503 T---------------------------------------------QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFG 537 (573)
Q Consensus 503 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslG 537 (573)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001234789999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 008238 538 VLVLEIITGKKNSSF 552 (573)
Q Consensus 538 vll~elltG~~p~~~ 552 (573)
|++|||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=293.51 Aligned_cols=200 Identities=27% Similarity=0.458 Sum_probs=166.8
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc--------------cchHHHHHHHHHHHhcCCCccceEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG--------------QGGQEFKNEVVLVAKLQHRNLVRLLG 409 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l~~ 409 (573)
-+.|++.+.||+|.||.|-+++. .+++.||||++.+... ...+...+||.+|++++|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 45799999999999999999994 4789999999865311 12357889999999999999999999
Q ss_pred EEEc--CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCe
Q 008238 410 FCLE--GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 487 (573)
Q Consensus 410 ~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~v 487 (573)
+.-+ .+..|||+||+..|.+...= .....+++.+++++++++..||+|||.++ ||||||||.|+||+++|++
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcE
Confidence 9866 45789999999999874332 22223899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccccCCC---CccccccccccCCccchhccccCC----CCccchhHHHHHHHHHHHhCCCCC
Q 008238 488 KISDFGMAKIFGVDQ---TQGNTNRIVGTYGYMAPEYAMHGQ----FSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 488 kl~DfGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwslGvll~elltG~~p~ 550 (573)
||+|||.+..+.... ........+||+.|||||...++. .+.+.||||+||.||.|+.|+.||
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 999999998663221 122234579999999999887643 357899999999999999999996
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.85 Aligned_cols=195 Identities=28% Similarity=0.370 Sum_probs=172.8
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||.||+++.. +++.||+|.+.+.. ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46889999999999999999964 68899999986532 233456889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999998853 346889999999999999999999987 999999999999999999999999999865322
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 216 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCC
Confidence 223578999999999999999999999999999999999999974
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=305.66 Aligned_cols=196 Identities=28% Similarity=0.406 Sum_probs=173.9
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.++||+|+||.||+++.. +++.||||++++.. ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999964 58899999987542 233456888999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999843 356899999999999999999999987 99999999999999999999999999975432
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 200 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC
Confidence 23345789999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.29 Aligned_cols=203 Identities=23% Similarity=0.319 Sum_probs=173.6
Q ss_pred HHHHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 416 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 416 (573)
+....++|++.+.||+|+||.||+++.. +++.+|+|.+.+. .......+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344568999999999999999999964 6788999998642 22234567889999999999999999999999999
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence 9999999999999999843 35889999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccchhccccC----CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMHG----QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
...... ........||+.|+|||++.+. .++.++||||||+++|||++|+.||.
T Consensus 191 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~ 248 (370)
T cd05621 191 KMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248 (370)
T ss_pred ecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence 653221 1122345799999999998654 37889999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.60 Aligned_cols=200 Identities=24% Similarity=0.363 Sum_probs=171.5
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
+|++.++||+|+||.||+++. .+++.||||++.+.. ......+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 689999999999999999995 468899999986432 2234568899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999853 356889999999999999999999987 9999999999999999999999999975331100
Q ss_pred C-----------------------------------------ccccccccccCCccchhccccCCCCccchhHHHHHHHH
Q 008238 503 T-----------------------------------------QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVL 541 (573)
Q Consensus 503 ~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ 541 (573)
. .......+||+.|||||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0 00011347999999999999999999999999999999
Q ss_pred HHHhCCCCCCC
Q 008238 542 EIITGKKNSSF 552 (573)
Q Consensus 542 elltG~~p~~~ 552 (573)
||++|+.||..
T Consensus 236 ell~G~~Pf~~ 246 (376)
T cd05598 236 EMLVGQPPFLA 246 (376)
T ss_pred ehhhCCCCCCC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.85 Aligned_cols=197 Identities=27% Similarity=0.362 Sum_probs=172.5
Q ss_pred hCCCCcccccccccceeEEEEecCC--CCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPS--GQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
.++|++.+.||+|+||.||+|++.+ +..||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3468899999999999999998543 3689999986432 2334568899999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999853 346899999999999999999999987 9999999999999999999999999998653
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 21 2345789999999999988899999999999999999999999853
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.35 Aligned_cols=192 Identities=25% Similarity=0.327 Sum_probs=167.4
Q ss_pred cccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCC
Q 008238 352 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 427 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 427 (573)
+.||+|+||.||+++. .+|+.||+|++++.. ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 578899999987542 233456778999999999999999999999999999999999999
Q ss_pred ChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcccc
Q 008238 428 SLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT 507 (573)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 507 (573)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence 99888853 457899999999999999999999987 999999999999999999999999998753211 1223
Q ss_pred ccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 508 NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 508 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 196 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCC
Confidence 34579999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=288.17 Aligned_cols=204 Identities=25% Similarity=0.311 Sum_probs=175.5
Q ss_pred hCCCCcccccccccceeEEEEecCC-CCeeEEEEeccCCcc---chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSRSSGQ---GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.+.|++.+.||+|.-|+||++.+.+ +..+|+|++.+..-. ...+.+.|-+||+.++||.++.|+..++..+..+|+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3457788999999999999999754 578999999876433 334567799999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
||||+||+|...+++ ...+.+++..+.-++.+++-||+|||-.+ ||.|||||+||||.++|++.|+||.|+.....
T Consensus 156 meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999888765 34568999999999999999999999987 99999999999999999999999999764411
Q ss_pred CC---------------------------------C---------------------ccccccccccCCccchhccccCC
Q 008238 501 DQ---------------------------------T---------------------QGNTNRIVGTYGYMAPEYAMHGQ 526 (573)
Q Consensus 501 ~~---------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~~ 526 (573)
.. . ..+.+..+||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 00 0 01223468999999999999999
Q ss_pred CCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 527 FSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 527 ~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.+.++|+|+|||++|||+.|+.||.-
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG 337 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKG 337 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCC
Confidence 99999999999999999999999854
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=300.57 Aligned_cols=195 Identities=29% Similarity=0.442 Sum_probs=164.7
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|+..++||+|+||.||+++. .+++.||||++..... ...+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 3466788999999999999995 4689999999865432 3346789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.... ..++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986543 3467788899999999999999987 9999999999999999999999999998654221
Q ss_pred ccccccccccCCccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.......|+..|+|||.+.. ...+.++|||||||++|||++|+.||..
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 11234578999999998743 2345689999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=297.76 Aligned_cols=201 Identities=27% Similarity=0.445 Sum_probs=178.1
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC-CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
..|+..+.||+|.||.||+|.. ..++.||+|++.-. .....+++++|+.+|..++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3577789999999999999995 56889999999754 344567899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+.+|++.+.|. ....+++..+.-++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999994 3344588888899999999999999987 99999999999999999999999999987654433
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 554 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~ 554 (573)
.....+||+.|||||++....|+.|+||||||++.+||.+|.+|+....
T Consensus 167 --rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h 215 (467)
T KOG0201|consen 167 --RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH 215 (467)
T ss_pred --ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC
Confidence 3367899999999999998899999999999999999999999986543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=318.60 Aligned_cols=201 Identities=29% Similarity=0.516 Sum_probs=175.0
Q ss_pred hCCCCcccccccccceeEEEEecC-C---CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-S---GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
.....+.+.||.|.||+|++|.++ . ...||||.++... +..+.+|..|..||.++.||||++|.|+.......++
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 445778899999999999999974 2 3468999998654 4556789999999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
|.|||++|+|+.||+..+ .++++.++.-++++|+.||.||-+.+ +|||||.++|||++.+..+|++||||+|.+.
T Consensus 708 iTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999999998755 45999999999999999999999887 9999999999999999999999999999775
Q ss_pred CCCCccc-cccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCC
Q 008238 500 VDQTQGN-TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNS 550 (573)
Q Consensus 500 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~ 550 (573)
.+..... +..-.-+.+|.|||.|...+++.++||||||+++||.++ |.+||
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 5542221 111223679999999999999999999999999999876 89996
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=300.08 Aligned_cols=193 Identities=24% Similarity=0.325 Sum_probs=167.1
Q ss_pred cccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCC
Q 008238 352 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 427 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 427 (573)
+.||+|+||.||+++. .+|+.||+|+++... ......+.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999995 478999999987542 233456778999999999999999999999999999999999999
Q ss_pred ChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcccc
Q 008238 428 SLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT 507 (573)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 507 (573)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 99888743 346899999999999999999999987 9999999999999999999999999987432211 122
Q ss_pred ccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 508 NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 508 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 197 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence 345789999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.72 Aligned_cols=209 Identities=31% Similarity=0.420 Sum_probs=182.3
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
-|++.+.||.|+-|.|-.|+. ..|+..|||++.+.. ......+.+||.+|+.+.|||++++++++.+..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 478889999999999999995 579999999997652 2334568899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++|.|.+++. +.+++++.+..+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|..-..+
T Consensus 93 yv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 93 YVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred ecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 999999999984 4568999999999999999999999887 999999999999999999999999999753222
Q ss_pred CccccccccccCCccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
.-..+-||++.|.+||++.+.+| +.++||||-|||||.||||+.||+ +++...|+.-|.+
T Consensus 166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~~ 226 (786)
T KOG0588|consen 166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQR 226 (786)
T ss_pred --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHHc
Confidence 22345699999999999999988 689999999999999999999976 5666666665544
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=299.93 Aligned_cols=193 Identities=26% Similarity=0.338 Sum_probs=167.9
Q ss_pred cccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCC
Q 008238 352 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 427 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 427 (573)
+.||+|+||.||+++. .+++.||+|++.+.. ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999985 468999999987542 233456788999999999999999999999999999999999999
Q ss_pred ChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcccc
Q 008238 428 SLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT 507 (573)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 507 (573)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence 99888843 346899999999999999999999987 999999999999999999999999998753221 1122
Q ss_pred ccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 508 NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 508 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~ 197 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence 345789999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=294.49 Aligned_cols=204 Identities=30% Similarity=0.475 Sum_probs=169.9
Q ss_pred hCCCCcccccccccceeEEEEecCC-----------------CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccce
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPS-----------------GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVR 406 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 406 (573)
.++|++.++||+|+||.||++.+++ +..||+|.+.... .....++.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4578899999999999999997532 3369999987543 333467899999999999999999
Q ss_pred EEEEEEcCCeeEEEEEccCCCChhhhccCcC----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 008238 407 LLGFCLEGEEKILVYEFVPNKSLDYFLYEPE----------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRII 470 (573)
Q Consensus 407 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iv 470 (573)
+++++.+.+..++||||+++|+|.+++.... ....+++..+++++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999874321 1235788999999999999999999987 99
Q ss_pred eecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhC--CC
Q 008238 471 HRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG--KK 548 (573)
Q Consensus 471 H~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG--~~ 548 (573)
||||||+|||+++++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433222223344567889999999888999999999999999999975 44
Q ss_pred CCC
Q 008238 549 NSS 551 (573)
Q Consensus 549 p~~ 551 (573)
|+.
T Consensus 241 p~~ 243 (304)
T cd05096 241 PYG 243 (304)
T ss_pred CCC
Confidence 554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=296.14 Aligned_cols=190 Identities=28% Similarity=0.363 Sum_probs=166.4
Q ss_pred cccccceeEEEEecC-CCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCCh
Q 008238 354 LGEGGFGEVYKGVLP-SGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 429 (573)
Q Consensus 354 LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 429 (573)
||+|+||.||+++.. +++.||+|++.+. .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999964 6789999998643 233345678899999999999999999999999999999999999999
Q ss_pred hhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcccccc
Q 008238 430 DYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR 509 (573)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 509 (573)
.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 998853 346899999999999999999999987 9999999999999999999999999987532211 22334
Q ss_pred ccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 510 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 510 ~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~ 194 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcC
Confidence 579999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=298.53 Aligned_cols=199 Identities=28% Similarity=0.381 Sum_probs=174.5
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.++|++.++||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467999999999999999999964 67889999887543 2344678999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999853 346899999999999999999999853 4999999999999999999999999998755322
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 22345689999999999999999999999999999999999999853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.61 Aligned_cols=201 Identities=25% Similarity=0.371 Sum_probs=172.9
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||.||+++. .+++.||+|++.... ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688899999999999999985 468899999986432 233456788999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999853 356899999999999999999999987 999999999999999999999999998754221
Q ss_pred CC---------------------------------ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCC
Q 008238 502 QT---------------------------------QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548 (573)
Q Consensus 502 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~ 548 (573)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 000123479999999999999999999999999999999999999
Q ss_pred CCCC
Q 008238 549 NSSF 552 (573)
Q Consensus 549 p~~~ 552 (573)
||..
T Consensus 235 Pf~~ 238 (360)
T cd05627 235 PFCS 238 (360)
T ss_pred CCCC
Confidence 9853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=304.40 Aligned_cols=206 Identities=22% Similarity=0.303 Sum_probs=174.9
Q ss_pred hHHHHHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcC
Q 008238 339 ETIEVATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG 414 (573)
Q Consensus 339 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 414 (573)
..++...++|++.+.||+|+||.||+++.. +++.+|+|.+.+.. ......+.+|+.+++.++||||+++++.+.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344555678999999999999999999964 67889999986422 22345578899999999999999999999999
Q ss_pred CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 415 EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 415 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 999999999999999998843 45788999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhccccC----CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG----QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 986543211 122345799999999998654 378999999999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.40 Aligned_cols=202 Identities=24% Similarity=0.318 Sum_probs=172.1
Q ss_pred HHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
...++|++.++||+|+||.||+++. .+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 3445799999999999999999995 468899999986432 223345788999999999999999999999999999
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999998843 45788899999999999999999987 999999999999999999999999999765
Q ss_pred cCCCCccccccccccCCccchhccccC----CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHG----QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
..... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 43221 122345799999999998653 478999999999999999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.59 Aligned_cols=202 Identities=19% Similarity=0.272 Sum_probs=175.0
Q ss_pred CCCcccccccccceeEEEEecC-C-CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-S-GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
.|.+.+.||+|++|.||++... + ++.|++|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999843 3 6778888776555445567788999999999999999999999999999999999
Q ss_pred CCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 425 PNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 425 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
++|+|.+++... ....++++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887532 23456899999999999999999999987 99999999999999999999999999987643332
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~ 272 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 223345679999999999999999999999999999999999999975
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=295.28 Aligned_cols=198 Identities=28% Similarity=0.363 Sum_probs=169.0
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 421 (573)
+|++.+.||+|+||.||+++.. +++.||||.+.+.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999854 57899999987542 22334566788888777 5899999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988843 346899999999999999999999987 999999999999999999999999998753221
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~ 203 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence 1 123345789999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=294.96 Aligned_cols=198 Identities=28% Similarity=0.366 Sum_probs=169.2
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCC-ccceEEEEEEcCCeeEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHR-NLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 421 (573)
+|++.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+..|+.++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999954 57789999987532 23445678899999999765 5888999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999988843 346899999999999999999999987 999999999999999999999999998743211
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. .......||..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 1 122345789999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=302.76 Aligned_cols=201 Identities=27% Similarity=0.390 Sum_probs=175.6
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.++||+|+||+||+++.. +++.||||++.+.. ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36889999999999999999964 68999999987532 234567889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999854 257899999999999999999999987 999999999999999999999999999865433
Q ss_pred C---------------------------CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 Q---------------------------TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. .........||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 2 00122345789999999999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=294.71 Aligned_cols=196 Identities=27% Similarity=0.374 Sum_probs=167.2
Q ss_pred CCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHH---HhcCCCccceEEEEEEcCCeeEEE
Q 008238 348 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLV---AKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
|++.+.||+|+||.||++.. .+++.||||++++.. ....+.+.+|+.++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56789999999999999985 468899999987532 22334566666655 566799999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++++|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988874 346899999999999999999999987 99999999999999999999999999874322
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. ........|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~ 203 (324)
T cd05589 154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203 (324)
T ss_pred C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence 1 1223346789999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.11 Aligned_cols=194 Identities=28% Similarity=0.400 Sum_probs=166.8
Q ss_pred ccccccccceeEEEEec----CCCCeeEEEEeccCC----ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 351 DNKLGEGGFGEVYKGVL----PSGQEIAVKRLSRSS----GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.++||+|+||.||+++. ..++.||+|.+++.. ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36899999999999984 357889999987532 2233567889999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|.+++.. ...+.+..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 81 YLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999998843 356788899999999999999999987 9999999999999999999999999987542221
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 122345789999999999988899999999999999999999999853
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.73 Aligned_cols=200 Identities=25% Similarity=0.345 Sum_probs=171.1
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||+||+++. .+++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688999999999999999995 46889999998642 2223456888999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999853 2346899999999999999999999987 999999999999999999999999998765332
Q ss_pred CCccccccccccCCccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||.
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 21 11223468999999999863 457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=295.95 Aligned_cols=200 Identities=27% Similarity=0.382 Sum_probs=174.0
Q ss_pred HhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
..++|++.++||+|+||.||+++.. +++.+|+|.+.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3568999999999999999999964 67889999886543 233467899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+|||+++++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999853 346889999999999999999999742 4999999999999999999999999998754322
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12334689999999999988999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=295.71 Aligned_cols=200 Identities=27% Similarity=0.382 Sum_probs=170.4
Q ss_pred CCCcccccccccceeEEEEec----CCCCeeEEEEeccCC----ccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCee
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSRSS----GQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 417 (573)
+|++.++||+|+||.||+++. .+++.||+|++.+.. ....+.+.+|+.++..++ |+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999874 357889999986432 223456788999999995 99999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998853 356899999999999999999999987 99999999999999999999999999976
Q ss_pred ccCCCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
+..... .......||..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 532221 122345799999999998765 4789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=282.82 Aligned_cols=201 Identities=28% Similarity=0.466 Sum_probs=171.6
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEecc--CCccchHHHHHHHHHHHhcCCCccceEEEEEEc-----CCe
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSR--SSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE-----GEE 416 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~ 416 (573)
...|...+.||+|+||.|..+.. .+|+.||||++.. ......++..+|+++|+.++|+||+.+.+.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 34566678999999999999995 5789999999873 345556788899999999999999999998865 356
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.|+|+|+| +.+|...++ .++.++...+..++.||++||.|+|+.+ |+||||||+|+|++.+..+||+|||+++
T Consensus 101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 79999999 678888883 3445999999999999999999999988 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
...........+..+-|.+|.|||.+.. ..|+.+.||||.|||+.||++|++-|..
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 7754433334455678999999998754 5799999999999999999999997654
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.76 Aligned_cols=200 Identities=24% Similarity=0.322 Sum_probs=171.3
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.++||+|+||+||+++.. +++.||+|.+.+.. ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999954 67889999986421 223345788999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999542 346899999999999999999999987 999999999999999999999999999765432
Q ss_pred CCccccccccccCCccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.. .......|++.|+|||++.+ +.++.++||||||+++|||++|+.||.
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 21 12233568999999999865 467899999999999999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.18 Aligned_cols=193 Identities=25% Similarity=0.323 Sum_probs=166.4
Q ss_pred cccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCC
Q 008238 352 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 427 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 427 (573)
+.||+|+||.||+++. .+++.||+|.+++.. ......+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 478899999987532 233456778999999999999999999999999999999999999
Q ss_pred ChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 428 SLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 99888843 3468999999999999999999997 55 9999999999999999999999999987532211 12
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....||..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~ 198 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC
Confidence 2345789999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=294.08 Aligned_cols=193 Identities=27% Similarity=0.372 Sum_probs=167.2
Q ss_pred cccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|+||.||+++. .+++.||+|++++.. ......+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999995 468899999997532 23345678899999998 699999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence 999888743 357899999999999999999999987 999999999999999999999999998742111 122
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....||..|+|||++.+..++.++||||||+++|||++|+.||+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 3346789999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=293.21 Aligned_cols=193 Identities=30% Similarity=0.422 Sum_probs=163.9
Q ss_pred cccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHh-cCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAK-LQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|+||.||+++.. +++.||+|.++... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 57889999987532 2233445566666665 4799999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999988853 346899999999999999999999987 9999999999999999999999999997543222 22
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....||..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~ 198 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence 3446789999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=289.51 Aligned_cols=200 Identities=24% Similarity=0.360 Sum_probs=172.1
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++|++.+.||+|+||.||+++.+ +++.||+|+++... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999964 67889999987542 3334678899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|++++++..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999988776542 2346899999999999999999999887 9999999999999999999999999998653222
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. .......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~ 203 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence 1 122345689999999999998999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=293.81 Aligned_cols=193 Identities=26% Similarity=0.362 Sum_probs=166.9
Q ss_pred cccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|+||+||+++. .+++.||+|++++.. ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999995 467889999997542 23345678899999888 599999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence 999888743 356899999999999999999999987 999999999999999999999999998743211 112
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 3346789999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=289.19 Aligned_cols=199 Identities=26% Similarity=0.402 Sum_probs=168.9
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|++.++||+|+||.||++.. .+++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4688999999999999999985 468899999987543 22345678999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++ +|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 985 88887743 2345789999999999999999999987 9999999999999999999999999987543222
Q ss_pred ccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11233467899999998865 5689999999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=295.82 Aligned_cols=200 Identities=24% Similarity=0.324 Sum_probs=170.3
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.++||+|+||+||+++.+ .++.+|+|.+.+. .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36889999999999999999964 5778999998642 1223345788999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999954 2346899999999999999999999987 999999999999999999999999998754322
Q ss_pred CCccccccccccCCccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 21 1223457999999999986 3467899999999999999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=299.11 Aligned_cols=200 Identities=27% Similarity=0.384 Sum_probs=172.7
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||+||+++. .+++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688999999999999999985 478899999987542 234456889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998542 246899999999999999999999987 999999999999999999999999999865433
Q ss_pred CCccccccccccCCccchhccc------cCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAM------HGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence 221 223346899999999986 4567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.06 Aligned_cols=207 Identities=30% Similarity=0.451 Sum_probs=171.9
Q ss_pred HHHhCCCCcccccccccceeEEEEec------CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceEEEEEEc
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLE 413 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 413 (573)
....++|++.++||+|+||.||++++ ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 34455799999999999999999963 245689999987543 23345688999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCChhhhccCcC--------------------------------------------------------
Q 008238 414 GEEKILVYEFVPNKSLDYFLYEPE-------------------------------------------------------- 437 (573)
Q Consensus 414 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 437 (573)
.+..++||||+++|+|.+++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 999999999999999998885421
Q ss_pred ----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 438 ----------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 438 ----------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
....+++..+++++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 1125789999999999999999999987 999999999999999999999999999865433
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
..........++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~ 318 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP 318 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 22222222345678999999999999999999999999999998 788874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=292.79 Aligned_cols=193 Identities=28% Similarity=0.397 Sum_probs=165.8
Q ss_pred cccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 57899999987532 23345577888888876 799999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 999888843 356899999999999999999999987 9999999999999999999999999987532221 12
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 198 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence 2345789999999999988999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.16 Aligned_cols=208 Identities=30% Similarity=0.469 Sum_probs=172.1
Q ss_pred HHHhCCCCcccccccccceeEEEEec------CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceEEEEEEc
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLE 413 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 413 (573)
....++|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+.+++.+ +|+||+++++++..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 34455799999999999999999873 234579999997543 23345688999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCChhhhccCcC--------------------------------------------------------
Q 008238 414 GEEKILVYEFVPNKSLDYFLYEPE-------------------------------------------------------- 437 (573)
Q Consensus 414 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 437 (573)
.+..++||||+++|+|.++++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999998875321
Q ss_pred -----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 438 -----------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 438 -----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
....+++.++++++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++..........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 1135788999999999999999999987 99999999999999999999999999976533222111
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.....++..|||||++.+..++.++||||||+++|||++ |+.||..
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~ 317 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 222345678999999999999999999999999999997 9999754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=293.61 Aligned_cols=193 Identities=26% Similarity=0.370 Sum_probs=166.1
Q ss_pred cccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|+||.||+++. .+++.||+|++++.. ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999995 467899999987542 23345577888888776 799999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCc
Confidence 999888743 356899999999999999999999987 999999999999999999999999998753211 112
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....||..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 2345789999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=289.57 Aligned_cols=200 Identities=27% Similarity=0.408 Sum_probs=168.6
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.++|++.++||+|+||.||+++.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 357999999999999999999964 688999999875432 233467889999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 566666643 2356889999999999999999999987 9999999999999999999999999987543221
Q ss_pred CccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.......|++.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 12233467899999998865 4578999999999999999999999853
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=291.99 Aligned_cols=193 Identities=30% Similarity=0.421 Sum_probs=165.9
Q ss_pred cccccccceeEEEEecC-CCCeeEEEEeccC---CccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|+||+||+++.+ +++.||||++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 6889999998753 223345667888888876 699999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999988853 356899999999999999999999987 9999999999999999999999999987532211 12
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 3345789999999999989999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=291.76 Aligned_cols=198 Identities=28% Similarity=0.376 Sum_probs=168.9
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 421 (573)
+|+..+.||+|+||+||+++. .+++.||+|++.+.. ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367789999999999999985 468899999987532 233456778888888886 577888999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999988843 356899999999999999999999987 999999999999999999999999998753222
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. .......||..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence 1 122345689999999999988999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.48 Aligned_cols=193 Identities=24% Similarity=0.309 Sum_probs=165.6
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
..|.+.+.||+|+||.||++... .++.||||... ...+.+|+.++++++|+||+++++++..++..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 36999999999999999999964 57889999643 234578999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
. ++|..++.. ....+++..++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 243 ~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 243 R-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred C-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 5 677777743 2346999999999999999999999987 999999999999999999999999999865432222
Q ss_pred cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
.......||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 2223457999999999999999999999999999999999988764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=308.26 Aligned_cols=209 Identities=22% Similarity=0.311 Sum_probs=176.6
Q ss_pred HHHHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC-
Q 008238 340 TIEVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE- 415 (573)
Q Consensus 340 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~- 415 (573)
+.+...++|.+.+.||+|+||+||+++. .+++.||||++.... ......+.+|+..+..++|+||+++++.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3344567899999999999999999984 578999999986542 334456888999999999999999988765432
Q ss_pred -------eeEEEEEccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCe
Q 008238 416 -------EKILVYEFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 487 (573)
Q Consensus 416 -------~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~v 487 (573)
..++||||+++|+|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 357999999999999988643 23457899999999999999999999987 9999999999999999999
Q ss_pred EEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 488 KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 488 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
||+|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~ 246 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9999999986643333333345679999999999999999999999999999999999999985
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=287.29 Aligned_cols=190 Identities=19% Similarity=0.349 Sum_probs=164.1
Q ss_pred cccccccceeEEEEecCCCCeeEEEEeccCCccc---hHHHHHHHHHHHhcCCCccceEEEEEEc----CCeeEEEEEcc
Q 008238 352 NKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQG---GQEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILVYEFV 424 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 424 (573)
..||+|++|.||+|++ +|+.||||+++...... .+.+.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 78999999997653333 4678899999999999999999999877 34678999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++|+|.+++.. ...+++...++++.|++.||.|||+.. +++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999954 356899999999999999999999842 27899999999999999999999999988653221
Q ss_pred cccccccccCCccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~ 224 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC
Confidence 23467889999999876 6899999999999999999999999864
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=285.20 Aligned_cols=199 Identities=31% Similarity=0.447 Sum_probs=172.0
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
+|++.++||+|+||+||++.. .+++.||+|++.... ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999995 468899999986532 2223457789999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887542 2346899999999999999999999987 9999999999999999999999999987653221
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~ 203 (285)
T cd05605 157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203 (285)
T ss_pred ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCC
Confidence 12234689999999999988999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=291.85 Aligned_cols=202 Identities=32% Similarity=0.539 Sum_probs=169.8
Q ss_pred hCCCCcccccccccceeEEEEecC-CCC----eeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
..+|++.+.||+|+||.||+|++. +++ .||+|.++... ....+++.+|+.+++.++||||++++|++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 346899999999999999999853 343 38999987543 34456788999999999999999999998764 567
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+++||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999998642 346889999999999999999999987 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.|++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 54332222222334678999999999999999999999999999998 9998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=284.95 Aligned_cols=194 Identities=31% Similarity=0.445 Sum_probs=167.2
Q ss_pred cccccceeEEEEec-CCCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCCh
Q 008238 354 LGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 429 (573)
Q Consensus 354 LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 429 (573)
||+|+||+||+++. .+++.||+|++.+... ...+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999985 4788999999865322 2235677899999999999999999999999999999999999999
Q ss_pred hhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccc
Q 008238 430 DYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTN 508 (573)
Q Consensus 430 ~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 508 (573)
.+++... .....+++..++.++.||+.||+|||+++ |+||||||+||++++++.++|+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 8887532 23457899999999999999999999987 99999999999999999999999999876543221 223
Q ss_pred cccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 509 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 509 ~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 45789999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=283.79 Aligned_cols=194 Identities=29% Similarity=0.482 Sum_probs=158.9
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe-----eEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE-----KILV 420 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~lv 420 (573)
.|...+.+|.|+||.||+|+. .+++.||||++..+.. --.+|+.+|+.++|||||+++.++....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 466788999999999999995 4578999999864432 22468999999999999999988865332 2489
Q ss_pred EEccCCCChhhhccC-cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC-CCeEEeccCCcccc
Q 008238 421 YEFVPNKSLDYFLYE-PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAKIF 498 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~DfGla~~~ 498 (573)
||||+. +|.+.++. ...++.++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 56666643 233567888889999999999999999977 9999999999999976 89999999999987
Q ss_pred cCCCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
...... . ...-|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|.
T Consensus 177 ~~~epn--i-SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp 227 (364)
T KOG0658|consen 177 VKGEPN--I-SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP 227 (364)
T ss_pred ccCCCc--e-eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC
Confidence 543322 2 23458899999999875 68999999999999999999998754
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=285.56 Aligned_cols=204 Identities=30% Similarity=0.427 Sum_probs=179.0
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.+.|+.-+.||+|+||.|+-++. .+|+.+|.|++.+.. .....-..+|-.+|.+++.+.||.+-..++..+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 45688999999999999999984 479999999886432 23344567899999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
+..|.||+|..+|..... ..+++.+++-++.+|+.||++||... ||.|||||+|||||+.|+++|+|+||+..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999976443 57999999999999999999999987 99999999999999999999999999987643
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQT 555 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~ 555 (573)
... ....+||.+|||||++.++.|+...|+|||||++|||+.|+.||.....
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 332 2223899999999999999999999999999999999999999975544
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=289.27 Aligned_cols=192 Identities=30% Similarity=0.432 Sum_probs=164.4
Q ss_pred cccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|+||.||+++.. +++.||+|.+++.. ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999964 68899999987542 23345566777777754 899999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|+|..++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence 999988843 346899999999999999999999987 999999999999999999999999998743211 122
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.....||..|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~ 197 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 334678999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=293.39 Aligned_cols=199 Identities=25% Similarity=0.412 Sum_probs=166.2
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC-----eeE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKI 418 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 418 (573)
+|++.++||+|+||.||+|+. .+++.||||++.... ......+.+|+.++++++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478899999999999999995 478999999986432 233456889999999999999999999886432 479
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+||||++ ++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 678887743 346899999999999999999999987 999999999999999999999999999754
Q ss_pred cCCCC-ccccccccccCCccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 499 GVDQT-QGNTNRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 499 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
..... ........|+..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 32221 112234578999999999865 6789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=288.16 Aligned_cols=193 Identities=30% Similarity=0.438 Sum_probs=164.5
Q ss_pred cccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHh-cCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAK-LQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 57889999987542 2334456667777776 4899999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999998843 346899999999999999999999987 9999999999999999999999999987432211 12
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 3345789999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=292.30 Aligned_cols=193 Identities=27% Similarity=0.368 Sum_probs=163.7
Q ss_pred cccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHH-HHHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVV-LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|+||+||+++. .+|+.||+|++.+.. .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 478999999986532 223344555554 56779999999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|+|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence 99988874 3457899999999999999999999987 999999999999999999999999998743211 122
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC 198 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC
Confidence 3345789999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.94 Aligned_cols=210 Identities=27% Similarity=0.390 Sum_probs=177.0
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-C-----CccceEEEEEEcCCe
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-H-----RNLVRLLGFCLEGEE 416 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~ 416 (573)
...+|++.+.||+|.||.|.++.. ++++.||||+++.. .....+-..|+.+|..++ | -|+|++++++...++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 344799999999999999999994 57999999999744 344556678999999997 4 379999999999999
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC--CCeEEeccCC
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE--MNPKISDFGM 494 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~--~~vkl~DfGl 494 (573)
.+||+|.+ ..+|.++|+.. +...++...+..|+.||+.+|.+||+.+ |||+||||+||||.+- ..+||+|||.
T Consensus 263 lciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccc
Confidence 99999988 56899999654 3456999999999999999999999887 9999999999999643 3799999999
Q ss_pred cccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
+........ ..+.+..|.|||++.+.+|+.+.||||||||+.||++|.+ ++..+++.|.+.+|..
T Consensus 338 Sc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~P---LfpG~ne~DQl~~I~e 402 (586)
T KOG0667|consen 338 SCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEP---LFPGDNEYDQLARIIE 402 (586)
T ss_pred ccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcc---ccCCCCHHHHHHHHHH
Confidence 986432211 3467889999999999999999999999999999999955 3556777777777654
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=279.99 Aligned_cols=197 Identities=28% Similarity=0.473 Sum_probs=177.7
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
-|.++++||+|+||.||++.. .+|+.+|||++.. +...+++..|+.++.+.+.|++|+++|.+.....+|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 367789999999999999995 4799999999863 4567899999999999999999999999999999999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
.|+..+.++. ++.++++.++..+++..++||+|||... -||||||+.|||++.+|.+||+|||.+-.+.. +-.
T Consensus 112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMA 184 (502)
T KOG0574|consen 112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMA 184 (502)
T ss_pred CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hHH
Confidence 9999999965 5578999999999999999999999876 79999999999999999999999999976532 233
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
..+...||+-|||||++..-.|..++||||||+...||..|++|+..
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence 45568899999999999999999999999999999999999999753
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=291.79 Aligned_cols=193 Identities=27% Similarity=0.362 Sum_probs=163.3
Q ss_pred cccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHH-HHHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVV-LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|+||+||+++. .+++.||+|++.+.. .....++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999996 478999999986532 122234444544 56789999999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|+|..++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence 999988853 356899999999999999999999987 999999999999999999999999998743211 122
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 198 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence 3345789999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=283.26 Aligned_cols=204 Identities=32% Similarity=0.554 Sum_probs=173.9
Q ss_pred hCCCCcccccccccceeEEEEecCC------CCeeEEEEeccCCcc-chHHHHHHHHHHHhcCCCccceEEEEEEcCCee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSRSSGQ-GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 417 (573)
.++|.+.+.||+|+||.||+|+..+ ++.||||.++..... ..+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3468888999999999999998533 478999998765443 457899999999999999999999999999999
Q ss_pred EEEEEccCCCChhhhccCcC-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC
Q 008238 418 ILVYEFVPNKSLDYFLYEPE-----------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 486 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 486 (573)
++||||+++++|.+++.... ....+++..+..++.||+.+|.|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999986421 2345889999999999999999999987 999999999999999999
Q ss_pred eEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 487 PKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 487 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~ 226 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence 99999999875533222222233455788999999999999999999999999999999 999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=298.49 Aligned_cols=204 Identities=30% Similarity=0.486 Sum_probs=177.6
Q ss_pred CCCcccccccccceeEEEEe-cCCCCeeEEEEeccC-CccchHHHHHHHHHHHhcCCCccceEEEEEEcC------CeeE
Q 008238 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG------EEKI 418 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 418 (573)
.|...+.||+|+||.||+|+ ...|+.||||.+... .....+...+|+++|++++|+|||++++.-... ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 35667899999999999999 458999999998764 344556778999999999999999999976543 3568
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC--CCC--CeEEeccCC
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEM--NPKISDFGM 494 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~--~vkl~DfGl 494 (573)
+|||||.+|+|...|..+++...+++.+.+.+...+..||.|||+++ |+||||||.||++- ++| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999999999899999999999999999999999987 99999999999983 334 369999999
Q ss_pred cccccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~~~~~ 556 (573)
|+.+..+. .....+||..|.+||...+ +.|+..+|.|||||++||..||..||..+...
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99775433 4556899999999999985 88999999999999999999999999866544
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=289.76 Aligned_cols=193 Identities=28% Similarity=0.368 Sum_probs=162.8
Q ss_pred cccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHH-HHHHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEV-VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|+||.||+++. .+++.||+|++.+.. .....++..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999996 468899999986432 12233445554 467889999999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
++|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence 999888743 356888999999999999999999987 999999999999999999999999998743211 122
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence 3345789999999999988999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=289.57 Aligned_cols=192 Identities=27% Similarity=0.373 Sum_probs=161.8
Q ss_pred cccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHH-HHHHHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNE-VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e-~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|+||.||+++.. +++.||+|++.+.. .....++..| ..+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999964 67789999986532 1222334444 4457889999999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence 999998853 346788889999999999999999987 999999999999999999999999998753221 122
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 197 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCC
Confidence 334579999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=296.34 Aligned_cols=192 Identities=22% Similarity=0.305 Sum_probs=166.1
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
..+|++.++||+|+||.||++.. ..++.||+|+.. ...+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 45799999999999999999995 568899999753 23467899999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+. ++|..++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~ 236 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-N 236 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-c
Confidence 85 677777643 346899999999999999999999987 999999999999999999999999998753221 1
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
........||+.|+|||++.+..++.++||||||+++|||++|+.|+
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 12233467999999999999999999999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=282.88 Aligned_cols=201 Identities=28% Similarity=0.453 Sum_probs=169.5
Q ss_pred hCCCCcccccccccceeEEEEecC----CCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
.++|++.+.||+|+||.||+|+++ .+..||+|.++.... .....+.+|+..+.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356889999999999999999753 356899999875432 334578899999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998542 346899999999999999999999987 9999999999999999999999999876432
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
.... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||.
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~ 210 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 2111 11112234678999999999999999999999999999875 999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=297.64 Aligned_cols=209 Identities=28% Similarity=0.406 Sum_probs=174.0
Q ss_pred HHHHhCCCCcccccccccceeEEEEecC------CCCeeEEEEeccCCc-cchHHHHHHHHHHHhcC-CCccceEEEEEE
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQ-HRNLVRLLGFCL 412 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 412 (573)
++...++|.+.++||+|+||.||+|++. .+..||||++..... ...+.+.+|+++++++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 4455678999999999999999999842 234699999975433 33467899999999996 999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcC-------------------------------------------------------
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPE------------------------------------------------------- 437 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------- 437 (573)
+.+..++||||+++|+|.+++....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 9999999999999999998875321
Q ss_pred --------------------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCE
Q 008238 438 --------------------------------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479 (573)
Q Consensus 438 --------------------------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI 479 (573)
....+++..++.++.||++||+|||+.+ |+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence 0134788899999999999999999987 99999999999
Q ss_pred EeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 480 LLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 480 Ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
|+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 999999999999999986543322222333456788999999999999999999999999999997 8888753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=312.51 Aligned_cols=204 Identities=26% Similarity=0.404 Sum_probs=173.3
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.++||+|+||.||+|+.. .++.||||++..... ...+++.+|++++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47899999999999999999954 689999999875422 23457899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcC--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccC
Q 008238 422 EFVPNKSLDYFLYEPE--------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfG 493 (573)
||+++++|.+++.... ....+++..+++++.||++||+|||+++ |+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 1234667888999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCC----------------ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 494 MAKIFGVDQT----------------QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 494 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+++....... .......+||+.|||||.+.+..++.++|||||||++|||+||+.||..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9986521110 0111235799999999999999999999999999999999999999853
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=283.06 Aligned_cols=199 Identities=27% Similarity=0.456 Sum_probs=164.5
Q ss_pred CCCCcccccccccceeEEEEec-C-CCCeeEEEEeccCC--ccchHHHHHHHHHHHhc---CCCccceEEEEEEc-----
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-P-SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKL---QHRNLVRLLGFCLE----- 413 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----- 413 (573)
++|++.++||+|+||.||+++. . +++.||+|+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999985 3 46789999886433 22234566777777765 69999999998863
Q ss_pred CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccC
Q 008238 414 GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493 (573)
Q Consensus 414 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfG 493 (573)
....++||||++ ++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999997 5888887542 2345899999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+++..... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 211 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence 99765432 223345689999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=291.86 Aligned_cols=193 Identities=30% Similarity=0.354 Sum_probs=167.4
Q ss_pred cccccccceeEEEEec----CCCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 352 NKLGEGGFGEVYKGVL----PSGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
+.||+|+||.||+++. .+|+.||+|++.+... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 3678999999875432 233457789999999999999999999999999999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999998843 456899999999999999999999987 9999999999999999999999999987543221 1
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence 22345789999999999888899999999999999999999999853
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=280.93 Aligned_cols=209 Identities=39% Similarity=0.632 Sum_probs=169.4
Q ss_pred cccccccccceeEEEEecC-----CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 350 TDNKLGEGGFGEVYKGVLP-----SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 350 ~~~~LG~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+.+.||.|.||.||+|.+. .+..|+||.++... .+..+++.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 5678999999999999975 25679999996543 33467899999999999999999999999988889999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++|+|.++|... ....+++..+.+|+.||++||.|||+++ ++|+||+++|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999653 2457899999999999999999999987 99999999999999999999999999986632222
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHH
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLLSYV 565 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~~ll~~~ 565 (573)
............|+|||.+....++.++||||||+++|||++ |+.|+... ...++...+
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~ 218 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKL 218 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc
Confidence 222233456778999999999999999999999999999999 67776432 334444444
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=291.33 Aligned_cols=201 Identities=27% Similarity=0.399 Sum_probs=178.8
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe-eEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE-KILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 421 (573)
++|...+++|+|+||.++..+.+ +++.+++|++... .....+...+|+.++++++|||||.+.+.+..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46888999999999999998854 6788999988643 34444577899999999999999999999998888 89999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
+|++||++.+.+.+.+ ...++++++..++.||+.|+.|||++. |+|||||+.||++..++.|||+|||+++.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999996533 567999999999999999999999776 999999999999999999999999999988655
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. ......+||+.||.||.+.+.+|..|+|||||||++|||++-+++|.-
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a 208 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA 208 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc
Confidence 4 244567999999999999999999999999999999999999998764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=282.29 Aligned_cols=203 Identities=33% Similarity=0.557 Sum_probs=172.0
Q ss_pred CCCCcccccccccceeEEEEecCC------CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
++|++.+.||+|+||.||+|.... ...|++|.+.... .....++.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 368889999999999999998532 2578999986543 233467899999999999999999999999999999
Q ss_pred EEEEccCCCChhhhccCcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC
Q 008238 419 LVYEFVPNKSLDYFLYEPEK-------------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 485 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~ 485 (573)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999854211 146889999999999999999999987 99999999999999999
Q ss_pred CeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 486 NPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 486 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~ 228 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999986543332222334456788999999998999999999999999999998 998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=272.73 Aligned_cols=213 Identities=25% Similarity=0.327 Sum_probs=181.3
Q ss_pred CCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCCccchHH---HHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE---FKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~---~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|..++.||+|.||.|-+++ ...++.+|+|++++.......+ -..|-.+|+..+||.+..+-..++..+.+++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 568899999999999999998 4578999999998764433333 356888999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||..||.|..+|. +...+++....-+-.+|..+|.|||+++ ||.||||.+|.|+|.+|++||+|||+++.--
T Consensus 248 eyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 248 EYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred EEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc--
Confidence 9999999988884 3457888888889999999999999987 9999999999999999999999999998421
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhhc
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSINR 569 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~~ 569 (573)
.....+...+||+.|.|||++....|..+.|+|.+||++|||++|+.||-..+ .+.|.+.|....
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d---h~kLFeLIl~ed 384 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD---HEKLFELILMED 384 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc---hhHHHHHHHhhh
Confidence 12334567899999999999999999999999999999999999999985433 334555544433
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=285.95 Aligned_cols=192 Identities=30% Similarity=0.414 Sum_probs=165.6
Q ss_pred cccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|+||+||++... +++.||||++++.. ......+.+|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 57899999987542 23345677888898888 699999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999888843 346899999999999999999999987 9999999999999999999999999987432111 12
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~ 197 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCC
Confidence 234568999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=282.10 Aligned_cols=204 Identities=32% Similarity=0.544 Sum_probs=173.6
Q ss_pred hCCCCcccccccccceeEEEEec------CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
.++|.+.+.||+|+||+||++.. .++..+++|.+..........+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 45788999999999999999974 234568999987666556678999999999999999999999999999999
Q ss_pred EEEEccCCCChhhhccCcC----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeE
Q 008238 419 LVYEFVPNKSLDYFLYEPE----------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 488 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vk 488 (573)
+||||+++++|.+++.... +...+++..++.++.|++.+|+|||+++ ++||||||+|||+++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999885321 2235899999999999999999999987 99999999999999999999
Q ss_pred EeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 489 ISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 489 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~ 224 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 224 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999986543322222223445778999999988899999999999999999999 888864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=281.98 Aligned_cols=203 Identities=33% Similarity=0.499 Sum_probs=171.2
Q ss_pred CCCCcccccccccceeEEEEec-----CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
++|++.++||+|+||.||+|++ ..++.+++|.+.... .....++.+|+.+++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4578889999999999999984 245789999987533 2334678899999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcC--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC
Q 008238 420 VYEFVPNKSLDYFLYEPE--------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 485 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~ 485 (573)
+|||+++++|.+++.... ....+++.+++.++.|++.||+|||+++ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999885321 1245889999999999999999999987 99999999999999999
Q ss_pred CeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 486 NPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 486 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~ 228 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 999999999986543322222233445678999999988899999999999999999999 888874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=280.95 Aligned_cols=206 Identities=29% Similarity=0.508 Sum_probs=171.1
Q ss_pred HHhCCCCcccccccccceeEEEEecC------CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 415 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 415 (573)
+..++|++.++||+|+||.||+|.+. .++.||||++.... .....++.+|+.+++.++||||+++++++..+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34567999999999999999998742 34679999986432 233456889999999999999999999999999
Q ss_pred eeEEEEEccCCCChhhhccCcCc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeE
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEK-------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 488 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vk 488 (573)
..++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 99999999999999999854221 234688899999999999999999987 99999999999999999999
Q ss_pred EeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 489 ISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 489 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~ 223 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 223 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 999999876543222222222345778999999998899999999999999999999 677764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=276.82 Aligned_cols=203 Identities=32% Similarity=0.510 Sum_probs=174.1
Q ss_pred HHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
...++|++.+.||+|++|.||++.+.+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3456789999999999999999998778889999987543 345678999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999985432 346899999999999999999999987 9999999999999999999999999998765222
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
.. .......+..|+|||.+.+..++.++||||||+++|||++ |+.|+.
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 206 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYP 206 (261)
T ss_pred cc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 11 1112223457999999988899999999999999999999 888874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=279.85 Aligned_cols=198 Identities=29% Similarity=0.433 Sum_probs=171.0
Q ss_pred CCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 348 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
|+..+.||+|+||+||++.. .+++.+|+|.+.... ......+.+|+.+++.++|+||+++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67788999999999999985 468899999986542 22234578899999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999999888542 2346899999999999999999999987 9999999999999999999999999987543221
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~ 203 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 12234689999999999888999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=276.95 Aligned_cols=193 Identities=29% Similarity=0.432 Sum_probs=165.3
Q ss_pred cccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCCh
Q 008238 354 LGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 429 (573)
Q Consensus 354 LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 429 (573)
||+|+||.||+++. .+|+.||+|++.... ......+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999985 468999999986432 12234456799999999999999999999999999999999999999
Q ss_pred hhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcccccc
Q 008238 430 DYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR 509 (573)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 509 (573)
.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 8887542 2345899999999999999999999987 9999999999999999999999999987653221 1223
Q ss_pred ccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 510 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 510 ~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 46889999999999889999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=292.07 Aligned_cols=198 Identities=21% Similarity=0.295 Sum_probs=170.3
Q ss_pred HhCCCCcccccccccceeEEEEecC---CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP---SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
...+|++.++||+|+||.||++... .++.|++|.+... ....+|++++++++||||+++++++......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 4567999999999999999999742 3578999987643 2356899999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
||++. ++|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+++....
T Consensus 165 ~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99986 56777772 3457899999999999999999999987 99999999999999999999999999986644
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
...........||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 33333334567999999999999999999999999999999999999997543
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=279.79 Aligned_cols=201 Identities=33% Similarity=0.506 Sum_probs=167.2
Q ss_pred CCCCcccccccccceeEEEEecC-CCC----eeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
++|++.+.||+|+||+||+|++. +++ .+++|.+..... ....++..|+..+++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46888899999999999999863 444 477787754332 23456788888999999999999999875 456788
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
++||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999854 2346899999999999999999999987 9999999999999999999999999998654
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
............++..|++||.+.++.++.++||||||+++|||++ |+.|+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 3332222334456778999999998899999999999999999998 9988753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=276.00 Aligned_cols=200 Identities=31% Similarity=0.468 Sum_probs=171.3
Q ss_pred CCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
++|++.+.||+|+||.||++.++++..+|+|.+... .....++.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 357888999999999999999888889999988643 2335678899999999999999999999999999999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+|+|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999988542 235899999999999999999999987 999999999999999999999999998754322211
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence 1122335668999999988889999999999999999999 8888753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=278.16 Aligned_cols=202 Identities=33% Similarity=0.515 Sum_probs=173.9
Q ss_pred HhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
..++|++.++||+|++|.||+|...+++.|++|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 345789999999999999999998788899999886433 3356889999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.++|+|||+++.......
T Consensus 83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999998543 2346889999999999999999999887 99999999999999999999999999986543221
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
. ......++..|+|||.+....++.++||||||+++|||++ |+.||.
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~ 206 (261)
T cd05072 159 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP 206 (261)
T ss_pred e-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCC
Confidence 1 1122345678999999988889999999999999999998 888874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=288.86 Aligned_cols=207 Identities=29% Similarity=0.424 Sum_probs=170.9
Q ss_pred HHhCCCCcccccccccceeEEEEecC------CCCeeEEEEeccCCc-cchHHHHHHHHHHHhc-CCCccceEEEEEEcC
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEG 414 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 414 (573)
.+.++|++.+.||+|+||.||+|... .++.||+|+++.... ...+.+.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 44567999999999999999999632 347899999875432 2345677899999999 799999999988654
Q ss_pred -CeeEEEEEccCCCChhhhccCcCc-------------------------------------------------------
Q 008238 415 -EEKILVYEFVPNKSLDYFLYEPEK------------------------------------------------------- 438 (573)
Q Consensus 415 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 438 (573)
...+++|||+++++|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 567899999999999988753211
Q ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCC
Q 008238 439 ---QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG 515 (573)
Q Consensus 439 ---~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~ 515 (573)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||+++.+.............++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 136899999999999999999999987 99999999999999999999999999987643332222333456778
Q ss_pred ccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 516 y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999999999998 9988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=278.43 Aligned_cols=198 Identities=30% Similarity=0.449 Sum_probs=170.6
Q ss_pred CCcccccccccceeEEEEec-CCCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 348 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
|+..+.||+|+||+||++.. .+++.||+|.+..... .....+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 67788999999999999995 4688999999865422 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 9999999888542 2346899999999999999999999887 9999999999999999999999999987543221
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 11234689999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=286.85 Aligned_cols=199 Identities=28% Similarity=0.415 Sum_probs=177.5
Q ss_pred HhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCcc---chHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQ---GGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 418 (573)
....|++.+.||+|.||.||+++.+ +|+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+++.+.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4457888999999999999999965 5999999999766443 3468999999999999 999999999999999999
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC----CCCeEEeccCC
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA----EMNPKISDFGM 494 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~----~~~vkl~DfGl 494 (573)
+|||++.||.|.+.+... .+++..+..++.||+.++.|||+.+ |+||||||+|+|+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998553 3999999999999999999999987 999999999999953 35799999999
Q ss_pred cccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+..... .......+||+.|+|||++....++.++||||+|+++|.|++|..||.-
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~ 240 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG 240 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC
Confidence 987654 3455678999999999999999999999999999999999999999753
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=279.57 Aligned_cols=203 Identities=32% Similarity=0.533 Sum_probs=173.3
Q ss_pred CCCCcccccccccceeEEEEecC------CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
.+|.+.+.||+|+||.||+++.. ++..+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999742 345689999876655556789999999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC
Q 008238 420 VYEFVPNKSLDYFLYEPE-------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 486 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 486 (573)
||||+++++|.+++.... ....+++..++.++.||+.+|+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985421 1235899999999999999999999987 999999999999999999
Q ss_pred eEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 487 PKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 487 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 227 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999976543322222233456788999999999999999999999999999999 999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=277.69 Aligned_cols=204 Identities=36% Similarity=0.576 Sum_probs=177.8
Q ss_pred HHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
....+|++.++||+|+||.||+|+..+++.+++|.+..........+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34556889999999999999999987899999999987665566789999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|.+++.... ...+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||.+.......
T Consensus 83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999996532 356899999999999999999999987 9999999999999999999999999997654322
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.. .....++..|++||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus 159 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~ 207 (261)
T cd05148 159 YL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207 (261)
T ss_pred cc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Confidence 11 112345678999999988899999999999999999998 7888753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=324.16 Aligned_cols=205 Identities=26% Similarity=0.498 Sum_probs=168.9
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
....+...+.||+|+||.||+|+. .+++.||||+++..... ..+|++.+++++|||||+++|++.+.+..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345678888999999999999995 57899999998644321 2346889999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++|+|.++++ .++|.++.+++.||++||+|||....++|+||||||+||+++.++..++. ||.......
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 999999999994 38999999999999999999997655679999999999999999888875 665543211
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVS 566 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~ 566 (573)
.....++..|||||++.+..++.++|||||||++|||+||+.|+.... .....+.+|++
T Consensus 835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~ 893 (968)
T PLN00113 835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWAR 893 (968)
T ss_pred ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHH
Confidence 112367899999999999999999999999999999999999985322 23344555544
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=295.96 Aligned_cols=198 Identities=25% Similarity=0.436 Sum_probs=161.6
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcC--------
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG-------- 414 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 414 (573)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 456799999999999999999995 468899999885432 2345799999999999999999876432
Q ss_pred CeeEEEEEccCCCChhhhccC-cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC-CeEEecc
Q 008238 415 EEKILVYEFVPNKSLDYFLYE-PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDF 492 (573)
Q Consensus 415 ~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~Df 492 (573)
...++||||+++ +|.+++.. ......+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999986 55555432 234467899999999999999999999987 99999999999998665 6999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 273 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9998654222 22235689999999998764 689999999999999999999999753
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=262.43 Aligned_cols=210 Identities=26% Similarity=0.308 Sum_probs=177.8
Q ss_pred HHHhCCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCC-----
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE----- 415 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 415 (573)
.+..++|++.++||+|||+-||.++ ..+++.+|+|++.-...+..+...+|++..++++||||++++++...+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3456789999999999999999999 6789999999998777777888999999999999999999998876543
Q ss_pred eeEEEEEccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 416 EKILVYEFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
+.||+++|...|+|.+.+... .++..+++.+++.|+.+|.+||++||+.. +++.||||||.|||+.+++.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 489999999999999888653 34568999999999999999999999986 5799999999999999999999999999
Q ss_pred cccccCCCCcc-------ccccccccCCccchhcc---ccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 495 AKIFGVDQTQG-------NTNRIVGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 495 a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+......-... .......|..|.|||.+ .+...+.++|||||||+||+|+.|.-||+.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 87543211110 01122458899999987 345678999999999999999999999874
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=290.27 Aligned_cols=198 Identities=25% Similarity=0.399 Sum_probs=167.0
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC-----eeE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKI 418 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 418 (573)
+|++.++||+|+||.||++.. .+++.||||++.... ....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999995 578999999986432 233467889999999999999999999998776 789
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+|+||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 46766663 3457899999999999999999999987 999999999999999999999999999865
Q ss_pred cCCCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
..... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 207 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCC
Confidence 33221 122234678899999998774 478999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=275.91 Aligned_cols=193 Identities=26% Similarity=0.393 Sum_probs=169.3
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|++.++||+|+||.||+++. .+++.||+|.+.... ....+++.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3578889999999999999984 578899999986542 33446788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999996543 4678889999999999999999987 999999999999999999999999998765322
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 22335789999999999999999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=274.68 Aligned_cols=200 Identities=31% Similarity=0.474 Sum_probs=171.4
Q ss_pred CCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
++|++.+.||+|+||.||++.+.++..+|+|.+.... ....++.+|+.++++++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4578889999999999999998777789999887433 335678999999999999999999999999888999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 99999998542 236899999999999999999999987 999999999999999999999999998765332211
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
......++..|++||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 204 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 1112235678999999988889999999999999999999 9988753
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=275.29 Aligned_cols=201 Identities=30% Similarity=0.514 Sum_probs=171.5
Q ss_pred CCCCcccccccccceeEEEEecCC----CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
++|++.+.||+|+||.||+|++.. ...|+||.++... .....++.+|+.++++++||||+++++.+...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568899999999999999998642 3578999887543 33346788999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++++|.+++... ...+++..+++++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998542 247899999999999999999999987 99999999999999999999999999987642
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
...........++..|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~ 210 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence 222222222345678999999998899999999999999999998 988874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=274.18 Aligned_cols=199 Identities=26% Similarity=0.419 Sum_probs=172.2
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.++|++.++||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++.+...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999995 57889999998765555556788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998853 346899999999999999999999987 99999999999999999999999999986532211
Q ss_pred ccccccccccCCccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......|+..|+|||.+. ...++.++||||||+++|||++|+.|+.
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 122346788999999874 3457889999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=281.26 Aligned_cols=199 Identities=25% Similarity=0.419 Sum_probs=167.7
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|.+.++||+|+||.||+++.+ +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46889999999999999999854 67889999987543 22334678899999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++ +|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 985 67776643 2345889999999999999999999987 99999999999999999999999999875432221
Q ss_pred ccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 207 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG 207 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1223467889999998865 4688999999999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=287.75 Aligned_cols=197 Identities=28% Similarity=0.381 Sum_probs=166.2
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCC-----
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE----- 415 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 415 (573)
..++|++.+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 346899999999999999999985 46889999998653 2334567789999999999999999999986543
Q ss_pred -eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 416 -EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 416 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
..++||||++++ |...+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 468999999765 444442 24788999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
++..... .......||..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 9754321 122345789999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=272.71 Aligned_cols=200 Identities=31% Similarity=0.461 Sum_probs=170.2
Q ss_pred CCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
.+|++.+.||+|+||.||++++++++.+|+|.+.+.. ....++.+|+++++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3578899999999999999998777889999986433 234578889999999999999999999999999999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++....... .
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~ 156 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-T 156 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-c
Confidence 99999998542 236899999999999999999999987 99999999999999999999999999875532211 1
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 1112234567999999998999999999999999999999 7888753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=272.97 Aligned_cols=201 Identities=29% Similarity=0.458 Sum_probs=166.8
Q ss_pred CCcccccccccceeEEEEecCC----CCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe-----
Q 008238 348 FSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE----- 416 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 416 (573)
|.+.+.||+|+||.||+|+... +..||+|+++... ......+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998532 3679999987542 2334678999999999999999999998876554
Q ss_pred -eEEEEEccCCCChhhhccCcC---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEecc
Q 008238 417 -KILVYEFVPNKSLDYFLYEPE---KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492 (573)
Q Consensus 417 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df 492 (573)
.+++|||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999998885422 2346899999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~ 217 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP 217 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 99986643332222222334678999999988899999999999999999999 888864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=280.10 Aligned_cols=202 Identities=30% Similarity=0.491 Sum_probs=169.6
Q ss_pred CCCcccccccccceeEEEEecC------CCCeeEEEEeccCCcc-chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSSGQ-GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
+|++.++||+|+||.||+|... .++.||+|+++..... ..+.+.+|+.++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4777899999999999999853 2467999998754332 34668899999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCc-------------CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC
Q 008238 420 VYEFVPNKSLDYFLYEP-------------EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 486 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 486 (573)
++||+++++|.+++... .....+++..++.++.|++.||+|||+++ |+||||||.|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999987421 11345889999999999999999999987 999999999999999999
Q ss_pred eEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 487 PKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 487 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..|+.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 228 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999886543322222233456778999999988899999999999999999998 777764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=276.99 Aligned_cols=204 Identities=32% Similarity=0.528 Sum_probs=172.9
Q ss_pred hCCCCcccccccccceeEEEEec------CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
.+++...++||+|+||.||+++. .++..+++|.+..........+.+|+++++.++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 35678899999999999999963 235678999987766666778999999999999999999999999999999
Q ss_pred EEEEccCCCChhhhccCcCc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC
Q 008238 419 LVYEFVPNKSLDYFLYEPEK------------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 486 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 486 (573)
++|||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999864221 135889999999999999999999887 999999999999999999
Q ss_pred eEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 487 PKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 487 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 99999999875533222112223345678999999999999999999999999999998 888863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=278.16 Aligned_cols=199 Identities=27% Similarity=0.477 Sum_probs=175.2
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
..+|++.+.||+|++|.||+++. .+++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 45799999999999999999984 57889999999876655667889999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~- 170 (296)
T cd06654 99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (296)
T ss_pred cCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence 99999999884 345889999999999999999999987 9999999999999999999999999987543221
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~ 218 (296)
T cd06654 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (296)
T ss_pred -cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 112234688899999999888899999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=279.31 Aligned_cols=198 Identities=28% Similarity=0.396 Sum_probs=171.2
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|++.++||+|+||.||+++. .+++.+++|.+.... .....++.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688999999999999999995 467888999886542 23345688999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++.. ...+++..+..++.|+++||.|||+.. +++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 999999999853 356899999999999999999999742 3999999999999999999999999998754322
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 12334688999999999888899999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=276.13 Aligned_cols=202 Identities=32% Similarity=0.546 Sum_probs=168.8
Q ss_pred hCCCCcccccccccceeEEEEec-CCCC----eeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQ----EIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
.++|++.++||+|+||+||+|++ .+++ .||+|.++... ....+++.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35688899999999999999985 3444 47999986543 3345678899999999999999999999875 4577
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+++||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998642 346899999999999999999999987 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.|++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 43322222222344678999999998999999999999999999998 8888753
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=300.13 Aligned_cols=210 Identities=26% Similarity=0.339 Sum_probs=174.6
Q ss_pred HHHhCCCCcccccccccceeEEEEecCCC-CeeEEEEeccCCccchHHHHHHHHHHHhcC-CCccceEEEE-EEc-----
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSG-QEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGF-CLE----- 413 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~----- 413 (573)
++...++++.+.|.+|||+.||.++...+ .++|+|++-..++...+.+++||.+|++|+ |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34556788899999999999999997655 999999987777888899999999999998 9999999993 221
Q ss_pred -CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEecc
Q 008238 414 -GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492 (573)
Q Consensus 414 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df 492 (573)
.-+.+|.||||++|.|-+++..... ..|++.++++|+.|+++|+.+||... ++|||||||-+||||+.+++.|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 1356899999999999999965433 44999999999999999999999985 78999999999999999999999999
Q ss_pred CCcccccCCCCc-c------ccccccccCCccchhcc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 493 GMAKIFGVDQTQ-G------NTNRIVGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 493 Gla~~~~~~~~~-~------~~~~~~gt~~y~aPE~~---~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
|.+.-....... . ..-...-|+.|.|||.+ .+...+.|+|||+|||+||-|+....||+..
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 998633222211 0 00112358899999987 5678899999999999999999999998643
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=271.74 Aligned_cols=195 Identities=30% Similarity=0.466 Sum_probs=164.4
Q ss_pred cccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCCh
Q 008238 352 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 429 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 429 (573)
++||+|+||.||+++. .+++.+|+|.+.... .+....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4799999999999996 478899999876443 33456789999999999999999999999999999999999999999
Q ss_pred hhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcccccc
Q 008238 430 DYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR 509 (573)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 509 (573)
.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999853 2346899999999999999999999887 99999999999999999999999999875432211111111
Q ss_pred ccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 510 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 510 ~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
...+..|+|||.+.++.++.++||||||+++|||++ |..|+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~ 198 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA 198 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 123457999999988899999999999999999998 888874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=271.35 Aligned_cols=200 Identities=31% Similarity=0.474 Sum_probs=171.7
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc-----cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG-----QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
++|++.+.||+|++|.||++.. .+++.+++|.+..... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999985 4689999998864321 123568889999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 356889999999999999999999987 9999999999999999999999999987653
Q ss_pred CCCCcc-ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 500 VDQTQG-NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 500 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 208 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA 208 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 321111 1123457889999999999889999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.28 Aligned_cols=210 Identities=34% Similarity=0.534 Sum_probs=179.9
Q ss_pred CCcccccccccceeEEEEec-CCCC----eeEEEEeccC-CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 348 FSTDNKLGEGGFGEVYKGVL-PSGQ----EIAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
.+..++||+|+||+||+|.| +.|+ +||||++... ..+...++.+|+-+|.+++|||+++|+|+|.... ..||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 45578999999999999995 4454 5799988654 4455788999999999999999999999998766 88999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
+||+.|+|.++++.. +..+..+..+.|..|||+||.|||++. ++||||.++||||.+-.++||.|||+++.+..+
T Consensus 777 q~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999999763 456888999999999999999999886 999999999999999999999999999988776
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcccHHH
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLLS 563 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~~ll~ 563 (573)
..........-.+.|||-|.+....++.++|||||||.+||++| |.+|++-...++..++++
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle 914 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE 914 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh
Confidence 66555555555788999999999999999999999999999998 888987555454444443
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=269.30 Aligned_cols=200 Identities=32% Similarity=0.474 Sum_probs=174.1
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+|++.+.||+|++|.||+++. .+++.|++|.+... ......++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477889999999999999996 46889999998643 234456788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998653 2357899999999999999999999887 99999999999999999999999999886543221
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......|+..|+|||++.+..++.++|+||||+++|||++|+.|+..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 203 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 22334678899999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=273.58 Aligned_cols=198 Identities=35% Similarity=0.558 Sum_probs=171.9
Q ss_pred CCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchH--HHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 348 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQ--EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
|++.++||+|+||+||+++.. +++.+|+|.+......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999964 5668999999866543332 3456999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++++|.+++. +...+++..+..++.||++||++||+.+ ++|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence 9999999995 4567899999999999999999999987 9999999999999999999999999987541 122
Q ss_pred cccccccccCCccchhccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
.......++..|+|||.+. +...+.++||||+|+++|+|++|+.|+...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2334557889999999998 788999999999999999999999998643
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=275.06 Aligned_cols=205 Identities=28% Similarity=0.474 Sum_probs=172.8
Q ss_pred HhCCCCcccccccccceeEEEEecC------CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 416 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 416 (573)
..++|++.+.||+|+||.||++... .+..|++|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 4457889999999999999999863 23679999986543 2334578899999999999999999999999999
Q ss_pred eEEEEEccCCCChhhhccCcC-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEE
Q 008238 417 KILVYEFVPNKSLDYFLYEPE-------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 489 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl 489 (573)
.++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||+++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 999999999999999985422 1235789999999999999999999887 999999999999999999999
Q ss_pred eccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 490 SDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 490 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 223 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCc
Confidence 99999886543322222233456788999999988899999999999999999998 888874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=281.80 Aligned_cols=206 Identities=29% Similarity=0.443 Sum_probs=170.4
Q ss_pred HHhCCCCcccccccccceeEEEEecC--------CCCeeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceEEEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCL 412 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 412 (573)
...++|.+.++||+|+||.||+++.. ....+|+|.+.... .....++.+|++++..+ +||||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 33467999999999999999999742 23469999987542 33445788899999999 7999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCE
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPEK-------------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI 479 (573)
..+..++||||+++|+|.+++..... ...+++.++++++.|++.||+|||+.+ ++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence 99999999999999999999864321 235899999999999999999999887 99999999999
Q ss_pred EeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 480 LLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 480 Ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
|+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999876533221111222234568999999988899999999999999999998 777764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=276.40 Aligned_cols=206 Identities=33% Similarity=0.525 Sum_probs=170.2
Q ss_pred HhCCCCcccccccccceeEEEEecCC------CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 416 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 416 (573)
..++|.+.+.||+|++|.||++.+.+ +..|++|.+.... ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678999999999999999999643 5678999876443 2334568999999999999999999999999999
Q ss_pred eEEEEEccCCCChhhhccCcC----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC---CeEE
Q 008238 417 KILVYEFVPNKSLDYFLYEPE----KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKI 489 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~vkl 489 (573)
.++||||+++++|.+++.... ....+++..+++++.||+.||+|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 999999999999999985432 1236899999999999999999999987 99999999999998654 5999
Q ss_pred eccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 490 SDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 490 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~ 224 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999986532222111222334568999999999999999999999999999997 8888753
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=306.92 Aligned_cols=207 Identities=24% Similarity=0.337 Sum_probs=181.3
Q ss_pred chhHHHHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEE
Q 008238 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412 (573)
Q Consensus 337 ~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 412 (573)
....+....++|.+++.||+|+||.|..++. ..++.||+|++.+- ......-|.+|-.+|..-+.+-|++++..|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 3455667778999999999999999999996 46788999999762 2334456889999999999999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEecc
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df 492 (573)
+...+|+|||||+||+|-.++.. ...+++..+..++.+|.-||+-||+.+ +|||||||.|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999843 347899999999999999999999887 999999999999999999999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccc----c-CCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM----H-GQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
|.+-.+..+... .....+|||.|++||++. + +.|+..+|+||+||++|||+.|..||
T Consensus 220 GsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 220 GSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred hhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 999877655433 345679999999999983 2 57899999999999999999999997
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=285.94 Aligned_cols=190 Identities=28% Similarity=0.371 Sum_probs=159.3
Q ss_pred cccccceeEEEEec-CCCCeeEEEEeccCCc---cchHHHHHHHHHHHhc---CCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 354 LGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKL---QHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 354 LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
||+|+||+||+++. .+++.||||++.+... .....+..|..++... +||||+++++.+...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999995 4689999999864321 1223345566666655 699999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999988843 456899999999999999999999987 9999999999999999999999999987532211 22
Q ss_pred cccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.....||..|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~ 198 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC
Confidence 3345799999999998765 47999999999999999999999974
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=271.56 Aligned_cols=201 Identities=31% Similarity=0.492 Sum_probs=164.3
Q ss_pred CCcccccccccceeEEEEecCCC-C--eeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcC------Ce
Q 008238 348 FSTDNKLGEGGFGEVYKGVLPSG-Q--EIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG------EE 416 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 416 (573)
+.+.++||+|+||.||+|++.+. . .+|+|.++.. .....+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999996543 2 5899988654 233456788999999999999999999987542 24
Q ss_pred eEEEEEccCCCChhhhccCc---CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccC
Q 008238 417 KILVYEFVPNKSLDYFLYEP---EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfG 493 (573)
.+++|||+++|+|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999887432 12345899999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
+++...............++..|++||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 216 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP 216 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9986543322111222345678999999999999999999999999999999 788874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=274.76 Aligned_cols=198 Identities=28% Similarity=0.440 Sum_probs=170.4
Q ss_pred CCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 348 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
|++.++||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++.+..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677889999999999999964 5778899998766555667889999999999999999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
++|..++.. ....+++..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 999888753 2357899999999999999999999987 9999999999999999999999999987543211 12
Q ss_pred cccccccCCccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....++..|+|||.+. +..++.++||||||+++|||++|+.|+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 23356889999999873 34578899999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=262.40 Aligned_cols=213 Identities=27% Similarity=0.398 Sum_probs=178.6
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEecc--CCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSR--SSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.++.|++-+.||+|.|+.|++... .+|+.+|+|++.. -+....+++.+|+.|-+.++||||+++.+.+......++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 345688889999999999999884 5789999998753 2344678899999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC---CCCeEEeccCCccc
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMAKI 497 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGla~~ 497 (573)
+|+|.|++|..-+- .+..+++..+-..++||+++|.|+|.++ |||||+||+|+|+-. .--+||+|||++..
T Consensus 89 Fe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999865542 2245677888889999999999999988 999999999999943 33599999999987
Q ss_pred ccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhh
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSIN 568 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~ 568 (573)
++ ........+||++|||||++...+++..+|||+-||+||-|+.|.+||.- ++..++.+.|.+.
T Consensus 163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I~~g 227 (355)
T KOG0033|consen 163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQIKAG 227 (355)
T ss_pred eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhcc
Confidence 76 22334456899999999999999999999999999999999999999742 3455666666543
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=276.35 Aligned_cols=199 Identities=27% Similarity=0.479 Sum_probs=175.8
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.++|++.+.||+|++|.||+++. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46799999999999999999995 57899999999766555567788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++. ...+++..+..++.|++.+|.|||+.+ ++||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999984 346889999999999999999999987 99999999999999999999999999875433221
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 12234678899999999988899999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=276.09 Aligned_cols=206 Identities=28% Similarity=0.475 Sum_probs=170.3
Q ss_pred HHhCCCCcccccccccceeEEEEecC------CCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCC
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 415 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 415 (573)
+..++|++.++||+|+||.||+|..+ .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999743 245799998864432 23346788999999999999999999999999
Q ss_pred eeEEEEEccCCCChhhhccCcC-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeE
Q 008238 416 EKILVYEFVPNKSLDYFLYEPE-------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 488 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vk 488 (573)
..++||||+++|+|.+++.... .....++..++.++.|++.||.|||+++ |+||||||+|||+++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 9999999999999999985421 1234577888999999999999999987 99999999999999999999
Q ss_pred EeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 489 ISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 489 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
|+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~ 223 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 223 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999886533222222222345678999999998999999999999999999999 677764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=278.81 Aligned_cols=196 Identities=26% Similarity=0.442 Sum_probs=159.6
Q ss_pred ccccccccceeEEEEecC---CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEc--CCeeEEEEEccC
Q 008238 351 DNKLGEGGFGEVYKGVLP---SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILVYEFVP 425 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 425 (573)
.++||+|+||+||+++.. +++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 46789999986432 23567889999999999999999998864 456789999986
Q ss_pred CCChhhhccCc------CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe----CCCCCeEEeccCCc
Q 008238 426 NKSLDYFLYEP------EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMA 495 (573)
Q Consensus 426 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl----~~~~~vkl~DfGla 495 (573)
+ +|.+++... .+...+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 666665321 12246899999999999999999999987 9999999999999 46678999999999
Q ss_pred ccccCCCCc-cccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 496 KIFGVDQTQ-GNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+.+...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 866433221 223346789999999998774 589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=275.36 Aligned_cols=202 Identities=28% Similarity=0.436 Sum_probs=173.5
Q ss_pred HhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
..++|++.++||+|+||.||+|+.. +++.+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 3467899999999999999999964 588999999987666667788999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|..++... ...+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 90 FCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred cCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 99999998887432 346899999999999999999999887 999999999999999999999999998754221
Q ss_pred CccccccccccCCccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
........++..|+|||.+. ...++.++||||||+++|||++|+.|+..
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 11223346788999999884 34568899999999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=271.47 Aligned_cols=197 Identities=28% Similarity=0.407 Sum_probs=159.2
Q ss_pred cccccccceeEEEEecCC---CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCC
Q 008238 352 NKLGEGGFGEVYKGVLPS---GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 427 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 427 (573)
++||+|+||.||+|...+ ...+++|.+.... ......+.+|+..++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999997533 3467888776443 233456889999999999999999999999999999999999999
Q ss_pred ChhhhccCcCc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 428 SLDYFLYEPEK--QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 428 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+|.+++..... ....++...+.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865322 234567888999999999999999987 9999999999999999999999999986543222111
Q ss_pred ccccccccCCccchhcccc-------CCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMH-------GQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
......++..|+|||++.. ..++.++||||||+++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCC
Confidence 1233455778999998743 356889999999999999999 677764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=270.74 Aligned_cols=198 Identities=30% Similarity=0.428 Sum_probs=162.4
Q ss_pred cccccccceeEEEEecCC---CCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCC
Q 008238 352 NKLGEGGFGEVYKGVLPS---GQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 427 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 427 (573)
+.||+|+||.||+|++.+ +..+++|+++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998543 45789998875432 33457889999999999999999999999999999999999999
Q ss_pred ChhhhccCcC--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 428 SLDYFLYEPE--KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 428 sL~~~l~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+|.+++.... .....++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986422 2235677888899999999999999987 9999999999999999999999999987543222222
Q ss_pred ccccccccCCccchhccccC-------CCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHG-------QFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~-------~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 22335678889999988542 35789999999999999996 9999854
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=273.31 Aligned_cols=198 Identities=25% Similarity=0.436 Sum_probs=172.1
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
++|++.++||+|+||.||+++. .+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4688889999999999999985 468899999987665555567889999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++++|.+++.. ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 99999998843 356899999999999999999999987 9999999999999999999999999987653221
Q ss_pred cccccccccCCccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.......|+..|+|||.+. ...++.++||||||+++|||++|+.|+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 1223456899999999874 4568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=272.82 Aligned_cols=201 Identities=32% Similarity=0.498 Sum_probs=171.3
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
..+|++.++||+|++|.||++.+. .++.|++|++... .....++.+|+++++.++|+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 345788899999999999999964 5888999998743 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999998542 2346899999999999999999999887 99999999999999999999999999986543221
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
. ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~ 207 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 207 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 1 1112234568999999988999999999999999999998 888874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=275.60 Aligned_cols=205 Identities=28% Similarity=0.443 Sum_probs=172.5
Q ss_pred HhCCCCcccccccccceeEEEEecCC-----CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEc-CCe
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLPS-----GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEE 416 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 416 (573)
..++|++.+.||+|+||.||+|.+.+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45678899999999999999999755 6789999887543 3335668899999999999999999998776 467
Q ss_pred eEEEEEccCCCChhhhccCcCcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEec
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQ-----QQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 491 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~D 491 (573)
.++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998653222 56899999999999999999999887 99999999999999999999999
Q ss_pred cCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 492 FGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 492 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.|+.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 221 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV 221 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcC
Confidence 999986543322212223345778999999988889999999999999999999 999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.92 Aligned_cols=209 Identities=29% Similarity=0.435 Sum_probs=173.1
Q ss_pred HHHHhCCCCcccccccccceeEEEEecC------CCCeeEEEEeccCCc-cchHHHHHHHHHHHhcC-CCccceEEEEEE
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQ-HRNLVRLLGFCL 412 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 412 (573)
++...++|.+.++||+|+||.||++++. .++.||||+++.... ...+.+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4455567888999999999999999853 346799999975432 22356889999999997 999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcC-------------------------------------------------------
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPE------------------------------------------------------- 437 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------- 437 (573)
..+..++||||+++|+|.++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999986421
Q ss_pred ----------------------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCC
Q 008238 438 ----------------------------------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 477 (573)
Q Consensus 438 ----------------------------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~ 477 (573)
....+++..++.++.||+.||+|||+.+ ++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 1124678889999999999999999876 999999999
Q ss_pred CEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 478 NILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 478 NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999986532222112223456788999999988889999999999999999998 8888753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=277.83 Aligned_cols=204 Identities=30% Similarity=0.459 Sum_probs=168.4
Q ss_pred hCCCCcccccccccceeEEEEecCC---------------CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPS---------------GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLL 408 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~ 408 (573)
.++|++.++||+|+||.||+++... ...||+|++.... ......+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578999999999999999987532 2248999987542 33345789999999999999999999
Q ss_pred EEEEcCCeeEEEEEccCCCChhhhccCcC---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCE
Q 008238 409 GFCLEGEEKILVYEFVPNKSLDYFLYEPE---------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479 (573)
Q Consensus 409 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI 479 (573)
+++...+..++||||+++++|.+++.... ....+++..+++++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999885421 1124788999999999999999999987 99999999999
Q ss_pred EeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhC--CCCCC
Q 008238 480 LLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG--KKNSS 551 (573)
Q Consensus 480 Ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG--~~p~~ 551 (573)
|+++++.+||+|||++................++..|+|||.+.++.++.++||||||+++|||+++ ..||.
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 9999999999999998765332222222233457789999999989999999999999999999984 45554
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=276.19 Aligned_cols=202 Identities=30% Similarity=0.459 Sum_probs=168.8
Q ss_pred CCCcccccccccceeEEEEecC------CCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
+|++.+.||+|+||.||+|+.. ....+++|.+..... ....++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999852 235688888865432 334678899999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcC---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 008238 420 VYEFVPNKSLDYFLYEPE---------------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 478 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~N 478 (573)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1245889999999999999999999887 9999999999
Q ss_pred EEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 479 ILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 479 ILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999976533222222223345678999999988889999999999999999999 888874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=275.14 Aligned_cols=201 Identities=25% Similarity=0.413 Sum_probs=170.7
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccC-CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|++.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35788999999999999999964 7899999988654 233346788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|..++........+++..+..++.|++.+|.|||+.. +|+||||||+||+++.++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999998865333457899999999999999999999742 3999999999999999999999999998755322
Q ss_pred ccccccccccCCccchhccccCC------CCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQ------FSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~------~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 122345788999999885543 48899999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=276.12 Aligned_cols=199 Identities=26% Similarity=0.498 Sum_probs=175.6
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.++|+..++||.|++|.||++.. .+++.|++|.+........+.+.+|+++++.++||||+++++.+...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 34689999999999999999984 57899999998766555567889999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|..++. ...+++.++..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999884 346899999999999999999999987 99999999999999999999999999876543221
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~ 217 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12234678899999999888899999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=287.19 Aligned_cols=209 Identities=31% Similarity=0.473 Sum_probs=180.4
Q ss_pred hhHHHHHhCCCCcccccccccceeEEEEecCC-CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe
Q 008238 338 FETIEVATNNFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 416 (573)
Q Consensus 338 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 416 (573)
.++++....+....++||-|.||.||.|.|+. .-.||||.++... ...++|..|..+|+.++|||+|+|+|+|.....
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 46677777778889999999999999999863 5679999997543 457899999999999999999999999999999
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.|||.|||..|+|.++|++.. .+.++.-.++.++.||..||+||..++ +|||||.++|+|+.++..+|++||||++
T Consensus 338 FYIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred eEEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 999999999999999997643 356778888999999999999999887 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
++..+..-.. ....-+..|.|||.+....++.|+|||+|||+|||+.| |.-||.-
T Consensus 414 lMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 414 LMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred hhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 8765443222 12223678999999999999999999999999999987 6667643
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=259.52 Aligned_cols=198 Identities=28% Similarity=0.465 Sum_probs=169.8
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC----ccc----hHHHHHHHHHHHhcC-CCccceEEEEEEc
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS----GQG----GQEFKNEVVLVAKLQ-HRNLVRLLGFCLE 413 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~----~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 413 (573)
.-.+|.-.+.||+|..++|.++.. ..|+++|+|++.... .+. .+.-.+|+.||+++. ||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345678888999999999999885 578899999885321 111 234467999999985 9999999999999
Q ss_pred CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccC
Q 008238 414 GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493 (573)
Q Consensus 414 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfG 493 (573)
....++|+|.|+.|.|.++|.. .-.+++++..+|+.|+.+|++|||..+ |+||||||+|||+|++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999943 457899999999999999999999988 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccCCccchhcccc------CCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH------GQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
.+..+.... .....+||++|.|||.+.- ..|+...|+|+.|||+|-|+.|-+||
T Consensus 169 Fa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF 228 (411)
T KOG0599|consen 169 FACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF 228 (411)
T ss_pred eeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence 998775433 3446799999999999833 35788999999999999999999986
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=278.58 Aligned_cols=207 Identities=29% Similarity=0.454 Sum_probs=172.7
Q ss_pred HHHhCCCCcccccccccceeEEEEecC------CCCeeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceEEEEEEc
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLE 413 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 413 (573)
+...++|++.+.||+|+||.||++... ....+|+|.+.... .....++.+|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 344567889999999999999999853 23578999887542 23345688999999999 79999999999999
Q ss_pred CCeeEEEEEccCCCChhhhccCc-------------CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEE
Q 008238 414 GEEKILVYEFVPNKSLDYFLYEP-------------EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 480 (573)
Q Consensus 414 ~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIL 480 (573)
.+..+++|||+++|+|..++... .....+++..++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 99999999999999999998532 22356899999999999999999999887 999999999999
Q ss_pred eCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 481 LDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 481 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence 99999999999999986643322222222345678999999988899999999999999999998 888864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=273.20 Aligned_cols=199 Identities=32% Similarity=0.486 Sum_probs=169.3
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+|++.++||+|++|.||+|+.. +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999964 68899999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
++ ++|.+++........+++..+..++.||++||+|||+++ ++|+||||+|||+++++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 678888755444567899999999999999999999987 99999999999999999999999999876543221
Q ss_pred ccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 12233568899999988654 47899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=272.13 Aligned_cols=201 Identities=25% Similarity=0.447 Sum_probs=172.5
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||.||+|+. .+++.||||.+... .......+.+|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4789999999999999999995 47899999987542 2233456889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 422 EFVPNKSLDYFLYEPE-KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
||+++++|.+++.... +...+++..+..++.||++||.|||+++ ++|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875322 3356889999999999999999999987 99999999999999999999999999876543
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
... ......|+..|+|||.+.+..++.++|+||||+++|||++|+.|+.
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~ 207 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 221 1223467889999999988889999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=271.65 Aligned_cols=200 Identities=31% Similarity=0.512 Sum_probs=169.4
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
.++|++.++||+|+||.||+|++.+...||+|+++... ...+++.+|+.+++.++||||+++++.+. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 45689999999999999999998777789999987533 23467899999999999999999999875 45679999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++|+|.+++... ....+++..+..++.|++++|+|||+.+ ++||||||+||++++++.++|+|||.++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998642 2346799999999999999999999987 999999999999999999999999999765432211
Q ss_pred cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~ 205 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 205 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 1123346678999999988899999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=296.83 Aligned_cols=198 Identities=23% Similarity=0.326 Sum_probs=162.3
Q ss_pred HHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCC------ccceEEEEEEcC
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHR------NLVRLLGFCLEG 414 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~ 414 (573)
....++|++.++||+|+||+||+++. ..++.||||+++... ...+++..|+.+++.++|. +++++++++...
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 34567899999999999999999985 467889999986432 2344566788888777654 588888888764
Q ss_pred -CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCEEeCCCC-------
Q 008238 415 -EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEM------- 485 (573)
Q Consensus 415 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlkp~NILl~~~~------- 485 (573)
...++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||++ + |+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 4678999988 6677777743 35789999999999999999999974 5 99999999999998765
Q ss_pred ---------CeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 486 ---------NPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 486 ---------~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999875322 122346799999999999999999999999999999999999999864
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=288.97 Aligned_cols=191 Identities=34% Similarity=0.490 Sum_probs=169.2
Q ss_pred ccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCChhh
Q 008238 353 KLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDY 431 (573)
Q Consensus 353 ~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 431 (573)
.||+|.||+||-|+.. +...+|||.+........+.+.+||.+.+.++|.|||+++|.+.++...-+.||-.+||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 5899999999999964 456789999987777777889999999999999999999999999999999999999999999
Q ss_pred hccCcCccCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC-CCCCeEEeccCCcccccCCCCccccc
Q 008238 432 FLYEPEKQQQL--DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMAKIFGVDQTQGNTN 508 (573)
Q Consensus 432 ~l~~~~~~~~l--~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~vkl~DfGla~~~~~~~~~~~~~ 508 (573)
+|+... +++ ++.++-.+.+||++||.|||++. |||||||-.||||+ -.|.+||+|||-++++-. ...-+.
T Consensus 662 LLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 662 LLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 997643 455 88888999999999999999987 99999999999997 478999999999987632 233455
Q ss_pred cccccCCccchhccccC--CCCccchhHHHHHHHHHHHhCCCCC
Q 008238 509 RIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 509 ~~~gt~~y~aPE~~~~~--~~s~~~DvwslGvll~elltG~~p~ 550 (573)
+..||..|||||++..+ .|+.++|||||||.+.||.||++||
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF 778 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPF 778 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCe
Confidence 67899999999999776 4889999999999999999999997
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=278.82 Aligned_cols=206 Identities=28% Similarity=0.445 Sum_probs=172.0
Q ss_pred HHhCCCCcccccccccceeEEEEec--------CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceEEEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCL 412 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 412 (573)
...++|.+.+.||+|+||.||+++. .++..||+|.+.... .....++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 4456788999999999999999973 124478999886542 33456789999999999 7999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCE
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPE-------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI 479 (573)
.....+++|||+++|+|.+++.... ....+++.+++.++.||++||.|||+++ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999986421 1246889999999999999999999987 99999999999
Q ss_pred EeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 480 LLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 480 Ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
|+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999986643332222333345678999999988889999999999999999998 777764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=284.40 Aligned_cols=197 Identities=28% Similarity=0.371 Sum_probs=166.1
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcC------
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 414 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 414 (573)
..++|++.+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 446899999999999999999985 468899999987542 23346678899999999999999999988653
Q ss_pred CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 415 EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 415 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
...++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 346899999976 4555552 24788999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
++..... .......||..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9864322 122335789999999999998999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=284.58 Aligned_cols=196 Identities=28% Similarity=0.376 Sum_probs=165.9
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcC------C
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG------E 415 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 415 (573)
.++|++.+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46799999999999999999985 468899999987532 33346778899999999999999999987643 3
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 46899999976 5555552 24788999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 174 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 174 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred cccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 764322 122335689999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=273.69 Aligned_cols=196 Identities=30% Similarity=0.400 Sum_probs=172.7
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999954 68899999986532 233466889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999853 357899999999999999999999987 999999999999999999999999998865332
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....++..|+|||.+.+...+.++||||||+++|||++|+.|+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 2334688999999999888899999999999999999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=270.58 Aligned_cols=200 Identities=32% Similarity=0.522 Sum_probs=170.1
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
.++|++.++||+|+||.||++..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 456889999999999999999987888899999875433 3467899999999999999999999875 45688999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++++|.+++... ....+++..++.++.|++.+|+|||+.+ ++||||||+||++++++.++|+|||++..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999998642 2345899999999999999999999987 999999999999999999999999999865432211
Q ss_pred cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~ 205 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCC
Confidence 1122235668999999988899999999999999999999 888874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=275.50 Aligned_cols=204 Identities=30% Similarity=0.474 Sum_probs=169.8
Q ss_pred hCCCCcccccccccceeEEEEecC-----------------CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccce
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-----------------SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVR 406 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 406 (573)
.++|++.++||+|+||.||++... ++..+|+|.+.... .....++.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 456899999999999999998532 23468999987543 334567899999999999999999
Q ss_pred EEEEEEcCCeeEEEEEccCCCChhhhccCcC--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 008238 407 LLGFCLEGEEKILVYEFVPNKSLDYFLYEPE--------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 478 (573)
Q Consensus 407 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~N 478 (573)
+++++...+..+++|||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999986422 1235788899999999999999999987 9999999999
Q ss_pred EEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh--CCCCCC
Q 008238 479 ILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT--GKKNSS 551 (573)
Q Consensus 479 ILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt--G~~p~~ 551 (573)
||+++++.++|+|||+++.+.............++..|++||...++.++.++||||||+++|||++ |..|+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999986543322222223345678999999888899999999999999999998 566764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=263.71 Aligned_cols=196 Identities=27% Similarity=0.425 Sum_probs=169.8
Q ss_pred ccccccccceeEEEEe-cCCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEEEEccCCCC
Q 008238 351 DNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKS 428 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 428 (573)
.+.||+|+|+.|--++ +.+|.++|||++.+.......++.+|++++...+ |+||++++++|++++..|||||-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4689999999999988 6799999999999988888899999999999997 9999999999999999999999999999
Q ss_pred hhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC---CeEEeccCCcccccCCC--C
Q 008238 429 LDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMAKIFGVDQ--T 503 (573)
Q Consensus 429 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~vkl~DfGla~~~~~~~--~ 503 (573)
|..+++ ++..+++.++.+++++|+.||.+||.++ |.||||||+|||-.+-. -+||+||.|..-..... +
T Consensus 163 lLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999885 4567999999999999999999999998 99999999999986443 38999999875432221 1
Q ss_pred ---ccccccccccCCccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 ---QGNTNRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ---~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.......+|+..|||||+.. ...|..+.|.||||||+|-|++|.+||.-
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 12234578999999999762 23578899999999999999999999853
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=278.45 Aligned_cols=206 Identities=29% Similarity=0.447 Sum_probs=169.9
Q ss_pred HHhCCCCcccccccccceeEEEEecC--------CCCeeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceEEEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCL 412 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 412 (573)
...++|.+.++||+|+||.||+++.. ....+|+|.++... .....++.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 33457889999999999999999741 24568999887543 23346788999999999 5999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCE
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPE-------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI 479 (573)
.....+++|||+++|+|.+++.... ....+++.++.+++.||+.||.|||+++ ++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 9899999999999999999985422 1245899999999999999999999987 99999999999
Q ss_pred EeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 480 LLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 480 Ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
|+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence 999999999999999986543222111222234567999999988899999999999999999999 788764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=273.49 Aligned_cols=201 Identities=26% Similarity=0.418 Sum_probs=173.8
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.++|++.++||+|++|.||++... +++.+++|.+........+.+.+|++++++++||||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456889999999999999999964 6889999998766555667889999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++... ...+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 9999999998542 346899999999999999999999987 9999999999999999999999999987543221
Q ss_pred ccccccccccCCccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.......++..|++||.+. ...++.++||||||+++|||++|+.|+..
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 1223456889999999874 34567899999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=268.23 Aligned_cols=200 Identities=25% Similarity=0.437 Sum_probs=175.2
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.++|++.+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.++++++||||+++++.+.+.+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 35788999999999999999996 45788999999866655677899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++.. ....+++..+..++.|++.||+|||+++ ++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 999999998854 2256899999999999999999999987 9999999999999999999999999987653221
Q ss_pred ccccccccccCCccchhccccC---CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHG---QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~ 205 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 112334678899999998776 78999999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=282.18 Aligned_cols=196 Identities=28% Similarity=0.426 Sum_probs=166.4
Q ss_pred HHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcC-----
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG----- 414 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 414 (573)
...++|++.+.||+|+||+||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3456899999999999999999985 568899999987542 22345677899999999999999999987543
Q ss_pred -CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccC
Q 008238 415 -EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493 (573)
Q Consensus 415 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfG 493 (573)
...++++|++ +++|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 778888773 356899999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+++..... .....|++.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99865321 223468999999999877 568999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=269.08 Aligned_cols=200 Identities=29% Similarity=0.427 Sum_probs=168.7
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-----ccchHHHHHHHHHHHhcCCCccceEEEEEEcC--Cee
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-----GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK 417 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 417 (573)
.+|++.+.||+|+||.||+++. .+++.|+||.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688999999999999999995 468899999875321 12235788899999999999999999988764 457
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
+++|||+++++|.+++.. ...+++...++++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999998853 245788999999999999999999987 99999999999999999999999999876
Q ss_pred ccCCCC-ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 498 FGVDQT-QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 498 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
...... ........|+..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence 532211 112233468889999999988889999999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=276.25 Aligned_cols=205 Identities=29% Similarity=0.453 Sum_probs=171.9
Q ss_pred HHhCCCCcccccccccceeEEEEec------CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceEEEEEEcC
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEG 414 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 414 (573)
...++|.+.+.||+|+||.||++.. ..+..||||+++... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 4445799999999999999999973 134579999987543 23346789999999999 799999999999999
Q ss_pred CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 415 EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 415 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
+..+++|||+++|+|.+++.... ...+++.++..++.||+.||+|||+++ |+|+||||+|||++.++.++|+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999985422 234899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~ 245 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP 245 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcC
Confidence 986543222111222345778999999999999999999999999999998 898864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=269.17 Aligned_cols=202 Identities=34% Similarity=0.540 Sum_probs=172.5
Q ss_pred HHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
+..++|++.++||+|+||.||++..++++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 4456789999999999999999998889999999987543 33567899999999999999999999864 456899999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|.+++... ....+++.++..++.|++.+|+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999988543 2356899999999999999999999887 9999999999999999999999999997654222
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
.. ......++..|+|||.+....++.++||||||+++|||++ |+.||.
T Consensus 157 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 205 (260)
T cd05067 157 YT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYP 205 (260)
T ss_pred cc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCC
Confidence 11 1122345678999999988899999999999999999999 999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=271.95 Aligned_cols=202 Identities=33% Similarity=0.543 Sum_probs=169.6
Q ss_pred hCCCCcccccccccceeEEEEecC-CCC----eeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
..+|++.+.||+|+||.||+|.++ +++ .+++|.+..... ....++.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356888999999999999999853 333 589998875543 344678899999999999999999999887 7889
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999998642 345899999999999999999999977 999999999999999999999999999866
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.............++..|+|||.+....++.++|+||||+++|||++ |+.|+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 214 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC
Confidence 43322211112233568999999988899999999999999999999 9999764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=268.87 Aligned_cols=203 Identities=34% Similarity=0.557 Sum_probs=174.5
Q ss_pred HHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
...++|++.++||+|++|.||++..++++.|+||.+.... ...+++.+|+.++++++|+||+++++++......+++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4456899999999999999999998788889999987543 345678999999999999999999999998889999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||+++.+....
T Consensus 82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999998653 2346899999999999999999999987 9999999999999999999999999988654321
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 158 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 206 (261)
T cd05034 158 Y-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYP 206 (261)
T ss_pred h-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 1 11112234568999999998899999999999999999999 888874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=267.75 Aligned_cols=194 Identities=34% Similarity=0.512 Sum_probs=162.5
Q ss_pred cccccccceeEEEEec---CCCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVL---PSGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
++||+|+||.||+|.+ ++++.+|+|+++.... ...+++.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 3689999999999974 3578899999864432 33567899999999999999999999875 4567899999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc-
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG- 505 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~- 505 (573)
++|.+++.. ...+++..+..++.|++.+|+|||+++ ++||||||+|||+++++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 80 GPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999999843 346899999999999999999999987 9999999999999999999999999998654332211
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
......++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 1112234578999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=281.45 Aligned_cols=207 Identities=28% Similarity=0.426 Sum_probs=168.9
Q ss_pred HHhCCCCcccccccccceeEEEEec------CCCCeeEEEEeccCCc-cchHHHHHHHHHHHhc-CCCccceEEEEEEcC
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEG 414 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 414 (573)
...++|++.++||+|+||.||+|++ .+++.||||+++.... .....+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3456799999999999999999973 3567899999975432 3345688999999999 689999999987654
Q ss_pred -CeeEEEEEccCCCChhhhccCcCc-------------------------------------------------------
Q 008238 415 -EEKILVYEFVPNKSLDYFLYEPEK------------------------------------------------------- 438 (573)
Q Consensus 415 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 438 (573)
...+++|||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 457899999999999988753210
Q ss_pred ---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcccccc
Q 008238 439 ---------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR 509 (573)
Q Consensus 439 ---------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 509 (573)
...+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 124788899999999999999999987 99999999999999999999999999876533222222223
Q ss_pred ccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 510 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 510 ~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
..++..|+|||.+.+..++.++||||||+++|||++ |..|+..
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 284 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 345678999999988899999999999999999997 8888753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=268.53 Aligned_cols=200 Identities=33% Similarity=0.550 Sum_probs=170.9
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCCcc---------chHHHHHHHHHHHhcCCCccceEEEEEEcCCe
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQ---------GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 416 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 416 (573)
+|.+.+.||+|++|.||+|.. .+++.+++|.+...... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467889999999999999985 46789999988654322 12467889999999999999999999999999
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.+++|||+++++|.+++.. ...+++..+..++.|++.+|+|||+.+ ++||||+|+||++++++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 356889999999999999999999987 9999999999999999999999999988
Q ss_pred cccCCCCc----cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 497 IFGVDQTQ----GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 497 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
........ .......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 66422111 111234578899999999988999999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=272.36 Aligned_cols=197 Identities=29% Similarity=0.497 Sum_probs=162.5
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc--cchHHHHHHHHHHHhc---CCCccceEEEEEEcC-----C
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKL---QHRNLVRLLGFCLEG-----E 415 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~ 415 (573)
+|++.+.||+|+||+||+++.. +++.||+|.++.... .....+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788999999999999999854 688999999875422 2234556677777665 699999999987642 4
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
..+++|||+++ +|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 777777542 2345899999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+...... ......|+..|+|||++.+..++.++|||||||++|||++|++||.
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 7653221 1233467899999999998999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=271.55 Aligned_cols=200 Identities=33% Similarity=0.529 Sum_probs=168.1
Q ss_pred CCCCcccccccccceeEEEEec-----CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEc--CCeeE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKI 418 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 418 (573)
++|++.+.||+|+||.||++.. .+++.|++|++........+.+.+|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999974 2578899999987666666789999999999999999999998754 34678
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998542 345899999999999999999999987 999999999999999999999999999865
Q ss_pred cCCCCccc-cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 499 GVDQTQGN-TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 499 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
........ .....++..|+|||.+.+..++.++||||||+++|||++|..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~ 211 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcC
Confidence 43221111 11122345699999998889999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=273.45 Aligned_cols=204 Identities=31% Similarity=0.464 Sum_probs=171.5
Q ss_pred hCCCCcccccccccceeEEEEecCC-----------------CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccce
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPS-----------------GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVR 406 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 406 (573)
.++|++.++||+|+||.||+++... +..||+|.+.... ....+++.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999988532 2458999987543 234567889999999999999999
Q ss_pred EEEEEEcCCeeEEEEEccCCCChhhhccCcC--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 008238 407 LLGFCLEGEEKILVYEFVPNKSLDYFLYEPE--------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 478 (573)
Q Consensus 407 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~N 478 (573)
+++++..++..+++|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985432 1236899999999999999999999987 9999999999
Q ss_pred EEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh--CCCCCC
Q 008238 479 ILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT--GKKNSS 551 (573)
Q Consensus 479 ILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt--G~~p~~ 551 (573)
|+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 9999999999999999886543322222334456788999999988899999999999999999998 555654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=270.98 Aligned_cols=202 Identities=30% Similarity=0.486 Sum_probs=170.3
Q ss_pred HHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEcC------
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEG------ 414 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------ 414 (573)
.+...|++.+.||+|+||.||+|.. .+++.||+|.+.... ....++.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3556788899999999999999985 467889999986543 3456788999999998 699999999998753
Q ss_pred CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 415 EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 415 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
...+++|||+++++|.+++... ....+++..+..++.|++.||+|||+++ |+|+||||+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4578999999999999998542 3356899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
++...... .......|+..|+|||++. +..++.++||||||+++|||++|+.|+.
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~ 217 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 87653221 2233457889999999986 3457889999999999999999999974
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=268.18 Aligned_cols=199 Identities=32% Similarity=0.510 Sum_probs=171.4
Q ss_pred CCCcccccccccceeEEEEecCCCCeeEEEEeccCCc------cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSG------QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
+|++.+.||+|+||+||+|...+++.+|+|.++.... .....+.+|+.++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999987889999998864321 1234588899999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
+||+++++|.+++.. ...+++..+..++.|++.+|+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999843 346889999999999999999999887 99999999999999999999999999876532
Q ss_pred CCC----ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 501 DQT----QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 501 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
... ........|+..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 209 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA 209 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccc
Confidence 111 111223468889999999988889999999999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=266.55 Aligned_cols=199 Identities=29% Similarity=0.462 Sum_probs=174.8
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.++|++.++||+|+||.||+++.. +++.+++|.+..... .+++.+|++++++++|+||+++++.+...+..++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 357899999999999999999975 478999999875433 67899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++.. ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999853 2357899999999999999999999987 99999999999999999999999999886543221
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~ 201 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22234578899999999888999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=273.94 Aligned_cols=201 Identities=30% Similarity=0.487 Sum_probs=166.4
Q ss_pred CCCCcccccccccceeEEEEecC-CCC--eeEEEEeccC-CccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQ--EIAVKRLSRS-SGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 420 (573)
++|++.+.||+|+||.||+|+.+ ++. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46889999999999999999864 333 4688887643 233456789999999999 799999999999999999999
Q ss_pred EEccCCCChhhhccCcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCe
Q 008238 421 YEFVPNKSLDYFLYEPE-------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 487 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~v 487 (573)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985421 1235889999999999999999999987 9999999999999999999
Q ss_pred EEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 488 KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 488 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
||+|||++....... .......+..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~ 221 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999986432111 1111123557999999988899999999999999999998 9998753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=266.86 Aligned_cols=198 Identities=38% Similarity=0.560 Sum_probs=171.3
Q ss_pred cccccccceeEEEEecCC----CCeeEEEEeccCCccc-hHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVLPS----GQEIAVKRLSRSSGQG-GQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|+||.||++.... +..|++|.+....... .+.+.+|++++..++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999643 7889999987654333 67889999999999999999999999999999999999999
Q ss_pred CChhhhccCcCc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 427 KSLDYFLYEPEK------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 427 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
++|.+++..... ...+++..+..++.|+++||+|||+++ ++|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999965321 367899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
...........++..|+|||.+....++.++||||||++++||++ |+.|+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 210 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCC
Confidence 332222334567889999999988899999999999999999999 5888754
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=266.89 Aligned_cols=201 Identities=26% Similarity=0.463 Sum_probs=174.0
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|++|.||++... +++.|++|.++.. .....+.+.+|++++++++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999965 7899999988642 2233567889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 422 EFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 422 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
||+++++|..++... .....+++..++.++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988542 23456899999999999999999999987 99999999999999999999999999876533
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 207 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcc
Confidence 221 1223467889999999988889999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=286.26 Aligned_cols=192 Identities=34% Similarity=0.495 Sum_probs=166.8
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.|+.++.||.|+||.||.+.. .+.+.||||++.-+ +.+...++..|+.+|.+++|||++.+.|++......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 477789999999999999994 57889999999754 34456789999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
||-| +-.+++.- -..++.+.++..|..+.+.||.|||+++ .||||||+.|||+++.|.|||+|||.+....
T Consensus 107 YClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--- 177 (948)
T KOG0577|consen 107 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA--- 177 (948)
T ss_pred HHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC---
Confidence 9954 55555532 2357889999999999999999999988 9999999999999999999999999987543
Q ss_pred CccccccccccCCccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
..+..+||+.|||||+|. .+.|+-|+||||||+...||...++|.
T Consensus 178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 234578999999999984 468999999999999999999999884
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=270.75 Aligned_cols=198 Identities=34% Similarity=0.488 Sum_probs=165.8
Q ss_pred CCcccccccccceeEEEEec-----CCCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcC--CeeEE
Q 008238 348 FSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKIL 419 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 419 (573)
|++.+.||+|+||+||++.. .+++.||+|.++.... .....+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988652 3577899999875432 3456788999999999999999999988654 35789
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
+|||+++++|.+++.. ..+++..++.++.|+++||+|||+++ ++||||||+|||+++++.++|+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999843 45899999999999999999999987 9999999999999999999999999998654
Q ss_pred CCCCccc-cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 500 VDQTQGN-TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 500 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 3221111 1122356679999999888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=269.80 Aligned_cols=200 Identities=29% Similarity=0.530 Sum_probs=167.8
Q ss_pred CCCcccccccccceeEEEEecC-CC---CeeEEEEeccC-CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SG---QEIAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
.|++.+.||+|+||.||+|++. ++ ..|+||.+... ......+|..|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4778899999999999999964 33 35999998754 2334567999999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++++|.+++... ...+++.+++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999998542 346899999999999999999999987 999999999999999999999999998765432
Q ss_pred CCcccccccc---ccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 502 QTQGNTNRIV---GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 502 ~~~~~~~~~~---gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
.......... .+..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~ 213 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 213 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCC
Confidence 2211111111 2457999999998999999999999999999886 999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=280.12 Aligned_cols=203 Identities=29% Similarity=0.494 Sum_probs=173.4
Q ss_pred HHhCCCCcccccccccceeEEEEecCC---CC--eeEEEEecc-CCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPS---GQ--EIAVKRLSR-SSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 416 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~---~~--~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 416 (573)
...+.....++||.|.||.||+|.+.+ |+ .||||.-+. ...+..+.|..|..++++++||||++++|+|.+ ..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 344456667889999999999999633 33 478998776 345567889999999999999999999999986 57
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.|+|||.++-|.|..+|.. +...++......++.||..+|.|||+.. +|||||..+|||+....-+||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 8999999999999999965 3456888999999999999999999987 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.+..+.... .+...-+..|||||.+.-.+++.++|||-|||.+||+++ |.+||.-
T Consensus 540 ~~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 540 YLEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred hccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 876554332 234455788999999999999999999999999999976 8899863
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=269.51 Aligned_cols=197 Identities=29% Similarity=0.469 Sum_probs=173.6
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|++.+.||.|++|.||+++.. +++.|++|.+.... ......+.+|+.+++.++|+||+++++.+.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999954 68899999987543 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999999843 37899999999999999999999987 9999999999999999999999999998764332
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~ 199 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS 199 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 12233567889999999998889999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=302.47 Aligned_cols=207 Identities=27% Similarity=0.435 Sum_probs=169.6
Q ss_pred HHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEc--CCe
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEE 416 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 416 (573)
+....+|++.++||+|+||+||+++. ..++.||+|.+... .......+..|+.++..++||||+++++++.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34456899999999999999999995 45778899988643 23345678899999999999999999998865 356
Q ss_pred eEEEEEccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeecCCCCCEEeCC--------
Q 008238 417 KILVYEFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSR----LRIIHRDLKASNILLDA-------- 483 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~----~~ivH~Dlkp~NILl~~-------- 483 (573)
.+|||||+++++|.++|... .....+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999988542 223579999999999999999999998531 34999999999999964
Q ss_pred ---------CCCeEEeccCCcccccCCCCccccccccccCCccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 484 ---------EMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 484 ---------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 3358999999998653322 2234578999999999864 458899999999999999999999985
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=267.22 Aligned_cols=195 Identities=33% Similarity=0.478 Sum_probs=167.2
Q ss_pred cccccccceeEEEEecCC--CC--eeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVLPS--GQ--EIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~--~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
++||+|++|.||++.+.+ ++ .||||.+..... ...+.+.+|+.++++++||||+++++.+.+ ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998643 33 589999886655 556789999999999999999999999988 888999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc-
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG- 505 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~- 505 (573)
++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865332 56899999999999999999999987 9999999999999999999999999998764422211
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 202 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA 202 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 1123456788999999988899999999999999999999 999974
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=268.19 Aligned_cols=205 Identities=30% Similarity=0.418 Sum_probs=171.7
Q ss_pred HHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
+.+++++.....||+|+||.||+|+. .++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..+++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 34556666778999999999999995 46778999998876666677899999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC-CCCeEEeccCCccccc
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMAKIFG 499 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~~~ 499 (573)
+||+++++|.+++.........++..+..++.||++||+|||+.+ |+||||||+||+++. ++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999864322112278888999999999999999887 999999999999976 6799999999987553
Q ss_pred CCCCccccccccccCCccchhccccCC--CCccchhHHHHHHHHHHHhCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.... ......|+..|+|||.+.+.. ++.++||||||+++|||++|+.|+.
T Consensus 161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~ 212 (268)
T cd06624 161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212 (268)
T ss_pred cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence 2221 122345788999999986644 7889999999999999999999974
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=269.76 Aligned_cols=201 Identities=24% Similarity=0.447 Sum_probs=173.1
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|++|.||+++. .+++.++||.+.... .....++.+|+.+++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3688889999999999999994 578999999876432 223457889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 422 EFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 422 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
||+++++|.+++... .....+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988532 23456899999999999999999999987 99999999999999999999999999876533
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
... ......|+..|+|||.+.+..++.++|+||||+++|||++|..|+.
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 207 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcc
Confidence 221 1223468889999999988889999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=266.74 Aligned_cols=193 Identities=32% Similarity=0.527 Sum_probs=161.0
Q ss_pred ccccccceeEEEEecC---CCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCC
Q 008238 353 KLGEGGFGEVYKGVLP---SGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS 428 (573)
Q Consensus 353 ~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 428 (573)
.||+|+||.||+|++. .+..||+|.+..... ...+++.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 345699999875533 33467899999999999999999999875 457899999999999
Q ss_pred hhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc-c
Q 008238 429 LDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN-T 507 (573)
Q Consensus 429 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~-~ 507 (573)
|.+++.. ....+++..+++++.||+.||+|||+++ ++||||||+|||++.++.+||+|||+++.......... .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999854 2356899999999999999999999987 99999999999999999999999999986543322111 1
Q ss_pred ccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 508 NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 508 ~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 11223578999999988889999999999999999996 999975
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=267.73 Aligned_cols=189 Identities=28% Similarity=0.445 Sum_probs=159.1
Q ss_pred cccccccceeEEEEecCC-------------CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 352 NKLGEGGFGEVYKGVLPS-------------GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
+.||+|+||.||+|++.. ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258889887655555667889999999999999999999999999999
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC-------eEEec
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-------PKISD 491 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~-------vkl~D 491 (573)
++|||+++++|..++.. +...+++..+++++.||++||+|||+++ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988753 2356899999999999999999999987 999999999999987664 89999
Q ss_pred cCCcccccCCCCccccccccccCCccchhccc-cCCCCccchhHHHHHHHHHHH-hCCCCCC
Q 008238 492 FGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEII-TGKKNSS 551 (573)
Q Consensus 492 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwslGvll~ell-tG~~p~~ 551 (573)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+.
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK 211 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9998654211 2235778899999886 466899999999999999998 5777764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=265.02 Aligned_cols=196 Identities=32% Similarity=0.493 Sum_probs=166.7
Q ss_pred cccccccceeEEEEecCCCCeeEEEEeccCCcc-chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCChh
Q 008238 352 NKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQ-GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 430 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 430 (573)
++||+|++|.||++...+++.|++|++...... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999766999999998765433 4567899999999999999999999999999999999999999999
Q ss_pred hhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccc
Q 008238 431 YFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRI 510 (573)
Q Consensus 431 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 510 (573)
+++... ...+++..++.++.+++.+|+|||+++ ++||||||+|||++.++.++|+|||+++..............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998542 346789999999999999999999987 999999999999999999999999998755322111111122
Q ss_pred cccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 511 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 511 ~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.++..|+|||.+.++.++.++||||||+++|||++ |..|+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 33567999999988899999999999999999999 7777754
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=265.40 Aligned_cols=199 Identities=25% Similarity=0.357 Sum_probs=172.4
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccC-CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
+|++.++||+|+||.||+++.. +++.+++|.++.. .....+.+.+|+.+++.++|+||+++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999954 6889999988643 2334567888999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++++|.+++... +...+++..++.++.||+.||.|||+++ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998887532 3356889999999999999999999987 99999999999999999999999999876533221
Q ss_pred cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 201 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCC
Confidence 2233568889999999988889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=272.87 Aligned_cols=203 Identities=29% Similarity=0.521 Sum_probs=170.4
Q ss_pred hCCCCcccccccccceeEEEEecC------CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 417 (573)
.++|++.++||+|+||.||++..+ ++..||+|.+.... .....++.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457899999999999999999853 46789999987543 23356788999999999999999999999999999
Q ss_pred EEEEEccCCCChhhhccCcC-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 008238 418 ILVYEFVPNKSLDYFLYEPE-------------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 478 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~N 478 (573)
+++|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 1235788999999999999999999987 9999999999
Q ss_pred EEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCC
Q 008238 479 ILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNS 550 (573)
Q Consensus 479 ILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~ 550 (573)
||+++++.++|+|||+++................+..|+|||.+.+..++.++||||||+++|||++ |..|+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999875533222112222334667999999988999999999999999999998 77776
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=274.58 Aligned_cols=196 Identities=27% Similarity=0.446 Sum_probs=158.7
Q ss_pred ccccccccceeEEEEecC---CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEc--CCeeEEEEEccC
Q 008238 351 DNKLGEGGFGEVYKGVLP---SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILVYEFVP 425 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 425 (573)
.++||+|+||+||+++.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999854 35689999986542 23567889999999999999999998854 456789999987
Q ss_pred CCChhhhccCc------CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe----CCCCCeEEeccCCc
Q 008238 426 NKSLDYFLYEP------EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMA 495 (573)
Q Consensus 426 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl----~~~~~vkl~DfGla 495 (573)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 555555321 12346889999999999999999999987 9999999999999 56679999999999
Q ss_pred ccccCCCCc-cccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 496 KIFGVDQTQ-GNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+........ .......||..|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 866433221 122345789999999998764 579999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=269.40 Aligned_cols=198 Identities=27% Similarity=0.404 Sum_probs=169.8
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++|++.+.||+|++|.||+++.+ +++.||+|++.... ....+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888999999999999999965 68899999886442 2234567899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|..++.. ...+++..++.++.|++.+|+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999999887643 346899999999999999999999987 9999999999999999999999999998654322
Q ss_pred CccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~ 202 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 1 1223457788999999876 457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=266.65 Aligned_cols=200 Identities=30% Similarity=0.442 Sum_probs=168.9
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc-----cchHHHHHHHHHHHhcCCCccceEEEEEEcC--Cee
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG-----QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK 417 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 417 (573)
.+|+..+.||+|+||.||++.. ..++.|++|++..... ...+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688999999999999999985 4688999998864321 2235688899999999999999999988753 567
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999843 345889999999999999999999887 99999999999999999999999999876
Q ss_pred ccCCCC-ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 498 FGVDQT-QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 498 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~ 210 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA 210 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcc
Confidence 532211 111223457889999999998889999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=265.28 Aligned_cols=212 Identities=27% Similarity=0.390 Sum_probs=181.3
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
+|++.+.||+|++|.||+++.. +++.|++|++..... .....+.+|+..+.+++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 6888999999999999999965 589999999876544 44678999999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
++++|.+++.. ...+++..++.++.|++++|+|||+ .+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 82 DGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999853 2678999999999999999999999 77 99999999999999999999999999886543222
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVS 566 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~ 566 (573)
. .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+.........++.+.++
T Consensus 156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~ 216 (264)
T cd06623 156 Q--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC 216 (264)
T ss_pred c--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh
Confidence 1 224567889999999988899999999999999999999999986543223444444444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=273.25 Aligned_cols=201 Identities=24% Similarity=0.368 Sum_probs=175.6
Q ss_pred CCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCCcc--chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQ--GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.-|.+.+.||+|.|..|-+++ .-.|++||||++.+..-. ....+.+|+..|+.++|||||+|+.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 457888999999999999998 458999999999875433 34567889999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC-CCCCeEEeccCCcccccCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~vkl~DfGla~~~~~~ 501 (573)
.-++|+|.+|+.+.+. .+.+....+++.||+.++.|+|+.. +|||||||+||.+- .-|-+||+|||.+..+.+.
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999976553 5889999999999999999999876 99999999999875 5688999999999876543
Q ss_pred CCccccccccccCCccchhccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSSFYQ 554 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwslGvll~elltG~~p~~~~~ 554 (573)
. ..+..+|++.|-|||++.+..|. ++.||||||||||.|++|+.||+--.
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN 223 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN 223 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence 3 34567999999999999999885 68999999999999999999987543
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=268.84 Aligned_cols=201 Identities=29% Similarity=0.505 Sum_probs=169.4
Q ss_pred CCCCcccccccccceeEEEEecC-C---CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-S---GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.+|++.+.||+|+||.||+|+.. + +..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999853 2 3368999886543 23356789999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+++ ++||||||+|||++.++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998542 346899999999999999999999987 99999999999999999999999999986643
Q ss_pred CCCccc-cccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 501 DQTQGN-TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 501 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
...... .....++..|++||.+.+..++.++|+||||+++||+++ |+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~ 211 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 211 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcc
Confidence 322111 112233567999999998899999999999999999887 999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=264.67 Aligned_cols=200 Identities=25% Similarity=0.408 Sum_probs=173.8
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+|+..+.||+|+||.||.++. .+++.+++|++... ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478899999999999999884 56889999987644 234456788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++.... ...+++..+..++.|++++|.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999985432 356899999999999999999999887 99999999999999999999999999876543321
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence 22345688999999999888899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=274.36 Aligned_cols=196 Identities=29% Similarity=0.470 Sum_probs=170.8
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
.|.....||+|+||.||++.. .+++.||||++........+.+.+|+.+++.++|+||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 344456799999999999985 4688999999876555556778999999999999999999999999999999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+++|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+||++++++.++|+|||++....... .
T Consensus 103 ~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~ 173 (292)
T cd06658 103 GGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--P 173 (292)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--c
Confidence 999999883 245889999999999999999999987 9999999999999999999999999987543222 1
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2233568899999999988889999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=274.44 Aligned_cols=202 Identities=33% Similarity=0.566 Sum_probs=167.1
Q ss_pred hCCCCcccccccccceeEEEEecC-CCC----eeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
.++|+..+.||+|+||.||++++. +++ .||+|.+..... ....++.+|+.+++.++||||+++++++... ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 346788899999999999999853 444 468888765432 2234688999999999999999999998754 467
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+++||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 89999999999999854 2346889999999999999999999987 999999999999999999999999999866
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 43322222223445778999999988899999999999999999998 8888753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-33 Score=262.79 Aligned_cols=202 Identities=27% Similarity=0.438 Sum_probs=167.9
Q ss_pred CCCCcccccccccceeEEEEecC---C--CCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEc-CCee
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP---S--GQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEK 417 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 417 (573)
..|+...+||+|.||.||++.-. + .+.+|||+++.... .......+|+.+++.++||||+.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46889999999999999999632 2 33789999976532 234567899999999999999999999887 6788
Q ss_pred EEEEEccCCCChhhhcc--CcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC----CCeEEec
Q 008238 418 ILVYEFVPNKSLDYFLY--EPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE----MNPKISD 491 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~----~~vkl~D 491 (573)
++++||.+.. |..+++ ...+...++...+..|+.||+.|+.|||++. |+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 9999999875 444443 2234468899999999999999999999999 9999999999999766 9999999
Q ss_pred cCCcccccCCCCcc-ccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 492 FGMAKIFGVDQTQG-NTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 492 fGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
||+++.+...-... .....+-|.+|.|||.+.+. .|+.+.|||+.|||+.||+|-++-|.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 99999886544332 44566789999999999886 58999999999999999999876553
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=270.14 Aligned_cols=198 Identities=29% Similarity=0.433 Sum_probs=172.5
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|++.++||+|+||+||+++. ++++.||+|++.... ....+.+.+|+++++.++||||+++++.+...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4688889999999999999995 468899999876543 34457889999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++.. ...+++..+..++.|++.+|.|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 999999988843 346899999999999999999999742 3999999999999999999999999998654221
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~ 204 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence 12345789999999999888999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=262.95 Aligned_cols=194 Identities=32% Similarity=0.480 Sum_probs=165.6
Q ss_pred cccccccceeEEEEecCCCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCChh
Q 008238 352 NKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 430 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 430 (573)
+.||+|+||.||+|...+++.+|+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47899999999999987889999999875543 33456889999999999999999999999999999999999999999
Q ss_pred hhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccc
Q 008238 431 YFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRI 510 (573)
Q Consensus 431 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 510 (573)
+++.. ....+++..++.++.|++.+|.|||+++ ++||||||+||++++++.+||+|||++........ ......
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 154 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLK 154 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCC
Confidence 98854 2346899999999999999999999887 99999999999999999999999999875432211 111122
Q ss_pred cccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 511 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 511 ~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
.++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~ 196 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYP 196 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCC
Confidence 34567999999988899999999999999999998 888874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=274.41 Aligned_cols=195 Identities=30% Similarity=0.479 Sum_probs=170.7
Q ss_pred CCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 348 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
|+...+||+|+||.||++.. .+++.|++|.+........+.+.+|+.++..++||||+++++.+..++..++++||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44556899999999999985 46889999998765555567788999999999999999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
++|..++. ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~ 173 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PK 173 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cc
Confidence 99998873 346899999999999999999999987 9999999999999999999999999987543322 12
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 218 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 233568899999999988899999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=278.97 Aligned_cols=207 Identities=29% Similarity=0.444 Sum_probs=170.6
Q ss_pred HHHhCCCCcccccccccceeEEEEecC--------CCCeeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceEEEEE
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRLLGFC 411 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 411 (573)
+....+|++.+.||+|+||.||+++.. .+..||+|.++... ....+++.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 344456899999999999999999742 12368999887443 33456789999999999 799999999999
Q ss_pred EcCCeeEEEEEccCCCChhhhccCcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 008238 412 LEGEEKILVYEFVPNKSLDYFLYEPE-------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 478 (573)
Q Consensus 412 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~N 478 (573)
...+..+++|||+++|+|.+++.... ....+++..++.++.||++||+|||+++ ++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 99999999999999999999986421 2345889999999999999999999987 9999999999
Q ss_pred EEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 479 ILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 479 ILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999986543222112222334567999999999999999999999999999998 777764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=272.23 Aligned_cols=199 Identities=26% Similarity=0.425 Sum_probs=167.9
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|++.++||+|+||.||++... +++.||+|.++... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46889999999999999999854 67899999986443 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
++ ++|.+++.. ....+++..+..++.||++||+|||+.+ |+|+||||+|||+++++.++|+|||++........
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 578777754 2346889999999999999999999987 99999999999999999999999999875432221
Q ss_pred ccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence 12233568899999988654 578899999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=268.73 Aligned_cols=202 Identities=29% Similarity=0.554 Sum_probs=169.8
Q ss_pred hCCCCcccccccccceeEEEEecC-CCC---eeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQ---EIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
.++|+..+.||+|+||.||+|+.. +++ .+++|+++... ....+++.+|++++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346888899999999999999864 333 68999886543 3345678899999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||+++++|.+++.. +...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999854 2356899999999999999999999987 9999999999999999999999999987654
Q ss_pred CCCCcccc-ccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 500 VDQTQGNT-NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 500 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
........ .....+..|+|||.+.+..++.++||||||+++|||++ |+.|+.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~ 212 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW 212 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 32221111 11223457999999988889999999999999999998 999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=265.34 Aligned_cols=204 Identities=28% Similarity=0.456 Sum_probs=175.9
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|++.+.||+|++|+||++.. .++..+++|++.... ......+.+|++.++.++|+||+++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688999999999999999995 467889999986543 33457789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++........+++..+..++.|++.+|+|||+.+ ++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865333356899999999999999999999887 99999999999999999999999999876644322
Q ss_pred cc--ccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QG--NTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~--~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.. ......|+..|++||.+... .++.++|+||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 209 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK 209 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc
Confidence 21 22344688999999998777 789999999999999999999999753
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=272.94 Aligned_cols=202 Identities=26% Similarity=0.327 Sum_probs=173.4
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCcc---chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQ---GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|++|.||++... +++.||+|.+...... ..+.+.+|+++++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999964 5899999998754322 4456889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+.+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988532 2357899999999999999999999987 999999999999999999999999998754322
Q ss_pred CCc---------------------------cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 502 QTQ---------------------------GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 502 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 110 01123468889999999998899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=274.38 Aligned_cols=200 Identities=31% Similarity=0.498 Sum_probs=166.5
Q ss_pred CCCCcccccccccceeEEEEecC-CCC--eeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQ--EIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 420 (573)
++|++.+.||+|+||.||++.++ ++. .+++|.++... ......+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888999999999999999864 444 45777776432 33456788999999999 899999999999999999999
Q ss_pred EEccCCCChhhhccCcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCe
Q 008238 421 YEFVPNKSLDYFLYEPE-------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 487 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~v 487 (573)
|||+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1236899999999999999999999887 9999999999999999999
Q ss_pred EEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 488 KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 488 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
||+|||+++..... .......++..|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 99999998642211 11111234567999999988889999999999999999998 999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=277.76 Aligned_cols=193 Identities=24% Similarity=0.367 Sum_probs=164.0
Q ss_pred HHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
....+|++.+.||+|+||.||+++.. +++.||+|..... ....|+.++++++||||+++++++...+..++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999964 5678999975432 2356899999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
|++. ++|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 577777743 3456899999999999999999999987 999999999999999999999999998743211
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
.......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999999999999999999999999976653
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=269.46 Aligned_cols=200 Identities=32% Similarity=0.529 Sum_probs=168.3
Q ss_pred CCCCcccccccccceeEEEEec-----CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcC--Cee
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK 417 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 417 (573)
+.|++.++||+|+||.||++++ .+++.||+|.++... ......+.+|+.+++.++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578899999999999999973 357889999987543 33446789999999999999999999998775 567
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+++++|.+++... ...+++..++.++.||+.+|+|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998532 236899999999999999999999987 99999999999999999999999999986
Q ss_pred ccCCCCc-cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 498 FGVDQTQ-GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 498 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
+...... .......++..|+|||.+.+..++.++||||||+++|||++++.|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 5432221 1112345677899999998888999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=274.38 Aligned_cols=198 Identities=19% Similarity=0.272 Sum_probs=164.0
Q ss_pred cccccccc--cceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 350 TDNKLGEG--GFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 350 ~~~~LG~G--~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
+.++||+| +|++||++.. .+|+.||+|++.... ....+.+++|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 7889999985 578999999987542 233456788999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC-
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT- 503 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~- 503 (573)
++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+++.||+..........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985422 235899999999999999999999987 99999999999999999999999986543211110
Q ss_pred ----ccccccccccCCccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 ----QGNTNRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ----~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 011122356778999999876 458899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=264.74 Aligned_cols=197 Identities=34% Similarity=0.533 Sum_probs=171.8
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
.++|++.+.||+|++|.||++.. .++.|++|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 45788899999999999999987 478999999976544 5678899999999999999999999999989999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999985432 236899999999999999999999987 99999999999999999999999999986532211
Q ss_pred cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
....+..|+|||.+..+.++.++||||||+++|||++ |+.|+..
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 202 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 2234567999999988899999999999999999998 8888753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=283.50 Aligned_cols=199 Identities=34% Similarity=0.479 Sum_probs=171.7
Q ss_pred CCCcccccccccceeEEEEecC--CCC--eeEEEEeccCCcc-chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP--SGQ--EIAVKRLSRSSGQ-GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
+..+.++||+|.||.|++|.|. +|+ .||||.++..... ...+|.+|+.+|.+|+|||+++|+|+..+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 4556789999999999999985 455 4799999866544 66889999999999999999999999988 7788999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
|.++.|+|.+.|++ ..+..|....+..++.|||.||.||..+. +|||||..+|+||-....|||+||||.+.++..
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999987 56678889999999999999999999887 999999999999999999999999999987654
Q ss_pred CCccc-cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhC-CCCC
Q 008238 502 QTQGN-TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG-KKNS 550 (573)
Q Consensus 502 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG-~~p~ 550 (573)
..... .....-...|.|||.+....++.++|||+|||.+|||+|+ ..||
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW 316 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPW 316 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCC
Confidence 43221 1222336689999999999999999999999999999994 4565
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=264.85 Aligned_cols=200 Identities=34% Similarity=0.525 Sum_probs=168.9
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
.++|++.++||+|++|.||++.++++..+++|.+.... ...+.+.+|+.+++.++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35688899999999999999998777789999876433 34567889999999999999999999875 45678999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence 999999998643 2345899999999999999999999887 99999999999999999999999999976533221
Q ss_pred cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
.......++..|+|||.+.+...+.++||||||+++|||++ |+.|+.
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 205 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11122345678999999988899999999999999999999 888874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=270.11 Aligned_cols=196 Identities=29% Similarity=0.498 Sum_probs=170.3
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 466778999999999999985 457889999887443 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++++|.+++. ...+++..+..++.|+++||.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 9999999884 356899999999999999999999887 9999999999999999999999999987653221
Q ss_pred cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCc
Confidence 12223467889999999998889999999999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=265.29 Aligned_cols=202 Identities=31% Similarity=0.514 Sum_probs=171.8
Q ss_pred HHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
+..++|++.++||+|+||.||++.+.++..+++|.+.... .....+.+|+.+++.++|+||+++++.+.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4456899999999999999999997777889999886432 334678899999999999999999999887 77899999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|.+++... ....+++..+..++.|++.+|+|||+.+ ++|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999998653 2346789999999999999999999887 9999999999999999999999999987653322
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
. .......++..|+|||++....++.++|+||||+++|||++ |+.||.
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~ 205 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 205 (260)
T ss_pred c-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCC
Confidence 1 11222345678999999988889999999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=265.64 Aligned_cols=200 Identities=29% Similarity=0.476 Sum_probs=171.4
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc------cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG------QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
+|+..+.||+|++|.||++.. .+++.||+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999984 5789999999864321 134678899999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC-CeEEeccCCcccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMAKIF 498 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~ 498 (573)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++ .++|+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999853 346899999999999999999999987 99999999999998776 5999999998766
Q ss_pred cCCCCc--cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 499 GVDQTQ--GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 499 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
...... .......++..|+|||.+.+..++.++||||+|++++||++|+.|+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 433111 112234678899999999888899999999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=268.93 Aligned_cols=189 Identities=27% Similarity=0.399 Sum_probs=157.3
Q ss_pred ccccccceeEEEEecCC-------------------------CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceE
Q 008238 353 KLGEGGFGEVYKGVLPS-------------------------GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRL 407 (573)
Q Consensus 353 ~LG~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 407 (573)
+||+|+||.||+|.+.. ...|++|.+.........++.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13488998876554555678899999999999999999
Q ss_pred EEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC--
Q 008238 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-- 485 (573)
Q Consensus 408 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-- 485 (573)
++++.+....++||||+++|+|..++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998854 2346889999999999999999999887 99999999999997643
Q ss_pred -----CeEEeccCCcccccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHH-HhCCCCCCC
Q 008238 486 -----NPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEI-ITGKKNSSF 552 (573)
Q Consensus 486 -----~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~el-ltG~~p~~~ 552 (573)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.|+..
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 3899999997643211 12356788999998865 5689999999999999999 478888753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=263.84 Aligned_cols=197 Identities=33% Similarity=0.486 Sum_probs=171.2
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCC-----ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-----GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999965 78999999886533 22446788999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
+||+++++|.+++.. ...+++..+..++.||+++|+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999853 346889999999999999999999987 99999999999999999999999999876533
Q ss_pred CCCccccccccccCCccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.. ......|+..|++||.+.... ++.++|+||||+++|||++|+.||..
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~ 204 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 22 223456788999999987776 89999999999999999999999753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=265.93 Aligned_cols=199 Identities=30% Similarity=0.476 Sum_probs=169.1
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc----------cchHHHHHHHHHHHhcCCCccceEEEEEEcCC
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG----------QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 415 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 415 (573)
+|.+.+.||+|++|.||+|.. .+++.+|+|.++.... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999985 4688999998753211 01245788999999999999999999999999
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
..++||||+++++|.+++.. ...+++..+..++.||+.+|.|||+++ ++||||+|+||++++++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999854 257899999999999999999999987 999999999999999999999999998
Q ss_pred ccccCCCCccccccccccCCccchhccccCC--CCccchhHHHHHHHHHHHhCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+...............|+..|+|||.+.... ++.++|+||||+++|||++|+.|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 7653322222233456788999999987654 7899999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=278.65 Aligned_cols=199 Identities=27% Similarity=0.426 Sum_probs=176.9
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCcc--chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQ--GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
...|.+.+.||+|.|++|.+++. ..+..||||.+.+.... ..+.+.+|+++|+.++|||||+++.+......+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 34688999999999999999994 47999999999876433 3355889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||..+|.+.+++.. ...+.+..+..++.|+.++++|||+++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~- 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY- 207 (596)
T ss_pred EeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc-
Confidence 99999999999954 445666888999999999999999998 99999999999999999999999999987753
Q ss_pred CCccccccccccCCccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.......+|++.|.|||+..+..+ ++++|+||+|+++|-|+.|..||+.
T Consensus 208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 234556799999999999988876 6899999999999999999999874
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=264.58 Aligned_cols=197 Identities=22% Similarity=0.387 Sum_probs=157.7
Q ss_pred cccccccceeEEEEecCCCC---eeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCC
Q 008238 352 NKLGEGGFGEVYKGVLPSGQ---EIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 427 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 427 (573)
++||+|+||.||+++..++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999754333 45677665433 234567899999999999999999999999999999999999999
Q ss_pred ChhhhccCcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 428 SLDYFLYEPE-KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 428 sL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
+|.+++.... .....++..+..++.||++||+|||+.+ ++||||||+|||++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999986432 2345677788899999999999999887 99999999999999999999999999864322211122
Q ss_pred cccccccCCccchhcccc-------CCCCccchhHHHHHHHHHHHhC-CCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMH-------GQFSVKSDVYSFGVLVLEIITG-KKNSS 551 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwslGvll~elltG-~~p~~ 551 (573)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 210 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence 234567889999998743 2457899999999999999975 55654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=269.54 Aligned_cols=199 Identities=28% Similarity=0.492 Sum_probs=174.4
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.++|++.+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 35789999999999999999985 46788999998765555567789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999843 45789999999999999999999987 99999999999999999999999999875533221
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......++..|++||.+.+..++.++||||||+++|||++|+.||..
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~ 217 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22334688899999999888899999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=266.54 Aligned_cols=197 Identities=28% Similarity=0.491 Sum_probs=171.7
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
..|+..++||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++.+.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35778899999999999999964 68899999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++. ...+++..+..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999884 246889999999999999999999887 99999999999999999999999999976543221
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......++..|+|||.+.+..++.++|+||||+++|||++|+.|+.
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence 1223467889999999988889999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=262.19 Aligned_cols=200 Identities=27% Similarity=0.371 Sum_probs=170.5
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEc-CCeeEEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYE 422 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 422 (573)
.|++.+.||+|++|.||+++.. +++.|++|++.... ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999954 57889999986432 2344568899999999999999999998764 446789999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|.+++... ....+++.+++.++.|++.+|+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999988642 2356899999999999999999999987 9999999999999999999999999998653322
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. ......+++.|+|||.+.+..++.++||||||++++||++|+.|+..
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 204 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 1 22345678899999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=270.54 Aligned_cols=200 Identities=23% Similarity=0.317 Sum_probs=169.8
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||.||++... .++.|++|.+..... .....+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999954 578999999875432 23456789999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 346899999999999999999999987 999999999999999999999999998632111
Q ss_pred CC-------------ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 502 QT-------------QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 502 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.. ........++..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~ 217 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 00 001112457889999999988899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=263.48 Aligned_cols=193 Identities=30% Similarity=0.465 Sum_probs=157.4
Q ss_pred cccccccceeEEEEecC----CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEc-CCeeEEEEEccC
Q 008238 352 NKLGEGGFGEVYKGVLP----SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVP 425 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 425 (573)
+.||+|+||.||+|++. +...+|+|++.... ....+.+.+|+.+++.++||||+++++++.. +...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 23578999885432 3345678899999999999999999998764 556789999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc-
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ- 504 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~- 504 (573)
+++|.+++... ....++..++.++.||++||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998542 234678888999999999999999887 999999999999999999999999998754322111
Q ss_pred -cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCC
Q 008238 505 -GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN 549 (573)
Q Consensus 505 -~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p 549 (573)
.......++..|+|||.+.+..++.++||||||+++|||++|..|
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~ 201 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCC
Confidence 111223456789999999888999999999999999999996544
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=263.74 Aligned_cols=188 Identities=28% Similarity=0.495 Sum_probs=158.6
Q ss_pred cccccccceeEEEEecCCCC-----------eeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 352 NKLGEGGFGEVYKGVLPSGQ-----------EIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999975433 4778877644333 6788999999999999999999999988 778999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC-------CeEEeccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-------NPKISDFG 493 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-------~vkl~DfG 493 (573)
|||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999998642 226899999999999999999999887 99999999999999887 79999999
Q ss_pred CcccccCCCCccccccccccCCccchhccccC--CCCccchhHHHHHHHHHHHhC-CCCCCC
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITG-KKNSSF 552 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwslGvll~elltG-~~p~~~ 552 (573)
++..... .....++..|+|||++.+. .++.++||||||+++|||++| ..|+..
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~ 209 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence 9876432 1223566789999998776 789999999999999999995 666543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=268.42 Aligned_cols=208 Identities=26% Similarity=0.428 Sum_probs=172.2
Q ss_pred hhHHHHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEE---
Q 008238 338 FETIEVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCL--- 412 (573)
Q Consensus 338 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~--- 412 (573)
++.+..+.++|++.+.||+|+||.||+++. .+++.+++|.+.... ....++.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 445556778999999999999999999985 467899999876432 2346688899999999 6999999999874
Q ss_pred --cCCeeEEEEEccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEE
Q 008238 413 --EGEEKILVYEFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 489 (573)
Q Consensus 413 --~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl 489 (573)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345689999999999999887532 23456889999999999999999999987 999999999999999999999
Q ss_pred eccCCcccccCCCCccccccccccCCccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 490 SDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 490 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+|||+++...... .......|+..|+|||++.. ..++.++||||||+++|||++|+.|+.
T Consensus 166 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~ 230 (286)
T cd06638 166 VDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230 (286)
T ss_pred ccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence 9999987653221 12233468999999998753 457889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=263.01 Aligned_cols=200 Identities=29% Similarity=0.436 Sum_probs=169.2
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC-----CccchHHHHHHHHHHHhcCCCccceEEEEEEcC--Cee
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS-----SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEK 417 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 417 (573)
.+|++.+.||+|+||.||+++. .+++.|++|.+... .......+++|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688999999999999999995 46889999987532 123345788999999999999999999998764 457
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++++||+++++|.+++.. ...+++.....++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998843 345889999999999999999999987 99999999999999999999999999986
Q ss_pred ccCCCC-ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 498 FGVDQT-QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 498 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
...... ........++..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 210 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 532211 111223468889999999988889999999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=270.69 Aligned_cols=204 Identities=26% Similarity=0.428 Sum_probs=168.7
Q ss_pred CCCcccccccccceeEEEEecC---CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcC--CeeE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP---SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKI 418 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 418 (573)
+|++.++||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999964 47899999987633 34456778899999999999999999999988 7899
Q ss_pred EEEEccCCCChhhhccCc-C-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC----CCCeEEecc
Q 008238 419 LVYEFVPNKSLDYFLYEP-E-KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA----EMNPKISDF 492 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~-~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~----~~~vkl~Df 492 (573)
+||||+++ +|.+++... . ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 455555322 1 2237899999999999999999999987 999999999999999 999999999
Q ss_pred CCcccccCCCC-ccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008238 493 GMAKIFGVDQT-QGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFYQ 554 (573)
Q Consensus 493 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~~~ 554 (573)
|+++....... ........++..|+|||.+.+. .++.++||||||++++||++|+.|+....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99986543322 1222345678899999988664 57899999999999999999999986443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=265.89 Aligned_cols=199 Identities=30% Similarity=0.398 Sum_probs=174.2
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
+|++.+.||+|+||.||++... +++.|++|.+.+.. ....+.+.+|++++++++||||+++++.+.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999964 68899999987543 2345678999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|.+++.. ...+++..+..++.||+++|.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999843 257899999999999999999999987 9999999999999999999999999987653322
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 554 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~ 554 (573)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+....
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 2233467889999999988889999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=268.02 Aligned_cols=196 Identities=24% Similarity=0.443 Sum_probs=165.4
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+|++.+.||+|+||.||+++. .+|+.+++|++.... ......+.+|+.++++++||||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999996 468899999986432 22235678899999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++ +|.+++.. ....+++..++.++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 975 67666643 2346899999999999999999999987 99999999999999999999999999986543221
Q ss_pred ccccccccccCCccchhccccCC-CCccchhHHHHHHHHHHHhCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslGvll~elltG~~p~ 550 (573)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.|+
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 122345788999999987654 689999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=267.44 Aligned_cols=200 Identities=26% Similarity=0.413 Sum_probs=166.6
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
+++|.+.+.||+|+||.||+|.. .+++.|++|.+..... .....+.+|+.+++.++|+||+++.+++..++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46799999999999999999985 4688999999865432 223467889999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+. ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 996 566555533 2245788889999999999999999987 9999999999999999999999999987543221
Q ss_pred CccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||+.
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 12234568899999998764 578899999999999999999999853
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=261.78 Aligned_cols=194 Identities=31% Similarity=0.481 Sum_probs=165.8
Q ss_pred CCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEE-cCCeeEEEEEcc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL-EGEEKILVYEFV 424 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 424 (573)
++|++.+.||+|+||.||++.. .++.+++|.++.. ...+.+.+|+.++++++|+|++++++++. .++..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4688899999999999999987 4788999988643 23467889999999999999999999765 456789999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++++|.+++... ....+++..++.++.|++.+|+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999998642 2345889999999999999999999987 9999999999999999999999999987543221
Q ss_pred cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+.
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 12234568999999988889999999999999999998 888875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=262.18 Aligned_cols=199 Identities=30% Similarity=0.504 Sum_probs=170.5
Q ss_pred CCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
.+|++.+.||+|+||.||++.+.+++.+++|.+.... ....++.+|++++++++|||++++++++......+++|||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3578889999999999999998778899999886443 234678999999999999999999999999999999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+++|.+++... ...+++..+..++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 99999988542 246889999999999999999999987 999999999999999999999999998755322111
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
......++.+|+|||.+.++.++.++||||||+++|||++ |+.|+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 203 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 1112234678999999988899999999999999999998 888875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=266.59 Aligned_cols=217 Identities=27% Similarity=0.357 Sum_probs=180.9
Q ss_pred HHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc---cchHHHHHHHHHHHhc-CCCccceEEEEEEcCCee
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 417 (573)
+...+|..+..||+|+||.|.++..+ ..+.+|||++++... ...+--..|-++|... +-|.+++++.+++.-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34457889999999999999999854 467799999987632 2222234566677665 478899999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+.||+|-.+++. -..+.+..+.-++.+|+-||-+||+++ ||.||||..|||||.+|++||+|||+++.
T Consensus 426 yFVMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeEEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 999999999999888853 346788889999999999999999998 99999999999999999999999999974
Q ss_pred ccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhhcc
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSINRV 570 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~~~ 570 (573)
--. ....+.+.+||+.|+|||++...+|+..+|+|||||+||||+.|++||+ .+++++|.+-|..+.+
T Consensus 500 ni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd---GeDE~elF~aI~ehnv 567 (683)
T KOG0696|consen 500 NIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD---GEDEDELFQAIMEHNV 567 (683)
T ss_pred ccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC---CCCHHHHHHHHHHccC
Confidence 211 1234556899999999999999999999999999999999999999975 4667778887776654
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=269.59 Aligned_cols=198 Identities=31% Similarity=0.445 Sum_probs=169.4
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++|++.++||+|+||.||++..+ +++.||+|++.+... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999965 588999998865432 234568899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|..+... ...+++..++.++.||+++|+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887643 235899999999999999999999987 9999999999999999999999999987653322
Q ss_pred CccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
. ......++..|+|||++.+ ..++.++||||||+++|||++|++|+.
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 1 1223457889999999875 457889999999999999999998875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=265.57 Aligned_cols=200 Identities=27% Similarity=0.441 Sum_probs=167.4
Q ss_pred hCCCCcccccccccceeEEEEecCC----CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
.++|.+.++||+|+||.||+|.+.+ ...|+||...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568889999999999999998643 2468999886554 3445678999999999999999999998875 55789
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.++|+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998542 345899999999999999999999887 9999999999999999999999999987654
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
...... .....++..|+|||.+....++.++||||||+++|||++ |+.||.
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~ 210 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 332111 112334568999999988889999999999999999986 999974
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=244.72 Aligned_cols=222 Identities=27% Similarity=0.362 Sum_probs=176.7
Q ss_pred hhHHHHHhCCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceEEEEEEcC
Q 008238 338 FETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEG 414 (573)
Q Consensus 338 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 414 (573)
...+++..+.+.-...||+|++|.|-+-+ ..+|...|+|++.... .+..++..+|+.+..+. .+|.+|.++|.....
T Consensus 38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 33466777777888899999999998888 4689999999987543 34445667777776554 699999999999999
Q ss_pred CeeEEEEEccCCCChhhhccC-cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccC
Q 008238 415 EEKILVYEFVPNKSLDYFLYE-PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493 (573)
Q Consensus 415 ~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfG 493 (573)
...|+.||.|+ .||+.+-.+ ..+++.+++.-+-+|+..+.+||.|||++ +.+||||+||+||||+.+|++||+|||
T Consensus 118 gdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 118 GDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccc
Confidence 99999999984 567655432 24567899999999999999999999995 479999999999999999999999999
Q ss_pred CcccccCCCCccccccccccCCccchhcccc----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH----GQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
++-.+..+- ..+-..|...|||||.+.. ..|+.|+||||||+.+.||.+++.|++.|.. ..+.|+.+-.
T Consensus 195 IsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t--pF~qLkqvVe 267 (282)
T KOG0984|consen 195 ISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT--PFQQLKQVVE 267 (282)
T ss_pred cceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC--HHHHHHHHhc
Confidence 987653221 1122357788999999843 3689999999999999999999999887653 4445555443
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=260.12 Aligned_cols=194 Identities=37% Similarity=0.560 Sum_probs=162.1
Q ss_pred cccccccceeEEEEecCC----CCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVLPS----GQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
++||+|+||.||+|++.. +..+|+|.+..... ...+++.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 579999999999998532 26899999875543 34567889999999999999999999876 4567999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
++|.+++.. ...+++..++.++.|++.+|+|||+.+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999954 236899999999999999999999887 99999999999999999999999999986643322111
Q ss_pred -cccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 507 -TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 507 -~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~ 201 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc
Confidence 111223567999999988899999999999999999998 8998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=266.16 Aligned_cols=198 Identities=26% Similarity=0.458 Sum_probs=170.2
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+|++.+.||+|++|.||+++. .+++.|++|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478889999999999999995 478999999987543 33356789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+ +++|.+++... ...+++.+++.++.||+++|+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999988542 256899999999999999999999987 99999999999999999999999999886643321
Q ss_pred ccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.......|+..|+|||.+.+. .++.++||||+|++++||++|++|+.
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 202 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence 112334688999999988654 46899999999999999999977663
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=265.36 Aligned_cols=202 Identities=31% Similarity=0.467 Sum_probs=170.5
Q ss_pred CCCCcccccccccceeEEEEecC------CCCeeEEEEeccCCcc-chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSSGQ-GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
++|++.+.||+|+||.||+++.+ +.+.|++|.+...... ...++.+|+.++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999853 2457899988654443 4567999999999999999999999999989999
Q ss_pred EEEEccCCCChhhhccCcCcc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEecc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQ------QQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df 492 (573)
+||||+++++|.+++...... ..+++..+..++.|++.+|+|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998643321 26899999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
|+++...... ........++..|+|||.+.+...+.++||||||+++|||++ |..||.
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~ 220 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY 220 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 9987442221 112223356778999999988889999999999999999999 677763
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=266.94 Aligned_cols=198 Identities=26% Similarity=0.436 Sum_probs=167.2
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|++.+.||+|++|.||+++.+ +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56889999999999999999964 688999999865432 2234567899999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++ +|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 888887542 246899999999999999999999987 99999999999999999999999999875432211
Q ss_pred ccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 205 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1122346788999998865 457899999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=261.55 Aligned_cols=200 Identities=32% Similarity=0.496 Sum_probs=173.2
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCCcc--chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQ--GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+|++.++||+|+||.||++.. .+++.|++|.+...... ..+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 478889999999999999985 47889999998765443 567889999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999853 345789999999999999999999987 99999999999999999999999999886643322
Q ss_pred ccc--cccccccCCccchhccccCC---CCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGN--TNRIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
... .....++..|++||.+.+.. .+.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~ 208 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence 111 12356788999999987766 88999999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=263.42 Aligned_cols=194 Identities=31% Similarity=0.504 Sum_probs=160.8
Q ss_pred cccccccceeEEEEecC-CCC--eeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVLP-SGQ--EIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|+||.||+|+++ ++. .+++|.++... ....+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999964 343 46888886432 34456788999999999 799999999999999999999999999
Q ss_pred CChhhhccCcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccC
Q 008238 427 KSLDYFLYEPE-------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493 (573)
Q Consensus 427 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfG 493 (573)
|+|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986422 1235789999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
+++..... ........+..|+|||++....++.++||||||+++|||++ |+.||.
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~ 213 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 213 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 98632211 01111223567999999988889999999999999999997 999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=264.21 Aligned_cols=197 Identities=28% Similarity=0.506 Sum_probs=170.4
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccC-CccchHHHHHHHHHHHhcC---CCccceEEEEEEcCCeeEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS-SGQGGQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 421 (573)
.|+..+.||+|+||.||+|.. .+++.|++|.+... ......++.+|+.++++++ |||++++++++..++..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999995 57899999998654 3344567889999999997 999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++++|.+++.. ..+++..++.++.|++.+|.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998843 37899999999999999999999987 999999999999999999999999998866433
Q ss_pred CCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. .......|+..|+|||.+.++ .++.++|+||||+++|||++|+.||..
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 204 (277)
T cd06917 155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204 (277)
T ss_pred c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence 2 122334688899999988654 468999999999999999999999853
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=265.19 Aligned_cols=197 Identities=35% Similarity=0.561 Sum_probs=164.7
Q ss_pred cccccccceeEEEEecCC-------CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 352 NKLGEGGFGEVYKGVLPS-------GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+.||+|+||.||+|+..+ ++.+++|.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998642 2578999886543 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcC----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC-----CeEEeccCC
Q 008238 424 VPNKSLDYFLYEPE----KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-----NPKISDFGM 494 (573)
Q Consensus 424 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-----~vkl~DfGl 494 (573)
+++++|.+++.... ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986422 2234789999999999999999999887 99999999999999877 899999999
Q ss_pred cccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~ 215 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCc
Confidence 876533222222223345778999999999999999999999999999998 998874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=257.95 Aligned_cols=199 Identities=39% Similarity=0.591 Sum_probs=168.9
Q ss_pred CCcccccccccceeEEEEecCC-----CCeeEEEEeccCCcc-chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 348 FSTDNKLGEGGFGEVYKGVLPS-----GQEIAVKRLSRSSGQ-GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
+++.+.||+|+||.||++++.+ +..||+|++...... ..+.+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999643 378999999755433 5678899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++++|.+++..... ..+++..+..++.|++.+|+|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854221 12899999999999999999999987 999999999999999999999999999866443
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
..... ....++..|+|||.+.+..++.++||||||++++||++ |+.|+.
T Consensus 157 ~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~ 206 (258)
T smart00219 157 DYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYP 206 (258)
T ss_pred ccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 22111 12236789999999988889999999999999999998 777764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-33 Score=282.09 Aligned_cols=198 Identities=26% Similarity=0.428 Sum_probs=172.5
Q ss_pred CCCCcccccccccceeEEEEecCCCCe-eEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPSGQE-IAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~~~~-vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
+.|.|+..||.|+||.||+++.++... -|.|.+...+.+..+++.-||+||...+||+||+|++.+...+.+|+..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 346777899999999999999765444 4678887777788889999999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
.||-.+.++-+ -...+.+.++..++.|++.+|.|||++. |||||||+.|||+..+|.++|+|||.+.... ...
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR 184 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence 99999988754 4568999999999999999999999987 9999999999999999999999999975321 122
Q ss_pred cccccccccCCccchhcc-----ccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYA-----MHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~-----~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
.......||+.|||||+. ...+|..++||||||+.|.||..+.+|-
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH 235 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH 235 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc
Confidence 233457899999999987 4567999999999999999999999984
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=264.43 Aligned_cols=201 Identities=27% Similarity=0.389 Sum_probs=164.1
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc-cchHHHHHHHHH-HHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG-QGGQEFKNEVVL-VAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++|++.+.||+|+||.||+++.. +|+.||+|+++.... ....++..|+.+ ++..+||||+++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36889999999999999999964 689999999875432 233455556665 666789999999999999999999999
Q ss_pred ccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 423 FVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 423 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
|++ |+|.+++... .....+++..++.++.||+.||+|||++. +++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 6777776432 23457899999999999999999999861 3999999999999999999999999998765322
Q ss_pred CCccccccccccCCccchhcccc----CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMH----GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+..
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 1 1123467889999998865 4568899999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=260.21 Aligned_cols=199 Identities=23% Similarity=0.388 Sum_probs=171.8
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+|++.++||+|+||.||+++. .+++.|++|++... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478899999999999999985 46889999998643 233446789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++... ....+++..++.++.|++.+|.|||+++ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999888542 2345789999999999999999999987 99999999999999999999999999876533221
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......|+..|+|||.+.+...+.++|+||||++++||++|+.|+.
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCcc
Confidence 1223457889999999988899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=262.98 Aligned_cols=193 Identities=30% Similarity=0.437 Sum_probs=165.3
Q ss_pred cccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCCh
Q 008238 354 LGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 429 (573)
Q Consensus 354 LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 429 (573)
||+|+||+||++.. .+|+.|++|.+.... ......+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999985 468899999986432 22344567899999999999999999999999999999999999999
Q ss_pred hhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcccccc
Q 008238 430 DYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR 509 (573)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 509 (573)
.+++.... ...+++..++.++.|++.+|.|||+.+ ++||||+|+||++++++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 99886432 246899999999999999999999987 9999999999999999999999999987653211 1223
Q ss_pred ccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 510 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 510 ~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
..++..|++||.+.+..++.++||||||+++|||++|+.||...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 45788999999998888999999999999999999999998543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-33 Score=304.74 Aligned_cols=204 Identities=32% Similarity=0.454 Sum_probs=174.2
Q ss_pred hCCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
+-++....+||.|.||.||-+. .++|+..|+|.++... ......+.+|.+++..++|||+|+++|+-.+.++.+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3457788899999999999999 5678889999876443 334467889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
|||++|+|.+.+.. ....++.....+..|++.|+.|||+++ ||||||||.||||+.+|.+|++|||.+..+...
T Consensus 1314 EyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999843 344566667778899999999999998 999999999999999999999999999877543
Q ss_pred C--CccccccccccCCccchhccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008238 502 Q--TQGNTNRIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSSFYQ 554 (573)
Q Consensus 502 ~--~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwslGvll~elltG~~p~~~~~ 554 (573)
. .....+...||+.|||||++.+.. ...++||||+||++.||+||++||.-++
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence 2 223445678999999999997643 6789999999999999999999986443
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=265.75 Aligned_cols=199 Identities=27% Similarity=0.396 Sum_probs=171.5
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++|++.++||+|++|.||++..+ +++.|++|+++.. .....+.+.+|++++++++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999964 5789999988653 23345678999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|++++.+..++. +...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999988876653 2345899999999999999999999987 9999999999999999999999999988664433
Q ss_pred CccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
. .......++..|+|||++.+. .++.++||||||+++|||++|+.|+.
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2 122234678899999999888 78999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=262.27 Aligned_cols=196 Identities=29% Similarity=0.485 Sum_probs=170.4
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
-|+..++||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 367788999999999999985 468899999886443 233467889999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++++|.+++. ...+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999884 346899999999999999999999987 99999999999999999999999999876532211
Q ss_pred cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......++..|+|||.+.+..++.++|+||||+++|||++|+.|+.
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 202 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHS 202 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 1223467889999999988889999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=262.25 Aligned_cols=197 Identities=30% Similarity=0.427 Sum_probs=172.5
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
+|+..+.||+|++|.||++... +++.+++|.+.... ....+++.+|++++++++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5788899999999999999964 68899999987653 344567889999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
++++|.+++.... ..+++..+..++.|++++|+|||+ .+ ++|+||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999985422 578999999999999999999998 66 99999999999999999999999999875532211
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 201 (265)
T cd06605 157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP 201 (265)
T ss_pred ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 125678899999999888999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=264.79 Aligned_cols=201 Identities=34% Similarity=0.519 Sum_probs=170.2
Q ss_pred CCCCcccccccccceeEEEEecC-----CCCeeEEEEeccCCcc-chHHHHHHHHHHHhcCCCccceEEEEEEc--CCee
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-----SGQEIAVKRLSRSSGQ-GGQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEK 417 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 417 (573)
+.|++.+.||+|+||.||++++. .++.+|||.+...... ..+.+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45778899999999999999853 3678999999765443 46789999999999999999999999887 5578
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999542 235899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCCcc-ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 498 FGVDQTQG-NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 498 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
........ ......++..|++||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcc
Confidence 64222111 1112344567999999988899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=265.47 Aligned_cols=208 Identities=30% Similarity=0.423 Sum_probs=172.3
Q ss_pred hhHHHHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEcC-
Q 008238 338 FETIEVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEG- 414 (573)
Q Consensus 338 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 414 (573)
...+..+.++|++.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 344555678899999999999999999995 468899999986432 2345678899999999 799999999998754
Q ss_pred ----CeeEEEEEccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEE
Q 008238 415 ----EEKILVYEFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 489 (573)
Q Consensus 415 ----~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl 489 (573)
...++||||+++++|.+++... .....+++..+..++.|++.+|+|||+.+ ++||||||+||++++++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence 3579999999999999887532 23456899999999999999999999987 999999999999999999999
Q ss_pred eccCCcccccCCCCccccccccccCCccchhccccC-----CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 490 SDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-----QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 490 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+|||+++....... ......|+..|+|||.+... .++.++||||||+++|||++|+.|+.
T Consensus 170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~ 234 (291)
T cd06639 170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234 (291)
T ss_pred eecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence 99999876542221 12234678899999987543 36889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=265.64 Aligned_cols=197 Identities=28% Similarity=0.434 Sum_probs=167.2
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCCcc-----chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQ-----GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
+|++.+.||+|++|.||+|... +++.|+||++...... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999954 6899999998754322 334577899999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+ +++|.+++.... ..+++..++.++.||++||+|||+++ ++|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999985422 36899999999999999999999987 99999999999999999999999999986543
Q ss_pred CCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|..|+.
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~ 204 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP 204 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence 221 1222346778999998855 457899999999999999999977654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=263.25 Aligned_cols=200 Identities=30% Similarity=0.494 Sum_probs=169.7
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
+|++.++||+|++|.||+|+.. +++.||||+++.... .....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788999999999999999964 688999999875533 23456778999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++ +|.+++........+++..+..++.||+.||+|||+.+ ++||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 78777755444457899999999999999999999987 99999999999999999999999999975533211
Q ss_pred cccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......++..|++||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 203 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG 203 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 12234568899999988664 568999999999999999999999753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=260.81 Aligned_cols=201 Identities=29% Similarity=0.448 Sum_probs=164.5
Q ss_pred CCcccccccccceeEEEEecC----CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC------
Q 008238 348 FSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 415 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 415 (573)
|.+.+.||+|+||.||+|.+. .++.||||.+.... ....+++.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999853 36789999986542 334567889999999999999999999886543
Q ss_pred eeEEEEEccCCCChhhhccCc---CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEecc
Q 008238 416 EKILVYEFVPNKSLDYFLYEP---EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df 492 (573)
..++++||+++|+|.+++... .+...+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 237899999999998886432 12235789999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
|+++...............++..|++||.+....++.++||||||+++|||++ |+.|+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~ 217 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA 217 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCC
Confidence 99986543322222223345678999999988889999999999999999999 788864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=262.93 Aligned_cols=196 Identities=28% Similarity=0.464 Sum_probs=170.7
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
.|...++||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 355567999999999999985 4788999999875555556678899999999999999999999999999999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+++|.+++.. ..+++..+..++.|++.+|+|||+++ ++||||+|+||+++.++.++|+|||.+........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999999843 46899999999999999999999987 99999999999999999999999998875432221
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~ 216 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF 216 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCc
Confidence 1223468889999999988889999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=263.21 Aligned_cols=201 Identities=27% Similarity=0.379 Sum_probs=170.6
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcC--CeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 421 (573)
++|+..++||.|++|.||++.. .+++.+|+|.+..... ....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3578889999999999999996 4678899999875432 3456789999999999999999999988654 3679999
Q ss_pred EccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 422 EFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 422 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
||+++++|.+++... .....+++..+..++.||+++|.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998886432 23456889999999999999999999987 99999999999999999999999999875432
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 21 12345788999999998889999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=270.94 Aligned_cols=206 Identities=26% Similarity=0.360 Sum_probs=173.8
Q ss_pred HHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEec--cCCccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCee
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLS--RSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 417 (573)
+.+....|++.++||+||.+.||++...+.+.+|+|++. ..+.+...-|.+|+++|.+++ |.+||+|++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 344566799999999999999999998888889998764 334556678999999999997 99999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
|+||||- ..+|..+|.... ..++...+..+..||+.++.++|+++ |||.||||.|+|+-. |.+||+|||++..
T Consensus 436 YmvmE~G-d~DL~kiL~k~~--~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKK--SIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred EEEeecc-cccHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 9999964 678888886532 23332377889999999999999998 999999999999954 6899999999998
Q ss_pred ccCCCCccccccccccCCccchhccccCC-----------CCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQ-----------FSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
+..+.+......-+||..||+||.+.... .++++||||+|||||+|+.|+.||..+
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 87777666666679999999999985432 457899999999999999999998643
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=261.61 Aligned_cols=190 Identities=27% Similarity=0.398 Sum_probs=157.1
Q ss_pred ccccccceeEEEEec-CCCCeeEEEEeccCCc---cchHHHHHHHHHHH---hcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 353 KLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---QGGQEFKNEVVLVA---KLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 353 ~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
.||+|+||.||++.. .+++.+|+|.+.+... .....+.+|..++. ..+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 4688999998865321 11223444544443 3479999999999999999999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999988843 356899999999999999999999987 9999999999999999999999999987543221
Q ss_pred ccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 123468999999998864 5689999999999999999999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=258.18 Aligned_cols=199 Identities=26% Similarity=0.417 Sum_probs=171.0
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+|++.+.||+|++|.||++.. .+++.+++|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478899999999999999985 468889999986542 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC-CCeEEeccCCcccccCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~DfGla~~~~~~~ 502 (573)
+++++|.+++... ....+++..+.+++.|++++|+|||+++ ++|+||||+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998542 2346899999999999999999999987 9999999999999855 458999999998654322
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 203 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc
Confidence 22235678899999999888899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=254.92 Aligned_cols=199 Identities=35% Similarity=0.551 Sum_probs=175.9
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+|++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3778899999999999999964 688999999976655566789999999999999999999999999999999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+++|.+++.... ..+++..+..++.|++++|.|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999985422 57899999999999999999999977 99999999999999999999999999876543321
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
.....++..|++||.+.+...+.++||||||++++||++|+.|+...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23456888999999998888999999999999999999999997643
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=249.87 Aligned_cols=210 Identities=26% Similarity=0.419 Sum_probs=167.5
Q ss_pred CCcccccccccceeEEEEecC-CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEEEEcc
Q 008238 348 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
.+++..||.|..|+||+.... .|..+|||.+.+.. .+..+++...+.++.+.+ .|+||+.+|+|..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 445678999999999999954 68899999997654 344456677777766654 899999999999999999999988
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
. ..++.++.. -.+++++.-+-++...+.+||.||.++. +|+|||+||+|||+|+.|++||+|||++-++-.+.
T Consensus 174 s-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-- 246 (391)
T KOG0983|consen 174 S-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 246 (391)
T ss_pred H-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence 3 445555543 3457888888899999999999998854 79999999999999999999999999998764333
Q ss_pred cccccccccCCccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 505 GNTNRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
..++..|-+.|||||.+.- ..|..++||||||+.++||.||+.||..- +...+++.-|..
T Consensus 247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c--~tdFe~ltkvln 309 (391)
T KOG0983|consen 247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC--KTDFEVLTKVLN 309 (391)
T ss_pred -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC--CccHHHHHHHHh
Confidence 2334578899999999854 36889999999999999999999998642 233445544443
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=264.68 Aligned_cols=194 Identities=28% Similarity=0.447 Sum_probs=169.0
Q ss_pred cccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCC
Q 008238 350 TDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS 428 (573)
Q Consensus 350 ~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 428 (573)
...+||+|+||.||++.. .+++.||||++..........+.+|+.+++.++|+||+++++.+..++..+++|||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 346899999999999986 4788999999865555556678999999999999999999999999999999999999999
Q ss_pred hhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccc
Q 008238 429 LDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTN 508 (573)
Q Consensus 429 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~ 508 (573)
|.+++. ...+++..+..++.|++.+|+|||+.+ ++||||+|+||++++++.++|+|||++....... ....
T Consensus 104 L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~ 174 (292)
T cd06657 104 LTDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK 174 (292)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccc
Confidence 998873 345899999999999999999999987 9999999999999999999999999987543221 1123
Q ss_pred cccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 509 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 509 ~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
...|+..|++||.+.+..++.++|+||||+++|||++|+.|+..
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 34678899999999888899999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=260.68 Aligned_cols=200 Identities=28% Similarity=0.474 Sum_probs=168.1
Q ss_pred CCCcccccccccceeEEEEecCC--CCeeEEEEeccCC----------ccchHHHHHHHHHHHh-cCCCccceEEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLPS--GQEIAVKRLSRSS----------GQGGQEFKNEVVLVAK-LQHRNLVRLLGFCLE 413 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 413 (573)
+|++.+.||+|+||.||+++... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999654 6789999875321 1223456778888865 799999999999999
Q ss_pred CCeeEEEEEccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEecc
Q 008238 414 GEEKILVYEFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492 (573)
Q Consensus 414 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df 492 (573)
++..+++|||+++++|.+++... .....+++..++.++.|++.+|.|||+.. +++|+||+|+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999998887432 23456899999999999999999999632 4999999999999999999999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
|++....... ......|+..|++||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~ 214 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY 214 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccc
Confidence 9998654322 2334568889999999998889999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=233.56 Aligned_cols=207 Identities=26% Similarity=0.442 Sum_probs=169.8
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+|...++||+|.||+||+++. ..++.||+|+++-.. +..-....+|+.+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456678999999999999994 567889999986443 22235678999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+. .+|..+... -+..++.+.+..++.|+++||.++|+++ +.||||||.|.||+.+|++|++|||+++.++.+..
T Consensus 83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 95 455555532 4567899999999999999999999988 99999999999999999999999999998876543
Q ss_pred ccccccccccCCccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLS 563 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~ 563 (573)
.. +..+-|.+|.+|.++.+.+ |+...|+||-||++.|+..-.+|. +...+.+|.+.
T Consensus 157 cy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl--fpg~dvddqlk 213 (292)
T KOG0662|consen 157 CY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLK 213 (292)
T ss_pred ee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC--CCCCcHHHHHH
Confidence 22 2235689999999998865 789999999999999998876663 23333444444
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=262.55 Aligned_cols=188 Identities=27% Similarity=0.474 Sum_probs=158.8
Q ss_pred cccccccceeEEEEecCC--------CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 352 NKLGEGGFGEVYKGVLPS--------GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+.||+|+||.||+|.... ..++++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999998532 234888888665555567889999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC--------eEEeccCCc
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--------PKISDFGMA 495 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------vkl~DfGla 495 (573)
+++|+|..++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998642 236899999999999999999999987 999999999999987765 699999988
Q ss_pred ccccCCCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCC-CCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK-KNS 550 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~-~p~ 550 (573)
..... .....++..|+|||.+.+. .++.++||||||+++|||++|. .|+
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~ 206 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence 64422 1234578899999998764 5799999999999999999995 444
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=262.08 Aligned_cols=201 Identities=28% Similarity=0.493 Sum_probs=175.2
Q ss_pred HhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
..+.|+..+.||+|++|.||++..+ +++.+++|.+..... ..+.+.+|+++++.++|+||+++++.+...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4556888899999999999999975 688999999876544 56678899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|.+++.... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999996422 37899999999999999999999977 9999999999999999999999999986543221
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. ......++..|++||.+.+..++.++|+||||+++|||++|+.|+..
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~ 218 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR 218 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 1 22334578899999999888899999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=258.55 Aligned_cols=193 Identities=34% Similarity=0.554 Sum_probs=165.1
Q ss_pred CCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
++|++.+.||+|+||.||++.. .++.||+|.+... ...+.+.+|+.++++++||||+++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588899999999999999986 6788999998643 2346788999999999999999999998654 5799999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999986432 346899999999999999999999887 999999999999999999999999998754221
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
......+..|+|||.+.++.++.++|+||||+++|||++ |+.||.
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 199 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP 199 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 112234567999999988899999999999999999998 888874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=263.16 Aligned_cols=206 Identities=29% Similarity=0.476 Sum_probs=170.8
Q ss_pred hHHHHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEc---
Q 008238 339 ETIEVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLE--- 413 (573)
Q Consensus 339 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--- 413 (573)
..+..+.+.|++.+.||+|+||.||+++. .+++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 33445567899999999999999999995 568899999886543 3345688899999998 69999999999853
Q ss_pred ---CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEe
Q 008238 414 ---GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 490 (573)
Q Consensus 414 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~ 490 (573)
.+..+++|||+++|+|.+++... ....+++..+..++.||+++|.|||+.+ |+|+||||+||++++++.++|+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence 45679999999999999988542 2345788899999999999999999987 9999999999999999999999
Q ss_pred ccCCcccccCCCCccccccccccCCccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 491 DFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 491 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
|||++....... .......|+..|+|||.+. +..++.++||||||+++|||++|+.||.
T Consensus 164 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 164 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred eCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence 999987543221 1223456889999999875 3467889999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=283.77 Aligned_cols=201 Identities=20% Similarity=0.384 Sum_probs=157.5
Q ss_pred HhCCCCcccccccccceeEEEEecCC--CCeeEEEE--------------ec---cCCccchHHHHHHHHHHHhcCCCcc
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLPS--GQEIAVKR--------------LS---RSSGQGGQEFKNEVVLVAKLQHRNL 404 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~e~~~l~~l~h~ni 404 (573)
..++|++.++||+|+||+||++.++. +...++|. +. .........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45689999999999999999987432 22222221 11 1112234568899999999999999
Q ss_pred ceEEEEEEcCCeeEEEEEccCCCChhhhccCcC--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC
Q 008238 405 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPE--KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 482 (573)
Q Consensus 405 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~ 482 (573)
+++++++...+..++++|++.. +|..++.... .........+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 9999999999999999999864 5555553211 1122345677889999999999999987 99999999999999
Q ss_pred CCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCC
Q 008238 483 AEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN 549 (573)
Q Consensus 483 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p 549 (573)
.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999986643222 122345799999999999999999999999999999999999864
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=258.04 Aligned_cols=204 Identities=28% Similarity=0.457 Sum_probs=170.6
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEc--CCeeEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILVY 421 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 421 (573)
+|++.+.||.|+||.||++.. .+++.+++|.+.... ....+.+.+|+.++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999985 467889999886432 3334568889999999999999999998764 45678999
Q ss_pred EccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 422 EFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 422 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
||+++++|.+++... .....+++..++.++.||++||+|||..+ ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998542 22467899999999999999999999332 234999999999999999999999999998866
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+..
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 43321 12234688999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=265.79 Aligned_cols=215 Identities=31% Similarity=0.452 Sum_probs=175.9
Q ss_pred hCCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCC-------ccchHHHHHHHHHHHhcCCCccceEEEEEE-cCC
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSS-------GQGGQEFKNEVVLVAKLQHRNLVRLLGFCL-EGE 415 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~ 415 (573)
.++|-+++.||+|||+.||++. +...+.||||+-.... ....+...+|..|.+.+.||.||++++++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3568888999999999999998 4567889999754221 112244678999999999999999999886 556
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC---CCCCeEEecc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDF 492 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~vkl~Df 492 (573)
..+-|+||++|.+|+.+|. ....++++++..|+.||+.+|.||.+. +++|||-||||.||||- .-|.+||+||
T Consensus 542 sFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 7789999999999999994 456789999999999999999999987 47899999999999994 4578999999
Q ss_pred CCcccccCCCCc-----cccccccccCCccchhccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 008238 493 GMAKIFGVDQTQ-----GNTNRIVGTYGYMAPEYAMHG----QFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLS 563 (573)
Q Consensus 493 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~ 563 (573)
||++.+..+... .-+....||.+|++||.+.-+ +.+.|+||||.|||+|+.+.|++||+. ....+++|+
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh--nqsQQdILq 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH--NQSQQDILQ 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC--chhHHHHHh
Confidence 999988654432 123456799999999987433 468899999999999999999999875 334566766
Q ss_pred HH
Q 008238 564 YV 565 (573)
Q Consensus 564 ~~ 565 (573)
+-
T Consensus 696 eN 697 (775)
T KOG1151|consen 696 EN 697 (775)
T ss_pred hh
Confidence 53
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=257.44 Aligned_cols=192 Identities=27% Similarity=0.375 Sum_probs=167.4
Q ss_pred cccccceeEEEEecC-CCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCCh
Q 008238 354 LGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 429 (573)
Q Consensus 354 LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 429 (573)
||+|++|.||+++.. +++.+++|.+.+... ...+.+.+|+.+++.++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999964 588999999875432 3446789999999999999999999999999999999999999999
Q ss_pred hhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcccccc
Q 008238 430 DYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR 509 (573)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 509 (573)
.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||+++...... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999853 345899999999999999999999987 9999999999999999999999999998654322 2223
Q ss_pred ccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008238 510 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 554 (573)
Q Consensus 510 ~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~ 554 (573)
..++..|++||.+.+..++.++|+||||+++|||++|+.|+....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 467889999999988889999999999999999999999986443
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=264.95 Aligned_cols=201 Identities=27% Similarity=0.443 Sum_probs=164.7
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe------
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE------ 416 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------ 416 (573)
++|++.++||+|+||.||+++. .+++.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 4689999999999999999995 468899999886432 2223456789999999999999999999876543
Q ss_pred --eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 417 --KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 417 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
.++||||+.+ +|.+.+.. ....+++.+++.++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4999999975 67766643 2246899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCc--cccccccccCCccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 495 AKIFGVDQTQ--GNTNRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 495 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+......... .......++..|+|||.+.+.. ++.++||||||+++|||++|+.|+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9865432221 1122345788899999886654 68899999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=264.63 Aligned_cols=195 Identities=32% Similarity=0.468 Sum_probs=165.1
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.+.|++.+.||+|+||+||+++.. +++.|++|.+..... ...+++.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888999999999999999954 688999998864332 2335688999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||++ |++.+++.. ....+++..+..++.|++.+|.|||+.+ ++||||+|+||++++++.++|+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 456555532 2346899999999999999999999987 99999999999999999999999999875432
Q ss_pred CCCccccccccccCCccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
. ....++..|+|||.+. ...++.++||||||+++|||++|+.|+.
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 1 2345788999999874 4568899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=260.58 Aligned_cols=199 Identities=28% Similarity=0.394 Sum_probs=168.7
Q ss_pred CCCcccccccccceeEEEEec----CCCCeeEEEEeccCC----ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCee
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSRSS----GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 417 (573)
+|++.+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 368899999987532 22346678899999999 599999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+++++|.+++.. ...+++..+..++.|++++|.|||+.+ ++||||+|+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999853 346889999999999999999999987 99999999999999999999999999876
Q ss_pred ccCCCCccccccccccCCccchhccccC--CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
...... .......|+..|+|||.+.+. .++.++||||||+++|||++|+.|+..
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 533221 122235688899999998753 467899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=262.29 Aligned_cols=198 Identities=29% Similarity=0.483 Sum_probs=167.4
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+|++.+.||.|++|.||+++. .+++.|+||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478899999999999999985 468899999886443 22335788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+. ++|..++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 5788877543 2356899999999999999999999887 99999999999999999999999999876543221
Q ss_pred ccccccccccCCccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||.
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 202 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 202 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 122235678899999887654 5889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=258.47 Aligned_cols=191 Identities=28% Similarity=0.411 Sum_probs=157.9
Q ss_pred ccccccceeEEEEec-CCCCeeEEEEeccCCc---cchHHHHHHHH---HHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 353 KLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---QGGQEFKNEVV---LVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 353 ~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
.||+|+||.||++.. .+++.||+|.+.+... .....+.+|.. +++...||||+++++.+...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4688999999865422 11222344443 3444579999999999999999999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++..+...
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---- 150 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence 9999988843 356999999999999999999999987 999999999999999999999999998754322
Q ss_pred ccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
......|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 12234689999999998754 6899999999999999999999998543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=262.75 Aligned_cols=199 Identities=28% Similarity=0.415 Sum_probs=167.5
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcC--CeeEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILV 420 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 420 (573)
++|++.+.||+|++|.||+|+.+ +++.+++|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999965 588899999864432 2234567899999999999999999998877 789999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++ +|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.++|+|||+++....
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 888887542 236899999999999999999999987 99999999999999999999999999986643
Q ss_pred CCCccccccccccCCccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.. .......++..|+|||.+.+.. ++.++|+||||+++|||++|+.||..
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 32 1122345788999999886654 68999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=261.99 Aligned_cols=200 Identities=25% Similarity=0.391 Sum_probs=165.1
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc--cchHHHHHHHHHHHhcC-CCccceEEEEEEcCCe-----
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEE----- 416 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 416 (573)
++|++.+.||+|+||.||++.. .+++.||+|++..... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688999999999999999995 4688999998765432 23457888999999995 6999999999887665
Q ss_pred eEEEEEccCCCChhhhccCcCc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC-CCCeEEeccC
Q 008238 417 KILVYEFVPNKSLDYFLYEPEK--QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFG 493 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfG 493 (573)
.++||||+++ +|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78777654221 356899999999999999999999987 999999999999998 8899999999
Q ss_pred CcccccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+++.+..... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 9876533221 1122356788999998865 457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=275.94 Aligned_cols=195 Identities=30% Similarity=0.480 Sum_probs=164.9
Q ss_pred CCcccccccccceeEEEEecC-CCCeeE---EEEecc-CCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe--eEEE
Q 008238 348 FSTDNKLGEGGFGEVYKGVLP-SGQEIA---VKRLSR-SSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE--KILV 420 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~-~~~~va---vK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv 420 (573)
.+....||+|+|-+||||.+. +|.+|| ||.-+. ..+...++|.+|+.+|+.|+||||++++....+... .-+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 456678999999999999863 566675 332211 234455889999999999999999999998887655 6799
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC-CCCCeEEeccCCccccc
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMAKIFG 499 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~vkl~DfGla~~~~ 499 (573)
.|.+..|+|..|+. +.+.++.+.+..|++||++||.|||++. |+|||||||=.||+|+ ..|.|||+|+|||....
T Consensus 122 TEL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 122 TELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999985 4556889999999999999999999986 7899999999999997 56899999999998753
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
. ......+||+.|||||... ..|....||||||+.++||+|+..||.
T Consensus 198 ~----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 198 K----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred c----cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 2 2233478999999999775 889999999999999999999999974
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=268.55 Aligned_cols=199 Identities=27% Similarity=0.471 Sum_probs=165.6
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC-----ee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~ 417 (573)
.++|++.++||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46799999999999999999984 578999999986432 334466888999999999999999999876543 57
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++++||+++ +|...+ ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999975 676666 3356899999999999999999999987 99999999999999999999999999876
Q ss_pred ccCCCCc-cccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 498 FGVDQTQ-GNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 498 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
....... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~ 211 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 5332211 11233568899999998755 468999999999999999999999984
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=259.23 Aligned_cols=202 Identities=31% Similarity=0.491 Sum_probs=170.2
Q ss_pred HhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEcCC------
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGE------ 415 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------ 415 (573)
+.++|++.+.||+|++|.||++... +++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4578999999999999999999964 678899999875443 346789999999999 6999999999997644
Q ss_pred eeEEEEEccCCCChhhhccCcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 416 EKILVYEFVPNKSLDYFLYEPE-KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
..++||||+++++|.+++.... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4799999999999999885422 2457899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+....... .......|+..|+|||.+.. ..++.++||||||+++|||++|+.|+.
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 219 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc
Confidence 87543221 22233468889999998743 346789999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=253.87 Aligned_cols=201 Identities=32% Similarity=0.483 Sum_probs=175.1
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcC--CeeEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILVY 421 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 421 (573)
+|+..+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|+.++++++|+||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999965 688999999875542 4467789999999999999999999999988 8899999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++++|.+++.. ...+++..+..++.|++++|+|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999854 237899999999999999999999977 999999999999999999999999998876543
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
..........++..|++||.+.+...+.++||||||++++||++|+.|+...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3211233456788999999998888999999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=259.66 Aligned_cols=197 Identities=30% Similarity=0.485 Sum_probs=166.4
Q ss_pred CCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 348 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
|++.++||.|++|.||++.. .+|+.|++|++.... ......+.+|++++++++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999985 478999999986543 223456889999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
+ ++|.+++.... ...+++..++.++.|++++|+|||+++ ++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 68888875422 246899999999999999999999987 99999999999999999999999999976533221
Q ss_pred cccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......++..|+|||++.+. .++.++||||||+++|||++|+.||.
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 11223568899999988664 56899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=254.35 Aligned_cols=192 Identities=25% Similarity=0.358 Sum_probs=160.5
Q ss_pred HhCCCCccccc--ccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEE
Q 008238 344 ATNNFSTDNKL--GEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 344 ~~~~~~~~~~L--G~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 419 (573)
..++|++.+.+ |+|+||.||+++. .+++.+++|.+....... .|+.....+ +||||+++++.+...+..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34567777776 9999999999995 467889999986532211 122222222 69999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC-CeEEeccCCcccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMAKIF 498 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~ 498 (573)
||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999853 237899999999999999999999987 99999999999999988 9999999998755
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
... ....++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 161 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 208 (267)
T PHA03390 161 GTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208 (267)
T ss_pred CCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 322 123578899999999988999999999999999999999999863
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=267.77 Aligned_cols=197 Identities=29% Similarity=0.405 Sum_probs=166.6
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcC------
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 414 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 414 (573)
..++|++.+.||+|+||.||++.. .+++.||+|.+.+. ......++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 456899999999999999999995 47899999998643 233345677899999999999999999988643
Q ss_pred CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 415 EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 415 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
...++||||+.+ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 346899999964 77776632 2889999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
++...... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 98654321 12234678899999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=257.59 Aligned_cols=192 Identities=29% Similarity=0.430 Sum_probs=166.5
Q ss_pred cccccceeEEEEecC-CCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCCh
Q 008238 354 LGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 429 (573)
Q Consensus 354 LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 429 (573)
||+|+||.||+++.. +++.+++|.+..... ...+.+.+|+.++++++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999975 589999999875433 3456788999999999999999999999999999999999999999
Q ss_pred hhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC------
Q 008238 430 DYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT------ 503 (573)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~------ 503 (573)
.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999853 237899999999999999999999987 99999999999999999999999999875433211
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
........++..|++||...+...+.++||||||+++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 202 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 112234567889999999988889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=261.57 Aligned_cols=204 Identities=18% Similarity=0.215 Sum_probs=153.3
Q ss_pred HHhCCCCcccccccccceeEEEEecCC----CCeeEEEEeccCCccchH-----------HHHHHHHHHHhcCCCccceE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSRSSGQGGQ-----------EFKNEVVLVAKLQHRNLVRL 407 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~-----------~~~~e~~~l~~l~h~niv~l 407 (573)
+..++|++.++||+|+||.||+|+..+ +..+++|+.......... ....+...+..++|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 445689999999999999999999644 345666654322221111 11223344556789999999
Q ss_pred EEEEEcCC----eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC
Q 008238 408 LGFCLEGE----EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 483 (573)
Q Consensus 408 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~ 483 (573)
++++.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 99766543 33677777643 45444422 234578889999999999999999987 999999999999999
Q ss_pred CCCeEEeccCCcccccCCCCc-----cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 484 EMNPKISDFGMAKIFGVDQTQ-----GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 484 ~~~vkl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
++.++|+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999866432211 1122346999999999999999999999999999999999999998654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=266.58 Aligned_cols=210 Identities=28% Similarity=0.447 Sum_probs=177.0
Q ss_pred ccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCC
Q 008238 351 DNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 427 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 427 (573)
.+.||.|.||+||-|+. ++|+.||||++.+- .......+++|+.||.++.||.||.+--.|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 57899999999999994 68999999998754 2344567899999999999999999999999999999999999777
Q ss_pred ChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC---CCeEEeccCCcccccCCCCc
Q 008238 428 SLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~---~~vkl~DfGla~~~~~~~~~ 504 (573)
-|+-+|.. ....+++..-..++.||+.+|.|||.++ |+|.||||+|||+.+. -++||+|||.++.++...
T Consensus 649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 77766643 3356888888889999999999999998 9999999999999644 369999999999876432
Q ss_pred cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhhcc
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSINRV 570 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~~~ 570 (573)
.....+||+.|.|||++.++.|...-|+||.|||+|--++|.-|| .++++..|.++.+--+++
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPF--NEdEdIndQIQNAaFMyP 784 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPF--NEDEDINDQIQNAAFMYP 784 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccC--CCccchhHHhhccccccC
Confidence 334579999999999999999999999999999999999999886 445566666655444433
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=262.34 Aligned_cols=199 Identities=30% Similarity=0.460 Sum_probs=165.3
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcC--CeeEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKIL 419 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 419 (573)
.++|++.+.||+|+||.||+++. .+|+.||+|+++.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 35789999999999999999996 4689999999864332 2233567899999999999999999998765 46799
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||+++ +|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 777777432 256899999999999999999999987 9999999999999999999999999998664
Q ss_pred CCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 3221 1122345778999999865 457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=268.31 Aligned_cols=204 Identities=25% Similarity=0.349 Sum_probs=172.3
Q ss_pred CCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCCccc---hHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQG---GQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
.-|..++.||-|+||+|.++. .+....+|+|.+++.+.-. ....+.|-.||..-..+-||+|+..|++.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 458888999999999999998 4456678999998764322 345678999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc--
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG-- 499 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~-- 499 (573)
||++||++-.+|. +...|++..+..++.++..++++.|..+ +|||||||.|||||.+|++||+||||+.-+.
T Consensus 709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999988884 4567889999999999999999999876 9999999999999999999999999986331
Q ss_pred CC------CCcc--------------------------------ccccccccCCccchhccccCCCCccchhHHHHHHHH
Q 008238 500 VD------QTQG--------------------------------NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVL 541 (573)
Q Consensus 500 ~~------~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ 541 (573)
.+ ..+. .....+||..|+|||++....++..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00 0000 011357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCC
Q 008238 542 EIITGKKNSSFYQT 555 (573)
Q Consensus 542 elltG~~p~~~~~~ 555 (573)
||+.|+.||--..+
T Consensus 863 em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTP 876 (1034)
T ss_pred HHhhCCCCccCCCC
Confidence 99999999854433
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=258.71 Aligned_cols=200 Identities=28% Similarity=0.432 Sum_probs=165.0
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++|++.++||+|++|+||+|+.. +++.|++|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46889999999999999999964 688999999865432 234568899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC-CCCeEEeccCCcccccCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~~~~~ 501 (573)
|+++ +|.+++... ....+++..+..++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9964 676666432 2234688889999999999999999987 999999999999985 567999999999765432
Q ss_pred CCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.. ......++..|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11 11234568899999988664 578999999999999999999999853
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=258.40 Aligned_cols=198 Identities=27% Similarity=0.454 Sum_probs=167.5
Q ss_pred CCcccccccccceeEEEEecC-CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcC--CeeEEEEE
Q 008238 348 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILVYE 422 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 422 (573)
|++.++||+|++|.||+++.. +++.+++|++.... ......+.+|+.+++.++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999964 58899999997653 33446788999999999999999999999988 78999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++ +|..++... ...+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 787777442 247899999999999999999999987 9999999999999999999999999998664432
Q ss_pred CccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|++-
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~ 204 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 21 1223456788999998765 4578999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=266.33 Aligned_cols=200 Identities=27% Similarity=0.461 Sum_probs=166.7
Q ss_pred HhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccC--CccchHHHHHHHHHHHhc-CCCccceEEEEEEcC--Cee
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEG--EEK 417 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~ 417 (573)
..++|++.+.||+|+||.||+|... +++.+++|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467889999999999999999964 6889999988542 233345677899999999 999999999988653 367
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 588888743 37889999999999999999999987 99999999999999999999999999986
Q ss_pred ccCCCCc---cccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 498 FGVDQTQ---GNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 498 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
....... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~ 214 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 5433221 12234568899999998765 457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=254.47 Aligned_cols=188 Identities=25% Similarity=0.345 Sum_probs=159.1
Q ss_pred cccccccceeEEEEec-CCCCeeEEEEeccCCcc---chHHHHHHHHH-HHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQ---GGQEFKNEVVL-VAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.||+|++|.||++.. .+++.||+|.+.+.... ....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999985 46889999998654321 12234445444 4455899999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999999853 346899999999999999999999987 99999999999999999999999999875432
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.....++..|++||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 194 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCC
Confidence 223457889999999988888999999999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=251.15 Aligned_cols=197 Identities=30% Similarity=0.475 Sum_probs=173.0
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+|++.++||+|++|.||+++.. +++.|++|.+..... .....+.+|++++.+++|+|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999854 678999999876543 4556789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++.. ...+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999999853 257899999999999999999999887 99999999999999999999999999986643322
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
. .....++..|+|||...+...+.++|||++|+++|||++|+.|+.
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~ 200 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYY 200 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 1 223467889999999988888999999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=260.14 Aligned_cols=203 Identities=26% Similarity=0.423 Sum_probs=167.2
Q ss_pred HHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC----
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE---- 415 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 415 (573)
...++|++.+.||+|+||.||+|..+ +++.|++|+++... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45568999999999999999999964 68899999986543 233456788999999999999999999987655
Q ss_pred ------eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEE
Q 008238 416 ------EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 489 (573)
Q Consensus 416 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl 489 (573)
..++|+||+++ ++...+.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 56565533 2346899999999999999999999987 999999999999999999999
Q ss_pred eccCCcccccCCCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 490 SDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 490 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+|||++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+..
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999865433211 11223457789999988653 578999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=254.40 Aligned_cols=199 Identities=25% Similarity=0.419 Sum_probs=170.3
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+|++.+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999964 68889999986532 23445788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC-CeEEeccCCcccccCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~~~~~ 502 (573)
+++++|.+++... ....+++..+..++.|++++|.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988542 2345799999999999999999999987 99999999999999886 46999999987654322
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
. ......|+..|+|||.+.+..++.++|+||||+++|||++|+.|+.
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 203 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1 1223458889999999988889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=251.21 Aligned_cols=202 Identities=25% Similarity=0.400 Sum_probs=175.6
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+|++.+.||+|++|.||++... +++.+++|++..... ....++.+|+++++.++|+|++++++.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999964 688999999875433 4556788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 424 VPNKSLDYFLYEPE-KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 424 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886421 2467899999999999999999999987 9999999999999999999999999987654332
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
.......|++.|+|||.+.+..++.++|+||+|+++++|++|+.|+...
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 1223346888999999998888999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=247.42 Aligned_cols=220 Identities=24% Similarity=0.348 Sum_probs=182.7
Q ss_pred HHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCee
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 417 (573)
...++|.+.+.||+|+|.+|..+++ +..+.+|+|++++. ..+...-.+.|-.+.... +||.+|-++.+++....+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 4456899999999999999999996 46778999998764 334445566677666665 799999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++|.||.++|+|-.+++ +++.++++.+..+..+|.-+|.|||+++ ||.||||..|||+|.+|++||+|+|+++.
T Consensus 327 ffvieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999977774 4567999999999999999999999988 99999999999999999999999999984
Q ss_pred ccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC-----CCCCcccHHHHHHhhcc
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY-----QTDGAADLLSYVSINRV 570 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~-----~~~~~~~ll~~~~~~~~ 570 (573)
-- .....+++.+||+.|+|||++.+..|....|+|+|||+++||+.|+.||+.- +.+.++.|.+.|...++
T Consensus 401 ~l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi 476 (593)
T KOG0695|consen 401 GL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI 476 (593)
T ss_pred CC--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence 22 1223456789999999999999999999999999999999999999999753 22334445555544443
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=260.28 Aligned_cols=193 Identities=33% Similarity=0.487 Sum_probs=164.0
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.|+..+.||+|+||.||+++. .+++.|++|++..... .....+.+|++++++++|||++++++++.+.+..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 377788999999999999995 4688999999864422 233568889999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++ +|.+.+.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9975 66666543 2356899999999999999999999987 99999999999999999999999999865322
Q ss_pred CccccccccccCCccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.....|+..|+|||.+. .+.++.++||||||+++|||++|+.|+.
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 225 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 22346788999999874 4568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=258.62 Aligned_cols=201 Identities=29% Similarity=0.447 Sum_probs=174.0
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 420 (573)
++|.+.+.||+|++|.||+++.. +++.|++|.+.+.. ....+.+.+|.+++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888999999999999999964 78999999986532 233467888999999998 99999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999853 347999999999999999999999987 99999999999999999999999999886543
Q ss_pred CCCc------------------cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQ------------------GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.... .......++..|++||...+...+.++||||||++++|+++|+.|+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 3221 222345678899999999888899999999999999999999999763
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=255.48 Aligned_cols=195 Identities=24% Similarity=0.361 Sum_probs=161.0
Q ss_pred CCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcC-CCccceEEEEEEcC--CeeEEEEE
Q 008238 348 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEG--EEKILVYE 422 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 422 (573)
|++.++||+|+||.||+++. .+++.||+|+++... ........+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999995 468899999987542 222234457888888885 99999999999987 88999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9974 67676643 2346899999999999999999999987 999999999999999 999999999998654322
Q ss_pred CccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. .....++..|+|||.+.. +.++.++||||||+++|||++|+.||..
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~ 201 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG 201 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence 1 123457889999997644 5578999999999999999999999853
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=264.21 Aligned_cols=200 Identities=29% Similarity=0.436 Sum_probs=167.3
Q ss_pred hHHHHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcC-
Q 008238 339 ETIEVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG- 414 (573)
Q Consensus 339 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~- 414 (573)
..+....++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 34556678999999999999999999984 578899999987542 22345678899999999999999999987643
Q ss_pred -----CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEE
Q 008238 415 -----EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 489 (573)
Q Consensus 415 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl 489 (573)
...+++++++ +++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 2357788776 788888773 245899999999999999999999987 999999999999999999999
Q ss_pred eccCCcccccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 490 SDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 490 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+|||+++.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999875422 1223467889999998866 568899999999999999999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=258.76 Aligned_cols=200 Identities=30% Similarity=0.417 Sum_probs=163.6
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+|+..++||+|+||.||+++. .+++.+|+|++.... ......+.+|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 456678999999999999995 468899999987543 234567889999999996 99999999999998999999999
Q ss_pred cCCCChhhhccC--cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 424 VPNKSLDYFLYE--PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 424 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
+.. ++.++... ......+++..+..++.|++.||+|||+.. +++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 44433211 112357899999999999999999999742 3999999999999999999999999998765322
Q ss_pred CCccccccccccCCccchhccccC---CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHG---QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. ......|+..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 2 11233578899999998776 689999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=264.80 Aligned_cols=200 Identities=23% Similarity=0.408 Sum_probs=167.1
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEc----CCee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 417 (573)
.++|++.+.||+|++|.||++.. .+++.|++|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36799999999999999999995 468999999987542 2344667889999999999999999988753 3467
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+. ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 588888743 345899999999999999999999987 99999999999999999999999999876
Q ss_pred ccCCCCc--cccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 498 FGVDQTQ--GNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 498 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
....... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 213 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP 213 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccC
Confidence 5332211 11224578899999998865 458899999999999999999999984
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=263.30 Aligned_cols=197 Identities=26% Similarity=0.433 Sum_probs=166.7
Q ss_pred HHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC---
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE--- 415 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 415 (573)
....++|++.+.||+|+||.||++.. .+++.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 33567899999999999999999984 578999999986432 223456889999999999999999999987654
Q ss_pred ---eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEecc
Q 008238 416 ---EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492 (573)
Q Consensus 416 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df 492 (573)
..++||||+ +++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 358999998 778888773 346899999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
|++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 998754321 123456889999999876 458899999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=252.60 Aligned_cols=199 Identities=32% Similarity=0.469 Sum_probs=172.4
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+|++.++||+|++|.||+++. .+++.+++|.+.... .....++.+|+++++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999984 477899999987543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 424 VPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 424 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988542 12356899999999999999999999987 999999999999999999999999999866433
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......++..|++||.+.+..++.++|+||||+++|||++|+.|+..
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~ 203 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12224578899999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=252.54 Aligned_cols=202 Identities=29% Similarity=0.411 Sum_probs=162.8
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc-cchHHHHHHHHHHHh-cCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAK-LQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+.+....||.|.||+|+|-.. +.|+..|||+++.... ...+++..|.+...+ -+.||||+++|.+..+...|+.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 445567899999999999985 5799999999976544 445667777776544 4699999999999999999999999
Q ss_pred cCCCChhhhccC--cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 424 VPNKSLDYFLYE--PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 424 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
|+ .||+.+-.. ..+...+++.-+-.|..-..+||.||.+. ++|||||+||+||||+..|.+||+|||++-.+..+
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 84 455544321 13456788888888998999999999874 46999999999999999999999999998765322
Q ss_pred CCccccccccccCCccchhccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSSFYQ 554 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwslGvll~elltG~~p~~~~~ 554 (573)
...+.-.|-..|||||.+... .|..+|||||||+.|+|+.||+-|+..|.
T Consensus 222 ---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~ 273 (361)
T KOG1006|consen 222 ---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD 273 (361)
T ss_pred ---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence 223345788899999999543 48899999999999999999999987654
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=255.77 Aligned_cols=199 Identities=29% Similarity=0.406 Sum_probs=168.0
Q ss_pred CCCcccccccccceeEEEEec----CCCCeeEEEEeccCC----ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCee
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSRSS----GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 417 (573)
+|++.+.||+|++|.||+++. .+++.||||.+++.. ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 377889999999999999874 356789999986432 22345678899999999 599999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+++++|.+++.. ...+++..+..++.|++++|+|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998843 346889999999999999999999877 99999999999999999999999999876
Q ss_pred ccCCCCccccccccccCCccchhccccCC--CCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+..... .......|+..|++||.+.+.. .+.++||||||+++|||++|+.|+..
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 543221 1122346888999999987665 78899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=262.53 Aligned_cols=199 Identities=25% Similarity=0.421 Sum_probs=166.2
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCC-----e
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----E 416 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~ 416 (573)
.++|.+.+.||+|+||+||+++. .+++.||||.+... .......+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35789999999999999999995 46899999998653 2233456778999999999999999999876542 4
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++++||+. ++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 678777743 356899999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 653321 12233457889999998865 4689999999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=252.85 Aligned_cols=197 Identities=29% Similarity=0.481 Sum_probs=164.0
Q ss_pred CCcccccccccceeEEEEecC-CCCeeEEEEeccCCc--cchHHHHHHHHHHHhc---CCCccceEEEEEEcCCe-----
Q 008238 348 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKL---QHRNLVRLLGFCLEGEE----- 416 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 416 (573)
|++.+.||+|+||.||+++.+ +++.||+|++..... .....+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999975 489999999874322 2234566788777666 59999999999988776
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.+++|||+.+ +|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 7887775422 236899999999999999999999987 9999999999999999999999999987
Q ss_pred cccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~ 208 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence 6543321 1233578899999999999999999999999999999999988753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=257.78 Aligned_cols=199 Identities=20% Similarity=0.230 Sum_probs=163.2
Q ss_pred CcccccccccceeEEEEecCCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 349 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 349 ~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
.+.+.+|.|+++.|+++.. +++.||||++... .....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445556666666666655 7899999998754 344556799999999999999999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC---
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT--- 503 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~--- 503 (573)
++|.+++.... ...+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999986432 245889999999999999999999987 99999999999999999999999998875432111
Q ss_pred --ccccccccccCCccchhccccC--CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 --QGNTNRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 --~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
........++..|+|||.+... .++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 1112234567789999998663 578999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=255.81 Aligned_cols=200 Identities=29% Similarity=0.465 Sum_probs=163.9
Q ss_pred hCCCCcccccccccceeEEEEecCC-CCeeEEEEeccCCc-cchHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 421 (573)
.++|++.+.||+|++|.||++++++ ++.||||.++.... ....++.+|+.++.+.. ||||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3568889999999999999999754 88999999875432 33455667777776665 999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+. +++.+++.. ....+++..+..++.||++||+|||+.. +|+||||+|+||++++++.+||+|||++..+...
T Consensus 94 e~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 466666533 2347899999999999999999999742 3999999999999999999999999998765322
Q ss_pred CCccccccccccCCccchhccccCC----CCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQ----FSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 21 12335788999999986554 78899999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=280.40 Aligned_cols=224 Identities=29% Similarity=0.432 Sum_probs=181.7
Q ss_pred HHHHHhCCCCcccccccccceeEEEEecC----C----CCeeEEEEeccCCc-cchHHHHHHHHHHHhc-CCCccceEEE
Q 008238 340 TIEVATNNFSTDNKLGEGGFGEVYKGVLP----S----GQEIAVKRLSRSSG-QGGQEFKNEVVLVAKL-QHRNLVRLLG 409 (573)
Q Consensus 340 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~ 409 (573)
.++...++..+.+.||+|.||.|++|... . ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56677777788889999999999999842 1 34689999976543 4557799999999998 5999999999
Q ss_pred EEEcCCeeEEEEEccCCCChhhhccCcC-----------cc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCC
Q 008238 410 FCLEGEEKILVYEFVPNKSLDYFLYEPE-----------KQ--QQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKA 476 (573)
Q Consensus 410 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp 476 (573)
+|......++|+||++.|+|..+|+..+ .. ..++..+.+.++.||+.||+||++.. ++||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999997644 00 24899999999999999999999886 99999999
Q ss_pred CCEEeCCCCCeEEeccCCcccccCCCCcc-ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 008238 477 SNILLDAEMNPKISDFGMAKIFGVDQTQG-NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQ 554 (573)
Q Consensus 477 ~NILl~~~~~vkl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~ 554 (573)
+|||+.++..+||+|||+++......... ......-+..|||||.+....|+.|+|||||||+||||+| |..|+.-
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-- 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-- 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC--
Confidence 99999999999999999998654333221 1111013567999999999999999999999999999999 5566532
Q ss_pred CCCcccHHHHHHhh
Q 008238 555 TDGAADLLSYVSIN 568 (573)
Q Consensus 555 ~~~~~~ll~~~~~~ 568 (573)
.....++++++...
T Consensus 525 ~~~~~~l~~~l~~G 538 (609)
T KOG0200|consen 525 IPPTEELLEFLKEG 538 (609)
T ss_pred CCcHHHHHHHHhcC
Confidence 23356667766654
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=258.96 Aligned_cols=200 Identities=27% Similarity=0.393 Sum_probs=164.2
Q ss_pred CCCC-cccccccccceeEEEEec-CCCCeeEEEEeccCCccc--------------hHHHHHHHHHHHhcCCCccceEEE
Q 008238 346 NNFS-TDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQG--------------GQEFKNEVVLVAKLQHRNLVRLLG 409 (573)
Q Consensus 346 ~~~~-~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~ 409 (573)
++|. +.+.||+|+||+||++.. .+++.||||+++...... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 457799999999999995 468999999986542221 125778999999999999999999
Q ss_pred EEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEE
Q 008238 410 FCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 489 (573)
Q Consensus 410 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl 489 (573)
++...+..++||||++ ++|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 588888743 346899999999999999999999987 999999999999999999999
Q ss_pred eccCCcccccCCCC------------ccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 490 SDFGMAKIFGVDQT------------QGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 490 ~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+|||+++....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999976541110 0111223467889999998764 468999999999999999999999764
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=258.63 Aligned_cols=202 Identities=29% Similarity=0.434 Sum_probs=164.0
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcCC------
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 415 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 415 (573)
.++|++.++||+|++|.||+++. .+++.+++|++..... .....+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46799999999999999999995 4688999998864332 22346788999999999999999999875543
Q ss_pred --eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccC
Q 008238 416 --EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493 (573)
Q Consensus 416 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfG 493 (573)
..++|+||+.+ +|...+.. ....+++..+..++.|++++|+|||+++ |+|+||||+|||+++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 45899999975 45555533 2346899999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCCcc---------ccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 494 MAKIFGVDQTQG---------NTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 494 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 997654322111 11234568889999987654 578999999999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=258.93 Aligned_cols=197 Identities=29% Similarity=0.448 Sum_probs=166.6
Q ss_pred HHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEc-CCeeE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKI 418 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~ 418 (573)
..+++|++.+.||+|+||.||++.. .+++.||||++.+. .....+.+.+|+++++.++||||+++.+++.. .+..+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 3567899999999999999999984 47899999988643 22345678899999999999999999998876 55788
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+++||+ +++|..++. ...+++..+..++.|+++||+|||+.+ |+||||+|+|||+++++.++|+|||++...
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 568888773 346788889999999999999999987 999999999999999999999999998754
Q ss_pred cCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 159 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 159 DP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred CC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 22 1123456888999998766 5689999999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=254.74 Aligned_cols=192 Identities=33% Similarity=0.486 Sum_probs=162.7
Q ss_pred CCcccccccccceeEEEEec-CCCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 348 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
|...++||+|+||+||+|+. .+++.|++|++..... .....+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999985 4688999999864332 2335678899999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+. +++.+++.. ....+++..+..++.||+.+|.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 96 466666643 2356899999999999999999999987 9999999999999999999999999986422
Q ss_pred ccccccccccCCccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......|+..|+|||.+. ...++.++||||||+++|||++|+.|+.
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 122456888999999984 4568889999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-30 Score=262.17 Aligned_cols=199 Identities=24% Similarity=0.412 Sum_probs=164.9
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcC---------
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--------- 414 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------- 414 (573)
..+|++.+.||+|+||.||+|.. .+++.|++|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36799999999999999999995 46889999998766656667789999999999999999999776543
Q ss_pred -----CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC-CCCCeE
Q 008238 415 -----EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPK 488 (573)
Q Consensus 415 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~vk 488 (573)
...++||||++ ++|.+++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35689999997 58877773 346899999999999999999999987 99999999999997 456789
Q ss_pred EeccCCcccccCCCCc-cccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 489 ISDFGMAKIFGVDQTQ-GNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 489 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
|+|||+++........ .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 220 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA 220 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999998765322111 11223457889999998754 467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=253.29 Aligned_cols=196 Identities=28% Similarity=0.458 Sum_probs=167.5
Q ss_pred CCcccccccccceeEEEEecC-CCCeeEEEEeccCCcc--chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 348 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQ--GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
|++.+.||+|++|.||++... +++.+++|++...... ....+.+|+.++++++|+||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999964 7889999998754332 4567888999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++ +|.+++.. +...+++..+..++.||+++|.|||+.+ |+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 75 77777744 2257899999999999999999999987 9999999999999999999999999987664432
Q ss_pred cccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 200 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 112224577889999998776 78999999999999999999998874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=260.03 Aligned_cols=198 Identities=29% Similarity=0.455 Sum_probs=169.3
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC-----eeE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKI 418 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 418 (573)
+|++.+.||+|++|.||+++.. +++.|+||++.... ....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788999999999999999964 58899999987543 344567889999999999999999999988775 789
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
++|||++ ++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 478887743 337899999999999999999999987 999999999999999999999999999865
Q ss_pred cCCCC-ccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 499 GVDQT-QGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 499 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
..... ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 43321 0112334678899999999887 78999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=257.68 Aligned_cols=198 Identities=23% Similarity=0.328 Sum_probs=161.2
Q ss_pred ccccccc--cceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 351 DNKLGEG--GFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 351 ~~~LG~G--~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
.+.||+| +||+||+++. .+++.||+|++.... ....+.+++|+.+++.++||||+++++++..++..++|+||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3567777 8999999995 478999999986432 2234678899999999999999999999999999999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc-
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ- 504 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~- 504 (573)
+++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 83 YGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999885432 245899999999999999999999887 999999999999999999999999865432111110
Q ss_pred ----cccccccccCCccchhccccC--CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 505 ----GNTNRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 505 ----~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 011112345679999998764 478999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=241.22 Aligned_cols=195 Identities=26% Similarity=0.334 Sum_probs=164.0
Q ss_pred hCCCCcc-cccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEc----CCee
Q 008238 345 TNNFSTD-NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLE----GEEK 417 (573)
Q Consensus 345 ~~~~~~~-~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~ 417 (573)
+++|++. ++||-|-.|.|..+.. ..++++|+|++... ...++|+++.-.. .|||||.+++++.+ ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4455554 4789999999999885 47899999998643 3457888887666 49999999998764 3567
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC---CCCCeEEeccCC
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGM 494 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~vkl~DfGl 494 (573)
++|||.|+||.|...+.+. ..+.+++.++-.|+.||..++.|||+.+ |.||||||+|+|.. .|-.+||+|||.
T Consensus 135 LiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 8999999999998888653 4467999999999999999999999987 99999999999996 455699999999
Q ss_pred cccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
++.-. ........+-|+.|.|||++-..+|....|+||+||++|-|++|.+||-
T Consensus 211 AK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 211 AKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred ccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence 98643 2334456788999999999999999999999999999999999999973
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=259.39 Aligned_cols=194 Identities=26% Similarity=0.448 Sum_probs=162.8
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC------
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 415 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 415 (573)
.++|.+.+.||+|+||.||+|+. .+++.||||++.+.. ......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46799999999999999999995 468999999986532 233456789999999999999999999987543
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 45899999964 666554 235889999999999999999999987 999999999999999999999999998
Q ss_pred ccccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 75422 1223467889999999876 4688999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-31 Score=263.21 Aligned_cols=202 Identities=26% Similarity=0.338 Sum_probs=177.7
Q ss_pred HhCCCCcccccccccceeEEEEecCCCC-eeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
...+++.+..||-|+||.|-+++.++.+ .+|+|++++. .....+.+..|-.+|...+.|.||+++..+.+....|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 3456777788999999999999975444 4888888654 33445668889999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
.||-|-||.|...|+ .++.++.....-++.-+++|++|||.++ ||.|||||+|.+|+.+|-+||.|||.++.+.
T Consensus 498 LmEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 498 LMEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hHHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999995 4567888999999999999999999988 9999999999999999999999999999875
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 554 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~ 554 (573)
. ...+.+.+||+.|.|||++.+.....++|.||||+++|||++|++||+-.+
T Consensus 572 ~---g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 572 S---GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred c---CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 3 345667899999999999999999999999999999999999999987533
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=254.94 Aligned_cols=193 Identities=34% Similarity=0.491 Sum_probs=163.1
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.|+..+.||+|++|.||+|+. .+++.+++|.+... .....+++.+|+++++.++|+|++++++++...+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 477788999999999999995 46788999988642 22334567889999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+. |++.+.+.. ....+++..+..++.|++.+|.|||+.+ ++||||+|+|||++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 997 577666643 2346899999999999999999999887 999999999999999999999999998754321
Q ss_pred CccccccccccCCccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
....++..|+|||.+. ....+.++||||||+++|||++|+.|+.
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 215 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence 2345788999999874 3567889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=268.93 Aligned_cols=209 Identities=28% Similarity=0.498 Sum_probs=180.2
Q ss_pred cchhHHHHHhCCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEc
Q 008238 336 FDFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLE 413 (573)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 413 (573)
.+++.+...++.|++.+.||+|.+|.||+++ .++++..|+|++.... ...++++.|.++|+.. .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3445555667789999999999999999999 5688899999887543 4456788899999888 49999999999864
Q ss_pred -----CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeE
Q 008238 414 -----GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 488 (573)
Q Consensus 414 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vk 488 (573)
++++|||||||.+|+..++++.-. ...+.|..+..|+.+++.||.+||... ++|||||-.|||++.++.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 578999999999999999997644 778999999999999999999999886 99999999999999999999
Q ss_pred EeccCCcccccCCCCccccccccccCCccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 489 ISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 489 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
|.|||++..+. .+..+.+..+||+.|||||++.- ..|+..+|+||||++..||--|.+|+-
T Consensus 164 LvDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~ 229 (953)
T KOG0587|consen 164 LVDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC 229 (953)
T ss_pred Eeeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence 99999998653 34556667899999999999943 346789999999999999999999864
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=245.20 Aligned_cols=191 Identities=32% Similarity=0.430 Sum_probs=166.4
Q ss_pred cccccceeEEEEecC-CCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCCh
Q 008238 354 LGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 429 (573)
Q Consensus 354 LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 429 (573)
||+|+||.||++... +++.+++|.+..... .....+.+|+.++++++|+||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999964 588999999875432 2345788999999999999999999999999999999999999999
Q ss_pred hhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcccccc
Q 008238 430 DYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR 509 (573)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~ 509 (573)
.+++.. ...+++..+..++.|++++|.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 999853 346899999999999999999999977 9999999999999999999999999987654322 12334
Q ss_pred ccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 510 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 510 ~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
..++..|++||.+.+...+.++|+||||+++|||++|+.||..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 5678899999999888899999999999999999999999853
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=251.44 Aligned_cols=197 Identities=31% Similarity=0.483 Sum_probs=168.2
Q ss_pred CCcccccccccceeEEEEecC-CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 348 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
|+..+.||+|++|.||+++.. +++.+++|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566789999999999999964 58999999987653 334467888999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
+ ++|.+++.... ..+++..+..++.|++++|+|||+++ |+||||+|+||++++++.++|+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58988885421 46899999999999999999999987 99999999999999999999999999886543221
Q ss_pred cccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 12223457789999998776 789999999999999999999988753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=256.71 Aligned_cols=199 Identities=26% Similarity=0.384 Sum_probs=162.5
Q ss_pred CCCcccccccccceeEEEEecC-C--CCeeEEEEeccCC--ccchHHHHHHHHHHHhc-CCCccceEEEEEEcC----Ce
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-S--GQEIAVKRLSRSS--GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEG----EE 416 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~ 416 (573)
+|++.+.||+|+||.||+++.. . +..||+|++.... ....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999954 3 7789999986432 22345678899999999 599999999875432 34
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++++||+. ++|.+++. ....+++..+..++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678889886 57888774 3456899999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCC--ccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 497 IFGVDQT--QGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 497 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.+..... ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 6543221 112234578999999998765 4689999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=250.94 Aligned_cols=197 Identities=27% Similarity=0.397 Sum_probs=165.3
Q ss_pred CCcccccccccceeEEEEecC-CCCeeEEEEeccCCc-cchHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEEEEcc
Q 008238 348 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
|++.+.||+|++|+||+|+.. +++.|+||++..... .......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999964 578899999865432 22234567899999999 999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
+|+|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 788888875422 246899999999999999999999987 99999999999999999999999999876533221
Q ss_pred cccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....++..|+|||.+.. ..++.++|+||||+++|||++|+.||..
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence 223467889999998754 4578999999999999999999988743
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=245.47 Aligned_cols=209 Identities=25% Similarity=0.373 Sum_probs=175.6
Q ss_pred HHHHHhCCCCcccccccccceeEEEEecCC------CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEE
Q 008238 340 TIEVATNNFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412 (573)
Q Consensus 340 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 412 (573)
++.+...+++....+-+|.||.||+|.|.+ .+.|-+|.++... ......+..|-.++..+.|||+.++.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 344556678888899999999999997643 4457788876543 333456788999999999999999999986
Q ss_pred c-CCeeEEEEEccCCCChhhhcc-----CcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC
Q 008238 413 E-GEEKILVYEFVPNKSLDYFLY-----EPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 486 (573)
Q Consensus 413 ~-~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 486 (573)
+ .+.++++++++.-|+|..||. +....+.++..+...++.|++.|++|||.++ +||.||.++|.+||+..+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence 5 567899999999999999997 5556678888999999999999999999987 999999999999999999
Q ss_pred eEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 487 PKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 487 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
+||+|=.++|.+-+.+.+.-....-.+..||+||.+.+..|+.++|||||||++|||+| |+.|+.
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya 500 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA 500 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc
Confidence 99999999997765555443333345679999999999999999999999999999988 777864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=277.63 Aligned_cols=197 Identities=31% Similarity=0.510 Sum_probs=155.5
Q ss_pred HhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccC-CccchHHHHHHHHHHHhcCCCccceEEEEEEcC-------
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG------- 414 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 414 (573)
-..+|+..+.||+||||.||+++.+ ||+.||||++... +......+.+|++.|++++|||||+++....+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3456888999999999999999954 8999999998654 334446788999999999999999987532200
Q ss_pred --------------------------------------------------------------------------------
Q 008238 415 -------------------------------------------------------------------------------- 414 (573)
Q Consensus 415 -------------------------------------------------------------------------------- 414 (573)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHH
Q 008238 415 --------------------------------EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLH 462 (573)
Q Consensus 415 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH 462 (573)
..+||-||||+..+|+++++...-.+ .....+++++||++||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 01356678887777777774321111 46678899999999999999
Q ss_pred hCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc----------------CCCCccccccccccCCccchhccccC-
Q 008238 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG----------------VDQTQGNTNRIVGTYGYMAPEYAMHG- 525 (573)
Q Consensus 463 ~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~- 525 (573)
+++ ||||||||.||++++++.|||+|||++.... ........+..+||.-|+|||.+.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 998 9999999999999999999999999998621 00111234557899999999998654
Q ss_pred --CCCccchhHHHHHHHHHHHh
Q 008238 526 --QFSVKSDVYSFGVLVLEIIT 545 (573)
Q Consensus 526 --~~s~~~DvwslGvll~ellt 545 (573)
.|+.|+|+|||||+++||+.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc
Confidence 49999999999999999975
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=274.73 Aligned_cols=145 Identities=28% Similarity=0.373 Sum_probs=129.9
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|.+.++||+|+||.||+++.. +++.||||+++... ......+.+|+.++..++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999964 68899999987543 223367888999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999853 346889999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=246.18 Aligned_cols=199 Identities=28% Similarity=0.406 Sum_probs=164.4
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccC-----CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS-----SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
+|.+.++||+|+||.||+++.. .+..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999854 3445666655432 122334567899999999999999999999999999999
Q ss_pred EEccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 421 YEFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
|||+++++|.+++... .....+++..++.++.|+++||.|||+.+ ++|+||||+||++++ +.++|+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888542 23457899999999999999999999987 999999999999975 569999999987653
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+.
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~ 206 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 3221 2223457889999999988888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=256.89 Aligned_cols=195 Identities=29% Similarity=0.472 Sum_probs=165.4
Q ss_pred HhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe----
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE---- 416 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 416 (573)
..++|++.+.||+|++|.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567999999999999999999964 6789999998643 22334567789999999999999999988766554
Q ss_pred --eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 417 --KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 417 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
.++|+||+ +++|.+++. ...+++..+..++.|++++|+|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 79999998 568888884 356899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 8765322 223457888999998865 367899999999999999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=240.54 Aligned_cols=179 Identities=21% Similarity=0.236 Sum_probs=152.1
Q ss_pred ccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCChhhhccC
Q 008238 357 GGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE 435 (573)
Q Consensus 357 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 435 (573)
|.+|.||+++. .+++.+|+|++.... .+.+|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999995 478899999987543 233455555566799999999999999999999999999999998853
Q ss_pred cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCC
Q 008238 436 PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG 515 (573)
Q Consensus 436 ~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~ 515 (573)
...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 345899999999999999999999987 999999999999999999999999987654322 112345678
Q ss_pred ccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 516 y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
|+|||.+.+..++.++||||+|+++|||++|+.|+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 999999988889999999999999999999997654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=259.42 Aligned_cols=203 Identities=24% Similarity=0.331 Sum_probs=152.9
Q ss_pred HhCCCCcccccccccceeEEEEec-----------------CCCCeeEEEEeccCCccchHH--------------HHHH
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-----------------PSGQEIAVKRLSRSSGQGGQE--------------FKNE 392 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e 392 (573)
..++|++.++||+|+||+||+|.+ ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356799999999999999999963 235679999986543322223 3346
Q ss_pred HHHHHhcCCCcc-----ceEEEEEEc--------CCeeEEEEEccCCCChhhhccCcC---------------------c
Q 008238 393 VVLVAKLQHRNL-----VRLLGFCLE--------GEEKILVYEFVPNKSLDYFLYEPE---------------------K 438 (573)
Q Consensus 393 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~---------------------~ 438 (573)
+.++.+++|.++ +++++++.. .+..+|||||+++++|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677777653 356799999999999999886421 1
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccc
Q 008238 439 QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMA 518 (573)
Q Consensus 439 ~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 518 (573)
...+++..+..++.|++++|.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123577889999999999999999987 99999999999999999999999999975432211 11112234789999
Q ss_pred hhccccCCC----------------------CccchhHHHHHHHHHHHhCCC-CC
Q 008238 519 PEYAMHGQF----------------------SVKSDVYSFGVLVLEIITGKK-NS 550 (573)
Q Consensus 519 PE~~~~~~~----------------------s~~~DvwslGvll~elltG~~-p~ 550 (573)
||.+..... ..+.||||+||+++||++|.. |+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 998754321 134799999999999999985 54
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-28 Score=231.56 Aligned_cols=214 Identities=31% Similarity=0.441 Sum_probs=177.9
Q ss_pred CCcccccccccceeEEEEecCC-CCeeEEEEeccCCcc-chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 348 FSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSRSSGQ-GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
|++.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999754 889999999866544 56788999999999999999999999999999999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999999854221 1889999999999999999999986 99999999999999999999999999887644321 1
Q ss_pred ccccccccCCccchhcc-ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhh
Q 008238 506 NTNRIVGTYGYMAPEYA-MHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSIN 568 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~-~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~ 568 (573)
......++..|++||.+ ....++.++|+|+||++++||++|+.||.. ..+....+.+.+...
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~-~~~~~~~~~~~~~~~ 217 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG-EGEFTSLLSDVWSFG 217 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc-cchhHHHHHHHHhcC
Confidence 22334677889999998 667788899999999999999999999832 134444555554443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=226.53 Aligned_cols=203 Identities=22% Similarity=0.425 Sum_probs=168.5
Q ss_pred hCCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-CCccceEEEEEEcCC--eeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGE--EKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~lv 420 (573)
.++|++.+++|+|.+++||.|. ..+.++++||+++.. ..+.+++|+++|..+. ||||+++++...+.. .+.||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3579999999999999999999 567889999999743 3478899999999998 999999999988754 46799
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC-CCeEEeccCCccccc
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAKIFG 499 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~DfGla~~~~ 499 (573)
+||+.+.+...+- +.++...+..++.|+++||.|+|+.+ |+|||+||+|++||.. ..++|+|+|++.++.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998876654 46788889999999999999999988 9999999999999954 579999999998875
Q ss_pred CCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLS 563 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~ 563 (573)
+... .+..+.+..|--||.+.. ..+...-|+|||||++.+|+..+.||-. ..++.+.|++
T Consensus 185 p~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh-G~dN~DQLVk 245 (338)
T KOG0668|consen 185 PGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVK 245 (338)
T ss_pred CCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC-CCCCHHHHHH
Confidence 4432 223456778899998876 4578899999999999999999999843 3344444443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=239.07 Aligned_cols=197 Identities=26% Similarity=0.420 Sum_probs=160.9
Q ss_pred CCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcC-----CeeEE
Q 008238 348 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EEKIL 419 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~l 419 (573)
.+-.+.||.|+||.||.+.+ ++|+.|++|++..- +-...+.+.+|+++|..++|.|++..++..+-. +++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34468999999999999996 47999999998532 223346788999999999999999988876543 24567
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
+.|.|. .+|..++- ..+.++...+.-+..||++||.|||+.+ |.||||||.|.|++.+-.+||+|||+++...
T Consensus 135 ~TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 788774 45666663 4577888999999999999999999987 9999999999999999999999999999765
Q ss_pred CCCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.+.....+ ..+-|..|.|||++++. .|+.+.||||.|||+.||+..+.-|+-
T Consensus 208 ~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 208 QRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred hhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 54443333 34558899999999986 589999999999999999987776543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=254.75 Aligned_cols=192 Identities=28% Similarity=0.402 Sum_probs=162.0
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++.|.....+|.|+|+.|-++.. .+++..++|++.+... +-.+|+.++... +||||+++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 45688888899999999999984 5788899999976522 234567555555 69999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe-CCCCCeEEeccCCcccccCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-DAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl-~~~~~vkl~DfGla~~~~~~ 501 (573)
.+.++.+.+.+.. . +.....+..|+.+|+.++.|||+++ ++||||||+|||+ ++.++++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~~---~-~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRS---K-PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHh---c-chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999988777743 2 2223677789999999999999987 9999999999999 69999999999999865433
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
....+-|..|.|||++....++.++||||||++||||++|+.|+.-
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~ 515 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAA 515 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcccc
Confidence 2334668899999999999999999999999999999999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=235.12 Aligned_cols=212 Identities=25% Similarity=0.459 Sum_probs=167.4
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcC--------C
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--------E 415 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~ 415 (573)
.|+...+||+|.||+||+++- +.|+.||+|++-.. ....-....+|+++|..++|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 466677999999999999994 46788999875332 223335568899999999999999999887542 3
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
..++||++++. +|..+|.. ....++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 47899999975 45555533 2356899999999999999999999876 999999999999999999999999999
Q ss_pred ccccCCCCcc--ccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 496 KIFGVDQTQG--NTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 496 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
+.+....... ..+..+-|.+|.+||.+.+. .++++.|||+-||++.||+||.+-++ .+.++.-+..|..
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq---gnteqqql~~Is~ 243 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ---GNTEQQQLHLISQ 243 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc---CChHHHHHHHHHH
Confidence 8775443322 22234559999999998875 58999999999999999999988654 3455555555543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=249.28 Aligned_cols=195 Identities=26% Similarity=0.420 Sum_probs=165.7
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc--------cchHHHHHHHHHHHhcC---CCccceEEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG--------QGGQEFKNEVVLVAKLQ---HRNLVRLLGFCLE 413 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 413 (573)
.+|...+++|+|+||.|+.+.++ +..+|+||.+.+..- ...-.+-.||.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45899999999999999999965 566789998865421 11123456999999998 9999999999999
Q ss_pred CCeeEEEEEccC-CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEecc
Q 008238 414 GEEKILVYEFVP-NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492 (573)
Q Consensus 414 ~~~~~lv~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df 492 (573)
++..+|+||-.. +-+|.+++. ....+++.++..|+.||+.|+++||+++ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999764 457778873 4457899999999999999999999998 999999999999999999999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccccCCC-CccchhHHHHHHHHHHHhCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslGvll~elltG~~p~ 550 (573)
|.+..... +.....+||..|.|||++.+.+| ...-|||++|++||-++....||
T Consensus 715 gsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99875432 33455789999999999998887 56689999999999999888886
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=236.33 Aligned_cols=199 Identities=25% Similarity=0.335 Sum_probs=167.0
Q ss_pred HHHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCC--Cc----cceEEEEEEcC
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH--RN----LVRLLGFCLEG 414 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~n----iv~l~~~~~~~ 414 (573)
...+.+|.+.+.+|+|.||.|-++... .+..||||+++. .....+..+-|+++|.++.+ |+ +|++.+++.-.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 344778999999999999999999854 468899999863 34455666779999999942 33 78888899999
Q ss_pred CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC-----------
Q 008238 415 EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA----------- 483 (573)
Q Consensus 415 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~----------- 483 (573)
++.++|+|.+ |-|+.++|... +..+++...+..|+.|+++++++||+.. ++|-||||+|||+-+
T Consensus 164 ghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred CceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCC
Confidence 9999999987 66889999542 4467899999999999999999999987 999999999999821
Q ss_pred ---------CCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 484 ---------EMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 484 ---------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+..+||+|||.+..-. .....++.|..|.|||++.+-.++..+||||+||||.|+.||..-|+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ccceeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 3358999999997532 22356788999999999999999999999999999999999998764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=226.25 Aligned_cols=186 Identities=32% Similarity=0.478 Sum_probs=163.5
Q ss_pred cceeEEEEecC-CCCeeEEEEeccCCccc-hHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCChhhhccC
Q 008238 358 GFGEVYKGVLP-SGQEIAVKRLSRSSGQG-GQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE 435 (573)
Q Consensus 358 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 435 (573)
+||.||+++.. +++.+++|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 58999999997655444 67899999999999999999999999999999999999999999999854
Q ss_pred cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCC
Q 008238 436 PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG 515 (573)
Q Consensus 436 ~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~ 515 (573)
. ..+++..+..++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 2 23899999999999999999999987 9999999999999999999999999998764332 2234567889
Q ss_pred ccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 516 y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|++||.+.+..++.++|||+||++++||++|+.|+..
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999888899999999999999999999999754
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=255.04 Aligned_cols=199 Identities=24% Similarity=0.303 Sum_probs=139.9
Q ss_pred HhCCCCcccccccccceeEEEEecC-C----CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEE------EE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP-S----GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGF------CL 412 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~ 412 (573)
..++|++.++||+|+||.||+|++. + +..||||++..... .+...+| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4568999999999999999999964 4 68999998764321 1111111 1122222222222211 24
Q ss_pred cCCeeEEEEEccCCCChhhhccCcCc-----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCC
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPEK-----------------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK 475 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk 475 (573)
.....++||||+++++|.+++..... ........+..++.||+.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56678999999999999988854211 011123345679999999999999987 9999999
Q ss_pred CCCEEeCC-CCCeEEeccCCcccccCCCCccccccccccCCccchhccccC----------------------CCCccch
Q 008238 476 ASNILLDA-EMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG----------------------QFSVKSD 532 (573)
Q Consensus 476 p~NILl~~-~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~~D 532 (573)
|+|||+++ ++.+||+|||+++.+..... .......+++.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 57999999999986532221 123345789999999966332 2345679
Q ss_pred hHHHHHHHHHHHhCCCCC
Q 008238 533 VYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 533 vwslGvll~elltG~~p~ 550 (573)
||||||++|||+++..++
T Consensus 362 VwSlGviL~el~~~~~~~ 379 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRS 379 (566)
T ss_pred cHHHHHHHHHHHhCcCCC
Confidence 999999999999977653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=252.14 Aligned_cols=197 Identities=28% Similarity=0.409 Sum_probs=160.6
Q ss_pred CCccccccccccee-EEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEEEEccC
Q 008238 348 FSTDNKLGEGGFGE-VYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 348 ~~~~~~LG~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
|...+.+|.|+-|+ ||+|.+ +|+.||||++-. +......+|+..|+.-+ |||||++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 55667789999985 899999 789999999853 23345678999998884 999999999999999999999999
Q ss_pred CCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC---C--CCeEEeccCCccccc
Q 008238 426 NKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---E--MNPKISDFGMAKIFG 499 (573)
Q Consensus 426 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~--~~vkl~DfGla~~~~ 499 (573)
.-+|++++... ...........+.+..|+++||++||+.+ ||||||||.||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56898888653 11111111345678899999999999976 999999999999965 2 579999999999886
Q ss_pred CCCCc-cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhC-CCCCCC
Q 008238 500 VDQTQ-GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG-KKNSSF 552 (573)
Q Consensus 500 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG-~~p~~~ 552 (573)
.+... .......||.+|+|||.+.....+.++||||+||++|..++| ..||+.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 65543 334567899999999999999999999999999999999997 778863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-24 Score=202.95 Aligned_cols=183 Identities=39% Similarity=0.628 Sum_probs=157.8
Q ss_pred cccccceeEEEEecC-CCCeeEEEEeccCCcc-chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCChhh
Q 008238 354 LGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQ-GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDY 431 (573)
Q Consensus 354 LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 431 (573)
||+|.+|.||+++.. +++.+++|++...... ....+.+|+..++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999974 3899999998755432 34678999999999999999999999999999999999999999999
Q ss_pred hccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC-CCCeEEeccCCcccccCCCCccccccc
Q 008238 432 FLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMAKIFGVDQTQGNTNRI 510 (573)
Q Consensus 432 ~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~~~~~~~~~~~~~~ 510 (573)
++.... ..+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985321 46899999999999999999999987 999999999999999 89999999999986543321 12234
Q ss_pred cccCCccchhccccC-CCCccchhHHHHHHHHHH
Q 008238 511 VGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEI 543 (573)
Q Consensus 511 ~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~el 543 (573)
.+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 567889999998777 888999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-26 Score=235.51 Aligned_cols=198 Identities=26% Similarity=0.426 Sum_probs=173.9
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
..++|+....+|.|.||.|||++. ..++..|+|.++-.......-+++|+-+++..+||||+.++|-+...+..|+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 345788899999999999999995 5788999999987777777788999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+.+|+|++.-+ -..++++.++....++.++||+|||+.+ -+|||||-.|||+++.|.+|++|||.+-.+..
T Consensus 93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--
Confidence 999999998875 3568899999999999999999999988 79999999999999999999999999876532
Q ss_pred CccccccccccCCccchhcc---ccCCCCccchhHHHHHHHHHHHhCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGKKN 549 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~---~~~~~s~~~DvwslGvll~elltG~~p 549 (573)
...+.....||+.|||||+. ..+.|..++|||+.|+...|+-.-+.|
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp 214 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP 214 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence 22334456899999999986 456789999999999999998766665
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=210.87 Aligned_cols=192 Identities=29% Similarity=0.387 Sum_probs=158.3
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCC------e
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------E 416 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~ 416 (573)
.+|...+.+|.|.- .|-.+.. -.++.||+|++... .....++..+|..++..++|+||++++.++.-.. +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45777788888888 4544442 25889999987543 3444567789999999999999999999986543 4
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++|||+|. .+|...+. ..++-.++..|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+++
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 589999995 56766664 34677888999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
.-+.+ ...+..+.|..|.|||++.+..+...+||||.||++.||++|+--|
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf 217 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF 217 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEe
Confidence 54322 3445667899999999999988999999999999999999999754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=213.61 Aligned_cols=131 Identities=25% Similarity=0.384 Sum_probs=108.9
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-----C---CccceEEEEEEc---
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-----H---RNLVRLLGFCLE--- 413 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~--- 413 (573)
.+|.+.++||+|.|++||++.. .+.+.||+|+.+. .....+....||++|++++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6899999999999999999995 4677899998863 3455677789999999984 3 359999999875
Q ss_pred -CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe
Q 008238 414 -GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 481 (573)
Q Consensus 414 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl 481 (573)
+.+.++|+|++. .+|..+|.. ...+-++...+.+|++||+.||.|||.+. +|||-||||+|||+
T Consensus 157 NG~HVCMVfEvLG-dnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVLG-DNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhhh-hHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 567899999994 455555533 24467899999999999999999999975 79999999999998
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=216.27 Aligned_cols=168 Identities=18% Similarity=0.190 Sum_probs=130.3
Q ss_pred HHHhCCCCcccccccccceeEEEEecC--CCCeeEEEEeccC-----CccchHHHHHHHHHHHhcCCCccceEEEEEEcC
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVLP--SGQEIAVKRLSRS-----SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG 414 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 414 (573)
.....+|.+.+.||+|+||+||+++.. +++.||||++... .....+.+.+|+++|++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999864 5777899987533 12234568999999999999999854332 2
Q ss_pred CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC-CCCCEEeCCCCCeEEeccC
Q 008238 415 EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDL-KASNILLDAEMNPKISDFG 493 (573)
Q Consensus 415 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dl-kp~NILl~~~~~vkl~DfG 493 (573)
...++||||+++++|.... . .. ...++.|++++|.|||+++ |+|||| ||+|||++.++++||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4579999999999996321 1 11 1467889999999999987 999999 9999999999999999999
Q ss_pred CcccccCCCCccc------cccccccCCccchhccccC
Q 008238 494 MAKIFGVDQTQGN------TNRIVGTYGYMAPEYAMHG 525 (573)
Q Consensus 494 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 525 (573)
+++.+........ .....++..|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9997654332111 1356788899999988543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=212.58 Aligned_cols=209 Identities=25% Similarity=0.410 Sum_probs=169.8
Q ss_pred HHhCCCCcccccccccceeEEEEecC----CCCeeEEEEeccCCccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCee
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 417 (573)
...+.|..+++||+|.|++||++.+. ..+.||+|.+...+. -..+.+|+++|..+. +.||+++.+++..++..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34567899999999999999999853 467899999875433 356899999999996 99999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC-CCCeEEeccCCcc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMAK 496 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~ 496 (573)
.+|+||++.....++.. .++...+..+++.++.+|.++|.++ ||||||||+|+|.+. .++-.|.|||++.
T Consensus 111 ~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 99999999999988883 4678899999999999999999998 999999999999974 5678999999987
Q ss_pred cccCCC-------------Cc-----------------------------cccccccccCCccchhcccc-CCCCccchh
Q 008238 497 IFGVDQ-------------TQ-----------------------------GNTNRIVGTYGYMAPEYAMH-GQFSVKSDV 533 (573)
Q Consensus 497 ~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv 533 (573)
..+... .. .......||++|.|||++.. ..-+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 321000 00 00112469999999999866 456899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 008238 534 YSFGVLVLEIITGKKNSSFYQTDGAADLLS 563 (573)
Q Consensus 534 wslGvll~elltG~~p~~~~~~~~~~~ll~ 563 (573)
||-|||++-+++++.||- ...++...+.+
T Consensus 262 ws~GVI~Lslls~~~PFf-~a~dd~~al~e 290 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFF-KAKDDADALAE 290 (418)
T ss_pred eeccceeehhhccccccc-cCccccchHHH
Confidence 999999999999999974 33344444444
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-25 Score=220.34 Aligned_cols=217 Identities=21% Similarity=0.250 Sum_probs=177.7
Q ss_pred hHHHHHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCC------CccceEEEEE
Q 008238 339 ETIEVATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH------RNLVRLLGFC 411 (573)
Q Consensus 339 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~ 411 (573)
...+....+|.+....|+|-|++|.++... -|..||||++..... -.+.=..|+++|++|+. -|.++++-.|
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 334566778999999999999999999853 577999999975432 22344679999999963 4789999999
Q ss_pred EcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC-CeEEe
Q 008238 412 LEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKIS 490 (573)
Q Consensus 412 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~ 490 (573)
...++++||||-+ .-+|.++|....++..|....+..++.|+.-+|..|...+ |+|.||||.|||+++.. .+|||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeec
Confidence 9999999999977 5688999988777788999999999999999999999887 99999999999998765 58999
Q ss_pred ccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 491 DFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 491 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
|||.|....... .+...-+..|.|||++.+-+|....|+||.||.||||.||+..|. .....++|.+...
T Consensus 580 DfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp---G~TNN~MLrl~me 649 (752)
T KOG0670|consen 580 DFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP---GRTNNQMLRLFME 649 (752)
T ss_pred cCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC---CCCcHHHHHHHHH
Confidence 999997654322 222234667999999999999999999999999999999998754 2345566666543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=202.09 Aligned_cols=195 Identities=24% Similarity=0.407 Sum_probs=154.9
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEE-EEcCCeeEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGF-CLEGEEKILVY 421 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 421 (573)
.+.|.+.+.||+|.||.+-+++.+ +...+++|.+.+.. ....+|.+|..---.+ .|.||+.-+++ |+..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 356889999999999999999964 57789999886543 3457888888765555 48999987764 55667778999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC--CCCCeEEeccCCccccc
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEMNPKISDFGMAKIFG 499 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~~vkl~DfGla~~~~ 499 (573)
||++.|+|..-+ ....+.+....+++.|++.+++|||+++ +||||||.+||||- +..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999998777 3355778888999999999999999998 99999999999993 44589999999987543
Q ss_pred CCCCccccccccccCCccchhccccC---C--CCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHG---Q--FSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~--~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
... ...--+..|.+||..... . ..+.+|||.||++++..+||+.||+.
T Consensus 175 ~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 175 TTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred cee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 221 122235578999976433 2 35679999999999999999999873
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=182.29 Aligned_cols=101 Identities=44% Similarity=0.878 Sum_probs=78.0
Q ss_pred ccCCC----ccc-cCCChHHHHHHHHHHhcccccCCCCCCCCCceeeccCCCCceeeEEEeccCCCCccchHHHHHHHHH
Q 008238 39 YHVCS----ANF-TGNSTYQTNRNLLLSSLPTNASRGNGYSSGFYNETTGQDPNKVYGLFLCRGDQTASSCQDCVTFATR 113 (573)
Q Consensus 39 ~~~C~----~~~-~~~s~~~~~l~~ll~~l~~~~~~~~~~~~~f~~~~~g~~~~~vyg~~~Cr~D~~~~~C~~Cl~~a~~ 113 (573)
|+.|+ ++| +++++|++||+.||+.|..+++.++ +.+|++++.|.++++|||++||++|+++.+|..||+.|+.
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~--~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~ 78 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSS--SKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVA 78 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT---TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHC
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhcc--ccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHH
Confidence 56785 346 6788899999999999999987432 3689999999999999999999999999999999999999
Q ss_pred HHHHhCCCCcceEEEcceeEEEEcCCcc
Q 008238 114 DLVQRCPDGKQTIIWYDQCLLRYSNRSI 141 (573)
Q Consensus 114 ~~~~~C~~~~~~~~~~~~C~~ry~~~~f 141 (573)
.+.+.|+++++|+||++.|+|||++++|
T Consensus 79 ~~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 79 NISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp CHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHHhCCCCceEEEECCCEEEEEECCCC
Confidence 9999999999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8e-23 Score=208.29 Aligned_cols=203 Identities=23% Similarity=0.310 Sum_probs=165.9
Q ss_pred CCCcccccccccceeEEEEecCCC--CeeEEEEeccCCccchHHHHHHHHHHHhcCC----CccceEEEEE-EcCCeeEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLPSG--QEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH----RNLVRLLGFC-LEGEEKIL 419 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l 419 (573)
+|.+.++||+|+||.||++..... +.+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996443 4788887765433333377889999988873 6899999988 47778899
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC-----CCeEEeccCC
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-----MNPKISDFGM 494 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-----~~vkl~DfGl 494 (573)
||+.+ |.+|.++..... .+.++..+.++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99976 778888775433 578999999999999999999999988 9999999999999754 4699999999
Q ss_pred ccccc--CCCC----ccc--cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008238 495 AKIFG--VDQT----QGN--TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 554 (573)
Q Consensus 495 a~~~~--~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~ 554 (573)
++.+. .... ... .....||.+|.+++.+.+...+++.|+||++.++.|++.|..||+...
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 98332 1111 111 123559999999999999999999999999999999999999986543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=188.01 Aligned_cols=206 Identities=22% Similarity=0.330 Sum_probs=170.8
Q ss_pred HhCCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCC-CccceEEEEEEcCCeeEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH-RNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 421 (573)
...+|.++++||.|+||.+|.|. ..+|++||||.-+.... ...+..|.++...+++ ..|..+..+..+.+...+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34679999999999999999999 67999999998654332 3456778999999985 67778888888888999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC---CCCeEEeccCCcccc
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMAKIF 498 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGla~~~ 498 (573)
|.+ |-+|+++..- -...++.++++-++-|++.-++|+|.++ +|||||||+|.|+.- ..++.++|||+++.+
T Consensus 91 dLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 987 6788887743 2356899999999999999999999988 999999999999963 456899999999977
Q ss_pred cCCCCc-----cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 008238 499 GVDQTQ-----GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDG 557 (573)
Q Consensus 499 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~ 557 (573)
....+. .....+.||.+|.+-..+.+...+.+.|+-|+|.+|..+..|..||+-.....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 443322 12345789999999998888899999999999999999999999997554433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=191.40 Aligned_cols=199 Identities=25% Similarity=0.366 Sum_probs=169.1
Q ss_pred CCCcccccccccceeEEEEe-cCCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEEEEcc
Q 008238 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
+|++.++||+|.||.++.|+ +-+++.||||.-...+ ...++..|....+.|. .++|...+.+-..+....||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68999999999999999999 5589999999865433 2356777888888886 689999999989999999999987
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC-----CCCeEEeccCCccccc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----EMNPKISDFGMAKIFG 499 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~vkl~DfGla~~~~ 499 (573)
|-+|+++..- ..+.++.+++..++.|++.-++|+|++. +|.|||||+|.||.. ...+.|+|||+++.+-
T Consensus 107 -GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 6788887643 3567999999999999999999999998 999999999999953 3458999999999875
Q ss_pred CCCCcc-----ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 500 VDQTQG-----NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 500 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
...+.. ......||.+||+-....+...+.+.|+-|||-+++..|.|..||+-.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 443321 334578999999999999999999999999999999999999999743
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.9e-21 Score=191.87 Aligned_cols=200 Identities=35% Similarity=0.509 Sum_probs=169.0
Q ss_pred CCcccccccccceeEEEEecCCCCeeEEEEeccCCcc---chHHHHHHHHHHHhcCCC-ccceEEEEEEcCCeeEEEEEc
Q 008238 348 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQ---GGQEFKNEVVLVAKLQHR-NLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 423 (573)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567889999999999999975 78899998765433 367899999999999988 799999999777778999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC-CeEEeccCCcccccCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~~~~~ 502 (573)
+.++++.+++........+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .+++.|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966643211136889999999999999999999987 99999999999999988 79999999998554333
Q ss_pred Ccc----ccccccccCCccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQG----NTNRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
... ......|+..|++||.+.+ ...+...|+|++|++++++++|..|+..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~ 213 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 221 2356789999999999987 5788999999999999999999999544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=229.43 Aligned_cols=148 Identities=20% Similarity=0.288 Sum_probs=112.8
Q ss_pred hcCC-CccceEEEEE-------EcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 008238 398 KLQH-RNLVRLLGFC-------LEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRI 469 (573)
Q Consensus 398 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 469 (573)
.++| +||+++++.+ ...+..++++||+ +++|.++|... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3455 5788888876 2234567788887 66999999642 356999999999999999999999987 9
Q ss_pred EeecCCCCCEEeCC-------------------CCCeEEeccCCcccccCCCC--------------ccccccccccCCc
Q 008238 470 IHRDLKASNILLDA-------------------EMNPKISDFGMAKIFGVDQT--------------QGNTNRIVGTYGY 516 (573)
Q Consensus 470 vH~Dlkp~NILl~~-------------------~~~vkl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y 516 (573)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566666776653211000 0001124578899
Q ss_pred cchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 517 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 517 ~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
||||++.+..++.++|||||||+||||++|..|+.
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 99999999999999999999999999999988754
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-22 Score=167.27 Aligned_cols=101 Identities=45% Similarity=0.789 Sum_probs=77.8
Q ss_pred EEEee---cccC-CchhhHHHHHHHHHHHHHHHHhcC-CccceeeeecccccccEEEEEeecCCCCccchHHHHHHHHhh
Q 008238 151 VSLLN---TQNV-TDRGRFNQILASLMSQVVNQAVNN-SRKFATRTANFTALQTLYSLAQCTPDLSSSDCNVCLQAAIAE 225 (573)
Q Consensus 151 ~~~~~---~~~~-~~~~~f~~~~~~ll~~l~~~a~~~-~~~~a~~~~~~~~~~~vy~l~qC~~Dls~~~C~~Cl~~a~~~ 225 (573)
|..|+ .+++ ++++.|+.++++||..|+++|+.+ +.+|++++. ..++++||||+||++||+++||..||+.+..+
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~ 79 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVAN 79 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence 35677 4445 566779999999999999998865 478999986 46788999999999999999999999999999
Q ss_pred cCcCCCCCcCcEEEccccceeeecCcc
Q 008238 226 LPNCCSGKTGAQVLIPSCIVRYEFYPF 252 (573)
Q Consensus 226 ~~~~c~~~~g~~~~~~~C~lry~~~~f 252 (573)
+..+|++..||++++++|+|||++++|
T Consensus 80 ~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 80 ISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHhCCCCceEEEECCCEEEEEECCCC
Confidence 999999999999999999999999987
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=180.35 Aligned_cols=139 Identities=19% Similarity=0.184 Sum_probs=108.8
Q ss_pred ccccccccceeEEEEecCCCCeeEEEEeccCCcc--c-------hH-----------------HHHHHHHHHHhcCCCcc
Q 008238 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQ--G-------GQ-----------------EFKNEVVLVAKLQHRNL 404 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~e~~~l~~l~h~ni 404 (573)
...||+|++|.||+|+..+|+.||||+++..... . .. ...+|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999998754211 1 11 22349999999988877
Q ss_pred ceEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeecCCCCCEEeCC
Q 008238 405 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYL-HEDSRLRIIHRDLKASNILLDA 483 (573)
Q Consensus 405 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~ivH~Dlkp~NILl~~ 483 (573)
.....+.. ...++||||++++++...+. +...+++..+..++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 23489999999987765432 234688999999999999999999 6776 99999999999998
Q ss_pred CCCeEEeccCCcccc
Q 008238 484 EMNPKISDFGMAKIF 498 (573)
Q Consensus 484 ~~~vkl~DfGla~~~ 498 (573)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.3e-21 Score=181.80 Aligned_cols=172 Identities=14% Similarity=0.182 Sum_probs=133.3
Q ss_pred HHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHH---------HHHHHHHHHhcCCCccceEEEEEEc
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQE---------FKNEVVLVAKLQHRNLVRLLGFCLE 413 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~l~~~~~~ 413 (573)
....+|+..+.||.|+||.||.... ++..+|||.+.......... +.+|+..+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4577899999999999999999766 57789999997543332222 6789999999999999999888654
Q ss_pred C--------CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC
Q 008238 414 G--------EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 485 (573)
Q Consensus 414 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~ 485 (573)
. ...+|+|||++|.+|.++.. ++. ....+++.+|..||+.+ ++|||+||+||++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 35789999999999987741 222 24568999999999988 99999999999999988
Q ss_pred CeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHH
Q 008238 486 NPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 544 (573)
Q Consensus 486 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ell 544 (573)
++|+|||.......+... ..+.....+..++|+|+||+.+..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988654211110 11334445667999999999876553
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.2e-20 Score=173.53 Aligned_cols=141 Identities=21% Similarity=0.207 Sum_probs=111.5
Q ss_pred cccccccccceeEEEEecCCCCeeEEEEeccCCccc--------------------------hHHHHHHHHHHHhcCCCc
Q 008238 350 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQG--------------------------GQEFKNEVVLVAKLQHRN 403 (573)
Q Consensus 350 ~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~n 403 (573)
+.+.||+|++|.||+|...+|+.||||+++...... ...++.|...+.++.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 357899999999999997789999999987542210 112357899999999998
Q ss_pred cceEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCEEeC
Q 008238 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLD 482 (573)
Q Consensus 404 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlkp~NILl~ 482 (573)
+.....+... ..++||||++++++..... ....++......++.|++.++.+||+ .+ |+||||||+|||++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~ 152 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH 152 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence 7554444332 3589999999886543321 22457788999999999999999999 76 99999999999999
Q ss_pred CCCCeEEeccCCccccc
Q 008238 483 AEMNPKISDFGMAKIFG 499 (573)
Q Consensus 483 ~~~~vkl~DfGla~~~~ 499 (573)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 7899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=166.96 Aligned_cols=184 Identities=16% Similarity=0.142 Sum_probs=139.4
Q ss_pred CcccccccccceeEEEEecCCCCeeEEEEeccCCccc----hHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEEEEc
Q 008238 349 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQG----GQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 349 ~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.....|++|+||+|+.+.. .+.+++.+.+.....-. ...+.+|+++|++++ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997766 67888888776543211 225789999999996 5889999886 456999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC-CCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDL-KASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dl-kp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
+.|.+|...+.. ....++.|++++|+++|+++ |+|||| ||.|||+++++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998654310 12357789999999999988 999999 7999999999999999999998654322
Q ss_pred Cc----c--c-----cccccccCCccchhccccC-CCC-ccchhHHHHHHHHHHHhCCCCC
Q 008238 503 TQ----G--N-----TNRIVGTYGYMAPEYAMHG-QFS-VKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 503 ~~----~--~-----~~~~~gt~~y~aPE~~~~~-~~s-~~~DvwslGvll~elltG~~p~ 550 (573)
.. . . ......++.|++|+...-- ..+ ...++++-|..+|+++|++.+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 10 0 0 0112357788888865322 333 6789999999999999999874
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.1e-21 Score=176.47 Aligned_cols=196 Identities=23% Similarity=0.333 Sum_probs=155.3
Q ss_pred CcccccccccceeEEEEecCCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 349 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 349 ~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
.+.-+|.+...|+.|+|+| .|..+++|++... .....++|.+|.-.|+.+.||||++++|.|.....+.++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3445788999999999999 4556667776533 344457899999999999999999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|+|...|++.. .-.++-.++.+++.+|++|++|||+.. +-|.---|.++.|++|++.+.+|+ ++-.++.. .
T Consensus 272 gslynvlhe~t-~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kfsf------q 342 (448)
T KOG0195|consen 272 GSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF------Q 342 (448)
T ss_pred hHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccceeee------e
Confidence 99999998643 345678889999999999999999986 335555799999999999988875 22222110 0
Q ss_pred cccccccCCccchhccccCCC---CccchhHHHHHHHHHHHhCCCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQF---SVKSDVYSFGVLVLEIITGKKNSSFYQ 554 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~---s~~~DvwslGvll~elltG~~p~~~~~ 554 (573)
.....-.+.||+||.+...+. -.++|+|||.+++|||.|...||..+.
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence 111234678999999977654 367999999999999999999987543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.4e-20 Score=170.11 Aligned_cols=106 Identities=24% Similarity=0.233 Sum_probs=92.3
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|+|.+++.. ....+++.+++.++.||++||+|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 688888853 2456999999999999999999999864 999999999999999 99987653221
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
..|++.|||||++.+..++.++||||||+++|||++|+.||..
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~ 106 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 2578999999999999999999999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=164.71 Aligned_cols=138 Identities=21% Similarity=0.314 Sum_probs=107.0
Q ss_pred CCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhc-----CCCccceEEEEEEcCC---e-eE
Q 008238 348 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-----QHRNLVRLLGFCLEGE---E-KI 418 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~~ 418 (573)
+...+.||+|+||.||. .++....+||++........+.+.+|+.+++.+ +||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567999999999996 433333479988765445567899999999999 5799999999998864 3 33
Q ss_pred EEEEc--cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeecCCCCCEEeCC----CCCeEEec
Q 008238 419 LVYEF--VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGI-LYLHEDSRLRIIHRDLKASNILLDA----EMNPKISD 491 (573)
Q Consensus 419 lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L-~yLH~~~~~~ivH~Dlkp~NILl~~----~~~vkl~D 491 (573)
+|+|| .++++|.+++.. ..+++. ..++.|++.++ +|||+++ |+||||||+|||++. +.+++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 558999999943 235555 35677888777 9999987 999999999999973 34799999
Q ss_pred cCCcc
Q 008238 492 FGMAK 496 (573)
Q Consensus 492 fGla~ 496 (573)
|+.+.
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 44443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8e-20 Score=189.13 Aligned_cols=185 Identities=29% Similarity=0.334 Sum_probs=154.1
Q ss_pred cccccceeEEEEec----CCCCeeEEEEeccCCccc--hHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEEEEccCC
Q 008238 354 LGEGGFGEVYKGVL----PSGQEIAVKRLSRSSGQG--GQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 354 LG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+|+|.||.|+.+.. +.|+.+|+|.+.+..... ....+.|..++...+ ||.+|++...++.....+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999998752 357778999886543211 124566888888887 99999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|.|...+. +...+++.....+..+++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-...
T Consensus 82 g~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 82 GDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred chhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 99877774 3445677777788888999999999887 9999999999999999999999999998653221
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
..+||..|||||++. ......|+||||++++||+||-.||.-
T Consensus 152 --~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 --IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 128999999999987 677889999999999999999999864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.8e-19 Score=194.01 Aligned_cols=199 Identities=21% Similarity=0.258 Sum_probs=161.7
Q ss_pred HHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcC---CCccceEEEEEEcCCeeE
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~ 418 (573)
++..+.|.|.+.||+|+||+||+|...+|+.||+|.-+.... .+|.--.+++.+|+ -+.|..+.....-.+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 444567999999999999999999987899999998765433 23333334444444 244555556666677889
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC-------CCCCeEEec
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-------AEMNPKISD 491 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~-------~~~~vkl~D 491 (573)
||+||.+.|+|.+++. ..+.++|.....++.|+++.++.||..+ |||+||||+|.||. +...++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999996 4567999999999999999999999987 99999999999993 334699999
Q ss_pred cCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCC
Q 008238 492 FGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN 549 (573)
Q Consensus 492 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p 549 (573)
||.+.-+..-.........++|-.+--+|...+..++.+.|.|.|.-+++-||.|+..
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9998755444444455667889999999999999999999999999999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.4e-19 Score=194.51 Aligned_cols=200 Identities=25% Similarity=0.365 Sum_probs=159.2
Q ss_pred CcccccccccceeEEEEec-CCCCeeEEEEec----cC-C-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 349 STDNKLGEGGFGEVYKGVL-PSGQEIAVKRLS----RS-S-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 349 ~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~----~~-~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
...+.+|.|.+|.|+..+. ...+..+.|.+. .. . ......+..|+.+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998877763 334444444432 11 1 111122666888888899999988887777777666669
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++ +|..++.. ...+...++..++.|++.|+.|||+.+ |.|||||++|+++..+|.+||+|||.+..+..+
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99888843 246888899999999999999999988 999999999999999999999999999877555
Q ss_pred CCc--cccccccccCCccchhccccCCCCc-cchhHHHHHHHHHHHhCCCCCCCCCC
Q 008238 502 QTQ--GNTNRIVGTYGYMAPEYAMHGQFSV-KSDVYSFGVLVLEIITGKKNSSFYQT 555 (573)
Q Consensus 502 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~-~~DvwslGvll~elltG~~p~~~~~~ 555 (573)
... ......+|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||.....
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~ 530 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK 530 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc
Confidence 443 4556788999999999999999865 68999999999999999999876443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=161.48 Aligned_cols=143 Identities=18% Similarity=0.224 Sum_probs=111.9
Q ss_pred CCCcccccccccceeEEEEe--cCCCCeeEEEEeccCCcc------------------------chHHHHHHHHHHHhcC
Q 008238 347 NFSTDNKLGEGGFGEVYKGV--LPSGQEIAVKRLSRSSGQ------------------------GGQEFKNEVVLVAKLQ 400 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 400 (573)
.|++.+.||+|++|.||+|. ..+|+.||+|++...... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 568999999998643211 0123568999999997
Q ss_pred CCc--cceEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 008238 401 HRN--LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 478 (573)
Q Consensus 401 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~N 478 (573)
+.. +.++++. ...++||||+++++|...... ...+.......++.||+.++++||+++ +++||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 633 3444443 235899999999888665422 234566677899999999999999875 49999999999
Q ss_pred EEeCCCCCeEEeccCCccccc
Q 008238 479 ILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 479 ILl~~~~~vkl~DfGla~~~~ 499 (573)
|+++ ++.++|+|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-17 Score=158.06 Aligned_cols=134 Identities=21% Similarity=0.325 Sum_probs=113.2
Q ss_pred cccccccceeEEEEecCCCCeeEEEEeccCCcc--------chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 352 NKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQ--------GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
+.||+|++|.||+|.+ .|..+++|+....... ....+.+|+.++..++|+++.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999987 7778999976533211 123577899999999999998877777777888999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988431 12 78899999999999999987 99999999999999 78899999999875
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.8e-19 Score=191.93 Aligned_cols=198 Identities=19% Similarity=0.208 Sum_probs=150.2
Q ss_pred CCCcccccccccceeEEEEecCCCCeeEEEEeccCC-ccchHHHHHHHHH--HHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS-GQGGQEFKNEVVL--VAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++...+.||.+.|=+|.+++.++|. |+||++-+.. .-..+.|.++++- ...++|||.+++.-+-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777899999999999999998887 8999886554 3344555554433 4556899999998887777777889898
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
..+ +|.|.+. .+.-+...+..-|+.|++.||.-+|..+ |+|||||.+||||..-..+.|+||...+....+..
T Consensus 103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 854 5666662 3345677788889999999999999987 99999999999999999999999998774432221
Q ss_pred -ccccccc----cccCCccchhccccC-----------CCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 504 -QGNTNRI----VGTYGYMAPEYAMHG-----------QFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 504 -~~~~~~~----~gt~~y~aPE~~~~~-----------~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
....... ..-..|+|||.+... ..+++.||||+||++.||++ |+++|++
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 1111111 223469999987441 15789999999999999987 5777753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-17 Score=155.36 Aligned_cols=141 Identities=20% Similarity=0.210 Sum_probs=111.0
Q ss_pred HHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCcc----------------------chHHHHHHHHHHHhcC
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQ----------------------GGQEFKNEVVLVAKLQ 400 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~ 400 (573)
.....|.+.+.||+|+||.||++..++|+.||||++...... .......|+.++..+.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 333448888999999999999999888999999987543210 1123567899999998
Q ss_pred CCc--cceEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 008238 401 HRN--LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 478 (573)
Q Consensus 401 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~N 478 (573)
|++ +++.++ ....++||||+++++|...... .....++.+++.++.++|+.+ |+||||||+|
T Consensus 92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~N 155 (198)
T cd05144 92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFN 155 (198)
T ss_pred HcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCccc
Confidence 874 444444 2456899999999998765420 235678899999999999977 9999999999
Q ss_pred EEeCCCCCeEEeccCCccccc
Q 008238 479 ILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 479 ILl~~~~~vkl~DfGla~~~~ 499 (573)
|++++++.++|+|||++..+.
T Consensus 156 ill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEEcCCCcEEEEECCccccCC
Confidence 999999999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=154.59 Aligned_cols=131 Identities=23% Similarity=0.369 Sum_probs=106.6
Q ss_pred ccccccceeEEEEecCCCCeeEEEEeccCCc---c-----chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 353 KLGEGGFGEVYKGVLPSGQEIAVKRLSRSSG---Q-----GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 353 ~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
.||+|++|.||+|.+ ++..+++|....... . ...++.+|++++..++|+++.....+....+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 678899998653221 1 1245778999999999987665555566667779999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
++++|.+++.... . .++.+++++|.+||+.+ ++|+|++|+||+++ ++.+++.|||+++..
T Consensus 80 ~g~~l~~~~~~~~---------~-~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN---------D-ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH---------H-HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999988873311 0 78999999999999987 99999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.6e-17 Score=179.14 Aligned_cols=140 Identities=20% Similarity=0.325 Sum_probs=113.3
Q ss_pred HHhCCCCcccccccccceeEEEEecCCCCeeEEEE-eccCCc-------cchHHHHHHHHHHHhcCCCccceEEEEEEcC
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKR-LSRSSG-------QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG 414 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 414 (573)
.....|...++||+|+||+||+|.+... .+++|+ +.+... ...+.+.+|++++..++|++++....+..+.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 3344567789999999999999987444 444443 222111 1234678999999999999999888888777
Q ss_pred CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 415 EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 415 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
+..++||||+++++|.+++. ....++.|++++|.+||+.+ ++||||||+|||+ +++.++|+|||+
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 78899999999999988873 35678999999999999987 9999999999999 677899999999
Q ss_pred cccc
Q 008238 495 AKIF 498 (573)
Q Consensus 495 a~~~ 498 (573)
++..
T Consensus 474 a~~~ 477 (535)
T PRK09605 474 GKYS 477 (535)
T ss_pred cccC
Confidence 9754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.3e-18 Score=173.14 Aligned_cols=217 Identities=22% Similarity=0.277 Sum_probs=150.6
Q ss_pred CCCcccccccccceeEEEEecCCC----CeeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceEE------EEEE--
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLPSG----QEIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRLL------GFCL-- 412 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~------~~~~-- 412 (573)
...+.+..++.+++.++..+..++ +.+.-+..+... ......+ +++..+... .|+..+..- ....
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~-r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~ 323 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTF-RQLGVLVDSSHSNRSILEDLRPSLFESSKRN 323 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhh-hhhhheeccccCCcccccCCCCchhhhcccc
Confidence 345556667777777776653332 233434333222 1222223 333333333 344332211 0111
Q ss_pred ---cCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEE
Q 008238 413 ---EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 489 (573)
Q Consensus 413 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl 489 (573)
.....++.|+++...+|.+||..++.....++...+.++.|++.+++| ++ .+|+|+||.||+...+..+||
T Consensus 324 ~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 324 KVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred ccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhh
Confidence 122467999999999999999877777778999999999999999999 55 899999999999999999999
Q ss_pred eccCCcccccCCC----CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-----------------CCC
Q 008238 490 SDFGMAKIFGVDQ----TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-----------------GKK 548 (573)
Q Consensus 490 ~DfGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-----------------G~~ 548 (573)
.|||+........ ........+||..||+||.+.+..|+.|+||||||+||+||++ |..
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~i 477 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGII 477 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCC
Confidence 9999986554333 1224456789999999999999999999999999999999998 555
Q ss_pred CCCCCCCC-CcccHHHHHHhhcc
Q 008238 549 NSSFYQTD-GAADLLSYVSINRV 570 (573)
Q Consensus 549 p~~~~~~~-~~~~ll~~~~~~~~ 570 (573)
|..+..+. ...+++++...+++
T Consensus 478 p~~~~~d~p~e~~ll~~lls~~p 500 (516)
T KOG1033|consen 478 PPEFLQDYPEEYTLLQQLLSPSP 500 (516)
T ss_pred ChHHhhcCcHHHHHHHHhcCCCc
Confidence 54444433 34478888776655
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.69 E-value=6e-17 Score=158.21 Aligned_cols=201 Identities=18% Similarity=0.302 Sum_probs=128.5
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCC----------CccceEEEEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQH----------RNLVRLLGFCL 412 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~ 412 (573)
.+...+.||.|+++.||.++.. +++++|||.+.... ....+++++|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456788999999999999964 58999999875332 2334566666655444322 12222222211
Q ss_pred ---------cC---C-----eeEEEEEccCCCChhhhccC---cC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 008238 413 ---------EG---E-----EKILVYEFVPNKSLDYFLYE---PE-KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 471 (573)
Q Consensus 413 ---------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH 471 (573)
.. . ..+++|+-+ .++|.+++.. .. ....+....++.+..|+++.+++||.++ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 125677766 5677766531 11 1122344556778899999999999998 999
Q ss_pred ecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccC--------CCCccchhHHHHHHHHHH
Q 008238 472 RDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG--------QFSVKSDVYSFGVLVLEI 543 (573)
Q Consensus 472 ~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~~~DvwslGvll~el 543 (573)
+||||+|+|++++|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999987765432211 2235679999976432 478899999999999999
Q ss_pred HhCCCCCCCCCCC
Q 008238 544 ITGKKNSSFYQTD 556 (573)
Q Consensus 544 ltG~~p~~~~~~~ 556 (573)
.+|+.|++....+
T Consensus 244 WC~~lPf~~~~~~ 256 (288)
T PF14531_consen 244 WCGRLPFGLSSPE 256 (288)
T ss_dssp HHSS-STCCCGGG
T ss_pred HHccCCCCCCCcc
Confidence 9999999865443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.5e-15 Score=136.35 Aligned_cols=135 Identities=21% Similarity=0.210 Sum_probs=114.8
Q ss_pred cccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCC--CccceEEEEEEcCCeeEEEEEccCCC
Q 008238 350 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH--RNLVRLLGFCLEGEEKILVYEFVPNK 427 (573)
Q Consensus 350 ~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 427 (573)
+.+.||+|.++.||++...+ +.+++|....... ...+.+|+.++..++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46789999999999999744 7899998865433 5678899999999987 58999999888888899999999988
Q ss_pred ChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 428 SLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 428 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
.+..+ +......++.+++++|++||.....+++|+|++|+||++++++.+++.|||.++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4566778899999999999986545699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=142.97 Aligned_cols=137 Identities=20% Similarity=0.235 Sum_probs=98.7
Q ss_pred ccccccccceeEEEEecCCCCeeEEEEeccCCccc--hHH----------------------HHHHHHHHHhcCCCc--c
Q 008238 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQG--GQE----------------------FKNEVVLVAKLQHRN--L 404 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~n--i 404 (573)
.+.||+|+||+||++...+++.||||++....... ... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 57899999999999998789999999886532211 111 134566666665443 4
Q ss_pred ceEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCEEeCC
Q 008238 405 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDA 483 (573)
Q Consensus 405 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~ 483 (573)
.+.++. ...++||||++++.+........ ... .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 34689999999965432211100 011 5678899999999999998 66 99999999999999
Q ss_pred CCCeEEeccCCccccc
Q 008238 484 EMNPKISDFGMAKIFG 499 (573)
Q Consensus 484 ~~~vkl~DfGla~~~~ 499 (573)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=6.4e-16 Score=160.42 Aligned_cols=168 Identities=26% Similarity=0.450 Sum_probs=133.4
Q ss_pred HHhcCCCccceEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCC
Q 008238 396 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK 475 (573)
Q Consensus 396 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk 475 (573)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ....+++.-...++++|++||+|||... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568899999999999999999999999999999999965 4567899999999999999999999854 23999999
Q ss_pred CCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccC---C----CCccchhHHHHHHHHHHHhCCC
Q 008238 476 ASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG---Q----FSVKSDVYSFGVLVLEIITGKK 548 (573)
Q Consensus 476 p~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~s~~~DvwslGvll~elltG~~ 548 (573)
+.|.++|..+.+||+|||+.................-..-|.|||.+... . .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998765321111111111234569999988663 1 4678999999999999999999
Q ss_pred CCCCCCC-CCcccHHHHHHh
Q 008238 549 NSSFYQT-DGAADLLSYVSI 567 (573)
Q Consensus 549 p~~~~~~-~~~~~ll~~~~~ 567 (573)
||..... +..++++.++..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK 176 (484)
T ss_pred ccccccccCChHHHHHHHHh
Confidence 9875332 233566666554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.4e-16 Score=169.16 Aligned_cols=175 Identities=24% Similarity=0.369 Sum_probs=121.2
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
.+|..++.|..|++|.||.++.+ ..+.+|+|+ .+.... .++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li----lRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI----LRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccchh----hhc---cccccCCccee-------------------
Confidence 46888999999999999999865 356677743 322110 000 22222233322
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC--
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ-- 502 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~-- 502 (573)
|+-...+.. -.+++.. ++.+++|||+.+ |+|||+||.|.||..-|++|++|||+++......
T Consensus 136 --gDc~tllk~---~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLKN---IGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhccc---CCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 333333321 1223322 277899999887 9999999999999999999999999987431110
Q ss_pred -----------CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 008238 503 -----------TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVS 566 (573)
Q Consensus 503 -----------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~ 566 (573)
........+||+.|+|||++....|...+|||++|+|+||.+.|..||.- |..++|+..+.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG---dtpeelfg~vi 271 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG---DTPEELFGQVI 271 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC---CCHHHHHhhhh
Confidence 01112346899999999999999999999999999999999999999643 44445555443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=6e-15 Score=143.20 Aligned_cols=135 Identities=23% Similarity=0.275 Sum_probs=104.6
Q ss_pred ccccc-cccceeEEEEecCCCCeeEEEEeccCC-------------ccchHHHHHHHHHHHhcCCCcc--ceEEEEEEcC
Q 008238 351 DNKLG-EGGFGEVYKGVLPSGQEIAVKRLSRSS-------------GQGGQEFKNEVVLVAKLQHRNL--VRLLGFCLEG 414 (573)
Q Consensus 351 ~~~LG-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~ 414 (573)
...|| .|+.|+||++.. ++..++||.+.... ......+.+|+.++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35677 888999999887 47789999875321 1223467889999999998885 6777764432
Q ss_pred C----eeEEEEEccCC-CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEE
Q 008238 415 E----EKILVYEFVPN-KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 489 (573)
Q Consensus 415 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl 489 (573)
. ..++|||++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 688888743 234443 3568999999999988 999999999999999999999
Q ss_pred eccCCccc
Q 008238 490 SDFGMAKI 497 (573)
Q Consensus 490 ~DfGla~~ 497 (573)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99999875
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=5e-14 Score=138.15 Aligned_cols=144 Identities=25% Similarity=0.362 Sum_probs=105.1
Q ss_pred CCCccceEEEEEEcC---------------------------CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHH
Q 008238 400 QHRNLVRLLGFCLEG---------------------------EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIG 452 (573)
Q Consensus 400 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 452 (573)
+|||||++.++|.+. ...|+||.-.+ -+|..++.. +..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 599999998877642 24578887663 467777743 3456667778899
Q ss_pred HHHHHHHHHHhCCCCCeEeecCCCCCEEe--CCCC--CeEEeccCCcccccCC----CCccccccccccCCccchhcccc
Q 008238 453 GIARGILYLHEDSRLRIIHRDLKASNILL--DAEM--NPKISDFGMAKIFGVD----QTQGNTNRIVGTYGYMAPEYAMH 524 (573)
Q Consensus 453 qia~~L~yLH~~~~~~ivH~Dlkp~NILl--~~~~--~vkl~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 524 (573)
|+++|+.|||.++ |.|||+|++|||| |+|+ .+.|+|||.+-.-+.. .........-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999988 9999999999999 4444 4789999987532210 01111223346778899998744
Q ss_pred CC------CCccchhHHHHHHHHHHHhCCCCCC
Q 008238 525 GQ------FSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 525 ~~------~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.+ .-.|+|.|+.|.+.||++....||-
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY 458 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY 458 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCccc
Confidence 32 2358999999999999999999873
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.6e-15 Score=161.19 Aligned_cols=206 Identities=24% Similarity=0.349 Sum_probs=164.3
Q ss_pred CCCCcccccccccceeEEEEecCC--CCeeEEEEeccCC--ccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPS--GQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 420 (573)
..|.+.+.||+|.|+.|-...... ...+|+|.+.... ....+.+..|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 357777889999999998887533 3445666665432 233345556888888887 99999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeecCCCCCEEeCCCC-CeEEeccCCcccc
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLH-EDSRLRIIHRDLKASNILLDAEM-NPKISDFGMAKIF 498 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH-~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~ 498 (573)
.+|..++++...+..... ...+....-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||++..+
T Consensus 100 ~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999888732111 13455666778999999999999 666 99999999999999999 9999999999877
Q ss_pred cC-CCCccccccccc-cCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 008238 499 GV-DQTQGNTNRIVG-TYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFYQT 555 (573)
Q Consensus 499 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~~~~ 555 (573)
.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 65 444444556788 9999999998874 457789999999999999999999876443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=2e-13 Score=143.96 Aligned_cols=141 Identities=21% Similarity=0.271 Sum_probs=99.3
Q ss_pred ccccccccceeEEEEecCCCCeeEEEEeccCCccch----------------------------------------HHHH
Q 008238 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGG----------------------------------------QEFK 390 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 390 (573)
.+.||.|++|.||+|++++|+.||||+.+....... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 468999999999999999999999999865321100 0244
Q ss_pred HHHHHHHhcC----CCccceEEEEEE-cCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 008238 391 NEVVLVAKLQ----HRNLVRLLGFCL-EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIAR-GILYLHED 464 (573)
Q Consensus 391 ~e~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-~L~yLH~~ 464 (573)
+|...+.+++ |.+-+.+-.++. .....+|||||++|++|.++..... ... ...+++.++++ .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHHHHHHHHhC
Confidence 4555555542 332233322322 2456799999999999988763211 112 23456666666 46788987
Q ss_pred CCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 465 SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 465 ~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
+ ++|+|+||.||++++++++++.|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 7 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.4e-12 Score=118.38 Aligned_cols=130 Identities=21% Similarity=0.163 Sum_probs=97.6
Q ss_pred ccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccc-eEEEEEEcCCeeEEEEEccCCCCh
Q 008238 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEFVPNKSL 429 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL 429 (573)
.+.|+.|..+.||+++. .++.+++|....... ....+..|+++++.+.+.+++ +++.+. .+..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 46789999999999987 478899998754432 233567899999998766654 444432 3346899999999887
Q ss_pred hhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 430 DYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.... . ....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5431 0 11235678999999999876 23469999999999999 6689999999975
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.6e-11 Score=131.09 Aligned_cols=144 Identities=16% Similarity=0.204 Sum_probs=94.4
Q ss_pred hCCCCcccccccccceeEEEEecCC-CCeeEEEEeccCCcc----------------------------------chH--
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSRSSGQ----------------------------------GGQ-- 387 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~-- 387 (573)
...|+. +.||.|++|.||++++++ |+.||||+.++.... ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445776 799999999999999877 999999998744210 011
Q ss_pred ----HHHHHHHHHHhcC----CCccceEEEEEEc-CCeeEEEEEccCCCChhhhccCcCcc---CCCCHHHHHHHHHHHH
Q 008238 388 ----EFKNEVVLVAKLQ----HRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFLYEPEKQ---QQLDWSRRYKIIGGIA 455 (573)
Q Consensus 388 ----~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qia 455 (573)
++.+|...+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++..-...+ ..+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 2334444444442 3333444344433 45678999999999997752111111 112222233333333
Q ss_pred HHHHHHHhCCCCCeEeecCCCCCEEeCCCC----CeEEeccCCccccc
Q 008238 456 RGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFGMAKIFG 499 (573)
Q Consensus 456 ~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~vkl~DfGla~~~~ 499 (573)
+..+ ++|+|+||.||+++.++ ++++.|||+...+.
T Consensus 277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3445 99999999999999888 99999999988664
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=9.7e-11 Score=108.90 Aligned_cols=137 Identities=16% Similarity=0.145 Sum_probs=99.6
Q ss_pred ccccccccceeEEEEecCC-------CCeeEEEEeccCCc----------------------cchHHHH----HHHHHHH
Q 008238 351 DNKLGEGGFGEVYKGVLPS-------GQEIAVKRLSRSSG----------------------QGGQEFK----NEVVLVA 397 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~~----~e~~~l~ 397 (573)
...||.|--+.||.|...+ +..+|||+.+.... ...+.+. +|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998543 47899997653210 0112233 7999999
Q ss_pred hcCC--CccceEEEEEEcCCeeEEEEEccCCCChhh-hccCcCccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeec
Q 008238 398 KLQH--RNLVRLLGFCLEGEEKILVYEFVPNKSLDY-FLYEPEKQQQLDWSRRYKIIGGIARGILYL-HEDSRLRIIHRD 473 (573)
Q Consensus 398 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~ivH~D 473 (573)
++.. -++.+++++ ...+|||||+.++.+.. .+ +...++..+...+..+++.+|..| |+.+ ++|+|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9864 456677764 56789999998754422 22 112345556677889999999999 7776 99999
Q ss_pred CCCCCEEeCCCCCeEEeccCCccccc
Q 008238 474 LKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 474 lkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
|++.|||+++ +.+.|+|||.+....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 679999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.1e-11 Score=124.71 Aligned_cols=166 Identities=19% Similarity=0.229 Sum_probs=125.3
Q ss_pred cCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHH
Q 008238 367 LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSR 446 (573)
Q Consensus 367 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 446 (573)
..++.+|.|+..+..........++-++.|+.++||||++++.........|||.|-+. .|..++.+ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34788899988877666445667889999999999999999999999999999999774 34444522 23556
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCC
Q 008238 447 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ 526 (573)
Q Consensus 447 ~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 526 (573)
....+.||+.||.|||+.+ +++|++|.-..|++++.|..||++|.++........ ......---.|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 6678899999999999765 599999999999999999999999998764321111 111111223466777543222
Q ss_pred CCccchhHHHHHHHHHHHhC
Q 008238 527 FSVKSDVYSFGVLVLEIITG 546 (573)
Q Consensus 527 ~s~~~DvwslGvll~elltG 546 (573)
-..|.|.||+++||++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.6e-10 Score=111.02 Aligned_cols=142 Identities=18% Similarity=0.269 Sum_probs=110.9
Q ss_pred ccccccccceeEEEEecCCCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCC--ccceEEEEEEcCC---eeEEEEEcc
Q 008238 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHR--NLVRLLGFCLEGE---EKILVYEFV 424 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~ 424 (573)
.+.|+.|..+.||++...+|+.+++|....... .....+.+|.++++.+++. ++.+++.+..... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367899999999999986678999998764332 2356788999999999764 4577777766542 568999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS--------------------------------------- 465 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--------------------------------------- 465 (573)
++.++.+.+.. ..++......++.++++.|..||+..
T Consensus 83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99988776521 35677788888889999998888531
Q ss_pred --------------CCCeEeecCCCCCEEeCC--CCCeEEeccCCcc
Q 008238 466 --------------RLRIIHRDLKASNILLDA--EMNPKISDFGMAK 496 (573)
Q Consensus 466 --------------~~~ivH~Dlkp~NILl~~--~~~vkl~DfGla~ 496 (573)
...++|+|+++.|||+++ ++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245899999999999998 6678999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.7e-11 Score=124.45 Aligned_cols=199 Identities=24% Similarity=0.311 Sum_probs=155.0
Q ss_pred hCCCCccccccc--ccceeEEEEec---CCCCeeEEEEecc--CCccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCe
Q 008238 345 TNNFSTDNKLGE--GGFGEVYKGVL---PSGQEIAVKRLSR--SSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEE 416 (573)
Q Consensus 345 ~~~~~~~~~LG~--G~~g~V~~~~~---~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 416 (573)
...+.+.+.+|. |.+|.||.+.. .++..+|+|+-+. ........=.+|+....+++ |+|.++....+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345777889999 99999999986 3678899998433 22233334456777777775 9999998888888888
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeecCCCCCEEeCCC-CCeEEec
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIAR----GILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISD 491 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~D 491 (573)
.++-.|.+. .+|..+.+. ....++...++.+..+..+ ||.++|... ++|-|+||.||++..+ ...+++|
T Consensus 193 lfiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred ceeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 999999885 677666644 2334677778888888888 999999987 9999999999999998 8899999
Q ss_pred cCCcccccCCCCccc---cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 492 FGMAKIFGVDQTQGN---TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 492 fGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
||+...++....... ..+..|...|++||.+ .+.++..+|+|++|.++.|-..|....
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccc
Confidence 999987765442221 1233677889999964 677899999999999999998887653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.8e-10 Score=100.16 Aligned_cols=131 Identities=21% Similarity=0.340 Sum_probs=101.4
Q ss_pred cccccccceeEEEEecCCCCeeEEEE-eccCC--ccc-----hHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 352 NKLGEGGFGEVYKGVLPSGQEIAVKR-LSRSS--GQG-----GQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~~~~vavK~-~~~~~--~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
..+.+|+-+.++.+.+. |..+++|. +++.- ++. .+.-.+|..++.+++--.|.-.+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999873 44466664 22221 111 23456799999999877776666677788888999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..++ +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888442 2556777888888999988 99999999999998775 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.6e-10 Score=99.23 Aligned_cols=143 Identities=23% Similarity=0.331 Sum_probs=106.8
Q ss_pred cccccccccceeEEEEecCCCCeeEEEE-eccCC-------ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 350 TDNKLGEGGFGEVYKGVLPSGQEIAVKR-LSRSS-------GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 350 ~~~~LG~G~~g~V~~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
....|-||+-+.|+++.+ .|+...||. +.+.- .-...+.++|+++|.+++--.|.-..-++.+.....|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467889999999999998 677777774 33221 112345678999999998667766666677777888999
Q ss_pred EccCC-CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC---CeEEeccCCccc
Q 008238 422 EFVPN-KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMAKI 497 (573)
Q Consensus 422 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~vkl~DfGla~~ 497 (573)
||+++ .++.+++........ .......++..|-+.+.-||..+ |+|+||..+||+|.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 477777754333222 22333678889999999999988 99999999999996554 358999999864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-10 Score=112.36 Aligned_cols=156 Identities=23% Similarity=0.277 Sum_probs=118.1
Q ss_pred HHHHHHhcCCCccceEEEEEEcC-----CeeEEEEEccCCCChhhhccCcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 008238 392 EVVLVAKLQHRNLVRLLGFCLEG-----EEKILVYEFVPNKSLDYFLYEPE-KQQQLDWSRRYKIIGGIARGILYLHEDS 465 (573)
Q Consensus 392 e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~ 465 (573)
-..-|-.+.|.|||+++.++.+. ....++.|||..|++..+|++-+ .+..+......+|+.||+.||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34445566799999999887653 34578999999999999997643 3455777788899999999999999985
Q ss_pred CCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC---CccccccccccCCccchhccccCCCCccchhHHHHHHHHH
Q 008238 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ---TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE 542 (573)
Q Consensus 466 ~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~e 542 (573)
|+|+|+++.-+.|++..++-+||.- +......... .........+-++|.+||.-.....+.++|||+||...+|
T Consensus 197 -PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 197 -PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred -CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 7899999999999999999888852 1111111110 0111222346789999998777778889999999999999
Q ss_pred HHhCCCC
Q 008238 543 IITGKKN 549 (573)
Q Consensus 543 lltG~~p 549 (573)
|..|..-
T Consensus 275 mailEiq 281 (458)
T KOG1266|consen 275 MAILEIQ 281 (458)
T ss_pred HHHheec
Confidence 9887753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.1e-09 Score=97.66 Aligned_cols=125 Identities=26% Similarity=0.355 Sum_probs=82.2
Q ss_pred eEEEEecCCCCeeEEEEeccCCc-------------c-------------chHHHHHHHHHHHhcCCC--ccceEEEEEE
Q 008238 361 EVYKGVLPSGQEIAVKRLSRSSG-------------Q-------------GGQEFKNEVVLVAKLQHR--NLVRLLGFCL 412 (573)
Q Consensus 361 ~V~~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 412 (573)
.||.|...+|..+|||..+.... . .....++|.+.|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999988899999998653210 0 012357799999999866 46666655
Q ss_pred cCCeeEEEEEccC--CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEeecCCCCCEEeCCCCCeEE
Q 008238 413 EGEEKILVYEFVP--NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY-LHEDSRLRIIHRDLKASNILLDAEMNPKI 489 (573)
Q Consensus 413 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~y-LH~~~~~~ivH~Dlkp~NILl~~~~~vkl 489 (573)
....|||||++ +..+..+... .++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24589999999 6555444321 11133455677788886666 46766 9999999999999988 8999
Q ss_pred eccCCcccc
Q 008238 490 SDFGMAKIF 498 (573)
Q Consensus 490 ~DfGla~~~ 498 (573)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.4e-09 Score=105.93 Aligned_cols=169 Identities=22% Similarity=0.339 Sum_probs=130.0
Q ss_pred ceeEEEEe-cCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEc----CCeeEEEEEccCC-CChhhh
Q 008238 359 FGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILVYEFVPN-KSLDYF 432 (573)
Q Consensus 359 ~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~ 432 (573)
-.+.||+. .-+|..|++|++.............-+++++++.|+|||++.+++.. +..+++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35788888 34899999999965544444444567889999999999999998873 4467899999986 466555
Q ss_pred ccCc------------CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 433 LYEP------------EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 433 l~~~------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
-+.. ..+...++..++.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4322 23345788999999999999999999998 88899999999999999999998888766543
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN 549 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p 549 (573)
++. |.+ .--.+-|.=.||.+++.|.||...
T Consensus 446 d~~----------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 331 001 112356889999999999999654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.8e-10 Score=117.79 Aligned_cols=194 Identities=24% Similarity=0.253 Sum_probs=146.5
Q ss_pred HhCCCCcccccccccceeEEEEec--CCCCeeEEEEeccCCccchHHH--HHHHHHHHhcC-CCccceEEEEEEcCCeeE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSRSSGQGGQEF--KNEVVLVAKLQ-HRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~--~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 418 (573)
...+|..+..||.|.|+.|++... .++..+++|.+.+.......++ ..|+.+...+. |.++++....+...+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 345788999999999999999774 3567889998765543333332 34666666664 888888777777777778
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC-CCeEEeccCCccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAKI 497 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~DfGla~~ 497 (573)
+--||++++++...+ ...+.+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||....
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999887666 23456788889999999999999999876 9999999999999875 7889999999864
Q ss_pred ccCCCCccccccccccCCcc--chhccccCCCCccchhHHHHHHHHHHHhCCC
Q 008238 498 FGVDQTQGNTNRIVGTYGYM--APEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~~DvwslGvll~elltG~~ 548 (573)
+...... ....-+++ +|+......+-.+.|+++||.-+.|.++|..
T Consensus 417 ~~~~~~~-----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 417 LAFSSGV-----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred cceeccc-----ccccccccccchhhccccccccccccccccccccccccCcc
Confidence 3221111 11223444 5555566678899999999999999998875
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=2e-08 Score=98.68 Aligned_cols=133 Identities=17% Similarity=0.156 Sum_probs=97.5
Q ss_pred eeEEEEecCCCCeeEEEEeccCCc-----------cchHHHHHHHHHHHhcCCCcc--ceEEEEEEc-----CCeeEEEE
Q 008238 360 GEVYKGVLPSGQEIAVKRLSRSSG-----------QGGQEFKNEVVLVAKLQHRNL--VRLLGFCLE-----GEEKILVY 421 (573)
Q Consensus 360 g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~-----~~~~~lv~ 421 (573)
..|.+..+ +|+.+.||....... .....+.+|...+.++...+| ++++++... ....+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34667766 678899997643221 111247789999988865444 455666543 23468999
Q ss_pred EccCCC-ChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC-------CCCeEEeccC
Q 008238 422 EFVPNK-SLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-------EMNPKISDFG 493 (573)
Q Consensus 422 e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-------~~~vkl~DfG 493 (573)
|++++. +|.+++.... ....+......++.+++..+.-||+.+ |+|+|++++|||++. +..+.|+||+
T Consensus 115 e~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 115 EDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred eeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 999986 8888874211 234566777889999999999999998 999999999999975 4689999999
Q ss_pred Cccc
Q 008238 494 MAKI 497 (573)
Q Consensus 494 la~~ 497 (573)
.++.
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8853
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=5e-10 Score=122.82 Aligned_cols=203 Identities=19% Similarity=0.225 Sum_probs=143.2
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
..+.+.+.+.+..|.++.++...- ..|...++|....... ...+....+-.++-..+||-++...--+.......|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 445677888899999999988763 2344444444332211 111222223333333445666555444556678899
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
+++|..+++|...|+... ..+..-....+..+...++|||... +.|+|++|.|+|+..+++.+++|||.....+
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999988886532 4455555666777889999999875 8999999999999999999999998433221
Q ss_pred CC---------------------CC--------ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 500 VD---------------------QT--------QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 500 ~~---------------------~~--------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
.- .. ........||+.|.+||.+.+......+|+|++|+.++|.++|..|+
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 00 00122357899999999999999999999999999999999999997
Q ss_pred CC
Q 008238 551 SF 552 (573)
Q Consensus 551 ~~ 552 (573)
.-
T Consensus 1036 na 1037 (1205)
T KOG0606|consen 1036 NA 1037 (1205)
T ss_pred CC
Confidence 53
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.9e-08 Score=95.81 Aligned_cols=136 Identities=21% Similarity=0.274 Sum_probs=97.6
Q ss_pred CCcccccccccceeEEEEecCCCCeeEEEEeccCCc----------------------cchHHHHHHHHHHHhcCCC--c
Q 008238 348 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSG----------------------QGGQEFKNEVVLVAKLQHR--N 403 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--n 403 (573)
..+.++||-|--+.||.|..++|.++|||.-+.... ......++|.+.|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 567789999999999999999999999995332100 0112457899999999765 6
Q ss_pred cceEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC
Q 008238 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 483 (573)
Q Consensus 404 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~ 483 (573)
+.+.+++ +...+||||+++-.|...- ++....-.++..|++-+.-+-..+ +||+|+++-|||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7777765 5568999999997664332 122223334444444444443444 999999999999999
Q ss_pred CCCeEEeccCCcccc
Q 008238 484 EMNPKISDFGMAKIF 498 (573)
Q Consensus 484 ~~~vkl~DfGla~~~ 498 (573)
+|.+.++||-.+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999877543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.1e-07 Score=101.06 Aligned_cols=140 Identities=19% Similarity=0.274 Sum_probs=91.8
Q ss_pred cccccccceeEEEEecCCCCeeEEEEeccCCccch----------------------------------H------HHHH
Q 008238 352 NKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGG----------------------------------Q------EFKN 391 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------~------~~~~ 391 (573)
+.|+.++-|.||+|++++|+.||||+.+....+.. + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68999999999999999999999998765421110 0 1334
Q ss_pred HHHHHHhcC----CCccceEEEEEEc-CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 008238 392 EVVLVAKLQ----HRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARG-ILYLHEDS 465 (573)
Q Consensus 392 e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~-L~yLH~~~ 465 (573)
|...+.+++ +..-+++=.++.+ .....|+|||++|..+.+..... ...++.+.+. ..++++ +..+=..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d~k~ia---~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--SAGIDRKELA---ELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH--hcCCCHHHHH---HHHHHHHHHHHHhcC
Confidence 444444442 2222223233332 46778999999999998885321 2345533332 222222 12222233
Q ss_pred CCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 466 ~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
+.|.|..|.||+++.++++.+.|||+...+.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999987664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.8e-07 Score=88.85 Aligned_cols=106 Identities=26% Similarity=0.332 Sum_probs=83.9
Q ss_pred hHHHHHHHHHHHhcCCCc--cceEEEEEEcCC----eeEEEEEccCCC-ChhhhccCcCccCCCCHHHHHHHHHHHHHHH
Q 008238 386 GQEFKNEVVLVAKLQHRN--LVRLLGFCLEGE----EKILVYEFVPNK-SLDYFLYEPEKQQQLDWSRRYKIIGGIARGI 458 (573)
Q Consensus 386 ~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L 458 (573)
.....+|...+..+.... ..+.+++..... ..++|+|++++. +|.+++... ...+......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 346788888888886444 456677665532 347999999984 788888431 1256667788999999999
Q ss_pred HHHHhCCCCCeEeecCCCCCEEeCCCC---CeEEeccCCccc
Q 008238 459 LYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMAKI 497 (573)
Q Consensus 459 ~yLH~~~~~~ivH~Dlkp~NILl~~~~---~vkl~DfGla~~ 497 (573)
.-||+.+ |+|+|++++|||++.+. .+.++||+.++.
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999998 99999999999999887 899999998775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.8e-07 Score=83.92 Aligned_cols=138 Identities=16% Similarity=0.142 Sum_probs=102.1
Q ss_pred ccccceeEEEEecCCCCeeEEEEeccC---C---ccchHHHHHHHHHHHhcCCCc--cceEEEEEEcC----CeeEEEEE
Q 008238 355 GEGGFGEVYKGVLPSGQEIAVKRLSRS---S---GQGGQEFKNEVVLVAKLQHRN--LVRLLGFCLEG----EEKILVYE 422 (573)
Q Consensus 355 G~G~~g~V~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~----~~~~lv~e 422 (573)
|+||-+.|++..+ +|+.+-+|+-... + +.....|.+|+..|.++...+ +.+++...... -..+||+|
T Consensus 27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 5688888999877 4557888876521 1 345678999999999996433 44555222221 13479999
Q ss_pred ccCC-CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC--eEEeccCCccc
Q 008238 423 FVPN-KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--PKISDFGMAKI 497 (573)
Q Consensus 423 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~--vkl~DfGla~~ 497 (573)
-+++ .+|.+++... ...+.+...+..++.+|++.+.-||+.+ +.|+|+.++|||++.++. ++++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7764 5888887432 2235677778899999999999999988 999999999999986667 99999987763
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.1e-06 Score=88.15 Aligned_cols=194 Identities=16% Similarity=0.197 Sum_probs=127.1
Q ss_pred CCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEE------EcCC-eeEE
Q 008238 348 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFC------LEGE-EKIL 419 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~------~~~~-~~~l 419 (573)
....+.||+|+-+.+|-.- +-..-+.|++.........+ .++.|... .||-+-.-+.|= -+.. ..-+
T Consensus 13 i~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 3456789999999998642 11223457766554432222 23333333 455433211111 1122 2457
Q ss_pred EEEccCCCChhhhccCc----CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 420 VYEFVPNKSLDYFLYEP----EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
.|+.+.+..--..+... ......+|.-.++.++.++.+.+-||+.+ -+-+|++++|+|+++++.+.|.|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence 77777665222222221 22345789999999999999999999998 788999999999999999999986543
Q ss_pred ccccCCCCccccccccccCCccchhccc-----cCCCCccchhHHHHHHHHHHHhC-CCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITG-KKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslGvll~elltG-~~p~~~ 552 (573)
... .........+|...|.+||.-. +..-+...|.|.||+++++++.| +.||+-
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 322 1222334468899999999654 23446789999999999999887 888863
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.9e-06 Score=81.63 Aligned_cols=132 Identities=20% Similarity=0.237 Sum_probs=86.0
Q ss_pred cccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCc--cceEEEEEEcCCeeEEEEEccCCCC-
Q 008238 352 NKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN--LVRLLGFCLEGEEKILVYEFVPNKS- 428 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs- 428 (573)
.+||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 35567888876432 3456788999999987544 4677788777777889999999963
Q ss_pred hhhhccCcCccCCCCHHHHHHHHHHHHHH---------------------------------------HHHHHh-CCCCC
Q 008238 429 LDYFLYEPEKQQQLDWSRRYKIIGGIARG---------------------------------------ILYLHE-DSRLR 468 (573)
Q Consensus 429 L~~~l~~~~~~~~l~~~~~~~i~~qia~~---------------------------------------L~yLH~-~~~~~ 468 (573)
+...+.. +......++.++++. ..+|.. .....
T Consensus 82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 2211110 000011111111111 122221 12345
Q ss_pred eEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 469 IIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 469 ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
++|+|+.|.||++++++ +.|.||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 79999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.9e-06 Score=78.84 Aligned_cols=149 Identities=19% Similarity=0.229 Sum_probs=96.8
Q ss_pred HHHHHhCCCCccc---ccccccceeEEEEecCCCCeeEEEEeccCCccchH------------------------HHHHH
Q 008238 340 TIEVATNNFSTDN---KLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQ------------------------EFKNE 392 (573)
Q Consensus 340 ~~~~~~~~~~~~~---~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~e 392 (573)
.+.....+..+.+ .|++|--+.||+|...++..+|||+++.......+ -...|
T Consensus 39 ~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kE 118 (268)
T COG1718 39 TLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKE 118 (268)
T ss_pred HHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHH
Confidence 3334444444444 45567777899999878999999998654221111 12346
Q ss_pred HHHHHhcC--CCccceEEEEEEcCCeeEEEEEccCCCCh-hhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 008238 393 VVLVAKLQ--HRNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRI 469 (573)
Q Consensus 393 ~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 469 (573)
..-|.++. +-.+.+.+++ .+..|||||+..... .-.|. .-++...+...+..++++.+.-|-... ++
T Consensus 119 f~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a--~L 188 (268)
T COG1718 119 FRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEA--GL 188 (268)
T ss_pred HHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhc--Cc
Confidence 66666664 3344555554 345799999976521 12221 122233356677788888888876632 49
Q ss_pred EeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 470 IHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 470 vH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||+||+.-|||+. ++.+.|+|||.+....
T Consensus 189 VHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 189 VHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ccccchhhheEEE-CCeEEEEECccccccC
Confidence 9999999999999 7899999999987544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.5e-06 Score=78.27 Aligned_cols=139 Identities=15% Similarity=0.158 Sum_probs=92.9
Q ss_pred HHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHH---------HHHHHHHHhcCCCc---cceEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEF---------KNEVVLVAKLQHRN---LVRLLGF 410 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~h~n---iv~l~~~ 410 (573)
....+|.+.+.+-......|.+-.. +|+.+.+|..+.......+.| .+++..+.+++... +..++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3456788888887777777877776 678899998765433332222 33444444443322 2232222
Q ss_pred EE-----cCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC
Q 008238 411 CL-----EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 485 (573)
Q Consensus 411 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~ 485 (573)
.. .....+++|||++|..|.+... ++. .+...+.+.+.-||+.+ +.|+|.+|.|+++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence 22 2245578999999988866541 222 24456778899999988 99999999999998665
Q ss_pred CeEEeccCCccc
Q 008238 486 NPKISDFGMAKI 497 (573)
Q Consensus 486 ~vkl~DfGla~~ 497 (573)
+++.||+..+.
T Consensus 173 -i~iID~~~k~~ 183 (229)
T PF06176_consen 173 -IRIIDTQGKRM 183 (229)
T ss_pred -EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.1e-07 Score=99.89 Aligned_cols=196 Identities=18% Similarity=0.126 Sum_probs=139.8
Q ss_pred hhHHHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCc-cceEEEEEEcCCe
Q 008238 338 FETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN-LVRLLGFCLEGEE 416 (573)
Q Consensus 338 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~ 416 (573)
..+++..++-+...+.++++++++++|.+-.-.+....+.+... ....-++++|.+++||| .+..++-+..++.
T Consensus 234 pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 234 PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred CCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence 33444455556677788999999999987433344445554322 45566899999999999 6666666666677
Q ss_pred eEEEEEccCCC-ChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 417 KILVYEFVPNK-SLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 417 ~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
.+++++++..+ +-..-.. .....+..-+...+.+.-.+++++||+.. -+|+| |||..+ +..+..||+..
T Consensus 309 ~~i~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~ 378 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVP 378 (829)
T ss_pred cchhhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCC
Confidence 88999999887 2211110 11122334445566677788999999864 48998 887766 57899999998
Q ss_pred ccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
..+.... ......+++.|+|||+...+.+..+.|.|++++-..+|--|-.|..
T Consensus 379 ~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 379 PQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 7664332 3445678999999999999999999999999988778877777643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.24 E-value=7.4e-06 Score=79.07 Aligned_cols=143 Identities=20% Similarity=0.225 Sum_probs=85.2
Q ss_pred ccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCc--cceEEEEEEcC---CeeEEEEEccC
Q 008238 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN--LVRLLGFCLEG---EEKILVYEFVP 425 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~---~~~~lv~e~~~ 425 (573)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+.... +.+++...... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999999866 69999987544 45567888999998886443 45666644332 34689999999
Q ss_pred CCChhhh----------------cc---Cc-CccCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 008238 426 NKSLDYF----------------LY---EP-EKQQQLDWSR---------RYKI------------IGGIAR-GILYLHE 463 (573)
Q Consensus 426 ~gsL~~~----------------l~---~~-~~~~~l~~~~---------~~~i------------~~qia~-~L~yLH~ 463 (573)
+..+... +. .. .......+.. .... ...+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 9888771 00 00 0001111100 0000 111222 2333332
Q ss_pred ----CCCCCeEeecCCCCCEEeC-CCCCeEEeccCCcc
Q 008238 464 ----DSRLRIIHRDLKASNILLD-AEMNPKISDFGMAK 496 (573)
Q Consensus 464 ----~~~~~ivH~Dlkp~NILl~-~~~~vkl~DfGla~ 496 (573)
.....++|+|+.|+|||++ +++.+.|.||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2345699999999999999 66667899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.8e-05 Score=77.26 Aligned_cols=140 Identities=16% Similarity=0.151 Sum_probs=86.1
Q ss_pred ccccccc-eeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEEEEccCCCChh
Q 008238 353 KLGEGGF-GEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKSLD 430 (573)
Q Consensus 353 ~LG~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 430 (573)
.|..|.. ..||+.... +..+.||+..... ..++.+|+++++.+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 679998764 4778888875432 345678888888885 344567788777666789999999998876
Q ss_pred hhcc-------------------CcC-ccCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----C
Q 008238 431 YFLY-------------------EPE-KQQQLDW--SRRYKIIG--------------------GIARGILYLHE----D 464 (573)
Q Consensus 431 ~~l~-------------------~~~-~~~~l~~--~~~~~i~~--------------------qia~~L~yLH~----~ 464 (573)
.... ... ...++.. ...+.... .+...++.|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4421 000 0001110 00000000 01111222211 1
Q ss_pred CCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 465 SRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 465 ~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
..+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23569999999999999998778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.2e-07 Score=96.67 Aligned_cols=96 Identities=25% Similarity=0.472 Sum_probs=74.8
Q ss_pred HHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC-------ccccccccccCCccchhcccc
Q 008238 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT-------QGNTNRIVGTYGYMAPEYAMH 524 (573)
Q Consensus 452 ~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~ 524 (573)
.+++.||.|+|..- ++||++|.|++|.++.++.+||+.|+.+........ .....-......|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34569999999864 799999999999999999999999998764322111 011111234568999999999
Q ss_pred CCCCccchhHHHHHHHHHHHhCCCC
Q 008238 525 GQFSVKSDVYSFGVLVLEIITGKKN 549 (573)
Q Consensus 525 ~~~s~~~DvwslGvll~elltG~~p 549 (573)
...+.++|+||+|+++|-+..|.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcc
Confidence 8889999999999999999955554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.5e-05 Score=74.31 Aligned_cols=105 Identities=23% Similarity=0.209 Sum_probs=82.4
Q ss_pred HHHHHHHHhcCC-CccceEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 008238 390 KNEVVLVAKLQH-RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLR 468 (573)
Q Consensus 390 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ 468 (573)
.+|..++..+++ +++++++|.|- .+++.||...+++...-..-..-..-+|..+.+|+.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999986 69999999984 3778999998766421100011124689999999999999999998854445
Q ss_pred eEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 469 IIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 469 ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+.-.|++++|+-+++++++|+.|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.6e-05 Score=84.66 Aligned_cols=141 Identities=14% Similarity=0.235 Sum_probs=90.8
Q ss_pred ccccccccceeEEEEecCCCCeeEEEEeccCCccc-------------------------------hH------HHHHHH
Q 008238 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQG-------------------------------GQ------EFKNEV 393 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~e~ 393 (573)
.+.||..+.|.||++++++|+.||||+-+..-... .+ +|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46899999999999999999999999876432111 00 234444
Q ss_pred HHHHh----cCCCcc---ceEEEEEEc-CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 008238 394 VLVAK----LQHRNL---VRLLGFCLE-GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465 (573)
Q Consensus 394 ~~l~~----l~h~ni---v~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~ 465 (573)
+-..+ ++|-++ |.+=.++++ .....|+|||++|..+.+...- ....++...+..-+.++..-+-+-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf~~--- 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIFKT--- 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHHhc---
Confidence 44333 345451 112223332 3467899999999888776422 2234555554444433322222222
Q ss_pred CCCeEeecCCCCCEEeCC----CCCeEEeccCCcccc
Q 008238 466 RLRIIHRDLKASNILLDA----EMNPKISDFGMAKIF 498 (573)
Q Consensus 466 ~~~ivH~Dlkp~NILl~~----~~~vkl~DfGla~~~ 498 (573)
+++|.|=.|.||++.. +..+.+.|||+....
T Consensus 321 --GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 321 --GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred --CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 3999999999999984 678999999998754
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.06 E-value=6e-05 Score=86.59 Aligned_cols=79 Identities=11% Similarity=0.307 Sum_probs=58.4
Q ss_pred ccccccccceeEEEEecCCC---CeeEEEEeccCC-ccchHHHHHHHHHHHhcC-CCcc--ceEEEEEEcC---CeeEEE
Q 008238 351 DNKLGEGGFGEVYKGVLPSG---QEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQ-HRNL--VRLLGFCLEG---EEKILV 420 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 420 (573)
.++|+.|.+..+|+....++ ..+++|+..... ......+.+|.++++.+. |.++ .+++.++.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999886543 467778764322 223457889999999996 6665 7778887764 357899
Q ss_pred EEccCCCCh
Q 008238 421 YEFVPNKSL 429 (573)
Q Consensus 421 ~e~~~~gsL 429 (573)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=6.3e-05 Score=67.57 Aligned_cols=130 Identities=19% Similarity=0.274 Sum_probs=88.4
Q ss_pred CCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccc-eEEEEEEcCCeeEEEEEccCC
Q 008238 348 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~ 426 (573)
....+.|++|+.|.||+|.+ .|..+|+|+-.. +.....++.|.++|..++-.++- +++.+- +.++.|||+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW-RGGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeec-cCceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcC
Confidence 34567899999999999999 455888888653 34457889999999999877764 444442 33455999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCC-CCCEEeCCCCCeEEeccCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK-ASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk-p~NILl~~~~~vkl~DfGla~~ 497 (573)
-.|.+.-.. .+.++++. +++.---|...+ |-|+.|+ |..++|-.++.+.|+||..+..
T Consensus 97 ~~L~~~~~~------~~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIG------GDRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhc------ccHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 888766522 12333333 333322343334 8888886 4444444444899999999874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00011 Score=68.80 Aligned_cols=134 Identities=21% Similarity=0.327 Sum_probs=91.7
Q ss_pred CcccccccccceeEEEEecCCCCeeEEEEeccCC----------------ccchHHHHHHHHHHHhcC------CCccce
Q 008238 349 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS----------------GQGGQEFKNEVVLVAKLQ------HRNLVR 406 (573)
Q Consensus 349 ~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~ 406 (573)
+....||+|+.-.||. .++.....||+..... ....++..+|+.-...+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 3456899999999997 4556677888876544 122355666766666655 788999
Q ss_pred EEEEEEcCCeeEEEEEccCC------CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEE
Q 008238 407 LLGFCLEGEEKILVYEFVPN------KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 480 (573)
Q Consensus 407 l~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIL 480 (573)
++|+.+.+...-+|+|.+.+ -+|.+++ +...++. ...+.+. +-.+||-++. |+.+|++|+||+
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEE
Confidence 99999999999999998743 2456666 3344555 3333333 4445666555 999999999999
Q ss_pred eCCC--C--CeEEec-cCCc
Q 008238 481 LDAE--M--NPKISD-FGMA 495 (573)
Q Consensus 481 l~~~--~--~vkl~D-fGla 495 (573)
+... + .+.|+| ||-.
T Consensus 151 ~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EEecCCCceEEEEEeCCCCc
Confidence 9532 2 477777 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00018 Score=72.39 Aligned_cols=80 Identities=11% Similarity=0.064 Sum_probs=59.0
Q ss_pred CCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCC---CccceEEEEEEcC---CeeEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH---RNLVRLLGFCLEG---EEKILV 420 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~---~~~~lv 420 (573)
.....+.||.|..+.||+....++ .+.+|..+. ......+..|.+.|+.+.. -.+.++++++... +..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 445567899999999999876555 466676432 1133578899999998863 3578888887653 568999
Q ss_pred EEccCCCCh
Q 008238 421 YEFVPNKSL 429 (573)
Q Consensus 421 ~e~~~~gsL 429 (573)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.95 E-value=8.3e-05 Score=72.18 Aligned_cols=74 Identities=18% Similarity=0.268 Sum_probs=47.2
Q ss_pred cccccccce-eEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCC---ccceEEEEEEcCC---eeEEEEEcc
Q 008238 352 NKLGEGGFG-EVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHR---NLVRLLGFCLEGE---EKILVYEFV 424 (573)
Q Consensus 352 ~~LG~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~e~~ 424 (573)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|.+++..+... -+.++++.....+ ..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777776 48875 235777765432 2345788999999888632 2444444433322 347899999
Q ss_pred CCCChhh
Q 008238 425 PNKSLDY 431 (573)
Q Consensus 425 ~~gsL~~ 431 (573)
+|.++.+
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9987753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00015 Score=67.34 Aligned_cols=125 Identities=27% Similarity=0.407 Sum_probs=88.1
Q ss_pred CCCCcccccccccc-eeEEEEecCCCCeeEEEEecc---CCc------------------cchHHHHHHHHHHHhcC---
Q 008238 346 NNFSTDNKLGEGGF-GEVYKGVLPSGQEIAVKRLSR---SSG------------------QGGQEFKNEVVLVAKLQ--- 400 (573)
Q Consensus 346 ~~~~~~~~LG~G~~-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l~--- 400 (573)
.+++..+.||.|.- |.||++++ +|+.+|+|.++. ... .....|..|.....+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 56888999999999 99999998 778999999321 100 11235777888777765
Q ss_pred CCcc--ceEEEEEEcCC------------------eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHH
Q 008238 401 HRNL--VRLLGFCLEGE------------------EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460 (573)
Q Consensus 401 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~y 460 (573)
+.++ |+.+||..-.. ...||.||.+... .+.. +-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4566 89999874221 1246777765442 1222 234567778888
Q ss_pred HHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 461 LH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
+|..+ |+-+|+++.|.. + -+|+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc---C--CEEEecccC
Confidence 99877 999999999986 3 388999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00016 Score=70.19 Aligned_cols=141 Identities=20% Similarity=0.245 Sum_probs=82.8
Q ss_pred ccccccccceeEEEEecCC--CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCcc-ceEEEEEEcCCeeEEEEEccCCC
Q 008238 351 DNKLGEGGFGEVYKGVLPS--GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFVPNK 427 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g 427 (573)
.+.|..|-...+|+....+ ++.|++|+....... ..+..+|+.+++.+...++ +++++... ..++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567778888999998654 678899977543222 2334578889888864444 44444322 24899999997
Q ss_pred Chhhh-c----------------cCcCcc--------CCC-CHHHHHHHHH----------------------HHHHHHH
Q 008238 428 SLDYF-L----------------YEPEKQ--------QQL-DWSRRYKIIG----------------------GIARGIL 459 (573)
Q Consensus 428 sL~~~-l----------------~~~~~~--------~~l-~~~~~~~i~~----------------------qia~~L~ 459 (573)
++... + +..... ... -+..+..+.. .+.+-+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 76322 1 000000 011 1222212211 1111112
Q ss_pred HH----HhC-CCCCeEeecCCCCCEEeCC-CCCeEEeccCCcc
Q 008238 460 YL----HED-SRLRIIHRDLKASNILLDA-EMNPKISDFGMAK 496 (573)
Q Consensus 460 yL----H~~-~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~ 496 (573)
.| ... ....++|+|+.+.|||+++ ++.+.|+||..+.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 22 111 2346999999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00014 Score=71.53 Aligned_cols=139 Identities=17% Similarity=0.111 Sum_probs=81.3
Q ss_pred ccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCcc-ceEEEEEEcCCeeEEEEEccCCCChhh
Q 008238 353 KLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFVPNKSLDY 431 (573)
Q Consensus 353 ~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~ 431 (573)
.+..|-...+|+... +++.+++|...........+..+|..+++.+....+ .+++... ..++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 355677788998874 677888887654333221245789999998875444 3444432 2478999999877643
Q ss_pred h-----------------ccCcC-ccCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCeEeecCCCCC
Q 008238 432 F-----------------LYEPE-KQQQLDWSRR-YKIIGG---------IARGILYLHED-----SRLRIIHRDLKASN 478 (573)
Q Consensus 432 ~-----------------l~~~~-~~~~l~~~~~-~~i~~q---------ia~~L~yLH~~-----~~~~ivH~Dlkp~N 478 (573)
. ++... ...+++.... ..+..+ +.+.+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2 01110 1112222211 111111 11112222211 12358999999999
Q ss_pred EEeCCCCCeEEeccCCccc
Q 008238 479 ILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 479 ILl~~~~~vkl~DfGla~~ 497 (573)
|++++++ +.|.||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00045 Score=69.51 Aligned_cols=142 Identities=18% Similarity=0.170 Sum_probs=85.9
Q ss_pred ccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCc--cceEEEE------EEcCCeeEEEEE
Q 008238 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN--LVRLLGF------CLEGEEKILVYE 422 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e 422 (573)
.+.|..|....+|+.... +..+++|+... .....+..|+.++..+.+.+ +.+++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 557777888899998764 45788898764 23455677888888885433 4444431 223445689999
Q ss_pred ccCCCChhhh----cc----------Cc----C----ccCCCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 008238 423 FVPNKSLDYF----LY----------EP----E----KQQQLDWSRRY----------KIIGGIARGILYLHE----DSR 466 (573)
Q Consensus 423 ~~~~gsL~~~----l~----------~~----~----~~~~l~~~~~~----------~i~~qia~~L~yLH~----~~~ 466 (573)
|++|..+... .. .. . ......|.... .....+...+.++.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9999776431 00 00 0 00111221110 011123334445443 122
Q ss_pred CCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 467 LRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 467 ~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
..++|+|+.|.|||+++++.+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 459999999999999998777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00095 Score=69.33 Aligned_cols=76 Identities=14% Similarity=0.184 Sum_probs=54.1
Q ss_pred ccccccccceeEEEEecCCC-CeeEEEEeccC------C-ccchHHHHHHHHHHHhcC---CCccceEEEEEEcCCeeEE
Q 008238 351 DNKLGEGGFGEVYKGVLPSG-QEIAVKRLSRS------S-GQGGQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l 419 (573)
.+.||.|.+..||++...+| +.++||.-... . ....+....|.+.|..+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46799999999999998776 48999974311 1 123456677888887763 2456777776 4456789
Q ss_pred EEEccCCCC
Q 008238 420 VYEFVPNKS 428 (573)
Q Consensus 420 v~e~~~~gs 428 (573)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0025 Score=64.88 Aligned_cols=142 Identities=16% Similarity=0.171 Sum_probs=78.3
Q ss_pred ccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCc--cceEEE------EEEcCCeeEEEEE
Q 008238 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN--LVRLLG------FCLEGEEKILVYE 422 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~e 422 (573)
.+.|+.|....+|+....+| .+++|++... ..+.+..|+.++..+...+ +.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 45677777789999886555 6888987621 2234445556666553222 333332 1223456789999
Q ss_pred ccCCCChhhh----c----------cCcC--------ccCCCCH-HHHHH------------HH-HHHHHHHHHHHhC--
Q 008238 423 FVPNKSLDYF----L----------YEPE--------KQQQLDW-SRRYK------------II-GGIARGILYLHED-- 464 (573)
Q Consensus 423 ~~~~gsL~~~----l----------~~~~--------~~~~l~~-~~~~~------------i~-~qia~~L~yLH~~-- 464 (573)
|++|..+... . +... ....+.| ..... .+ ..+...++.+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 9998754211 0 0000 0011112 11111 11 1111222333211
Q ss_pred --CCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 465 --SRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 465 --~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
-...++|+|+.|.|||++.+...-|.||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999977656899999875
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00033 Score=68.85 Aligned_cols=148 Identities=19% Similarity=0.229 Sum_probs=98.6
Q ss_pred cccchhHHHHHhC---CCCcccccccccceeEEEEecCCCCeeEEEEeccC------------------Cccc----hHH
Q 008238 334 LQFDFETIEVATN---NFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRS------------------SGQG----GQE 388 (573)
Q Consensus 334 ~~~~~~~~~~~~~---~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~------------------~~~~----~~~ 388 (573)
..+++-.+..... -++..++||-|--+.||.+...+|++.++|.-+-. +..+ .-.
T Consensus 77 ~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRla 156 (465)
T KOG2268|consen 77 AGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLA 156 (465)
T ss_pred ccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHH
Confidence 3455544444333 36788999999999999999989999998843210 0000 112
Q ss_pred HHHHHHHHHhcCCCc--cceEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 008238 389 FKNEVVLVAKLQHRN--LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSR 466 (573)
Q Consensus 389 ~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~ 466 (573)
...|...|+.+.... +.+.+++ +..++|||++.+-.|...-+ ..+..++ ...+..-+--|-.++
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~l---y~~lm~~Iv~la~~G- 222 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTL---YDDLMGLIVRLANHG- 222 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHH---HHHHHHHHHHHHHcC-
Confidence 456888888886322 3444443 45689999999888765442 1233333 333333444565555
Q ss_pred CCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 467 LRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 467 ~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
+||+|..--||++++++.++++||--...
T Consensus 223 --lIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 223 --LIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred --ceecccchheeEEecCCCEEEeechHhhc
Confidence 99999999999999999999999986543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0048 Score=62.43 Aligned_cols=143 Identities=17% Similarity=0.191 Sum_probs=83.1
Q ss_pred ccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCc--cceEEEE------EEcCCeeEEEEE
Q 008238 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN--LVRLLGF------CLEGEEKILVYE 422 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e 422 (573)
.+.++.|....+|+.+..++ .+++|+..... ...++..|++++..+.... +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876444 67788765422 2345566777777774322 3444431 122456789999
Q ss_pred ccCCCChhhh--------------ccCcCc----c-----CCCCHHHHH------------HHHHHHHHHHHHHHh----
Q 008238 423 FVPNKSLDYF--------------LYEPEK----Q-----QQLDWSRRY------------KIIGGIARGILYLHE---- 463 (573)
Q Consensus 423 ~~~~gsL~~~--------------l~~~~~----~-----~~l~~~~~~------------~i~~qia~~L~yLH~---- 463 (573)
|++|..+... ++.... . ..-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998654311 010000 0 001111110 011223344555532
Q ss_pred CCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 464 ~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.....++|+|+++.||++++++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123569999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0028 Score=63.58 Aligned_cols=144 Identities=19% Similarity=0.205 Sum_probs=96.7
Q ss_pred CcccccccccceeEEEEecCCCCeeEEEEeccCCc-----------c-----------chH----HHHHHHHHHHhcCCC
Q 008238 349 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSG-----------Q-----------GGQ----EFKNEVVLVAKLQHR 402 (573)
Q Consensus 349 ~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~-----------~~~----~~~~e~~~l~~l~h~ 402 (573)
.+...|..|--+.||.+.-.+|..+|||+++.+.- + ..+ -...|+.-|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 34557888999999999988999999998764310 0 001 124467777777654
Q ss_pred ccceEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC
Q 008238 403 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 482 (573)
Q Consensus 403 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~ 482 (573)
.|.-.--... ....|||+|+..... -...-+.-.++...+..+-.|++.-|.-|-+.. ++||.||.--|+|+-
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 4321111111 234689999964322 111123455677778888888999888887765 599999999999984
Q ss_pred CCCCeEEeccCCcccccC
Q 008238 483 AEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 483 ~~~~vkl~DfGla~~~~~ 500 (573)
+|.+.|+|.+-+.....
T Consensus 300 -dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred -CCEEEEEEccccccCCC
Confidence 56899999988765443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0038 Score=62.98 Aligned_cols=141 Identities=26% Similarity=0.337 Sum_probs=84.6
Q ss_pred cccccccceeEEEEecCC-------CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCcc-ceEEEEEEcCCeeEEEEEc
Q 008238 352 NKLGEGGFGEVYKGVLPS-------GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 423 (573)
+.|..|-...+|+....+ ++.+++|+..... ....+..+|.+++..+....+ .++++.+. ..+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 455566667899988654 5789999876543 233456788888888864444 35555543 2368999
Q ss_pred cCCCChhhh-cc----------------CcCccC------CCC--HHHHHH--------------------------HHH
Q 008238 424 VPNKSLDYF-LY----------------EPEKQQ------QLD--WSRRYK--------------------------IIG 452 (573)
Q Consensus 424 ~~~gsL~~~-l~----------------~~~~~~------~l~--~~~~~~--------------------------i~~ 452 (573)
++|..+... +. ...... ..+ +..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776432 11 100000 010 111111 112
Q ss_pred HHHHHHHHHHh------CCCCCeEeecCCCCCEEeCCC----CCeEEeccCCccc
Q 008238 453 GIARGILYLHE------DSRLRIIHRDLKASNILLDAE----MNPKISDFGMAKI 497 (573)
Q Consensus 453 qia~~L~yLH~------~~~~~ivH~Dlkp~NILl~~~----~~vkl~DfGla~~ 497 (573)
++..-+..|.. .....++|+|+.+.|||++++ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22233444432 234579999999999999885 8899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0029 Score=63.01 Aligned_cols=76 Identities=18% Similarity=0.265 Sum_probs=49.5
Q ss_pred CCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcC---CCccceEEEEEEcCCeeEEEEEcc
Q 008238 348 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
.+..+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+++++....+..+|++||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 4456678989999999988 478889999875 233456788888888884 445778899888888889999999
Q ss_pred CCC
Q 008238 425 PNK 427 (573)
Q Consensus 425 ~~g 427 (573)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0031 Score=71.73 Aligned_cols=154 Identities=22% Similarity=0.197 Sum_probs=110.4
Q ss_pred HHHHHHHHhcCCCccceEEEEEEcCCeeE----EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 008238 390 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI----LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465 (573)
Q Consensus 390 ~~e~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~ 465 (573)
.-|++.+.+..|+|++.++.|-......- +.-+++..-++...+.. -..++....+.+..++.+||.|+|+..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 44777888889999999999876654332 33456666666666632 356788899999999999999999875
Q ss_pred CCCeEeecCCCC---CEEeCCCCCeEEe--ccCCcccccCCCCccccccccccCCccchhccccCCCC--ccchhHHHHH
Q 008238 466 RLRIIHRDLKAS---NILLDAEMNPKIS--DFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFS--VKSDVYSFGV 538 (573)
Q Consensus 466 ~~~ivH~Dlkp~---NILl~~~~~vkl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s--~~~DvwslGv 538 (573)
..|.-|..+ +...+.++.+.++ ||+.++.+....... ...-+..|.+||........ ...|+|.+|.
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHH
Confidence 566655555 5556677777777 999887654332211 12235568888877666554 4579999999
Q ss_pred HHHHHHhCCCCCCC
Q 008238 539 LVLEIITGKKNSSF 552 (573)
Q Consensus 539 ll~elltG~~p~~~ 552 (573)
++..+..|..+...
T Consensus 381 l~~~~~~~~~i~~~ 394 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEK 394 (1351)
T ss_pred HHhhhhhcCccccc
Confidence 99999999876543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.007 Score=60.14 Aligned_cols=31 Identities=29% Similarity=0.544 Sum_probs=25.8
Q ss_pred CCeEeecCCCCCEEeCCCCC-eEEeccCCccc
Q 008238 467 LRIIHRDLKASNILLDAEMN-PKISDFGMAKI 497 (573)
Q Consensus 467 ~~ivH~Dlkp~NILl~~~~~-vkl~DfGla~~ 497 (573)
+.++|+|+++.|||++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0076 Score=61.98 Aligned_cols=141 Identities=23% Similarity=0.281 Sum_probs=82.8
Q ss_pred cccccccceeEEEEecCC-----CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccc-eEEEEEEcCCeeEEEEEccC
Q 008238 352 NKLGEGGFGEVYKGVLPS-----GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~ 425 (573)
+.|-.|-.-.+|+..+.+ ++.|++|+......... +..+|..+++.+...++- ++++.+..+ .|.+|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345456667899987532 36788998765543332 337789998888755553 556655332 5899998
Q ss_pred CCChhhh-c----------------cCcC---ccCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 008238 426 NKSLDYF-L----------------YEPE---KQQQLDWSRRYKIIGGI-----------------ARGILYL----HE- 463 (573)
Q Consensus 426 ~gsL~~~-l----------------~~~~---~~~~l~~~~~~~i~~qi-----------------a~~L~yL----H~- 463 (573)
+.++... + |... ......+.++.++..++ ..-+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776422 1 1100 01112233333332221 1112222 21
Q ss_pred CCCCCeEeecCCCCCEEeCC-CCCeEEeccCCccc
Q 008238 464 DSRLRIIHRDLKASNILLDA-EMNPKISDFGMAKI 497 (573)
Q Consensus 464 ~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~ 497 (573)
.....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346999999999999986 46899999998764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.022 Score=57.27 Aligned_cols=140 Identities=19% Similarity=0.285 Sum_probs=82.4
Q ss_pred CcccccccccceeEEEEecCCCCeeEEEEec-cCCccchHHHHHHHHHHHhcCC--CccceEEEEEEcCC--eeEEEEEc
Q 008238 349 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLS-RSSGQGGQEFKNEVVLVAKLQH--RNLVRLLGFCLEGE--EKILVYEF 423 (573)
Q Consensus 349 ~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~ 423 (573)
.+.+.+..|..-.+|.... .++++++++-. ...........+|..+++.+.- --+.+.++.|.++. ..+.||+|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred ceeeeccCCcccceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 3444443343334555444 37778888221 1223334556778888888753 22345566676665 66999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHH-HHHHHHHHHHH----------------------------------------
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKII-GGIARGILYLH---------------------------------------- 462 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~-~qia~~L~yLH---------------------------------------- 462 (573)
.+|..+...+.... .. .+++ ..+++.|.-||
T Consensus 107 veGe~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 107 VEGEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred ecceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 99854433321100 00 0111 13333333333
Q ss_pred ----------hC-----CCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 463 ----------ED-----SRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 463 ----------~~-----~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
.+ +++.++|+|+.+.||++++++-+-+.||+++..
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 22 235699999999999999998899999999864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.024 Score=57.86 Aligned_cols=74 Identities=18% Similarity=0.188 Sum_probs=47.7
Q ss_pred cccccccceeEEEEecCCC-CeeEEEEecc-------CCccchHHHHHHHHHHHhcC--CC-ccceEEEEEEcCCeeEEE
Q 008238 352 NKLGEGGFGEVYKGVLPSG-QEIAVKRLSR-------SSGQGGQEFKNEVVLVAKLQ--HR-NLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv 420 (573)
+.||.|....||++..++| +.|+||.-.. +-+-..++...|.+.|+... -| .+++++.+ +.+...+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 3579999999999997654 5899996321 11233345556777776653 34 34445443 55566799
Q ss_pred EEccCCC
Q 008238 421 YEFVPNK 427 (573)
Q Consensus 421 ~e~~~~g 427 (573)
||+++..
T Consensus 79 MEdL~~~ 85 (370)
T TIGR01767 79 MEDLSHH 85 (370)
T ss_pred HhhCccc
Confidence 9999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.048 Score=55.35 Aligned_cols=140 Identities=21% Similarity=0.301 Sum_probs=83.1
Q ss_pred ccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCcc---ce---EEE----EEEcCCeeEEEEE
Q 008238 353 KLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNL---VR---LLG----FCLEGEEKILVYE 422 (573)
Q Consensus 353 ~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni---v~---l~~----~~~~~~~~~lv~e 422 (573)
.|.+ .-..+|+....+|+. ++|..+.. ....++..|++.+..+.-..| ++ +-| ....+...+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 456799998867666 88887654 455677778888888743222 12 212 1112236778999
Q ss_pred ccCCCChhh-hcc------------------C-----cCccCCCCHHH-------------HHHHHHHHHHHHHHHHhC-
Q 008238 423 FVPNKSLDY-FLY------------------E-----PEKQQQLDWSR-------------RYKIIGGIARGILYLHED- 464 (573)
Q Consensus 423 ~~~~gsL~~-~l~------------------~-----~~~~~~l~~~~-------------~~~i~~qia~~L~yLH~~- 464 (573)
|++|..+.. ... . +.......|.. ......++...++.+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988873 110 0 00011223320 011233344444444432
Q ss_pred ---CC---CCeEeecCCCCCEEeCCCCC-eEEeccCCcc
Q 008238 465 ---SR---LRIIHRDLKASNILLDAEMN-PKISDFGMAK 496 (573)
Q Consensus 465 ---~~---~~ivH~Dlkp~NILl~~~~~-vkl~DfGla~ 496 (573)
-. ..+||+|+.|.|||++++.. +-+.||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11 22899999999999999885 8899999875
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.08 Score=55.04 Aligned_cols=74 Identities=12% Similarity=0.125 Sum_probs=50.0
Q ss_pred cccccccccceeEEEEecCCCCeeEEEEeccC----Cc---cchHHHHHHHHHHHhcC---CCccceEEEEEEcCCeeEE
Q 008238 350 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRS----SG---QGGQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 350 ~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l 419 (573)
..+.||.|....||+... .++.++||.-... .. ....+-..|...|+.+. ...+.+++.++. +..++
T Consensus 36 ~~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 356889999999999886 4567889975411 11 12334444566666553 347778888866 45688
Q ss_pred EEEccCC
Q 008238 420 VYEFVPN 426 (573)
Q Consensus 420 v~e~~~~ 426 (573)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999977
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.064 Score=54.26 Aligned_cols=29 Identities=28% Similarity=0.351 Sum_probs=25.4
Q ss_pred CCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 467 LRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 467 ~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
..++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 46999999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.022 Score=54.13 Aligned_cols=122 Identities=21% Similarity=0.264 Sum_probs=60.4
Q ss_pred CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCcc-ceEEEEEEcCCeeEEEEEccCCCChhhh-ccC------------
Q 008238 370 GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFVPNKSLDYF-LYE------------ 435 (573)
Q Consensus 370 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~------------ 435 (573)
++.|+||+....+ ...-...+|..+++.+...++ .++++.+.+ ..|.+|+++..|..- +..
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 4678888876553 334556788999988875555 455555433 257799977665321 110
Q ss_pred ------c--CccCCCCHHHHHHH----------------------HHHHHHHHHHHH----h-CCCCCeEeecCCCCCEE
Q 008238 436 ------P--EKQQQLDWSRRYKI----------------------IGGIARGILYLH----E-DSRLRIIHRDLKASNIL 480 (573)
Q Consensus 436 ------~--~~~~~l~~~~~~~i----------------------~~qia~~L~yLH----~-~~~~~ivH~Dlkp~NIL 480 (573)
. .....--|..+..+ ..++..-+..+. . ....-++|.|+.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 0 00011111222111 011111122221 1 11235899999999999
Q ss_pred e-CCCCCeEEeccCCcc
Q 008238 481 L-DAEMNPKISDFGMAK 496 (573)
Q Consensus 481 l-~~~~~vkl~DfGla~ 496 (573)
+ +.++.++++||..+.
T Consensus 157 ~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAG 173 (211)
T ss_dssp ETSSSSCEEE--GTT-E
T ss_pred eccCCCeEEEecHHHHh
Confidence 9 888999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.065 Score=54.78 Aligned_cols=141 Identities=16% Similarity=0.254 Sum_probs=79.8
Q ss_pred cccccccceeEEEEecCC----CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCcc-ceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVLPS----GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 426 (573)
+.|..|=.-.+|+....+ +..|++|+....... .-+..+|..+++.+..-++ .++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 344445566788886432 237888987654332 2334678899988876555 4556655322 58999987
Q ss_pred CChhhh-------c----------cCcC---ccCCCCHHHHHHHHHHH----------------------HHHHHH----
Q 008238 427 KSLDYF-------L----------YEPE---KQQQLDWSRRYKIIGGI----------------------ARGILY---- 460 (573)
Q Consensus 427 gsL~~~-------l----------~~~~---~~~~l~~~~~~~i~~qi----------------------a~~L~y---- 460 (573)
..|..- + |... ...+--|..+.++..++ .+-+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665321 1 1100 00111233332222221 111111
Q ss_pred HHh-CCCCCeEeecCCCCCEEeCC-CCCeEEeccCCccc
Q 008238 461 LHE-DSRLRIIHRDLKASNILLDA-EMNPKISDFGMAKI 497 (573)
Q Consensus 461 LH~-~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~ 497 (573)
+.. ....-++|.|+.+.|||+++ ++.++++||..+..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 12234899999999999974 57899999998753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.042 Score=56.81 Aligned_cols=74 Identities=12% Similarity=0.123 Sum_probs=49.3
Q ss_pred ccccccccceeEEEEecCC-CCeeEEEEec----c--CCccchHHHHHHHHHHHhcC--CC-ccceEEEEEEcCCeeEEE
Q 008238 351 DNKLGEGGFGEVYKGVLPS-GQEIAVKRLS----R--SSGQGGQEFKNEVVLVAKLQ--HR-NLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~-~~~vavK~~~----~--~~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv 420 (573)
.+.||.|.-.-||++...+ ++.|+||.-. . +-+-..++...|.+.|+... -| .+++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5688999999999999743 5679999532 1 11333455666777777664 34 45556554 45566789
Q ss_pred EEccCC
Q 008238 421 YEFVPN 426 (573)
Q Consensus 421 ~e~~~~ 426 (573)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.063 Score=54.33 Aligned_cols=31 Identities=26% Similarity=0.350 Sum_probs=27.9
Q ss_pred CCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 466 ~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
+..++|+|+.++|||+++++.+.|+||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 3469999999999999999999999999875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.0017 Score=75.34 Aligned_cols=159 Identities=13% Similarity=-0.040 Sum_probs=109.8
Q ss_pred HHHHHHHHhcCCCccceEEEEEEc--CCeeEEEEEccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 008238 390 KNEVVLVAKLQHRNLVRLLGFCLE--GEEKILVYEFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDS- 465 (573)
Q Consensus 390 ~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~- 465 (573)
..|...++..+|+++.....-... ..+.+.+++|+..|.+...+.+. ++...++..-+.....+......-+|...
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 345555666788887655443332 34558899999999998887543 33344444444444444344445545432
Q ss_pred -CCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHH
Q 008238 466 -RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEII 544 (573)
Q Consensus 466 -~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ell 544 (573)
..-.+|++||+-|.+|..+.++|+.++|+.+...+. .......++++.|+.|+....-.++.++|+|..|+.+|+.-
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 234799999999999999999999999999832221 12233456788899999888888899999999999999887
Q ss_pred hCCCCC
Q 008238 545 TGKKNS 550 (573)
Q Consensus 545 tG~~p~ 550 (573)
-|..++
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 776543
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.14 Score=60.34 Aligned_cols=141 Identities=21% Similarity=0.273 Sum_probs=78.1
Q ss_pred cccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-------CCccceEE-E----EEEc-CC--e
Q 008238 352 NKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-------HRNLVRLL-G----FCLE-GE--E 416 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-------h~niv~l~-~----~~~~-~~--~ 416 (573)
+.|+ |..-.+|+.+..+|+.+++|+.+... .......|...|..+. -|.+++-. | .... .. .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4554 44577899887788899999987543 2234444555665442 22223221 1 1111 11 3
Q ss_pred eEEEEEccCCCChhhhccC------------------------cCccCCCCHH-----------------HHHHHHHHHH
Q 008238 417 KILVYEFVPNKSLDYFLYE------------------------PEKQQQLDWS-----------------RRYKIIGGIA 455 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~------------------------~~~~~~l~~~-----------------~~~~i~~qia 455 (573)
.+-+++|++|..+.+.... +.....+.|. ....++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999999877551110 0001122221 1122233333
Q ss_pred HHHH-----HHHhCCCCCeEeecCCCCCEEeCCCC--CeE-EeccCCcc
Q 008238 456 RGIL-----YLHEDSRLRIIHRDLKASNILLDAEM--NPK-ISDFGMAK 496 (573)
Q Consensus 456 ~~L~-----yLH~~~~~~ivH~Dlkp~NILl~~~~--~vk-l~DfGla~ 496 (573)
+..+ .|.+. +..+||+|+.+.|||++.++ ++. |+|||.+.
T Consensus 188 ~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 3222 12222 24599999999999999875 555 99999875
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.064 Score=50.68 Aligned_cols=77 Identities=17% Similarity=0.217 Sum_probs=54.8
Q ss_pred cccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcC---CCccceEEEEEEcCCeeEEEEEccCC
Q 008238 350 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 350 ~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
..+++.-|.--.-|.... ...++.||+-. .+....|..|+.-|..+. --.+.+++.+-......++|+||++-
T Consensus 20 er~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~ 95 (286)
T COG3001 20 EREEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT 95 (286)
T ss_pred cccccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence 345666666666666654 56788888743 233456777777766664 35577888888889999999999998
Q ss_pred CChh
Q 008238 427 KSLD 430 (573)
Q Consensus 427 gsL~ 430 (573)
+.++
T Consensus 96 ~~~d 99 (286)
T COG3001 96 GPLD 99 (286)
T ss_pred CCCC
Confidence 7775
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.21 Score=50.92 Aligned_cols=72 Identities=13% Similarity=0.096 Sum_probs=45.3
Q ss_pred ccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCc--cceEE---E--EEEcCCeeEEEEEccCCCCh
Q 008238 357 GGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN--LVRLL---G--FCLEGEEKILVYEFVPNKSL 429 (573)
Q Consensus 357 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~---~--~~~~~~~~~lv~e~~~~gsL 429 (573)
+.-..||+....+++.+++|..+.. .....++..|++.+..+.... ++..+ | ....++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 3445799998877888999987532 234566777888887774222 22211 1 12234567789999988654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.13 Score=52.03 Aligned_cols=71 Identities=18% Similarity=0.244 Sum_probs=55.6
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
..+++|++. ++++.. + ..-.+++.+.|+.+.+..++-+..+ .++-|||+.-.||||+ +|+|.|+||-++
T Consensus 300 y~yl~~kdh-gt~is~-i------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeee-e------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence 345666654 444422 1 2347889999999999888888764 4799999999999999 999999999999
Q ss_pred cc
Q 008238 496 KI 497 (573)
Q Consensus 496 ~~ 497 (573)
|.
T Consensus 369 Rl 370 (488)
T COG5072 369 RL 370 (488)
T ss_pred ec
Confidence 84
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.24 Score=51.61 Aligned_cols=74 Identities=18% Similarity=0.278 Sum_probs=45.3
Q ss_pred cccccccceeEEEEecCCC--Ce-----eEEEEeccCCccchHHHHHHHHHHHhcCCCccc-eEEEEEEcCCeeEEEEEc
Q 008238 352 NKLGEGGFGEVYKGVLPSG--QE-----IAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLV-RLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~ 423 (573)
+.|..|=...+|++...++ .. |.++.... .....-+-.+|+.+++.+...++- ++++.+. .+++.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 4555577788999875433 22 33333222 222222346789999999766654 4555543 3699999
Q ss_pred cCCCChh
Q 008238 424 VPNKSLD 430 (573)
Q Consensus 424 ~~~gsL~ 430 (573)
++|..|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9998774
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.2 Score=47.10 Aligned_cols=115 Identities=16% Similarity=0.160 Sum_probs=71.6
Q ss_pred cceeEEEEecCCCCeeEEEEeccCCcc-chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCChhhhccCc
Q 008238 358 GFGEVYKGVLPSGQEIAVKRLSRSSGQ-GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEP 436 (573)
Q Consensus 358 ~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 436 (573)
+-.+.-+++-+-| ...+|++....-. ...-|.++..+++++. .|+++..- ++-..-++.|.|-.-..
T Consensus 74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------- 141 (308)
T PF07387_consen 74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------- 141 (308)
T ss_pred CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------
Confidence 3344444443222 3455666543333 4456788888888875 56666632 33345688888733211
Q ss_pred CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 437 EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 437 ~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
.. ..++.-=++.|.-.|+.. ...+|+|-.|+||+-|..|.+||.|=+.
T Consensus 142 -----~~----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 -----NF----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -----ch----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 11 112222246778889653 4699999999999999999999999764
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 573 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-50 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-41 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-39 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-39 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-39 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-25 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-25 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-24 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-22 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-22 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-22 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-22 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-22 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-22 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-22 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-21 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-21 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-21 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-21 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-21 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-21 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-21 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-21 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-21 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-21 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-21 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-21 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-21 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-21 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-21 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-21 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-21 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-21 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-21 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-21 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-21 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-21 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-21 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-21 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-21 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-21 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-21 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-21 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-21 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-21 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-21 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-21 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-21 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-21 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-21 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-21 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-21 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-21 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-21 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-21 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-21 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-21 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-20 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-20 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-20 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-17 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-12 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-12 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 394 bits (1014), Expect = e-135
Identities = 101/242 (41%), Positives = 140/242 (57%), Gaps = 15/242 (6%)
Query: 323 NADNDITTLESLQFDFETIEVATNNFS------TDNKLGEGGFGEVYKGVLPSGQEIAVK 376
N +++ F F ++ TNNF NK+GEGGFG VYKG + +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVK 60
Query: 377 RLS----RSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF 432
+L+ ++ + Q+F E+ ++AK QH NLV LLGF +G++ LVY ++PN SL
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 433 LYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492
L + L W R KI G A GI +LHE+ IHRD+K++NILLD KISDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177
Query: 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552
G+A+ T+RIVGT YMAPE + G+ + KSD+YSFGV++LEIITG
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 553 YQ 554
++
Sbjct: 237 HR 238
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 380 bits (979), Expect = e-129
Identities = 103/234 (44%), Positives = 147/234 (62%), Gaps = 5/234 (2%)
Query: 336 FDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQ-EFKNEVV 394
F ++VA++NFS N LG GGFG+VYKG L G +AVKRL QGG+ +F+ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQ-QLDWSRRYKIIGG 453
+++ HRNL+RL GFC+ E++LVY ++ N S+ L E + Q LDW +R +I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
ARG+ YLH+ +IIHRD+KA+NILLD E + DFG+AK+ T T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAAD--LLSYV 565
G++APEY G+ S K+DV+ +GV++LE+ITG++ + D LL +V
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-118
Identities = 97/255 (38%), Positives = 148/255 (58%), Gaps = 6/255 (2%)
Query: 310 RKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPS 369
K N++ + + + + ES + +E ATNNF +G G FG+VYKGVL
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 370 GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 429
G ++A+KR + S QG +EF+ E+ ++ +H +LV L+GFC E E IL+Y+++ N +L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 430 DYFLYEPEKQQQ-LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 488
LY + + W +R +I G ARG+ YLH + IIHRD+K+ NILLD PK
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 489 ISDFGMAKIF-GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
I+DFG++K +DQT +T + GT GY+ PEY + G+ + KSDVYSFGV++ E++ +
Sbjct: 180 ITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 548 KNSSFYQTDGAADLL 562
+L
Sbjct: 239 SAIVQSLPREMVNLA 253
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 6e-94
Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 22/235 (9%)
Query: 333 SLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNE 392
+ E + + G FG V+K L + +AVK Q + + E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQNEYE 68
Query: 393 VVLVAKLQHRNLVRLLGFCLEGE----EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRY 448
V + ++H N+++ +G G + L+ F SL FL K + W+
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELC 124
Query: 449 KIIGGIARGILYLHED-------SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501
I +ARG+ YLHED + I HRD+K+ N+LL + I+DFG+A F
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 502 QTQGNTNRIVGTYGYMAPEYAMHG-----QFSVKSDVYSFGVLVLEIITGKKNSS 551
++ G+T+ VGT YMAPE ++ D+Y+ G+++ E+ + +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 237 bits (605), Expect = 2e-73
Identities = 62/248 (25%), Positives = 99/248 (39%), Gaps = 34/248 (13%)
Query: 334 LQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNE- 392
++ + +N +G G +G VYKG L + +AVK S Q F NE
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF---ANRQNFINEK 56
Query: 393 -VVLVAKLQHRNLVRLLGFCLEGE-----EKILVYEFVPNKSLDYFLYEPEKQQQLDWSR 446
+ V ++H N+ R + E +LV E+ PN SL +L DW
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVS 112
Query: 447 RYKIIGGIARGILYLHED------SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF-- 498
++ + RG+ YLH + + I HRDL + N+L+ + ISDFG++
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 499 ----GVDQTQGNTNRIVGTYGYMAPEYAM-------HGQFSVKSDVYSFGVLVLEIITGK 547
+ VGT YMAPE + D+Y+ G++ EI
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 548 KNSSFYQT 555
+ ++
Sbjct: 233 TDLFPGES 240
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 6e-69
Identities = 67/239 (28%), Positives = 122/239 (51%), Gaps = 6/239 (2%)
Query: 311 KAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSG 370
K + ++ + + + D + +++ + + K+G G FG V++ G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HG 60
Query: 371 QEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS 428
++AVK L + EF EV ++ +L+H N+V +G + +V E++ S
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 429 LDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 488
L L++ ++QLD RR + +A+G+ YLH I+HR+LK+ N+L+D + K
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 489 ISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
+ DFG++++ T ++ GT +MAPE + KSDVYSFGV++ E+ T +
Sbjct: 180 VCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 6e-65
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLV 396
D++ IEV + +G G FG V K +++A+K++ S + + F E+ +
Sbjct: 6 DYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQL 55
Query: 397 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIAR 456
+++ H N+V+L G CL LV E+ SL L+ E + ++
Sbjct: 56 SRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAEMN-PKISDFGMAKIFGVDQTQGNTNRIVGTYG 515
G+ YLH +IHRDLK N+LL A KI DFG A Q + G+
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAA 168
Query: 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548
+MAPE +S K DV+S+G+++ E+IT +K
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 7e-63
Identities = 67/240 (27%), Positives = 114/240 (47%), Gaps = 32/240 (13%)
Query: 324 ADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSRSS 382
++ IE + ++G+GGFG V+KG L +A+K L
Sbjct: 4 GGSEFPKSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 383 GQGG-------QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE 435
+G QEF+ EV +++ L H N+V+L G +V EFVP L + L +
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD 114
Query: 436 PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-----AEMNPKIS 490
+ WS + +++ IA GI Y+ + I+HRDL++ NI L A + K++
Sbjct: 115 KAH--PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 491 DFGMAKIFGVDQTQGNTNRIVGTYGYMAPE--YAMHGQFSVKSDVYSFGVLVLEIITGKK 548
DFG+++ + +G + +MAPE A ++ K+D YSF +++ I+TG+
Sbjct: 172 DFGLSQQSVHSVSGL-----LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-62
Identities = 74/223 (33%), Positives = 112/223 (50%), Gaps = 28/223 (12%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL----SRSSGQGGQEFKNE 392
DF + + + +G GGFG+VY+ G E+AVK Q + + E
Sbjct: 5 DFAELTL-------EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQE 56
Query: 393 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIG 452
L A L+H N++ L G CL+ LV EF L+ L +++
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAV 112
Query: 453 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--------KISDFGMAKIFGVDQTQ 504
IARG+ YLH+++ + IIHRDLK+SNIL+ ++ KI+DFG+A+ +T
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTT 170
Query: 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
+ G Y +MAPE FS SDV+S+GVL+ E++TG+
Sbjct: 171 KMSA--AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-62
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 352 NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGF 410
LG+G FG+ K +G+ + +K L R + + F EV ++ L+H N+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 411 CLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRII 470
+ + + E++ +L + + Q WS+R IA G+ YLH + II
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 471 HRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR------------IVGTYGYMA 518
HRDL + N L+ N ++DFG+A++ ++TQ R +VG +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548
PE + K DV+SFG+++ EII
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-59
Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 352 NKLGEGGFGEVYKGVLPSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLG 409
KL E GE++KG G +I VK L S + ++F E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 410 FCLEGEEKIL--VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRL 467
C + ++P SL L+E +D S+ K +ARG+ +LH L
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ- 526
I L + ++++D +M +IS + F Q+ G ++APE
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSF---QSPGRM----YAPAWVAPEALQKKPE 185
Query: 527 --FSVKSDVYSFGVLVLEIITGK 547
+D++SF VL+ E++T +
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-59
Identities = 69/216 (31%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRS--SGQGGQEFKNEVV 394
I V ++G G FG VYKG ++AVK L+ + + Q Q FKNEV
Sbjct: 22 PDGQITVG-------QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGI 454
++ K +H N++ +G+ + I V ++ SL + L+ E + + + I
Sbjct: 73 VLRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETK--FEMKKLIDIARQT 129
Query: 455 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTY 514
ARG+ YLH IIHRDLK++NI L + KI DFG+A ++ G+
Sbjct: 130 ARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 515 GYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGK 547
+MAPE +S +SDVY+FG+++ E++TG+
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-57
Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 29/225 (12%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL--SRSSGQGGQEFKNEVV 394
FE +E+ +G+G FG+VY G E+A++ + R + + FK EV+
Sbjct: 31 PFEQLEI-------GELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVM 81
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGI 454
+ +H N+V +G C+ ++ ++L + + + LD ++ +I I
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEI 139
Query: 455 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRI---V 511
+G+ YLH I+H+DLK+ N+ D I+DFG+ I GV Q +++
Sbjct: 140 VKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 512 GTYGYMAPE---------YAMHGQFSVKSDVYSFGVLVLEIITGK 547
G ++APE FS SDV++ G + E+ +
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 8e-54
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNE--VVLVAKLQHRNLVRLL 408
++G+G +GEV+ G G+++AVK + E + ++H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 409 GFCLEGEEKI----LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED 464
++G L+ ++ N SL +L K LD K+ G+ +LH +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 465 SRLR-----IIHRDLKASNILLDAEMNPKISDFGMAKIF--GVDQTQGNTNRIVGTYGYM 517
I HRDLK+ NIL+ I+D G+A F ++ N VGT YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 518 APE------YAMHGQFSVKSDVYSFGVLVL-EIITG 546
PE H Q + +D+YSFG L+L E+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFG-LILWEVARR 248
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-53
Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 352 NKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNE--VVLVAKLQHRNLVRLLG 409
+G+G +GEV++G G+ +AVK S + + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 410 FCLEGEEKI----LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
+ L+ + SL +L + LD +I+ IA G+ +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 466 RLR-----IIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT--NRIVGTYGYMA 518
I HRDLK+ NIL+ I+D G+A + Q + N VGT YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 519 PE------YAMHGQFSVKSDVYSFGVLVLEIITG 546
PE + D+++FG+++ E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 8e-51
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 27/215 (12%)
Query: 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNE--VVLVAKLQHRNLVRLL 408
+G+G FGEV++G G+E+AVK S + + + E + L+H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 102
Query: 409 GFCLEGEEKI----LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED 464
+ LV ++ + SL +L + + K+ A G+ +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 465 -----SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF--GVDQTQGNTNRIVGTYGYM 517
+ I HRDLK+ NIL+ I+D G+A D N VGT YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 518 APE------YAMHGQFSVKSDVYSFGVLVLEIITG 546
APE H + ++D+Y+ G++ EI
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-47
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 15/210 (7%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRL-SRSSGQGGQEFKNEVVLVAKL 399
+ + ++G G FGEV+ G L +AVK +F E ++ +
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169
Query: 400 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL 459
H N+VRL+G C + + +V E V FL + +L +++G A G+
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGME 227
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY--- 516
YL IHRDL A N L+ + KISDFGM++ ++ G G
Sbjct: 228 YLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVK 280
Query: 517 -MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
APE +G++S +SDV+SFG+L+ E +
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-47
Identities = 66/223 (29%), Positives = 95/223 (42%), Gaps = 29/223 (13%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL---SRSSGQGGQEFKNEVV 394
+ + KLG+G FG V +G PSG+ + AVK L S + +F EV
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYK 449
+ L HRNL+RL G L + +V E P SL L + + ++
Sbjct: 74 AMHSLDHRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--- 128
Query: 450 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR 509
+A G+ YL R IHRDL A N+LL KI DFG+ + +
Sbjct: 129 ---QVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 510 IVGT---YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 548
+ + APE FS SD + FGV + E+ T G++
Sbjct: 183 --HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-47
Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 43/272 (15%)
Query: 327 DITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLP-----SGQEIAVKRL-SR 380
DI + + + + LGEG FG+V +G+++AVK L
Sbjct: 2 DIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE 61
Query: 381 SSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFLYEPEK 438
S G + K E+ ++ L H N+V+ G C E L+ EF+P+ SL +L + +
Sbjct: 62 SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN 121
Query: 439 Q----QQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494
+ QQL ++ I +G+ YL + +HRDL A N+L+++E KI DFG+
Sbjct: 122 KINLKQQLKYAV------QICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL 172
Query: 495 AKIFGVDQTQGNTNRIVGTYG----------YMAPEYAMHGQFSVKSDVYSFGVLVLEII 544
K D+ Y + APE M +F + SDV+SFGV + E++
Sbjct: 173 TKAIETDK---------EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223
Query: 545 T-GKKNSSFYQTDGAADLLSY--VSINRVINL 573
T +SS ++ +++ R++N
Sbjct: 224 TYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-47
Identities = 67/263 (25%), Positives = 116/263 (44%), Gaps = 47/263 (17%)
Query: 304 GLCYFIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVY 363
L + + + ++ A P + + E+ + + +G G GEV
Sbjct: 13 NLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTR------EIEASRIHIEKIIGSGDSGEVC 66
Query: 364 KGVL--PSGQEI--AVKRL-SRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418
G L P +++ A+K L + + + ++F +E ++ + H N++RL G G +
Sbjct: 67 YGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126
Query: 419 LVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDL 474
+V E++ N SLD FL + Q Q + R G+ G+ YL S L +HRDL
Sbjct: 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR------GVGAGMRYL---SDLGYVHRDL 177
Query: 475 KASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY------------MAPEYA 522
A N+L+D+ + K+SDFG++++ D APE
Sbjct: 178 AARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTTGGKIPIRWTAPEAI 226
Query: 523 MHGQFSVKSDVYSFGVLVLEIIT 545
FS SDV+SFGV++ E++
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-47
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 43/217 (19%)
Query: 352 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVR 406
+LG+G FG V +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 407 LLGFCLEGEEK--ILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKIIGGIARGILY 460
G C + L+ E++P SL +L + +++ + L ++ I +G+ Y
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QICKGMEY 129
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY---- 516
L R IHRDL NIL++ E KI DFG+ K+ D+ +
Sbjct: 130 LGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-----------FFKVKE 175
Query: 517 --------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
APE +FSV SDV+SFGV++ E+ T
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-46
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
+ + + ++G G FG V+ G + ++A+K + R ++F E ++ KL H
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH 62
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKIIGGIARG 457
LV+L G CLE LV EF+ + L +L L + G
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL------DVCEG 116
Query: 458 ILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT---Y 514
+ YL +IHRDL A N L+ K+SDFGM + DQ +T GT
Sbjct: 117 MAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPV 169
Query: 515 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ +PE ++S KSDV+SFGVL+ E+ +
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-46
Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 43/217 (19%)
Query: 352 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVR 406
+LG+G FG V +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 407 LLGFCLEGEEK--ILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKIIGGIARGILY 460
G C + L+ E++P SL +L + +++ + L ++ I +G+ Y
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QICKGMEY 160
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY---- 516
L R IHRDL NIL++ E KI DFG+ K+ D+ Y
Sbjct: 161 LGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-----------YYKVKE 206
Query: 517 --------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
APE +FSV SDV+SFGV++ E+ T
Sbjct: 207 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-46
Identities = 72/276 (26%), Positives = 110/276 (39%), Gaps = 47/276 (17%)
Query: 323 NADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKR 377
+ + L D T LGEG FG+V +G+ +AVK
Sbjct: 10 HHHGALEVLFQGPGD-PT-VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA 67
Query: 378 LSRSSGQGG-QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFL- 433
L +G +K E+ ++ L H ++++ G C + LV E+VP SL +L
Sbjct: 68 LKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP 127
Query: 434 -YEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492
+ Q L +++ I G+ YLH IHRDL A N+LLD + KI DF
Sbjct: 128 RHSIGLAQLLLFAQ------QICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDF 178
Query: 493 GMAKIFGVDQTQGNTNRIVGTYGY------------MAPEYAMHGQFSVKSDVYSFGVLV 540
G+AK Y Y APE +F SDV+SFGV +
Sbjct: 179 GLAKAVPEGH----------EY-YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227
Query: 541 LEIIT-GKKNSSFYQTDGAADLLSY--VSINRVINL 573
E++T + S ++ +++ R+ L
Sbjct: 228 YELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-46
Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 39/223 (17%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSGQE-----IAVKRL-SRSSGQGGQEFKNEVVLVAKL 399
F LG G FG VYKG+ E +A+K L +S + +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 400 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKIIGGIA 455
+ ++ RLLG CL L+ + +P L ++ E + L+W IA
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 456 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG 515
+G+ YL R++HRDL A N+L+ + KI+DFG+AK+ G ++ Y
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYH 175
Query: 516 Y---------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 548
MA E +H ++ +SDV+S+GV V E++T G K
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-46
Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 352 NKLGEGGFGEVYKGVLP-----SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVR 406
++LG+G FG V +G +AVK+L S ++F+ E+ ++ L +V+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 407 LLGFCLEGEEK--ILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKIIGGIARGILY 460
G + LV E++P+ L FL + + L +S I +G+ Y
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QICKGMEY 142
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG----- 515
L R +HRDL A NIL+++E + KI+DFG+AK+ +D+ +V G
Sbjct: 143 LGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY----YVVREPGQSPIF 195
Query: 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ APE FS +SDV+SFGV++ E+ T
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-46
Identities = 67/225 (29%), Positives = 112/225 (49%), Gaps = 41/225 (18%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL-SRSSGQGGQEFKNEVVLV 396
E+ N S D +G G FGEV G L PS +EI A+K L + + ++F E ++
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 397 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKIIG 452
+ H N++RL G + + ++V E++ N SLD FL + + Q Q + R
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR------ 154
Query: 453 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVG 512
GIA G+ YL S + +HRDL A NIL+++ + K+SDFG+ ++ D
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP---------- 201
Query: 513 TYGY------------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+PE + +F+ SDV+S+G+++ E+++
Sbjct: 202 -EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-46
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 351 DNKLGEGGFGEVYKGVLPSGQE---IAVKRL-SRSSGQGGQEFKNEVVLVAKLQHRNLVR 406
D +LG G FG V +GV ++ +A+K L + +E E ++ +L + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 407 LLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKIIGGIARGILYLH 462
L+G C E +LV E L FL ++ + ++ G+ YL
Sbjct: 75 LIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH------QVSMGMKYL- 126
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG------Y 516
+HRDL A N+LL KISDFG++K G D + +
Sbjct: 127 --EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-----YTARSAGKWPLKW 179
Query: 517 MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
APE +FS +SDV+S+GV + E ++
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 7e-46
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 351 DNKLGEGGFGEVYKGVLPSG---QEIAVKRL--SRSSGQGGQEFKNEVVLVAKLQHRNLV 405
D +LG G FG V KG + +AVK L + E E ++ +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEK---QQQLDWSRRYKIIGGIARGILYLH 462
R++G C E +LV E L+ +L + + ++ ++ G+ YL
Sbjct: 82 RMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH------QVSMGMKYL- 133
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG------Y 516
+HRDL A N+LL + KISDFG++K D+ N +
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKWPVKW 186
Query: 517 MAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 548
APE + +FS KSDV+SFGVL+ E + G+K
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 7e-46
Identities = 65/230 (28%), Positives = 118/230 (51%), Gaps = 43/230 (18%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL--PSGQE---IAVKRL-SRSSGQGGQEFKNEVVL 395
E+ + + +G G FGEVYKG+L SG++ +A+K L + + + +F E +
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99
Query: 396 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKII 451
+ + H N++RL G + + +++ E++ N +LD FL E + + Q + R
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR----- 154
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
GIA G+ YL + + +HRDL A NIL+++ + K+SDFG++++ D
Sbjct: 155 -GIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP--------- 201
Query: 512 GTYGY------------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 548
APE + +F+ SDV+SFG+++ E++T G++
Sbjct: 202 --EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-45
Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 336 FDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVL 395
+ + E+ + + +LG G FG V G ++A+K + + EF E +
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKV 72
Query: 396 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKII 451
+ L H LV+L G C + ++ E++ N L +L E + Q L+ +
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----- 127
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
+ + YL + +HRDL A N L++ + K+SDFG+++ D+ V
Sbjct: 128 -DVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY----TSSV 179
Query: 512 GT---YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
G+ + PE M+ +FS KSD+++FGVL+ EI +
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-45
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 35/216 (16%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
+ +G+G FG+V G G ++AVK + + Q F E ++ +L+H
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 245
Query: 402 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQ-----QQLDWSRRYKIIGGIA 455
NLV+LLG +E + + +V E++ SL +L + L +S +
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL------DVC 299
Query: 456 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG 515
+ YL +HRDL A N+L+ + K+SDFG+ K
Sbjct: 300 EAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDT 345
Query: 516 ------YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ APE +FS KSDV+SFG+L+ EI +
Sbjct: 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-45
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 30/219 (13%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQE-----IAVKRLSRSSG-QGGQEFKNEVVL 395
LG G FG V+KGV E + +K + SG Q Q + ++
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 396 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKII 451
+ L H ++VRLLG C LV +++P SL + + L+W
Sbjct: 69 IGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV----- 122
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
IA+G+ YL ++HR+L A N+LL + +++DFG+A + D Q +
Sbjct: 123 -QIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-- 176
Query: 512 GTYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+MA E G+++ +SDV+S+GV V E++T
Sbjct: 177 ---AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
+ +G+G FG+V G G ++AVK + + Q F E ++ +L+H
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 73
Query: 402 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
NLV+LLG +E + + +V E++ SL +L + L K + + Y
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEY 132
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG----- 515
L +HRDL A N+L+ + K+SDFG+ K + +
Sbjct: 133 L---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EAS-------STQDTGKLPV 178
Query: 516 -YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ APE +FS KSDV+SFG+L+ EI +
Sbjct: 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-45
Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 44/225 (19%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSR-SSGQGGQEFKNEVVLV 396
+A + + LGEG FGEVY+GV G++I AVK + + ++F +E V++
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 397 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKIIG 452
L H ++V+L+G E E ++ E P L ++L + + +S
Sbjct: 68 KNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL------ 120
Query: 453 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVG 512
I + + YL + +HRD+ NIL+ + K+ DFG++ R +
Sbjct: 121 QICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLS-------------RYIE 164
Query: 513 TYGY------------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
Y M+PE +F+ SDV+ F V + EI++
Sbjct: 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-45
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
E+ + +LG G FG V G ++AVK + + EF E + KL H
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSH 62
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYL 461
LV+ G C + +V E++ N L +L + L+ S+ ++ + G+ +L
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT---YGYMA 518
+ IHRDL A N L+D ++ K+SDFGM + DQ VGT + A
Sbjct: 121 ---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY----VSSVGTKFPVKWSA 173
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIIT 545
PE + ++S KSDV++FG+L+ E+ +
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 7e-45
Identities = 53/231 (22%), Positives = 100/231 (43%), Gaps = 48/231 (20%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRLSRSSGQGGQEFKNEV 393
++ + + LG+G F +++KGV E+ +K L ++ + F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63
Query: 394 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYK 449
+++KL H++LV G C+ G+E ILV EFV SLD +L + + +L+ ++
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK--- 120
Query: 450 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--------KISDFGMAKIFGVD 501
+A + +L +IH ++ A NILL E + K+SD G++
Sbjct: 121 ---QLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT---- 170
Query: 502 QTQGNTNRIVGTYGY------MAPEYAMHG-QFSVKSDVYSFGVLVLEIIT 545
++ + PE + ++ +D +SFG + EI +
Sbjct: 171 --------VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL-SRSSGQGGQEFKNEVVLV 396
E+ +GEG FG+V++G+ P + A+K + +S ++F E + +
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 397 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKIIG 452
+ H ++V+L+G E ++ E L FL + + ++
Sbjct: 71 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY------ 123
Query: 453 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVG 512
++ + YL R +HRD+ A N+L+ + K+ DFG+++
Sbjct: 124 QLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKA 174
Query: 513 TYG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ G +MAPE +F+ SDV+ FGV + EI+
Sbjct: 175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 9/206 (4%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ 400
E+ + + +KLG G +GEVY+GV +AVK L + +EF E ++ +++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIK 67
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
H NLV+LLG C ++ EF+ +L +L E +Q+ + + I+ + Y
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEY 126
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ-TQGNTNRIVGTYGYMAP 519
L + IHRDL A N L+ K++DFG++++ D T + + AP
Sbjct: 127 L---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAP 181
Query: 520 EYAMHGQFSVKSDVYSFGVLVLEIIT 545
E + +FS+KSDV++FGVL+ EI T
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 65/229 (28%), Positives = 111/229 (48%), Gaps = 34/229 (14%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSSGQGGQEFKNEVVL 395
+ + +LGEG FG+V+ +AVK L + ++F+ E L
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 396 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YEPEKQQQL 442
+ LQH ++V+ G C +G+ I+V+E++ + L+ FL + + +L
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 443 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVD 501
S+ I IA G++YL + +HRDL N L+ A + KI DFGM++ ++ D
Sbjct: 131 GLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 502 QTQGNTN-----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ + R +M PE M+ +F+ +SDV+SFGV++ EI T
Sbjct: 188 YYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-44
Identities = 67/228 (29%), Positives = 110/228 (48%), Gaps = 33/228 (14%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL----PSGQEI--AVKRLSRSSGQGGQEFKNEVVL 395
+ + +LGEG FG+V+ P ++ AVK L +S Q+F+ E L
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 396 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL------------YEPEKQQQLD 443
+ LQH+++VR G C EG ++V+E++ + L+ FL E L
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 444 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQ 502
+ + +A G++YL + L +HRDL N L+ + KI DFGM++ I+ D
Sbjct: 157 LGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213
Query: 503 TQGNTN-----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ R +M PE ++ +F+ +SDV+SFGV++ EI T
Sbjct: 214 YRVGGRTMLPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 30/215 (13%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSGQE-----IAVKRL-SRSSGQGGQEFKNEVVLVAKL 399
F LG G FG VYKG+ E +A+K L +S + +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 400 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKIIGGIA 455
+ ++ RLLG CL L+ + +P L ++ E + L+W IA
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 456 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG 515
+G+ YL R++HRDL A N+L+ + KI+DFG+AK+ G ++ + + G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179
Query: 516 -----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+MA E +H ++ +SDV+S+GV V E++T
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 69/206 (33%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
EV +LG G FGEV+ G ++AVK L + F E L+ +LQH
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQH 67
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYL 461
+ LVRL + E ++ E++ N SL FL P + L ++ + IA G+ ++
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI 125
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY--MAP 519
IHRDL+A+NIL+ ++ KI+DFG+A++ ++ T R + AP
Sbjct: 126 ---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAP 179
Query: 520 EYAMHGQFSVKSDVYSFGVLVLEIIT 545
E +G F++KSDV+SFG+L+ EI+T
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 67/211 (31%), Positives = 108/211 (51%), Gaps = 21/211 (9%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
E+ + + KLG G FGEV+ ++AVK + + + F E ++ LQH
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQH 242
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ-----QQLDWSRRYKIIGGIAR 456
LV+L + E ++ EF+ SL FL E + +D+S IA
Sbjct: 243 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA------QIAE 295
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY 516
G+ ++ + IHRDL+A+NIL+ A + KI+DFG+A++ ++ T R +
Sbjct: 296 GMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPI 349
Query: 517 --MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
APE G F++KSDV+SFG+L++EI+T
Sbjct: 350 KWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-43
Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 350 TDNKLGEGGFGEVYKGVL-PSGQEI--AVKRL-SRSSGQGGQEFKNEVVLVAKLQHRNLV 405
D +LG G FG V +GV ++I A+K L + +E E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKIIGGIARGILYL 461
RL+G C E +LV E L FL ++ + ++ G+ YL
Sbjct: 400 RLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH------QVSMGMKYL 452
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG------ 515
+HR+L A N+LL KISDFG++K G D +
Sbjct: 453 ---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-----YTARSAGKWPLK 504
Query: 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ APE +FS +SDV+S+GV + E ++
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-43
Identities = 65/223 (29%), Positives = 111/223 (49%), Gaps = 17/223 (7%)
Query: 329 TTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQ 387
T+ + +++ E+ + + +KLG G +GEVY+GV +AVK L + +
Sbjct: 203 PTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVE 261
Query: 388 EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ-----QQL 442
EF E ++ +++H NLV+LLG C ++ EF+ +L +L E +Q L
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 321
Query: 443 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502
+ I+ + YL + IHR+L A N L+ K++DFG++++ D
Sbjct: 322 YMAT------QISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
Query: 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ + APE + +FS+KSDV++FGVL+ EI T
Sbjct: 373 YTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-43
Identities = 72/224 (32%), Positives = 101/224 (45%), Gaps = 29/224 (12%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SRSSGQGGQEFKNEVV 394
EV N + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL----YEPEKQQQLDWSRRYKI 450
+++K H+N+VR +G L+ + ++ E + L FL P + L +
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 451 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMAK-IFGVDQTQGN 506
IA G YL IHRD+ A N LL KI DFGMA+ I+ +
Sbjct: 146 ARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR-- 200
Query: 507 TNRIVGTYGY-----MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
G M PE M G F+ K+D +SFGVL+ EI +
Sbjct: 201 ----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-43
Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 29/224 (12%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SRSSGQGGQEFKNEVV 394
EVA + +LG+G FG VY+GV +A+K + +S + EF NE
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------YEPEKQQQLDWSRR 447
++ + ++VRLLG +G+ +++ E + L +L S+
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 448 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA-KIFGVDQTQGN 506
++ G IA G+ YL+ + +HRDL A N ++ + KI DFGM I+ D +
Sbjct: 141 IQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 507 TN-----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
R +M+PE G F+ SDV+SFGV++ EI T
Sbjct: 198 GKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 9e-43
Identities = 67/237 (28%), Positives = 113/237 (47%), Gaps = 49/237 (20%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SRSSGQGGQEFKNEVV 394
E++ + +LGE FG+VYKG L Q +A+K L ++ G +EF++E +
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YEPEKQQQ 441
L A+LQH N+V LLG + + +++ + + L FL + +
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 442 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501
L+ ++ IA G+ YL S ++H+DL N+L+ ++N KISD G+
Sbjct: 125 LEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF------ 175
Query: 502 QTQGNTNRIVGTYGY-------------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
R V Y MAPE M+G+FS+ SD++S+GV++ E+ +
Sbjct: 176 -------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-42
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 351 DNKLGEGGFGEVYKGVLPSGQE----IAVKRLSR-SSGQGGQEFKNEVVLVAKLQHRNLV 405
D +G+G FG VY G + A+K LSR + Q + F E +L+ L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 406 RLLGFCLEGEEKIL-VYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKIIGGIARGILY 460
L+G L E + ++ + L F+ P++ + + +ARG+ Y
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL------QVARGMEY 139
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQGNTNRIVGTYG---- 515
L + + +HRDL A N +LD K++DFG+A+ I + +
Sbjct: 140 L---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ----HRHARLPV 192
Query: 516 -YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ A E +F+ KSDV+SFGVL+ E++T
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-42
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 341 IEVATNNFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSR-SSGQGGQEFKNEVVL 395
I ++ + +G G FG VY G L G++I AVK L+R + +F E ++
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 396 VAKLQHRNLVRLLGFCLEGEEKIL-VYEFVPNKSLDYFL----YEPEKQQQLDWSRRYKI 450
+ H N++ LLG CL E L V ++ + L F+ + P + + +
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL---- 135
Query: 451 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRI 510
+A+G+ YL + +HRDL A N +LD + K++DFG+A+ D +
Sbjct: 136 --QVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSV 186
Query: 511 VGTYG------YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
G +MA E +F+ KSDV+SFGVL+ E++T
Sbjct: 187 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 17/209 (8%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
E+ + + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 238
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ-----QQLDWSRRYKIIGGIAR 456
LV+L E E +V E++ SL FL + Q +D + IA
Sbjct: 239 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA------QIAS 291
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY 516
G+ Y+ R+ +HRDL+A+NIL+ + K++DFG+A++ ++ +
Sbjct: 292 GMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKW 347
Query: 517 MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 67/234 (28%), Positives = 106/234 (45%), Gaps = 29/234 (12%)
Query: 332 ESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSR--SSGQG 385
E LQ E + + N LGEG FG V +G L G + AVK + SS +
Sbjct: 20 EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE 79
Query: 386 GQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-----EKILVYEFVPNKSLDYFLYE---PE 437
+EF +E + H N++RLLG C+E + +++ F+ L +L
Sbjct: 80 IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139
Query: 438 KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK- 496
+ + K + IA G+ YL S +HRDL A N +L +M ++DFG++K
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK 196
Query: 497 IFGVDQTQGNTN-----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
I+ D + + ++A E ++ KSDV++FGV + EI T
Sbjct: 197 IYSGDYYRQGRIAKMPVK------WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 30/235 (12%)
Query: 332 ESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRL--SRSSGQG 385
+ L+ E + + F+ LG+G FG V + L S ++AVK L +
Sbjct: 9 DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD 68
Query: 386 GQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI------LVYEFVPNKSLDYFLYE---P 436
+EF E + + H ++ +L+G L K ++ F+ + L FL
Sbjct: 69 IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG 128
Query: 437 EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA- 495
E L + + IA G+ YL S IHRDL A N +L +M ++DFG++
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 496 KIFGVDQTQGNTN-----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
KI+ D + + ++A E ++V SDV++FGV + EI+T
Sbjct: 186 KIYSGDYYRQGCASKLPVK------WLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 4e-42
Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 17/209 (8%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
E+ + + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 321
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ-----QQLDWSRRYKIIGGIAR 456
LV+L E E +V E++ SL FL + Q +D + IA
Sbjct: 322 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA------QIAS 374
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY 516
G+ Y+ R+ +HRDL+A+NIL+ + K++DFG+A++ ++ +
Sbjct: 375 GMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKW 430
Query: 517 MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
APE A++G+F++KSDV+SFG+L+ E+ T
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-42
Identities = 72/224 (32%), Positives = 101/224 (45%), Gaps = 29/224 (12%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SRSSGQGGQEFKNEVV 394
EV N + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL----YEPEKQQQLDWSRRYKI 450
+++K H+N+VR +G L+ + ++ E + L FL P + L +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 451 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMAK-IFGVDQTQGN 506
IA G YL IHRD+ A N LL KI DFGMA+ I+ +
Sbjct: 187 ARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-- 241
Query: 507 TNRIVGTYGY-----MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
G M PE M G F+ K+D +SFGVL+ EI +
Sbjct: 242 ----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-41
Identities = 58/234 (24%), Positives = 104/234 (44%), Gaps = 23/234 (9%)
Query: 329 TTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRS--SGQGG 386
L + F+++ V +S ++G GG +V++ + Q A+K ++ Q
Sbjct: 11 VDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 70
Query: 387 QEFKNEVVLVAKLQHRNL--VRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDW 444
++NE+ + KLQ + +RL + + + +V E N L+ +L +K++ +D
Sbjct: 71 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDP 126
Query: 445 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504
R + + +H+ I+H DLK +N L+ + K+ DFG+A D T
Sbjct: 127 WERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 182
Query: 505 GNTNRIVGTYGYMAPE-----------YAMHGQFSVKSDVYSFGVLVLEIITGK 547
+ VGT YM PE + S KSDV+S G ++ + GK
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 29/221 (13%)
Query: 341 IEVATNNFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSR-SSGQGGQEFKNEVVL 395
I ++ + +G G FG VY G L G++I AVK L+R + +F E ++
Sbjct: 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 143
Query: 396 VAKLQHRNLVRLLGFCLEGEEKIL-VYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKI 450
+ H N++ LLG CL E L V ++ + L F+ + +
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL---- 199
Query: 451 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRI 510
+A+G+ +L + + +HRDL A N +LD + K++DFG+A+ D + +
Sbjct: 200 --QVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSV 250
Query: 511 VGTYG------YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
G +MA E +F+ KSDV+SFGVL+ E++T
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-41
Identities = 63/249 (25%), Positives = 101/249 (40%), Gaps = 51/249 (20%)
Query: 332 ESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SRSSGQ 384
E L +D E + LG G FG+V + + + +AVK L ++
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 385 GGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV-YEFVPNKSLDYFL--------- 433
+ +E+ ++ + H N+V LLG C + ++V EF +L +L
Sbjct: 73 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 434 ----YEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKI 489
E + L +A+G+ +L + + IHRDL A NILL + KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 490 SDFGMAKIFGVDQTQGNTNRIVGTYGY-------------MAPEYAMHGQFSVKSDVYSF 536
DFG+A R + MAPE ++++SDV+SF
Sbjct: 190 CDFGLA-------------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 537 GVLVLEIIT 545
GVL+ EI +
Sbjct: 237 GVLLWEIFS 245
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-41
Identities = 59/240 (24%), Positives = 100/240 (41%), Gaps = 52/240 (21%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRL-SRSSGQGGQEFKNE 392
E + + LGEG FG+V +AVK L ++ + + +E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 393 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YEPEK 438
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 439 QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498
++Q+ + +ARG+ YL + + IHRDL A N+L+ KI+DFG+A
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA--- 204
Query: 499 GVDQTQGNTNRIVGTYGY-------------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
R + Y MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 205 ----------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 71/266 (26%), Positives = 113/266 (42%), Gaps = 29/266 (10%)
Query: 304 GLCYFIRKAKNKYN---AVPEVNADNDITTLESLQFDF-ETIEVATNNFSTDNKLGEGGF 359
G+ Y ++ K KY + E N T ++ Q + E E NN LG G F
Sbjct: 1 GVDYKYKQ-KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAF 59
Query: 360 GEVYKGVL------PSGQEIAVKRL-SRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFC 411
G+V + + ++AVK L S + + +E+ +++ L QH N+V LLG C
Sbjct: 60 GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119
Query: 412 LEGEEKILVYEFVPNKSLDYFL-----------YEPEKQQQLDWSRRYKIIGGIARGILY 460
G +++ E+ L FL +A+G+ +
Sbjct: 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA-KIFGVDQTQGNTNRIVGTYGYMAP 519
L + IHRD+ A N+LL KI DFG+A I N + +MAP
Sbjct: 180 L---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL-PVKWMAP 235
Query: 520 EYAMHGQFSVKSDVYSFGVLVLEIIT 545
E ++V+SDV+S+G+L+ EI +
Sbjct: 236 ESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 59/240 (24%), Positives = 100/240 (41%), Gaps = 52/240 (21%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRL-SRSSGQGGQEFKNE 392
E + + LGEG FG+V +AVK L ++ + + +E
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 393 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YEPEK 438
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 439 QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498
++Q+ + +ARG+ YL + + IHRDL A N+L+ KI+DFG+A
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA--- 250
Query: 499 GVDQTQGNTNRIVGTYGY-------------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
R + Y MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 251 ----------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 25/225 (11%)
Query: 339 ETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRS--SGQGGQEFKNEVVLV 396
E I V +S ++G GG +V++ + Q A+K ++ Q ++NE+ +
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 397 AKLQHRNL--VRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGG 453
KLQ + +RL + ++ I +V E N L+ +L +K++ +D R
Sbjct: 62 NKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKN 116
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
+ + +H+ I+H DLK +N L+ + K+ DFG+A D T + VGT
Sbjct: 117 MLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 514 YGYMAPE-----------YAMHGQFSVKSDVYSFGVLVLEIITGK 547
YM PE + S KSDV+S G ++ + GK
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 43/238 (18%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SRSSGQGGQEFKNEVV 394
E N LGEG FG+V K +AVK L +S ++ +E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE--PEKQQQLDWSRRYKIIG 452
++ ++ H ++++L G C + +L+ E+ SL FL E L
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 453 G-------------------IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493
I++G+ YL + ++++HRDL A NIL+ KISDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 494 MA-KIFGVDQTQGNTN-----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
++ ++ D + + +MA E ++ +SDV+SFGVL+ EI+T
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 43/238 (18%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSG------QEIAVKRL-SRSSGQGGQEFKNEVV 394
E NN +GEG FG V++ P +AVK L +S +F+ E
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL--------------------- 433
L+A+ + N+V+LLG C G+ L++E++ L+ FL
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 434 YEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493
L + + I +A G+ YL S + +HRDL N L+ M KI+DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 494 MA-KIFGVDQTQGNTN-----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
++ I+ D + + N R +M PE + +++ +SDV+++GV++ EI +
Sbjct: 220 LSRNIYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQE---IAVKRL-SRSSGQGGQEFKNEVVLVA 397
+ N+ + +GEG FG+V K + A+KR+ +S ++F E+ ++
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80
Query: 398 KL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------YEPEKQQQLD 443
KL H N++ LLG C L E+ P+ +L FL L
Sbjct: 81 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 444 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503
+ +ARG+ YL S+ + IHRDL A NIL+ KI+DFG+++ G +
Sbjct: 141 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVY 195
Query: 504 QGNTN-----RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
T R +MA E + ++ SDV+S+GVL+ EI++
Sbjct: 196 VKKTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-40
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 351 DNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSRSSGQGGQEFKNEVVLVAKLQHRNLVRL 407
D ++G G F VYKG+ + E+A + + + Q FK E ++ LQH N+VR
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 408 LGFCLEGEEK----ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
+ +LV E + + +L +L ++ + + I +G+ +LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 464 DSRLRIIHRDLKASNILLDAEM-NPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA 522
+ IIHRDLK NI + + KI D G+A + + ++GT +MAPE
Sbjct: 148 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM- 201
Query: 523 MHGQFSVKSDVYSFGVLVLEIITGK 547
++ DVY+FG+ +LE+ T +
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSE 226
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-40
Identities = 49/214 (22%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRL-SRSSGQGGQEFKNEVVLV 396
E+ +GEG FG+V++G+ P + A+K + +S ++F E + +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 397 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ----QQLDWSRRYKIIG 452
+ H ++V+L+G E ++ E L FL + + ++
Sbjct: 446 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAY------ 498
Query: 453 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQGNTNRIV 511
++ + YL R +HRD+ A N+L+ + K+ DFG+++ + + + ++
Sbjct: 499 QLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL- 554
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+MAPE +F+ SDV+ FGV + EI+
Sbjct: 555 -PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-40
Identities = 59/240 (24%), Positives = 94/240 (39%), Gaps = 52/240 (21%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SRSSGQGGQEFKNEVV 394
E N S LG G FG+V + + +AVK L + + +E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 395 LVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL---------------YEPEK 438
+++ L H N+V LLG C G +++ E+ L FL +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 439 QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498
+ LD +A+G+ +L + IHRDL A NILL KI DFG+A
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA--- 192
Query: 499 GVDQTQGNTNRIVGTYGY-------------MAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
R + MAPE + ++ +SDV+S+G+ + E+ +
Sbjct: 193 ----------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-40
Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 16/233 (6%)
Query: 320 PEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL 378
PE + + E L+ + + ++G G FGEV++ +G + AVK++
Sbjct: 32 PETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV 91
Query: 379 SRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEK 438
+ E+V A L +V L G EG + E + SL + ++
Sbjct: 92 RLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQ 143
Query: 439 QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMAKI 497
L R +G G+ YLH RI+H D+KA N+LL ++ + + DFG A
Sbjct: 144 MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALC 200
Query: 498 F---GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
G+ ++ + I GT +MAPE M K D++S ++L ++ G
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 62/198 (31%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412
LG+G +G VY G L + IA+K + + Q E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 413 EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 472
E + E VP SL L + + I G+ YLH++ +I+HR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 473 DLKASNILLDAEM-NPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ--FSV 529
D+K N+L++ KISDFG +K + T GT YMAPE G +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 530 KSDVYSFGVLVLEIITGK 547
+D++S G ++E+ TGK
Sbjct: 205 AADIWSLGCTIIEMATGK 222
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNL 404
+F +G GGFG+V+K G+ +KR+ ++ ++ + EV +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 405 VRLLGFCLEGEEKILVYEFVPNKSLDYFLY---------------EPEKQQQLDWSRRYK 449
V G + ++S L+ E + ++LD +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 450 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR 509
+ I +G+ Y+H ++I+RDLK SNI L KI DFG+ + G R
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTR 180
Query: 510 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548
GT YM+PE + + D+Y+ G+++ E++
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-39
Identities = 66/271 (24%), Positives = 111/271 (40%), Gaps = 49/271 (18%)
Query: 304 GLCYFIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVY 363
+ V E D E+ + LGEG FG+V
Sbjct: 38 IPTTENLYFQGMLAGVSEYELPED-----------PRWELPRDRLVLGKPLGEGAFGQVV 86
Query: 364 KGVLP--------SGQEIAVKRL-SRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLE 413
++AVK L S ++ + + +E+ ++ + +H+N++ LLG C +
Sbjct: 87 LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146
Query: 414 GEEKILVYEFVPNKSLDYFL-------------YEPEKQQQLDWSRRYKIIGGIARGILY 460
++ E+ +L +L ++QL +ARG+ Y
Sbjct: 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA-KIFGVDQTQGNTN-----RIVGTY 514
L + + IHRDL A N+L+ + KI+DFG+A I +D + TN +
Sbjct: 207 L---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK----- 258
Query: 515 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 259 -WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-39
Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 339 ETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRS--SGQGGQEFKNEVVLV 396
E I V +S ++G GG +V++ + Q A+K ++ Q ++NE+ +
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 397 AKLQHRNL--VRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGI 454
KLQ + +RL + + + +V E N L+ +L +K++ +D R +
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNM 164
Query: 455 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTY 514
+ +H+ I+H DLK +N L+ + K+ DFG+A D T + VG
Sbjct: 165 LEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 515 GYMAPE-----------YAMHGQFSVKSDVYSFGVLVLEIITGK 547
YM PE + S KSDV+S G ++ + GK
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 48/205 (23%), Positives = 96/205 (46%), Gaps = 9/205 (4%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSRSSGQGGQEFKNEVVLVAKLQHR 402
+ K+GEG FG+ G++ +K +SR S + +E + EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 403 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLH 462
N+V+ E +V ++ L + +K + I + ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA 522
+ +I+HRD+K+ NI L + ++ DFG+A++ +GT Y++PE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 523 MHGQFSVKSDVYSFGVLVLEIITGK 547
+ ++ KSD+++ G ++ E+ T K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK 222
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 29/227 (12%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN 403
++F LG+G FG+V K + A+K++ + + +EV+L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNHQY 63
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYF---------LYE--PEKQQQLDWSRRYKIIG 452
+VR LE + V KS + LY+ + +++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 453 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF------------GV 500
I + Y+H IIHRDLK NI +D N KI DFG+AK +
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 501 DQTQGNTNRIVGTYGYMAPE-YAMHGQFSVKSDVYSFGVLVLEIITG 546
+ N +GT Y+A E G ++ K D+YS G++ E+I
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-38
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 343 VATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE-FKNEVVLVAKLQ 400
+ + + + LG+G V++G +G A+K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 401 HRNLVRLLGF--CLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGI 458
H+N+V+L K+L+ EF P SL L EP L S ++ + G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 459 LYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTY 514
+L E I+HR++K NI+ D + K++DFG A+ D Q + + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179
Query: 515 GYMAPE--------YAMHGQFSVKSDVYSFGVLVLEIITGK 547
Y+ P+ ++ D++S GV TG
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-38
Identities = 59/207 (28%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE---FKNEVVLVAKL-QH 401
+F ++LG G +GEV+K G+ AVKR S S +G ++ EV K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYL 461
VRL EG L E SL L ++ + + + +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHL 173
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY 521
H ++H D+K +NI L K+ DFG+ G T G G YMAPE
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPE- 226
Query: 522 AMHGQFSVKSDVYSFGVLVLEIITGKK 548
+ G + +DV+S G+ +LE+ +
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 51/207 (24%), Positives = 99/207 (47%), Gaps = 10/207 (4%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL---SRSSGQGGQEFKNEVVLVAKLQH 401
NF + K+G G F EVY+ L G +A+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE-PEKQQQLDWSRRYKIIGGIARGILY 460
N+++ +E E +V E L + ++++ + +K + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520
+H R++HRD+K +N+ + A K+ D G+ + F T ++ +VGT YM+PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 521 YAMHGQFSVKSDVYSFGVLVLEIITGK 547
++ KSD++S G L+ E+ +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 59/245 (24%), Positives = 94/245 (38%), Gaps = 57/245 (23%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SRSSGQGGQEFKNEVV 394
E N LG G FG+V ++AVK L ++ + +E+
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 395 LVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-------------------- 433
++ +L H N+V LLG C L++E+ L +L
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 434 YEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493
E E L + +A+G+ +L +HRDL A N+L+ KI DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 494 MAKIFGVDQTQGNTNRIVGTYGY-------------MAPEYAMHGQFSVKSDVYSFGVLV 540
+A R + + MAPE G +++KSDV+S+G+L+
Sbjct: 218 LA-------------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264
Query: 541 LEIIT 545
EI +
Sbjct: 265 WEIFS 269
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 4e-37
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 343 VATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE-FKNEVVLVAKLQ 400
+ + + + LG+G V++G +G A+K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 401 HRNLVRLLGF--CLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGI 458
H+N+V+L K+L+ EF P SL L EP L S ++ + G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 459 LYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTY 514
+L E I+HR++K NI+ D + K++DFG A+ D Q + + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179
Query: 515 GYMAPE--------YAMHGQFSVKSDVYSFGVLVLEIITGK 547
Y+ P+ ++ D++S GV TG
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-37
Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 37/233 (15%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS-SGQGGQEFKNEVV 394
DFE I+ LG GGFG V++ A+KR+ ++ EV
Sbjct: 6 DFEPIQC----------LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 55
Query: 395 LVAKLQHRNLVRLLGFCLEGEE---------KILVY---EFVPNKSLDYFLYEPEKQQQL 442
+AKL+H +VR LE K+ +Y + ++L ++ ++
Sbjct: 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115
Query: 443 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502
+ S I IA + +LH ++HRDLK SNI + K+ DFG+ D+
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 503 TQGNT----------NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+ VGT YM+PE +S K D++S G+++ E++
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 58/246 (23%), Positives = 97/246 (39%), Gaps = 21/246 (8%)
Query: 340 TIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAK 398
+ + ++ KLGEGGF V L G A+KR+ Q +E + E +
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82
Query: 399 LQHRNLVRLLGFCLE----GEEKILVYEFVPNKSLDYFLYEPEKQQQ-LDWSRRYKIIGG 453
H N++RL+ +CL E L+ F +L + + + L + ++ G
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV-- 511
I RG+ +H HRDLK +NILL E P + D G + +
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 512 -----GTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLS 563
T Y APE H ++DV+S G ++ ++ G+ + D ++
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE--GPYDMVFQKGDSVA 257
Query: 564 YVSINR 569
N+
Sbjct: 258 LAVQNQ 263
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSS-GQGGQE--FKNEVVLVAKLQHRNLVRLLG 409
LG+GGF + ++ + + A K + +S + Q E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 410 FCLEGEEKI-LVYEFVPNKSL-DYF-----LYEPEKQQQLDWSRRYKIIGGIARGILYLH 462
E + + +V E +SL + L EPE +R Y + I G YLH
Sbjct: 83 -FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE-------ARYY--LRQIVLGCQYLH 132
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA 522
R R+IHRDLK N+ L+ ++ KI DFG+A D + + GT Y+APE
Sbjct: 133 ---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVL 187
Query: 523 MHGQFSVKSDVYSFGVLVLEIITGK 547
S + DV+S G ++ ++ GK
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSS-GQGGQE--FKNEVVLVAKLQHRNLVRLLG 409
LG+GGF + ++ + + A K + +S + Q E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 410 FCLEGEEKI-LVYEFVPNKSL-DYF-----LYEPEKQQQLDWSRRYKIIGGIARGILYLH 462
E + + +V E +SL + L EPE +R Y + I G YLH
Sbjct: 109 -FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE-------ARYY--LRQIVLGCQYLH 158
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA 522
R R+IHRDLK N+ L+ ++ KI DFG+A D + + GT Y+APE
Sbjct: 159 ---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVL 213
Query: 523 MHGQFSVKSDVYSFGVLVLEIITGK 547
S + DV+S G ++ ++ GK
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 6e-36
Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE-FKNEVVLVAKLQHRNL 404
+ +LG GGFG V + + +G+++A+K+ + +E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 405 VRLL------GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGI 458
V + +L E+ L +L + E L ++ I+ +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMAKIFGVDQTQGNTNRIVGTYG 515
YLHE RIIHRDLK NI+L KI D G AK VGT
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVGTLQ 188
Query: 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
Y+APE +++V D +SFG L E ITG
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 10/210 (4%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSRSSGQGGQEFKNEVVLVAKLQHR 402
++ +G G +G K G+ + K + Q +EV L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 403 NLVRLLGFCLEGEEKIL--VYEFVPNKSLDYFLYE-PEKQQQLDWSRRYKIIGGIARGIL 459
N+VR ++ L V E+ L + + +++Q LD +++ + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 460 YLHE--DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYM 517
H D ++HRDLK +N+ LD + N K+ DFG+A+I D + T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
+PE ++ KSD++S G L+ E+
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 26/222 (11%)
Query: 340 TIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFK---NEV-V 394
++EV ++ +LG G +G V K +PSGQ +AVKR+ + QE K ++ +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDI 58
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL-YEPEKQQQLDWSRRYKIIGG 453
+ + V G + + E + + SLD F +K Q + I+G
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP----EDILGK 113
Query: 454 IARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR 509
IA I+ +LH S+L +IHRD+K SN+L++A K+ DFG++ VD + +
Sbjct: 114 IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID- 169
Query: 510 IVGTYGYMAPE----YAMHGQFSVKSDVYSFGVLVLEIITGK 547
G YMAPE +SVKSD++S G+ ++E+ +
Sbjct: 170 -AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-35
Identities = 61/200 (30%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRS----SGQGGQEFKNEVVLVAKLQHRNLVRLL 408
LG+G F VY+ + +G E+A+K + + +G + +NEV + +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77
Query: 409 GFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRL 467
E + LV E N ++ +L K + +R + + I G+LYLH
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYLH---SH 131
Query: 468 RIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF 527
I+HRDL SN+LL MN KI+DFG+A + + T + GT Y++PE A
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAH 189
Query: 528 SVKSDVYSFGVLVLEIITGK 547
++SDV+S G + ++ G+
Sbjct: 190 GLESDVWSLGCMFYTLLIGR 209
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 49/229 (21%), Positives = 91/229 (39%), Gaps = 21/229 (9%)
Query: 329 TTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQE 388
+ + + V +F + LG G G + + +++AVKR+
Sbjct: 7 LEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSF--- 63
Query: 389 FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSR 446
EV L+ + +H N++R + + + E +Y +K
Sbjct: 64 ADREVQLLRESDEHPNVIRYFCTE-KDRQFQYIAIELCAATLQEYVE---QKDFAHLGLE 119
Query: 447 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DAEMNPKISDFGMAKIFGVD 501
++ G+ +LH L I+HRDLK NIL+ ++ ISDFG+ K V
Sbjct: 120 PITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176
Query: 502 Q-TQGNTNRIVGTYGYMAPEY---AMHGQFSVKSDVYSFGVLVLEIITG 546
+ + + + GT G++APE + D++S G + +I+
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 332 ESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEF- 389
L + E+ ++F ++LG G G V+K PSG +A K + +
Sbjct: 19 AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI 78
Query: 390 KNEVVLVAKLQHRNLVRLLG-FCLEGEEKILVYEFVPNKSLDYFLYE----PEKQQQLDW 444
E+ ++ + +V G F +GE I E + SLD L + PE+
Sbjct: 79 IRELQVLHECNSPYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVLKKAGRIPEQ------ 131
Query: 445 SRRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500
I+G ++ ++ YL E +I+HRD+K SNIL+++ K+ DFG++
Sbjct: 132 -----ILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-- 182
Query: 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
+ N+ VGT YM+PE +SV+SD++S G+ ++E+ G+
Sbjct: 183 IDSMANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 353 KLGEGGFGEVYKG---VLPSGQEIAVKRLSRSSGQGGQE----FKNEVVLVAKLQHRNLV 405
KLG GG VY +L ++A+K + + +E F+ EV ++L H+N+V
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
++ E + LV E++ +L ++ E L I GI + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH--- 128
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG 525
+RI+HRD+K NIL+D+ KI DFG+AK + + TN ++GT Y +PE A
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 526 QFSVKSDVYSFGVLVLEIITGK 547
+D+YS G+++ E++ G+
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGE 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 66/232 (28%), Positives = 105/232 (45%), Gaps = 28/232 (12%)
Query: 332 ESLQFDFE-TIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEF 389
L+ E + + ++G G +G V K V PSGQ +AVKR+ + + +E
Sbjct: 7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQ 64
Query: 390 K---NEV-VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWS 445
K ++ V++ +V+ G + + E + + S D F K
Sbjct: 65 KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLD 119
Query: 446 RRY--KIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499
+I+G I + +L E+ L+IIHRD+K SNILLD N K+ DFG++
Sbjct: 120 DVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL- 176
Query: 500 VDQTQGNTNRIVGTYGYMAPE----YAMHGQFSVKSDVYSFGVLVLEIITGK 547
+ T G YMAPE A + V+SDV+S G+ + E+ TG+
Sbjct: 177 -VDSIAKTR-DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 58/206 (28%), Positives = 110/206 (53%), Gaps = 20/206 (9%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVR 406
++ K+G+G G VY + + +GQE+A+++++ + NE++++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 407 LLGFCLEGEEKILVYEFVPNKSL-DYFLYEPEKQQQLDWSRRYKIIGGIARGIL----YL 461
L L G+E +V E++ SL D + Q I + R L +L
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ---------IAAVCRECLQALEFL 132
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY 521
H + ++IHRD+K+ NILL + + K++DFG +Q++ +T +VGT +MAPE
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEV 187
Query: 522 AMHGQFSVKSDVYSFGVLVLEIITGK 547
+ K D++S G++ +E+I G+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS----SGQGGQEFKNEVVLVAKLQ 400
+F LG+G FG VY S +A+K L ++ +G Q + EV + + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 401 HRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL 459
H N++RL G+ ++ L+ E+ P ++ L +K + D R I +A +
Sbjct: 68 HPNILRLYGY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAP 519
Y H R+IHRD+K N+LL + KI+DFG + ++ + GT Y+ P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTD--LCGTLDYLPP 176
Query: 520 EYAMHGQFSVKSDVYSFGVLVLEIITGK 547
E K D++S GVL E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVR 406
+ K+GEG G V SG+++AVK + Q + NEVV++ QH N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 407 LLGFCLEGEEKILVYEFVPNKSLDYFLYE---PEKQQQLDWSRRYKIIGGIARGIL---- 459
+ L GEE ++ EF+ +L + + E+Q I + +L
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ-----------IATVCEAVLQALA 155
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM-AKIFGVDQTQGNTNRIVGTYGYMA 518
YLH +IHRD+K+ +ILL + K+SDFG A+I + +VGT +MA
Sbjct: 156 YLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMA 209
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
PE ++ + D++S G++V+E++ G+
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 50/203 (24%), Positives = 82/203 (40%), Gaps = 19/203 (9%)
Query: 353 KLGEGGFGEVYKGVLPS-GQEIAVKRLSRSSGQGGQE----FKNEVVLVAKLQHRNLVRL 407
+G GG G+VY+ + +A+K + + + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 408 LGFCLEGEEKILVY---EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED 464
F GE +Y + L L +Q L R I+ I + H
Sbjct: 100 HDF---GEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 465 SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH 524
HRD+K NIL+ A+ + DFG+A D+ VGT YMAPE
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSE 209
Query: 525 GQFSVKSDVYSFGVLVLEIITGK 547
+ ++D+Y+ ++ E +TG
Sbjct: 210 SHATYRADIYALTCVLYECLTGS 232
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 5e-33
Identities = 46/207 (22%), Positives = 82/207 (39%), Gaps = 32/207 (15%)
Query: 353 KLGEGGFGEVYKG---VLPSGQEIAVKRLSRSSGQGGQE-FKNEVVLVAKLQHRNLVRLL 408
+ GG G +Y + +G+ + +K L S Q E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 409 GFCLEGEEKI--------LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
F E +V E+V +SL + L + + I + Y
Sbjct: 146 NF---VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSY 197
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520
LH + +++ DLK NI+L E K+ D G + + GT G+ APE
Sbjct: 198 LH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPE 247
Query: 521 YAMHGQFSVKSDVYSFGVLVLEIITGK 547
G +V +D+Y+ G + +
Sbjct: 248 IVRTGP-TVATDIYTVGRTLAALTLDL 273
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 47/255 (18%), Positives = 100/255 (39%), Gaps = 43/255 (16%)
Query: 323 NADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS 382
+ ++ + L L + + N++ L +G F ++ + A+K+ +S
Sbjct: 8 DILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSL 66
Query: 383 GQGGQEF-----------------KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFV 424
+ ++F KNE+ ++ +++ + G + +++ ++YE++
Sbjct: 67 LEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYM 125
Query: 425 PNKSL-DY------FLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 477
N S+ + + + I + Y+H + I HRD+K S
Sbjct: 126 ENDSILKFDEYFFVLDKNYTCFIPIQVIKCI--IKSVLNSFSYIH--NEKNICHRDVKPS 181
Query: 478 NILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE-----YAMHGQFSVKSD 532
NIL+D K+SDFG ++ GTY +M PE + +G K D
Sbjct: 182 NILMDKNGRVKLSDFGESEYM----VDKKIKGSRGTYEFMPPEFFSNESSYNGA---KVD 234
Query: 533 VYSFGVLVLEIITGK 547
++S G+ + +
Sbjct: 235 IWSLGICLYVMFYNV 249
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG-QEFKNEVVLVAKLQHRNLV 405
F+ K+G+G FGEV+KG+ + + +A+K + + ++ + E+ ++++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 406 RLLGFCLEGEEKILVYEFVPNKSL-DYFLYEPEKQQQLDWSRRYKIIGGIARGIL----Y 460
+ G L+ + ++ E++ S D L EP + I I R IL Y
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGPLDE-------TQIATILREILKGLDY 134
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520
LH + + IHRD+KA+N+LL K++DFG+A + TQ N VGT +MAPE
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE 189
Query: 521 YAMHGQFSVKSDVYSFGVLVLEIITGK 547
+ K+D++S G+ +E+ G+
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGE 216
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 50/229 (21%), Positives = 85/229 (37%), Gaps = 36/229 (15%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKR--LSRSSGQGGQEFKNEVVLVAKL-Q 400
T F K+G G FG V+K V G A+KR + Q EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ-QQLDWSRRYKIIGGIARGIL 459
H ++VR E + ++ E+ SL + E + + ++ + RG+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNP-------------------KISDFGMAKIFGV 500
Y+H ++H D+K SNI + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFS--VKSDVYSFGVLVLEIITGK 547
Q + G ++A E + ++ K+D+++ + V+ +
Sbjct: 187 PQVE------EGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 21/236 (8%), Positives = 53/236 (22%), Gaps = 43/236 (18%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE---FKNEVVLVAKLQHR 402
L G V+ + ++ A+K + + E A+L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 403 NLVRLLGFC----------LEGEEKI----------------LVYEFVP---NKSLDYFL 433
+ ++ + L+
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 434 YEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493
+ + + + + R L ++H N+ + + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGK 547
G T+G Y E+ F+ + + G+ + +
Sbjct: 240 ALWKVG---TRGPA--SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 353 KLGEGGFGEVYKG---VLPSGQEIAVKRLSRSSGQGGQE----FKNEVVLVAKLQHRNLV 405
LG GG EV+ +++AVK L R+ F+ E A L H +V
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 406 RLL--GFCLEGEEKI--LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYL 461
+ G + +V E+V +L + + + R ++I + + +
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFS 132
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK-IFGVDQTQGNTNRIVGTYGYMAPE 520
H + IIHRD+K +NI++ A K+ DFG+A+ I + T ++GT Y++PE
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 521 YAMHGQFSVKSDVYSFGVLVLEIITGK 547
A +SDVYS G ++ E++TG+
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 54/228 (23%), Positives = 84/228 (36%), Gaps = 34/228 (14%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEV-VLVAKLQHRNL 404
N ++ LG G G V G+ +AVKR+ E+ +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 405 VRLLGFCLEGEEKI-LVYEFVPNKSLDYFL---YEPEKQQQLDWSRRYKIIGGIARGILY 460
+R + + + E D E + ++ IA G+ +
Sbjct: 72 IRYYCSE-TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNP-------------KISDFGMAKIFGVDQT--QG 505
LH L+IIHRDLK NIL+ ISDFG+ K Q+ +
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 506 NTNRIVGTYGYMAPE-------YAMHGQFSVKSDVYSFGVLVLEIITG 546
N N GT G+ APE + + D++S G + I++
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 58/233 (24%), Positives = 102/233 (43%), Gaps = 38/233 (16%)
Query: 334 LQFDFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN- 391
L + + N+ ++G G G+V+K +G IAVK++ RS + +E K
Sbjct: 13 LTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK--EENKRI 70
Query: 392 --EV-VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE-----PEKQQQLD 443
++ V++ +V+ G + + + E + + PE+
Sbjct: 71 LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPER----- 124
Query: 444 WSRRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499
I+G + I+ YL E +IHRD+K SNILLD K+ DFG++
Sbjct: 125 ------ILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL- 175
Query: 500 VDQTQGNTNRIVGTYGYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITGK 547
VD + + G YMAPE + +++DV+S G+ ++E+ TG+
Sbjct: 176 VDDKAKDRS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVR 406
+ +LG+G FG+VYK +G A K + S + +++ E+ ++A H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 407 LLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL----YLH 462
LLG + ++ EF P ++D + E ++ I + R +L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ------IQVVCRQMLEALNFLH 134
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGM-AKIFGVDQTQGNTNRIVGTYGYMAPEY 521
RIIHRDLKA N+L+ E + +++DFG+ AK +T + +GT +MAPE
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN---LKTLQKRDSFIGTPYWMAPEV 188
Query: 522 AMHGQFS-----VKSDVYSFGVLVLEIITGK 547
M K+D++S G+ ++E+ +
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 23/231 (9%)
Query: 339 ETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVA 397
+T+E+ L EGGF VY+ + SG+E A+KRL + + + EV +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 398 KLQ-HRNLVRLLGFCL-------EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYK 449
KL H N+V+ G+ + L+ + L FL + E + L K
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 450 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR 509
I R + ++H + IIHRDLK N+LL + K+ DFG A + +
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 510 I----------VGTYGYMAPE-YAMHGQFSV--KSDVYSFGVLVLEIITGK 547
T Y PE ++ F + K D+++ G ++ + +
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS----SGQGGQEFKNEVVLVAKLQ 400
++F LG+G FG VY + +A+K L +S G Q + E+ + + L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLR 72
Query: 401 HRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL 459
H N++R+ + ++I L+ EF P L Y + + S + + +A +
Sbjct: 73 HPNILRMYNY-FHDRKRIYLMLEFAPRGEL-YKELQKHGRFDEQRSATF--MEELADALH 128
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAP 519
Y H ++IHRD+K N+L+ + KI+DFG + + T + GT Y+ P
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRT--MCGTLDYLPP 181
Query: 520 EYAMHGQFSVKSDVYSFGVLVLEIITGK 547
E K D++ GVL E + G
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 6e-31
Identities = 33/228 (14%), Positives = 71/228 (31%), Gaps = 22/228 (9%)
Query: 339 ETIEVATNNFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSRSSGQGGQEFKNE 392
++ + + LGEG F +VY+ + Q+ +K ++
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 393 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL--YEPEKQQQLDWSRRYKI 450
+ + ++ L +LV E +L + Y+ ++ +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 451 IGGIARGILYLHEDSRLRIIHRDLKASNILL-----------DAEMNPKISDFGMAKIFG 499
+ I +H+ IIH D+K N +L D + D G +
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
+ T G+ E + ++ + D + V ++ G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN 403
F KLGEG +G VYK + +GQ +A+K++ S QE E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPH 85
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL---- 459
+V+ G + + +V E+ S+ + K D I I + L
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE------IATILQSTLKGLE 139
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAP 519
YLH R IHRD+KA NILL+ E + K++DFG+A + T N ++GT +MAP
Sbjct: 140 YLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQ--LTDTMAKRNTVIGTPFWMAP 194
Query: 520 EYAMHGQFSVKSDVYSFGVLVLEIITGK 547
E ++ +D++S G+ +E+ GK
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE-FKNEVVLVAKLQHR 402
+ F KLG G FG+V+ SG E +K +++ Q E + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 403 NLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
N++++ E + +V E L + + + + L +++ + + Y
Sbjct: 81 NIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 461 LHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYM 517
H ++H+DLK NIL KI DFG+A++F D+ GT YM
Sbjct: 140 FHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYM 193
Query: 518 APEYAMHGQFSVKSDVYSFGV 538
APE + K D++S GV
Sbjct: 194 APE-VFKRDVTFKCDIWSAGV 213
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG-QEFKNEVVLVAKLQHRN 403
+++ +G G V P +++A+KR++ Q E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYEPEKQQQLDWSRRYKIIGGIARGIL--- 459
+V + +E LV + + S+ D + K + I I R +L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 460 -YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM-AKIFGVDQTQGNTNR--IVGTYG 515
YLH++ IHRD+KA NILL + + +I+DFG+ A + N R VGT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 516 YMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 547
+MAPE + + K+D++SFG+ +E+ TG
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-30
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 32/217 (14%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQH 401
+ + KLG G +GEV + E A+K + ++ S + EV ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 402 RNLVRLLGFCLEGEEKI-LVYEFVPNKSL-------DYFLYEPEKQQQLDWSRRYKIIGG 453
N+++L F E + LV E L F E II
Sbjct: 96 PNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRMKF---NEVDAA-------VIIKQ 144
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFGVDQTQGNTNRI 510
+ G+ YLH+ I+HRDLK N+LL + + KI DFG++ +F +
Sbjct: 145 VLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KER 198
Query: 511 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
+GT Y+APE + ++ K DV+S GV++ ++ G
Sbjct: 199 LGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 30/230 (13%)
Query: 336 FDFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVV 394
D + F +G G +G+VYKG + +GQ A+K + +G +E K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEIN 72
Query: 395 LVAKL-QHRNLVRLLGFCLEGEEKI------LVYEFVPNKSL-DYFLYEPEKQQQLDWSR 446
++ K HRN+ G ++ LV EF S+ D L + K L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLK--- 127
Query: 447 RYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502
+ I I R IL +LH+ ++IHRD+K N+LL K+ DFG++ +D+
Sbjct: 128 -EEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDR 181
Query: 503 TQGNTNRIVGTYGYMAPEYAMHGQFS-----VKSDVYSFGVLVLEIITGK 547
T G N +GT +MAPE + KSD++S G+ +E+ G
Sbjct: 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 32/228 (14%)
Query: 333 SLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS--SGQGGQEF 389
S + + ++ LG+G FGEV K + QE AVK ++++ +
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 390 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSL-------DYFLYEPEKQQQ 441
EV L+ KL H N+++L E +V E L F E
Sbjct: 69 LREVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAA 124
Query: 442 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIF 498
+II + GI Y+H+ I+HRDLK NILL + + + KI DFG++ F
Sbjct: 125 -------RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 546
+ +GT Y+APE + G + K DV+S GV++ +++G
Sbjct: 175 QQNTKM---KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSS----GQGGQEFKNEVVLVAKLQHRNLVRLL 408
LGEG +G+V + + + AVK L + G K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 409 G-FCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRY--KIIGGIARGILYLHED 464
E ++K+ +V E+ + PEK+ + + Y ++I G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH-- 126
Query: 465 SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM- 523
I+H+D+K N+LL KIS G+A+ G+ + PE A
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 524 ----HGQFSVKSDVYSFGVLVLEIITGK 547
G K D++S GV + I TG
Sbjct: 186 LDTFSGF---KVDIWSAGVTLYNITTGL 210
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-29
Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQ 400
++ + LG+G FGEV +GQE AVK +S+ + EV L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYEPEKQQQLDWSRRYKIIGG 453
H N+++L F + LV E L F E +II
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF---SEVDAA-------RIIRQ 134
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFGVDQTQGNTNRI 510
+ GI Y+H+ +I+HRDLK N+LL + N +I DFG++ F +
Sbjct: 135 VLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDK 188
Query: 511 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 546
+GT Y+APE +HG + K DV+S GV++ +++G
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 35/215 (16%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLS---RSSGQGGQEFKNEVVLVAKLQHRN 403
FS ++G G FG VY + + + +A+K++S + S + Q+ EV + KL+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEP----EKQQQLDWSRRYKIIGGIARGIL 459
++ G L LV E+ + D E + I + G L
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----------IAAVTHGAL 164
Query: 460 ----YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG 515
YLH +IHRD+KA NILL K+ DFG A I N+ VGT
Sbjct: 165 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANS--FVGTPY 215
Query: 516 YMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGK 547
+MAPE + GQ+ K DV+S G+ +E+ K
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 5e-29
Identities = 45/214 (21%), Positives = 79/214 (36%), Gaps = 28/214 (13%)
Query: 352 NKLGEG--GFGEVYKGV-LPSGQEIAVKR--LSRSSGQGGQEFKNEVVLVAKLQHRNLVR 406
+G+G V P+G+ + V+R L S + + E+ + H N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 407 LLGFCLEGEEKILVYEFVPNKSL-DYFLYEPEKQQQLDWSRRYKIIGGIARGIL----YL 461
+ E +V F+ S D L ++ I I +G+L Y+
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMN----ELAIAYILQGVLKALDYI 144
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT-----NRIVGTYGY 516
H +HR +KAS+IL+ + +S + V +
Sbjct: 145 HHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 517 MAPE---YAMHGQFSVKSDVYSFGVLVLEIITGK 547
++PE + G + KSD+YS G+ E+ G
Sbjct: 202 LSPEVLQQNLQG-YDAKSDIYSVGITACELANGH 234
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 54/239 (22%), Positives = 95/239 (39%), Gaps = 39/239 (16%)
Query: 320 PEVNADNDITTLESLQFDFETIEVATNNFS----TDNKLGEGGFGEVYKGV-LPSGQEIA 374
P++N + ++ + +EV + +LG G FG V++ V +G+
Sbjct: 21 PKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFV 80
Query: 375 VKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL----- 429
K ++ KNE+ ++ +L H L+ L + E +L+ EF+ L
Sbjct: 81 AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 140
Query: 430 --DYFLYEPE-----KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 482
DY + E E +Q G+ ++HE I+H D+K NI+ +
Sbjct: 141 AEDYKMSEAEVINYMRQ--------------ACEGLKHMHE---HSIVHLDIKPENIMCE 183
Query: 483 AEMNP--KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 539
+ KI DFG+A D+ T + APE +D+++ GVL
Sbjct: 184 TKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE-FKNEVVLVAKLQHRNLVRLLGFC 411
LGEG +GEV V + + +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 412 LEGEEKI-LVYEFVPNKSL-DYF-----LYEPEKQQQLDWSRRY--KIIGGIARGILYLH 462
L E+ L D + EP+ ++R+ +++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-------AQRFFHQLMAGVV----YLH 122
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE-- 520
+ I HRD+K N+LLD N KISDFG+A +F + + N++ GT Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 521 ----YAMHGQFSVKSDVYSFGV 538
+ H + DV+S G+
Sbjct: 180 KRREF--HAE---PVDVWSCGI 196
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE-FKNEVVLVAKLQHRNLVRLLGFC 411
LGEG +GEV V + + +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 412 LEGEEKI-LVYEFVPNKSL-DYF-----LYEPEKQQQLDWSRRY--KIIGGIARGILYLH 462
L E+ L D + EP+ ++R+ +++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-------AQRFFHQLMAGVV----YLH 122
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE-- 520
+ I HRD+K N+LLD N KISDFG+A +F + + N++ GT Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 521 ----YAMHGQFSVKSDVYSFGV 538
+ H + DV+S G+
Sbjct: 180 KRREF--HAE---PVDVWSCGI 196
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 43/227 (18%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG-------------QEFK 390
++ KLG G +GEV E A+K + +S G +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 391 NEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSL-------DYFLYEPEKQQQL 442
NE+ L+ L H N+++L E ++ LV EF L F E
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHKF---DECDAA- 149
Query: 443 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFG 499
I+ I GI YLH+ I+HRD+K NILL ++ +N KI DFG++ F
Sbjct: 150 ------NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200
Query: 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITG 546
D +GT Y+APE + +++ K DV+S GV++ ++ G
Sbjct: 201 KDYKL---RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQH 401
++ LG+G FGEV K + QE AVK ++++ + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 402 RNLVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYEPEKQQQLDWSRRY--KIIGGIARG 457
N+++L E +V E L D + ++++ +S +II + G
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEII---KRKR---FSEHDAARIIKQVFSG 133
Query: 458 ILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTY 514
I Y+H+ I+HRDLK NILL + + + KI DFG++ F + +GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTA 187
Query: 515 GYMAPEYAMHGQFSVKSDVYSFGV 538
Y+APE + G + K DV+S GV
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGV 210
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 29/239 (12%), Positives = 63/239 (26%), Gaps = 54/239 (22%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE---FKNEVVLVAKLQ--------- 400
LG+ + +G+ V + K EV+ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 401 ----------------HRNLVRLLG-FCLEGEEKILVYEFVPNKSL----DYFLYEPEKQ 439
+ ++R+ +L + L
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 440 QQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499
+ L R ++ + R + LH ++H L+ +I+LD ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 500 VDQTQGNTNRIVGTYGYMAPEY-----------AMHGQFSVKSDVYSFGVLVLEIITGK 547
+ G+ PE + D ++ G+++ I
Sbjct: 258 ARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 6e-28
Identities = 30/233 (12%), Positives = 66/233 (28%), Gaps = 43/233 (18%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG---QEFKNEVVLVAKLQH-------R 402
LG+ + +G+ V + ++ K EV+ + L+ +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 403 NLVRLLGFC--LEGEEKILVYEFVPNKS----LDYFLYEP-----------------EKQ 439
+R + ++ +K + ++ L F P
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 440 QQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499
+ L R ++ + R + LH ++H L+ +I+LD ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 500 VDQTQGNTNRIVGTYGYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITGK 547
R A + D ++ G+ + I
Sbjct: 263 -ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 9e-28
Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 28/205 (13%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN 403
++ +N +G G +GEV V + A K++ + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 404 LVRLLGFCLEGEEKI-LVYEFVPNKSL-DY-----FLYEPEKQQQLDWSRRYKIIGGIAR 456
++RL E I LV E L + E + +I+ +
Sbjct: 68 IIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---------RIMKDVLS 117
Query: 457 GILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
+ Y H+ L + HRDLK N L + K+ DFG+A F + VGT
Sbjct: 118 AVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGT 171
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGV 538
Y++P+ + G + + D +S GV
Sbjct: 172 PYYVSPQ-VLEGLYGPECDEWSAGV 195
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 41/225 (18%)
Query: 336 FDFETIEVATNNFSTD------NKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE 388
FD + ++ LG G FG+V+K +G ++A K + + +E
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 389 FKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYEPE---- 437
KNE+ ++ +L H NL++L + +LV E+V L Y L E +
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 438 -KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--KISDFGM 494
KQ I GI ++H+ + I+H DLK NIL KI DFG+
Sbjct: 193 MKQ--------------ICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGL 235
Query: 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 539
A+ + + GT ++APE + S +D++S GV+
Sbjct: 236 ARRYKPREKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 33/211 (15%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK-----RLSRSSGQGGQEFKNEVVLVAKLQH 401
+ +G+G F V + + +GQ+ AVK + + S G ++ K E + L+H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 402 RNLVRLLGFCLEGEEKILVYEF----------VPNKSLDYFLYEPEKQQQLDWSRRYKII 451
++V LL +V+EF V + E +
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS---------HYM 136
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMAKIFGVDQTQGNTN 508
I + Y H+ IIHRD+K +LL ++ N K+ FG+A G
Sbjct: 137 RQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG- 192
Query: 509 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 539
VGT +MAPE + DV+ GV+
Sbjct: 193 -RVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-27
Identities = 66/302 (21%), Positives = 113/302 (37%), Gaps = 39/302 (12%)
Query: 246 RYEFYPF-YNLSATSPP--PPAPVLLPPPPPGSARGKSGISSSTIIAIVAPIAVTAVLFI 302
+YEF N S P P APVL+P RG I+ ++
Sbjct: 77 QYEFRIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVS------- 129
Query: 303 VGLCYFIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEV 362
N N V ++ +E +++ +LG G FG V
Sbjct: 130 ----------SNYDNYVFDIWKQYYPQPVEIKHDHVL------DHYDIHEELGTGAFGVV 173
Query: 363 YKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421
++ +G A K + + + E+ ++ L+H LV L + E +++Y
Sbjct: 174 HRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233
Query: 422 EFVPNKSL-DYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 480
EF+ L + E K + + + + +G+ ++HE +H DLK NI+
Sbjct: 234 EFMSGGELFEKVADEHNKMSEDEAVE---YMRQVCKGLCHMHE---NNYVHLDLKPENIM 287
Query: 481 LDAEMNP--KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGV 538
+ + K+ DFG+ Q + GT + APE A +D++S GV
Sbjct: 288 FTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
Query: 539 LV 540
L
Sbjct: 345 LS 346
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG---------QEFKNEVV 394
N+ LG G V + + P+ +E AVK + + G + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 395 LVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DY-----FLYEPEKQQQLDWSRR 447
++ K+ H N+++L LV++ + L DY L E E +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-------- 127
Query: 448 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT 507
KI+ + I LH+ L I+HRDLK NILLD +MN K++DFG + +
Sbjct: 128 -KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---L 180
Query: 508 NRIVGTYGYMAPE------YAMHGQFSVKSDVYSFGV 538
+ GT Y+APE H + + D++S GV
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 55/275 (20%), Positives = 96/275 (34%), Gaps = 54/275 (19%)
Query: 323 NADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK----- 376
+ + + E+L F ++ + +G+G +G V + + A+K
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 377 RLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFV----------- 424
++ + + + + K EV L+ KL H N+ RL E E+ I LV E
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNV 121
Query: 425 --------------------PNKSLDYFLYEPEKQQQLDWSRRY------KIIGGIARGI 458
+ + + + I+ I +
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 459 LYLHEDSRLRIIHRDLKASNILL--DAEMNPKISDFGMAKIFGVDQTQGNT--NRIVGTY 514
YLH I HRD+K N L + K+ DFG++K F GT
Sbjct: 182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238
Query: 515 GYMAPE--YAMHGQFSVKSDVYSFGVLVLEIITGK 547
++APE + + K D +S GVL+ ++ G
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 43/213 (20%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGF 410
+G+G F +V + +G+E+A+K + ++ + Q+ EV ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE- 81
Query: 411 CLEGEEKI-LVYEFVPNKSL-DYF-----LYEPEKQQQLDWSRRY--KIIGGIARGILYL 461
+E E+ + L+ E+ + DY + E E +R +I+ + Y
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE-------ARSKFRQIVSAVQ----YC 130
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT-NRIVGTYGYMAPE 520
H + RI+HRDLKA N+LLDA+MN KI+DFG + F T G + G Y APE
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF----TVGGKLDAFCGAPPYAAPE 183
Query: 521 ------YAMHGQFSVKSDVYSFGVLVLEIITGK 547
Y + DV+S GV++ +++G
Sbjct: 184 LFQGKKYD-----GPEVDVWSLGVILYTLVSGS 211
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 32/212 (15%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG------QEFKNEVVLVA 397
+ + +LG G F V K +G E A K + + + +E + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 398 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL------DYFLYEPEKQQQLDWSRRYKII 451
++ H N++ L + +L+ E V L L E E I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---------SFI 121
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMAKIFGVDQTQGNT 507
I G+ YLH +I H DLK NI+L + P K+ DFG+A
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---F 175
Query: 508 NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 539
I GT ++APE + +++D++S GV+
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 37/215 (17%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE--------FKNEVVL 395
+ + LG G GEV + +++A+K +S+ G + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 396 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DY-----FLYEPEKQQQLDWSRRYK 449
+ KL H ++++ F + E+ +V E + L D L E +
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEAT-------CKL-- 118
Query: 450 IIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFGVDQTQGN 506
+ + YLHE IIHRDLK N+LL + + KI+DFG +KI G
Sbjct: 119 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--- 172
Query: 507 TNRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGV 538
+ GT Y+APE ++ D +S GV
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 55/256 (21%), Positives = 96/256 (37%), Gaps = 63/256 (24%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS--------SGQGGQEFKNEVVLVA 397
+ST + LG G FG V+ V +E+ VK + + + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 398 KLQHRNLVRLLGFCLEGEEKI-LVYEF-VPNKSL-DYF-----LYEPEKQQQLDWSRRY- 448
+++H N++++L E + LV E L + L EP +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL-------ASYIF 136
Query: 449 -KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT 507
+++ + YL IIHRD+K NI++ + K+ DFG A +G
Sbjct: 137 RQLVSAVG----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL----ERGKL 185
Query: 508 -NRIVGTYGYMAPE------YAMHGQFSVKSDVYSFGVL--VL-----------EIITGK 547
GT Y APE Y G + +++S GV L E +
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPY--RGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAA 240
Query: 548 KNSSFYQTDGAADLLS 563
+ + + L+S
Sbjct: 241 IHPPYLVSKELMSLVS 256
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-27
Identities = 68/229 (29%), Positives = 101/229 (44%), Gaps = 33/229 (14%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRS---SGQGGQEFKNE 392
F V LG+GGFGEV + + ++ A K+L + +G NE
Sbjct: 185 TFRQYRV----------LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 234
Query: 393 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQ-QLDWSRRYKI 450
++ K+ R +V L + E ++ + LV + L + +Y + + Y
Sbjct: 235 KQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY-- 291
Query: 451 IGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRI 510
I G+ LH RI++RDLK NILLD + +ISD G+A QT
Sbjct: 292 AAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGR 345
Query: 511 VGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
VGT GYMAPE + FS D ++ G L+ E+I G+ S F Q
Sbjct: 346 VGTVGYMAPEVVKNERYT-FSP--DWWALGCLLYEMIAGQ--SPFQQRK 389
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-27
Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 37/217 (17%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE--------FKNEVVL 395
+ + LG G GEV + +++A++ +S+ G + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 396 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL-DY-----FLYEPEKQQQLDWSRRYK 449
+ KL H ++++ F + E+ +V E + L D L E +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---------L 243
Query: 450 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMAKIFGVDQTQGN 506
+ + YLHE IIHRDLK N+LL ++ KI+DFG +KI G
Sbjct: 244 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--- 297
Query: 507 TNRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLV 540
+ GT Y+APE ++ D +S GV++
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 36/228 (15%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKN-EVVL 395
D +T E ++ +G G FG V++ L E+A+K++ + + FKN E+ +
Sbjct: 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQI 85
Query: 396 VAKLQHRNLVRLLGFCLEGEEKI------LVYEFVP---NKSLDYFLYEPEKQQQLDW-- 444
+ ++H N+V L F +K LV E+VP ++ ++ + +Q +
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHY---AKLKQTMPMLL 142
Query: 445 --SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMAKIFGVD 501
Y+++ R + Y+H + I HRD+K N+LLD K+ DFG AKI
Sbjct: 143 IKLYMYQLL----RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--I 193
Query: 502 QTQGNTNRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGK 547
+ N + I Y Y APE + G ++ D++S G ++ E++ G+
Sbjct: 194 AGEPNVSYICSRY-YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 59/278 (21%), Positives = 90/278 (32%), Gaps = 76/278 (27%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE-FKNEVV 394
DFE I+ +G GGFG V++ A+KR+ + + +E EV
Sbjct: 7 DFEPIQC----------MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 56
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKI---- 450
+AKL+H +VR LE + E D P + KI
Sbjct: 57 ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116
Query: 451 -----------IGGIARGILYLH-----------------------EDSRLRI------- 469
+ LY+ L I
Sbjct: 117 PFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA 176
Query: 470 ---------IHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTN----------RI 510
+HRDLK SNI + K+ DFG+ D+ +
Sbjct: 177 VEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236
Query: 511 VGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548
VGT YM+PE +S K D++S G+++ E++
Sbjct: 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQH 401
++N+ +LG+G F V + V +G E A K ++ S + Q+ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSL-DY-----FLYEPEKQQQLDWSRRYKIIGGIA 455
N+VRL E LV++ V L + F E + I I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---------HCIQQIL 115
Query: 456 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMAKIFGVDQTQGNTNRIVG 512
I Y H I+HR+LK N+LL ++ K++DFG+A + + G
Sbjct: 116 ESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 169
Query: 513 TYGYMAPEYAMHGQFSVKSDVYSFGV 538
T GY++PE +S D+++ GV
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGV 195
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 32/212 (15%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG------QEFKNEVVLVA 397
+ + +LG G F V K +G E A K + + + +E + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 398 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL------DYFLYEPEKQQQLDWSRRYKII 451
++ H N++ L + +L+ E V L L E E I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---------SFI 121
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMAKIFGVDQTQGNT 507
I G+ YLH +I H DLK NI+L + P K+ DFG+A
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---F 175
Query: 508 NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 539
I GT ++APE + +++D++S GV+
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 58/206 (28%), Positives = 87/206 (42%), Gaps = 30/206 (14%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN 403
F LG G F EV+ +G+ A+K + +S +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 404 LVRLLGFCLEGEEKI-LVYEFVPNKSL-DYFLYEPEKQQQLDWSRRY------KIIGGIA 455
+V L E LV + V L D L E+ Y +I +
Sbjct: 68 IVTLEDIY-ESTTHYYLVMQLVSGGELFDRIL---ERG-------VYTEKDASLVIQQVL 116
Query: 456 RGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFGVDQTQGNTNRIVG 512
+ YLHE I+HRDLK N+L + I+DFG++K+ G + G
Sbjct: 117 SAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACG 169
Query: 513 TYGYMAPEYAMHGQFSVKSDVYSFGV 538
T GY+APE +S D +S GV
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGV 195
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 57/244 (23%), Positives = 96/244 (39%), Gaps = 53/244 (21%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN------EVVLVAKLQHR--NL 404
LG GGFG VY G+ + +A+K + + E N EVVL+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 405 VRLLGFCLEGEEKI-LVYEFV-PNKSL-DY-----FLYEPEKQQQLDWSRRY--KIIGGI 454
+RLL + E + L+ E P + L D+ L E +R + +++ +
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQVLEAV 162
Query: 455 ARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
+ H ++HRD+K NIL+D K+ DFG + GT
Sbjct: 163 R----HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGT 211
Query: 514 YGYMAPEYAMHGQFS-VKSDVYSFGVL--VL-----------EIITGKKNSSFYQTDGAA 559
Y PE+ + ++ + V+S G+L + EII G+ +
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 271
Query: 560 DLLS 563
L+
Sbjct: 272 HLIR 275
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 56/250 (22%), Positives = 96/250 (38%), Gaps = 37/250 (14%)
Query: 311 KAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPS 369
K N N E D+ + + + +G G V + V +
Sbjct: 59 KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118
Query: 370 GQEIAVKRLSRSSGQGGQE--------FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 420
G E AVK + ++ + E + E ++ ++ H +++ L+ LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 421 YEFVPNKSL-DY-----FLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDL 474
++ + L DY L E E + I+ + + +LH I+HRDL
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETR---------SIMRSLLEAVSFLHA---NNIVHRDL 226
Query: 475 KASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE------YAMHGQFS 528
K NILLD M ++SDFG + + + GT GY+APE H +
Sbjct: 227 KPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYG 283
Query: 529 VKSDVYSFGV 538
+ D+++ GV
Sbjct: 284 KEVDLWACGV 293
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 42/217 (19%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK-----RLSRSSGQGGQE-FKNEVVLVA 397
+++ +LG G F V K +G+E A K RLS S +E + EV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 398 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL------DYFLYEPE-----KQQQLDWSR 446
+++H N++ L + +L+ E V L L E E KQ
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ------- 116
Query: 447 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMAKIFGVDQ 502
I G+ YLH RI H DLK NI+L + P K+ DFG+A
Sbjct: 117 -------ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
Query: 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 539
I GT ++APE + +++D++S GV+
Sbjct: 167 E---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 36/229 (15%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSRS---SGQGGQEFKNE 392
DF + +G GGFGEVY +G+ A+K L + QG NE
Sbjct: 190 DFSVHRI----------IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 393 ---VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRY 448
+ LV+ +V + + +K+ + + + L Y L + R Y
Sbjct: 240 RIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFY 297
Query: 449 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTN 508
I G+ ++H +++RDLK +NILLD + +ISD G+A F +
Sbjct: 298 --AAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--- 349
Query: 509 RIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSSFYQ 554
VGT+GYMAPE G S D +S G ++ +++ G S F Q
Sbjct: 350 -SVGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH--SPFRQ 393
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 46/210 (21%), Positives = 77/210 (36%), Gaps = 36/210 (17%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN 403
+ LG G FG V++ V S + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRN 62
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSL-------DYFLYEPE-----KQQQLDWSRRYKII 451
++ L EE ++++EF+ + + L E E Q
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ------------ 110
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP--KISDFGMAKIFGVDQTQGNTNR 509
+ + +LH I H D++ NI+ + KI +FG A+
Sbjct: 111 --VCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RL 162
Query: 510 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 539
+ Y APE H S +D++S G L
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 34/235 (14%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRS---SGQGGQEFKNE 392
F V LG GGFGEV+ + + ++ A K+L++ +G Q E
Sbjct: 186 WFLDFRV----------LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 393 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQL---DWSRRY 448
++AK+ R +V L + E + + LV + + Y +Y ++ + Y
Sbjct: 236 KKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 449 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTN 508
I G+ +LH+ II+RDLK N+LLD + N +ISD G+A QT+ T
Sbjct: 295 --TAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TK 347
Query: 509 RIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAAD 560
GT G+MAPE + FSV D ++ GV + E+I + F +
Sbjct: 348 GYAGTPGFMAPELLLGEEYD-FSV--DYFALGVTLYEMIAAR--GPFRARGEKVE 397
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 344 ATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN-----EVVLVA 397
AT+ + ++G G +G VYK SG +A+K + +G GG EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 398 KLQ---HRNLVRLL----GFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYK 449
+L+ H N+VRL+ + E K+ LV+E V ++ L +L + L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 450 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR 509
++ RG+ +LH + I+HRDLK NIL+ + K++DFG+A+I+ T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPV 179
Query: 510 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
+V T Y APE + ++ D++S G + E+ K
Sbjct: 180 VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 32/212 (15%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL------SRSSGQGGQEFKNEVVLVA 397
+ + T +LG G F V K +G + A K + S G ++ + EV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 398 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL------DYFLYEPEKQQQLDWSRRYKII 451
++QH N++ L + IL+ E V L L E E + +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT---------EFL 120
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMAKIFGVDQTQGNT 507
I G+ YLH L+I H DLK NI+L P KI DFG+A
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 174
Query: 508 NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 539
I GT ++APE + +++D++S GV+
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQH 401
++N+ +LG+G F V + V +G E A K ++ S + Q+ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSL-DY-----FLYEPEKQQQLDWSRRYKIIGGIA 455
N+VRL E LV++ V L + F E + I I
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---------HCIQQIL 138
Query: 456 RGILYLHEDSRLRIIHRDLKASNILLDAEMNP---KISDFGMAKIFGVDQTQGNTNRIVG 512
I Y H I+HR+LK N+LL ++ K++DFG+A + + G
Sbjct: 139 ESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 192
Query: 513 TYGYMAPEYAMHGQFSVKSDVYSFGV 538
T GY++PE +S D+++ GV
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 60/246 (24%), Positives = 99/246 (40%), Gaps = 55/246 (22%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRS------SGQGGQEFKNEVVLVAKL----QHR 402
LG+GGFG V+ G L ++A+K + R+ EV L+ K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 403 NLVRLLGFCLEGEEKI-LVYEF-VPNKSL-DY-----FLYEPEKQQQLDWSRRY--KIIG 452
++RLL + E +E LV E +P + L DY L E SR + +++
Sbjct: 99 GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP-------SRCFFGQVVA 150
Query: 453 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMAKIFGVDQTQGNTNRIV 511
I + H ++HRD+K NIL+D K+ DFG +
Sbjct: 151 AIQ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYTDFD 199
Query: 512 GTYGYMAPEYAMHGQFS-VKSDVYSFGVL--VL-----------EIITGKKNSSFYQTDG 557
GT Y PE+ Q+ + + V+S G+L + EI+ + + + +
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPD 259
Query: 558 AADLLS 563
L+
Sbjct: 260 CCALIR 265
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSRSSGQGGQEF--- 389
DF+ ++ LGEG F V + +E A+K L + +
Sbjct: 31 DFKFGKI----------LGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYV 77
Query: 390 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRY 448
E ++++L H V+L F + +EK+ + N L ++ + +R Y
Sbjct: 78 TRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFY 135
Query: 449 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTN 508
I + YLH IIHRDLK NILL+ +M+ +I+DFG AK+ + Q N
Sbjct: 136 --TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 509 RIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
VGT Y++PE SD+++ G ++ +++ G
Sbjct: 191 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 6e-25
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN--EVVLVAKLQHR 402
+ +GEG +G V K +G+ +A+K+ S + E+ L+ +L+H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 403 NLVRLLGFCLEGEEKILVYEFVPN---KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL 459
NLV LL C + + LV+EFV + L+ LD+ K + I GI
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDHTILDDLE------LFPNGLDYQVVQKYLFQIINGIG 138
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAP 519
+ H IIHRD+K NIL+ K+ DFG A+ + + + T Y AP
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWYRAP 193
Query: 520 E-------YAMHGQFSVKSDVYSFGVLVLEIITGK 547
E Y +V DV++ G LV E+ G+
Sbjct: 194 ELLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 53/223 (23%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRS-------------------SGQGGQEFKN-- 391
+G+G +G V A+K LS+ + G + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 392 -----EVVLVAKLQHRNLVRLLGFCLE-----GEEKI-LVYEFVPNKSLDYFLYEPEKQQ 440
E+ ++ KL H N+V+L+ E E+ + +V+E V + K
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPV--MEVPTLKPL 134
Query: 441 QLDWSRRY--KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498
D +R Y +I GI YLH +IIHRD+K SN+L+ + + KI+DFG++ F
Sbjct: 135 SEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 499 GVDQTQGNTNRIVGTYGYMAPE--YAMHGQFS-VKSDVYSFGV 538
+ + VGT +MAPE FS DV++ GV
Sbjct: 188 --KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 17/208 (8%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKN--EVVLVAKLQHRN 403
+ K+GEG +G VYK G+ +A+KR+ + G E+ L+ +L H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 404 LVRLLGFCLEGEEKILVYEFVPN---KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
+V L+ LV+EF+ K LD E + L S+ + + RG+ +
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEKDLKKVLD------ENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520
H+ RI+HRDLK N+L++++ K++DFG+A+ FG+ + T+ +V T Y AP+
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPD 189
Query: 521 YAMHG-QFSVKSDVYSFGVLVLEIITGK 547
M ++S D++S G + E+ITGK
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 16/212 (7%)
Query: 344 ATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN----EVVLVAK 398
+++ F KLG G + VYKG+ +G +A+K + S +G + E+ L+ +
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKE 59
Query: 399 LQHRNLVRLLGFCLEGEEKILVYEFVPN--KSLDYFLYEPEKQQQLDWSRRYKIIGGIAR 456
L+H N+VRL + LV+EF+ N K + L+ + + +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY 516
G+ + HE+ +I+HRDLK N+L++ K+ DFG+A+ FG+ ++ +V T Y
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV-TLWY 174
Query: 517 MAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 547
AP+ M +S D++S G ++ E+ITGK
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 37/221 (16%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKN-EVVLVAKLQHR 402
+++ +G G FG VY+ L SG+ +A+K++ + + FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHC 107
Query: 403 NLVRLLGFCLEGEEKI------LVYEFVP---NKSLDYFLYEPEKQQQLDW----SRRYK 449
N+VRL F EK LV ++VP + ++ +Q L Y+
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY---SRAKQTLPVIYVKLYMYQ 164
Query: 450 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMAKIFGVDQTQGNTN 508
+ R + Y+H I HRD+K N+LLD + K+ DFG AK + + N +
Sbjct: 165 LF----RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVS 215
Query: 509 RIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGK 547
I Y Y APE + G ++ DV+S G ++ E++ G+
Sbjct: 216 YICSRY-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN--EVVLVAKLQHR 402
+ K+GEG +G V+K +GQ +A+K+ S + E+ ++ +L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 403 NLVRLLGFCLEGEEKILVYEFVPN---KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL 459
NLV LL LV+E+ + LD Q+ + I + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTVLHELD------RYQRGVPEHLVKSITWQTLQAVN 116
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAP 519
+ H + IHRD+K NIL+ K+ DFG A++ + + + T Y +P
Sbjct: 117 FCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSP 171
Query: 520 EYAMHG-QFSVKSDVYSFGVLVLEIITGK 547
E + Q+ DV++ G + E+++G
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 24/216 (11%)
Query: 346 NNFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSRSSGQGGQEFKN----EVVLVAKL 399
+ ++GEG +G+V+K + G+ +A+KR+ +G+ G EV ++ L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHL 68
Query: 400 Q---HRNLVRLL----GFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKII 451
+ H N+VRL + E K+ LV+E V ++ L +L + + + ++
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
+ RG+ +LH R++HRDLK NIL+ + K++DFG+A+I+ T+ +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVV 181
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
T Y APE + ++ D++S G + E+ K
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKN--EVVLVAKLQHRN 403
+ K+GEG +G VYK G+ A+K++ G E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 404 LVRLLGFCLEGEEKI-LVYEFVPN---KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL 459
+V+L + ++++ LV+E + K LD + L+ + + GI
Sbjct: 62 IVKLYD-VIHTKKRLVLVFEHLDQDLKKLLD------VCEGGLESVTAKSFLLQLLNGIA 114
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAP 519
Y H+ R++HRDLK N+L++ E KI+DFG+A+ FG+ + T+ IV T Y AP
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWYRAP 169
Query: 520 EYAMHG-QFSVKSDVYSFGVLVLEIITGK 547
+ M ++S D++S G + E++ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 20/203 (9%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG--QEFKNEVVLVAKLQH 401
T + +LG+G F V + V + +GQE A ++ Q+ + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYEPEKQQQLDWSRRY--KIIGGIARGI 458
N+VRL E L+++ V L + + ++ +S I I +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV---AREY---YSEADASHCIQQILEAV 123
Query: 459 LYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG 515
L+ H+ + ++HR+LK N+LL K++DFG+A +Q GT G
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPG 178
Query: 516 YMAPEYAMHGQFSVKSDVYSFGV 538
Y++PE + D+++ GV
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGV 201
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 32/206 (15%)
Query: 350 TDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSRSSGQGGQEFKNEVVLVAKLQHR-NLV 405
T +LG G F V + + +GQE A K + R E +E+ ++ + ++
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 406 RLLGFCLEGEEKILVYEFVP---------NKSLDYFLYEPEKQQQLDWSRRYKIIGGIAR 456
L E IL+ E+ + + E ++I I
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV---SENDVI-------RLIKQILE 142
Query: 457 GILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
G+ YLH+ I+H DLK NILL + KI DFGM++ G I+GT
Sbjct: 143 GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGT 196
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGVL 539
Y+APE + + +D+++ G++
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGII 222
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 44/214 (20%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLG 409
LG G FG+V G +G ++AVK L+R S + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 410 FCLEGEEKI-LVYEFVPNKSL-DY-----FLYEPEKQQQLDWSRRY--KIIGGIARGILY 460
+ +V E+V L DY + E E +RR +I+ + Y
Sbjct: 79 -VISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-------ARRLFQQILSAVD----Y 126
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV-GTYGYMAP 519
H R ++HRDLK N+LLDA MN KI+DFG++ + + G R G+ Y AP
Sbjct: 127 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRTSCGSPNYAAP 179
Query: 520 E------YAMHGQFSVKSDVYSFGVLVLEIITGK 547
E Y G + D++S GV++ ++ G
Sbjct: 180 EVISGRLY--AGP---EVDIWSCGVILYALLCGT 208
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL---SRSSGQGGQEFKN----EVVLVA 397
+ + LGEG F VYK + Q +A+K++ RS + G E+ L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG--INRTALREIKLLQ 67
Query: 398 KLQHRNLVRLLGFCLEGEEKI-LVYEFVPN------KSLDYFLYEPEKQ---QQLDWSRR 447
+L H N++ LL + I LV++F+ K L +
Sbjct: 68 ELSHPNIIGLLD-AFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT----- 121
Query: 448 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT 507
+G+ YLH+ I+HRDLK +N+LLD K++DFG+AK FG + T
Sbjct: 122 -------LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYT 170
Query: 508 NRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 547
+++V T Y APE + V D+++ G ++ E++
Sbjct: 171 HQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN--EVVLVAKLQHR 402
+ K+GEG +G V+K + + +A+KR+ G E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 403 NLVRLLGFCLEGEEKI-LVYEFVPN---KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGI 458
N+VRL L ++K+ LV+EF K D LD + + +G+
Sbjct: 62 NIVRLHD-VLHSDKKLTLVFEFCDQDLKKYFD------SCNGDLDPEIVKSFLFQLLKGL 114
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMA 518
+ H ++HRDLK N+L++ K+++FG+A+ FG+ + + +V T Y
Sbjct: 115 GFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLWYRP 169
Query: 519 PEYAMHG-QFSVKSDVYSFGVLVLEIITGKK 548
P+ +S D++S G + E+ +
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 54/206 (26%), Positives = 85/206 (41%), Gaps = 28/206 (13%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN 403
T+ + +G G + + + + E AVK + +S +E +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSL-DY-----FLYEPEKQQQLDWSRRYKIIGGIARG 457
++ L +G+ +V E + L D F E E ++ I +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS---------AVLFTITKT 128
Query: 458 ILYLHEDSRLRIIHRDLKASNILL-DAEMNP---KISDFGMAKIFGVDQTQGNTNRIVGT 513
+ YLH ++HRDLK SNIL D NP +I DFG AK + T T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGVL 539
++APE + D++S GVL
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 47/187 (25%), Positives = 87/187 (46%), Gaps = 28/187 (14%)
Query: 353 KLGEGGFGEVYKGV---LPSGQEIAVKRLSR----SSGQGGQEFKNEVVLVAKLQHRNLV 405
K+G G +G VYK ++ A+K++ S E+ L+ +L+H N++
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVI 81
Query: 406 RLLGFCLE-GEEKI-LVYEFVPN---KSLDYFLYEPEKQQQLDWSRRY--KIIGGIARGI 458
L L + K+ L++++ + + + ++ + R ++ I GI
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMAKIFGV-DQTQGNTNRIVGT 513
YLH + ++HRDLK +NIL+ E KI+D G A++F + + + +V T
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 514 YGYMAPE 520
+ Y APE
Sbjct: 199 FWYRAPE 205
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN----EVVLVAKLQ 400
+ + KLGEG +GEVYK + + + +A+KR+ + G EV L+ +LQ
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG--VPGTAIREVSLLKELQ 91
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
HRN++ L L++E+ L ++ +K + + + G+ +
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYM---DKNPDVSMRVIKSFLYQLINGVNF 147
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNP-----KISDFGMAKIFGVDQTQGNTNRIVGTYG 515
H R +HRDLK N+LL KI DFG+A+ FG+ + T+ I+ T
Sbjct: 148 CHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII-TLW 202
Query: 516 YMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 547
Y PE + +S D++S + E++
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 29/205 (14%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN 403
++ F +++LG G VY+ + + A+K L ++ + + + E+ ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYEPEKQQQLDWSRRY------KIIGGIAR 456
+++L E LV E V L D + EK Y + I
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIV---EKG-------YYSERDAADAVKQILE 159
Query: 457 GILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
+ YLHE I+HRDLK N+L + KI+DFG++KI + GT
Sbjct: 160 AVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGT 213
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGV 538
GY APE + + D++S G+
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGI 238
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKN----EVVLVAKLQ 400
+ +KLGEG + VYKG + +A+K + +G EV L+ L+
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLK 58
Query: 401 HRNLVRLLGFCLEGEEKI-LVYEFVPN---KSLDYFLYEPEKQQQLDWSRRYKIIGGIAR 456
H N+V L + E+ + LV+E++ + LD + ++ + + R
Sbjct: 59 HANIVTLHD-IIHTEKSLTLVFEYLDKDLKQYLD------DCGNIINMHNVKLFLFQLLR 111
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY 516
G+ Y H +++HRDLK N+L++ K++DFG+A+ + T+ N +V T Y
Sbjct: 112 GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWY 166
Query: 517 MAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 547
P+ + +S + D++ G + E+ TG+
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 33/208 (15%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLG 409
LGEG FG+V + Q++A+K +SR + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 410 FCLEGEEKI-LVYEFVPNKSLDYF-----LYEPEKQQQLDWSRRY--KIIGGIARGILYL 461
+ I +V E+ + DY + E E RR+ +II I Y
Sbjct: 77 V-ITTPTDIVMVIEYAGGELFDYIVEKKRMTEDE-------GRRFFQQIICAIE----YC 124
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV-GTYGYMAPE 520
H R +I+HRDLK N+LLD +N KI+DFG++ I T GN + G+ Y APE
Sbjct: 125 H---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPE 177
Query: 521 YAMHGQFS-VKSDVYSFGVLVLEIITGK 547
++ + DV+S G+++ ++ G+
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 65/261 (24%), Positives = 108/261 (41%), Gaps = 46/261 (17%)
Query: 308 FIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVY---- 363
F++ A+ + EV D DFE ++V +G G F EV
Sbjct: 42 FLQWAEPIVVRLKEVRLQRD---------DFEILKV----------IGRGAFSEVAVVKM 82
Query: 364 KGVLPSGQEIAVKRLSRSSGQGGQE---FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-L 419
K +GQ A+K +++ E F+ E ++ R + +L F + E + L
Sbjct: 83 KQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYL 138
Query: 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479
V E+ L L + ++ + +R Y + I I +H L +HRD+K NI
Sbjct: 139 VMEYYVGGDLLTLLSKFGERIPAEMARFY--LAEIVMAIDSVHR---LGYVHRDIKPDNI 193
Query: 480 LLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE-------YAMHGQFSVKSD 532
LLD + +++DFG D T + VGT Y++PE G + + D
Sbjct: 194 LLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECD 252
Query: 533 VYSFGVLVLEIITGKKNSSFY 553
++ GV E+ G+ + FY
Sbjct: 253 WWALGVFAYEMFYGQ--TPFY 271
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 44/214 (20%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLG 409
LG G FG+V G +G ++AVK L+R S + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 410 FCLEGEEKI-LVYEFVPNKSL-DYF-----LYEPEKQQQLDWSRRY--KIIGGIARGILY 460
+ I +V E+V L DY L E E SRR +I+ G+ Y
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE-------SRRLFQQILSGVD----Y 131
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR-IVGTYGYMAP 519
H R ++HRDLK N+LLDA MN KI+DFG++ + + G R G+ Y AP
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRTSCGSPNYAAP 184
Query: 520 E------YAMHGQFSVKSDVYSFGVLVLEIITGK 547
E YA + D++S GV++ ++ G
Sbjct: 185 EVISGRLYA-----GPEVDIWSSGVILYALLCGT 213
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 39/232 (16%)
Query: 338 FETIEVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKN----E 392
E + F + G+G FG V G +G +A+K++ + F+N
Sbjct: 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQI 69
Query: 393 VVLVAKLQHRNLVRLLGFCLEGEEK-------ILVYEFVP---NKSLDYFLYEPEKQQQL 442
+ +A L H N+V+L + E+ +V E+VP ++ + +Q
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY---YRRQVAP 126
Query: 443 DW----SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP-KISDFGMAKI 497
+++I R I LH S + + HRD+K N+L++ K+ DFG AK
Sbjct: 127 PPILIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181
Query: 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGK 547
+ N I Y Y APE + G ++ D++S G + E++ G+
Sbjct: 182 LSPSEP--NVAYICSRY-YRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 33/207 (15%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFC 411
LGEG V + L + QE AVK + + G EV ++ + Q HRN++ L+ F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 412 LEGEEKILVYEFVPNKSL-DY-----FLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
E + LV+E + S+ + E E ++ +A + +LH
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---------VVQDVASALDFLHN-- 129
Query: 466 RLRIIHRDLKASNILL---DAEMNPKISDFGMAKIF-----GVDQTQGNTNRIVGTYGYM 517
I HRDLK NIL + KI DF + + G+ YM
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 518 APE-----YAMHGQFSVKSDVYSFGVL 539
APE + + D++S GV+
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 56/230 (24%), Positives = 104/230 (45%), Gaps = 29/230 (12%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQE---FKNE 392
DFE ++V +G G FGEV L + ++ A+K L++ E F+ E
Sbjct: 75 DFEILKV----------IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 393 VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKII 451
++ + + L + + + + LV ++ L L + E + + +R Y +
Sbjct: 125 RDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--L 181
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
+ I +H+ L +HRD+K NIL+D + +++DFG D T ++ V
Sbjct: 182 AEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAV 237
Query: 512 GTYGYMAPE-----YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
GT Y++PE G++ + D +S GV + E++ G+ + FY
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAES 285
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 56/228 (24%), Positives = 105/228 (46%), Gaps = 44/228 (19%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN----EVVLVAKLQ 400
+ + K+G+G FGEV+K +GQ++A+K++ + + G F E+ ++ L+
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG--FPITALREIKILQLLK 74
Query: 401 HRNLVRLLGFCLEGEEKI--------LVYEFVPN------KSLDYFLYEPEKQ---QQLD 443
H N+V L+ C LV++F + ++ E + Q L
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML- 133
Query: 444 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503
G+ Y+H + +I+HRD+KA+N+L+ + K++DFG+A+ F + +
Sbjct: 134 -----------LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 504 QGN---TNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGK 547
TNR+V T Y PE + + D++ G ++ E+ T
Sbjct: 180 SQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 7e-23
Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 42/203 (20%)
Query: 354 LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412
+G G FG + + +AVK + R + + E++ L+H N+VR +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKE-VI 85
Query: 413 EGEEKI-LVYEFVPNKSL-DYF-----LYEPEKQQQLDWSRRY--KIIGGIARGILYLHE 463
+ ++ E+ L + E E +R + +++ G++ Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDE-------ARFFFQQLLSGVS----YCH- 133
Query: 464 DSRLRIIHRDLKASNILLDA--EMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE- 520
++I HRDLK N LLD KI DFG +K + +T VGT Y+APE
Sbjct: 134 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEV 188
Query: 521 -----YAMHGQFSVKSDVYSFGV 538
Y G+ +DV+S GV
Sbjct: 189 LLRQEYD--GK---IADVWSCGV 206
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 50/231 (21%), Positives = 85/231 (36%), Gaps = 45/231 (19%)
Query: 332 ESLQFDFETIEVATNNFS-----TDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQG 385
L+ F+ E + + LG G G+V + +GQ+ A+K L S
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---- 65
Query: 386 GQEFKNEV-VLVAKLQHRNLVRLLGFCLEGEEKI----LVYEFVP---------NKSLDY 431
+ + EV ++V +L ++ E + +
Sbjct: 66 -PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA 124
Query: 432 FLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPK 488
F E++ +I+ I I +LH I HRD+K N+L + + K
Sbjct: 125 F---TEREAA-------EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLK 171
Query: 489 ISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 539
++DFG AK TQ T Y+APE ++ D++S GV+
Sbjct: 172 LTDFGFAKET----TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 51/203 (25%), Positives = 80/203 (39%), Gaps = 30/203 (14%)
Query: 349 STDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVR 406
D LGEG F K V S Q AVK +S+ + E+ + + H N+V+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA---NTQKEITALKLCEGHPNIVK 70
Query: 407 LLGFCLEGEEKI-LVYEFVPNKSL-DY-----FLYEPEKQQQLDWSRRYKIIGGIARGIL 459
L + LV E + L + E E I+ + +
Sbjct: 71 LHEVF-HDQLHTFLVMELLNGGELFERIKKKKHFSETEASY---------IMRKLVSAVS 120
Query: 460 YLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY 516
++H+ + ++HRDLK N+L + + KI DFG A++ D T T Y
Sbjct: 121 HMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHY 175
Query: 517 MAPEYAMHGQFSVKSDVYSFGVL 539
APE + D++S GV+
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVI 198
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-21
Identities = 55/249 (22%), Positives = 103/249 (41%), Gaps = 55/249 (22%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN-EVVLVAKL 399
E ++ +S LG G FG V + + SG+ A+K++ + +KN E+ ++ L
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVL 57
Query: 400 QHRNLVRLLGF---CLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRR--------- 447
H N+++L+ + + E K NK + + +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 448 -------YKIIGG-------------------IARGILYLHEDSRLRIIHRDLKASNILL 481
+K++ + R + ++H L I HRD+K N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174
Query: 482 DAEMNP-KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGV 538
+++ N K+ DFG AK ++ + I + Y APE M G +++ D++S G
Sbjct: 175 NSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPEL-MLGATEYTPSIDLWSIGC 230
Query: 539 LVLEIITGK 547
+ E+I GK
Sbjct: 231 VFGELILGK 239
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 8e-21
Identities = 69/235 (29%), Positives = 114/235 (48%), Gaps = 44/235 (18%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVY---KGVLPSGQEI-AVKRLSRSSGQGGQEFKNE 392
FE ++V LG+G FG+V+ K +++ A+K L +++ + ++
Sbjct: 25 QFELLKV----------LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV----RDR 70
Query: 393 V-------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDW 444
V +L ++ H +V+L + + E K+ L+ +F+ L L + E +
Sbjct: 71 VRTKMERDIL-VEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEED 127
Query: 445 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504
+ Y + +A + +LH L II+RDLK NILLD E + K++DFG++K +D +
Sbjct: 128 VKFY--LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEK 181
Query: 505 GNTNRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
GT YMAPE H Q S D +SFGVL+ E++TG F D
Sbjct: 182 K-AYSFCGTVEYMAPEVVNRRGHTQ-SA--DWWSFGVLMFEMLTGT--LPFQGKD 230
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 48/246 (19%)
Query: 318 AVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVY----KGVLPSGQEI 373
++P V +N+ + FE + +G+G FG+V + +
Sbjct: 1 SMPPVFDENEDVNFD----HFEILRA----------IGKGSFGKVCIVQKND---TKKMY 43
Query: 374 AVKRLSRSSGQGGQEFKN---EVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSL 429
A+K +++ E +N E+ ++ L+H LV L + + EE + +V + + L
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL 102
Query: 430 DYFLYEPEKQQQL--DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 487
Y L ++ + + + I + + YL RIIHRD+K NILLD +
Sbjct: 103 RYHL---QQNVHFKEETVKLF--ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHV 154
Query: 488 KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE------YAMHGQFSVKSDVYSFGVLVL 541
I+DF +A + + + GT YMAPE A + F+V D +S GV
Sbjct: 155 HITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYS-FAV--DWWSLGVTAY 208
Query: 542 EIITGK 547
E++ G+
Sbjct: 209 ELLRGR 214
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 9e-21
Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 39/208 (18%)
Query: 350 TDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEV-VLVAKLQHRNLVRL 407
T LG G G+V + + ++ A+K L + + EV + Q ++VR+
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120
Query: 408 LGFC---LEGEEKI-LVYEFVP---------NKSLDYFLYEPEKQQQLDWSRRYKIIGGI 454
+ G + + +V E + ++ F E++ +I+ I
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREAS-------EIMKSI 170
Query: 455 ARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
I YLH + I HRD+K N+L K++DFG AK +
Sbjct: 171 GEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPC 224
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVL 539
T Y+APE ++ D++S GV+
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVI 252
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 65/234 (27%), Positives = 110/234 (47%), Gaps = 36/234 (15%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVY---KGVLPSGQEI-AVKRLSRSSGQGGQEF--- 389
+FE ++V LG G +G+V+ K ++ A+K L +++ +
Sbjct: 55 NFELLKV----------LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 104
Query: 390 -KNE-VVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSR 446
+ E VL Q LV L + + E K+ L+ +++ L L + ++ +
Sbjct: 105 TRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQ 162
Query: 447 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506
Y +G I + +LH+ L II+RD+K NILLD+ + ++DFG++K F D+T+
Sbjct: 163 IY--VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER- 216
Query: 507 TNRIVGTYGYMAPE---YAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
GT YMAP+ G +V D +S GVL+ E++TG S F
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA--SPFTVDG 266
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 6e-20
Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 48/235 (20%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSRSSGQGGQE---F 389
D+E ++V +G G FGEV K + + A+K LS+ + F
Sbjct: 70 DYEVVKV----------IGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFF 116
Query: 390 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYE---PEKQQQLDWS 445
E ++A +V+L + + + + +V E++P L + PE W+
Sbjct: 117 WEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-----KWA 170
Query: 446 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505
R Y + + +H + IHRD+K N+LLD + K++DFG +
Sbjct: 171 RFY--TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 506 NTNRIVGTYGYMAPE-------YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553
+ VGT Y++PE +G+ D +S GV + E++ G + FY
Sbjct: 226 -CDTAVGTPDYISPEVLKSQGGDGYYGR-EC--DWWSVGVFLYEMLVGD--TPFY 274
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 55/244 (22%)
Query: 333 SLQFDFETIEVATNNFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQG 385
+F ++E+ + F+ + +G G G V + +A+K+LSR
Sbjct: 6 KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---- 61
Query: 386 GQEFKN---------EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF---- 432
F+N E+VL+ + H+N++ LL F P KSL+ F
Sbjct: 62 ---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVY 106
Query: 433 ---------LYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 483
L + + + Y ++ + GI +LH IIHRDLK SNI++ +
Sbjct: 107 IVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 162
Query: 484 EMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEI 543
+ KI DFG+A+ + T V T Y APE + + D++S G ++ E+
Sbjct: 163 DCTLKILDFGLAR--TAGTSFMMTPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 544 ITGK 547
I G
Sbjct: 220 IKGG 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-20
Identities = 20/201 (9%), Positives = 54/201 (26%), Gaps = 45/201 (22%)
Query: 353 KLGEGGFGEVYKG---VLPSGQEIAVKRLSRSSGQGG---QEFKNEVVLVAKLQHRNLVR 406
G + ++ L +++A+ + QE + + ++++ + R
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 407 LLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSR 466
+L ++V E++ SL + + +A H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---R 147
Query: 467 LRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ 526
+ S + +S G + M
Sbjct: 148 AGVALSIDHPSRVR--------VSIDGDVV--------------LAYPATMPDA------ 179
Query: 527 FSVKSDVYSFGVLVLEIITGK 547
+ + D+ G + ++ +
Sbjct: 180 -NPQDDIRGIGASLYALLVNR 199
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 9e-20
Identities = 60/236 (25%), Positives = 108/236 (45%), Gaps = 44/236 (18%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVY---KGVLPSGQEI-AVKRLSRSSGQGGQEFKNE 392
FE + V LG+GG+G+V+ K + +I A+K L ++ +
Sbjct: 18 CFELLRV----------LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV---RNAKD 64
Query: 393 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLD 443
+L +++H +V L+ + + K+ L+ E++ L L E D
Sbjct: 65 TAHTKAERNIL-EEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLER-EGIFMED 121
Query: 444 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503
+ Y + I+ + +LH+ II+RDLK NI+L+ + + K++DFG+ K +
Sbjct: 122 TACFY--LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDG 175
Query: 504 QGNTNRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
T+ GT YMAPE + H + +V D +S G L+ +++TG F +
Sbjct: 176 TV-THTFCGTIEYMAPEILMRSGHNR-AV--DWWSLGALMYDMLTGA--PPFTGEN 225
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 56/234 (23%), Positives = 103/234 (44%), Gaps = 44/234 (18%)
Query: 337 DFETIEVATNNFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEF 389
F +V + +G G +G V + SG+++A+K+LSR F
Sbjct: 9 GFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------F 61
Query: 390 KN---------EVVLVAKLQHRNLVRLL-----GFCLEGEEKI-LVYEFVPNKSLDYFLY 434
++ E++L+ +QH N++ LL L LV F + L
Sbjct: 62 QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQ 116
Query: 435 EPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494
+ + + +Y ++ + +G+ Y+H ++HRDLK N+ ++ + KI DFG+
Sbjct: 117 KIMGLKFSEEKIQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172
Query: 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 547
A+ + T V T Y APE + ++ D++S G ++ E++TGK
Sbjct: 173 ARHADAEMTG-----YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 70/238 (29%), Positives = 108/238 (45%), Gaps = 51/238 (21%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSRSSGQGGQEFKNE 392
DF + V LG+G FG+V KG + + AVK L + ++
Sbjct: 21 DFNFLMV----------LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQ----DDD 63
Query: 393 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLD 443
V VL + L +L C + +++ V E+V L Y + + + +
Sbjct: 64 VECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEP 121
Query: 444 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK--IFGVD 501
+ Y IA G+ +L II+RDLK N++LD+E + KI+DFGM K I+
Sbjct: 122 HAVFY--AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176
Query: 502 QTQGNTNRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
T T GT Y+APE Y +G SV D ++FGVL+ E++ G+ + F D
Sbjct: 177 TT--KT--FCGTPDYIAPEIIAYQPYG-KSV--DWWAFGVLLYEMLAGQ--APFEGED 225
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 1e-19
Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 41/237 (17%)
Query: 333 SLQFDFETIEVATNNFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQG 385
+ F ++EV + F+ + +G G G V + +A+K+LSR
Sbjct: 43 KVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---- 98
Query: 386 GQEFKN---------EVVLVAKLQHRNLVRLL------GFCLEGEEKILVYEFVPNKSLD 430
F+N E+VL+ + H+N++ LL E ++ LV E +D
Sbjct: 99 ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MD 150
Query: 431 YFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 490
L + + + Y ++ + GI +LH IIHRDLK SNI++ ++ KI
Sbjct: 151 ANLCQVIQMELDHERMSY-LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 206
Query: 491 DFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
DFG+A+ + T V T Y APE + + D++S G ++ E++ K
Sbjct: 207 DFGLAR--TAGTSFMMTPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 63/233 (27%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQEFKNEV-- 393
+FE I V LG+G FG+V + ++ AVK L + ++V
Sbjct: 24 NFEFIRV----------LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ----DDDVEC 69
Query: 394 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSR 446
+L H L +L C + +++ V EFV L + + + ++ +R
Sbjct: 70 TMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARAR 127
Query: 447 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506
Y I +++LH+ II+RDLK N+LLD E + K++DFGM K +
Sbjct: 128 FY--AAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA 182
Query: 507 TNRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
T GT Y+APE ++G +V D ++ GVL+ E++ G + F +
Sbjct: 183 T--FCGTPDYIAPEILQEMLYG-PAV--DWWAMGVLLYEMLCGH--APFEAEN 228
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 45/235 (19%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQEFKNEV-- 393
DF ++V +G+G FG+V + + AVK L + + K E
Sbjct: 39 DFHFLKV----------IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK----KKEEKH 84
Query: 394 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSR 446
VL+ ++H LV L F + +K+ V +++ L Y L E+ +R
Sbjct: 85 IMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRAR 142
Query: 447 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK--IFGVDQTQ 504
Y IA + YLH L I++RDLK NILLD++ + ++DFG+ K I T
Sbjct: 143 FY--AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT- 196
Query: 505 GNTNRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
+T GT Y+APE + +V D + G ++ E++ G FY +
Sbjct: 197 -ST--FCGTPEYLAPEVLHKQPYD-RTV--DWWCLGAVLYEMLYGL--PPFYSRN 243
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 4e-19
Identities = 70/238 (29%), Positives = 108/238 (45%), Gaps = 51/238 (21%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSRSSGQGGQEFKNE 392
DF + V LG+G FG+V KG + + AVK L + ++
Sbjct: 342 DFNFLMV----------LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQ----DDD 384
Query: 393 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLD 443
V VL + L +L C + +++ V E+V L Y + + + +
Sbjct: 385 VECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEP 442
Query: 444 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK--IFGVD 501
+ Y IA G+ +L II+RDLK N++LD+E + KI+DFGM K I+
Sbjct: 443 HAVFY--AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497
Query: 502 QTQGNTNRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
T T GT Y+APE Y +G SV D ++FGVL+ E++ G+ + F D
Sbjct: 498 TT--KT--FCGTPDYIAPEIIAYQPYG-KSV--DWWAFGVLLYEMLAGQ--APFEGED 546
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 41/233 (17%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQEFKNEV-- 393
+FE +++ LG+G FG+V + A+K L + K+EV
Sbjct: 149 EFEYLKL----------LGKGTFGKVILVKEKATGRYYAMKILKKEVIVA----KDEVAH 194
Query: 394 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSR 446
VL +H L L + + +++ V E+ L + L E+ D +R
Sbjct: 195 TLTENRVL-QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRAR 251
Query: 447 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506
Y I + YLH S +++RDLK N++LD + + KI+DFG+ K D
Sbjct: 252 FY--GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 307
Query: 507 TNRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
T GT Y+APE +G+ +V D + GV++ E++ G+ FY D
Sbjct: 308 T--FCGTPEYLAPEVLEDNDYGR-AV--DWWGLGVVMYEMMCGR--LPFYNQD 353
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 49/229 (21%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSRSSGQGGQEFKNE 392
DF+ + V +G G + +V K + + A+K + + +
Sbjct: 10 DFDLLRV----------IGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVND----DED 52
Query: 393 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLD 443
+ V H LV L C + E ++ V E+V L + + +++ +
Sbjct: 53 IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEE 110
Query: 444 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK--IFGVD 501
+R Y I+ + YLHE II+RDLK N+LLD+E + K++D+GM K + D
Sbjct: 111 HARFY--SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165
Query: 502 QTQGNTNRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGK 547
T +T GT Y+APE +G FSV D ++ GVL+ E++ G+
Sbjct: 166 TT--ST--FCGTPNYIAPEILRGEDYG-FSV--DWWALGVLMFEMMAGR 207
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 61/241 (25%), Positives = 105/241 (43%), Gaps = 57/241 (23%)
Query: 337 DFETIEVATNNFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEF 389
F EV + +G G +G V V +G ++A+K+L R F
Sbjct: 10 GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------F 62
Query: 390 KN---------EVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-------- 432
++ E+ L+ ++H N++ LL F P+++LD F
Sbjct: 63 QSELFAKRAYRELRLLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMP 110
Query: 433 -----LYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 487
L + K ++L R ++ + +G+ Y+H IIHRDLK N+ ++ +
Sbjct: 111 FMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCEL 167
Query: 488 KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITG 546
KI DFG+A+ + T V T Y APE + +++ D++S G ++ E+ITG
Sbjct: 168 KILDFGLARQADSEMTG-----YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
Query: 547 K 547
K
Sbjct: 223 K 223
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 46/235 (19%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSRSSGQGGQEFKNEV-- 393
DF+ +++ LG+G FG+V + A+K L + K+EV
Sbjct: 6 DFDYLKL----------LGKGTFGKVILVREKATGRYYAMKILRKEVIIA----KDEVAH 51
Query: 394 ------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSR 446
VL +H L L + + +++ V E+ L + L E+ + +R
Sbjct: 52 TVTESRVL-QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERAR 108
Query: 447 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK--IFGVDQTQ 504
Y I + YLH +++RD+K N++LD + + KI+DFG+ K I
Sbjct: 109 FY--GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM- 162
Query: 505 GNTNRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
T GT Y+APE +G+ +V D + GV++ E++ G+ FY D
Sbjct: 163 -KT--FCGTPEYLAPEVLEDNDYGR-AV--DWWGLGVVMYEMMCGR--LPFYNQD 209
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 59/233 (25%), Positives = 96/233 (41%), Gaps = 45/233 (19%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSRSSGQGGQEF--- 389
F+ I+ LG G FG V K SG A+K L + ++
Sbjct: 42 QFDRIKT----------LGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHT 88
Query: 390 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQL--DWSR 446
NE ++ + LV+L F + + +V E+V + L + + +R
Sbjct: 89 LNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHAR 144
Query: 447 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506
Y I YLH L +I+RDLK N+L+D + +++DFG AK G
Sbjct: 145 FY--AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GR 194
Query: 507 TNRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
T + GT +APE + + + +V D ++ GVL+ E+ G F+
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNK-AV--DWWALGVLIYEMAAGY--PPFFADQ 242
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 69/238 (28%), Positives = 106/238 (44%), Gaps = 51/238 (21%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEV----YKGVLPSGQEIAVKRLSRSSGQGGQEFKNE 392
DF ++ LG+G FG+V +K + Q A+K L + ++
Sbjct: 18 DFILHKM----------LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLM----DDD 60
Query: 393 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLD 443
V VL +H L + + +E + V E++ L Y + + L
Sbjct: 61 VECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLS 118
Query: 444 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK--IFGVD 501
+ Y I G+ +LH I++RDLK NILLD + + KI+DFGM K + G
Sbjct: 119 RATFY--AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173
Query: 502 QTQGNTNRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
+T NT GT Y+APE + SV D +SFGVL+ E++ G+ S F+ D
Sbjct: 174 KT--NT--FCGTPDYIAPEILLGQKYN-HSV--DWWSFGVLLYEMLIGQ--SPFHGQD 222
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 49/229 (21%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSRSSGQGGQEFKNE 392
DF+ + V +G G + +V K + + A++ + + +
Sbjct: 53 DFDLLRV----------IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVND----DED 95
Query: 393 V--------VLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLD 443
+ V H LV L C + E ++ V E+V L + + +++ +
Sbjct: 96 IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEE 153
Query: 444 WSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK--IFGVD 501
+R Y I+ + YLHE II+RDLK N+LLD+E + K++D+GM K + D
Sbjct: 154 HARFY--SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208
Query: 502 QTQGNTNRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITGK 547
T +T GT Y+APE +G FSV D ++ GVL+ E++ G+
Sbjct: 209 TT--ST--FCGTPNYIAPEILRGEDYG-FSV--DWWALGVLMFEMMAGR 250
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 50/235 (21%), Positives = 100/235 (42%), Gaps = 49/235 (20%)
Query: 332 ESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFK 390
ES ++ + ++ KLG G + EV++ + + + +++ VK L + + K
Sbjct: 26 ESHVVEWGNQD----DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIK 78
Query: 391 NEVVLVAKLQ-HRNLVRLLGFCLEGEEK--ILVYEFVPNKSLD------------YFLYE 435
E+ ++ L+ N++ L + + LV+E V N +++YE
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE 138
Query: 436 PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGM 494
I + + Y H S I+HRD+K N+++D E ++ D+G+
Sbjct: 139 ------------------ILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
Query: 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKS-DVYSFGVLVLEIITGKK 548
A+ + Q R+ Y + PE + Q S D++S G ++ +I K+
Sbjct: 178 AEFYHPGQEY--NVRVASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 13/97 (13%)
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
+A+G+ +L + + IHRDL A NILL + KI DFG+A+ + + +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKG 253
Query: 514 YG-----YMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
+MAPE ++++SDV+SFGVL+ EI +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 38/174 (21%), Positives = 66/174 (37%), Gaps = 19/174 (10%)
Query: 332 ESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSSGQG 385
E L +D E + LG G FG+V + + + +AVK L +
Sbjct: 8 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 67
Query: 386 -GQEFKNEV-VLVAKLQHRNLVRLLGFCLEGEEKILV-YEFVPNKSLDYFLYEPEKQQQL 442
+ +E+ +L+ H N+V LLG C + ++V EF +L +L
Sbjct: 68 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--------- 118
Query: 443 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496
S+R + + +G + + I DLK + + + S F K
Sbjct: 119 -RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 55/237 (23%), Positives = 90/237 (37%), Gaps = 38/237 (16%)
Query: 337 DFETIEVATNNFSTDNK------LGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQE-- 388
+ ++ + + + G +G V GV G +A+KR+ + G
Sbjct: 7 EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI 66
Query: 389 FKN---------EVVLVAKLQHRNLVRLLG----FCLEGEEKI-LVYEFVPNKSLDYFLY 434
+ E+ L+ H N++ L F K+ LV E + L
Sbjct: 67 LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLA 121
Query: 435 EPEKQQQLDWSR---RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 491
+ Q++ S +Y + I G+ LHE ++HRDL NILL + I D
Sbjct: 122 QVIHDQRIVISPQHIQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICD 177
Query: 492 FGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 547
F +A+ D N V Y APE M F+ D++S G ++ E+ K
Sbjct: 178 FNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 43/234 (18%)
Query: 337 DFETIEVATNNFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEF 389
F E+ + + +G G +G V +G +AVK+LSR F
Sbjct: 14 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------F 66
Query: 390 KN---------EVVLVAKLQHRNLVRLL-----GFCLEGEEKI-LVYEFVPNKSLDYFLY 434
++ E+ L+ ++H N++ LL LE + LV + L
Sbjct: 67 QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLN 121
Query: 435 EPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494
K Q+L +I I RG+ Y+H IIHRDLK SN+ ++ + KI DFG+
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178
Query: 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 547
A+ + T V T Y APE + ++ D++S G ++ E++TG+
Sbjct: 179 ARHTADEMTG-----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 7e-18
Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 47/225 (20%)
Query: 337 DFETIEVATNNFSTDNKLGEGGFGEVY----KGVLPSGQEIAVKRLSRSSGQGGQEF--- 389
DF+ + LG G FG V+ + +G+ A+K L + ++
Sbjct: 7 DFQILRT----------LGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHT 53
Query: 390 KNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYE----PEKQQQLDW 444
+E ++++ + H ++R+ + ++I ++ +++ L L + P
Sbjct: 54 NDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV----- 107
Query: 445 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504
++ Y + + YLH II+RDLK NILLD + KI+DFG AK
Sbjct: 108 AKFY--AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----- 157
Query: 505 GNTNRIVGTYGYMAPE---YAMHGQFSVKSDVYSFGVLVLEIITG 546
T + GT Y+APE + + S+ D +SFG+L+ E++ G
Sbjct: 158 DVTYTLCGTPDYIAPEVVSTKPYNK-SI--DWWSFGILIYEMLAG 199
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 51/229 (22%), Positives = 104/229 (45%), Gaps = 37/229 (16%)
Query: 338 FETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN----- 391
+ ++ + +GEG +G V + +A+K++S F++
Sbjct: 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQ 70
Query: 392 ----EVVLVAKLQHRNLVRLLGF----CLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQL 442
E+ ++ + +H N++ + +E + + +V + ++ LY+ K Q L
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHL 125
Query: 443 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502
+ I RG+ Y+H + ++HRDLK SN+LL+ + KI DFG+A+ D
Sbjct: 126 SNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR--VADP 180
Query: 503 TQGNTNRI---VGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 547
+T + V T Y APE + ++ D++S G ++ E+++ +
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 40/211 (18%), Positives = 80/211 (37%), Gaps = 57/211 (27%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN---------EVV 394
+ + + +G G +G V + + +A+K++ R F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 395 LVAKLQHRNLVRLLGFC----LEGEEKI-LVYEFVP---------NKSLD-----YFLYE 435
++ +L H ++V++L +E +++ +V E L LY
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY- 163
Query: 436 PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495
L G+ Y+H S I+HRDLK +N L++ + + K+ DFG+A
Sbjct: 164 ----NLL-------------VGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLA 203
Query: 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ 526
+ + + I M H +
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTK 234
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 48/232 (20%), Positives = 97/232 (41%), Gaps = 48/232 (20%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN---------EVV 394
+ + LG GG G V+ V + +A+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 395 LVAKLQHRNLVRLL--------------GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQ 440
++ +L H N+V++ G E +V E+ ++ L +Q
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQG 115
Query: 441 QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAKIFG 499
L + + RG+ Y+H + ++HRDLK +N+ ++ E + KI DFG+A+
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR--I 170
Query: 500 VDQTQGNTNRI---VGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 547
+D + + + T Y +P + ++ D+++ G + E++TGK
Sbjct: 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 39/181 (21%), Positives = 70/181 (38%), Gaps = 41/181 (22%)
Query: 339 ETIEVATNNFSTD-----NKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNE 392
+++ N D LG G G+V + + ++ A+K L + + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60
Query: 393 V-VLVAKLQHRNLVRLLGFC---LEGEEKI-LVYEFVP---------NKSLDYFLYEPEK 438
V + Q ++VR++ G + + +V E + ++ F E+
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TER 117
Query: 439 QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMA 495
+ +I+ I I YLH + I HRD+K N+L K++DFG A
Sbjct: 118 EAS-------EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
Query: 496 K 496
K
Sbjct: 168 K 168
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 53/234 (22%), Positives = 97/234 (41%), Gaps = 42/234 (17%)
Query: 339 ETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN------ 391
+ +++F + LGEG +G V P+G+ +A+K++ F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALR 55
Query: 392 ---EVVLVAKLQHRNLVRLL-----GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQL- 442
E+ ++ +H N++ + E ++ E + L+ Q L
Sbjct: 56 TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLS 110
Query: 443 DWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502
D +Y I R + LH + +IHRDLK SN+L+++ + K+ DFG+A+I
Sbjct: 111 DDHIQY-FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 503 TQGNTNRI--------VGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 547
+ V T Y APE + ++S DV+S G ++ E+ +
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 53/223 (23%), Positives = 96/223 (43%), Gaps = 44/223 (19%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ----------- 400
KLG G F V+ + + +A+K + R + ++E+ L+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 401 HRNLVRLLG-FCLEGEEKI---LVYEFVPNKSLDYFLYEPEKQQQLDWSRRY--KIIGGI 454
++++LL F +G + +V+E L L K+ + R + I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYE---HRGIPLIYVKQI 136
Query: 455 ARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNP------KISDFGMAKIFGVDQTQ 504
++ +L Y+H R IIH D+K N+L++ +P KI+D G A +
Sbjct: 137 SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDE 190
Query: 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
TN I T Y +PE + + +D++S L+ E+ITG
Sbjct: 191 HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 41/224 (18%), Positives = 77/224 (34%), Gaps = 63/224 (28%)
Query: 338 FETIEVATNNFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFK 390
N + +G G +G VY + + +A+K+++R F+
Sbjct: 12 ENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FE 64
Query: 391 N---------EVVLVAKLQHRNLVRLLGFCL-----EGEEKILVYEFVP---------NK 427
+ E+ ++ +L+ ++RL + + +E +V E
Sbjct: 65 DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI 124
Query: 428 SLD-----YFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 482
L LY L G ++HE IIHRDLK +N LL+
Sbjct: 125 FLTEEHIKTILY-----NLL-------------LGENFIHESG---IIHRDLKPANCLLN 163
Query: 483 AEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ 526
+ + K+ DFG+A+ ++ N + + Q
Sbjct: 164 QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 72.2 bits (176), Expect = 7e-14
Identities = 39/276 (14%), Positives = 77/276 (27%), Gaps = 57/276 (20%)
Query: 343 VATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQ--------EFKNEVV 394
+ T K+GEG FGEV++ + +A+K ++ E E++
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 395 LVAKLQ---------HRNLVRLLGFCL-------------------EGEEKILVYEFVPN 426
+ +L + L +G F +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 427 KSLDYFLYEP-------EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479
+ +E + + + I+ + + LR HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNV 193
Query: 480 LLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVL 539
LL K+ K + + V Y G V+ +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTI----PSCGLQVSIIDYTLSRLERDGIV-----VFCDVSM 244
Query: 540 VLEIITGKKNSSF--YQTDGAADLLSYVSINRVINL 573
++ TG + F Y+ + + + N+
Sbjct: 245 DEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNV 280
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 60/243 (24%), Positives = 115/243 (47%), Gaps = 50/243 (20%)
Query: 339 ETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN------ 391
+ KLG+G +G V+K + +G+ +AVK++ + F+N
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQR 54
Query: 392 ---EVVLVAKLQ-HRNLVRLLG-FCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQL-DW 444
E++++ +L H N+V LL + + + LV+++ ++ L+ + L
Sbjct: 55 TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY-----METDLHAVIRANILEPV 109
Query: 445 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504
++Y ++ + + I YLH S ++HRD+K SNILL+AE + K++DFG+++ F +
Sbjct: 110 HKQY-VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 505 GNTNRI-------------------VGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEII 544
N + V T Y APE + +++ D++S G ++ EI+
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 545 TGK 547
GK
Sbjct: 226 CGK 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 60/269 (22%), Positives = 103/269 (38%), Gaps = 60/269 (22%)
Query: 307 YFIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGV 366
YF + +K E ND ++ + + E + + D+ +G+G FG+V K
Sbjct: 19 YFQSMSSHK----KERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAY 74
Query: 367 -LPSGQEIAVK---RLSRSSGQGGQEFKNEVVLVAKLQHR------NLVRLLGF------ 410
+ +A+K Q + EV L+ + +V L
Sbjct: 75 DRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130
Query: 411 -CLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ-----LDWSRRYKIIGGIARGILYLHED 464
CL V+E L Y LY+ + L+ +R++ + +L+L
Sbjct: 131 LCL-------VFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQ--QMCTALLFLA-T 175
Query: 465 SRLRIIHRDLKASNILLDAEMNP--KISDFGMAKIFGVDQTQGNTNRIVGTY----GYMA 518
L IIH DLK NILL KI DFG + + + Y Y +
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---------LGQRIYQYIQSRFYRS 226
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
PE + + + D++S G +++E+ TG+
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 35/173 (20%), Positives = 65/173 (37%), Gaps = 23/173 (13%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEI------AVKRLSRSSGQGGQEFKNEVVLVAKL 399
+ +G+GGFG +Y + S + + VK +G E K
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 400 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-----LYEPEKQQQLDWSRR---YKII 451
Q + +R G K Y + + Q+ + + + K +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 452 GGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKI--SDFGMAKIF 498
++ IL Y+HE +H D+KASN+LL+ + ++ D+G+A +
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 34/194 (17%), Positives = 68/194 (35%), Gaps = 25/194 (12%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIA---VKRLSRSSGQGGQEFKNEVVLVAKLQH 401
N + K+G GGFG +Y ++ A VK + +G E K + K
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYF-----LYEPEKQQQLDWSRRY--KIIGGI 454
+ + G K Y + Q+ + + + +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156
Query: 455 ARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKI--SDFGMAKIFGVDQT----- 503
+L Y+HE+ +H D+KA+N+LL + ++ +D+G++ + +
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213
Query: 504 QGNTNRIVGTYGYM 517
+ GT +
Sbjct: 214 ENPRKGHNGTIEFT 227
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 60/273 (21%), Positives = 109/273 (39%), Gaps = 67/273 (24%)
Query: 307 YFIRKAKNKYNAVPE----VNADND-----ITTLESLQFDFETIEVATNNFSTDNKLGEG 357
YF+ K + D+D + + + +E ++V +G+G
Sbjct: 59 YFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKV----------IGKG 108
Query: 358 GFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHR------NLVRLLGF 410
FG+V K Q +A+K + R+ + ++ E+ ++ L+ + N++ +L
Sbjct: 109 SFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167
Query: 411 -------CLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ---LDWSRRYKIIGGIARGILY 460
C+ +E L LYE K+ + K I + +
Sbjct: 168 FTFRNHICM-------TFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNP--KISDFGMAKIFGVDQTQGNTNRIVGTY---- 514
LH + RIIH DLK NILL + K+ DFG + ++ V TY
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---------EHQRVYTYIQSR 263
Query: 515 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
Y APE + ++ + D++S G ++ E++TG
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 39/167 (23%), Positives = 72/167 (43%), Gaps = 21/167 (12%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH-RN 403
N + K+G G FG++Y G + +G+E+A+K + + E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL---- 459
+ + EG+ ++V E + SL+ ++ L K + +A ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL------KTVLLLADQMISRIE 119
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPK---ISDFGMAKIFGVDQT 503
Y+H + IHRD+K N L+ I DFG+AK + +T
Sbjct: 120 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 42/168 (25%), Positives = 67/168 (39%), Gaps = 31/168 (18%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH-RN 403
NF K+G G FGE+ G L + + +A+K S + E +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSL-DYFLYEPEKQQQLDWSRR---YKIIGGIARGIL 459
+ ++ F G+ +V E + SL D F D R K + IA ++
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLEDLF----------DLCDRTFSLKTVLMIAIQLI 115
Query: 460 ----YLHEDSRLRIIHRDLKASNILLDAEMNPK-----ISDFGMAKIF 498
Y+H + +I+RD+K N L+ N I DF +AK +
Sbjct: 116 SRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 23/164 (14%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH-RN 403
++ ++GEG FG +++G L + Q++A+K R S + ++E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 67
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL---- 459
+ + F EG +LV + + SL+ L ++ + K + A+ +L
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSV------KTVAMAAKQMLARVQ 120
Query: 460 YLHEDSRLRIIHRDLKASNILLDAEMNPK-----ISDFGMAKIF 498
+HE S +++RD+K N L+ + + DFGM K +
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 34/207 (16%), Positives = 70/207 (33%), Gaps = 39/207 (18%)
Query: 320 PEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGV---------LPSG 370
+ + T+LE+L + + + + G +Y+ P
Sbjct: 16 ENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQK 75
Query: 371 QEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRL-----LGF-------CLEGEEKI 418
Q+ ++K L G+ E LQ +L L + + +
Sbjct: 76 QKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF 134
Query: 419 LVYEFVPNKSL-DYFLYEPEKQQQLDWSRRYKIIGGIARGIL----YLHEDSRLRIIHRD 473
LV + +SL P+ + + +A +L +LHE+ +H +
Sbjct: 135 LVLPSL-GRSLQSALDVSPKHVLSE------RSVLQVACRLLDALEFLHENE---YVHGN 184
Query: 474 LKASNILLDAEMNPKI--SDFGMAKIF 498
+ A NI +D E ++ + +G A +
Sbjct: 185 VTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 36/221 (16%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNL 404
N F K+G G FGE+Y G + + +E+A+K + + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64
Query: 405 V-RLLGFCLEGEEKILVYEFVPNKSL-DYFLYEPEKQQQLDWSRR---YKIIGGIARGIL 459
+ + F +EG+ +LV + + SL D F ++ R K + +A ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLF----------NFCSRKLSLKTVLMLADQMI 113
Query: 460 ----YLHEDSRLRIIHRDLKASNILLDAEMNPK---ISDFGMAKIFGVDQTQG-----NT 507
++H S +HRD+K N L+ I DFG+AK + T
Sbjct: 114 NRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 508 NRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGK 547
+ GT Y A G S + D+ S G +++ + G
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 51/269 (18%), Positives = 98/269 (36%), Gaps = 74/269 (27%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ 400
++ + KLG G F V+ + + +A+K + +S+ + +E+ L+ ++
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVR 91
Query: 401 --------HRNLVRLLG-FCLEGEEKI---LVYEFVPNKSLDYFLYE-PEKQQQLDWSRR 447
+V+LL F + G +V+E V L ++ + + L ++
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKK 150
Query: 448 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE----------------------- 484
II + +G+ YLH ++ RIIH D+K NILL
Sbjct: 151 --IIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 485 --------------------------MNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMA 518
+ KI+D G A T+ + T Y +
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRS 261
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
E + ++ +D++S + E+ TG
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 3e-07
Identities = 76/592 (12%), Positives = 155/592 (26%), Gaps = 186/592 (31%)
Query: 83 GQDPNKVYGLFLCRGDQTASSCQDCVTFATRDLVQRCPDGKQTIIWYDQCLLRYSNRSIF 142
+ LF + Q V ++++ + Y +
Sbjct: 58 KDAVSGTLRLFWTLLSKQEEMVQKFV----EEVLR--IN-------YKFLMSPIKTEQRQ 104
Query: 143 STMDTVPYVS----LLNT------QNVTDRGRFNQI---LASL----------M-----S 174
+M T Y+ L N NV+ + ++ L L + +
Sbjct: 105 PSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKT 164
Query: 175 QVVNQAVNNSR---KFA------------TRTANFTALQTLYSLAQCTPDLSS---SDCN 216
V + + K + LQ L Q P+ +S N
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY--QIDPNWTSRSDHSSN 222
Query: 217 V-----CLQAAIAEL------PNC-------CSGKT------GAQVLIPSCIVRYEFYPF 252
+ +QA + L NC + K ++L+ + R++
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT---RFK---- 275
Query: 253 YNLSATSPPPPAPVLLPPPPPGSARGKS--------GISSSTI---IAIVAPIAVTAVLF 301
S + L + + + P ++
Sbjct: 276 QVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS---- 331
Query: 302 IVGLCYFIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGE 361
I+ IR ++ VN D L IE + N + +
Sbjct: 332 IIAE--SIRDGLATWDNWKHVNCDK----LT------TIIESSLNVLEPAE------YRK 373
Query: 362 VYK--GVLPSGQEIAVKRLSR----SSGQGGQEFKNEVV---LVAKLQHRNLVRL----L 408
++ V P I LS N++ LV K + + + L
Sbjct: 374 MFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL 433
Query: 409 GFCLEGEE-----KILV--YE---------FVPNKSLDYF-------LYEPEKQQQLDWS 445
++ E + +V Y +P YF L E +++
Sbjct: 434 ELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLF 493
Query: 446 RRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE--MNPKISDFGMAKIFGVDQT 503
R ++L D R + + ++ + +A + + K + D
Sbjct: 494 RM-----------VFL--D--FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDN- 537
Query: 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQT 555
R+V P+ + S +D +L I ++ + ++
Sbjct: 538 DPKYERLVNAILDFLPKIEENLICSKYTD-------LLRIALMAEDEAIFEE 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 8e-06
Identities = 32/170 (18%), Positives = 62/170 (36%), Gaps = 43/170 (25%)
Query: 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH-------RN 403
D + GE + YK +L ++ V + Q+ ++ ++ H +
Sbjct: 8 DFETGEHQYQ--YKDILSVFEDAFVDNFD---CKDVQDMPKSILSKEEIDHIIMSKDAVS 62
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSL--DY-FLYEPEKQQQLDWSRRYKIIGGIARGILY 460
L + L +++ +V +FV + L +Y FL P K +Q S + +Y
Sbjct: 63 GTLRLFWTLLSKQEEMVQKFV-EEVLRINYKFLMSPIKTEQRQPSMMTR---------MY 112
Query: 461 ------LHED---------SRLRIIHRDLKASNILLDAEMNPKISDFGMA 495
L+ D SRL+ + L+ LL+ + G+
Sbjct: 113 IEQRDRLYNDNQVFAKYNVSRLQPYLK-LR--QALLELRPAKNVLIDGVL 159
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 59/256 (23%), Positives = 89/256 (34%), Gaps = 80/256 (31%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK------RLSRSSGQGGQEFKNEVV 394
+ N F K+G+G FG V + + + AVK + +RS+ K E
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-------KIEAD 83
Query: 395 LVAKLQHR-----NLVRLLGF-------CLEGEEKILVYEFVPNKSLDYFLYEPEKQQQL 442
++ K+Q+ N+V+ G CL ++E L LY
Sbjct: 84 ILKKIQNDDINNNNIVKYHGKFMYYDHMCL-------IFE-----PLGPSLY-------- 123
Query: 443 DWSRRYKIIG-------GIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNPKISD 491
+ R G IL YL + + + H DLK NILLD K
Sbjct: 124 EIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLI 180
Query: 492 FGMAKIFGVDQTQGNTNR--------------------IVGTYGYMAPEYAMHGQFSVKS 531
G T I+ T Y APE ++ + V S
Sbjct: 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSS 240
Query: 532 DVYSFGVLVLEIITGK 547
D++SFG ++ E+ TG
Sbjct: 241 DMWSFGCVLAELYTGS 256
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 46/252 (18%), Positives = 88/252 (34%), Gaps = 76/252 (30%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGV--LPSGQEIAVK------RLSRSSGQGGQEFKNEV 393
+ + LGEG FG+V + + ++A+K + ++ + E+
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-------RLEI 67
Query: 394 VLVAKLQHR------NLVRLLGF-------CLEGEEKILVYEFVPNKSLDYFLYEPEKQQ 440
++ K++ + V + + C+ +E L +E K+
Sbjct: 68 NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI-------AFE-----LLGKNTFEFLKEN 115
Query: 441 QLDWSRRYKI--IGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNP------- 487
+ Y + + +A + +LHE ++ H DLK NIL
Sbjct: 116 NF---QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHK 169
Query: 488 ------------KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYS 535
+++DFG A F + IV T Y PE + ++ DV+S
Sbjct: 170 SCEEKSVKNTSIRVADFGSA-TF-DHEHH---TTIVATRHYRPPEVILELGWAQPCDVWS 224
Query: 536 FGVLVLEIITGK 547
G ++ E G
Sbjct: 225 IGCILFEYYRGF 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 54/252 (21%), Positives = 95/252 (37%), Gaps = 76/252 (30%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGV--LPSGQEIAVK------RLSRSSGQGGQEFKNEV 393
+V + + + LGEG FG+V + + G+ +AVK R ++ ++E+
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-------RSEI 62
Query: 394 VLVAKLQHR------NLVRLLGF-------CLEGEEKILVYEFVPNKSLDYFLYEPEKQQ 440
++ L V++L + C+ V+E L Y+ K+
Sbjct: 63 QVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI-------VFE-----LLGLSTYDFIKEN 110
Query: 441 QLDWSRRYKI--IGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAEMNP------- 487
+++ I +A I +LH ++ H DLK NIL
Sbjct: 111 GF---LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKI 164
Query: 488 ------------KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYS 535
K+ DFG A + D+ + +V T Y APE + +S DV+S
Sbjct: 165 KRDERTLINPDIKVVDFGSA-TY-DDEHH---STLVSTRHYRAPEVILALGWSQPCDVWS 219
Query: 536 FGVLVLEIITGK 547
G +++E G
Sbjct: 220 IGCILIEYYLGF 231
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 33/202 (16%), Positives = 63/202 (31%), Gaps = 35/202 (17%)
Query: 308 FIRKAKNKYNAVPEVNADNDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVL 367
++ + Y + +L L + + +GEG V+
Sbjct: 59 VVQNRQKDYEGSTFTFIGLSLYSLHRLVRSGKVDAI-------GKLMGEGKESAVFNCYS 111
Query: 368 PSGQEIAVK--RLSRSS--------GQGGQEFKNEVVLVAKLQHRNLVRLLGFC----LE 413
E VK ++ +S G F + A+ + R L +L G
Sbjct: 112 EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 171
Query: 414 GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD 473
E ++ E + K L ++ +++ I + + I+H D
Sbjct: 172 WEGNAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYHR---GIVHGD 218
Query: 474 LKASNILLDAEMNPKISDFGMA 495
L N+L+ E I DF +
Sbjct: 219 LSQYNVLVSEEG-IWIIDFPQS 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 573 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.94 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.91 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.64 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.56 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.37 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.34 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.0 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.98 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.97 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.93 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.68 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.55 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.49 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.31 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.3 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.27 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.24 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.14 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.99 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.77 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.97 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.5 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.11 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 91.36 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.37 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.19 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.28 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=393.38 Aligned_cols=218 Identities=30% Similarity=0.508 Sum_probs=186.0
Q ss_pred hCCCCcccccccccceeEEEEecC------CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
.++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|++.+.+..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 356888999999999999999863 46789999998777667788999999999999999999999999999999
Q ss_pred EEEEccCCCChhhhccCc----------CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeE
Q 008238 419 LVYEFVPNKSLDYFLYEP----------EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 488 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vk 488 (573)
|||||+++|+|.++|+.. .....++|.+++.|+.||++||+|||+++ |+||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 999999999999999642 12357999999999999999999999987 99999999999999999999
Q ss_pred EeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHh
Q 008238 489 ISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 489 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~~ll~~~~~ 567 (573)
|+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||.. ....+++..+..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~---~~~~~~~~~i~~ 245 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ---LSNNEVIECITQ 245 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT---SCHHHHHHHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHHHc
Confidence 999999987644333333344679999999999999999999999999999999999 8999753 234556666655
Q ss_pred h
Q 008238 568 N 568 (573)
Q Consensus 568 ~ 568 (573)
.
T Consensus 246 ~ 246 (299)
T 4asz_A 246 G 246 (299)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=393.23 Aligned_cols=216 Identities=30% Similarity=0.494 Sum_probs=178.0
Q ss_pred CCCCcccccccccceeEEEEecC------CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45778899999999999999864 467899999987777777889999999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcC------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCe
Q 008238 420 VYEFVPNKSLDYFLYEPE------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 487 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~v 487 (573)
||||+++|+|.++++... ...+++|.+++.|+.||++||+|||+++ |+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999996532 2346999999999999999999999987 9999999999999999999
Q ss_pred EEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 008238 488 KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLLSYVS 566 (573)
Q Consensus 488 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~~ll~~~~ 566 (573)
||+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||.. ....+++..+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~---~~~~~~~~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ---LSNTEAIDCIT 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS---SCHHHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC---CCHHHHHHHHH
Confidence 9999999987654443334455689999999999999999999999999999999999 8999753 23445555554
Q ss_pred h
Q 008238 567 I 567 (573)
Q Consensus 567 ~ 567 (573)
.
T Consensus 275 ~ 275 (329)
T 4aoj_A 275 Q 275 (329)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=389.56 Aligned_cols=217 Identities=29% Similarity=0.479 Sum_probs=184.3
Q ss_pred CCCCcccccccccceeEEEEecC------CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
.++++.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34677889999999999999862 46789999997543 344578999999999999999999999999999999
Q ss_pred EEEEccCCCChhhhccCcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC
Q 008238 419 LVYEFVPNKSLDYFLYEPE-------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 485 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~ 485 (573)
|||||+++|+|.++|.... ....++|.++++|+.||++||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999996432 1356999999999999999999999987 99999999999999999
Q ss_pred CeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHH
Q 008238 486 NPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLLSY 564 (573)
Q Consensus 486 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~~ll~~ 564 (573)
++||+|||+++...............||++|||||++.++.++.++|||||||++|||+| |+.||.. ....++++.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~---~~~~~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG---YSNQDVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT---CCHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC---CCHHHHHHH
Confidence 999999999987654443344455689999999999999999999999999999999999 8999753 234556666
Q ss_pred HHhh
Q 008238 565 VSIN 568 (573)
Q Consensus 565 ~~~~ 568 (573)
+...
T Consensus 260 i~~~ 263 (308)
T 4gt4_A 260 IRNR 263 (308)
T ss_dssp HHTT
T ss_pred HHcC
Confidence 5543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=389.71 Aligned_cols=210 Identities=26% Similarity=0.416 Sum_probs=185.5
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
+.|++.++||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4689999999999999999995 479999999998766666778899999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++|+|.+++. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++.+....
T Consensus 154 ~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 9999999984 356999999999999999999999988 9999999999999999999999999998764332
Q ss_pred cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.. +...+++..+..
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~---~~~~~~~~~i~~ 284 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN---EPPLKAMKMIRD 284 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT---SCHHHHHHHHHH
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHHHHHc
Confidence 234457899999999999999999999999999999999999999853 334445554443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=386.08 Aligned_cols=214 Identities=26% Similarity=0.388 Sum_probs=188.5
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||+||+++. .+++.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3589999999999999999994 57899999999753 2344567899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++. +...+++.++..++.||+.||+|||+++ |+||||||+||||++++++||+|||+++.+...
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999995 3457999999999999999999999988 999999999999999999999999999987655
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhh
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSIN 568 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~ 568 (573)
.........+||+.|||||++.+..++.++||||+||++|||++|+.||.. +...++++.+...
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~---~~~~~~~~~i~~~ 249 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEGLIFAKIIKL 249 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHT
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHcC
Confidence 444555677999999999999999999999999999999999999999853 3445555555544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=384.80 Aligned_cols=202 Identities=31% Similarity=0.520 Sum_probs=169.3
Q ss_pred HHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
+..+++++.++||+|+||+||+|++++ .||||+++... .+..++|.+|+.++++++|||||+++|++.+ +..+||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 445678899999999999999999753 59999986443 3445789999999999999999999998865 568999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++|+|.++|+.. ...++|.+++.|+.||++||+|||+++ ||||||||+||||++++++||+|||+++....
T Consensus 110 mEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999652 356999999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCccccccccccCCccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
..........+||+.|||||++.+ +.++.++|||||||++|||+||+.||..
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~ 239 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH 239 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence 333334456789999999999864 4689999999999999999999999853
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=387.86 Aligned_cols=213 Identities=22% Similarity=0.359 Sum_probs=177.6
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++|++.++||+|+||+||+++. .+|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999995 579999999997543 3345678999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++|+|.+++... +...+++.+++.|+.||+.||+|||+++ |+||||||+||||++++++||+|||+++.+...
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 99999999999542 3456799999999999999999999988 999999999999999999999999999865321
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
.......+||+.|||||++.+..++.++|||||||++|||++|+.||.. +...+++..+..
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~---~~~~~~~~~i~~ 239 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA---GSMKNLVLKIIS 239 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHH
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHHHHHc
Confidence 1223456899999999999999999999999999999999999999853 334445444443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=391.25 Aligned_cols=211 Identities=26% Similarity=0.414 Sum_probs=186.5
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.+.|++.++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 35799999999999999999995 57999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++|+|.+++. ...+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.+....
T Consensus 230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 99999999984 356999999999999999999999988 9999999999999999999999999998764332
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.. +...+++..+..
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~---~~~~~~~~~i~~ 361 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN---EPPLKAMKMIRD 361 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT---SCHHHHHHHHHH
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHHHHHc
Confidence 234457899999999999999999999999999999999999999742 334445554443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=378.61 Aligned_cols=196 Identities=28% Similarity=0.361 Sum_probs=170.7
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
+.|++.++||+|+||+||+++. .+|+.||||+++.... ..+|+.++++++|||||++++++.+++..+|||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4688889999999999999995 5789999999975432 247999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC-CeEEeccCCcccccCCCC
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~~~~~~ 503 (573)
++|+|.+++. +...+++.++..++.||+.||+|||+++ |+||||||+||||+.++ ++||+|||+++.+.....
T Consensus 133 ~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999995 3457999999999999999999999987 99999999999999987 699999999987654322
Q ss_pred c---cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 Q---GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~---~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. ......+||+.|||||++.+..++.++|||||||++|||++|+.||.-
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 258 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 1 122346899999999999999999999999999999999999999853
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=382.59 Aligned_cols=218 Identities=28% Similarity=0.420 Sum_probs=187.7
Q ss_pred cccccchhHHHHHhCCCCcccccccccceeEEEEecCC------CCeeEEEEeccCCc-cchHHHHHHHHHHHhcCC-Cc
Q 008238 332 ESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQH-RN 403 (573)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-~n 403 (573)
+.+.++..++++..++|++.++||+|+||+||+|++.. ++.||||++..... ...++|.+|+++|.+++| ||
T Consensus 50 ~~lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpn 129 (353)
T 4ase_A 50 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 129 (353)
T ss_dssp GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred hcCCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCc
Confidence 44567777888888999999999999999999998532 35799999976543 335679999999999975 89
Q ss_pred cceEEEEEEcC-CeeEEEEEccCCCChhhhccCcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 008238 404 LVRLLGFCLEG-EEKILVYEFVPNKSLDYFLYEPEK-------------QQQLDWSRRYKIIGGIARGILYLHEDSRLRI 469 (573)
Q Consensus 404 iv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 469 (573)
||+++|+|.+. +..+||||||++|+|.++|+.... ...+++.+++.++.||++||+|||+++ |
T Consensus 130 IV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---i 206 (353)
T 4ase_A 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 206 (353)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---e
Confidence 99999999764 568999999999999999964321 345899999999999999999999987 9
Q ss_pred EeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCC
Q 008238 470 IHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 548 (573)
Q Consensus 470 vH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~ 548 (573)
|||||||+|||+++++.+||+|||+++.+..+..........||+.|||||++.+..++.++|||||||++|||+| |+.
T Consensus 207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~ 286 (353)
T 4ase_A 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286 (353)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence 9999999999999999999999999997655444444556789999999999999999999999999999999998 899
Q ss_pred CCCC
Q 008238 549 NSSF 552 (573)
Q Consensus 549 p~~~ 552 (573)
||..
T Consensus 287 Pf~~ 290 (353)
T 4ase_A 287 PYPG 290 (353)
T ss_dssp SSTT
T ss_pred CCCC
Confidence 9853
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=367.90 Aligned_cols=195 Identities=30% Similarity=0.461 Sum_probs=168.3
Q ss_pred CCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEc----CCeeEEE
Q 008238 348 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILV 420 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv 420 (573)
|++.++||+|+||+||+|.+ .+++.||+|++... .....+.|.+|+.++++++|||||++++++.+ .+..+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 36678899999999999995 46889999998644 23345679999999999999999999999865 3457899
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC-CCCCeEEeccCCccccc
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMAKIFG 499 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~vkl~DfGla~~~~ 499 (573)
|||+++|+|.+++. +...+++..+..++.||+.||+|||+++ ++|+||||||+||||+ +++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999995 3467999999999999999999999875 4699999999999997 57999999999998543
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
. ......+||+.|||||++. +.++.++|||||||++|||+||+.||.
T Consensus 184 ~----~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~ 230 (290)
T 3fpq_A 184 A----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp T----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred C----CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 2 2334568999999999875 569999999999999999999999985
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=362.20 Aligned_cols=209 Identities=25% Similarity=0.438 Sum_probs=167.1
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||+||+++. .+|+.||||++.+.. ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 4799999999999999999995 579999999997542 334567899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+ +|+|.+++. +...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++.....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 678888884 3457999999999999999999999988 999999999999999999999999999865432
Q ss_pred CCccccccccccCCccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
......+||+.|||||++.+..+ +.++||||+||++|||++|+.||.. +...++++.+..
T Consensus 166 ---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~---~~~~~~~~~i~~ 226 (275)
T 3hyh_A 166 ---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD---ESIPVLFKNISN 226 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHH
T ss_pred ---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC---CCHHHHHHHHHc
Confidence 22345689999999999988876 5799999999999999999999853 344455555443
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=374.36 Aligned_cols=212 Identities=27% Similarity=0.323 Sum_probs=175.5
Q ss_pred CCCCcccccccccceeEEEEec----CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
++|++.+.||+|+||+||+++. ..++.||||++++.. ......+.+|+.++++++|||||++++++.+.+..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4699999999999999999974 246789999997542 2334568899999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||+++|+|.+++. +...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999995 3457999999999999999999999988 9999999999999999999999999998653
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhh
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSIN 568 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~ 568 (573)
... ......+||+.|||||++.+..++.++|||||||++|||+||+.||.- +...+++..+...
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~---~~~~~~~~~i~~~ 241 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG---KDRKETMTMILKA 241 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHC
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC---cCHHHHHHHHHcC
Confidence 222 233456899999999999999999999999999999999999999853 3445555555443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=368.14 Aligned_cols=200 Identities=27% Similarity=0.371 Sum_probs=163.5
Q ss_pred CCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCC----eeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE----EKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 421 (573)
++|.+.++||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||+++|++.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4578889999999999999998 689999999964322 1223345666677899999999999998654 579999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED-----SRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-----~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
||+++|+|.++++ ...++|..+++++.|+++||+|||++ .+++|+||||||+||||++++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999999994 35689999999999999999999986 23469999999999999999999999999998
Q ss_pred cccCCCCc--cccccccccCCccchhccccC------CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 497 IFGVDQTQ--GNTNRIVGTYGYMAPEYAMHG------QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 497 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
........ ......+||+.|||||++.+. .++.++|||||||++|||+||+.|+.
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 76543322 123346899999999998664 36789999999999999999987754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=361.01 Aligned_cols=196 Identities=28% Similarity=0.451 Sum_probs=160.5
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCC---------
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE--------- 415 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------- 415 (573)
+|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 588999999999999999995 4789999999875443 34467899999999999999999999987544
Q ss_pred ---eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEecc
Q 008238 416 ---EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492 (573)
Q Consensus 416 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df 492 (573)
..++||||+++|+|.+++.........++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccC
Confidence 36899999999999999976544455677889999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCCc----------cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh
Q 008238 493 GMAKIFGVDQTQ----------GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545 (573)
Q Consensus 493 Gla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt 545 (573)
|+++.+...... ......+||+.|||||++.+..++.++|||||||++|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc
Confidence 999876543221 12234579999999999999999999999999999999996
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=356.84 Aligned_cols=199 Identities=23% Similarity=0.403 Sum_probs=170.4
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEc------CCe
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLE------GEE 416 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 416 (573)
++|++.++||+|+||+||+|+. .+|+.||||++++... ...+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999995 5799999999975432 334678899999999999999999998764 357
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.+|||||++ |+|.+++. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 67888884 3467999999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCCC--ccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 497 IFGVDQT--QGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 497 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.+..... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 7643221 2234457899999999998875 46999999999999999999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=353.18 Aligned_cols=198 Identities=22% Similarity=0.349 Sum_probs=169.8
Q ss_pred HHhCCCCcccccccccceeEEEEec----CCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCee
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 417 (573)
...++|++.++||+|+||+||+|+. ..++.||||++.+.. ...++.+|+++|+.+ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 3457899999999999999999974 246789999986543 345688999999998 699999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC-CCeEEeccCCcc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAK 496 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~DfGla~ 496 (573)
++||||+++|+|.+++ +.+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999998 24899999999999999999999988 9999999999999876 799999999998
Q ss_pred cccCCCCc--------------------------cccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCC
Q 008238 497 IFGVDQTQ--------------------------GNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKN 549 (573)
Q Consensus 497 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p 549 (573)
........ ......+||+.|||||++.+. .++.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432110 112335799999999999876 489999999999999999999999
Q ss_pred CC
Q 008238 550 SS 551 (573)
Q Consensus 550 ~~ 551 (573)
|.
T Consensus 247 f~ 248 (361)
T 4f9c_A 247 FY 248 (361)
T ss_dssp SS
T ss_pred CC
Confidence 73
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=372.90 Aligned_cols=212 Identities=26% Similarity=0.375 Sum_probs=177.4
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHH---HHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEF---KNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
++|++.+.||+|+||+||+++. .+|+.||||++.+.. ......+ ++++.+++.++|||||++++++.+.+..+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 4699999999999999999995 579999999996432 1222223 34466777789999999999999999999
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
|||||++||+|.++|. +...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+++.+
T Consensus 269 lVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999995 3467999999999999999999999987 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
... .....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||..........+...+..
T Consensus 343 ~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~ 408 (689)
T 3v5w_A 343 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 408 (689)
T ss_dssp SSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH
T ss_pred CCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC
Confidence 432 2345689999999999975 5799999999999999999999999864433334444444443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=364.85 Aligned_cols=211 Identities=23% Similarity=0.390 Sum_probs=184.1
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
++|++.+.||+|+||.||+++. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..+|||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 5799999999999999999995 579999999998766666678899999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC--CCeEEeccCCcccccCCC
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE--MNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~--~~vkl~DfGla~~~~~~~ 502 (573)
++|+|.+++.. +...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999998854 3357999999999999999999999988 9999999999999854 899999999998764332
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
.....+||+.|||||++.+..++.++|||||||++|||++|+.||.- +...+++..+..
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~---~~~~~~~~~i~~ 370 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG---ENDDETLRNVKS 370 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC---SSHHHHHHHHHT
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHHHHHh
Confidence 23456899999999999999999999999999999999999999753 333444444433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=329.24 Aligned_cols=222 Identities=40% Similarity=0.693 Sum_probs=192.0
Q ss_pred HHHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 340 TIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 340 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
+++...++|++.+.||+|+||.||+|++++++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34456778999999999999999999988899999999887766677889999999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 420 VYEFVPNKSLDYFLYEPE-KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
||||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999996533 2346899999999999999999999987 999999999999999999999999999865
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHH
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSY 564 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~ 564 (573)
.............||+.|+|||.+.+..++.++||||||+++|||++|+.||....+....++..|
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 255 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence 433333333445689999999999999999999999999999999999999875544444444444
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=316.91 Aligned_cols=200 Identities=27% Similarity=0.477 Sum_probs=179.9
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
..++|++.++||+|+||+||++.. .+++.||||++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346799999999999999999984 5789999999976666667789999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++|+|.+++. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999984 346899999999999999999999987 9999999999999999999999999998664332
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 23446799999999999999999999999999999999999999853
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=321.75 Aligned_cols=198 Identities=25% Similarity=0.342 Sum_probs=175.8
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||+||+++. .+++.||||++++. .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 5789999999999999999995 46899999999753 2334567889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|..++. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999884 3457899999999999999999999987 999999999999999999999999999853222
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
. ......+||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 159 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 206 (337)
T 1o6l_A 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred C--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCC
Confidence 1 23345689999999999999999999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.36 Aligned_cols=209 Identities=22% Similarity=0.319 Sum_probs=180.0
Q ss_pred chhHHHHHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEE
Q 008238 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412 (573)
Q Consensus 337 ~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 412 (573)
....++...++|++.++||+|+||+||+++.. +++.||||++.+.. ......+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34445566789999999999999999999965 57889999986532 222345889999999999999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEecc
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df 492 (573)
+.+..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999964 2356999999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
|+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 220 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~ 282 (437)
T 4aw2_A 220 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282 (437)
T ss_dssp TTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred hhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC
Confidence 99986543322 2233468999999999987 5678999999999999999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=316.06 Aligned_cols=204 Identities=29% Similarity=0.506 Sum_probs=178.7
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.++|++.++||+|+||+||+++. .+++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35688999999999999999995 46899999998776666778899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999954 2456899999999999999999999987 99999999999999999999999999986643322
Q ss_pred cc------------ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 504 QG------------NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 504 ~~------------~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|..|+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 11 111457999999999999999999999999999999999999987643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=315.10 Aligned_cols=196 Identities=30% Similarity=0.470 Sum_probs=177.0
Q ss_pred CCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 348 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 677889999999999999965 7999999999877666678899999999999999999999999999999999999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
++|.+++. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 127 ~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 197 (321)
T 2c30_A 127 GALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 197 (321)
T ss_dssp CBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred CCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--c
Confidence 99999984 346899999999999999999999987 99999999999999999999999999986643321 2
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3346799999999999999999999999999999999999999853
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=322.31 Aligned_cols=217 Identities=45% Similarity=0.784 Sum_probs=188.6
Q ss_pred cccchhHHHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEE
Q 008238 334 LQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412 (573)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 412 (573)
..+...+++...++|++.+.||+|+||.||++...+++.||||++..... .....+.+|+++++.++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 45678889999999999999999999999999988899999999875432 23347899999999999999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEec
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPE-KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 491 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~D 491 (573)
..+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||++..++|+||||||+|||+++++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999997543 344699999999999999999999998223499999999999999999999999
Q ss_pred cCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 492 FGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 492 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||+
T Consensus 178 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 178 FGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999987643322 22334569999999999999999999999999999999999999985
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=318.80 Aligned_cols=199 Identities=28% Similarity=0.455 Sum_probs=176.4
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
.++|++.+.||+|+||.||+++. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35799999999999999999995 589999999986542 334567889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999853 356899999999999999999999987 999999999999999999999999999865432
Q ss_pred CCccccccccccCCccchhccccCCCC-ccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwslGvll~elltG~~p~~~ 552 (573)
. .....+||+.|+|||.+.+..+. .++||||||+++|||++|+.||..
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 216 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 2 23456899999999999888775 799999999999999999999853
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=324.68 Aligned_cols=213 Identities=28% Similarity=0.397 Sum_probs=176.5
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 418 (573)
..++|++.+.||+|+||+||+++. .+++.||||++++. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 346899999999999999999995 46899999999753 223445678899999988 6999999999999999999
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999853 456999999999999999999999987 999999999999999999999999999753
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
... .......+||+.|+|||++.+..++.++||||||+++|||++|+.||.. +...++.+.+..
T Consensus 175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~---~~~~~~~~~i~~ 238 (353)
T 3txo_A 175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA---ENEDDLFEAILN 238 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHH
T ss_pred ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC---CCHHHHHHHHHc
Confidence 222 2233456899999999999999999999999999999999999999853 333444444433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=331.89 Aligned_cols=204 Identities=22% Similarity=0.310 Sum_probs=177.2
Q ss_pred HHHHHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC
Q 008238 340 TIEVATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 415 (573)
Q Consensus 340 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 415 (573)
.++...++|++.+.||+|+||+||+++.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34455678999999999999999999964 68899999986521 223356889999999999999999999999999
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
..++||||+++|+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence 9999999999999999984 346899999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhccccCC----CCccchhHHHHHHHHHHHhCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ----FSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+....... ......+||+.|+|||++.+.. ++.++||||||+++|||++|+.||.
T Consensus 216 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 274 (410)
T 3v8s_A 216 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274 (410)
T ss_dssp EECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC
T ss_pred EeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC
Confidence 86643321 2234568999999999997765 7899999999999999999999985
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=326.31 Aligned_cols=200 Identities=26% Similarity=0.364 Sum_probs=174.7
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 419 (573)
.++|++.+.||+|+||+||+++.. +++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457999999999999999999954 67889999997542 23345678899999887 89999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999998853 457999999999999999999999987 9999999999999999999999999998532
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.. .......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 21 2234456899999999999999999999999999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=325.21 Aligned_cols=206 Identities=28% Similarity=0.437 Sum_probs=177.1
Q ss_pred HhCCCCcccccccccceeEEEEec--------CCCCeeEEEEeccCCc-cchHHHHHHHHHHHhc-CCCccceEEEEEEc
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKL-QHRNLVRLLGFCLE 413 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~--------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 413 (573)
..++|++.+.||+|+||.||++++ .++..||||+++.... ...+.+.+|+.+++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 346789999999999999999984 2345799999975532 3456789999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCChhhhccCcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEE
Q 008238 414 GEEKILVYEFVPNKSLDYFLYEPE-------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 480 (573)
Q Consensus 414 ~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIL 480 (573)
.+..++||||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 999999999999999999986432 1245899999999999999999999987 999999999999
Q ss_pred eCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 481 LDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 481 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999987654433333444567889999999999999999999999999999999 9998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.34 Aligned_cols=195 Identities=27% Similarity=0.412 Sum_probs=174.8
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||.||+++. .+|+.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 5689999999999999999995 478999999987542 234567889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 99999999999853 456899999999999999999999987 99999999999999999999999999986532
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.....+||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 204 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 204 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 2234679999999999999999999999999999999999999985
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.69 Aligned_cols=209 Identities=24% Similarity=0.401 Sum_probs=179.6
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||.||+++. .+++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5689999999999999999995 468899999986432 334567889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999853 456999999999999999999999987 999999999999999999999999999865432
Q ss_pred CCccccccccccCCccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLS 563 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~ 563 (573)
......+||+.|+|||++.+ ..++.++||||||+++|||++|+.||.........++..
T Consensus 169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~ 230 (384)
T 4fr4_A 169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230 (384)
T ss_dssp ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH
T ss_pred ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH
Confidence 22345689999999999864 458999999999999999999999986544444433333
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=309.75 Aligned_cols=217 Identities=46% Similarity=0.682 Sum_probs=188.3
Q ss_pred ccccchhHHHHHhCCCCcc------cccccccceeEEEEecCCCCeeEEEEeccCC----ccchHHHHHHHHHHHhcCCC
Q 008238 333 SLQFDFETIEVATNNFSTD------NKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS----GQGGQEFKNEVVLVAKLQHR 402 (573)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~------~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~ 402 (573)
...+.+.++...+++|... ++||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3457788888888888777 8999999999999997 68899999986532 33456789999999999999
Q ss_pred ccceEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC
Q 008238 403 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 482 (573)
Q Consensus 403 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~ 482 (573)
||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999976555667999999999999999999999987 99999999999999
Q ss_pred CCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008238 483 AEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 554 (573)
Q Consensus 483 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~ 554 (573)
+++.+||+|||+++...............|++.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 999999999999986654333333345678999999998754 58999999999999999999999987543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=325.72 Aligned_cols=204 Identities=17% Similarity=0.200 Sum_probs=176.3
Q ss_pred HHHhCCCCcccccccccceeEEEEe------cCCCCeeEEEEeccCCccchHHHHHHHHHHHhcC---CCccceEEEEEE
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ---HRNLVRLLGFCL 412 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~ 412 (573)
+...++|.+.++||+|+||+||+|+ ...++.||||++... ...++.+|+.++..++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3456779999999999999999994 446889999999754 3457788888888887 999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcC--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC-------
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPE--KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA------- 483 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~------- 483 (573)
..+..++||||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence 9999999999999999999996421 3457999999999999999999999987 999999999999998
Q ss_pred ----CCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 484 ----EMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 484 ----~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
++.+||+|||+++.+............+||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 89999999999976543333334455689999999999999999999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=319.87 Aligned_cols=209 Identities=31% Similarity=0.499 Sum_probs=172.0
Q ss_pred HHHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCee
Q 008238 340 TIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 340 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 417 (573)
.++...++|++.++||+|+||+||+++. .++.||||++.... ....+++.+|++++++++||||+++++++.+.+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3445567899999999999999999987 68899999987553 23346788999999999999999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+++|+|.+++........+++..++.++.||++||+|||+++ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999999976444445899999999999999999999874 3499999999999999999999999999975
Q ss_pred ccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~ 241 (309)
T 3p86_A 189 KASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred ccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 43221 223345789999999999999999999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.08 Aligned_cols=201 Identities=29% Similarity=0.468 Sum_probs=174.8
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|++.++||+|+||+||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57999999999999999999954 78999999986443 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999853 346899999999999999999999987 99999999999999999999999999986644433
Q ss_pred ccccccccccCCccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslGvll~elltG~~p~~~ 552 (573)
........||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 210 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 333445689999999999988776 7899999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.73 Aligned_cols=202 Identities=29% Similarity=0.451 Sum_probs=175.9
Q ss_pred HHHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCe
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 416 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 416 (573)
....++|++.+.||+|+||.||+++.+ +++.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345578999999999999999999964 68899999997542 23456678899999887 89999999999999999
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999853 356899999999999999999999987 9999999999999999999999999997
Q ss_pred cccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
..... .......+||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 167 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (345)
T 1xjd_A 167 ENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 219 (345)
T ss_dssp CCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCC
Confidence 54322 123445689999999999999999999999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=329.85 Aligned_cols=209 Identities=23% Similarity=0.305 Sum_probs=179.6
Q ss_pred hhHHHHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEc
Q 008238 338 FETIEVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE 413 (573)
Q Consensus 338 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 413 (573)
+++.....++|++.+.||+|+||+||+++. .+++.||||++++.. ....+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 344455678899999999999999999996 478999999996532 2233458899999999999999999999999
Q ss_pred CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccC
Q 008238 414 GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493 (573)
Q Consensus 414 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfG 493 (573)
.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999999532 247899999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccCCccchhccc-------cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAM-------HGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 9987643322 1223468999999999987 35689999999999999999999999853
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=316.79 Aligned_cols=198 Identities=27% Similarity=0.411 Sum_probs=175.9
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCcc------chHHHHHHHHHHHhcCCCccceEEEEEEcCCee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQ------GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 417 (573)
.++|++.+.||+|+||.||+++. .+|+.||+|++.+.... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 45799999999999999999995 46899999998754322 346789999999999999999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC----CeEEeccC
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFG 493 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~vkl~DfG 493 (573)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999943 457999999999999999999999987 99999999999998877 79999999
Q ss_pred CcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~ 219 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 998764322 2334679999999999999999999999999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=311.52 Aligned_cols=201 Identities=28% Similarity=0.438 Sum_probs=171.7
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.++|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999994 478899999985433 23346788999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999853 357899999999999999999999987 99999999999999999999999999986543
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 164 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 214 (294)
T 4eqm_A 164 TS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred cc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 22 1223345799999999999999999999999999999999999999853
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.11 Aligned_cols=199 Identities=26% Similarity=0.369 Sum_probs=175.1
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 420 (573)
++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46889999999999999999964 68899999997543 23345678899999988 899999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999853 356899999999999999999999987 99999999999999999999999999975322
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. .......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 2 1233456899999999999999999999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=314.18 Aligned_cols=212 Identities=21% Similarity=0.282 Sum_probs=180.6
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999994 578999999986543 235688999999999 89999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC-----eEEeccCCccc
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-----PKISDFGMAKI 497 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----vkl~DfGla~~ 497 (573)
|+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998542 457999999999999999999999987 999999999999998887 99999999987
Q ss_pred ccCCCCcc-----ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHH
Q 008238 498 FGVDQTQG-----NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSY 564 (573)
Q Consensus 498 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~ 564 (573)
+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....+...+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~ 231 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK 231 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence 64332211 12456899999999999999999999999999999999999999976554444444433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.15 Aligned_cols=214 Identities=27% Similarity=0.347 Sum_probs=180.7
Q ss_pred HHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccC---CccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCee
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 417 (573)
...++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34568999999999999999999964 5788999998754 223456678899999887 799999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.
T Consensus 97 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 999999999999999853 356899999999999999999999987 99999999999999999999999999985
Q ss_pred ccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
..... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||.. +...++.+.+..
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~---~~~~~~~~~i~~ 235 (353)
T 2i0e_A 171 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG---EDEDELFQSIME 235 (353)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHH
T ss_pred cccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC---CCHHHHHHHHHh
Confidence 32221 233456899999999999999999999999999999999999999853 233344444433
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=313.88 Aligned_cols=200 Identities=27% Similarity=0.377 Sum_probs=166.7
Q ss_pred hCCCCcccccccccceeEEEEec----CCCCeeEEEEeccCC----ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSRSS----GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 416 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 416 (573)
.++|++.+.||+|+||.||+++. .+++.||+|++++.. ......+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 45799999999999999999985 478899999997542 2334567889999999999999999999999999
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999843 456899999999999999999999987 9999999999999999999999999987
Q ss_pred cccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 543221 123345799999999999999999999999999999999999999853
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=321.95 Aligned_cols=217 Identities=28% Similarity=0.427 Sum_probs=184.2
Q ss_pred ccccchhHHHHHhCCCCcccccccccceeEEEEec------CCCCeeEEEEeccCCc-cchHHHHHHHHHHHhc-CCCcc
Q 008238 333 SLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKL-QHRNL 404 (573)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~ni 404 (573)
...++...++...++|++.++||+|+||.||++++ .+++.||||+++.... ...+.+.+|++++.++ +||||
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence 45566777788889999999999999999999973 3467899999976433 3346789999999999 79999
Q ss_pred ceEEEEEEcCCe-eEEEEEccCCCChhhhccCcCc---------------------------------------------
Q 008238 405 VRLLGFCLEGEE-KILVYEFVPNKSLDYFLYEPEK--------------------------------------------- 438 (573)
Q Consensus 405 v~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------- 438 (573)
+++++++.+.+. .++||||+++|+|.+++.....
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 999999987654 8999999999999999965332
Q ss_pred ------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 439 ------------------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 439 ------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 122899999999999999999999987 99999999999999999999999999986644
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
...........||+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 298 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCc
Confidence 433333445678899999999999999999999999999999998 9999854
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=311.30 Aligned_cols=217 Identities=25% Similarity=0.394 Sum_probs=181.8
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC--eeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 420 (573)
.++|++.++||+|+||+||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 356899999999999999999964 58999999997543 334567889999999999999999999998765 67999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe----CCCCCeEEeccCCcc
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMAK 496 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl----~~~~~vkl~DfGla~ 496 (573)
|||+++++|.+++........+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999977555556999999999999999999999987 9999999999999 788889999999998
Q ss_pred cccCCCCccccccccccCCccchhccc--------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCC-CCcccHHHHHHh
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAM--------HGQFSVKSDVYSFGVLVLEIITGKKNSSFYQT-DGAADLLSYVSI 567 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~DvwslGvll~elltG~~p~~~~~~-~~~~~ll~~~~~ 567 (573)
...... ......||..|+|||.+. +..++.++||||||+++|||++|+.||..... +...+++..+..
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 764332 223457899999999986 57889999999999999999999999864332 333444444443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=316.46 Aligned_cols=195 Identities=26% Similarity=0.314 Sum_probs=175.1
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||.||+++. .+|+.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 4689999999999999999995 478999999986532 234567889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999853 356899999999999999999999987 999999999999999999999999999865322
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
....+||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 239 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCC
Confidence 234679999999999999999999999999999999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=308.49 Aligned_cols=201 Identities=30% Similarity=0.460 Sum_probs=171.5
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.++|++.++||+|+||+||+++..+++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 45799999999999999999998889999999987543 2234678899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++ +|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 67777654 3346899999999999999999999987 9999999999999999999999999998764322
Q ss_pred CccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
.......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 22334578999999999876 56899999999999999999999998643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.66 Aligned_cols=200 Identities=30% Similarity=0.478 Sum_probs=171.7
Q ss_pred HhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCC----eeEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE----EKIL 419 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 419 (573)
..++|++.++||+|+||+||+|++. ++.||||++.... .....+.+|+.++++++||||+++++++.... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3457999999999999999999974 7899999996543 33445667899999999999999999998754 3699
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEeecCCCCCEEeCCCCCeEE
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED----------SRLRIIHRDLKASNILLDAEMNPKI 489 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~----------~~~~ivH~Dlkp~NILl~~~~~vkl 489 (573)
||||+++|+|.+++. ...+++..++.++.||++||+|||+. + |+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~----~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLK----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 999999999999994 34689999999999999999999987 6 999999999999999999999
Q ss_pred eccCCcccccCCCCccccccccccCCccchhccccC-----CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 490 SDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-----QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 490 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+|||+++...............||+.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 999999877554444344456799999999998763 456789999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=310.33 Aligned_cols=199 Identities=23% Similarity=0.349 Sum_probs=175.8
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.++|++.+.||+|+||.||+++.. +++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467999999999999999999954 6888999998744 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC--CCCeEEeccCCcccccCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--EMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~--~~~vkl~DfGla~~~~~~ 501 (573)
+++++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999854 2346899999999999999999999987 999999999999987 789999999999876432
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 2 23346789999999999888899999999999999999999999853
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.75 Aligned_cols=197 Identities=28% Similarity=0.432 Sum_probs=175.1
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc------cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG------QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
++|++.+.||+|+||.||+++. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4689999999999999999995 4689999999875432 23577999999999999999999999999999999
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC----CeEEeccCC
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFGM 494 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~vkl~DfGl 494 (573)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999853 457999999999999999999999987 99999999999999887 899999999
Q ss_pred cccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 218 (326)
T 2y0a_A 165 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218 (326)
T ss_dssp CEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 98764322 2234579999999999998999999999999999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.16 Aligned_cols=211 Identities=25% Similarity=0.407 Sum_probs=175.7
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++|++.++||+|+||+||+++. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4789999999999999999996 468899999987543 2334678899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|++++.+..+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 998755544442 2457999999999999999999999987 9999999999999999999999999998764322
Q ss_pred CccccccccccCCccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVS 566 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~ 566 (573)
.......||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+. ......+.+..+.
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~--~~~~~~~~~~~i~ 216 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF--PGNDVDDQLKRIF 216 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC--CCSSHHHHHHHHH
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc--CCCCHHHHHHHHH
Confidence 2233457899999999997766 7999999999999999999999852 2334444444443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=312.40 Aligned_cols=202 Identities=26% Similarity=0.438 Sum_probs=172.4
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe-------
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE------- 416 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------- 416 (573)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46899999999999999999965 78999999997543 3345779999999999999999999999865432
Q ss_pred --------------------------------------------------eEEEEEccCCCChhhhccCcCccCCCCHHH
Q 008238 417 --------------------------------------------------KILVYEFVPNKSLDYFLYEPEKQQQLDWSR 446 (573)
Q Consensus 417 --------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 446 (573)
.++||||+++++|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 789999999999999997765556678888
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc----------cccccccccCCc
Q 008238 447 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ----------GNTNRIVGTYGY 516 (573)
Q Consensus 447 ~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~----------~~~~~~~gt~~y 516 (573)
++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 9999999999999999987 999999999999999999999999999876543211 122345799999
Q ss_pred cchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 517 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 517 ~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
+|||.+.+..++.++||||||+++|||++|..|+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 9999999999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.88 Aligned_cols=198 Identities=28% Similarity=0.431 Sum_probs=174.1
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
.++|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45799999999999999999995 468999999997543 233467889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC---CeEEeccCCcccc
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMAKIF 498 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~vkl~DfGla~~~ 498 (573)
||+++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 108 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999988853 356899999999999999999999987 99999999999998654 5999999999865
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 4322 2234679999999999999999999999999999999999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.76 Aligned_cols=198 Identities=26% Similarity=0.388 Sum_probs=167.6
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc--------------------------cchHHHHHHHHHHH
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG--------------------------QGGQEFKNEVVLVA 397 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 397 (573)
.++|++.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 35799999999999999999985 4688999999865421 12356889999999
Q ss_pred hcCCCccceEEEEEEc--CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCC
Q 008238 398 KLQHRNLVRLLGFCLE--GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLK 475 (573)
Q Consensus 398 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk 475 (573)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++..++.++.||++||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998876 3457999999999999999999999987 9999999
Q ss_pred CCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCC---CCccchhHHHHHHHHHHHhCCCCCC
Q 008238 476 ASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 476 p~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwslGvll~elltG~~p~~ 551 (573)
|+|||++.++.+||+|||+++...... .......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||.
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred HHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999998664322 1223457999999999997765 3788999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.35 Aligned_cols=202 Identities=31% Similarity=0.445 Sum_probs=177.8
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.++|++.+.||+|+||.||+++. .+|+.||||++.+. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 45689999999999999999996 47899999998653 223446688999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999986532 345899999999999999999999987 99999999999999999999999999986643
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 22 223458999999999999989999999999999999999999998653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=313.71 Aligned_cols=202 Identities=30% Similarity=0.507 Sum_probs=172.1
Q ss_pred hCCCCcccccccccceeEEEEecC----CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
.++|++.+.||+|+||.||+|++. .+..||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 456889999999999999999963 34459999997643 3445678999999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||+++++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999954 2356999999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCcc-ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 500 VDQTQG-NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 500 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
...... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 256 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 432221 2223456778999999999999999999999999999999 999974
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=316.40 Aligned_cols=209 Identities=29% Similarity=0.491 Sum_probs=178.3
Q ss_pred HHHHhCCCCcccccccccceeEEEEecC------CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEc
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE 413 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 413 (573)
++...++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3455678999999999999999999963 34789999997653 3345678999999999999999999999999
Q ss_pred CCeeEEEEEccCCCChhhhccCcCc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEee
Q 008238 414 GEEKILVYEFVPNKSLDYFLYEPEK---------------------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 472 (573)
Q Consensus 414 ~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~ 472 (573)
.+..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999999864221 257899999999999999999999987 9999
Q ss_pred cCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 473 DLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 473 Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
||||+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999986643332223344567899999999999999999999999999999999 998875
Q ss_pred C
Q 008238 552 F 552 (573)
Q Consensus 552 ~ 552 (573)
.
T Consensus 279 ~ 279 (343)
T 1luf_A 279 G 279 (343)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=324.67 Aligned_cols=205 Identities=29% Similarity=0.454 Sum_probs=175.2
Q ss_pred HHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
...++|++.++||+|+||.||+|++. +++.||||+++.... ...+++.+|+.++++++||||+++++++.+.+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 33457889999999999999999975 789999999875432 3345788999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999954 2346899999999999999999999987 99999999999999999999999999986433
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
...........++..|+|||.+.++.++.++||||||+++|||++ |+.||..
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~ 318 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 221111122345778999999999999999999999999999998 9988753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=315.44 Aligned_cols=200 Identities=24% Similarity=0.354 Sum_probs=177.0
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.++|++.+.||+|+||.||++.. .+++.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 35799999999999999999995 46889999999766555567889999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC--CCCeEEeccCCcccccCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--EMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~--~~~vkl~DfGla~~~~~~ 501 (573)
+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999854 2346899999999999999999999987 999999999999974 577999999999876433
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 252 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence 2 22345789999999999999999999999999999999999999853
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=326.49 Aligned_cols=204 Identities=29% Similarity=0.440 Sum_probs=179.0
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.++|++.+.||+|+||.||+++. .+|+.||||++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 35789999999999999999996 468999999996532 23346788999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 421 YEFVPNKSLDYFLYEPE-KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999986532 2456999999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 332 2233458999999999999999999999999999999999999998643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=317.94 Aligned_cols=198 Identities=25% Similarity=0.334 Sum_probs=165.9
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc---cchHHHHHHHHH-HHhcCCCccceEEEEEEcCCeeEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG---QGGQEFKNEVVL-VAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
++|++.+.||+|+||.||+++.+ +++.||||++.+... .....+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46889999999999999999964 678899999975432 223445666666 5778999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999853 456899999999999999999999987 99999999999999999999999999985432
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
. .......+||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~ 240 (373)
T 2r5t_A 192 H--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240 (373)
T ss_dssp C--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred C--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 2 123445689999999999999999999999999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.02 Aligned_cols=203 Identities=25% Similarity=0.373 Sum_probs=175.1
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC-----CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS-----SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
.++|++.+.||+|+||.||+++. .+++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34699999999999999999985 47899999998532 1224577999999999999999999999999999999
Q ss_pred EEEEccCCCChhhhccCcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC---eEEeccCC
Q 008238 419 LVYEFVPNKSLDYFLYEPE-KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFGM 494 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---vkl~DfGl 494 (573)
+||||+++++|.+.+.... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775422 2346899999999999999999999987 999999999999986654 99999999
Q ss_pred cccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 98764322 123345799999999999999999999999999999999999999853
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=318.50 Aligned_cols=202 Identities=30% Similarity=0.528 Sum_probs=163.4
Q ss_pred hCCCCcccccccccceeEEEEecC----CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
.++|++.+.||+|+||.||+|++. ++..||||+++... ....+++.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457999999999999999999864 56789999997543 3345679999999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||+++|+|.+++.. ....+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999964 2346899999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCcc-ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 500 VDQTQG-NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 500 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~ 252 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 332211 1222345778999999999999999999999999999998 999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.16 Aligned_cols=197 Identities=26% Similarity=0.440 Sum_probs=172.5
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|.+.+.||+|+||.||+++. .+++.||||++.+. .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999995 67899999998643 1233467899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+ +|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 6788887743 356999999999999999999999987 999999999999999999999999999865432
Q ss_pred CCccccccccccCCccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. .....+||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus 162 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 162 N---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp B---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred c---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence 2 2334579999999999988776 7899999999999999999999854
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=312.62 Aligned_cols=202 Identities=32% Similarity=0.558 Sum_probs=166.5
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCe----eEEEEeccC-CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQE----IAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
.++|++.++||+|+||+||+|++ .+++. ||+|.+... .....+++.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 34689999999999999999995 34444 588887543 3345678999999999999999999999998754 77
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 89999999999999864 2356899999999999999999999987 999999999999999999999999999877
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.............+|..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 222 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC
Confidence 55444333444567889999999999999999999999999999999 9999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.92 Aligned_cols=200 Identities=25% Similarity=0.357 Sum_probs=173.7
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
..++|++.++||+|+||.||++.. .+|+.+|+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 356799999999999999999984 5789999999875432 3346688999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC---CCCCeEEeccCCccc
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGMAKI 497 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~vkl~DfGla~~ 497 (573)
|||+++|+|.+.+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999988853 456999999999999999999999987 99999999999998 567899999999986
Q ss_pred ccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~ 214 (444)
T 3soa_A 163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214 (444)
T ss_dssp CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 54322 22234679999999999999999999999999999999999999974
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=318.28 Aligned_cols=206 Identities=33% Similarity=0.505 Sum_probs=175.4
Q ss_pred HhCCCCcccccccccceeEEEEecC------CCCeeEEEEeccC-CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 416 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 416 (573)
..++|++.++||+|+||.||+|++. +++.||||++... ......++.+|+.++++++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3457899999999999999999843 4568999999654 33445578899999999999999999999999999
Q ss_pred eEEEEEccCCCChhhhccCcC----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC---CeEE
Q 008238 417 KILVYEFVPNKSLDYFLYEPE----KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKI 489 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~vkl 489 (573)
.++||||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999986432 2246899999999999999999999987 99999999999999554 5999
Q ss_pred eccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 490 SDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 490 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~ 289 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999986543333333344578899999999999999999999999999999998 9888753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=311.43 Aligned_cols=209 Identities=26% Similarity=0.435 Sum_probs=161.4
Q ss_pred HHHHhCCCCcccccccccceeEEEEecCCCC----eeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcC
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVLPSGQ----EIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG 414 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~----~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 414 (573)
+....++|++.+.||+|+||.||+++..... .||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 3445678999999999999999999965432 7999998754 344567899999999999999999999999887
Q ss_pred Cee------EEEEEccCCCChhhhccCcC---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC
Q 008238 415 EEK------ILVYEFVPNKSLDYFLYEPE---KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 485 (573)
Q Consensus 415 ~~~------~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~ 485 (573)
+.. ++||||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||+++++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence 665 89999999999999985422 2236899999999999999999999987 99999999999999999
Q ss_pred CeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 486 NPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 486 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 242 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG 242 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 999999999987644333333334456788999999999999999999999999999999 8888753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.85 Aligned_cols=195 Identities=28% Similarity=0.381 Sum_probs=167.7
Q ss_pred cccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCCCC
Q 008238 350 TDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKS 428 (573)
Q Consensus 350 ~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 428 (573)
..+.||+|+||.||+++. .+|+.||+|+++.......+++.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 357899999999999985 5789999999987665667789999999999999999999999999999999999999999
Q ss_pred hhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe--CCCCCeEEeccCCcccccCCCCccc
Q 008238 429 LDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL--DAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 429 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl--~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+++...... .
T Consensus 173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~ 244 (373)
T 2x4f_A 173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K 244 (373)
T ss_dssp EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence 9888853 2346899999999999999999999987 9999999999999 677899999999998764332 2
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 290 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 2334799999999999988999999999999999999999999853
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=301.30 Aligned_cols=201 Identities=30% Similarity=0.482 Sum_probs=176.5
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
.++|++.+.||+|+||.||++++.+++.||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 45789999999999999999998888899999997543 34567999999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++++|.+++.. ....+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 99999999954 3346899999999999999999999987 99999999999999999999999999986533211
Q ss_pred cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~ 210 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence 12233456788999999999999999999999999999999 8988753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=312.84 Aligned_cols=202 Identities=26% Similarity=0.407 Sum_probs=167.1
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCe----
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE---- 416 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 416 (573)
.++|++.+.||+|+||.||+++. .+++.||||++..... .....+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999994 5788999999976432 234578899999999999999999999876543
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++||||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 3999999999999999853 356899999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCCc-cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 497 IFGVDQTQ-GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 497 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 221 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 66433221 223345789999999999999999999999999999999999999853
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.03 Aligned_cols=199 Identities=27% Similarity=0.454 Sum_probs=169.6
Q ss_pred CCCCcccccccccceeEEEEecCCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|++.++||+|+||+||+++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4689999999999999999998789999999986543 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++ +|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 986 88888754 2356899999999999999999999987 9999999999999999999999999998654322
Q ss_pred ccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.......||+.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 122345789999999998764 589999999999999999999999853
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=301.69 Aligned_cols=202 Identities=30% Similarity=0.452 Sum_probs=176.9
Q ss_pred HhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
..++|++.+.||+|+||.||+++++++..||+|++.... ...+++.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 456799999999999999999998888899999997543 3456789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999854 2346899999999999999999999987 99999999999999999999999999986543322
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
. ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (268)
T 3sxs_A 160 V-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208 (268)
T ss_dssp E-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred h-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc
Confidence 1 2223456778999999998899999999999999999999 9999753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=314.21 Aligned_cols=207 Identities=29% Similarity=0.422 Sum_probs=178.0
Q ss_pred HHhCCCCcccccccccceeEEEEecC--------CCCeeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceEEEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCL 412 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 412 (573)
...++|.+.++||+|+||+||+++.. .+..||||++.... ....+.+.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34567999999999999999999842 23579999997553 33346789999999999 8999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCE
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPEK-------------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI 479 (573)
+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 99999999999999999999864321 246999999999999999999999987 99999999999
Q ss_pred EeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 480 LLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 480 Ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
|+++++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999987654433333444567889999999999999999999999999999999 9998753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=313.29 Aligned_cols=209 Identities=28% Similarity=0.437 Sum_probs=177.0
Q ss_pred HHHHhCCCCcccccccccceeEEEEec------CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceEEEEEE
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCL 412 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 412 (573)
++...++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 345567899999999999999999985 245679999997542 34457789999999999 8999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcCc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEee
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPEK--------------------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 472 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~ 472 (573)
..+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 99999999999999999999965322 134899999999999999999999987 9999
Q ss_pred cCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 473 DLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 473 Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
||||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999986654433333344567889999999999999999999999999999998 999985
Q ss_pred C
Q 008238 552 F 552 (573)
Q Consensus 552 ~ 552 (573)
.
T Consensus 277 ~ 277 (344)
T 1rjb_A 277 G 277 (344)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=325.74 Aligned_cols=200 Identities=25% Similarity=0.324 Sum_probs=165.9
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.++|++.++||+|+||.||+++. .+++.||||++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35699999999999999999994 57899999998753 233445678899999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999998843 4578999999999999999999998 76 9999999999999999999999999997543
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 221 223456899999999999999999999999999999999999999853
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=304.94 Aligned_cols=202 Identities=30% Similarity=0.487 Sum_probs=160.1
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.++|++.++||+|+||.||+++. .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 35789999999999999999995 468999999987543 3344678899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCc---CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 423 FVPNKSLDYFLYEP---EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 423 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
|++ ++|.+++... .....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5888887532 12246899999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3221 22345789999999998764 689999999999999999999999853
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=307.60 Aligned_cols=203 Identities=32% Similarity=0.519 Sum_probs=171.4
Q ss_pred HhCCCCcccccccccceeEEEEec-----CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcC--Ce
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EE 416 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 416 (573)
..++|++.++||+|+||+||++++ .+++.||||++........+.+.+|+.++++++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 346789999999999999999983 36789999999877666677899999999999999999999998654 45
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 89999999999999999542 235899999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCCc-cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 497 IFGVDQTQ-GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 497 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
........ .......++..|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence 76433221 12223456778999999999999999999999999999999998865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=310.49 Aligned_cols=207 Identities=29% Similarity=0.436 Sum_probs=177.8
Q ss_pred HHhCCCCcccccccccceeEEEEec------CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 415 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 415 (573)
...++|.+.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3456799999999999999999985 245789999997543 334567889999999999999999999999999
Q ss_pred eeEEEEEccCCCChhhhccCcCc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecC
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEK---------------------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDL 474 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dl 474 (573)
..++||||+++++|.+++..... ...+++..++.++.||++||+|||+++ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 99999999999999999864322 234899999999999999999999987 999999
Q ss_pred CCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 475 KASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 475 kp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
||+|||+++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987654433333344567889999999999999999999999999999999 9999754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.76 Aligned_cols=202 Identities=31% Similarity=0.473 Sum_probs=170.2
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCe----eEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQE----IAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
.++|++.+.||+|+||+||+|++. +++. |++|.+.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 356889999999999999999953 4554 7778775432 334456788999999999999999999886 45688
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999998653 346889999999999999999999987 999999999999999999999999999877
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.............|+..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 220 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG 220 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccc
Confidence 55444334445678889999999999999999999999999999999 9999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=299.98 Aligned_cols=212 Identities=20% Similarity=0.316 Sum_probs=179.9
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 421 (573)
..++|++.+.||+|+||.||+++. .+++.||||++.... ..+.+.+|+.+++.+ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 356799999999999999999994 578999999986433 335688999999999 7999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC-----eEEeccCCcc
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-----PKISDFGMAK 496 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----vkl~DfGla~ 496 (573)
||+ +++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 99999999542 346999999999999999999999987 999999999999987776 9999999998
Q ss_pred cccCCCCc-----cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 008238 497 IFGVDQTQ-----GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLS 563 (573)
Q Consensus 497 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~ 563 (573)
........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 231 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH
Confidence 76543221 12345679999999999999999999999999999999999999987644433333333
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=310.06 Aligned_cols=197 Identities=26% Similarity=0.410 Sum_probs=159.4
Q ss_pred HhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
..++|++.+.||+|+||.||+++.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3467999999999999999999965 57889999997543 34668899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC---CCCeEEeccCCccccc
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMAKIFG 499 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGla~~~~ 499 (573)
|+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999853 356899999999999999999999987 999999999999975 8899999999998654
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 321 2234578999999999999999999999999999999999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=296.78 Aligned_cols=199 Identities=25% Similarity=0.379 Sum_probs=176.0
Q ss_pred HhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
..++|++.++||+|+||.||+++.. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3457999999999999999999954 577899999987666667889999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe---CCCCCeEEeccCCccccc
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~vkl~DfGla~~~~ 499 (573)
|+++++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999988843 456899999999999999999999987 9999999999999 788999999999998664
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||..
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSA 209 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Ccc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCC
Confidence 332 2234578999999998754 499999999999999999999999854
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=302.42 Aligned_cols=203 Identities=28% Similarity=0.454 Sum_probs=174.6
Q ss_pred HHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
...++|++.++||+|+||.||++.+.++..||||++.... ...+++.+|++++.+++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 3456789999999999999999998888899999997543 335678999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 99999999999652 356999999999999999999999987 9999999999999999999999999998653321
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
........+|..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 175 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~ 224 (283)
T 3gen_A 175 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224 (283)
T ss_dssp -HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred -cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 112223456788999999999999999999999999999998 9999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=313.26 Aligned_cols=200 Identities=27% Similarity=0.408 Sum_probs=167.6
Q ss_pred HhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCC--CccceEEEEEEcCCeeEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQH--RNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~l 419 (573)
..++|++.++||+|+||.||++...+++.||||++.... ....+.+.+|+.++.+++| |||+++++++.+.+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 456799999999999999999998889999999987543 3334678999999999987 999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||| +.+++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+++...
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 568899999853 457899999999999999999999987 99999999999997 5789999999998765
Q ss_pred CCCCccccccccccCCccchhcccc-----------CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMH-----------GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
............||+.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 221 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcch
Confidence 4433333445679999999999865 678999999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=334.70 Aligned_cols=215 Identities=27% Similarity=0.345 Sum_probs=182.3
Q ss_pred HHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCee
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 417 (573)
...++|++.+.||+|+||.||+++. .+++.||||++++. .....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 3456899999999999999999995 46888999998753 233456678899999987 699999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++.
T Consensus 418 ~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999953 356999999999999999999999987 99999999999999999999999999985
Q ss_pred ccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhh
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSIN 568 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~ 568 (573)
..... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||.. +...++.+.+...
T Consensus 492 ~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~---~~~~~~~~~i~~~ 557 (674)
T 3pfq_A 492 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG---EDEDELFQSIMEH 557 (674)
T ss_dssp CCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHSS
T ss_pred cccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC---CCHHHHHHHHHhC
Confidence 43222 234457899999999999999999999999999999999999999853 3344555555443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=312.59 Aligned_cols=204 Identities=18% Similarity=0.255 Sum_probs=175.7
Q ss_pred hCCCCcccccccc--cceeEEEEecC-CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 345 TNNFSTDNKLGEG--GFGEVYKGVLP-SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 345 ~~~~~~~~~LG~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
.++|++.++||+| +||+||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4579999999999 99999999964 78999999997543 3334678889999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999998542 2356899999999999999999999987 9999999999999999999999999986542
Q ss_pred CCC-----CccccccccccCCccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 500 VDQ-----TQGNTNRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 500 ~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
... .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 211 1112233478999999999987 5789999999999999999999999854
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=311.36 Aligned_cols=208 Identities=27% Similarity=0.340 Sum_probs=179.9
Q ss_pred cccchhHHHHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-----CCccceE
Q 008238 334 LQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-----HRNLVRL 407 (573)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l 407 (573)
..+.+.......++|++.++||+|+||+||+++. .+++.||||++... ....+.+..|+.+++.++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3455556666778999999999999999999995 57889999998642 344566788999999997 9999999
Q ss_pred EEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC----
Q 008238 408 LGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---- 483 (573)
Q Consensus 408 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---- 483 (573)
++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 99999999999999999 99999998542 2245899999999999999999999987 999999999999975
Q ss_pred ---------------------CCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHH
Q 008238 484 ---------------------EMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLE 542 (573)
Q Consensus 484 ---------------------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~e 542 (573)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 789999999999864321 234578999999999999999999999999999999
Q ss_pred HHhCCCCCCC
Q 008238 543 IITGKKNSSF 552 (573)
Q Consensus 543 lltG~~p~~~ 552 (573)
|++|+.||..
T Consensus 252 ll~g~~pf~~ 261 (360)
T 3llt_A 252 LYTGSLLFRT 261 (360)
T ss_dssp HHHSSCSCCC
T ss_pred HHHCCCCCCC
Confidence 9999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=311.84 Aligned_cols=210 Identities=29% Similarity=0.443 Sum_probs=178.7
Q ss_pred HHHHHhCCCCcccccccccceeEEEEecC-CC-----CeeEEEEeccCCc-cchHHHHHHHHHHHhc-CCCccceEEEEE
Q 008238 340 TIEVATNNFSTDNKLGEGGFGEVYKGVLP-SG-----QEIAVKRLSRSSG-QGGQEFKNEVVLVAKL-QHRNLVRLLGFC 411 (573)
Q Consensus 340 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 411 (573)
.++...++|++.+.||+|+||.||++... .+ +.||+|.+..... ...+.+.+|+.+++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45566788999999999999999999853 22 4799999975432 3456789999999999 899999999999
Q ss_pred EcCCeeEEEEEccCCCChhhhccCcC-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEE
Q 008238 412 LEGEEKILVYEFVPNKSLDYFLYEPE-----------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 480 (573)
Q Consensus 412 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIL 480 (573)
.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999986422 1346899999999999999999999987 999999999999
Q ss_pred eCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 481 LDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 481 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 269 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999986644333323334567889999999999999999999999999999999 8888753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=324.75 Aligned_cols=206 Identities=31% Similarity=0.496 Sum_probs=177.6
Q ss_pred HHHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 340 TIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 340 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
.+++..++|++.++||+|+||.||+|+++++..||||+++... ...+.|.+|+.++++++||||+++++++. .+..++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3455667899999999999999999998888899999997643 45678999999999999999999999986 567899
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 260 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999999643 2236889999999999999999999987 9999999999999999999999999998654
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.... .......++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 336 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 336 DNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp CHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 2211 11223346788999999999999999999999999999999 9999753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=313.01 Aligned_cols=202 Identities=28% Similarity=0.468 Sum_probs=162.5
Q ss_pred HHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcC-CCccceEEEEEEcCC--e
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGE--E 416 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~ 416 (573)
...++|++.++||+|+||.||++.. .+++.||||++... .....+.+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999985 57899999998643 2334566789999999997 999999999997544 6
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++||||++ ++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHH----HTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999998 58888884 357899999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCC-------------------CccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 497 IFGVDQ-------------------TQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 497 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.+.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 653211 0112234579999999999976 6789999999999999999999999853
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=302.39 Aligned_cols=202 Identities=25% Similarity=0.374 Sum_probs=169.5
Q ss_pred CCCCcc-cccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTD-NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~-~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 422 (573)
+.|++. +.||+|+||+||+++. .+++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 467774 7899999999999995 47899999999877666678899999999985 79999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC---eEEeccCCccccc
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFGMAKIFG 499 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---vkl~DfGla~~~~ 499 (573)
|+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999853 356899999999999999999999987 999999999999988776 9999999987653
Q ss_pred CCCC-----ccccccccccCCccchhcccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 500 VDQT-----QGNTNRIVGTYGYMAPEYAMH-----GQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 500 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
.... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 229 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence 2211 111223568999999999875 55889999999999999999999998643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.29 Aligned_cols=210 Identities=25% Similarity=0.395 Sum_probs=176.2
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.++|++.+.||+|+||.||+++.+ +++.||||++.+... ...+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 457999999999999999999954 688999999975543 235688888887 79999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC----CCeEEeccCCcccc
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE----MNPKISDFGMAKIF 498 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~----~~vkl~DfGla~~~ 498 (573)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999998853 356899999999999999999999987 9999999999998433 35999999999865
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVS 566 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~ 566 (573)
.... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||.....+...+++..+.
T Consensus 171 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 236 (342)
T 2qr7_A 171 RAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG 236 (342)
T ss_dssp BCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH
T ss_pred cCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc
Confidence 4332 22334678999999999988889999999999999999999999987544444445555443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=308.58 Aligned_cols=209 Identities=24% Similarity=0.307 Sum_probs=172.4
Q ss_pred HHHHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC-----CccchHHHHHHHHHHHhcCCCccceEEEEEEc
Q 008238 340 TIEVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS-----SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE 413 (573)
Q Consensus 340 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 413 (573)
.+....++|++.+.||+|+||.||+++. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3445667899999999999999999995 56889999998643 33456789999999999999999999999999
Q ss_pred CCeeEEEEEccCCCChhhhccCcC-------------------------------------ccCCCCHHHHHHHHHHHHH
Q 008238 414 GEEKILVYEFVPNKSLDYFLYEPE-------------------------------------KQQQLDWSRRYKIIGGIAR 456 (573)
Q Consensus 414 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia~ 456 (573)
.+..++||||+++|+|.+++.... ....+++..++.++.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999884210 0112367778899999999
Q ss_pred HHHHHHhCCCCCeEeecCCCCCEEeCCCC--CeEEeccCCcccccCCCCc--cccccccccCCccchhcccc--CCCCcc
Q 008238 457 GILYLHEDSRLRIIHRDLKASNILLDAEM--NPKISDFGMAKIFGVDQTQ--GNTNRIVGTYGYMAPEYAMH--GQFSVK 530 (573)
Q Consensus 457 ~L~yLH~~~~~~ivH~Dlkp~NILl~~~~--~vkl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~~ 530 (573)
||+|||+++ |+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999987 99999999999998776 8999999999865432221 12345678999999999865 678999
Q ss_pred chhHHHHHHHHHHHhCCCCCC
Q 008238 531 SDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 531 ~DvwslGvll~elltG~~p~~ 551 (573)
+||||||+++|||++|+.||.
T Consensus 257 ~DiwslG~il~el~~g~~pf~ 277 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFP 277 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSC
T ss_pred HHHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=318.59 Aligned_cols=198 Identities=30% Similarity=0.468 Sum_probs=171.7
Q ss_pred HHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCC-eeEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE-EKILVY 421 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 421 (573)
...++|++.++||+|+||.||+|++ .++.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 3456788999999999999999998 47899999997543 4578999999999999999999999987765 789999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp ECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999999642 2234799999999999999999999987 999999999999999999999999999854321
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 389 (450)
T 1k9a_A 343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 122356889999999999999999999999999999998 9999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.35 Aligned_cols=208 Identities=29% Similarity=0.446 Sum_probs=178.9
Q ss_pred HHHhCCCCcccccccccceeEEEEec------CCCCeeEEEEeccCCc-cchHHHHHHHHHHHhc-CCCccceEEEEEEc
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKL-QHRNLVRLLGFCLE 413 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 413 (573)
+...++|++.+.||+|+||.||++++ .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34556799999999999999999974 3567899999975543 3456789999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCChhhhccCcCc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCC
Q 008238 414 GEEKILVYEFVPNKSLDYFLYEPEK---------------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 478 (573)
Q Consensus 414 ~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~N 478 (573)
.+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence 9999999999999999999864321 235899999999999999999999987 9999999999
Q ss_pred EEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 479 ILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 479 ILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999987654433333334567889999999999999999999999999999999 9998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=309.94 Aligned_cols=198 Identities=25% Similarity=0.369 Sum_probs=165.3
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.++|++.++||+|+||+||+++.. +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457999999999999999999964 78999999997543 3346788999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC--eEEeccCCcccccCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--PKISDFGMAKIFGVD 501 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~--vkl~DfGla~~~~~~ 501 (573)
+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999843 356999999999999999999999987 999999999999987765 999999998743221
Q ss_pred CCccccccccccCCccchhccccCCCCcc-chhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVK-SDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~DvwslGvll~elltG~~p~~~ 552 (573)
.......||+.|+|||++.+..++.+ +||||||+++|||++|+.||..
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 22334579999999999988887655 8999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=304.87 Aligned_cols=192 Identities=26% Similarity=0.372 Sum_probs=151.1
Q ss_pred ccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEEEEccCCCC
Q 008238 351 DNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKS 428 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 428 (573)
.++||+|+||.||+++. .+++.||||++.+. ....+.+|+.+++.++ ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999996 46899999998643 3467788999999997 9999999999999999999999999999
Q ss_pred hhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC---CeEEeccCCcccccCCCCcc
Q 008238 429 LDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 429 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~vkl~DfGla~~~~~~~~~~ 505 (573)
|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++...... .
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~ 164 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q 164 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence 9999853 457999999999999999999999987 99999999999997665 89999999998654322 2
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 233457899999999999999999999999999999999999998643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=312.71 Aligned_cols=203 Identities=19% Similarity=0.247 Sum_probs=167.6
Q ss_pred HhCCCCcccccccccceeEEEEecCC------CCeeEEEEeccCCccch-----------HHHHHHHHHHHhcCCCccce
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLPS------GQEIAVKRLSRSSGQGG-----------QEFKNEVVLVAKLQHRNLVR 406 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~ 406 (573)
..++|++.++||+|+||.||+|.+.. ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45679999999999999999998654 47899999875432111 12344566677788999999
Q ss_pred EEEEEEcC----CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC
Q 008238 407 LLGFCLEG----EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 482 (573)
Q Consensus 407 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~ 482 (573)
+++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998764 4479999999 9999999854 3357999999999999999999999987 99999999999998
Q ss_pred --CCCCeEEeccCCcccccCCCCc-----cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 483 --AEMNPKISDFGMAKIFGVDQTQ-----GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 483 --~~~~vkl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.++.+||+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 8899999999999876433221 112335699999999999999999999999999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.66 Aligned_cols=204 Identities=31% Similarity=0.481 Sum_probs=177.1
Q ss_pred HHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
....+|++.++||+|+||.||+|++. .+..||||+++... ...++|.+|+.++++++||||+++++++.+.+..++||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 34456889999999999999999975 47899999997543 34678999999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 296 E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 296 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999999642 2356899999999999999999999987 999999999999999999999999999865432
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 372 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~ 422 (495)
T 1opk_A 372 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422 (495)
T ss_dssp CE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC
Confidence 21 12223456788999999999999999999999999999999 8888754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=295.80 Aligned_cols=202 Identities=29% Similarity=0.460 Sum_probs=176.6
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 56899999999999999999964 78999999986443 34457789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++.. ...+++..++.++.||++||+|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999999853 346899999999999999999999987 99999999999999999999999999986543333
Q ss_pred ccccccccccCCccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
........|+..|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 211 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence 233345678999999999987765 78999999999999999999998643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=302.67 Aligned_cols=196 Identities=27% Similarity=0.339 Sum_probs=163.3
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc--cchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 420 (573)
.++|++.++||+|+||+||+|+.. +++.||||++..... .....+..|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357999999999999999999965 789999999865432 2233445555555555 899999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+ +++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 6788888754 2356999999999999999999999987 99999999999999999999999999886543
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..|+
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~ 255 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELP 255 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCC
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 22 2234568999999998865 7999999999999999999997764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=296.58 Aligned_cols=199 Identities=36% Similarity=0.548 Sum_probs=164.4
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCc----cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSG----QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.++|++.+.||+|+||.||++++ .++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 45789999999999999999997 488999999865432 3346789999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC--------CCCeEEecc
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--------EMNPKISDF 492 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~--------~~~vkl~Df 492 (573)
|||+++++|.+++. ...+++..++.++.|+++||+|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999983 457899999999999999999999987555899999999999986 778999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|+++...... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9998654322 2235789999999999999999999999999999999999999854
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=306.14 Aligned_cols=218 Identities=28% Similarity=0.431 Sum_probs=184.6
Q ss_pred cccccchhHHHHHhCCCCcccccccccceeEEEEec------CCCCeeEEEEeccCCc-cchHHHHHHHHHHHhc-CCCc
Q 008238 332 ESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKL-QHRN 403 (573)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~n 403 (573)
+.+.++...++...++|++.+.||+|+||.||++++ .+++.||||++..... ...+.+.+|+.++.++ +|||
T Consensus 13 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 92 (316)
T 2xir_A 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92 (316)
T ss_dssp GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred hhccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCC
Confidence 345566677777888999999999999999999973 3567899999976533 3346788999999999 6999
Q ss_pred cceEEEEEEcCC-eeEEEEEccCCCChhhhccCcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 008238 404 LVRLLGFCLEGE-EKILVYEFVPNKSLDYFLYEPEK-------------QQQLDWSRRYKIIGGIARGILYLHEDSRLRI 469 (573)
Q Consensus 404 iv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 469 (573)
|+++++++...+ ..++||||+++++|.+++..... ...+++..++.++.||++||+|||+++ |
T Consensus 93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i 169 (316)
T 2xir_A 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 169 (316)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 999999988755 48999999999999999965332 223899999999999999999999987 9
Q ss_pred EeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCC
Q 008238 470 IHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKK 548 (573)
Q Consensus 470 vH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~ 548 (573)
+||||||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999986654433333445567889999999999999999999999999999998 999
Q ss_pred CCCC
Q 008238 549 NSSF 552 (573)
Q Consensus 549 p~~~ 552 (573)
||..
T Consensus 250 p~~~ 253 (316)
T 2xir_A 250 PYPG 253 (316)
T ss_dssp SSTT
T ss_pred CCcc
Confidence 9754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=306.51 Aligned_cols=207 Identities=28% Similarity=0.439 Sum_probs=176.1
Q ss_pred HHhCCCCcccccccccceeEEEEec--------CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceEEEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL--------PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCL 412 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 412 (573)
...++|++.+.||+|+||.||++++ .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 4456899999999999999999985 246789999997543 23456788999999999 8999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcCc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCE
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPEK-------------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI 479 (573)
+.+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 99999999999999999999965331 235899999999999999999999987 99999999999
Q ss_pred EeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 480 LLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 480 Ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
|++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 999999999999999987654333233334567889999999999999999999999999999999 9998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.04 Aligned_cols=198 Identities=27% Similarity=0.460 Sum_probs=175.1
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 47899999999999999999954 78999999986432 233467899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999853 456999999999999999999999987 999999999999999999999999999875432
Q ss_pred CCccccccccccCCccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. .....+||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus 170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 2 2334579999999999988776 6899999999999999999999853
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.11 Aligned_cols=199 Identities=27% Similarity=0.403 Sum_probs=175.7
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCcc------chHHHHHHHHHHHhcCCCccceEEEEEEcCCee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQ------GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 417 (573)
.++|++.+.||+|+||.||+++.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356899999999999999999954 6899999998754321 356799999999999999999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC----CeEEeccC
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFG 493 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~vkl~DfG 493 (573)
++||||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999953 356899999999999999999999987 99999999999999888 79999999
Q ss_pred CcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 220 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence 998664322 22345789999999999999999999999999999999999999853
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=309.56 Aligned_cols=201 Identities=27% Similarity=0.395 Sum_probs=172.5
Q ss_pred CCCCcccccccccceeEEEEec----CCCCeeEEEEeccCC----ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCe
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSRSS----GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEE 416 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 416 (573)
++|++.++||+|+||.||+++. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4689999999999999999986 378899999987532 23345677899999999 69999999999999999
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++||||+++++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999853 356899999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccchhccccC--CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
.+..... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 6543222 223345799999999999763 4789999999999999999999998643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.90 Aligned_cols=202 Identities=30% Similarity=0.481 Sum_probs=168.8
Q ss_pred HHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-----ccchHHHHHHHHHHHhcC---CCccceEEEEEEc
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-----GQGGQEFKNEVVLVAKLQ---HRNLVRLLGFCLE 413 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 413 (573)
...++|++.++||+|+||+||+++. .+++.||||++.... ......+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467899999999999999999995 578999999986432 122346677888777765 9999999999987
Q ss_pred CC-----eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeE
Q 008238 414 GE-----EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 488 (573)
Q Consensus 414 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vk 488 (573)
.. ..++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 65 4789999997 59998886532 234899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 489 ISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 489 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|+|||+++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 161 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 161 LADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp ECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred EeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999865432 223456789999999999999999999999999999999999999853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.47 Aligned_cols=196 Identities=28% Similarity=0.379 Sum_probs=164.2
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcC------C
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG------E 415 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 415 (573)
.++|++.++||+|+||+||+++. .+++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46799999999999999999984 46889999999754 333456788999999999999999999999754 3
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
..++||||++++ |.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999876 444442 24899999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 865432 223446899999999999999999999999999999999999999853
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=299.40 Aligned_cols=203 Identities=33% Similarity=0.541 Sum_probs=161.7
Q ss_pred HHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
++..++|++.++||+|+||+||++++. ..||||+++... ....+.+.+|+.++++++||||++++++. ..+..++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 345678999999999999999999864 359999987543 33446789999999999999999999965 4567899
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||+++++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 97 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999854 3456899999999999999999999987 9999999999999999999999999998654
Q ss_pred CCCCccccccccccCCccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
............||+.|+|||.+. +..++.++||||||+++|||++|+.||..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 227 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence 333333344567899999999986 56788999999999999999999999854
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=314.51 Aligned_cols=217 Identities=25% Similarity=0.395 Sum_probs=181.0
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC--eeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 420 (573)
.++|++.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457899999999999999999964 58999999997543 334567889999999999999999999998765 67999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe----CCCCCeEEeccCCcc
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKISDFGMAK 496 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl----~~~~~vkl~DfGla~ 496 (573)
|||+++|+|.+++........+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976555556999999999999999999999987 9999999999999 778889999999998
Q ss_pred cccCCCCccccccccccCCccchhcccc--------CCCCccchhHHHHHHHHHHHhCCCCCCCCC-CCCcccHHHHHHh
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMH--------GQFSVKSDVYSFGVLVLEIITGKKNSSFYQ-TDGAADLLSYVSI 567 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DvwslGvll~elltG~~p~~~~~-~~~~~~ll~~~~~ 567 (573)
...... ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||.... .+...+++..+..
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 654322 2234579999999999865 567889999999999999999999986433 2334444444443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=312.92 Aligned_cols=200 Identities=27% Similarity=0.399 Sum_probs=168.2
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcC--CCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQ--HRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv 420 (573)
.++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.++.+++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 35699999999999999999998789999999986543 334567899999999997 59999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|| +.+++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 678899999853 347899999999999999999999987 99999999999995 57899999999987654
Q ss_pred CCCccccccccccCCccchhcccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMH-----------GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
..........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 333333345679999999999865 4688999999999999999999999853
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=307.57 Aligned_cols=210 Identities=29% Similarity=0.494 Sum_probs=178.8
Q ss_pred HHHHHhCCCCcccccccccceeEEEEecC------CCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEE
Q 008238 340 TIEVATNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412 (573)
Q Consensus 340 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 412 (573)
.++...++|++.+.||+|+||.||+|+.. .++.||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34456678999999999999999999853 367899999875432 33456889999999999999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcC-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPE-------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 485 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~ 485 (573)
+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 9999999999999999999986422 1246799999999999999999999987 99999999999999999
Q ss_pred CeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 486 NPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 486 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 243 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 243 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence 999999999986543332223334567889999999999999999999999999999999 7888753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=295.33 Aligned_cols=201 Identities=29% Similarity=0.529 Sum_probs=156.0
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35689999999999999999995 578999999986432 23346789999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++++|.+++.. ....+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999864 2357899999999999999999999987 99999999999999999999999999986543
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 214 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 221 22335789999999999988999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=300.28 Aligned_cols=192 Identities=29% Similarity=0.441 Sum_probs=162.0
Q ss_pred HhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHh--cCCCccceEEEEEEcC----Cee
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAK--LQHRNLVRLLGFCLEG----EEK 417 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~ 417 (573)
..++|++.++||+|+||+||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 356799999999999999999998 7899999998643 34556667777766 7899999999987543 457
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeecCCCCCEEeCCCCCeEE
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLH--------EDSRLRIIHRDLKASNILLDAEMNPKI 489 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~ivH~Dlkp~NILl~~~~~vkl 489 (573)
++||||+++|+|.+++. ...+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 89999999999999993 357899999999999999999999 665 999999999999999999999
Q ss_pred eccCCcccccCCCCcc--ccccccccCCccchhccccC------CCCccchhHHHHHHHHHHHhC
Q 008238 490 SDFGMAKIFGVDQTQG--NTNRIVGTYGYMAPEYAMHG------QFSVKSDVYSFGVLVLEIITG 546 (573)
Q Consensus 490 ~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwslGvll~elltG 546 (573)
+|||+++......... ......||+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg 219 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence 9999998654332221 12335799999999999776 455799999999999999999
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=307.17 Aligned_cols=200 Identities=25% Similarity=0.363 Sum_probs=174.4
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc--------cchHHHHHHHHHHHhcCCCccceEEEEEEcC
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG--------QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG 414 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 414 (573)
..++|++.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456799999999999999999984 5788999999875431 1334678899999999999999999999999
Q ss_pred CeeEEEEEccCCC-ChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccC
Q 008238 415 EEKILVYEFVPNK-SLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFG 493 (573)
Q Consensus 415 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfG 493 (573)
+..++||||+.+| +|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99998853 346999999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccCCccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+++...... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 998664332 2234579999999999988877 8899999999999999999999853
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=299.80 Aligned_cols=199 Identities=26% Similarity=0.358 Sum_probs=168.7
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++|++.++||+|+||+||+++.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999964 589999999865433 234668899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999988743 356899999999999999999999987 9999999999999999999999999998654322
Q ss_pred CccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.......||..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 205 (311)
T 4agu_A 157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPG 205 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 12234578999999999876 5689999999999999999999999854
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=317.81 Aligned_cols=196 Identities=22% Similarity=0.405 Sum_probs=154.1
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcC-----Cee
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EEK 417 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 417 (573)
++|++.+.||+|+||+||+++. .+++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 5799999999999999999985 478999999986542 23446788999999999999999999998543 568
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+ +++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 133 ~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 9999997 4688888843 456999999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCCc-------------------------cccccccccCCccchhcc-ccCCCCccchhHHHHHHHHHHHhCCC
Q 008238 498 FGVDQTQ-------------------------GNTNRIVGTYGYMAPEYA-MHGQFSVKSDVYSFGVLVLEIITGKK 548 (573)
Q Consensus 498 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DvwslGvll~elltG~~ 548 (573)
....... ......+||+.|+|||++ ....++.++|||||||++|||++|..
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 6432211 122345789999999986 45679999999999999999999543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=306.91 Aligned_cols=194 Identities=34% Similarity=0.486 Sum_probs=169.2
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
+.|++.+.||+|+||+||+++. .+++.||||++..... ...+++.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999994 5789999999875432 23357889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||++ |+|.+++.. ....+++..+..++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9997 577777643 2357899999999999999999999987 99999999999999999999999999976532
Q ss_pred CCccccccccccCCccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.....||+.|+|||++. ++.++.++||||||+++|||++|+.||.
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 254 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 22357899999999985 5678999999999999999999999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=321.66 Aligned_cols=204 Identities=31% Similarity=0.513 Sum_probs=171.1
Q ss_pred HHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
+...++|++.++||+|+||.||+|.+.++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 34556789999999999999999998877889999997543 345789999999999999999999999876 6789999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999532 2346899999999999999999999987 999999999999999999999999999865432
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 334 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 384 (452)
T 1fmk_A 334 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence 21 12223456789999999999999999999999999999999 8988753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=308.29 Aligned_cols=195 Identities=24% Similarity=0.302 Sum_probs=160.0
Q ss_pred CCCCcc-cccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHH-hcCCCccceEEEEEEc----CCeeE
Q 008238 346 NNFSTD-NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVA-KLQHRNLVRLLGFCLE----GEEKI 418 (573)
Q Consensus 346 ~~~~~~-~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~~ 418 (573)
++|.+. +.||+|+||+||++.. .+++.||||++.. ...+.+|+.++. ..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 356665 6899999999999995 4688999999863 245678888874 4589999999998875 55689
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC---CCCeEEeccCCc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMA 495 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGla 495 (573)
+||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999652 2346999999999999999999999987 999999999999987 789999999999
Q ss_pred ccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 265 (400)
T 1nxk_A 212 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 865322 223356789999999999999999999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=302.48 Aligned_cols=218 Identities=28% Similarity=0.437 Sum_probs=167.9
Q ss_pred cccccchhHHHHHhCCCCcccccccccceeEEEEecC----CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccc
Q 008238 332 ESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLV 405 (573)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv 405 (573)
+.++...+.+....++|.+.+.||+|+||.||+|.+. .++.||||++.... ....+.+.+|+.++++++||||+
T Consensus 20 eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 99 (313)
T 3brb_A 20 EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99 (313)
T ss_dssp ----CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred HhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCee
Confidence 3344445555666778999999999999999999853 34479999987543 23346789999999999999999
Q ss_pred eEEEEEEcCCe-----eEEEEEccCCCChhhhccCc---CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCC
Q 008238 406 RLLGFCLEGEE-----KILVYEFVPNKSLDYFLYEP---EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 477 (573)
Q Consensus 406 ~l~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~ 477 (573)
++++++.+.+. .++||||+++++|.+++... .....+++..++.++.||++||.|||+++ |+||||||+
T Consensus 100 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~ 176 (313)
T 3brb_A 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAAR 176 (313)
T ss_dssp CCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGG
T ss_pred eeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcc
Confidence 99999987653 48999999999999998432 23457999999999999999999999987 999999999
Q ss_pred CEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 478 NILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 478 NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 177 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 252 (313)
T 3brb_A 177 NCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG 252 (313)
T ss_dssp GEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 99999999999999999986644332223334567889999999999999999999999999999999 8888754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=304.11 Aligned_cols=202 Identities=32% Similarity=0.558 Sum_probs=165.0
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCe----eEEEEeccC-CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQE----IAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
.++|++.++||+|+||.||++++ .+++. |++|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 45799999999999999999995 34554 477776543 3445678999999999999999999999998754 78
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 89999999999999854 2356899999999999999999999987 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.............+|..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 222 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 54433333344567889999999999999999999999999999999 9999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=293.61 Aligned_cols=198 Identities=28% Similarity=0.433 Sum_probs=173.8
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
.++|++.++||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46899999999999999999985 468899999986543 233467889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC---eEEeccCCcccc
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFGMAKIF 498 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---vkl~DfGla~~~ 498 (573)
||+++++|.+.+.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888743 356899999999999999999999987 999999999999986655 999999999765
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 208 (284)
T 3kk8_A 159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 208 (284)
T ss_dssp CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence 4322 2234578999999999999999999999999999999999999974
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=300.59 Aligned_cols=197 Identities=30% Similarity=0.454 Sum_probs=165.2
Q ss_pred CCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
++|++.+.||+|+||.||++++ .++.||||++... ...+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 4688999999999999999997 4788999998643 34578899999999999999999999876 35799999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC-eEEeccCCcccccCCCCc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-PKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~-vkl~DfGla~~~~~~~~~ 504 (573)
+++|.+++........+++..++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976554456899999999999999999999943234999999999999998886 799999999754322
Q ss_pred cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 205 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence 2234689999999999999999999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=295.07 Aligned_cols=200 Identities=26% Similarity=0.420 Sum_probs=175.7
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.++|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356889999999999999999964 57889999986542 23456788999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++++|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998843 357899999999999999999999987 99999999999999999999999999986543
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 217 (294)
T 2rku_A 168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217 (294)
T ss_dssp TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22 123345789999999999988999999999999999999999999854
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=299.96 Aligned_cols=195 Identities=28% Similarity=0.488 Sum_probs=170.5
Q ss_pred hCCCCcccccccccceeEEEEecCC-C-------CeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPS-G-------QEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 416 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 416 (573)
.++|++.+.||+|+||+||+++... + ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4578999999999999999998643 3 4699999987666677889999999999999999999999999999
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC--------eE
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--------PK 488 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------vk 488 (573)
.++||||+++++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999642 334899999999999999999999987 999999999999998887 99
Q ss_pred EeccCCcccccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 489 ISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 489 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
|+|||++..... .....|+..|+|||.+.+ ..++.++||||||+++|||++|..|+
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 999999865421 223467889999999987 67899999999999999999966543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=301.76 Aligned_cols=199 Identities=26% Similarity=0.423 Sum_probs=175.4
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 46889999999999999999964 57889999986542 234567889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++++|.+++.. ...+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 121 ELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp CCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999998843 357899999999999999999999987 999999999999999999999999999865432
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 195 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 243 (335)
T 2owb_A 195 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243 (335)
T ss_dssp T--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred c--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence 2 223345789999999999999999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=293.67 Aligned_cols=199 Identities=33% Similarity=0.598 Sum_probs=169.0
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccc-------hHHHHHHHHHHHhcCCCccceEEEEEEcCCe
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQG-------GQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 416 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 416 (573)
.++|++.+.||+|+||.||+++. .+++.||||++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46799999999999999999995 578999999986543221 167899999999999999999999986654
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC-----eEEec
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN-----PKISD 491 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----vkl~D 491 (573)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999888854 3457999999999999999999999875 34999999999999988776 99999
Q ss_pred cCCcccccCCCCccccccccccCCccchhcc--ccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 492 FGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA--MHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 492 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||...
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 231 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 999974322 23345789999999998 3456789999999999999999999998643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=294.72 Aligned_cols=199 Identities=28% Similarity=0.465 Sum_probs=176.7
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.+.|++.++||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 34689999999999999999985 578899999987543 3445789999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|.+++. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999984 357899999999999999999999987 9999999999999999999999999998654322
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 223345789999999999999999999999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.52 Aligned_cols=199 Identities=24% Similarity=0.414 Sum_probs=166.1
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcC-----Ce
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EE 416 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 416 (573)
.++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46799999999999999999995 468889999997542 23446788999999999999999999998776 56
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++||||++ ++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 589888853 456999999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCCc--------------------cccccccccCCccchhcc-ccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 497 IFGVDQTQ--------------------GNTNRIVGTYGYMAPEYA-MHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 497 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76433211 123456899999999986 5567999999999999999999876554
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=311.16 Aligned_cols=200 Identities=26% Similarity=0.420 Sum_probs=162.9
Q ss_pred HHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--------ccchHHHHHHHHHHHhcCCCccceEEEEEEc
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--------GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE 413 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 413 (573)
...++|.+.++||+|+||+||++.. .+++.||||++.+.. ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4467899999999999999999985 468999999986432 122235889999999999999999999975
Q ss_pred CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC---CeEEe
Q 008238 414 GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---NPKIS 490 (573)
Q Consensus 414 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~vkl~ 490 (573)
.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 4568999999999999998853 457999999999999999999999987 99999999999997544 59999
Q ss_pred ccCCcccccCCCCccccccccccCCccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 491 DFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 491 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 285 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 346 (419)
T 3i6u_A 285 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999865432 22334679999999999853 5678999999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=293.85 Aligned_cols=201 Identities=30% Similarity=0.467 Sum_probs=175.8
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
.++|++.+.||+|+||.||++++.+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 457889999999999999999988888999999976543 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++++|.+++.. ....+++..++.++.|+++||+|||+++ ++||||||+|||++.++.+||+|||+++...... .
T Consensus 86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~ 159 (267)
T 3t9t_A 86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y 159 (267)
T ss_dssp TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-c
Confidence 99999999854 2356899999999999999999999987 9999999999999999999999999998653221 1
Q ss_pred cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence 12223456788999999999999999999999999999999 8888753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=294.82 Aligned_cols=198 Identities=29% Similarity=0.461 Sum_probs=171.0
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.++|++.+.||+|+||.||+++. .+++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 45789999999999999999985 467789999986432 22346788999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999853 356899999999999999999999987 99999999999999999999999999864432
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 209 (279)
T 3fdn_A 162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence 2 22345789999999999999999999999999999999999999863
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=292.52 Aligned_cols=198 Identities=27% Similarity=0.423 Sum_probs=172.1
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc------cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG------QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
++|++.+.||+|+||.||+++.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46899999999999999999964 689999999865421 23577999999999999999999999999999999
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC----CeEEeccCC
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFGM 494 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~vkl~DfGl 494 (573)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999843 457899999999999999999999987 99999999999998877 899999999
Q ss_pred cccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 213 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence 98654322 22345689999999999999999999999999999999999999753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=300.16 Aligned_cols=201 Identities=32% Similarity=0.522 Sum_probs=171.5
Q ss_pred hCCCCcccccccccceeEEEEec-----CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcC--Ce
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EE 416 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 416 (573)
.+.|++.++||+|+||.||++++ .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34588999999999999999983 468899999997543 34457889999999999999999999999876 56
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++||||+++++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 7999999999999999854 2356899999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCCc-cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 497 IFGVDQTQ-GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 497 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
........ .......||..|+|||.+.+..++.++||||||+++|||++|+.|+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 229 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCC
Confidence 76543321 2233456788899999999999999999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.33 Aligned_cols=201 Identities=25% Similarity=0.402 Sum_probs=170.1
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.++|.+.++||+|+||.||+++. .+++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 35689999999999999999995 468899999987543 3446788999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe---CCCCCeEEeccCCcccc
Q 008238 423 FVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIF 498 (573)
Q Consensus 423 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~vkl~DfGla~~~ 498 (573)
|+++++|.+++... .....+++..++.++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999888542 23467999999999999999999999987 9999999999999 45688999999999765
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||..
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~ 227 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence 4322 233457899999999874 5789999999999999999999999853
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=296.75 Aligned_cols=197 Identities=27% Similarity=0.412 Sum_probs=171.9
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.++|.+.+.||+|+||.||+++. .+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 45689999999999999999995 47899999999866555556789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe---CCCCCeEEeccCCcccccC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~vkl~DfGla~~~~~ 500 (573)
+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999998843 356899999999999999999999987 9999999999999 7889999999999875432
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 1 2234568999999999999999999999999999999999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=294.90 Aligned_cols=204 Identities=34% Similarity=0.544 Sum_probs=175.3
Q ss_pred HHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++..++|++.+.||+|+||.||+++..+++.||||++.... ...+.+.+|++++++++||||+++++++.+ +..++||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence 34456799999999999999999998788899999997543 345788999999999999999999999764 5689999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++++|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999999999542 2236899999999999999999999987 999999999999999999999999999876433
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 21 12233456788999999998899999999999999999999 8888753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=298.94 Aligned_cols=206 Identities=32% Similarity=0.479 Sum_probs=178.9
Q ss_pred HHHHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
++...++|++.++||+|+||.||++.+. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 3345677999999999999999999964 4788999999754 3446778999999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||+++++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999998542 2356899999999999999999999987 9999999999999999999999999998664
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 163 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 163 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp SSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3322 22334456889999999999999999999999999999999 8888754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.70 Aligned_cols=195 Identities=28% Similarity=0.443 Sum_probs=164.2
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC------
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 415 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 415 (573)
.++|++.+.||+|+||.||+++. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35789999999999999999995 578999999986532 233467889999999999999999999998753
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
..++||||+ +++|.+++. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 889999884 356899999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 865322 234578999999999887 6799999999999999999999999853
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=296.15 Aligned_cols=203 Identities=24% Similarity=0.400 Sum_probs=161.9
Q ss_pred HHhCCCCcccccccccceeEEEEecCC----CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCee
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 417 (573)
...++|++.+.||+|+||.||+|+... +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 345679999999999999999998642 4469999987543 334567899999999999999999999974 5678
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+++++|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999999854 2346899999999999999999999987 99999999999999999999999999986
Q ss_pred ccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 166 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~ 220 (281)
T 1mp8_A 166 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCc
Confidence 643221 12233456788999999999999999999999999999997 8889754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=293.34 Aligned_cols=197 Identities=27% Similarity=0.434 Sum_probs=173.9
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56899999999999999999964 67789999986432 233467899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++++|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999853 346899999999999999999999987 999999999999999999999999998754322
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 214 (284)
T 2vgo_A 168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214 (284)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence 22345789999999999999999999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=293.58 Aligned_cols=200 Identities=31% Similarity=0.436 Sum_probs=171.1
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
++.....||+|+||.||+|+. .+++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 355566999999999999995 5688999999987666667889999999999999999999999999999999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC-CCCeEEeccCCcccccCCCCc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfGla~~~~~~~~~ 504 (573)
+++|.+++........+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 9999999965444456789999999999999999999987 999999999999987 8999999999998654321
Q ss_pred cccccccccCCccchhccccCC--CCccchhHHHHHHHHHHHhCCCCCC
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.......|+..|+|||.+.+.. ++.++||||||+++|||++|+.||.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 1223457899999999987654 7899999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=293.03 Aligned_cols=199 Identities=30% Similarity=0.414 Sum_probs=168.8
Q ss_pred CCCcccccccccceeEEEEecC-CC---CeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCee-EEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SG---QEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK-ILV 420 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv 420 (573)
.|.+.++||+|+||+||+|++. ++ ..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4666799999999999999853 22 2699999875433 3456789999999999999999999999876665 999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+.+++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999965 3457899999999999999999999987 99999999999999999999999999986543
Q ss_pred CCC--ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 501 DQT--QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 501 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
... ........++..|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 221 12233456788999999999999999999999999999999977664
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=291.08 Aligned_cols=212 Identities=22% Similarity=0.345 Sum_probs=176.3
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEE-EcCCeeEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFC-LEGEEKILVYE 422 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 422 (573)
.++|++.+.||+|+||.||+++. .+++.||||++..... .+++.+|+.+++.++|+++++.+..+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46799999999999999999995 5789999999865432 35688999999999998877666655 56777899999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe---CCCCCeEEeccCCccccc
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~vkl~DfGla~~~~ 499 (573)
|+ +++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999853 2356999999999999999999999987 9999999999999 488899999999998765
Q ss_pred CCCCcc-----ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHH
Q 008238 500 VDQTQG-----NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSY 564 (573)
Q Consensus 500 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~ 564 (573)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 229 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 229 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhh
Confidence 433211 22456799999999999999999999999999999999999999976544433344433
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=301.40 Aligned_cols=204 Identities=24% Similarity=0.417 Sum_probs=176.3
Q ss_pred hHHHHHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc--------cchHHHHHHHHHHHhc-CCCccceEE
Q 008238 339 ETIEVATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG--------QGGQEFKNEVVLVAKL-QHRNLVRLL 408 (573)
Q Consensus 339 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~ 408 (573)
.......++|++.+.||+|+||.||+++.. +|+.||||++..... ...+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999964 799999999865432 1135678899999999 799999999
Q ss_pred EEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeE
Q 008238 409 GFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPK 488 (573)
Q Consensus 409 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vk 488 (573)
+++......++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999853 356899999999999999999999987 99999999999999999999
Q ss_pred EeccCCcccccCCCCccccccccccCCccchhcccc------CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 489 ISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH------GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 489 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
|+|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 99999998764332 2334679999999999863 358899999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.14 Aligned_cols=203 Identities=26% Similarity=0.418 Sum_probs=163.3
Q ss_pred HHHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcCCee
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 417 (573)
.....++|++.++||+|+||+||+++. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 344556899999999999999999984 5788999999875432 2345678999999999999999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe-----CCCCCeEEecc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DAEMNPKISDF 492 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl-----~~~~~vkl~Df 492 (573)
++||||+++ +|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+ ++++.+||+||
T Consensus 109 ~lv~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 109 HLIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcC
Confidence 999999984 88888843 346899999999999999999999987 9999999999999 45556999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|+++...... .......||..|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 182 g~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 182 GLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 9998764322 223345789999999999875 489999999999999999999999753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.45 Aligned_cols=202 Identities=32% Similarity=0.468 Sum_probs=175.6
Q ss_pred hCCCCcccccccccceeEEEEec-----CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEE--cCCee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL--EGEEK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 417 (573)
.++|++.++||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35789999999999999999983 467889999998776666778999999999999999999999987 45568
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 8999999999999998542 245899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCCc-cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 498 FGVDQTQ-GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 498 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
....... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 6433321 12233467888999999999999999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=291.86 Aligned_cols=211 Identities=22% Similarity=0.350 Sum_probs=172.5
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEE-EcCCeeEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFC-LEGEEKILVY 421 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 421 (573)
..++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+|+++++.++|++++..++.+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 456899999999999999999994 578899999875433 234688899999999988877776655 6677889999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe---CCCCCeEEeccCCcccc
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIF 498 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~vkl~DfGla~~~ 498 (573)
||+ +++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999853 2356999999999999999999999987 9999999999999 78899999999999876
Q ss_pred cCCCCc-----cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHH
Q 008238 499 GVDQTQ-----GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLL 562 (573)
Q Consensus 499 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll 562 (573)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh
Confidence 543321 1223567899999999999999999999999999999999999999764444333333
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.62 Aligned_cols=199 Identities=26% Similarity=0.431 Sum_probs=163.6
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCcc-chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQ-GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|++.++||+|+||+||+++.. +++.||||++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46899999999999999999964 7889999998654322 223456799999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
++ |+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 98 578777754 2346899999999999999999999987 9999999999999999999999999997543222
Q ss_pred ccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 22234578999999999876 5689999999999999999999999854
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=303.33 Aligned_cols=200 Identities=20% Similarity=0.266 Sum_probs=164.9
Q ss_pred hCCCCcccccccccceeEEEEecC----CCCeeEEEEeccCCccc-----------hHHHHHHHHHHHhcCCCccceEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSRSSGQG-----------GQEFKNEVVLVAKLQHRNLVRLLG 409 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~~ 409 (573)
.++|++.++||+|+||.||+++.. .+..+|||++....... ...+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 457999999999999999999964 57789999987553221 234667888999999999999999
Q ss_pred EEEc----CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC
Q 008238 410 FCLE----GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 485 (573)
Q Consensus 410 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~ 485 (573)
++.. ....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67889999999 9999999854 237999999999999999999999987 99999999999998877
Q ss_pred --CeEEeccCCcccccCCCCc-----cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 486 --NPKISDFGMAKIFGVDQTQ-----GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 486 --~vkl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.+||+|||+++.+...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999999999876432211 11234579999999999999999999999999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=297.11 Aligned_cols=201 Identities=23% Similarity=0.322 Sum_probs=165.2
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.++|++.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467999999999999999999954 688999999875432 2346788999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++++|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999853 356899999999999999999999987 99999999999999999999999999876543
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence 221 222345689999999999999999999999999999999999999853
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=324.59 Aligned_cols=205 Identities=31% Similarity=0.508 Sum_probs=176.2
Q ss_pred HHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
+++..++|++.++||+|+||.||+|++.++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++|
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 345566789999999999999999998877889999997544 345789999999999999999999999876 678999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++|+|.+++... ....+++.+++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 340 ~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999999532 2346899999999999999999999987 99999999999999999999999999986542
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 416 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 416 NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp HHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred Cce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 211 11223456788999999999999999999999999999999 8988753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=298.61 Aligned_cols=199 Identities=31% Similarity=0.443 Sum_probs=168.5
Q ss_pred CCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCcc--chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQ--GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++|++.+.||+|+||.||+++.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46899999999999999999964 5899999998654332 34567899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999888643 346899999999999999999999987 9999999999999999999999999997654322
Q ss_pred CccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.......|+..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (331)
T 4aaa_A 179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPG 227 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCC
Confidence 122345789999999998775 789999999999999999999999854
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=302.75 Aligned_cols=208 Identities=24% Similarity=0.332 Sum_probs=169.5
Q ss_pred cchhHHHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCcc-----------chHHHHHHHHHHHhcCCCcc
Q 008238 336 FDFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQ-----------GGQEFKNEVVLVAKLQHRNL 404 (573)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni 404 (573)
.....+....++|++.+.||+|+||.||++...+++.||||++...... ..+.+.+|+.++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3456677888999999999999999999999888999999998643221 12678999999999999999
Q ss_pred ceEEEEEEcC-----CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCE
Q 008238 405 VRLLGFCLEG-----EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479 (573)
Q Consensus 405 v~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI 479 (573)
+++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 9999998543 35799999998 577777753 3457899999999999999999999987 99999999999
Q ss_pred EeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 480 LLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 480 Ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|++.++.+||+|||+++..... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 9999999999999999754322 22334578999999999877 6789999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=292.23 Aligned_cols=202 Identities=32% Similarity=0.531 Sum_probs=172.0
Q ss_pred hCCCCccc-ccccccceeEEEEecC---CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 345 TNNFSTDN-KLGEGGFGEVYKGVLP---SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 345 ~~~~~~~~-~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
.++|.+.+ .||+|+||.||+|++. +++.||||+++... ....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34566666 9999999999999853 57789999997653 33456789999999999999999999999 4567899
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||+++++|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999854 3456899999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCc-cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 500 VDQTQ-GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 500 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 33221 12223456889999999988899999999999999999999 9999854
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=300.39 Aligned_cols=201 Identities=25% Similarity=0.445 Sum_probs=169.6
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcC--------
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG-------- 414 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 414 (573)
++|++.++||+|+||.||+++. .+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4799999999999999999996 578999999986543 23346788999999999999999999998873
Q ss_pred CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 415 EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 415 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
+..++||||+++ +|.+.+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 467999999986 56566543 2346899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCC--ccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 495 AKIFGVDQT--QGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 495 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
++.+..... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 231 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 231 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence 987643222 222344578999999999876 4579999999999999999999999764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.55 Aligned_cols=198 Identities=27% Similarity=0.385 Sum_probs=174.0
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.++|++.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 457999999999999999999964 68899999987553 3345678999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999853 34689999999999999999999985 6 999999999999999999999999998755321
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22345789999999999999999999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=323.08 Aligned_cols=201 Identities=31% Similarity=0.519 Sum_probs=167.0
Q ss_pred CCCCccc-ccccccceeEEEEecC---CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 346 NNFSTDN-KLGEGGFGEVYKGVLP---SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 346 ~~~~~~~-~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
+++.+.+ +||+|+||.||+|.+. ++..||||+++... ....+++.+|++++++++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3445555 7999999999999863 45679999997653 3456789999999999999999999999976 568999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999964 3456999999999999999999999987 99999999999999999999999999987643
Q ss_pred CCCcc-ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 501 DQTQG-NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 501 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
..... ......++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 542 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 32211 1122345689999999999999999999999999999998 9999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=296.25 Aligned_cols=208 Identities=25% Similarity=0.398 Sum_probs=175.4
Q ss_pred hhHHHHHhCCCCcc-cccccccceeEEEEecC-CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcC-CCccceEEEEEE
Q 008238 338 FETIEVATNNFSTD-NKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCL 412 (573)
Q Consensus 338 ~~~~~~~~~~~~~~-~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 412 (573)
+...+...++|.+. ++||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++ ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34445566677777 89999999999999954 68999999987542 334578899999999995 699999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC---CCCeEE
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKI 489 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~vkl 489 (573)
+.+..++||||+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999998542 3357899999999999999999999987 999999999999987 789999
Q ss_pred eccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 490 SDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 490 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 176 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 176 VDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999998664322 22345789999999999999999999999999999999999999853
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=299.28 Aligned_cols=207 Identities=34% Similarity=0.521 Sum_probs=171.4
Q ss_pred HHhCCCCcccccccccceeEEEEec------CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 415 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 415 (573)
...++|++.+.||+|+||.||++++ .+++.||||++.... .....++.+|+.++++++||||+++++++.+.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 3456799999999999999999984 246789999997443 344567889999999999999999999999999
Q ss_pred eeEEEEEccCCCChhhhccCcC----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC---CCCeE
Q 008238 416 EKILVYEFVPNKSLDYFLYEPE----KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPK 488 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~vk 488 (573)
..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999996432 1245899999999999999999999987 999999999999984 45699
Q ss_pred EeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 489 ISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 489 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
|+|||+++...............|++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 248 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999986544333333344567899999999999999999999999999999998 8888753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.53 Aligned_cols=208 Identities=27% Similarity=0.345 Sum_probs=161.2
Q ss_pred HHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-CCccceEEEEEE-------
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCL------- 412 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~------- 412 (573)
+....+|++.++||+|+||.||+++. .+++.||||++........+.+.+|+.++.++. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 34456799999999999999999995 478999999987666666678899999999996 999999999984
Q ss_pred -cCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEec
Q 008238 413 -EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 491 (573)
Q Consensus 413 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~D 491 (573)
.....++||||++ |+|.+++........+++..++.++.||+.||+|||+++ ++|+||||||+|||++.++.+||+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence 3345789999996 788888865444567999999999999999999999874 3599999999999999999999999
Q ss_pred cCCcccccCCCCcc----------ccccccccCCccchhcc---ccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 492 FGMAKIFGVDQTQG----------NTNRIVGTYGYMAPEYA---MHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 492 fGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
||+++......... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||.
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 99998764332211 11234689999999998 56678999999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=299.62 Aligned_cols=200 Identities=28% Similarity=0.409 Sum_probs=165.8
Q ss_pred HhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc-----cchHHHHHHHHHHHhcCCCccceEEEEEEcCCee
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG-----QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 417 (573)
..++|++.+.||+|+||.||+++.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3567999999999999999999964 689999999864322 1234688999999999999999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+++ +|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 78777754 3346889999999999999999999987 99999999999999999999999999986
Q ss_pred ccCCCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
..... .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~ 214 (346)
T 1ua2_A 162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 214 (346)
T ss_dssp TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 64322 223345789999999998764 58999999999999999999998864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=292.87 Aligned_cols=200 Identities=29% Similarity=0.453 Sum_probs=166.3
Q ss_pred hCCCCcccccccccceeEEEEecCC----CCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEc-CCeeE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~ 418 (573)
..+|++.++||+|+||.||+|++.+ ...+|+|.+..... ...+.+.+|+.++++++||||+++++++.. .+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468889999999999999998532 22589999875433 345678999999999999999999998654 55779
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+||||+++|+|.+++.. ....+++..++.++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999964 3456899999999999999999999987 999999999999999999999999999865
Q ss_pred cCCCC--ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCC
Q 008238 499 GVDQT--QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN 549 (573)
Q Consensus 499 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p 549 (573)
..... ........+|+.|+|||.+.+..++.++||||||+++|||++|..|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~ 231 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 43221 1122334678899999999999999999999999999999995554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=296.43 Aligned_cols=197 Identities=32% Similarity=0.478 Sum_probs=169.5
Q ss_pred CCcccccccccceeEEEEec-----CCCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcC--CeeEE
Q 008238 348 FSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKIL 419 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 419 (573)
|++.++||+|+||+||++.+ .+++.||||++..... ...+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48999999999999988864 2678899999976532 3456789999999999999999999999874 57899
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
||||+++++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999943 45899999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCc-cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 500 VDQTQ-GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 500 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 43221 12234567888999999999999999999999999999999999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=312.49 Aligned_cols=198 Identities=15% Similarity=0.215 Sum_probs=163.0
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHH---HHHHhcCCCccceEE-------EE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEV---VLVAKLQHRNLVRLL-------GF 410 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~ 410 (573)
.++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+ .++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45788999999999999999995 56899999998743 334457788999 455566899999998 66
Q ss_pred EEcCCe-----------------eEEEEEccCCCChhhhccCcCc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 008238 411 CLEGEE-----------------KILVYEFVPNKSLDYFLYEPEK----QQQLDWSRRYKIIGGIARGILYLHEDSRLRI 469 (573)
Q Consensus 411 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 469 (573)
+.+.+. .++||||+ +|+|.+++..... ...+++..++.|+.||++||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 6899999864211 123446888899999999999999987 9
Q ss_pred EeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccC-----------CCCccchhHHHHH
Q 008238 470 IHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-----------QFSVKSDVYSFGV 538 (573)
Q Consensus 470 vH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~DvwslGv 538 (573)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985322 2334567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCC
Q 008238 539 LVLEIITGKKNSSF 552 (573)
Q Consensus 539 ll~elltG~~p~~~ 552 (573)
++|||++|+.||..
T Consensus 302 il~elltg~~Pf~~ 315 (377)
T 3byv_A 302 VIYWIWCADLPITK 315 (377)
T ss_dssp HHHHHHHSSCCC--
T ss_pred HHHHHHHCCCCCcc
Confidence 99999999999854
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.10 Aligned_cols=191 Identities=23% Similarity=0.404 Sum_probs=168.6
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-CCccceEEEEEEc--CCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLE--GEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 421 (573)
++|++.++||+|+||+||+++. .+++.||||+++.. ..+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5799999999999999999984 57899999998743 3567899999999997 9999999999987 56789999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC-CeEEeccCCcccccC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMAKIFGV 500 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~~~ 500 (573)
||+++++|.+++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999883 3889999999999999999999987 99999999999999776 899999999986543
Q ss_pred CCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.. ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 184 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 184 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 32 2234578999999999877 678999999999999999999999984
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.87 Aligned_cols=199 Identities=31% Similarity=0.451 Sum_probs=170.9
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc-------------cchHHHHHHHHHHHhcCCCccceEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG-------------QGGQEFKNEVVLVAKLQHRNLVRLLG 409 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~ 409 (573)
..++|++.++||+|+||+||+++. .+++.||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 356799999999999999999995 4678999999875421 33567899999999999999999999
Q ss_pred EEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC---C
Q 008238 410 FCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM---N 486 (573)
Q Consensus 410 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~ 486 (573)
++.+....++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999988843 456999999999999999999999987 99999999999998776 6
Q ss_pred eEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 487 PKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 487 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+||+|||+++...... ......||+.|+|||++. +.++.++||||||+++|||++|+.||..
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998764332 233457999999999876 5699999999999999999999999853
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=312.81 Aligned_cols=198 Identities=28% Similarity=0.446 Sum_probs=168.3
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
.++|++.++||+|+||+||+++.. +++.||||++.+.. ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346999999999999999999964 78899999987543 334577899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC---CCeEEeccCCcccc
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMAKIF 498 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~---~~vkl~DfGla~~~ 498 (573)
||+++|+|.+.+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999888843 356899999999999999999999987 9999999999999764 45999999999876
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.... ......||+.|+|||++. +.++.++||||||+++|||++|+.||..
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG 239 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 4332 233457999999999875 5799999999999999999999999853
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=291.64 Aligned_cols=196 Identities=28% Similarity=0.487 Sum_probs=171.0
Q ss_pred HhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEc---------
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE--------- 413 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 413 (573)
...+|++.+.||+|+||.||+++.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3456999999999999999999964 78999999987543 457789999999999999999998864
Q ss_pred -------CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC
Q 008238 414 -------GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN 486 (573)
Q Consensus 414 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 486 (573)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34578999999999999999542 2357899999999999999999999987 999999999999999999
Q ss_pred eEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 487 PKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 487 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus 161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 221 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221 (284)
T ss_dssp EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence 9999999998764332 223456899999999999999999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=303.31 Aligned_cols=195 Identities=28% Similarity=0.439 Sum_probs=153.6
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcC------C
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG------E 415 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 415 (573)
.++|++.+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36799999999999999999984 578999999986542 23456788999999999999999999998754 5
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
..++|+|++ +++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 579999998 789988884 357999999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 864321 234578999999999877 6789999999999999999999999854
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=290.49 Aligned_cols=197 Identities=25% Similarity=0.340 Sum_probs=169.0
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC--ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 420 (573)
.++|++.+.||+|+||+||+++.. +++.||||++.... .....++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456999999999999999999964 78999999987542 33456788899999999 899999999999999999999
Q ss_pred EEccCCCChhhhccCcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC---------------
Q 008238 421 YEFVPNKSLDYFLYEPE-KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE--------------- 484 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~--------------- 484 (573)
|||+++++|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999986432 1256899999999999999999999987 9999999999999844
Q ss_pred ----CCeEEeccCCcccccCCCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCC
Q 008238 485 ----MNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 485 ----~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~ 550 (573)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|++++
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 479999999998654322 23589999999999776 5678999999999999999999764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=289.54 Aligned_cols=198 Identities=25% Similarity=0.357 Sum_probs=169.9
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcC--CeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG--EEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 420 (573)
.++|++.++||+|+||.||+|++ .++.||||++.... ....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 35789999999999999999998 48899999987543 33456789999999999999999999999887 778999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++|+|.+++... ....+++..++.++.||++||+|||+++ ..++||||||+|||++.++.++|.|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 9999999999999653 2236899999999999999999999864 459999999999999999999999998875422
Q ss_pred CCCccccccccccCCccchhccccCCCCc---cchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSV---KSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~DvwslGvll~elltG~~p~~~ 552 (573)
.....||+.|+|||.+.+..++. ++||||||+++|||++|+.||..
T Consensus 165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 213 (271)
T 3kmu_A 165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213 (271)
T ss_dssp ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 12346789999999998765544 89999999999999999999853
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=292.56 Aligned_cols=201 Identities=29% Similarity=0.462 Sum_probs=171.5
Q ss_pred HHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
...++|++.+.||+|+||.||++... +|+.||||.+.... ..+++.+|+.+++.++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34567999999999999999999964 58999999987543 3577899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999852 3457899999999999999999999987 999999999999999999999999999765432
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 179 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 179 M--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp B--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred c--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 2 223345789999999999999999999999999999999999999853
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=313.71 Aligned_cols=198 Identities=30% Similarity=0.464 Sum_probs=174.1
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 456999999999999999999954 78999999986542 34567799999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe---CCCCCeEEeccCCccc
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKI 497 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~vkl~DfGla~~ 497 (573)
|||+.+|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999988853 356899999999999999999999987 9999999999999 5678999999999987
Q ss_pred ccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+.... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||..
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 229 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG 229 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence 64332 2334579999999998865 799999999999999999999999853
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=295.41 Aligned_cols=202 Identities=26% Similarity=0.439 Sum_probs=170.3
Q ss_pred HhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
..++|++.+.||+|+||.||+++.. +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467999999999999999999964 588999999987766677889999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999998853 2356899999999999999999999987 999999999999999999999999987543211
Q ss_pred CccccccccccCCccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
........|+..|+|||.+. +..++.++||||||+++|||++|+.|+..
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 224 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 11122356899999999983 66789999999999999999999999764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=291.74 Aligned_cols=202 Identities=28% Similarity=0.446 Sum_probs=169.1
Q ss_pred HhCCCCcccccccccceeEEEEecCC----CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
..++|++.+.||+|+||.||+|++.+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 44678999999999999999998532 2359999987653 3345778999999999999999999999765 4568
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+||||+++++|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999854 2356899999999999999999999987 999999999999999999999999999865
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 43221 12233456889999999999999999999999999999998 9999853
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=298.94 Aligned_cols=202 Identities=31% Similarity=0.525 Sum_probs=166.6
Q ss_pred hCCCCcccccccccceeEEEEecCC-----CCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPS-----GQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
.++|++.+.||+|+||.||+|++.. +..||||++..... .....+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4568889999999999999998642 23599999975432 33457889999999999999999999999999999
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+||||+++++|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999854 2356899999999999999999999987 999999999999999999999999999876
Q ss_pred cCCCCcc-ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 499 GVDQTQG-NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 499 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~ 252 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 252 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcc
Confidence 4332211 1223346788999999999999999999999999999999 999974
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=304.88 Aligned_cols=200 Identities=30% Similarity=0.470 Sum_probs=158.7
Q ss_pred CCCcccccccccceeEEEEecC--CC--CeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEc-CCeeEEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP--SG--QEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILV 420 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv 420 (573)
.|++.+.||+|+||.||+|++. ++ ..||||.++... ....+++.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677889999999999999853 22 358999986543 3445779999999999999999999998765 4577999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999964 3356889999999999999999999987 99999999999999999999999999986543
Q ss_pred CCCc--cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 501 DQTQ--GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 501 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~ 298 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCC
Confidence 2211 12233457889999999999999999999999999999999 556654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.13 Aligned_cols=205 Identities=23% Similarity=0.368 Sum_probs=173.5
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCC-CccceEEEEEEcCCeeEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH-RNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 422 (573)
.++|++.++||+|+||.||+++. .+++.||||++..... ..++.+|+++++.++| +++..+..+....+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46799999999999999999995 5789999998764432 3458899999999987 556666667778888999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe---CCCCCeEEeccCCccccc
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~vkl~DfGla~~~~ 499 (573)
|+ +++|.+++.. ....+++..++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999853 2356999999999999999999999987 9999999999999 688999999999998765
Q ss_pred CCCCc-----cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 008238 500 VDQTQ-----GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDG 557 (573)
Q Consensus 500 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~ 557 (573)
..... .......||..|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~ 220 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh
Confidence 43321 12235679999999999999999999999999999999999999987544433
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.68 Aligned_cols=198 Identities=30% Similarity=0.459 Sum_probs=171.5
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
..++|++.++||+|+||+||+++. .+++.||||++.+. .......+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 345799999999999999999995 47899999998643 234457789999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC---CCCCeEEeccCCccc
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGMAKI 497 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~vkl~DfGla~~ 497 (573)
|||+++|+|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999888843 356899999999999999999999987 99999999999995 556799999999986
Q ss_pred ccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+.... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||.
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 223 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY 223 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 54322 2334579999999998865 59999999999999999999999974
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=294.86 Aligned_cols=199 Identities=27% Similarity=0.422 Sum_probs=162.3
Q ss_pred HHHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhc--CCCccceEEEEEEcC---
Q 008238 340 TIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL--QHRNLVRLLGFCLEG--- 414 (573)
Q Consensus 340 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~--- 414 (573)
......++|++.++||+|+||.||+++.. ++.||||++... ....+..|.+++... +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33445678999999999999999999984 899999998643 233445555555554 899999999999887
Q ss_pred -CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeecCCCCCEEeCCCCCeE
Q 008238 415 -EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS-----RLRIIHRDLKASNILLDAEMNPK 488 (573)
Q Consensus 415 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~vk 488 (573)
...++||||+++|+|.+++. ...+++..++.++.|++.||+|||++. +++|+||||||+|||++.++.+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEeccCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 67899999999999999994 346899999999999999999999871 12399999999999999999999
Q ss_pred EeccCCcccccCCCCcc--ccccccccCCccchhccccCCCCcc------chhHHHHHHHHHHHhC
Q 008238 489 ISDFGMAKIFGVDQTQG--NTNRIVGTYGYMAPEYAMHGQFSVK------SDVYSFGVLVLEIITG 546 (573)
Q Consensus 489 l~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------~DvwslGvll~elltG 546 (573)
|+|||+++.+....... ......||+.|+|||.+.+.....+ +||||||+++|||++|
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 99999997654332221 1234579999999999987776655 9999999999999999
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=306.12 Aligned_cols=198 Identities=25% Similarity=0.377 Sum_probs=164.8
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe------eE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE------KI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~ 418 (573)
..+|++.+.||+|+||.||+++...+..||+|++..... ...+|+.+++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346899999999999999999987777799998864332 22469999999999999999999865433 78
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC-CCCCeEEeccCCccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMAKI 497 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~vkl~DfGla~~ 497 (573)
+||||++++.+............+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999988765544432234567999999999999999999999987 99999999999999 799999999999987
Q ss_pred ccCCCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
...... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 244 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 643222 2345789999999998765 589999999999999999999999853
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=298.31 Aligned_cols=202 Identities=32% Similarity=0.516 Sum_probs=174.2
Q ss_pred hCCCCcccccccccceeEEEEec-----CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCC--ee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-----PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE--EK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~ 417 (573)
.++|++.++||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688999999999999999983 368899999998776666778999999999999999999999987654 67
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+++++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999542 346899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCCcc-ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 498 FGVDQTQG-NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 498 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 65433211 1223456778999999999899999999999999999999998864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=301.34 Aligned_cols=196 Identities=28% Similarity=0.379 Sum_probs=161.2
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC------
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 415 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 415 (573)
.++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 35799999999999999999985 468899999987532 233467889999999999999999999998665
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999975 6777763 35899999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 8654221 22345789999999999999999999999999999999999999853
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=291.40 Aligned_cols=203 Identities=25% Similarity=0.366 Sum_probs=169.3
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC----ccchHHHHHHHHHHHhcCCCccceEEEEEE--cCCee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS----GQGGQEFKNEVVLVAKLQHRNLVRLLGFCL--EGEEK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 417 (573)
.++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36899999999999999999996 468899999987532 344577899999999999999999999985 44578
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||++++ |.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 55555432 2457899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCCccccccccccCCccchhccccCC--CCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 64433333334557899999999987654 37899999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=290.69 Aligned_cols=199 Identities=30% Similarity=0.435 Sum_probs=169.3
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEc----CCee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 417 (573)
.+.|++.++||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 34578889999999999999985 46788999998644 23345678999999999999999999998875 3557
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC-CCCCeEEeccCCcc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMAK 496 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~vkl~DfGla~ 496 (573)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ .+|+||||||+|||++ +++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999943 356899999999999999999999874 3599999999999997 88999999999997
Q ss_pred cccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
..... ......|++.|+|||.+. +.++.++||||||+++|||++|+.||..
T Consensus 181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 54322 223457899999999875 5699999999999999999999999853
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=293.67 Aligned_cols=201 Identities=24% Similarity=0.441 Sum_probs=164.2
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 3689999999999999999995 578999999987532 334567889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 422 EFVPNKSLDYFLYEPE-KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
||+++++|.+++.... ....+++..++.++.||++||+|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999985422 2456899999999999999999999987 99999999999999999999999999876543
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 189 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 237 (310)
T 2wqm_A 189 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 237 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 22 12234568999999999999999999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=308.05 Aligned_cols=195 Identities=28% Similarity=0.425 Sum_probs=160.5
Q ss_pred CCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcC----C--eeEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG----E--EKIL 419 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~--~~~l 419 (573)
+|++.+.||+|+||.||++++. +++.||||++.... ....+|++++++++||||+++++++... + ..++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 5888999999999999999964 68999999986432 2234799999999999999999988542 2 2568
Q ss_pred EEEccCCCChhhhccC-cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC-CCeEEeccCCccc
Q 008238 420 VYEFVPNKSLDYFLYE-PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAKI 497 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~vkl~DfGla~~ 497 (573)
||||+++ +|.+.+.. ......+++..+..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 45444422 123467999999999999999999999987 9999999999999965 5689999999986
Q ss_pred ccCCCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 207 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~ 259 (420)
T 1j1b_A 207 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 259 (420)
T ss_dssp CCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 54322 12345789999999998765 789999999999999999999999853
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.14 Aligned_cols=200 Identities=25% Similarity=0.410 Sum_probs=170.1
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcC-----Cee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EEK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 417 (573)
.++|++.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 35799999999999999999985 4688899999975432 3346788999999999999999999998765 367
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||++ ++|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 58888883 356999999999999999999999987 99999999999999999999999999986
Q ss_pred ccCCCCc-cccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 498 FGVDQTQ-GNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 498 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 234 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCC
Confidence 6433221 12344589999999998765 4589999999999999999999999854
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=293.95 Aligned_cols=200 Identities=25% Similarity=0.415 Sum_probs=164.7
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEE-----------
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL----------- 412 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----------- 412 (573)
.++|++.+.||+|+||.||+++.. +++.||||++........+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467999999999999999999965 58899999998766666778999999999999999999999874
Q ss_pred ---cCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC-CCCCeE
Q 008238 413 ---EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPK 488 (573)
Q Consensus 413 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~vk 488 (573)
+....++||||++ |+|.+++. ...+++..++.++.||++||+|||+++ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467799999998 68999883 356899999999999999999999987 99999999999997 567999
Q ss_pred EeccCCcccccCCCC-ccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 489 ISDFGMAKIFGVDQT-QGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 489 l~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|+|||+++....... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 227 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG 227 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCC
Confidence 999999986543221 122334567899999998865 6789999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=288.98 Aligned_cols=199 Identities=26% Similarity=0.439 Sum_probs=166.7
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 457999999999999999999964 78999999986432 23456789999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++++|.+++.. ...+++..+..++.||++||+|||+++ |+|+||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999853 346899999999999999999999987 99999999999999999999999999986543
Q ss_pred CCCccccccccccCCccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.. ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 213 (276)
T 2h6d_A 164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 22 1234568999999999987765 6899999999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=296.84 Aligned_cols=208 Identities=26% Similarity=0.421 Sum_probs=158.4
Q ss_pred HHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
....++|++.+.||+|+||.||++.. .+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 45567899999999999999999995 478899999986543 3345678899999999999999999999999999999
Q ss_pred EEEccCCCChhhhccCc-----CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 420 VYEFVPNKSLDYFLYEP-----EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
||||+++++|.+++... .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998531 12456899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCC---ccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 495 AKIFGVDQT---QGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 495 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+........ ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 229 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 876543221 112234578999999999876 5689999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.39 Aligned_cols=198 Identities=26% Similarity=0.425 Sum_probs=166.5
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--------ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--------GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE 415 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 415 (573)
.++|++.+.||+|+||.||+++. .+++.||||++.... ......+.+|+.++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 45799999999999999999985 468899999986432 122345889999999999999999999987655
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC---eEEecc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDF 492 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---vkl~Df 492 (573)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 8999999999999998853 457899999999999999999999987 999999999999987664 999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccc---cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|+++..... .......||+.|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 162 g~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (322)
T 2ycf_A 162 GHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221 (322)
T ss_dssp TTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred ccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 999865322 1223457899999999874 46789999999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=296.46 Aligned_cols=206 Identities=27% Similarity=0.367 Sum_probs=172.6
Q ss_pred HHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEE----cCCee
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL----EGEEK 417 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~ 417 (573)
...++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.+++.++||||+++++++. .....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 3456799999999999999999995 578999999987666666778999999999999999999999987 33477
Q ss_pred EEEEEccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 418 ILVYEFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
++||||+++++|.+++... .....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 8999999999999988542 23467999999999999999999999987 9999999999999999999999999987
Q ss_pred cccCCCCcc-------ccccccccCCccchhccccCC---CCccchhHHHHHHHHHHHhCCCCCC
Q 008238 497 IFGVDQTQG-------NTNRIVGTYGYMAPEYAMHGQ---FSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 497 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 543211110 112345799999999987554 6899999999999999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=290.88 Aligned_cols=206 Identities=27% Similarity=0.406 Sum_probs=171.4
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEc--CCeeEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKIL 419 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 419 (573)
.++|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 35789999999999999999996 478999999987543 3345678999999999999999999998754 567899
Q ss_pred EEEccCCCChhhhccCcC-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 420 VYEFVPNKSLDYFLYEPE-KQQQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986432 2345899999999999999999999865 1239999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 218 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 654322 112335789999999999999999999999999999999999999764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=288.04 Aligned_cols=200 Identities=29% Similarity=0.424 Sum_probs=173.5
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc---------cchHHHHHHHHHHHhcC-CCccceEEEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---------QGGQEFKNEVVLVAKLQ-HRNLVRLLGFCL 412 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 412 (573)
..++|++.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 346899999999999999999996 4688999999865431 22356788999999996 999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEecc
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df 492 (573)
..+..++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999853 357899999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccc------cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM------HGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|++....... ......|+..|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 9998654322 223457899999999885 45688999999999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=298.14 Aligned_cols=199 Identities=25% Similarity=0.392 Sum_probs=174.2
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccc-----------------hHHHHHHHHHHHhcCCCccceE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQG-----------------GQEFKNEVVLVAKLQHRNLVRL 407 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l 407 (573)
.++|++.+.||+|+||.||+++. +++.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46799999999999999999999 89999999986432111 1789999999999999999999
Q ss_pred EEEEEcCCeeEEEEEccCCCChhhh------ccCcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCEE
Q 008238 408 LGFCLEGEEKILVYEFVPNKSLDYF------LYEPEKQQQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNIL 480 (573)
Q Consensus 408 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlkp~NIL 480 (573)
++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||+|||+ ++ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 532 125679999999999999999999998 76 999999999999
Q ss_pred eCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccC-CCCc-cchhHHHHHHHHHHHhCCCCCCC
Q 008238 481 LDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-QFSV-KSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 481 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~DvwslGvll~elltG~~p~~~ 552 (573)
++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999865332 23345789999999999877 6666 99999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=302.98 Aligned_cols=199 Identities=18% Similarity=0.248 Sum_probs=170.0
Q ss_pred hCCCCcccccccccceeEEEEecCC---------CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccce---------
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPS---------GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVR--------- 406 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 406 (573)
.++|++.+.||+|+||.||+++... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4679999999999999999999653 789999998643 46789999999999999987
Q ss_pred ------EEEEEEc-CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCE
Q 008238 407 ------LLGFCLE-GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479 (573)
Q Consensus 407 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI 479 (573)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777766 67889999999 99999999642 2367999999999999999999999987 99999999999
Q ss_pred EeCCCC--CeEEeccCCcccccCCCCc-----cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 480 LLDAEM--NPKISDFGMAKIFGVDQTQ-----GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 480 Ll~~~~--~vkl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|++.++ .+||+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999866432211 122345799999999999999999999999999999999999999864
Q ss_pred C
Q 008238 553 Y 553 (573)
Q Consensus 553 ~ 553 (573)
.
T Consensus 271 ~ 271 (352)
T 2jii_A 271 C 271 (352)
T ss_dssp G
T ss_pred C
Confidence 3
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.21 Aligned_cols=200 Identities=25% Similarity=0.383 Sum_probs=164.6
Q ss_pred HHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcC------
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 414 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 414 (573)
+...++|++.+.||+|+||.||+++. .+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45567899999999999999999984 5789999999864432 234799999999999999999998543
Q ss_pred --------------------------------CeeEEEEEccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHH
Q 008238 415 --------------------------------EEKILVYEFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYL 461 (573)
Q Consensus 415 --------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yL 461 (573)
...++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 33789999998 4776666431 2346799999999999999999999
Q ss_pred HhCCCCCeEeecCCCCCEEeC-CCCCeEEeccCCcccccCCCCccccccccccCCccchhccccC-CCCccchhHHHHHH
Q 008238 462 HEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVL 539 (573)
Q Consensus 462 H~~~~~~ivH~Dlkp~NILl~-~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvl 539 (573)
|+++ |+||||||+|||++ +++.+||+|||+++...... ......||+.|+|||.+.+. .++.++||||||++
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9987 99999999999997 68899999999998664332 22345789999999998775 48999999999999
Q ss_pred HHHHHhCCCCCCC
Q 008238 540 VLEIITGKKNSSF 552 (573)
Q Consensus 540 l~elltG~~p~~~ 552 (573)
+|||++|+.||..
T Consensus 232 l~ell~g~~pf~~ 244 (383)
T 3eb0_A 232 FGELILGKPLFSG 244 (383)
T ss_dssp HHHHHHSSCSSCC
T ss_pred HHHHHhCCCCCCC
Confidence 9999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=295.60 Aligned_cols=201 Identities=31% Similarity=0.485 Sum_probs=168.7
Q ss_pred CCCCcccccccccceeEEEEecC-CCCe--eEEEEeccC-CccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQE--IAVKRLSRS-SGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 420 (573)
++|++.+.||+|+||.||+++.. ++.. +++|.+... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 46899999999999999999964 4554 499988653 334456789999999999 899999999999999999999
Q ss_pred EEccCCCChhhhccCcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCe
Q 008238 421 YEFVPNKSLDYFLYEPE-------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 487 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~v 487 (573)
|||+++++|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996532 2347899999999999999999999987 9999999999999999999
Q ss_pred EEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 488 KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 488 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
||+|||+++..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 244 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence 99999998743211 12223456889999999998889999999999999999998 9999753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=291.88 Aligned_cols=202 Identities=31% Similarity=0.477 Sum_probs=169.1
Q ss_pred HhCCCCccc-ccccccceeEEEEec---CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCee
Q 008238 344 ATNNFSTDN-KLGEGGFGEVYKGVL---PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 344 ~~~~~~~~~-~LG~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 417 (573)
..++|.+.+ .||+|+||.||++.+ ..++.||||++.... ....+++.+|+.+++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345678877 999999999999953 346789999987543 23356799999999999999999999998 56778
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+++++|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 999999999999999953 356899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCCcc-ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 498 FGVDQTQG-NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 498 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 223 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 64433211 1222346788999999998889999999999999999999 9999754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=295.19 Aligned_cols=206 Identities=29% Similarity=0.477 Sum_probs=169.4
Q ss_pred HHHHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEc----
Q 008238 340 TIEVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLE---- 413 (573)
Q Consensus 340 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~---- 413 (573)
.+....++|++.+.||+|+||.||+++. .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3344567899999999999999999995 578999999987543 3457789999999999 79999999999987
Q ss_pred --CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEec
Q 008238 414 --GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 491 (573)
Q Consensus 414 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~D 491 (573)
.+..++||||+++++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEee
Confidence 46789999999999999998643 2357899999999999999999999987 99999999999999999999999
Q ss_pred cCCcccccCCCCccccccccccCCccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 492 FGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 492 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
||++....... .......|++.|+|||.+. +..++.++||||||+++|||++|+.||..
T Consensus 173 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 173 FGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 99987653221 1223457899999999986 56789999999999999999999999753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.85 Aligned_cols=201 Identities=24% Similarity=0.315 Sum_probs=168.9
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcC--------CCccceEEEEEE--
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ--------HRNLVRLLGFCL-- 412 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~-- 412 (573)
..++|++.++||+|+||+||+++. .+++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 357899999999999999999984 56889999999743 334567889999999986 788999999987
Q ss_pred --cCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCEEeCCCC----
Q 008238 413 --EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEM---- 485 (573)
Q Consensus 413 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlkp~NILl~~~~---- 485 (573)
.....++||||+.++.+..++.. ....+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 55678999999955444444422 235699999999999999999999997 6 99999999999999775
Q ss_pred ---------------------------------------------CeEEeccCCcccccCCCCccccccccccCCccchh
Q 008238 486 ---------------------------------------------NPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520 (573)
Q Consensus 486 ---------------------------------------------~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 520 (573)
.+||+|||+++..... .....||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence 7999999999865422 23347899999999
Q ss_pred ccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 008238 521 YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQT 555 (573)
Q Consensus 521 ~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~ 555 (573)
++.+..++.++||||||+++|||++|+.||.....
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 99999999999999999999999999999875443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=302.73 Aligned_cols=198 Identities=23% Similarity=0.313 Sum_probs=170.0
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhc------CCCccceEEEEEEcCCe
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL------QHRNLVRLLGFCLEGEE 416 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~ 416 (573)
...+|++.++||+|+||+||++.. .+++.||||++... ....+.+.+|+.+++.+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 345799999999999999999985 46889999999743 23346678888888887 57799999999999999
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC--eEEeccCC
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN--PKISDFGM 494 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~--vkl~DfGl 494 (573)
.++||||+. ++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 6888887542 2345899999999999999999999987 999999999999999887 99999999
Q ss_pred cccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 975432 22345789999999999999999999999999999999999999754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.24 Aligned_cols=207 Identities=24% Similarity=0.314 Sum_probs=159.6
Q ss_pred hHHHHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe-
Q 008238 339 ETIEVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE- 416 (573)
Q Consensus 339 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~- 416 (573)
.......++|++.+.||+|+||.||+++. .+++.||||++.... .....+.+|+..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34456677999999999999999999996 468999999986543 334456788889999999999999999876433
Q ss_pred ------eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeecCCCCCEEeCC-CCCe
Q 008238 417 ------KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLH--EDSRLRIIHRDLKASNILLDA-EMNP 487 (573)
Q Consensus 417 ------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--~~~~~~ivH~Dlkp~NILl~~-~~~v 487 (573)
.++||||++++.+..+.........+++..+..++.||+.||.||| +++ |+||||||+|||++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999987544333322234567899999999999999999999 766 999999999999996 8999
Q ss_pred EEeccCCcccccCCCCccccccccccCCccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 488 KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 488 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
||+|||+++...... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 234 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234 (360)
T ss_dssp EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence 999999998664332 223457899999999986654 89999999999999999999999854
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=292.96 Aligned_cols=203 Identities=29% Similarity=0.381 Sum_probs=158.6
Q ss_pred HHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCcc--chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQ--GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
...++|++.++||+|+||+||+++. .+++.||||++...... ..+.+.++...++.++||||+++++++.+.+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 3456799999999999999999995 57899999999754322 22334556666888899999999999999999999
Q ss_pred EEEccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 420 VYEFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
||||+++ +|.+++... .....+++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+++.
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999984 777766431 2346799999999999999999999997 6 99999999999999999999999999986
Q ss_pred ccCCCCccccccccccCCccchhcc----ccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYA----MHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
..... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 160 LVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 54322 22234689999999996 556789999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=300.54 Aligned_cols=198 Identities=31% Similarity=0.491 Sum_probs=158.9
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHH--HHhcCCCccceEEEEEEc-----CCee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVL--VAKLQHRNLVRLLGFCLE-----GEEK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~~~ 417 (573)
.++|++.++||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 45799999999999999999987 78999999986432 3344444444 455899999999986542 2356
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEeecCCCCCEEeCCCCCeEEec
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS------RLRIIHRDLKASNILLDAEMNPKISD 491 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~------~~~ivH~Dlkp~NILl~~~~~vkl~D 491 (573)
++||||+++|+|.+++. ....++..++.++.||++||+|||+.. +++|+||||||+|||++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLS----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHh----hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 89999999999999994 344589999999999999999999880 11399999999999999999999999
Q ss_pred cCCcccccCCCC------ccccccccccCCccchhcccc-------CCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 492 FGMAKIFGVDQT------QGNTNRIVGTYGYMAPEYAMH-------GQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 492 fGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
||+++.+..... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 999987643221 112234579999999999876 35667899999999999999998775
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.67 Aligned_cols=194 Identities=32% Similarity=0.483 Sum_probs=163.0
Q ss_pred cccccccceeEEEEec---CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVL---PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
++||+|+||.||+|.+ ..++.||||+++... ....+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999964 346789999997543 2345789999999999999999999999864 568899999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc-c
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ-G 505 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~-~ 505 (573)
|+|.+++. ....+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999995 3457899999999999999999999987 999999999999999999999999999876443321 1
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
......+|..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 575 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 575 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2223456788999999999999999999999999999998 9999853
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=293.71 Aligned_cols=199 Identities=27% Similarity=0.390 Sum_probs=168.8
Q ss_pred chhHHHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHh--cCCCccceEEEEEEcC
Q 008238 337 DFETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAK--LQHRNLVRLLGFCLEG 414 (573)
Q Consensus 337 ~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~ 414 (573)
.....+...++|++.+.||+|+||.||+++. +++.||||++... ....+.+|.+++.. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3344456677899999999999999999998 5899999998643 34667888998888 7899999999999887
Q ss_pred C----eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeecCCCCCEEeC
Q 008238 415 E----EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLH--------EDSRLRIIHRDLKASNILLD 482 (573)
Q Consensus 415 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~ivH~Dlkp~NILl~ 482 (573)
. ..++||||+++|+|.+++. ...+++..++.++.||+.||+||| +.+ |+||||||+|||++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVK 181 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEEC
T ss_pred CCccceeEEEEeecCCCcHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEEC
Confidence 6 7899999999999999994 346899999999999999999999 655 99999999999999
Q ss_pred CCCCeEEeccCCcccccCCCCcc--ccccccccCCccchhccccCC------CCccchhHHHHHHHHHHHhC
Q 008238 483 AEMNPKISDFGMAKIFGVDQTQG--NTNRIVGTYGYMAPEYAMHGQ------FSVKSDVYSFGVLVLEIITG 546 (573)
Q Consensus 483 ~~~~vkl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~s~~~DvwslGvll~elltG 546 (573)
.++++||+|||+++......... ......||+.|+|||.+.+.. ++.++||||||+++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 99999999999998664433211 223457899999999987653 34789999999999999999
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.07 Aligned_cols=200 Identities=26% Similarity=0.435 Sum_probs=152.9
Q ss_pred CCCc-ccccccccceeEEEEecC---CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEc--CCeeEEE
Q 008238 347 NFST-DNKLGEGGFGEVYKGVLP---SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILV 420 (573)
Q Consensus 347 ~~~~-~~~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 420 (573)
.|++ .++||+|+||+||+++.. +++.||||++.... ....+.+|+.++++++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 4655 558999999999999954 57889999997543 33578899999999999999999999954 6788999
Q ss_pred EEccCCCChhhhccCc------CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe----CCCCCeEEe
Q 008238 421 YEFVPNKSLDYFLYEP------EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DAEMNPKIS 490 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl----~~~~~vkl~ 490 (573)
|||+++ +|.+++... .....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 666666321 12235899999999999999999999987 9999999999999 778899999
Q ss_pred ccCCcccccCCCC-ccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 491 DFGMAKIFGVDQT-QGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 491 DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9999987643221 1223456889999999999874 589999999999999999999999854
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=289.42 Aligned_cols=196 Identities=31% Similarity=0.465 Sum_probs=163.7
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcC-CeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG-EEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 423 (573)
.++|++.+.||+|+||.||+++. .++.||||+++.. ...+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 45789999999999999999987 5889999998743 3457789999999999999999999997655 468999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++++|.+++... ....+++..++.++.|+++||+|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999998542 1234789999999999999999999987 999999999999999999999999998754322
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 217 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 122356889999999999999999999999999999998 9999764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=294.26 Aligned_cols=205 Identities=27% Similarity=0.399 Sum_probs=168.7
Q ss_pred HHHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcC--CCccceEEEEEEcCC
Q 008238 340 TIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQ--HRNLVRLLGFCLEGE 415 (573)
Q Consensus 340 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~ 415 (573)
.+....++|++.+.||+|+||.||+++..+++.||||++.... ....+.+.+|+.++.+++ ||||+++++++...+
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 3345567799999999999999999998889999999986543 334567899999999997 599999999999999
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
..++||| +.+++|.+++.. ...+++..++.++.||++||.|||+++ |+||||||+|||+++ +.+||+|||++
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccc
Confidence 9999999 678899999853 357899999999999999999999987 999999999999965 89999999999
Q ss_pred ccccCCCCccccccccccCCccchhcccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMH-----------GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+...............|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 87654333323344578999999999865 4688899999999999999999999853
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=295.02 Aligned_cols=200 Identities=25% Similarity=0.402 Sum_probs=168.5
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcC-----Cee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EEK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 417 (573)
.++|++.+.||+|+||.||+++.. +|+.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467999999999999999999964 68899999997543 23346788999999999999999999988754 678
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||++ ++|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIS----TQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 58888884 356899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCCcc--------ccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 498 FGVDQTQG--------NTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 498 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 64322111 1223578999999998765 6789999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=302.03 Aligned_cols=197 Identities=10% Similarity=0.093 Sum_probs=151.6
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc---cchHHHHHHHHHHHhc--CCCccceEE-------EEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKL--QHRNLVRLL-------GFCL 412 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~~ 412 (573)
.+|++.++||+|+||.||++++ .+++.||||++..... ...+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4588999999999999999995 4788999999986543 2345677885555544 699988755 4444
Q ss_pred cC-----------------CeeEEEEEccCCCChhhhccCcCccCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCe
Q 008238 413 EG-----------------EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRR------YKIIGGIARGILYLHEDSRLRI 469 (573)
Q Consensus 413 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~~L~yLH~~~~~~i 469 (573)
.. ...++||||++ |+|.+++... ...+++..+ +.++.||++||+|||+++ |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 32 33799999999 8999999643 223455555 778899999999999987 9
Q ss_pred EeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhcccc--CCCCccchhHHHHHHHHHHHhCC
Q 008238 470 IHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGK 547 (573)
Q Consensus 470 vH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslGvll~elltG~ 547 (573)
+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999865321 113456799999999987 67999999999999999999999
Q ss_pred CCCCCC
Q 008238 548 KNSSFY 553 (573)
Q Consensus 548 ~p~~~~ 553 (573)
.||...
T Consensus 291 ~Pf~~~ 296 (371)
T 3q60_A 291 LPFGLV 296 (371)
T ss_dssp CSTTBC
T ss_pred CCCCCc
Confidence 998644
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=296.30 Aligned_cols=194 Identities=26% Similarity=0.450 Sum_probs=165.7
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCee----
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK---- 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 417 (573)
.++|.+.+.||+|+||.||+++. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 45799999999999999999985 468999999997543 23356788999999999999999999999887655
Q ss_pred --EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 418 --ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 418 --~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 67877772 34899999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 865322 234578999999999877 6789999999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=290.47 Aligned_cols=201 Identities=27% Similarity=0.463 Sum_probs=169.3
Q ss_pred HhCCCCcccccccccceeEEEEec--CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhc---CCCccceEEEEEE----
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKL---QHRNLVRLLGFCL---- 412 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 412 (573)
..++|++.+.||+|+||.||+++. .+++.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346799999999999999999996 467889999986432 22234567788777766 8999999999987
Q ss_pred -cCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEec
Q 008238 413 -EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 491 (573)
Q Consensus 413 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~D 491 (573)
.....++||||++ |+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 69988885422 345899999999999999999999987 99999999999999999999999
Q ss_pred cCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 492 FGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 492 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
||+++...... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 99997653221 23345789999999999999999999999999999999999999853
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=290.98 Aligned_cols=199 Identities=25% Similarity=0.366 Sum_probs=171.7
Q ss_pred HhCCCCcccccccccceeEEEEec--CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCc------cceEEEEEEcCC
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL--PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN------LVRLLGFCLEGE 415 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~ 415 (573)
..++|++.+.||+|+||.||++.. .+++.||||+++.. ....+.+.+|+.+++.++|++ ++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 356899999999999999999985 36889999998743 334567889999999987765 999999999999
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC------------
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA------------ 483 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~------------ 483 (573)
..++||||+ +++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 999999999 88998888542 2246899999999999999999999987 999999999999987
Q ss_pred -------CCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 484 -------EMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 484 -------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
++.+||+|||+++.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 67899999999976432 123457899999999999999999999999999999999999998643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=288.05 Aligned_cols=202 Identities=32% Similarity=0.429 Sum_probs=162.5
Q ss_pred hCCCCcccccccccceeEEEEecC--CCC--eeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP--SGQ--EIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 417 (573)
.++|++.++||+|+||+||++++. +++ .||||+++.. .....+.+.+|+.++++++||||+++++++...+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457999999999999999999853 333 5899998754 2344577899999999999999999999988755 8
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998542 346899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCCc-cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 498 FGVDQTQ-GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 498 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 6433221 12233457888999999998889999999999999999999 9999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=291.88 Aligned_cols=194 Identities=26% Similarity=0.447 Sum_probs=165.2
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe-----
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE----- 416 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 416 (573)
.++|.+.+.||+|+||.||+++. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35799999999999999999995 478999999997543 2334678899999999999999999999987654
Q ss_pred -eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 417 -KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 417 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
.++||||++ ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 58877773 34899999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 764322 233578999999999877 6789999999999999999999999853
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=282.22 Aligned_cols=201 Identities=30% Similarity=0.448 Sum_probs=173.0
Q ss_pred HHHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
....++|++.++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344568999999999999999999964 78999999986532 345678899999999999999999999999999999
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC---CCeEEeccCCc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE---MNPKISDFGMA 495 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~---~~vkl~DfGla 495 (573)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||+++ ++||||||+|||++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999888743 346899999999999999999999987 9999999999999754 46999999999
Q ss_pred ccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
....... ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||..
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (287)
T 2wei_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG 224 (287)
T ss_dssp GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence 8654322 2223468899999998765 589999999999999999999999753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=290.27 Aligned_cols=200 Identities=25% Similarity=0.419 Sum_probs=171.8
Q ss_pred HHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCcc------chHHHHHHHHHHHhcC--CCccceEEEEEE
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQ------GGQEFKNEVVLVAKLQ--HRNLVRLLGFCL 412 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~ 412 (573)
+...++|++.+.||+|+||.||+++. .+++.||||++...... ..+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999984 57889999998754321 2345778999999996 599999999999
Q ss_pred cCCeeEEEEEccCC-CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC-CCCCeEEe
Q 008238 413 EGEEKILVYEFVPN-KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKIS 490 (573)
Q Consensus 413 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~vkl~ 490 (573)
..+..++|||++.+ ++|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 899999853 457899999999999999999999987 99999999999999 78899999
Q ss_pred ccCCcccccCCCCccccccccccCCccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCC
Q 008238 491 DFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 491 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslGvll~elltG~~p~~ 551 (573)
|||+++..... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.
T Consensus 193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 250 (320)
T 3a99_A 193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250 (320)
T ss_dssp CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence 99999866432 2234568999999999987776 688999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=288.51 Aligned_cols=199 Identities=27% Similarity=0.437 Sum_probs=163.6
Q ss_pred HHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCcc------chHHHHHHHHHHHhc----CCCccceEEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQ------GGQEFKNEVVLVAKL----QHRNLVRLLGFC 411 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~l~~~~ 411 (573)
...++|++.+.||+|+||.||+++. .+++.||||++...... ....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 4456799999999999999999985 57889999999754321 233456799999998 899999999999
Q ss_pred EcCCeeEEEEEc-cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC-CCCCeEE
Q 008238 412 LEGEEKILVYEF-VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKI 489 (573)
Q Consensus 412 ~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~vkl 489 (573)
...+..++|||+ +.+++|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++ .++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999 789999999853 346899999999999999999999987 99999999999999 8899999
Q ss_pred eccCCcccccCCCCccccccccccCCccchhccccCCCC-ccchhHHHHHHHHHHHhCCCCCC
Q 008238 490 SDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFS-VKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 490 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwslGvll~elltG~~p~~ 551 (573)
+|||+++...... .....|+..|+|||.+.+..+. .++||||||+++|||++|+.||.
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 9999998764322 2345689999999999877764 58999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=291.36 Aligned_cols=206 Identities=26% Similarity=0.434 Sum_probs=169.3
Q ss_pred hHHHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe
Q 008238 339 ETIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 416 (573)
Q Consensus 339 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 416 (573)
..++...++|++.+.||+|+||.||+|+..+ .+|+|+++... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3444556789999999999999999998743 59999986542 3334567889999999999999999999999999
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++||||+++++|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++ ++.+||+|||+++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred eEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 9999999999999999954 2346899999999999999999999987 99999999999998 6799999999987
Q ss_pred cccCCCC---ccccccccccCCccchhcccc---------CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 497 IFGVDQT---QGNTNRIVGTYGYMAPEYAMH---------GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 497 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
....... ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 245 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5432211 122234468999999999864 4578999999999999999999999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=283.42 Aligned_cols=196 Identities=29% Similarity=0.460 Sum_probs=161.0
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEc----------
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE---------- 413 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------- 413 (573)
.++|++.+.||+|+||.||+++. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 35689999999999999999995 47899999998643 3345678899999999999999999998865
Q ss_pred ---CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEe
Q 008238 414 ---GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 490 (573)
Q Consensus 414 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~ 490 (573)
.+..++||||+++++|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3467899999999999999964 2345788999999999999999999987 9999999999999999999999
Q ss_pred ccCCcccccCCCC------------ccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhC
Q 008238 491 DFGMAKIFGVDQT------------QGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITG 546 (573)
Q Consensus 491 DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG 546 (573)
|||+++....... ........|+..|+|||.+.+. .++.++||||||+++|||+++
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p 227 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc
Confidence 9999986542210 1122345789999999998764 689999999999999999983
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=289.53 Aligned_cols=202 Identities=25% Similarity=0.339 Sum_probs=169.8
Q ss_pred HHHhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-CC-----ccceEEEEEEcC
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HR-----NLVRLLGFCLEG 414 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~ 414 (573)
+...++|++.++||+|+||+||+|+. .+++.||||+++.. .....++.+|+.+++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34457899999999999999999985 46788999999743 234566788999988885 44 499999999999
Q ss_pred CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC--CCCCeEEecc
Q 008238 415 EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEMNPKISDF 492 (573)
Q Consensus 415 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~~vkl~Df 492 (573)
+..++||||++ ++|.+++... ....+++..+..++.||+.||.|||.+. .+|+||||||+|||++ .++.+||+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999996 5898888542 2245899999999999999999999631 3599999999999994 5788999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999865422 2345789999999999999999999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=286.65 Aligned_cols=201 Identities=28% Similarity=0.406 Sum_probs=150.0
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc-cchHHHHHHHH-HHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG-QGGQEFKNEVV-LVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
.++|++.+.||+|+||.||++.. .+++.||||++..... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 46789999999999999999996 4788999999975432 23344555555 777789999999999999999999999
Q ss_pred EccCCCChhhhccC--cCccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 422 EFVPNKSLDYFLYE--PEKQQQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 422 e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 77666632 11246789999999999999999999997 6 999999999999999999999999999765
Q ss_pred cCCCCccccccccccCCccchhcc----ccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYA----MHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||..
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 4322 12234689999999998 456789999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=287.41 Aligned_cols=197 Identities=23% Similarity=0.360 Sum_probs=167.4
Q ss_pred hCCCCcccccccccceeEEEEecC-CC-CeeEEEEeccCCccchHHHHHHHHHHHhcCCCc------cceEEEEEEcCCe
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SG-QEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN------LVRLLGFCLEGEE 416 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~ 416 (573)
.++|++.+.||+|+||+||++... ++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999853 34 68999998743 344567888999999998766 8999999999999
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEe---------------
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL--------------- 481 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl--------------- 481 (573)
.++||||+ +++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 55555555332 2346899999999999999999999987 9999999999999
Q ss_pred ----CCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 482 ----DAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 482 ----~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 56789999999999764322 2345789999999999999999999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=311.82 Aligned_cols=204 Identities=25% Similarity=0.404 Sum_probs=169.3
Q ss_pred HHHhCCCCcccccccccceeEEEEecCC----CCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE 416 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 416 (573)
+...++|++.+.||+|+||.||+|.+.. +..||||++.... ....+.+.+|+.++++++||||+++++++. .+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3445678999999999999999998632 4568999987543 333467899999999999999999999985 456
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++||||+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 8999999999999999954 2346899999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 540 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 595 (656)
T 2j0j_A 540 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 6543221 12233456789999999999999999999999999999997 8888753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.52 Aligned_cols=201 Identities=30% Similarity=0.476 Sum_probs=173.2
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccC-CccchHHHHHHHHHHHhcCCCccceEEEEEEc------CCe
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE------GEE 416 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 416 (573)
.++|++.++||+|+||.||++.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36799999999999999999996 46899999998754 33445678999999999999999999998765 667
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCC---eEEeccC
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMN---PKISDFG 493 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---vkl~DfG 493 (573)
.++||||+++|+|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7999999999999999976555557999999999999999999999987 999999999999997765 9999999
Q ss_pred CcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+++...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~ 224 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 998664332 2234578999999999999999999999999999999999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=290.54 Aligned_cols=198 Identities=21% Similarity=0.336 Sum_probs=167.4
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-----------CCccceEEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-----------HRNLVRLLGFCL 412 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~ 412 (573)
.++|++.++||+|+||+||+++. .+++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 45799999999999999999995 57889999998743 234567888999999886 899999999988
Q ss_pred cCC----eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCEEeC-----
Q 008238 413 EGE----EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLD----- 482 (573)
Q Consensus 413 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlkp~NILl~----- 482 (573)
..+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 678999999 89999988542 234589999999999999999999997 7 99999999999994
Q ss_pred -CCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 483 -AEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 483 -~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
..+.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 4458999999999865422 23347899999999999999999999999999999999999998643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.05 Aligned_cols=199 Identities=27% Similarity=0.316 Sum_probs=155.4
Q ss_pred CCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEEEccC
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
.|.+.+.||+|+||+||.....+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+.+..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 45567889999999998766568999999998643 245678899999886 89999999999999999999999996
Q ss_pred CCChhhhccCcCccC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC-------------CCeE
Q 008238 426 NKSLDYFLYEPEKQQ----QLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-------------MNPK 488 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-------------~~vk 488 (573)
|+|.+++....... ..++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999986532211 1133346789999999999999987 9999999999999654 4899
Q ss_pred EeccCCcccccCCCCcc--ccccccccCCccchhcccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 008238 489 ISDFGMAKIFGVDQTQG--NTNRIVGTYGYMAPEYAMH-------GQFSVKSDVYSFGVLVLEIIT-GKKNSSF 552 (573)
Q Consensus 489 l~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwslGvll~ellt-G~~p~~~ 552 (573)
|+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||..
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 99999998765432211 2234579999999999865 578999999999999999999 8999853
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=285.79 Aligned_cols=196 Identities=23% Similarity=0.283 Sum_probs=145.8
Q ss_pred hCCCCccc-ccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEc----CCeeE
Q 008238 345 TNNFSTDN-KLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKI 418 (573)
Q Consensus 345 ~~~~~~~~-~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 418 (573)
.++|.+.+ .||+|+||+||+++.. +++.||||++... .....+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 45688855 6999999999999964 7899999998643 1222333445677799999999999876 44578
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC---CCCeEEeccCCc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMA 495 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGla 495 (573)
+||||+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999999653 2347999999999999999999999987 999999999999976 455999999999
Q ss_pred ccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (336)
T 3fhr_A 179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 231 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 865322 22345789999999999888899999999999999999999999853
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=295.43 Aligned_cols=191 Identities=17% Similarity=0.188 Sum_probs=160.7
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCC--------ccchHHHHHHHHHHHhcC---------CCccceE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS--------GQGGQEFKNEVVLVAKLQ---------HRNLVRL 407 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l 407 (573)
.++|++.++||+|+||+||+++. +|+.||||++.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45688999999999999999998 78999999997542 223477899999999886 7888877
Q ss_pred EEEEE------------------------------cCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHH
Q 008238 408 LGFCL------------------------------EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARG 457 (573)
Q Consensus 408 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~ 457 (573)
.+++. ..+..++||||+++|++.+.+. ...+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 77643 2678899999999997666663 2568999999999999999
Q ss_pred HHHHH-hCCCCCeEeecCCCCCEEeCCCC--------------------CeEEeccCCcccccCCCCccccccccccCCc
Q 008238 458 ILYLH-EDSRLRIIHRDLKASNILLDAEM--------------------NPKISDFGMAKIFGVDQTQGNTNRIVGTYGY 516 (573)
Q Consensus 458 L~yLH-~~~~~~ivH~Dlkp~NILl~~~~--------------------~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y 516 (573)
|+||| +++ |+||||||+|||++.++ .+||+|||+++.... ...+||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence 99999 887 99999999999999887 899999999986542 134799999
Q ss_pred cchhccccCCCCccchhHHHHHH-HHHHHhCCCCCC
Q 008238 517 MAPEYAMHGQFSVKSDVYSFGVL-VLEIITGKKNSS 551 (573)
Q Consensus 517 ~aPE~~~~~~~s~~~DvwslGvl-l~elltG~~p~~ 551 (573)
+|||++.+.. +.++|||||+++ .+++++|..|+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 9999998666 899999998776 788899999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=313.74 Aligned_cols=192 Identities=23% Similarity=0.381 Sum_probs=164.9
Q ss_pred HhCCCCcccccccccceeEEEEecC--CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCe----
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLP--SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEE---- 416 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 416 (573)
..++|++.++||+|+||+||++++. +++.||||++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3468999999999999999999964 68899999986543 3345678899999999999999999999987655
Q ss_pred -eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 417 -KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 417 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
.++||||+++++|.+++.. .+++.+++.++.||++||+|||+++ |+||||||+|||++++ .+||+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999887732 6899999999999999999999987 9999999999999986 8999999999
Q ss_pred ccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+..... ....||+.|+|||++.+.. +.++||||||+++|||++|..|+.
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~ 277 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN 277 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEET
T ss_pred hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCc
Confidence 865422 3457999999999987654 899999999999999999998865
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-33 Score=280.09 Aligned_cols=199 Identities=27% Similarity=0.430 Sum_probs=150.7
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCcc-c-hHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQ-G-GQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
.++|++.+.||+|+||.||+++.. +++.||||++...... . .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356889999999999999999964 7899999999754322 2 233455566788889999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
||+ ++.+..+... ....+++..+..++.||++||+|||++ + |+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4555555432 245789999999999999999999985 6 99999999999999999999999999976543
Q ss_pred CCCccccccccccCCccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.. ......|++.|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 22 223456899999999984 45688999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=294.01 Aligned_cols=199 Identities=24% Similarity=0.365 Sum_probs=157.3
Q ss_pred HhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 422 (573)
...+|++.+.||+|+||+|+.....+++.||||++..... ..+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3446888999999999996554445889999999865432 3457899999999 79999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC-----CCCeEEeccCCccc
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----EMNPKISDFGMAKI 497 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~vkl~DfGla~~ 497 (573)
|++ |+|.+++.... ..+.+..++.++.||++||+|||+++ |+||||||+|||++. ...+||+|||+++.
T Consensus 99 ~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 996 58988886532 23445567789999999999999987 999999999999953 33688999999987
Q ss_pred ccCCCC-ccccccccccCCccchhccc---cCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 498 FGVDQT-QGNTNRIVGTYGYMAPEYAM---HGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 498 ~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
...... ........||+.|+|||++. ...++.++|||||||++|||++ |+.||.
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 643321 12234467999999999997 4567889999999999999999 888874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=266.78 Aligned_cols=171 Identities=9% Similarity=0.060 Sum_probs=149.4
Q ss_pred hCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
.++|++.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357999999999999999999964 589999999975533 2346789999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++++|.+++.. . ....++.+++.||+.||+|||+++ |+||||||+|||+++++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999842 2 355678899999999999999987 9999999999999999999998443
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|++ .++.++||||||+++|||++|+.||..
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~ 204 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPE 204 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCC
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 333 368899999999999999999999864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-32 Score=283.65 Aligned_cols=197 Identities=16% Similarity=0.213 Sum_probs=152.7
Q ss_pred CCCCcccccccccceeEEEEe-cCCCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCC-Ccc---------ceEE---
Q 008238 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQH-RNL---------VRLL--- 408 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~ni---------v~l~--- 408 (573)
.+|...+.||+|+||.||+|+ ..+|+.||||++..... ...+.+++|+.+++.++| +|. +...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 457788999999999999999 45799999999874332 335778999999999987 221 1111
Q ss_pred ---------EEEEc-----CCeeEEEEEccCCCChhhhccC----cCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 008238 409 ---------GFCLE-----GEEKILVYEFVPNKSLDYFLYE----PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRII 470 (573)
Q Consensus 409 ---------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iv 470 (573)
.+... ....+++|+++ +++|.+++.. ......+++..++.++.||++||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 11111 12345666654 6889888841 122446788899999999999999999987 99
Q ss_pred eecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhcc----------ccCCCCccchhHHHHHHH
Q 008238 471 HRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA----------MHGQFSVKSDVYSFGVLV 540 (573)
Q Consensus 471 H~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~DvwslGvll 540 (573)
||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999998864322 334577 999999999 555688899999999999
Q ss_pred HHHHhCCCCCCC
Q 008238 541 LEIITGKKNSSF 552 (573)
Q Consensus 541 ~elltG~~p~~~ 552 (573)
|||++|+.||..
T Consensus 308 ~elltg~~Pf~~ 319 (413)
T 3dzo_A 308 YWIWCADLPNTD 319 (413)
T ss_dssp HHHHHSSCCCCT
T ss_pred HHHHHCCCCCCC
Confidence 999999999864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=261.29 Aligned_cols=173 Identities=24% Similarity=0.340 Sum_probs=148.9
Q ss_pred CCCCcc-cccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHH-HhcCCCccceEEEEEEc----CCeeE
Q 008238 346 NNFSTD-NKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLV-AKLQHRNLVRLLGFCLE----GEEKI 418 (573)
Q Consensus 346 ~~~~~~-~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~ 418 (573)
++|.+. +.||+|+||.||++.. .+++.||||+++. ...+.+|+.++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 356666 7799999999999995 5789999999863 24567888888 55689999999999876 66789
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC---CCCeEEeccCCc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMA 495 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGla 495 (573)
+||||+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999998642 2346999999999999999999999987 999999999999998 789999999998
Q ss_pred ccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.... +..++.++||||||+++|||++|+.||.
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~ 199 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFY 199 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 6432 2346778999999999999999999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=277.79 Aligned_cols=184 Identities=18% Similarity=0.183 Sum_probs=129.5
Q ss_pred ccccccceeEEEEe-cCCCCeeEEEEeccCC----------ccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEE
Q 008238 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSS----------GQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 353 ~LG~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 420 (573)
..+.|+.|.+..++ .--|+.+++|.+.+.. ....++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 44566666555544 3358899999986542 12335799999999999 699999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||++|++|.+.|.. ..+++.. +|+.||+.||+|||+++ ||||||||+||||++++++||+|||+++....
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999954 3456654 48899999999999998 99999999999999999999999999986643
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~ 548 (573)
.. ......+||+.|||||++.+ .+..++|+|++|++++++.+|..
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 32 23345789999999998865 56778999999999887766543
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-28 Score=201.05 Aligned_cols=105 Identities=17% Similarity=0.443 Sum_probs=95.6
Q ss_pred CCcccccCC-CccccCCChHHHHHHHHHHhcccccCCCCCCCCCceeeccCC-CCceeeEEEeccCCCCccchHHHHHHH
Q 008238 34 DPTYAYHVC-SANFTGNSTYQTNRNLLLSSLPTNASRGNGYSSGFYNETTGQ-DPNKVYGLFLCRGDQTASSCQDCVTFA 111 (573)
Q Consensus 34 ~~~~~~~~C-~~~~~~~s~~~~~l~~ll~~l~~~~~~~~~~~~~f~~~~~g~-~~~~vyg~~~Cr~D~~~~~C~~Cl~~a 111 (573)
++.++++.| .++|+++++|++||+.||++|+++++. .+.+|+++..|. ++++||||+|||||+++++|..||+.|
T Consensus 2 ~t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~---s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a 78 (108)
T 3a2e_A 2 NTAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAF---SGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNL 78 (108)
T ss_dssp CCCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGG---TTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHH
T ss_pred CcceeeeecCCCccCCCChHHHHHHHHHHHHHhhCcc---ccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHH
Confidence 467889999 689999999999999999999999873 345677777664 568999999999999999999999999
Q ss_pred HHHHHHhCCCCcceEEEcceeEEEEcCCcc
Q 008238 112 TRDLVQRCPDGKQTIIWYDQCLLRYSNRSI 141 (573)
Q Consensus 112 ~~~~~~~C~~~~~~~~~~~~C~~ry~~~~f 141 (573)
+.++.+.||++++|+||++.|+||||+++|
T Consensus 79 ~~~~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 79 VNRIFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HTTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 999999999999999999999999999998
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=258.56 Aligned_cols=185 Identities=16% Similarity=0.224 Sum_probs=146.1
Q ss_pred CcccccccccceeEEEEecCCCCeeEEEEeccCCcc--------chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 349 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQ--------GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 349 ~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
...+.||+|+||.||++.. .++.+++|+....... ..+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999965 6788899986432211 134578999999999999999766666677888999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++++|.+++.. ++.++.||+++|+|||+++ |+||||||+|||+++ ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999943 5689999999999999987 999999999999999 999999999987643
Q ss_pred CCCcc-----ccccccccCCccchhcccc--CCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 501 DQTQG-----NTNRIVGTYGYMAPEYAMH--GQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 501 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
..... ......||+.|||||++.. ..|+...|+|+..+-..+.+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 22111 1235689999999999976 56788899999999999999888775
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=181.69 Aligned_cols=106 Identities=26% Similarity=0.480 Sum_probs=97.8
Q ss_pred CcceEEEeecccCCchhhHHHHHHHHHHHHHHHHhcCCccceeeeecccccccEEEEEeecCCCCccchHHHHHHHHhhc
Q 008238 147 TVPYVSLLNTQNVTDRGRFNQILASLMSQVVNQAVNNSRKFATRTANFTALQTLYSLAQCTPDLSSSDCNVCLQAAIAEL 226 (573)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~f~~~~~~ll~~l~~~a~~~~~~~a~~~~~~~~~~~vy~l~qC~~Dls~~~C~~Cl~~a~~~~ 226 (573)
+......||.+++++++.|+++|+.||+.|+.+|+.++.+|+++..+..+.++||||+||+||+++.+|..||+.|..++
T Consensus 3 t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~ 82 (108)
T 3a2e_A 3 TAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRI 82 (108)
T ss_dssp CCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred cceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence 44566789999999999999999999999999998877788887776667889999999999999999999999999999
Q ss_pred CcCCCCCcCcEEEccccceeeecCcc
Q 008238 227 PNCCSGKTGAQVLIPSCIVRYEFYPF 252 (573)
Q Consensus 227 ~~~c~~~~g~~~~~~~C~lry~~~~f 252 (573)
+++|++++||++|+++|++|||+++|
T Consensus 83 ~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 83 FSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHCCCCceEEEECCCEEEEEeCCcC
Confidence 99999999999999999999999987
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.8e-24 Score=209.94 Aligned_cols=150 Identities=19% Similarity=0.114 Sum_probs=120.0
Q ss_pred HHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCc------------------cchHHHHHHHHHHHhcCCC
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSG------------------QGGQEFKNEVVLVAKLQHR 402 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~ 402 (573)
+......|++.+.||+|+||.||+|++.+|+.||||.++.... .....+.+|+.++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3344556778899999999999999997799999999864321 12456889999999999
Q ss_pred ccceEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC
Q 008238 403 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 482 (573)
Q Consensus 403 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~ 482 (573)
| +++.+++.. +..++||||+++++|.+ +.. .....++.||++||.|||+++ |+||||||+|||++
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 4 556554433 56699999999999988 421 224579999999999999987 99999999999999
Q ss_pred CCCCeEEeccCCcccccCCCCccccccccccCCccchhccc
Q 008238 483 AEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM 523 (573)
Q Consensus 483 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 523 (573)
++.+||+|||+++. +..++|||++.
T Consensus 228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp -TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred -CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99999999999863 33578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=178.14 Aligned_cols=137 Identities=18% Similarity=0.167 Sum_probs=106.5
Q ss_pred CCCcccccccccceeEEEEec-CCCCe--eEEEEeccCCccc------------------------hHHHHHHHHHHHhc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQE--IAVKRLSRSSGQG------------------------GQEFKNEVVLVAKL 399 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~~------------------------~~~~~~e~~~l~~l 399 (573)
-|++.+.||+|+||.||+|.. .+|+. ||||+++...... ...+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999997 68888 9999875432110 13578899999999
Q ss_pred CCCcc--ceEEEEEEcCCeeEEEEEccCC-C----ChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEe
Q 008238 400 QHRNL--VRLLGFCLEGEEKILVYEFVPN-K----SLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLH-EDSRLRIIH 471 (573)
Q Consensus 400 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH-~~~~~~ivH 471 (573)
+|+++ +.++.. +..+|||||+.+ | +|.++... .++..+..++.||+.+|.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 98864 444443 356899999942 4 56555421 224467789999999999999 877 999
Q ss_pred ecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 472 RDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 472 ~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
|||||+|||+++ .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-17 Score=170.59 Aligned_cols=136 Identities=16% Similarity=0.189 Sum_probs=99.8
Q ss_pred CCCcccccccccceeEEEEecCCCCeeEEEEeccCCcc--------------chHH--------HHHHHHHHHhcCCCcc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQ--------------GGQE--------FKNEVVLVAKLQHRNL 404 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------~~~~--------~~~e~~~l~~l~h~ni 404 (573)
-|++.++||+|++|.||+|...+|+.||||+++..... .... ...|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 48999999999999999999889999999987532100 0111 1235556666654443
Q ss_pred c--eEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC
Q 008238 405 V--RLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 482 (573)
Q Consensus 405 v--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~ 482 (573)
. ..++. ...+|||||+++++|..+... .....++.||+.+|.|||+.+ ||||||||.|||++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 2 22222 234799999999988765421 123567899999999999987 99999999999998
Q ss_pred CCC----------CeEEeccCCcccc
Q 008238 483 AEM----------NPKISDFGMAKIF 498 (573)
Q Consensus 483 ~~~----------~vkl~DfGla~~~ 498 (573)
+++ .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 776 3899999987644
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=4.4e-12 Score=124.00 Aligned_cols=143 Identities=17% Similarity=0.094 Sum_probs=113.4
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
-..|++...++.|+.+.||+... +++.+++|+...........+.+|+.+++.+. +..+.+++++..+.+..++||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 34688888889899999999986 46899999986532233456889999999985 67788999999988899999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS-------------------------------------- 465 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~-------------------------------------- 465 (573)
++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 92 i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999776411 1223467889999999999811
Q ss_pred ------------------CCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 466 ------------------RLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 466 ------------------~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
...++|+|++|.|||+++++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1449999999999999876666799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=1.9e-11 Score=119.07 Aligned_cols=137 Identities=17% Similarity=0.140 Sum_probs=101.9
Q ss_pred CCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCc--cceEEEEEEcCCeeEEEEEcc
Q 008238 347 NFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN--LVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~ 424 (573)
.+.+....+.|..+.||+....+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34443333456669999998777888999997643 2356788999999986545 456888888877889999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS--------------------------------------- 465 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--------------------------------------- 465 (573)
+|.+|. ... .+ ...++.++++.|..||+..
T Consensus 98 ~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 98 PGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 999884 211 11 2356778888888888743
Q ss_pred ----------------CCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 466 ----------------RLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 466 ----------------~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
...++|+|++|.|||+++++.+.|+||+.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999999753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=6.5e-10 Score=113.81 Aligned_cols=143 Identities=17% Similarity=0.272 Sum_probs=108.0
Q ss_pred CcccccccccceeEEEEecCCCCeeEEEEec--cCC-ccchHHHHHHHHHHHhcC--CCccceEEEEEEcC---CeeEEE
Q 008238 349 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLS--RSS-GQGGQEFKNEVVLVAKLQ--HRNLVRLLGFCLEG---EEKILV 420 (573)
Q Consensus 349 ~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv 420 (573)
...+.|+.|.++.||+.... +..+++|+.. ... ......+.+|..+++.+. +..+.+++.++.+. +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34678999999999999874 4678888875 322 123457888999999997 45578889888776 347999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS----------------------------------- 465 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~----------------------------------- 465 (573)
|||++|..+.+.. ...++..++..++.++++.|..||+..
T Consensus 120 me~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999998875422 124678888999999999999999731
Q ss_pred --------------------CCCeEeecCCCCCEEeCCCCC--eEEeccCCccc
Q 008238 466 --------------------RLRIIHRDLKASNILLDAEMN--PKISDFGMAKI 497 (573)
Q Consensus 466 --------------------~~~ivH~Dlkp~NILl~~~~~--vkl~DfGla~~ 497 (573)
...++|+|+++.|||+++++. +.|.||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.99 E-value=3.3e-10 Score=113.21 Aligned_cols=183 Identities=20% Similarity=0.205 Sum_probs=122.3
Q ss_pred ccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-CCc--cceEEEEEEcCC---eeEEEEEcc
Q 008238 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRN--LVRLLGFCLEGE---EKILVYEFV 424 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 424 (573)
.+.++.|....||+.. +.+++|+.... .....+.+|..+++.+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4678999999999863 56889986432 34567889999999884 333 344554433333 347899999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED---------------------------------------- 464 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~---------------------------------------- 464 (573)
+|..|..... ..++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865331 2467777888888888888888862
Q ss_pred ---------------CCCCeEeecCCCCCEEeCC--CCCeEEeccCCcccccCCCCccccccccccCCc---cchhcccc
Q 008238 465 ---------------SRLRIIHRDLKASNILLDA--EMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY---MAPEYAMH 524 (573)
Q Consensus 465 ---------------~~~~ivH~Dlkp~NILl~~--~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~ 524 (573)
..+.++|+|++|.||++++ +..+.|.||+.+..-....... ..... ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~------~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI------SLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH------TTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH------HHHhhccccCHHHHHH
Confidence 1245899999999999998 5568899999986432110000 00011 22222110
Q ss_pred -----CC---------CCccchhHHHHHHHHHHHhCCCCC
Q 008238 525 -----GQ---------FSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 525 -----~~---------~s~~~DvwslGvll~elltG~~p~ 550 (573)
+. .....+.|+++.++|++.+|+.++
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01 112258999999999999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.2e-06 Score=87.40 Aligned_cols=136 Identities=22% Similarity=0.174 Sum_probs=95.9
Q ss_pred ccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCC---ccceEEEEEE-cCCeeEEEEEccCC
Q 008238 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHR---NLVRLLGFCL-EGEEKILVYEFVPN 426 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 426 (573)
.+.++.|....||+. ++.+++|+.. .......+.+|..+|+.+.+. .+.+++.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899987 5778888853 223456788999999999753 3566677664 34567899999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED------------------------------------------ 464 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~------------------------------------------ 464 (573)
..+..... ..++..+...++.++++.|..||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88865321 1234455555555666665555542
Q ss_pred ---------------CCCCeEeecCCCCCEEeCC---CCC-eEEeccCCccc
Q 008238 465 ---------------SRLRIIHRDLKASNILLDA---EMN-PKISDFGMAKI 497 (573)
Q Consensus 465 ---------------~~~~ivH~Dlkp~NILl~~---~~~-vkl~DfGla~~ 497 (573)
..+.++|+|+++.|||+++ ++. +.|.||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.4e-06 Score=84.99 Aligned_cols=135 Identities=19% Similarity=0.181 Sum_probs=96.7
Q ss_pred ccccccce-eEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEEEEEccCCCCh
Q 008238 353 KLGEGGFG-EVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKSL 429 (573)
Q Consensus 353 ~LG~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 429 (573)
.+..|..| .||+.... ++..+++|+-.. ....++.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44556555 68988754 567789998643 23457888999998885 33367889999999999999999999887
Q ss_pred hhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 008238 430 DYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS-------------------------------------------- 465 (573)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~-------------------------------------------- 465 (573)
.+.... .......+..++++.|.-||...
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 665421 11223345666666666666421
Q ss_pred -----------CCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 466 -----------RLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 466 -----------~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
.+.++|+|+.+.|||+++++.+-|.||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999887778999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=8.5e-07 Score=90.32 Aligned_cols=81 Identities=7% Similarity=0.034 Sum_probs=57.3
Q ss_pred cccc-ccccceeEEEEecC-------CCCeeEEEEeccCC---ccchHHHHHHHHHHHhcCC---CccceEEEEEEcC--
Q 008238 351 DNKL-GEGGFGEVYKGVLP-------SGQEIAVKRLSRSS---GQGGQEFKNEVVLVAKLQH---RNLVRLLGFCLEG-- 414 (573)
Q Consensus 351 ~~~L-G~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~-- 414 (573)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|..+++.+.. -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88888999998764 26678888765322 1112567889998888853 3467788877655
Q ss_pred -CeeEEEEEccCCCChhh
Q 008238 415 -EEKILVYEFVPNKSLDY 431 (573)
Q Consensus 415 -~~~~lv~e~~~~gsL~~ 431 (573)
...++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999987754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.00 E-value=1.5e-05 Score=80.35 Aligned_cols=141 Identities=16% Similarity=0.216 Sum_probs=80.6
Q ss_pred ccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCC--CccceEEE------EEEcCCeeEEEEE
Q 008238 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH--RNLVRLLG------FCLEGEEKILVYE 422 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e 422 (573)
.+.|+.|..+.||+....+| .+++|+.... ..++..|..+++.+.. -.+.+++. +....+..+++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677889999987554 5899988642 2344455565555531 12333332 1234567889999
Q ss_pred ccCCCChhh--------------hccCc------Cc-----cCCCCHHHH------------------------------
Q 008238 423 FVPNKSLDY--------------FLYEP------EK-----QQQLDWSRR------------------------------ 447 (573)
Q Consensus 423 ~~~~gsL~~--------------~l~~~------~~-----~~~l~~~~~------------------------------ 447 (573)
|++|..+.. .++.. .. ...-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 999876531 01100 00 001123211
Q ss_pred -HHHHHHHHHHHHHHHh----------CCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 448 -YKIIGGIARGILYLHE----------DSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 448 -~~i~~qia~~L~yLH~----------~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
..+..++.+.+++|++ .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223445666763 123569999999999999888899999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=2.1e-05 Score=81.24 Aligned_cols=75 Identities=12% Similarity=0.121 Sum_probs=50.3
Q ss_pred ccccccccceeEEEEecC-CCCeeEEEEeccCCc-------cchHHHHHHHHHHHhcCC--Cc-cceEEEEEEcCCeeEE
Q 008238 351 DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSG-------QGGQEFKNEVVLVAKLQH--RN-LVRLLGFCLEGEEKIL 419 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 419 (573)
.+.||.|..+.||++... +++.++||....... .....+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568999999999999754 568899997643211 223456789999888742 33 3455543 4456789
Q ss_pred EEEccCCC
Q 008238 420 VYEFVPNK 427 (573)
Q Consensus 420 v~e~~~~g 427 (573)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.97 E-value=2.3e-05 Score=77.10 Aligned_cols=81 Identities=17% Similarity=0.263 Sum_probs=60.9
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCC---ccceEEEEEEcCCeeEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHR---NLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lv~ 421 (573)
.......+.+|.|..+.||+.+..+|+.|.+|+...........|..|...|+.+... -+.+++++ +..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEE
Confidence 4456677889999999999999989999999987655444455688899999988522 24455554 2347899
Q ss_pred EccCCCCh
Q 008238 422 EFVPNKSL 429 (573)
Q Consensus 422 e~~~~gsL 429 (573)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.93 E-value=5.9e-05 Score=74.98 Aligned_cols=141 Identities=19% Similarity=0.144 Sum_probs=94.4
Q ss_pred CCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcC---CCccceEEEEEEcCCeeEEEEEcc
Q 008238 348 FSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
....+.|+.|....+|+... +++.+++|+.... ....+..|...|+.+. ...+++++.+....+..++||||+
T Consensus 38 i~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 34456899999999999986 5678889987532 3566888999888884 356788898888888899999999
Q ss_pred CCCChhhh-----------ccCcCc---------------c----CCCCHHHHH---HHHH----------------HHH
Q 008238 425 PNKSLDYF-----------LYEPEK---------------Q----QQLDWSRRY---KIIG----------------GIA 455 (573)
Q Consensus 425 ~~gsL~~~-----------l~~~~~---------------~----~~l~~~~~~---~i~~----------------qia 455 (573)
++..+..- |+.... . -.-+|.... ++.. ++.
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 99865311 111100 0 012454332 1111 111
Q ss_pred HH-HHHHHh-CCCCCeEeecCCCCCEEeCCCCCeEEeccC
Q 008238 456 RG-ILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFG 493 (573)
Q Consensus 456 ~~-L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~vkl~DfG 493 (573)
+- ...|.. ..++.++|+|+.+.||+++.++ +.|.|+.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 223432 2356799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00017 Score=75.10 Aligned_cols=78 Identities=10% Similarity=0.135 Sum_probs=47.3
Q ss_pred CCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccc--cCCccchhccccC---CCCccchhHHHHHHH
Q 008238 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVG--TYGYMAPEYAMHG---QFSVKSDVYSFGVLV 540 (573)
Q Consensus 466 ~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~s~~~DvwslGvll 540 (573)
...++|+|+++.|||+++++ ++|.||+.+..-.... ....... ...|.+|+..... ......++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 34699999999999998876 9999999886421110 0000010 1345666554311 112234556777788
Q ss_pred HHHHhCC
Q 008238 541 LEIITGK 547 (573)
Q Consensus 541 ~elltG~ 547 (573)
|+.++++
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8877764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00032 Score=69.31 Aligned_cols=72 Identities=10% Similarity=0.162 Sum_probs=47.0
Q ss_pred cccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCcc-ceEEEEEEcCCeeEEEEEcc-CCC
Q 008238 350 TDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFV-PNK 427 (573)
Q Consensus 350 ~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g 427 (573)
-.+.|+.|....+|+. +.+++|+....... .....+|..+++.+...++ .+++++ +.+..++++||+ ++.
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 3678889999999998 67888987643221 1234568888877753333 455554 344567899999 665
Q ss_pred Ch
Q 008238 428 SL 429 (573)
Q Consensus 428 sL 429 (573)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 55
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00044 Score=68.88 Aligned_cols=143 Identities=15% Similarity=0.119 Sum_probs=80.1
Q ss_pred ccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCc--cceEEEE------EEcCCeeEEEEE
Q 008238 351 DNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN--LVRLLGF------CLEGEEKILVYE 422 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e 422 (573)
.+.|+.|....+|+....+| .+++|..... ...+++..|+.++..+...+ +.+++.. ....+..+++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 34567788889999987555 6889988652 12245566777777764322 2333321 122356789999
Q ss_pred ccCCCChhhh--------------ccCc----Ccc--CCC---CHHHHHH------------HHHHHHHHHHHHHhC---
Q 008238 423 FVPNKSLDYF--------------LYEP----EKQ--QQL---DWSRRYK------------IIGGIARGILYLHED--- 464 (573)
Q Consensus 423 ~~~~gsL~~~--------------l~~~----~~~--~~l---~~~~~~~------------i~~qia~~L~yLH~~--- 464 (573)
|++|..+... ++.. ... ... .|...+. +...+.+.++.+++.
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 9998764321 1100 000 001 1222110 011234455555432
Q ss_pred -CCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 465 -SRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 465 -~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
....++|+|+++.|||+++++.+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23469999999999999987666899999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0013 Score=65.82 Aligned_cols=142 Identities=16% Similarity=0.146 Sum_probs=73.5
Q ss_pred cccccccccee-EEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCC--ccceEEEEEEcCCeeEEEEEccCCC
Q 008238 351 DNKLGEGGFGE-VYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHR--NLVRLLGFCLEGEEKILVYEFVPNK 427 (573)
Q Consensus 351 ~~~LG~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g 427 (573)
.+.|+.|.... +|+....+++.+++|...... ..++..|+.+++.+... .+.+++.+..+. -+++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence 34566565444 677765446777777644322 13345567777666432 345666663332 37899999876
Q ss_pred ChhhhccCc---------------------Cc--cCCCCHHHHH-------H-------------HHHHHHHHHHHHH--
Q 008238 428 SLDYFLYEP---------------------EK--QQQLDWSRRY-------K-------------IIGGIARGILYLH-- 462 (573)
Q Consensus 428 sL~~~l~~~---------------------~~--~~~l~~~~~~-------~-------------i~~qia~~L~yLH-- 462 (573)
.+.+++... .. ...++..... . ....+.+.++.|.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 664433110 00 0112211100 0 0011112222331
Q ss_pred -hCCCCCeEeecCCCCCEEeCCC----CCeEEeccCCccc
Q 008238 463 -EDSRLRIIHRDLKASNILLDAE----MNPKISDFGMAKI 497 (573)
Q Consensus 463 -~~~~~~ivH~Dlkp~NILl~~~----~~vkl~DfGla~~ 497 (573)
......++|||+.+.|||++.+ +.+.|.||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123469999999999999875 6799999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0004 Score=72.31 Aligned_cols=73 Identities=16% Similarity=0.268 Sum_probs=50.5
Q ss_pred ccccccccceeEEEEecCC--------CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCcc-ceEEEEEEcCCeeEEEE
Q 008238 351 DNKLGEGGFGEVYKGVLPS--------GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVY 421 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 421 (573)
.+.|+.|-...+|+....+ ++.+++|+.... .....+.+|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567888889999998643 478899987432 112456679998888864444 566765532 3899
Q ss_pred EccCCCCh
Q 008238 422 EFVPNKSL 429 (573)
Q Consensus 422 e~~~~gsL 429 (573)
||+++..|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987555
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0017 Score=64.80 Aligned_cols=142 Identities=15% Similarity=0.158 Sum_probs=82.1
Q ss_pred cccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCc--cceEEEE-----EEcCCeeEEEEEcc
Q 008238 352 NKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN--LVRLLGF-----CLEGEEKILVYEFV 424 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~~ 424 (573)
+.|+ |....||+....+|+.+++|...... .....+..|..++..+.... +++++.. ....+..+++|+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 77789999887778789999986332 23456777888888775322 3444432 12244567899999
Q ss_pred CCCChhh-----h---------ccC----c--CccCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 008238 425 PNKSLDY-----F---------LYE----P--EKQQQLDWSRR----YKI---------------IGGIARGILYLHE-- 463 (573)
Q Consensus 425 ~~gsL~~-----~---------l~~----~--~~~~~l~~~~~----~~i---------------~~qia~~L~yLH~-- 463 (573)
+|..+.. . ++. . ......++... ..+ ...+.+.++.+.+
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 9865431 0 000 0 00111222211 000 1111122233321
Q ss_pred --CCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 464 --DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 464 --~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
.....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234589999999999999 4 899999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0015 Score=68.44 Aligned_cols=75 Identities=13% Similarity=0.070 Sum_probs=49.2
Q ss_pred ccccccccceeEEEEecCC-CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCcc-ceEEEEEEcCCeeEEEEEccCCCC
Q 008238 351 DNKLGEGGFGEVYKGVLPS-GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVYEFVPNKS 428 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 428 (573)
.+.|+.|-...+|+....+ ++.+++|+....... ..+..+|..++..+...++ .++++.+. + .+||||+++..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4567788889999998754 477889887543222 1223678999998875555 56677652 2 35999999865
Q ss_pred hh
Q 008238 429 LD 430 (573)
Q Consensus 429 L~ 430 (573)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0015 Score=66.50 Aligned_cols=142 Identities=20% Similarity=0.237 Sum_probs=84.6
Q ss_pred ccccccccceeEEEEecC--------CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCc-cceEEEEEEcCCeeEEEE
Q 008238 351 DNKLGEGGFGEVYKGVLP--------SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN-LVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 421 (573)
.+.|..|-...+|+.... +++.+++|+.... ......+.+|..+++.+...+ ..++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777888889999864 2478899986332 233456678999998885333 3566666543 2899
Q ss_pred EccCCCChhhh-cc----------------Cc--CccCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 008238 422 EFVPNKSLDYF-LY----------------EP--EKQQQLD--WSRRYKIIGGIAR-------------------GILYL 461 (573)
Q Consensus 422 e~~~~gsL~~~-l~----------------~~--~~~~~l~--~~~~~~i~~qia~-------------------~L~yL 461 (573)
||++|..|..- +. .. .-..... +.++.++..++.. .++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998666421 11 10 0011122 4455555544322 23333
Q ss_pred H----hC-CCCCeEeecCCCCCEEeCCC----CCeEEeccCCccc
Q 008238 462 H----ED-SRLRIIHRDLKASNILLDAE----MNPKISDFGMAKI 497 (573)
Q Consensus 462 H----~~-~~~~ivH~Dlkp~NILl~~~----~~vkl~DfGla~~ 497 (573)
. .. ....++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 21 23469999999999999876 7899999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0014 Score=66.66 Aligned_cols=74 Identities=9% Similarity=0.060 Sum_probs=45.4
Q ss_pred ccccccccceeEEEEecCC---------CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCc-cceEEEEEEcCCeeEEE
Q 008238 351 DNKLGEGGFGEVYKGVLPS---------GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN-LVRLLGFCLEGEEKILV 420 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 420 (573)
.+.|+.|..-.+|+....+ ++.+++|+...... ...+...|..+++.+...+ ..++++.. ..++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 4567778888999988643 26788888654322 1123467888888876444 34666543 23789
Q ss_pred EEccCCCCh
Q 008238 421 YEFVPNKSL 429 (573)
Q Consensus 421 ~e~~~~gsL 429 (573)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.013 Score=58.85 Aligned_cols=32 Identities=25% Similarity=0.415 Sum_probs=28.0
Q ss_pred CCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 466 ~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
...++|+|+.+.||++++++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34699999999999999888899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.50 E-value=0.06 Score=55.50 Aligned_cols=140 Identities=16% Similarity=0.157 Sum_probs=84.6
Q ss_pred ccccccccceeEEEEecCC--------CCeeEEEEeccCCccchHHHHHHHHHHHhcCCCc-cceEEEEEEcCCeeEEEE
Q 008238 351 DNKLGEGGFGEVYKGVLPS--------GQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN-LVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 421 (573)
.+.|..|-...+|+....+ ++.+++|+..... ....+..+|..+++.+...+ ..++++.+. .++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567777778899998653 5788998865432 22223467888888875333 345565332 37899
Q ss_pred EccCCCChhhh-cc----------------C--c------C--ccCCCCHHHHHHHHHHH-------------------H
Q 008238 422 EFVPNKSLDYF-LY----------------E--P------E--KQQQLDWSRRYKIIGGI-------------------A 455 (573)
Q Consensus 422 e~~~~gsL~~~-l~----------------~--~------~--~~~~l~~~~~~~i~~qi-------------------a 455 (573)
||++|..|..- +. . . . ...+.-|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998765321 10 0 0 0 11122244444443322 2
Q ss_pred HHHHHHHh---------------------CCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 456 RGILYLHE---------------------DSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 456 ~~L~yLH~---------------------~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
..+++|.+ .....++|+|+.+.||+ ++++.+.|+||..+.
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 22333321 12345899999999999 788899999999876
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.11 E-value=0.35 Score=49.37 Aligned_cols=30 Identities=27% Similarity=0.391 Sum_probs=25.3
Q ss_pred CeEeecCCCCCEEe------CCCCCeEEeccCCccc
Q 008238 468 RIIHRDLKASNILL------DAEMNPKISDFGMAKI 497 (573)
Q Consensus 468 ~ivH~Dlkp~NILl------~~~~~vkl~DfGla~~ 497 (573)
-++|+|+.+.|||+ +++..+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=91.36 E-value=0.65 Score=42.76 Aligned_cols=103 Identities=13% Similarity=0.085 Sum_probs=66.9
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCccc
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN 506 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 506 (573)
-+|.++|.. ..+++++.+++.++.|.+..|.-+-.... + ..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 367777754 46799999999999999999877622111 1 1233457899999999988764 1110
Q ss_pred cccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCC
Q 008238 507 TNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN 549 (573)
Q Consensus 507 ~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p 549 (573)
.....+.+||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122456787652 4556788999999999998876655
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.37 E-value=1.4 Score=40.36 Aligned_cols=116 Identities=9% Similarity=0.071 Sum_probs=76.9
Q ss_pred CCCccceEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCE
Q 008238 400 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479 (573)
Q Consensus 400 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI 479 (573)
.||++++. .+..+.+...+.++.-+ ....|- .-..++...+++++.+|+.-.++++. -+|--|.|.||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 58888876 55566666666555443 222222 12357889999999999988866654 37889999999
Q ss_pred EeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 480 LLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 480 Ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+++.++.++|.=.|+-..+ +|. ..+...=+-.+=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999876663221 111 11222223467778888888877664
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.19 E-value=0.16 Score=52.95 Aligned_cols=62 Identities=8% Similarity=0.077 Sum_probs=19.5
Q ss_pred CcccccccccceeEEEEecCC-CCeeEE------EEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEc
Q 008238 349 STDNKLGEGGFGEVYKGVLPS-GQEIAV------KRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE 413 (573)
Q Consensus 349 ~~~~~LG~G~~g~V~~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 413 (573)
.+.++|| ||.||+|.+.. ..+||| |..+.. ..+....+.+|..+++.++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4567787 99999999854 357888 665432 22333567888999999999999999887653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.28 E-value=3 Score=38.33 Aligned_cols=83 Identities=7% Similarity=0.016 Sum_probs=59.2
Q ss_pred CCCccceEEEEEEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEeecCCCCC
Q 008238 400 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL-YLHEDSRLRIIHRDLKASN 478 (573)
Q Consensus 400 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~-yLH~~~~~~ivH~Dlkp~N 478 (573)
.||++ -...-.+.+...+.++--+++.-...+ ..++...+++++.+|+.-.. +++. -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57887 444446667777777655343222223 35688899999988887666 5543 5788899999
Q ss_pred EEeCCCCCeEEeccCCc
Q 008238 479 ILLDAEMNPKISDFGMA 495 (573)
Q Consensus 479 ILl~~~~~vkl~DfGla 495 (573)
|+++.++.++|.-.|+-
T Consensus 115 L~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVK 131 (219)
T ss_dssp EEECTTCCEEESCCEET
T ss_pred EEEeCCCcEEEEEcCCc
Confidence 99999999999877763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 573 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-69 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-50 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-32 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-27 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 1e-69
Identities = 63/210 (30%), Positives = 109/210 (51%), Gaps = 9/210 (4%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
E+ + ++G G FG VYKG + + ++ + Q Q FKNEV ++ K +H
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYL 461
N++ +G+ + +V ++ SL + L+ E + + + I A+G+ YL
Sbjct: 64 VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYL 120
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY 521
H S IIHRDLK++NI L ++ KI DFG+A + ++ G+ +MAPE
Sbjct: 121 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 522 AMH---GQFSVKSDVYSFGVLVLEIITGKK 548
+S +SDVY+FG+++ E++TG+
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 2e-69
Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 11/209 (5%)
Query: 341 IEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG-QEFKNEVVLVAK 398
+E+ ++F ++LG G G V+K PSG +A K + + E+ ++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 399 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGI 458
+V G E + E + SLD L K ++ K+ + +G+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMA 518
YL + +I+HRD+K SNIL+++ K+ DFG++ N VGT YM+
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 171
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
PE +SV+SD++S G+ ++E+ G+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 1e-65
Identities = 70/224 (31%), Positives = 115/224 (51%), Gaps = 9/224 (4%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
EV +LG G FGEV+ G ++AVK L + S F E L+ +LQH
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYL 461
+ LVRL + E ++ E++ N SL FL P +L ++ + IA G+ ++
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 125
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY 521
E + IHRDL+A+NIL+ ++ KI+DFG+A++ ++ + APE
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEA 181
Query: 522 AMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYV 565
+G F++KSDV+SFG+L+ EI+T + Y +++ +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNL 223
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-62
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 7/203 (3%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLV 405
+ + ++G G FG V+ G + ++A+K + + ++F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
+L G CLE LV+EF+ + L Y ++ + + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG 525
+IHRDL A N L+ K+SDFGM + DQ ++ + +PE
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 526 QFSVKSDVYSFGVLVLEIITGKK 548
++S KSDV+SFGVL+ E+ + K
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK 200
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-61
Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 15/225 (6%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
+ +G+G FG+V G G ++AVK + + Q F E ++ +L+H
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 59
Query: 402 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
NLV+LLG +E + + +V E++ SL +L + L K + + Y
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520
L +HRDL A N+L+ + K+SDFG+ K Q G + APE
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPE 170
Query: 521 YAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYV 565
+FS KSDV+SFG+L+ EI + + Y D++ V
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGR--VPYPRIPLKDVVPRV 213
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 3e-61
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE-FKNEVVLVAKLQHRN 403
++ LGEG +GEV V + + +AVK + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
+V+ G EG + L E+ L + E + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM 523
+ I HRD+K N+LLD N KISDFG+A +F + + N++ GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 524 HGQF-SVKSDVYSFGVLVLEIITGK 547
+F + DV+S G+++ ++ G+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (514), Expect = 3e-61
Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 7/219 (3%)
Query: 331 LESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEF 389
++ +++ E+ + + +KLG G +GEVY+GV +AVK L + + +EF
Sbjct: 2 MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEF 60
Query: 390 KNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYK 449
E ++ +++H NLV+LLG C ++ EF+ +L +L E + Q++
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLY 119
Query: 450 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR 509
+ I+ + YL + IHRDL A N L+ K++DFG++++ D +
Sbjct: 120 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG- 175
Query: 510 IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548
+ APE + +FS+KSDV++FGVL+ EI T
Sbjct: 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 7e-61
Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 7/203 (3%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLV 405
+ + +LG G FG V G ++A+K + S EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
+L G C + ++ E++ N L +L E + + + ++ + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG 525
+ +HRDL A N L++ + K+SDFG+++ +D ++ + PE M+
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 526 QFSVKSDVYSFGVLVLEIITGKK 548
+FS KSD+++FGVL+ EI + K
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK 199
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (510), Expect = 1e-60
Identities = 64/260 (24%), Positives = 110/260 (42%), Gaps = 33/260 (12%)
Query: 334 LQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSSGQGGQ 387
L ++E NN +GEG FG V++ P +AVK L + Q
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 388 -EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQ------- 439
+F+ E L+A+ + N+V+LLG C G+ L++E++ L+ FL
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 440 --------------QQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM 485
L + + I +A G+ YL E + +HRDL N L+ M
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177
Query: 486 NPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT 545
KI+DFG+++ +M PE + +++ +SDV+++GV++ EI +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 546 GKKNSSFYQTDGAADLLSYV 565
Y +++ YV
Sbjct: 238 YGLQ--PYYGMAHEEVIYYV 255
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (511), Expect = 1e-60
Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG---QEFKNEVVLVAKLQHRN 403
FS ++G G FG VY + + + +A+K++S S Q Q+ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
++ G L LV E+ + D ++ L + G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM 523
+IHRD+KA NILL K+ DFG A I N VGT +MAPE +
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184
Query: 524 ---HGQFSVKSDVYSFGVLVLEIITGK 547
GQ+ K DV+S G+ +E+ K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-60
Identities = 67/224 (29%), Positives = 114/224 (50%), Gaps = 9/224 (4%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH 401
E+ + + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 71
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYL 461
LV+L E +V E++ SL FL E + L + + IA G+ Y+
Sbjct: 72 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY 521
R+ +HRDL+A+NIL+ + K++DFG+A++ ++ + APE
Sbjct: 130 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEA 185
Query: 522 AMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYV 565
A++G+F++KSDV+SFG+L+ E+ T + Y ++L V
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQV 227
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 5e-60
Identities = 63/231 (27%), Positives = 115/231 (49%), Gaps = 14/231 (6%)
Query: 341 IEVATNNFS-TDNKLGEGGFGEVYKGVL---PSGQEIAVKRLSRSSGQGG-QEFKNEVVL 395
+ + +N D +LG G FG V +GV ++A+K L + + + +E E +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 396 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIA 455
+ +L + +VRL+G C + E +LV E L FL K++++ S +++ ++
Sbjct: 63 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVS 119
Query: 456 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGN-TNRIVGTY 514
G+ YL +HRDL A N+LL KISDFG++K G D + +
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 515 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYV 565
+ APE +FS +SDV+S+GV + E ++ + Y+ ++++++
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ--KPYKKMKGPEVMAFI 225
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-59
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 10/209 (4%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG--QEFKNEVVLVAKLQHRN 403
++ +G G +G K G+ + K L S Q +EV L+ +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 404 LVRLLGFCLEGEEKIL--VYEFVPNKSLDYFLYEPEKQQQ-LDWSRRYKIIGGIARGILY 460
+VR ++ L V E+ L + + K++Q LD +++ + +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 461 LHE--DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMA 518
H D ++HRDLK +N+ LD + N K+ DFG+A+I D + VGT YM+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMS 182
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
PE ++ KSD++S G L+ E+
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM 211
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-59
Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 16/219 (7%)
Query: 338 FETIEVATN---NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEV 393
+E + N + +LG+G FG+VYK + A K + S + +++ E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 394 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGG 453
++A H N+V+LL ++ EF ++D + E ++ L S+ +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQ 118
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGT 513
+ YLH+ +IIHRDLKA NIL + + K++DFG++ +T + +GT
Sbjct: 119 TLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKN--TRTIQRRDSFIGT 173
Query: 514 YGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGK 547
+MAPE M + K+DV+S G+ ++E+ +
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (502), Expect = 2e-59
Identities = 62/230 (26%), Positives = 114/230 (49%), Gaps = 22/230 (9%)
Query: 336 FDFETIEVATNNFST---------DNKLGEGGFGEVYKGVLPSGQE----IAVKRLSRS- 381
F FE A F+ + +G G FGEV G L + +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 382 SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ 441
+ + ++F +E ++ + H N++ L G + +++ EF+ N SLD FL + + Q
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 442 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501
+ ++ GIA G+ YL + +HRDL A NIL+++ + K+SDFG+++ D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 502 QTQGNTNRIVG---TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548
+ +G + APE + +F+ SDV+S+G+++ E+++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-58
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 351 DNKLGEGGFGEVYKGVLP---SGQEIAVKRLSRSSGQGG--QEFKNEVVLVAKLQHRNLV 405
D +LG G FG V KG + +AVK L + E E ++ +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
R++G C E E +LV E L+ +L + + + +++ ++ G+ YL
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE--- 124
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTN-RIVGTYGYMAPEYAMH 524
+HRDL A N+LL + KISDFG++K D+ + APE +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 525 GQFSVKSDVYSFGVLVLEIITGKK 548
+FS KSDV+SFGVL+ E + +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQ 208
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 4e-58
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 14/206 (6%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQ---EFKNEVVLVAKLQH 401
+F LG+G FG VY S +A+K L ++ + + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYL 461
N++RL G+ + L+ E+ P ++ L +K + D R I +A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 122
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY 521
H R+IHRD+K N+LL + KI+DFG + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 175
Query: 522 AMHGQFSVKSDVYSFGVLVLEIITGK 547
K D++S GVL E + GK
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-58
Identities = 58/223 (26%), Positives = 117/223 (52%), Gaps = 11/223 (4%)
Query: 326 NDITTLESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQ 384
+D LE L+ ++ ++ K+G+G G VY + + +GQE+A+++++
Sbjct: 1 SDEEILEKLR-SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59
Query: 385 GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDW 444
+ NE++++ + ++ N+V L L G+E +V E++ SL + E +D
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDE 115
Query: 445 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504
+ + + + +LH ++IHRD+K+ NILL + + K++DFG +Q++
Sbjct: 116 GQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
+ +VGT +MAPE + K D++S G++ +E+I G+
Sbjct: 173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 7e-58
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 351 DNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRL 407
D ++G G F VYKG+ + E+A L + Q FK E ++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 408 LGFCLEGEEK----ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
+ +LV E + + +L +L ++ + + I +G+ +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 464 DSRLRIIHRDLKASNILLDAE-MNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA 522
+ IIHRDLK NI + + KI D G+A + + ++GT +MAPE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEM- 184
Query: 523 MHGQFSVKSDVYSFGVLVLEIITGKK 548
++ DVY+FG+ +LE+ T +
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEY 210
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 8e-58
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 23/221 (10%)
Query: 353 KLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCL 412
+G+G FGEV++G G+E+AVK S + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 413 EGEEKI----LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED---- 464
+ LV ++ + SL +L + + K+ A G+ +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 465 -SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF--GVDQTQGNTNRIVGTYGYMAPEY 521
+ I HRDLK+ NIL+ I+D G+A D N VGT YMAPE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 522 ------AMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
H + ++D+Y+ G++ EI ++
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 4e-57
Identities = 59/224 (26%), Positives = 115/224 (51%), Gaps = 12/224 (5%)
Query: 340 TIEVATNNFSTDNKLGEGGFGEVYKGVLPSGQE-----IAVKRLSRSSGQGGQ-EFKNEV 393
T E+ + + +G G FGEVYKG+L + +A+K L + + +F E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 394 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGG 453
++ + H N++RL G + + +++ E++ N + + EK + + ++ G
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRG 118
Query: 454 IARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT-NRIVG 512
IA G+ YL + +HRDL A NIL+++ + K+SDFG++++ D T +
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 513 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTD 556
+ APE + +F+ SDV+SFG+++ E++T + + ++
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 219
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 5e-57
Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 32/255 (12%)
Query: 323 NADNDITTLESLQFDFETI-EVATNNFSTDNKLGEGGFGEVYKGVLPS------GQEIAV 375
++DN+ ++ +++++ E N LG G FG+V ++AV
Sbjct: 13 SSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV 72
Query: 376 KRLSRSSGQGGQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 433
K L + +E +E+ ++ +L H N+V LLG C L++E+ L +L
Sbjct: 73 KMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 132
Query: 434 Y--------------------EPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD 473
E E L + +A+G+ +L +HRD
Sbjct: 133 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD 189
Query: 474 LKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDV 533
L A N+L+ KI DFG+A+ D +MAPE G +++KSDV
Sbjct: 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249
Query: 534 YSFGVLVLEIITGKK 548
+S+G+L+ EI +
Sbjct: 250 WSYGILLWEIFSLGV 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-56
Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 17/243 (6%)
Query: 331 LESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSRSSGQGG 386
++++Q +F + +G G FG VY G L AVK L+R + G
Sbjct: 14 VQAVQHVVIGPSSLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 71
Query: 387 -QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDW 444
+F E +++ H N++ LLG CL E +V ++ + L F+ +
Sbjct: 72 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 131
Query: 445 SRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504
+ + + + + +HRDL A N +LD + K++DFG+A+ +
Sbjct: 132 LIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186
Query: 505 GNTNR--IVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLL 562
N+ +MA E +F+ KSDV+SFGVL+ E++T Y D+
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDIT 244
Query: 563 SYV 565
Y+
Sbjct: 245 VYL 247
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-56
Identities = 62/255 (24%), Positives = 103/255 (40%), Gaps = 27/255 (10%)
Query: 326 NDITTLESLQFDFETI-EVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL 378
N+ ++ Q ++ E N S LG G FG+V + + +AVK L
Sbjct: 2 NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 379 SRSSGQGG-QEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE- 435
S+ + +E+ +++ L H N+V LLG C G +++ E+ L FL
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 436 --------------PEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 481
+ + LD +A+G+ +L IHRDL A NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178
Query: 482 DAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVL 541
KI DFG+A+ D +MAPE + ++ +SDV+S+G+ +
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 542 EIITGKKNSSFYQTD 556
E+ + +
Sbjct: 239 ELFSLGSSPYPGMPV 253
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 8e-55
Identities = 66/224 (29%), Positives = 114/224 (50%), Gaps = 14/224 (6%)
Query: 348 FSTDNKLGEGGFGEVYKGV-LPSGQE----IAVKRLSRS-SGQGGQEFKNEVVLVAKLQH 401
F LG G FG VYKG+ +P G++ +A+K L + S + +E +E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYL 461
++ RLLG CL +++ LDY E + + IA+G+ YL
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY 521
R++HRDL A N+L+ + KI+DFG+AK+ G ++ + + +MA E
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 522 AMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYV 565
+H ++ +SDV+S+GV V E++T Y A+++ S +
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS--KPYDGIPASEISSIL 226
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-54
Identities = 63/238 (26%), Positives = 106/238 (44%), Gaps = 26/238 (10%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSG---QEIAVKRLSR-SSGQGGQEFKNEVVLVAKL-Q 400
N+ + +GEG FG+V K + + A+KR+ +S ++F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYE-------------PEKQQQLDWSRR 447
H N++ LLG C L E+ P+ +L FL + L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 448 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT 507
+ARG+ YL + + IHRDL A NIL+ KI+DFG+++ +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 508 NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYV 565
+MA E + ++ SDV+S+GVL+ EI++ + Y A+L +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--TPYCGMTCAELYEKL 239
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 7e-54
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 10/205 (4%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHR 402
+F LGEG F V L + +E A+K L + E ++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 403 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLH 462
V+L + E+ + N L ++ K D + I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA 522
IIHRDLK NILL+ +M+ +I+DFG AK+ + Q N VGT Y++PE
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 523 MHGQFSVKSDVYSFGVLVLEIITGK 547
SD+++ G ++ +++ G
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-53
Identities = 64/217 (29%), Positives = 89/217 (41%), Gaps = 14/217 (6%)
Query: 340 TIEVATNNFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSR---SSGQGGQEFKNE 392
T + + KLG+G FG V +G + +AVK L S + +F E
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 393 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIG 452
V + L HRNL+RL G L K+ V E P SL + Q +
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLD--RLRKHQGHFLLGTLSRYAV 118
Query: 453 GIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG-NTNRIV 511
+A G+ YL R IHRDL A N+LL KI DFG+ + +
Sbjct: 119 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548
+ + APE FS SD + FGV + E+ T +
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (461), Expect = 8e-53
Identities = 45/205 (21%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNL 404
+++ +LG G FG V++ +G A K + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 405 VRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED 464
V L + E +++YEF+ L + ++ ++ + + + +G+ ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 465 SRLRIIHRDLKASNILLDAEMNP--KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA 522
+H DLK NI+ + + K+ DFG+ + + GT + APE A
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 197
Query: 523 MHGQFSVKSDVYSFGVLVLEIITGK 547
+D++S GVL +++G
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 8e-53
Identities = 65/238 (27%), Positives = 110/238 (46%), Gaps = 19/238 (7%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSSGQGG-QEFKNEVV 394
EVA + +LG+G FG VY+GV +A+K ++ ++ EF NE
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 75
Query: 395 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-------EPEKQQQLDWSRR 447
++ + ++VRLLG +G+ +++ E + L +L S+
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 448 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT 507
++ G IA G+ YL+ + + +HRDL A N ++ + KI DFGM +
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 508 NRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYV 565
+ + +M+PE G F+ SDV+SFGV++ EI T + YQ +L +V
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFV 248
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 3e-52
Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 12/212 (5%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSRSSGQGGQE-FKNEVVLV 396
E+ +GEG FG+V++G+ S +A+K + +E F E + +
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 397 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIAR 456
+ H ++V+L+G E ++ E L FL ++ LD + ++
Sbjct: 63 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLST 119
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY 516
+ YL R +HRD+ A N+L+ + K+ DFG+++ D T ++ +
Sbjct: 120 ALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKW 175
Query: 517 MAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548
MAPE +F+ SDV+ FGV + EI+
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGV 207
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (447), Expect = 9e-51
Identities = 46/198 (23%), Positives = 86/198 (43%), Gaps = 11/198 (5%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFC 411
+LG G FG V++ V +G+ K ++ KNE+ ++ +L H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 412 LEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 471
+ E +L+ EF+ L + + ++ + + G+ ++HE I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 150
Query: 472 RDLKASNILLDAEMNP--KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSV 529
D+K NI+ + + KI DFG+A D+ T + APE
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGF 207
Query: 530 KSDVYSFGVLVLEIITGK 547
+D+++ GVL +++G
Sbjct: 208 YTDMWAIGVLGYVLLSGL 225
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 3e-50
Identities = 61/237 (25%), Positives = 95/237 (40%), Gaps = 25/237 (10%)
Query: 334 LQFDFETIEVATNNFSTDNKLGEGGFGEVYKGV------LPSGQEIAVKRLSRSSGQGGQ 387
L +D E + LG G FG+V + + + +AVK L +
Sbjct: 1 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 60
Query: 388 E--FKNEVVLVAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLY---------- 434
+L+ H N+V LLG C + + ++ EF +L +L
Sbjct: 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 435 ---EPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 491
E + L +A+G+ +L + IHRDL A NILL + KI D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICD 177
Query: 492 FGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548
FG+A+ D +MAPE ++++SDV+SFGVL+ EI +
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 8e-50
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 7/207 (3%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG-QEFKNEVVLVAKLQHR 402
++ + +GEG +G V + +A+K++S Q Q E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 403 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLH 462
N++ + + + ++ + LY+ K Q L + I RG+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNT-NRIVGTYGYMAPEY 521
++HRDLK SN+LL+ + KI DFG+A++ D V T Y APE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 522 AMHGQFSVKS-DVYSFGVLVLEIITGK 547
++ + KS D++S G ++ E+++ +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-49
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 342 EVATNNFSTDNKLGEGGFGEVYKGVLPS--------GQEIAVKRLSRSSGQGG-QEFKNE 392
E+ + LGEG FG+V ++AVK L + + + +E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 393 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY-------------EPEK 438
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 439 QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498
++QL +ARG+ YL + IHRDL A N+L+ + KI+DFG+A+
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK 548
T +MAPE ++ +SDV+SFGVL+ EI T
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 172 bits (437), Expect = 2e-49
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRS---SGQGGQEFKNEVV---LVAK 398
N+FS +G GGFGEVY +G+ A+K L + QG NE + LV+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 399 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGI 458
+V + ++ + + + L Y L + + I G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMA 518
++H +++RDLK +NILLD + +ISD G+A F + + VGT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 519 PEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 547
PE G + +D +S G ++ +++ G
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (418), Expect = 1e-47
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 345 TNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG---QEFKNEVVLVAKLQ 400
++ + LG GG EV+ L +++AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 401 HRNLVRLLGFCLE----GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIAR 456
H +V + G +V E+V +L ++ + + R ++I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG-NTNRIVGTYG 515
+ + H+ IIHRD+K +NI++ A K+ DFG+A+ T ++GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
Y++PE A +SDVYS G ++ E++TG+
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 166 bits (420), Expect = 3e-47
Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQH 401
+F LG G FG V+ +G+ A+K L + + + +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYL 461
++R+ G + ++ ++ +++ L L + ++ + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY 521
II+RDLK NILLD + KI+DFG AK T + GT Y+APE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEV 172
Query: 522 AMHGQFSVKSDVYSFGVLVLEIITGKK 548
++ D +SFG+L+ E++ G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-47
Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 12/198 (6%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFC 411
LG G FG V++ V S + K + + G K E+ ++ +HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 412 LEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 471
EE ++++EF+ + + +L+ + + + +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 472 RDLKASNILLDAEMNP--KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSV 529
D++ NI+ + KI +FG A+ N + Y APE H S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVST 182
Query: 530 KSDVYSFGVLVLEIITGK 547
+D++S G LV +++G
Sbjct: 183 ATDMWSLGTLVYVLLSGI 200
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (417), Expect = 5e-47
Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 338 FETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE-FKNEVVL 395
++ E + + + LG G F EV + + +A+K +++ + +G + +NE+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 396 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIA 455
+ K++H N+V L G L+ + V L + ++ ++I +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVL 117
Query: 456 RGILYLHEDSRLRIIHRDLKASNILL---DAEMNPKISDFGMAKIFGVDQTQGNTNRIVG 512
+ YLH+ I+HRDLK N+L D + ISDFG++K+ + G
Sbjct: 118 DAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACG 171
Query: 513 TYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
T GY+APE +S D +S GV+ ++ G
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 7e-47
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN----EVVLVAKLQ 400
+F LG+G FG+V+ + Q A+K L + + + + VL +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 401 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILY 460
H L + E V E++ L Y + + + D SR I G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQF 118
Query: 461 LHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520
LH I++RDLK NILLD + + KI+DFGM K + + NT GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 521 YAMHGQFSVKSDVYSFGVLVLEIITGK 547
+ +++ D +SFGVL+ E++ G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (409), Expect = 3e-46
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG---------QEFKNEVVLV 396
N+ LG G V + + P+ +E AVK + + G + EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 397 AKLQ-HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIA 455
K+ H N+++L LV++ + L +L ++ L KI+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 456 RGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYG 515
I LH+ L I+HRDLK NILLD +MN K++DFG + + + GT
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPS 174
Query: 516 YMAPEYAM------HGQFSVKSDVYSFGVLVLEIITGK 547
Y+APE H + + D++S GV++ ++ G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 1e-45
Identities = 46/219 (21%), Positives = 87/219 (39%), Gaps = 18/219 (8%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNL 404
N + K+G G FG++Y G + +G+E+A+K + + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 405 VRLLGFCL-EGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
+ + +C EG+ ++V E + D F + ++ + + I Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 464 DSRLRIIHRDLKASNIL---LDAEMNPKISDFGMAKIFGVDQTQGN-----TNRIVGTYG 515
IHRD+K N L I DFG+AK + +T + + GT
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 516 YMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 554
Y + + + S + D+ S G +++ G +
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 159 bits (403), Expect = 2e-45
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 11/205 (5%)
Query: 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSRSSGQGGQEFKNEVVLVAKLQHRN 403
+ K+GEG +G VYK G+ A+K RL + E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
+V+L + +LV+E + + L+ + + GI Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAM 523
R++HRDLK N+L++ E KI+DFG+A+ FG+ + + T Y AP+ M
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
Query: 524 -HGQFSVKSDVYSFGVLVLEIITGK 547
++S D++S G + E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 3e-45
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 344 ATNNFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSRSSGQGGQE--FKNEVVLVAKL 399
A + ++GEG +G+V+K + G+ +A+KR+ +G+ G EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 400 ---QHRNLVRLLGFCLEGEEK-----ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKII 451
+H N+VRL C LV+E V Y PE + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMM 122
Query: 452 GGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIV 511
+ RG+ +LH R++HRDLK NIL+ + K++DFG+A+I+ +V
Sbjct: 123 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVV 176
Query: 512 GTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
T Y APE + ++ D++S G + E+ K
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 7e-45
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLV 405
+++ +G G FG VY+ L SG+ +A+K++ + + E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 406 RLLGFCLEGEEK------ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGIL 459
RL F EK LV ++VP + +Q L + + R +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 460 YLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMA 518
Y+H I HRD+K N+LLD + K+ DFG AK + + + + Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 519 PEYAMHG-QFSVKSDVYSFGVLVLEIITGK 547
PE ++ DV+S G ++ E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 8e-45
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 352 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE-----FKNEVVLVAKLQHRNLV 405
+ LGEG F VYK + Q +A+K++ ++ E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 406 RLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS 465
LL LV++F+ + L S + +G+ YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 466 RLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHG 525
I+HRDLK +N+LLD K++DFG+AK FG V T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGA 175
Query: 526 Q-FSVKSDVYSFGVLVLEIITGK 547
+ + V D+++ G ++ E++
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-44
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 11/205 (5%)
Query: 347 NFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSRSSGQGGQEFKNEVVLVAKLQHRN 403
NF K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
+V+LL + LV+EF+ + + + + +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 464 DSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE-YA 522
R++HRDLK N+L++ E K++DFG+A+ FGV V T Y APE
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175
Query: 523 MHGQFSVKSDVYSFGVLVLEIITGK 547
+S D++S G + E++T +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 155 bits (393), Expect = 9e-44
Identities = 41/214 (19%), Positives = 85/214 (39%), Gaps = 20/214 (9%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRN- 403
++ ++GEG FG +++G L + Q++A+K R S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 404 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
+ + F EG +LV + + D ++ + + +HE
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 464 DSRLRIIHRDLKASNILLDAEMNP-----KISDFGMAKIFGVDQTQGN-----TNRIVGT 513
+++RD+K N L+ + + DFGM K + T+ + + GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 514 YGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
YM+ + + S + D+ + G + + + G
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 9e-42
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSS------GQGGQEFKNEVVLVAK 398
+ + T +LG G F V K +G + A K + + G ++ + EV ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 399 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGI 458
+QH N++ L + IL+ E V L FL +++ L + + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNG- 125
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNP----KISDFGMAKIFGVDQTQGNTNRIVGTY 514
++ L+I H DLK NI+L P KI DFG+A I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 515 GYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
++APE + +++D++S GV+ +++G
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-41
Identities = 46/213 (21%), Positives = 85/213 (39%), Gaps = 20/213 (9%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE------FKNEVVLVAK 398
+ + LG GGFG VY G+ + +A+K + + E EVVL+ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 399 LQ--HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIAR 456
+ ++RLL + + +L+ E + ++ L +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAKIFGVDQTQGNTNRIVGTYG 515
+ + H ++HRD+K NIL+D K+ DFG + GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174
Query: 516 YMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGK 547
Y PE+ + ++ + V+S G+L+ +++ G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-41
Identities = 51/217 (23%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG--QEFKNEVVLVAKLQHR 402
+ + K+G+G FGEV+K +GQ++A+K++ + + G E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 403 NLVRLLGFCLEGEEKI--------LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGI 454
N+V L+ C LV++F + K + R +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR-------V 122
Query: 455 ARGIL-YLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR--IV 511
+ +L L+ R +I+HRD+KA+N+L+ + K++DFG+A+ F + + V
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 512 GTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 547
T Y PE + + + D++ G ++ E+ T
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 6e-41
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 21/207 (10%)
Query: 350 TDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRL 407
T LG G G+V + + ++ A+K L + + EV L + Q ++VR+
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 70
Query: 408 LGFCLEGEEK----ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE 463
+ ++V E + L + + Q +I+ I I YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 464 DSRLRIIHRDLKASNILLDAEMNP---KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPE 520
+ I HRD+K N+L ++ K++DFG AK + T Y+APE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPE 183
Query: 521 YAMHGQFSVKSDVYSFGVLVLEIITGK 547
++ D++S GV++ ++ G
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 12/209 (5%)
Query: 343 VATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE---FKNEVVLVAK 398
V N+F LG+G FG+V +G+ A+K L + E E ++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 399 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGI 458
+H L L + V E+ L + L +++ R I
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA- 117
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMA 518
L +++RD+K N++LD + + KI+DFG+ K D GT Y+A
Sbjct: 118 --LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLA 173
Query: 519 PEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
PE + D + GV++ E++ G+
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-40
Identities = 47/223 (21%), Positives = 94/223 (42%), Gaps = 12/223 (5%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGG--QEFKNEVVLVAKLQHR 402
+ K+GEG +G V+K + + +A+KR+ G E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 403 NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLH 462
N+VRL ++ LV+EF YF + + + + + + L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSF-----LFQLLKGLG 115
Query: 463 EDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYA 522
++HRDLK N+L++ K+++FG+A+ FG+ + +V +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLF 174
Query: 523 MHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYV 565
+S D++S G + E+ + + + D L +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR--PLFPGNDVDDQLKRI 215
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (361), Expect = 9e-39
Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 15/206 (7%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQE---FKNEVVLVAKLQH 401
+ F LG G FG V SG A+K L + ++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYL 461
LV+L + +V E+V + L + + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEY 521
H L +I+RDLK N+L+D + +++DFG AK + +G T + GT +APE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 522 AMHGQFSVKSDVYSFGVLVLEIITGK 547
+ ++ D ++ GVL+ E+ G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-38
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 346 NNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHR 402
+ +G G +G V V +G ++A+K+L R S + E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 403 NLVRLLGFCLEGE------EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIAR 456
N++ LL E + LV F+ K ++L R ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 457 GILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGY 516
G+ Y+H IIHRDLK N+ ++ + KI DFG+A+ Q V T Y
Sbjct: 133 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184
Query: 517 MAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 547
APE ++ ++ D++S G ++ E+ITGK
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 7e-37
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 27/226 (11%)
Query: 337 DFETIEVATNNFSTDNK------LGEGGFGEVYKGV-LPSGQEIAVKRLSRS--SGQGGQ 387
F ++EV + F+ + +G G G V + +A+K+LSR + +
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 388 EFKNEVVLVAKLQHRNLVRLLGFCL------EGEEKILVYEFVPNKSLDYFLYEPEKQQQ 441
E+VL+ + H+N++ LL E ++ LV E + Q +
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QME 115
Query: 442 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501
LD R ++ + GI +LH IIHRDLK SNI++ ++ KI DFG+A+ G
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
V T Y APE + + D++S G ++ E++ K
Sbjct: 173 FM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 136 bits (342), Expect = 2e-36
Identities = 49/221 (22%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 336 FDFETIEVATNN---FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKN 391
+D+E+ V N + KLG G + EV++ + + + +++ VK L ++ K
Sbjct: 22 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKR 78
Query: 392 EVVLVAKLQ-HRNLVRLLGFCLEGEEK--ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRY 448
E+ ++ L+ N++ L + + LV+E V N Q L
Sbjct: 79 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIR 132
Query: 449 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAKIFGVDQTQGNT 507
+ I + + Y H + I+HRD+K N+++D E ++ D+G+A+ + Q
Sbjct: 133 FYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--- 186
Query: 508 NRIVGTYGYMAPEYAM-HGQFSVKSDVYSFGVLVLEIITGK 547
N V + + PE + + + D++S G ++ +I K
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 8e-35
Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 18/228 (7%)
Query: 331 LESLQFDFETIEVATNNFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSRSS---- 382
L + +V NF LG G +G+V+ +G+ A+K L +++
Sbjct: 9 LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK 68
Query: 383 GQGGQEFKNEVVLVAKLQHR-NLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQ 441
+ + + E ++ ++ LV L + L+ +++ L L ++++
Sbjct: 69 AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRER 125
Query: 442 LDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501
+G I + +LH+ L II+RD+K NILLD+ + ++DFG++K F D
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182
Query: 502 QTQGNTNRIVGTYGYMAPEYAMHGQ--FSVKSDVYSFGVLVLEIITGK 547
+T+ GT YMAP+ G D +S GVL+ E++TG
Sbjct: 183 ETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 125 bits (315), Expect = 2e-32
Identities = 37/210 (17%), Positives = 81/210 (38%), Gaps = 18/210 (8%)
Query: 353 KLGEGGFGEVYKGV-LPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFC 411
KLG G F V+ + + +A+K + + ++E+ L+ ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 412 LEGEEKILVYEFVPNKSLDYFLYEPE-------------KQQQLDWSRRYKIIGGIARGI 458
K+L + + + + E + + + +I + G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 459 LYLHEDSRLRIIHRDLKASNILLDAE-MNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYM 517
Y+H R IIH D+K N+L++ + +A + + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 518 APEYAMHGQFSVKSDVYSFGVLVLEIITGK 547
+PE + + +D++S L+ E+ITG
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-32
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 13/214 (6%)
Query: 339 ETIEVATNNFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSRS--SGQGGQEFKNEVVL 395
+TI + + +G G +G V +G +AVK+LSR S + E+ L
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 396 VAKLQHRNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGI 454
+ ++H N++ LL ++ + L K Q+L +I I
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 455 ARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTY 514
RG+ Y+H IIHRDLK SN+ ++ + KI DFG+A+ + T R
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW---- 183
Query: 515 GYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGK 547
Y APE ++ ++ D++S G ++ E++TG+
Sbjct: 184 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 106 bits (264), Expect = 5e-27
Identities = 37/202 (18%), Positives = 73/202 (36%), Gaps = 27/202 (13%)
Query: 352 NKLGEGGFGEVYKGVLPSGQEIAVK--RLSRSSGQ--------GGQEFKNEVVLVAKLQH 401
+GEG V+ E VK ++ +S + G F + A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 402 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYL 461
R L +L G + VY + N ++ L + ++ ++ +++ I +
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 462 HEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNR-IVGTYGYMAPE 520
+ I+H DL N+L+ E I DF + G + + R + Y +
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175
Query: 521 YAMHGQFSVKSDVYSFGVLVLE 542
Y + D+ S +L+
Sbjct: 176 Y------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 573 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.98 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.62 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.09 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.49 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.15 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.46 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.18 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=367.43 Aligned_cols=201 Identities=29% Similarity=0.466 Sum_probs=176.2
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|++.++||+|+||+||+|+. .+|+.||||++.... .+..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4689999999999999999995 478999999987543 33446789999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++|+|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||+++++++||+|||+++.......
T Consensus 85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999853 457999999999999999999999987 99999999999999999999999999987654443
Q ss_pred ccccccccccCCccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.......+||+.|||||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~ 208 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCC
Confidence 344456789999999999988876 5789999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=366.38 Aligned_cols=198 Identities=27% Similarity=0.485 Sum_probs=179.6
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.++|++.++||+|+||+||+|+. .+|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 35799999999999999999995 57999999999876666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++|+|.+++. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+....
T Consensus 99 ~~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp CTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred cCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 99999998873 356999999999999999999999987 9999999999999999999999999998764332
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......+||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 217 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCC
Confidence 23345689999999999999999999999999999999999999984
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=365.72 Aligned_cols=202 Identities=33% Similarity=0.535 Sum_probs=169.2
Q ss_pred HHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
+..++|++.++||+|+||+||+|+++ ..||||+++.. .....+.|.+|+.++++++|||||++++++.+ +..++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 44578999999999999999999874 35999998654 34456789999999999999999999998754 568999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 82 ~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999999964 3356999999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCccccccccccCCccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
...........||+.|||||++.+ +.++.++|||||||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~ 211 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence 443344456789999999999864 3589999999999999999999999853
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=359.24 Aligned_cols=209 Identities=28% Similarity=0.444 Sum_probs=181.7
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||+||+++. .+++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 3688999999999999999996 46889999998643 2344567899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++. +...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999985 3457999999999999999999999987 999999999999999999999999999765322
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
......||+.|||||++.+..++.++|||||||++|||++|+.||.. ....++++.+..
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~---~~~~~~~~~i~~ 218 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISR 218 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHHT
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC---CCHHHHHHHHHc
Confidence 23456799999999999999999999999999999999999999753 334445554444
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=362.78 Aligned_cols=213 Identities=26% Similarity=0.399 Sum_probs=182.7
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
+.|++.++||+|+||+||+|+. .+++.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4689999999999999999995 578899999998777777788999999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++|+|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+|||++.++++||+|||+++..... .
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~ 164 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I 164 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence 99999998753 2357999999999999999999999987 999999999999999999999999999754321 1
Q ss_pred cccccccccCCccchhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhh
Q 008238 505 GNTNRIVGTYGYMAPEYAM-----HGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSIN 568 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~ 568 (573)
.......||+.|||||++. +..++.++|||||||++|||++|+.||.. ....+++..+...
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~---~~~~~~~~~i~~~ 230 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE---LNPMRVLLKIAKS 230 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT---SCGGGHHHHHHHS
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC---CCHHHHHHHHHcC
Confidence 1233467999999999984 45678999999999999999999999753 2344455444443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=358.44 Aligned_cols=213 Identities=29% Similarity=0.465 Sum_probs=173.0
Q ss_pred CCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
++|++.++||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788999999999999999998888899999997543 445789999999999999999999999999999999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 157 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence 9999999864 3456899999999999999999999987 99999999999999999999999999986643322 2
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
......||+.|+|||++.+..++.++|||||||++|||+||..|+. ......++++.+..
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~--~~~~~~~~~~~i~~ 217 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY--ENRSNSEVVEDIST 217 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT--CSCCHHHHHHHHHH
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC--CCCCHHHHHHHHHh
Confidence 2334578999999999999999999999999999999999655532 22344455555543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=363.10 Aligned_cols=214 Identities=26% Similarity=0.383 Sum_probs=181.2
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||+||+|+. .+++.||||++.+. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4699999999999999999995 57899999998643 2334567899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999884 3457999999999999999999999987 999999999999999999999999999977554
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhh
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSIN 568 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~ 568 (573)
.........+||+.|||||++.+..++.++|||||||++|||++|+.||.. ....++++.+...
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~~~~~~~~i~~~ 225 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKL 225 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHTT
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC---cCHHHHHHHHHcC
Confidence 444445567899999999999999999999999999999999999999853 3344455544443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=360.30 Aligned_cols=216 Identities=32% Similarity=0.513 Sum_probs=181.2
Q ss_pred HHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++..++|++.++||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 34456789999999999999999999888899999997543 445789999999999999999999998754 5679999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++... ....+++..+++|+.||++||+|||+++ |+||||||+||||++++.+||+|||+++.....
T Consensus 87 Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence 999999999987543 2346899999999999999999999987 999999999999999999999999999876533
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVS 566 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~ 566 (573)
.. .......||+.|||||++.++.++.++|||||||++|||+||..|+. ......++++.+.
T Consensus 163 ~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~--~~~~~~~~~~~i~ 224 (272)
T d1qpca_ 163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY--PGMTNPEVIQNLE 224 (272)
T ss_dssp CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS--TTCCHHHHHHHHH
T ss_pred cc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC--CCCCHHHHHHHHH
Confidence 22 22334578999999999999999999999999999999999776642 2233444555443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=372.10 Aligned_cols=199 Identities=28% Similarity=0.396 Sum_probs=176.6
Q ss_pred HhCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 344 ATNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 344 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
..++|++.++||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 456899999999999999999995 578999999997543 344567899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
||+++|+|.+++.+ ...+++..+..++.||+.||+|||++ + |+||||||+||||++++++||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999953 45699999999999999999999974 5 99999999999999999999999999986532
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
. .....+||+.|||||++.+..++.++||||+||++|||++|+.||..
T Consensus 158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2 23346899999999999999999999999999999999999999854
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-45 Score=362.34 Aligned_cols=205 Identities=31% Similarity=0.481 Sum_probs=179.5
Q ss_pred HHHHHhCCCCcccccccccceeEEEEecC-CCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 340 TIEVATNNFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 340 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
++++..++|++.++||+|+||+||+|++. +++.||||+++... ...++|.+|+.++++++|||||++++++.+++..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 34455667999999999999999999964 58899999987543 34678999999999999999999999999999999
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+||||+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++..
T Consensus 90 iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999999998542 3457899999999999999999999987 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
..... .......|++.|||||++.++.++.++|||||||++|||++|+.|+
T Consensus 166 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~ 216 (287)
T d1opja_ 166 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216 (287)
T ss_dssp CSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence 43322 2233456889999999999999999999999999999999988775
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=359.02 Aligned_cols=219 Identities=26% Similarity=0.387 Sum_probs=172.1
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEc--CCeeEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE--GEEKILV 420 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 420 (573)
++|++.+.||+|+||+||+++. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5699999999999999999985 578999999987653 2334668899999999999999999999875 3457899
Q ss_pred EEccCCCChhhhccCc-CccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 421 YEFVPNKSLDYFLYEP-EKQQQLDWSRRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
|||+++|+|.+++... .....+++..++.++.||+.||+|||+++ ..+|+||||||+||||++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998543 23467999999999999999999999864 23599999999999999999999999999987
Q ss_pred ccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhhc
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSINR 569 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~~ 569 (573)
+.... .......||+.|||||++.+..++.++|||||||++|||+||+.||.. ....++...+....
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~---~~~~~~~~~i~~~~ 230 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA---FSQKELAGKIREGK 230 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHTC
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC---CCHHHHHHHHHcCC
Confidence 64332 223456899999999999999999999999999999999999999853 33445555555443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=345.22 Aligned_cols=212 Identities=26% Similarity=0.439 Sum_probs=184.1
Q ss_pred CCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccC
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 425 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 425 (573)
++|++.++||+|+||+||+|++++++.||||++++.. ...++|.+|++++++++||||++++|++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5789999999999999999999888899999998654 345789999999999999999999999999999999999999
Q ss_pred CCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCcc
Q 008238 426 NKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQG 505 (573)
Q Consensus 426 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 505 (573)
+|+|..++.. ....+++..+++++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 156 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T 156 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-e
Confidence 9999999754 3457899999999999999999999987 99999999999999999999999999986644322 2
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHh
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~~ll~~~~~ 567 (573)
......||..|+|||.+.+..++.++||||||+++|||+| |+.||+.. ...++...+..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~---~~~~~~~~i~~ 216 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQ 216 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS---CHHHHHHHHHT
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC---CHHHHHHHHHh
Confidence 3334578999999999999999999999999999999998 78887643 34445554443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=358.78 Aligned_cols=213 Identities=23% Similarity=0.330 Sum_probs=184.7
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.+.||+|+||.||+++. .+|+.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 4699999999999999999995 57999999999754 2334567889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|.+++. +...+++..++.++.||+.||+|||+++ |+||||||+|||++++|.+||+|||+++.....
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999985 3467899999999999999999999988 999999999999999999999999999865332
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhhc
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSINR 569 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~~ 569 (573)
. ......+||+.|||||++.+..++.++|||||||++|||++|+.||.. ++..++.+.+....
T Consensus 159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~---~~~~~~~~~i~~~~ 221 (337)
T d1o6la_ 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEE 221 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHCC
T ss_pred C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC---cCHHHHHHHHhcCC
Confidence 2 233457899999999999999999999999999999999999999753 33445555554433
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=347.77 Aligned_cols=195 Identities=30% Similarity=0.463 Sum_probs=167.4
Q ss_pred CCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEc----CCeeEEE
Q 008238 348 FSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE----GEEKILV 420 (573)
Q Consensus 348 ~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv 420 (573)
|++.++||+|+||+||+|+. .+++.||+|++... .....+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 36677899999999999995 46889999998654 23345678999999999999999999999865 3457899
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC-CCCCeEEeccCCccccc
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-AEMNPKISDFGMAKIFG 499 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~vkl~DfGla~~~~ 499 (573)
|||+++|+|.+++. +...+++..++.++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999985 3457999999999999999999999875 4599999999999996 57899999999998543
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
. ......+||+.|||||++.+ .++.++|||||||++|||++|+.||.
T Consensus 167 ~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~ 213 (270)
T d1t4ha_ 167 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 213 (270)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred C----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCC
Confidence 2 22345689999999998754 69999999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-43 Score=359.79 Aligned_cols=211 Identities=23% Similarity=0.387 Sum_probs=183.8
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
++|++.+.||+|+||.||+++. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4799999999999999999995 578999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC--CCCCeEEeccCCcccccCCC
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~~vkl~DfGla~~~~~~~ 502 (573)
++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999998854 3356999999999999999999999988 99999999999995 46789999999998764332
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
......||+.|||||++.+..++.++|||||||++|||++|+.||.- +...+++..+..
T Consensus 181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~---~~~~~~~~~i~~ 239 (350)
T d1koaa2 181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG---ENDDETLRNVKS 239 (350)
T ss_dssp ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHH
T ss_pred ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC---CCHHHHHHHHHh
Confidence 23446899999999999999999999999999999999999999753 334455554443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-44 Score=355.92 Aligned_cols=214 Identities=28% Similarity=0.480 Sum_probs=168.1
Q ss_pred CCCCcccccccccceeEEEEecC-CCC---eeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQ---EIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
++|++.++||+|+||+||+|+++ +++ .||||++.... ....++|.+|+++|++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 46788899999999999999964 333 58899886543 34456799999999999999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++|+|.+++.. ....+++.+++.++.||++||+|||+++ |+||||||+||||+.++++||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998864 3456999999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCcc---ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHh
Q 008238 501 DQTQG---NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 501 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~~ll~~~~~ 567 (573)
..... ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.. ....+++..+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~---~~~~~~~~~i~~ 248 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD---MTNQDVINAIEQ 248 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHHHHHT
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC---CCHHHHHHHHHc
Confidence 33221 1222457899999999999999999999999999999998 8999753 233445555443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-44 Score=357.52 Aligned_cols=198 Identities=26% Similarity=0.384 Sum_probs=160.3
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
.+.|++.+.||+|+||+||+++. .+++.||||++.+.. ......+.+|+.++++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 45699999999999999999995 468999999987543 2334568899999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC---CCCCeEEeccCCccccc
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGMAKIFG 499 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~vkl~DfGla~~~~ 499 (573)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999953 457999999999999999999999987 99999999999994 57899999999998654
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
... .....+||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 210 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 210 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCC
Confidence 322 2334679999999999999999999999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-43 Score=358.31 Aligned_cols=211 Identities=23% Similarity=0.347 Sum_probs=183.5
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
++|++.++||+|+||+||+|+. .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4699999999999999999995 579999999998766556677899999999999999999999999999999999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC--CCCCeEEeccCCcccccCCC
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--AEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~~vkl~DfGla~~~~~~~ 502 (573)
++|+|.+++.. ....+++.+++.|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+++.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999887743 3456999999999999999999999987 99999999999997 67899999999998765332
Q ss_pred CccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
......||+.|||||++.+..++.++|||||||++|||++|+.||.. ....+++..+..
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~---~~~~~~~~~i~~ 242 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKR 242 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC---SSHHHHHHHHHH
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHh
Confidence 23446789999999999999999999999999999999999999753 334445554443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-43 Score=353.27 Aligned_cols=194 Identities=33% Similarity=0.490 Sum_probs=171.3
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
+.|+..++||+|+||+||+|+. .+++.||||++..... ...+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3489999999999999999994 5788999999876543 23356889999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|..++. ....+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999977663 3457999999999999999999999987 99999999999999999999999999986432
Q ss_pred CCccccccccccCCccchhcccc---CCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMH---GQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.....||+.|||||++.+ +.++.++|||||||++|||++|+.||.
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~ 215 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence 234579999999999854 468999999999999999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-44 Score=360.38 Aligned_cols=209 Identities=28% Similarity=0.436 Sum_probs=176.1
Q ss_pred HHHHhCCCCcccccccccceeEEEEecCC-C-----CeeEEEEeccC-CccchHHHHHHHHHHHhc-CCCccceEEEEEE
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVLPS-G-----QEIAVKRLSRS-SGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCL 412 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 412 (573)
+++..++|++.++||+|+||+||+|++.. + ..||||++... .......+.+|+.++.++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 34556789999999999999999998632 2 25899998654 334456789999999998 8999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcCc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEee
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPEK--------------------QQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHR 472 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~ 472 (573)
+.+..++||||+++|+|.++++.... ...+++..++.++.||++||+|||+++ |+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 99999999999999999999965321 245899999999999999999999987 9999
Q ss_pred cCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 008238 473 DLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSS 551 (573)
Q Consensus 473 Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~ 551 (573)
||||+|||++.++++||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654443333445678999999999999999999999999999999998 899975
Q ss_pred C
Q 008238 552 F 552 (573)
Q Consensus 552 ~ 552 (573)
.
T Consensus 269 ~ 269 (325)
T d1rjba_ 269 G 269 (325)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-43 Score=353.61 Aligned_cols=207 Identities=26% Similarity=0.385 Sum_probs=180.2
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.++||+|+||+||+++. .+|+.||||++++. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4689999999999999999995 57899999998643 2344577899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999998884 3456889999999999999999999987 999999999999999999999999999875422
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVS 566 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~ 566 (573)
....+||+.|||||++.+..++.++|||||||++|||++|+.||.. ....++...+.
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~---~~~~~~~~~i~ 214 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKIL 214 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHH
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC---cCHHHHHHHHH
Confidence 2346899999999999999999999999999999999999999853 33344444443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=348.67 Aligned_cols=213 Identities=30% Similarity=0.520 Sum_probs=177.4
Q ss_pred CCCCccc-ccccccceeEEEEecC---CCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEE
Q 008238 346 NNFSTDN-KLGEGGFGEVYKGVLP---SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 346 ~~~~~~~-~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 420 (573)
+++.+.+ +||+|+||+||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566667 5999999999999753 34579999997654 3345789999999999999999999999865 568999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++|+|.+++.. ....+++..+++++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998754 3457999999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCc-cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHh
Q 008238 501 DQTQ-GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 501 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~~ll~~~~~ 567 (573)
.... .......||+.|||||++.++.++.++|||||||++|||+| |+.||... ...+++..+..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~---~~~~~~~~i~~ 227 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQ 227 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CTHHHHHHHHT
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC---CHHHHHHHHHc
Confidence 3322 22334568999999999999999999999999999999998 89998642 23345555543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=346.27 Aligned_cols=211 Identities=28% Similarity=0.428 Sum_probs=181.1
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC------ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS------GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 417 (573)
.++|++.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35799999999999999999995 578999999986432 22357799999999999999999999999999999
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC----CeEEeccC
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM----NPKISDFG 493 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~vkl~DfG 493 (573)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999853 357999999999999999999999987 99999999999998776 59999999
Q ss_pred CcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.. +...+++..+..
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~~~~~~~~i~~ 230 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG---DTKQETLANVSA 230 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHT
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC---CCHHHHHHHHHh
Confidence 998764332 23345789999999999999999999999999999999999999753 334444444433
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=349.15 Aligned_cols=215 Identities=28% Similarity=0.493 Sum_probs=171.3
Q ss_pred hCCCCcccccccccceeEEEEecCCC-----CeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSG-----QEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
.+.|++.+.||+|+||+||+|+++.. ..||||++..... ....+|.+|+.++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 34688899999999999999986532 3699999975433 33457899999999999999999999999999999
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+||||+.++++.+++.. ....+++.++++++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999888754 3357999999999999999999999987 999999999999999999999999999876
Q ss_pred cCCCCcc-ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 008238 499 GVDQTQG-NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVS 566 (573)
Q Consensus 499 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~ 566 (573)
....... ......||+.|||||++.++.++.++|||||||++|||++|..|+.. .....++++.+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~--~~~~~~~~~~i~ 227 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAIN 227 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT--TCCHHHHHHHHH
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc--cCCHHHHHHHHh
Confidence 4432222 22345689999999999999999999999999999999997776532 223344554443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=351.17 Aligned_cols=214 Identities=30% Similarity=0.464 Sum_probs=175.7
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEcc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFV 424 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 424 (573)
.++|++.++||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 4579999999999999999999988889999999754 3456789999999999999999999999854 5689999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++|+|..++... ....++|.+++.++.||++||+|||+++ |+||||||+||||++++++||+|||+++.......
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence 999999888542 2356999999999999999999999987 99999999999999999999999999986643322
Q ss_pred cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 505 GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 505 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
.......||+.|+|||++.++.++.++||||||+++|||++|..|+.. .....+++..+..
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~--~~~~~~~~~~i~~ 229 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--GMVNREVLDQVER 229 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST--TCCHHHHHHHHHT
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC--CCCHHHHHHHHHh
Confidence 223345789999999999999999999999999999999998777532 3344555655543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=346.74 Aligned_cols=206 Identities=30% Similarity=0.463 Sum_probs=170.1
Q ss_pred cccccccceeEEEEecC---CCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEccCC
Q 008238 352 NKLGEGGFGEVYKGVLP---SGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPN 426 (573)
Q Consensus 352 ~~LG~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 426 (573)
++||+|+||+||+|.++ .++.||||+++... ....++|.+|++++++++|||||+++|++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 34679999986532 3345679999999999999999999999865 567899999999
Q ss_pred CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc-c
Q 008238 427 KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ-G 505 (573)
Q Consensus 427 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~-~ 505 (573)
|+|.+++. +...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999985 3457999999999999999999999987 999999999999999999999999999876543322 2
Q ss_pred ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHh
Q 008238 506 NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 506 ~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~~ll~~~~~ 567 (573)
......||+.|||||.+.+..++.++|||||||++|||+| |+.||... ...++...+..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~---~~~~~~~~i~~ 225 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEK 225 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHT
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC---CHHHHHHHHHc
Confidence 2234578999999999999999999999999999999998 89997532 33445555544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-43 Score=350.03 Aligned_cols=223 Identities=27% Similarity=0.461 Sum_probs=185.0
Q ss_pred HHHHHhCCCCcccccccccceeEEEEecC------CCCeeEEEEeccCCcc-chHHHHHHHHHHHhcCCCccceEEEEEE
Q 008238 340 TIEVATNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSSGQ-GGQEFKNEVVLVAKLQHRNLVRLLGFCL 412 (573)
Q Consensus 340 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~ 412 (573)
.++.+.++|++.++||+|+||+||+|+++ +++.||||+++..... ..++|.+|+.++++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34456678999999999999999999853 3568999999754433 3567999999999999999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcC---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPE---------------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIH 471 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH 471 (573)
..+..+++|||+++|+|.++++... ....+++..++.|+.||+.||+|||+++ |+|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999985321 2345899999999999999999999987 999
Q ss_pred ecCCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCC-CC
Q 008238 472 RDLKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK-NS 550 (573)
Q Consensus 472 ~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~-p~ 550 (573)
|||||+||||+.++++||+|||+++...............|++.|+|||.+.+..++.++|||||||++|||++|.. |+
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999999987654433334445678999999999999999999999999999999999975 44
Q ss_pred CCCCCCCcccHHHHHHhh
Q 008238 551 SFYQTDGAADLLSYVSIN 568 (573)
Q Consensus 551 ~~~~~~~~~~ll~~~~~~ 568 (573)
. .....+++..+...
T Consensus 244 ~---~~~~~e~~~~v~~~ 258 (301)
T d1lufa_ 244 Y---GMAHEEVIYYVRDG 258 (301)
T ss_dssp T---TSCHHHHHHHHHTT
T ss_pred C---CCCHHHHHHHHHcC
Confidence 3 33455566665544
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-42 Score=353.34 Aligned_cols=209 Identities=24% Similarity=0.302 Sum_probs=182.1
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 421 (573)
++|++.++||+|+||+||+++. .+|+.||||++.+. .....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4699999999999999999995 57999999998643 2334567899999999999999999999999999999999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVD 501 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~ 501 (573)
||+.+|+|..++. +...+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999984 3457999999999999999999999987 999999999999999999999999999876422
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhh
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSIN 568 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~ 568 (573)
.....||+.|||||++.+..++.++|||||||++|||+||+.||.. +....++..+...
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~---~~~~~~~~~i~~~ 253 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA---DQPIQIYEKIVSG 253 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHC
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC---cCHHHHHHHHhcC
Confidence 2346899999999999999999999999999999999999999753 3344555555443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=346.04 Aligned_cols=213 Identities=28% Similarity=0.444 Sum_probs=180.9
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHHHHHHHH-hcCCCccceEEEEEEcCCeeEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKNEVVLVA-KLQHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 420 (573)
++|++.+.||+|+||+||+|+. .+++.||||++++.. ....+.+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4789999999999999999995 478999999997532 333455666766665 68999999999999999999999
Q ss_pred EEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccC
Q 008238 421 YEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~ 500 (573)
|||+++|+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999995 3456899999999999999999999987 99999999999999999999999999986543
Q ss_pred CCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhhc
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSINR 569 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~~ 569 (573)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.. +...++...+....
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~---~~~~~~~~~i~~~~ 219 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELFHSIRMDN 219 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHCC
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC---CCHHHHHHHHHcCC
Confidence 22 233456899999999999999999999999999999999999999853 34455555554443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=348.50 Aligned_cols=212 Identities=31% Similarity=0.526 Sum_probs=172.1
Q ss_pred CCCCcccccccccceeEEEEecC-CCC----eeEEEEeccC-CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQ----EIAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 419 (573)
.+|++.++||+|+||+||+|++. +|+ +||+|+++.. .....++|.+|++++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35899999999999999999853 444 5899988653 345567899999999999999999999999875 5678
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFG 499 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~ 499 (573)
++||+.+|+|.+++.. ....+++..+++++.||++||+|||+++ |+||||||+||||+.++++||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999888754 3467999999999999999999999987 9999999999999999999999999999776
Q ss_pred CCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 008238 500 VDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLLSYVS 566 (573)
Q Consensus 500 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~~ll~~~~ 566 (573)
............||+.|||||++.++.++.++|||||||++|||+| |+.||... ...++...+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~---~~~~~~~~i~ 227 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 227 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS---CGGGHHHHHH
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC---CHHHHHHHHH
Confidence 5444444455678999999999999999999999999999999999 77786532 2334444443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.5e-42 Score=353.44 Aligned_cols=199 Identities=28% Similarity=0.402 Sum_probs=170.7
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC---ccchHHHHH---HHHHHHhcCCCccceEEEEEEcCCeeE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS---GQGGQEFKN---EVVLVAKLQHRNLVRLLGFCLEGEEKI 418 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~ 418 (573)
++|++.+.||+|+||.||+|+. .+|+.||||++.+.. ......+.+ |+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999995 478999999986432 122233333 466777788999999999999999999
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
+||||+++|+|.+++. +...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+
T Consensus 84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999985 3457899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 554 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~~~ 554 (573)
... ......||+.|||||++.. ..++.++|||||||++|||+||+.||....
T Consensus 158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 433 2334579999999999875 468999999999999999999999986443
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=344.48 Aligned_cols=213 Identities=28% Similarity=0.408 Sum_probs=170.4
Q ss_pred cchhHHHHHhCCCCcccccccccceeEEEEecC------CCCeeEEEEeccCC-ccchHHHHHHHHHHHhc-CCCccceE
Q 008238 336 FDFETIEVATNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKL-QHRNLVRL 407 (573)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l 407 (573)
++..++++..++|++.++||+|+||.||+|++. +++.||||+++... ....+.+.+|..++.++ +|+||+++
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 455666677788999999999999999999853 34679999987543 33345677888888777 68999999
Q ss_pred EEEEEcC-CeeEEEEEccCCCChhhhccCcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeec
Q 008238 408 LGFCLEG-EEKILVYEFVPNKSLDYFLYEPE-------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRD 473 (573)
Q Consensus 408 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~D 473 (573)
++++... ...++||||+++|+|.++++... ....+++.+++.++.||++||+|||+++ |+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 9998765 46799999999999999986432 1345899999999999999999999987 99999
Q ss_pred CCCCCEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCC-CCC
Q 008238 474 LKASNILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKK-NSS 551 (573)
Q Consensus 474 lkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~-p~~ 551 (573)
|||+||||++++++||+|||+++...............||+.|||||++.++.++.++|||||||++|||+||.. ||.
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987655544444556789999999999999999999999999999999999865 554
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=341.26 Aligned_cols=212 Identities=21% Similarity=0.327 Sum_probs=181.4
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.++|++.+.||+|+||+||+|+. .+++.||||+++... .....+.+|+++|+.++|||||++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 46799999999999999999995 468899999997643 3345688999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCC--CCeEEeccCCcccccCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAE--MNPKISDFGMAKIFGVD 501 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~--~~vkl~DfGla~~~~~~ 501 (573)
+++|+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999954 2346999999999999999999999987 9999999999999854 58999999999865432
Q ss_pred CCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHhh
Q 008238 502 QTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSIN 568 (573)
Q Consensus 502 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~~ 568 (573)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.. +...+++..+...
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~---~~~~~~~~~i~~~ 218 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNA 218 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHHHT
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhC
Confidence 2 23345789999999999999999999999999999999999999753 3444555555443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-41 Score=332.64 Aligned_cols=210 Identities=27% Similarity=0.395 Sum_probs=179.1
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCcc---------chHHHHHHHHHHHhcC-CCccceEEEEEEcC
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQ---------GGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEG 414 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 414 (573)
++|++.+.||+|+||+||+++. .+++.||||++++.... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6799999999999999999995 57899999998754321 1235788999999997 99999999999999
Q ss_pred CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 415 EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 415 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
+..++||||+++|+|.+++.. +..+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999953 457999999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhcccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 495 AKIFGVDQTQGNTNRIVGTYGYMAPEYAMH------GQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 495 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
++.+.... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||.- ....++++.+..
T Consensus 157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~---~~~~~~~~~i~~ 229 (277)
T d1phka_ 157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIMS 229 (277)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHH
T ss_pred eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC---CCHHHHHHHHHh
Confidence 98765432 2334679999999999853 3468899999999999999999999853 334445544443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-41 Score=336.23 Aligned_cols=201 Identities=26% Similarity=0.407 Sum_probs=167.4
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc---cchHHHHHHHHHHHhcCCCccceEEEEEEcCC----e
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG---QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE----E 416 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 416 (573)
.++|++.+.||+|+||+||+|+. .+|+.||||++++... ...+.+.+|+.++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999994 5799999999976432 23457899999999999999999999987644 3
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++||||+++++|.+++. ....+++.+++.++.||++||+|||+++ |+||||||+|||++.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999998884 3457999999999999999999999987 9999999999999999999999999987
Q ss_pred cccCCCC-ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 497 IFGVDQT-QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 497 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
....... .......+||+.|||||++.+..++.++|||||||++|||+||+.||.
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 215 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCC
Confidence 6533322 223345689999999999999999999999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=337.71 Aligned_cols=216 Identities=23% Similarity=0.383 Sum_probs=169.1
Q ss_pred HHhCCCCcccccccccceeEEEEecCC----CCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcCCee
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPS----GQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 417 (573)
+..++|++.+.||+|+||+||+|++.. +..||||+++.... ...+.+.+|+.++++++||||+++++++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345679999999999999999998642 34588998865433 33567999999999999999999999986 4678
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 83 ~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999988753 3457899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHhh
Q 008238 498 FGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLLSYVSIN 568 (573)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~~ll~~~~~~ 568 (573)
+..... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.|+.. ....++++.+...
T Consensus 158 ~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~---~~~~~~~~~i~~~ 225 (273)
T d1mp8a_ 158 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG---VKNNDVIGRIENG 225 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT---CCGGGHHHHHHTT
T ss_pred ccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC---CCHHHHHHHHHcC
Confidence 643322 23344578999999999999999999999999999999998 7888754 3345566655543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-42 Score=334.48 Aligned_cols=208 Identities=30% Similarity=0.440 Sum_probs=169.7
Q ss_pred hCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcC-CeeEEEEEc
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG-EEKILVYEF 423 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 423 (573)
.++|++.++||+|+||.||+|++ .|+.||||+++.. ...+.|.+|++++++++||||++++|++.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 35688899999999999999998 5788999999753 3457899999999999999999999998654 567999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+++|+|.+++... ....+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999998542 2345899999999999999999999987 999999999999999999999999999864322
Q ss_pred ccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHh
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~~ll~~~~~ 567 (573)
.....++..|+|||++.++.++.++||||||+++|||+| |+.|+.. ....++...+..
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~---~~~~~~~~~i~~ 215 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR---IPLKDVVPRVEK 215 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT---SCGGGHHHHHTT
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC---CCHHHHHHHHHc
Confidence 223467889999999999999999999999999999998 5666543 345566666544
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=334.42 Aligned_cols=214 Identities=30% Similarity=0.418 Sum_probs=168.4
Q ss_pred hCCCCcccccccccceeEEEEecC--CC--CeeEEEEeccC---CccchHHHHHHHHHHHhcCCCccceEEEEEEcCCee
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVLP--SG--QEIAVKRLSRS---SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK 417 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 417 (573)
.++|++.++||+|+||+||+|++. ++ ..||||++++. ..+..++|.+|+.++++++||||++++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 356899999999999999999853 22 36899998754 23445689999999999999999999999976 467
Q ss_pred EEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 418 ILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 418 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
++||||+++|++.+.+.. ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 899999999999988754 3356999999999999999999999987 99999999999999999999999999997
Q ss_pred ccCCCCcc-ccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHh
Q 008238 498 FGVDQTQG-NTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 498 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~~~ll~~~~~ 567 (573)
........ ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||. .....+++..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~---~~~~~~~~~~i~~ 229 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI---GLNGSQILHKIDK 229 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT---TCCHHHHHHHHHT
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC---CcCHHHHHHHHHh
Confidence 65443322 2334567889999999999999999999999999999998 899874 2344445555443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-41 Score=338.08 Aligned_cols=207 Identities=29% Similarity=0.440 Sum_probs=178.2
Q ss_pred HHHHhCCCCcccccccccceeEEEEec------CCCCeeEEEEeccCCc-cchHHHHHHHHHHHhc-CCCccceEEEEEE
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKL-QHRNLVRLLGFCL 412 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 412 (573)
++...++|++.++||+|+||.||+|++ .+++.||||+++.... ....+|.+|+.+++++ +|||||++++++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 445567899999999999999999974 3456899999976443 3445789999999999 6999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcC---------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCC
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPE---------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 477 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~ 477 (573)
+.+..++||||+++|+|.++++... ....+++..+++++.||++||+|||+++ ++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence 9999999999999999999986432 2346899999999999999999999987 999999999
Q ss_pred CEEeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 008238 478 NILLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNS 550 (573)
Q Consensus 478 NILl~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~ 550 (573)
|||++.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+|++.|+
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~ 247 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence 9999999999999999998765544444445568899999999999999999999999999999999955553
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-41 Score=334.40 Aligned_cols=194 Identities=28% Similarity=0.374 Sum_probs=165.1
Q ss_pred cccccccccceeEEEEec-CCCCeeEEEEeccCCcc-----chHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 350 TDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQ-----GGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 350 ~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
.+++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999996 46899999998654321 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
++++++..+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~- 154 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 154 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence 99988876663 3456899999999999999999999987 9999999999999999999999999998654332
Q ss_pred ccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 202 (299)
T d1ua2a_ 155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202 (299)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCC
Confidence 223345799999999998655 57999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=338.54 Aligned_cols=220 Identities=29% Similarity=0.480 Sum_probs=184.4
Q ss_pred HHHhCCCCcccccccccceeEEEEecC------CCCeeEEEEeccCCc-cchHHHHHHHHHHHhcCCCccceEEEEEEcC
Q 008238 342 EVATNNFSTDNKLGEGGFGEVYKGVLP------SGQEIAVKRLSRSSG-QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG 414 (573)
Q Consensus 342 ~~~~~~~~~~~~LG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 414 (573)
++..++|++.++||+|+||+||+|.+. .++.||||+++.... .....|.+|+.++++++||||+++++++...
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 344567899999999999999999863 356899999975433 3345689999999999999999999999999
Q ss_pred CeeEEEEEccCCCChhhhccCc-------CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCe
Q 008238 415 EEKILVYEFVPNKSLDYFLYEP-------EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 487 (573)
Q Consensus 415 ~~~~lv~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~v 487 (573)
+..++||||+++|+|.+++... .....+++..+.+++.|+++||.|||+++ |+||||||+|||+++++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceE
Confidence 9999999999999999988542 12245799999999999999999999987 9999999999999999999
Q ss_pred EEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCC-CCCCCCCCCCcccHHHHHH
Q 008238 488 KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGK-KNSSFYQTDGAADLLSYVS 566 (573)
Q Consensus 488 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~-~p~~~~~~~~~~~ll~~~~ 566 (573)
||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+||+ .|+. .....++++.+.
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~---~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---GLSNEQVLRFVM 249 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT---TSCHHHHHHHHH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC---CCCHHHHHHHHH
Confidence 999999998765544444455567899999999999999999999999999999999996 4543 334445555554
Q ss_pred h
Q 008238 567 I 567 (573)
Q Consensus 567 ~ 567 (573)
.
T Consensus 250 ~ 250 (308)
T d1p4oa_ 250 E 250 (308)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-41 Score=334.37 Aligned_cols=218 Identities=28% Similarity=0.410 Sum_probs=178.2
Q ss_pred HHhCCCCcccccccccceeEEEEecCC--------CCeeEEEEeccCCc-cchHHHHHHHHHHHhc-CCCccceEEEEEE
Q 008238 343 VATNNFSTDNKLGEGGFGEVYKGVLPS--------GQEIAVKRLSRSSG-QGGQEFKNEVVLVAKL-QHRNLVRLLGFCL 412 (573)
Q Consensus 343 ~~~~~~~~~~~LG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 412 (573)
+..++|++.+.||+|+||.||+|+... +..||||++++... ....++.+|...+.++ +|||||++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 445678999999999999999998522 23699999976543 3456788899999888 7999999999999
Q ss_pred cCCeeEEEEEccCCCChhhhccCcC-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCE
Q 008238 413 EGEEKILVYEFVPNKSLDYFLYEPE-------------KQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 479 (573)
Q Consensus 413 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI 479 (573)
+.+..++||||+++|+|.+++.... ....+++.++++++.||+.||+|||+++ |+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 9999999999999999999996532 2356899999999999999999999987 99999999999
Q ss_pred EeCCCCCeEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 008238 480 LLDAEMNPKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIIT-GKKNSSFYQTDGA 558 (573)
Q Consensus 480 Ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~ellt-G~~p~~~~~~~~~ 558 (573)
|++.++.+||+|||+++...............|++.|+|||.+.++.++.++||||||+++|||++ |+.||.. ...
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~---~~~ 243 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG---VPV 243 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT---CCH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC---CCH
Confidence 999999999999999987765554445556778999999999999999999999999999999998 6777643 333
Q ss_pred ccHHHHHH
Q 008238 559 ADLLSYVS 566 (573)
Q Consensus 559 ~~ll~~~~ 566 (573)
.++.+.+.
T Consensus 244 ~~~~~~i~ 251 (299)
T d1fgka_ 244 EELFKLLK 251 (299)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 44444443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-41 Score=335.81 Aligned_cols=213 Identities=30% Similarity=0.457 Sum_probs=174.9
Q ss_pred CCCCcccccccccceeEEEEecC-CCC--eeEEEEeccC-CccchHHHHHHHHHHHhc-CCCccceEEEEEEcCCeeEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLP-SGQ--EIAVKRLSRS-SGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 420 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 420 (573)
++|++.++||+|+||+||+|+++ ++. .||||+++.. .....++|.+|+++|.++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888999999999999999975 343 4788887643 344566899999999998 799999999999999999999
Q ss_pred EEccCCCChhhhccCc-------------CccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCe
Q 008238 421 YEFVPNKSLDYFLYEP-------------EKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNP 487 (573)
Q Consensus 421 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~v 487 (573)
|||+++|+|.++++.. .....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999653 23467999999999999999999999987 9999999999999999999
Q ss_pred EEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCC-CCCCCCCCcccHHHHHH
Q 008238 488 KISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKN-SSFYQTDGAADLLSYVS 566 (573)
Q Consensus 488 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p-~~~~~~~~~~~ll~~~~ 566 (573)
||+|||+++..... .......||..|+|||.+.++.++.++||||||+++|||++|..| +. .....++++.+.
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~---~~~~~~~~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC---GMTCAELYEKLP 240 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT---TCCHHHHHHHGG
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC---CCCHHHHHHHHH
Confidence 99999999754322 122345689999999999999999999999999999999998764 43 334555555554
Q ss_pred h
Q 008238 567 I 567 (573)
Q Consensus 567 ~ 567 (573)
.
T Consensus 241 ~ 241 (309)
T d1fvra_ 241 Q 241 (309)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-41 Score=338.67 Aligned_cols=194 Identities=24% Similarity=0.316 Sum_probs=167.3
Q ss_pred CCCCccc-ccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhc-CCCccceEEEEEEc----CCeeE
Q 008238 346 NNFSTDN-KLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKL-QHRNLVRLLGFCLE----GEEKI 418 (573)
Q Consensus 346 ~~~~~~~-~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~~ 418 (573)
++|++.+ .||+|+||+||+|+. .+++.||||+++. ...+.+|++++.++ +|||||++++++.+ ....+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4688775 599999999999995 5789999999863 24677899987655 89999999999875 35679
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC---CCCeEEeccCCc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---EMNPKISDFGMA 495 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~vkl~DfGla 495 (573)
+||||+++|+|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 999999999999999642 2357999999999999999999999987 999999999999975 567999999999
Q ss_pred ccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
+...... ......||+.|||||++.+..++.++|||||||++|||+||+.||.
T Consensus 162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~ 214 (335)
T d2ozaa1 162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 214 (335)
T ss_dssp EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCC
Confidence 8764332 2345689999999999999999999999999999999999999985
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=332.95 Aligned_cols=199 Identities=28% Similarity=0.458 Sum_probs=170.2
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++|++.++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999995 578999999996543 2335778999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
|+.++.+...... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9987655544322 3456999999999999999999999987 9999999999999999999999999998764332
Q ss_pred CccccccccccCCccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCC
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||.
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence 2334457999999999887765 5789999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=331.92 Aligned_cols=210 Identities=28% Similarity=0.432 Sum_probs=171.8
Q ss_pred ccccccccceeEEEEecCCC----CeeEEEEeccC-CccchHHHHHHHHHHHhcCCCccceEEEEEEc-CCeeEEEEEcc
Q 008238 351 DNKLGEGGFGEVYKGVLPSG----QEIAVKRLSRS-SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFV 424 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 424 (573)
.++||+|+||+||+|++.++ ..||||++++. .....++|.+|++++++++||||++++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999996432 25899999754 34445789999999999999999999999876 45789999999
Q ss_pred CCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCCc
Q 008238 425 PNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQTQ 504 (573)
Q Consensus 425 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 504 (573)
++|+|.+++.. ....+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999865 3456788999999999999999999987 999999999999999999999999999876443322
Q ss_pred --cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHh
Q 008238 505 --GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLSYVSI 567 (573)
Q Consensus 505 --~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~~~~~ 567 (573)
.......||..|+|||.+.++.++.++||||||+++|||+||+.|+... ....++..++..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~--~~~~~~~~~i~~ 249 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD--VNTFDITVYLLQ 249 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC--CCHHHHHHHHHc
Confidence 1223457899999999999999999999999999999999988886432 233345555443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-41 Score=335.22 Aligned_cols=200 Identities=27% Similarity=0.367 Sum_probs=162.4
Q ss_pred CCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcCC----eeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE----EKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 421 (573)
++|.+.++||+|+||+||+|++ +|+.||||+++... .....++.|+..+.+++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4577889999999999999997 68899999986432 11222334555566789999999999998654 578999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHED-----SRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-----~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
||+++|+|.+++++ ..++|..+++++.|++.||+|||+. .+.+|+||||||+||||++++++||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999953 4689999999999999999999974 12459999999999999999999999999998
Q ss_pred cccCCCCc--cccccccccCCccchhccccCC------CCccchhHHHHHHHHHHHhCCCCCC
Q 008238 497 IFGVDQTQ--GNTNRIVGTYGYMAPEYAMHGQ------FSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 497 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~~~DvwslGvll~elltG~~p~~ 551 (573)
........ .......||+.|||||++.+.. ++.++|||||||++|||+||..|+.
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 76443321 2334568999999999986643 5678999999999999999988764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-41 Score=329.09 Aligned_cols=198 Identities=24% Similarity=0.416 Sum_probs=168.8
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc------cchHHHHHHHHHHHhcC--CCccceEEEEEEcCC
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG------QGGQEFKNEVVLVAKLQ--HRNLVRLLGFCLEGE 415 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~ 415 (573)
.++|++.+.||+|+||+||+|+. .+|+.||||++.+... ....++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999995 5789999999865321 12234678999999997 899999999999999
Q ss_pred eeEEEEEccCC-CChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC-CCCeEEeccC
Q 008238 416 EKILVYEFVPN-KSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-EMNPKISDFG 493 (573)
Q Consensus 416 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~vkl~DfG 493 (573)
..++||||+.+ +++.+++. +...+++.++..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 57777764 3457999999999999999999999987 999999999999985 4799999999
Q ss_pred CcccccCCCCccccccccccCCccchhccccCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 008238 494 MAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQF-SVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 494 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 99865322 2334679999999999988776 5779999999999999999999853
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.2e-40 Score=327.58 Aligned_cols=198 Identities=26% Similarity=0.447 Sum_probs=171.2
Q ss_pred CCCCcccccccccceeEEEEecCCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 423 (573)
++|++.++||+|+||+||+|++++|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5799999999999999999998899999999996543 33357899999999999999999999999999999999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCCC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQT 503 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 503 (573)
+.++++..+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 99888777763 3467999999999999999999999987 9999999999999999999999999998764332
Q ss_pred ccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 504 QGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 504 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~ 202 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCC
Confidence 223345689999999998765 56899999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-39 Score=320.70 Aligned_cols=206 Identities=21% Similarity=0.324 Sum_probs=175.1
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCC-CccceEEEEEEcCCeeEEEEE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQH-RNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 422 (573)
.++|++.++||+|+||+||+|+. .+|+.||||++.... ....+.+|++.++.++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 46899999999999999999995 478899999886543 23467889999999975 899999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCC-----CCCeEEeccCCccc
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----EMNPKISDFGMAKI 497 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~vkl~DfGla~~ 497 (573)
|+ +++|.+++.. ....+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6888888754 3357899999999999999999999987 999999999999964 57899999999987
Q ss_pred ccCCCCc-----cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCc
Q 008238 498 FGVDQTQ-----GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQTDGA 558 (573)
Q Consensus 498 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~~~~~ 558 (573)
+...... .......||+.|||||.+.+..++.++||||||+++|||++|+.||........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~ 221 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH
Confidence 6433221 223456899999999999999999999999999999999999999975444333
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=326.27 Aligned_cols=200 Identities=27% Similarity=0.437 Sum_probs=167.1
Q ss_pred hCCCCcccccccccceeEEEEec-CC-CCeeEEEEeccCC--ccchHHHHHHHHHHHhc---CCCccceEEEEEEc----
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PS-GQEIAVKRLSRSS--GQGGQEFKNEVVLVAKL---QHRNLVRLLGFCLE---- 413 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 413 (573)
.++|++.++||+|+||+||+|+. ++ ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999985 34 5679999986432 22334566777777665 79999999999863
Q ss_pred -CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEecc
Q 008238 414 -GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDF 492 (573)
Q Consensus 414 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~Df 492 (573)
....+++|||++++++...... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 2467899999999887655433 4456899999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 493 GMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 493 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~ 217 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 217 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC
Confidence 998754322 233456899999999999999999999999999999999999999853
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-39 Score=321.88 Aligned_cols=200 Identities=25% Similarity=0.440 Sum_probs=167.4
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccC--CccchHHHHHHHHHHHhcCCCccceEEEEEEcC--------
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRS--SGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG-------- 414 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 414 (573)
++|++.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++||||+++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5799999999999999999995 57999999998643 334456789999999999999999999988653
Q ss_pred CeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCC
Q 008238 415 EEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGM 494 (573)
Q Consensus 415 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGl 494 (573)
...++||||++++++..+.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 45789999999888776553 3456899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCc--cccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 495 AKIFGVDQTQ--GNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 495 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
++.+...... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 9866533221 222345799999999998765 68999999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-39 Score=326.34 Aligned_cols=196 Identities=28% Similarity=0.399 Sum_probs=164.1
Q ss_pred CCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceEEEEEEcC------CeeEE
Q 008238 347 NFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG------EEKIL 419 (573)
Q Consensus 347 ~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l 419 (573)
+|+..++||+|+||+||+|+. .+|+.||||++..... .+.+|+.+|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 477889999999999999995 4789999999975432 234799999999999999999998643 24689
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC-CeEEeccCCcccc
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMAKIF 498 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~ 498 (573)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999988765555433334567999999999999999999999987 99999999999999775 8999999999876
Q ss_pred cCCCCccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 499 GVDQTQGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 4332 2234579999999998875 4689999999999999999999999853
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=324.31 Aligned_cols=201 Identities=24% Similarity=0.396 Sum_probs=167.2
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC-ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC----eeE
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS-GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE----EKI 418 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 418 (573)
+.+|++.++||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35799999999999999999984 589999999997543 334567889999999999999999999987643 235
Q ss_pred EEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccc
Q 008238 419 LVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIF 498 (573)
Q Consensus 419 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~ 498 (573)
++++++.+|+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 5566778999999984 346999999999999999999999987 999999999999999999999999999865
Q ss_pred cCCCC-ccccccccccCCccchhcccc-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 499 GVDQT-QGNTNRIVGTYGYMAPEYAMH-GQFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 499 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
..... .......+||+.|+|||++.. ..++.++||||+||++|||++|+.||.-
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence 43322 223345679999999999854 4678999999999999999999999853
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-38 Score=314.81 Aligned_cols=201 Identities=22% Similarity=0.326 Sum_probs=166.0
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccceE-EEEEEcCCeeEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLVRL-LGFCLEGEEKILVYEF 423 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e~ 423 (573)
++|++.++||+|+||+||+|+. .+|+.||||++..... ..++..|+++++.++|+|++.. .++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999995 5789999998865432 3467899999999987775554 5556778888999999
Q ss_pred cCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeC---CCCCeEEeccCCcccccC
Q 008238 424 VPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---AEMNPKISDFGMAKIFGV 500 (573)
Q Consensus 424 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~vkl~DfGla~~~~~ 500 (573)
+.+ +|.+.+.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++.+..
T Consensus 85 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 954 55554432 3457999999999999999999999988 99999999999985 455799999999997654
Q ss_pred CCCc-----cccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 008238 501 DQTQ-----GNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFYQ 554 (573)
Q Consensus 501 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~~ 554 (573)
.... .......||+.|||||.+.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 3321 22345689999999999999999999999999999999999999986544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-38 Score=322.68 Aligned_cols=195 Identities=28% Similarity=0.451 Sum_probs=163.0
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCC------
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGE------ 415 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 415 (573)
.++|++.++||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46799999999999999999995 579999999997543 233467889999999999999999999998654
Q ss_pred eeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCc
Q 008238 416 EKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMA 495 (573)
Q Consensus 416 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla 495 (573)
..++||||+ +.+|..++ +...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHH----HhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 56677666 3457999999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhccccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 496 KIFGVDQTQGNTNRIVGTYGYMAPEYAMHG-QFSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
+..... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 865432 2345789999999998764 568999999999999999999999854
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-38 Score=311.64 Aligned_cols=208 Identities=25% Similarity=0.416 Sum_probs=177.3
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEcCCeeEEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 422 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 422 (573)
++|++.++||+|+||+||+|+. .+++.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999995 578899999986543 3345788999999999999999999999999999999999
Q ss_pred ccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcccccCCC
Q 008238 423 FVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAKIFGVDQ 502 (573)
Q Consensus 423 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~~~~~~~ 502 (573)
++.+++|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988774 3457899999999999999999999987 9999999999999999999999999998764433
Q ss_pred CccccccccccCCccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 008238 503 TQGNTNRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSFYQTDGAADLLS 563 (573)
Q Consensus 503 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslGvll~elltG~~p~~~~~~~~~~~ll~ 563 (573)
. ......++..|+|||.+.... ++.++|||||||++|||++|+.|+. ...+..+.++
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~--~~~~~~~~~~ 213 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF--PGNDVDDQLK 213 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC--CCSSHHHHHH
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC--CCCCHHHHHH
Confidence 2 223345778899999987665 6899999999999999999999963 2334444444
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=319.00 Aligned_cols=201 Identities=27% Similarity=0.395 Sum_probs=172.0
Q ss_pred CCCCcccccccccceeEEEEec----CCCCeeEEEEeccCC----ccchHHHHHHHHHHHhcCC-CccceEEEEEEcCCe
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSRSS----GQGGQEFKNEVVLVAKLQH-RNLVRLLGFCLEGEE 416 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 416 (573)
++|++.++||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 4699999999999999999974 247899999986532 2335678899999999977 899999999999999
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.+++|||+.+|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999985 3456788999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccchhccccC--CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMHG--QFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
.+..... .......|++.|++||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 178 ~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~ 235 (322)
T d1vzoa_ 178 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235 (322)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred hhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 7643322 233456799999999998765 4688999999999999999999998643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-37 Score=314.72 Aligned_cols=192 Identities=24% Similarity=0.408 Sum_probs=166.7
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-CCccceEEEEEEcC--CeeEEEE
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEG--EEKILVY 421 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 421 (573)
++|++.++||+|+||+||+|+. .+++.||||+++.. ..+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999995 57899999998643 3467889999999996 99999999998754 4688999
Q ss_pred EccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCC-CeEEeccCCcccccC
Q 008238 422 EFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEM-NPKISDFGMAKIFGV 500 (573)
Q Consensus 422 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~vkl~DfGla~~~~~ 500 (573)
||+++++|..+. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997765 35899999999999999999999988 99999999999998655 699999999986643
Q ss_pred CCCccccccccccCCccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCCC
Q 008238 501 DQTQGNTNRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSSF 552 (573)
Q Consensus 501 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslGvll~elltG~~p~~~ 552 (573)
.. ......||+.|+|||.+.+.. ++.++||||+|+++|||++|+.||..
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence 32 234457899999999987654 79999999999999999999999754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-37 Score=313.49 Aligned_cols=194 Identities=28% Similarity=0.373 Sum_probs=159.0
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCC--ccchHHHHHHHHHHHhcCCCccceEEEEEEc------CCe
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSS--GQGGQEFKNEVVLVAKLQHRNLVRLLGFCLE------GEE 416 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 416 (573)
++|++.++||+|+||+||+|+. .+|+.||||++.... .....++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5799999999999999999995 469999999997543 2334568899999999999999999999864 367
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.++||||+.++++..+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999877665443 45899999999999999999999988 9999999999999999999999999988
Q ss_pred cccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~ 551 (573)
..... .......||+.|+|||++.+..++.++||||+||+++||++|+.||.
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~ 219 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCC
Confidence 65432 23345578999999999999999999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-37 Score=313.68 Aligned_cols=195 Identities=27% Similarity=0.428 Sum_probs=164.7
Q ss_pred hCCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCc--cchHHHHHHHHHHHhcCCCccceEEEEEEcC-----Ce
Q 008238 345 TNNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSG--QGGQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----EE 416 (573)
Q Consensus 345 ~~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 416 (573)
.++|++.++||+|+||+||+|+. .+|+.||||++++... ...+.+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999994 5799999999975432 3345788999999999999999999998643 34
Q ss_pred eEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 417 KILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 417 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
.+++++|+.+|+|.+++. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 467788889999999984 346999999999999999999999987 9999999999999999999999999987
Q ss_pred cccCCCCccccccccccCCccchhccccCC-CCccchhHHHHHHHHHHHhCCCCCC
Q 008238 497 IFGVDQTQGNTNRIVGTYGYMAPEYAMHGQ-FSVKSDVYSFGVLVLEIITGKKNSS 551 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwslGvll~elltG~~p~~ 551 (573)
.... ......|++.|+|||.+.+.. ++.++|||||||++|||++|+.||.
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence 5432 233457899999999877654 6899999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=9.7e-33 Score=282.82 Aligned_cols=199 Identities=21% Similarity=0.276 Sum_probs=160.6
Q ss_pred CCCCcccccccccceeEEEEec-CCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-----------CCccceEEEEEEc
Q 008238 346 NNFSTDNKLGEGGFGEVYKGVL-PSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-----------HRNLVRLLGFCLE 413 (573)
Q Consensus 346 ~~~~~~~~LG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~ 413 (573)
.+|++.++||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999995 579999999997543 23456788999888875 4789999988764
Q ss_pred --CCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCEEeCCCCC----
Q 008238 414 --GEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMN---- 486 (573)
Q Consensus 414 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~---- 486 (573)
....++++++...+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 34566777776665544333333455678999999999999999999998 55 999999999999986653
Q ss_pred --eEEeccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 008238 487 --PKISDFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLVLEIITGKKNSSFY 553 (573)
Q Consensus 487 --vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll~elltG~~p~~~~ 553 (573)
++++|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||...
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 99999999975432 223457999999999999999999999999999999999999998643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=6e-24 Score=196.51 Aligned_cols=169 Identities=18% Similarity=0.158 Sum_probs=120.4
Q ss_pred CcccccccccceeEEEEecCCCCeeEEEEeccCCcc------------------chHHHHHHHHHHHhcCCCccceEEEE
Q 008238 349 STDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQ------------------GGQEFKNEVVLVAKLQHRNLVRLLGF 410 (573)
Q Consensus 349 ~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~l~~~ 410 (573)
.+.++||+|+||+||+|+..+|+.||||+++..... .......|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999999888999999987532110 01234568889999999999998876
Q ss_pred EEcCCeeEEEEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeecCCCCCEEeCCCCCeEEe
Q 008238 411 CLEGEEKILVYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 490 (573)
Q Consensus 411 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~vkl~ 490 (573)
. ..+++|||++++.+..+ +......++.|++++|+|||+++ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 24799999988765432 33445678999999999999987 99999999999999764 8999
Q ss_pred ccCCcccccCCCCccccccccccCCccchhccccCCCCccchhHHHHHHH
Q 008238 491 DFGMAKIFGVDQTQGNTNRIVGTYGYMAPEYAMHGQFSVKSDVYSFGVLV 540 (573)
Q Consensus 491 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwslGvll 540 (573)
|||++.....+.......+.+. . -.| .....++.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~---~-~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVR---N-IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHH---H-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHHH---H-HHH-HHcCCCCCcccHHHHHHHH
Confidence 9999976532221100000000 0 011 1245678899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.62 E-value=1.4e-07 Score=89.23 Aligned_cols=147 Identities=17% Similarity=0.103 Sum_probs=102.6
Q ss_pred HHHHhCCCCcccccccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcC-CCccceEEEEEEcCCeeEE
Q 008238 341 IEVATNNFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 341 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 419 (573)
+...-+.|+..+..+.++...||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+..+++..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 333345677666655455578999875 56678889887655555556788998888775 3336788888888888999
Q ss_pred EEEccCCCChhhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 008238 420 VYEFVPNKSLDYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHEDS---------------------------------- 465 (573)
Q Consensus 420 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~---------------------------------- 465 (573)
||+++++..+....... .....++.++++.+..||+..
T Consensus 88 v~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999998886554211 112234555666666666421
Q ss_pred ----------------------CCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 466 ----------------------RLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 466 ----------------------~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
...++|+|+.|.|||+++++.+-|.||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1228999999999999987767799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.09 E-value=1.3e-05 Score=74.89 Aligned_cols=130 Identities=18% Similarity=0.153 Sum_probs=87.5
Q ss_pred ccccccc-eeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCC--ccceEEEEEEcCCeeEEEEEccCCCCh
Q 008238 353 KLGEGGF-GEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHR--NLVRLLGFCLEGEEKILVYEFVPNKSL 429 (573)
Q Consensus 353 ~LG~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL 429 (573)
.+..|.. +.||+...+++..+++|...... ...+..|...++.+... .+.+++.+..+.+..++||+|+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4445554 57999998788888999865432 34567788888777533 356778888888889999999998776
Q ss_pred hhhccCcCccCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 008238 430 DYFLYEPEKQQQLDWSRRYKIIGGIARGILYLHE---------------------------------------------- 463 (573)
Q Consensus 430 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~---------------------------------------------- 463 (573)
.... .... .++.++.+.|.-||+
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4322 1111 112233333333332
Q ss_pred -----C----CCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 464 -----D----SRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 464 -----~----~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
. ..+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 11238999999999999988777899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.49 E-value=0.00021 Score=71.05 Aligned_cols=77 Identities=13% Similarity=0.124 Sum_probs=49.3
Q ss_pred ccccccccceeEEEEecCC-CCeeEEEEeccC-------CccchHHHHHHHHHHHhcC-C--CccceEEEEEEcCCeeEE
Q 008238 351 DNKLGEGGFGEVYKGVLPS-GQEIAVKRLSRS-------SGQGGQEFKNEVVLVAKLQ-H--RNLVRLLGFCLEGEEKIL 419 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l 419 (573)
.+.||.|....||+....+ ++.++||.-... -.....+...|.+.|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998654 678899964311 1122344566888777663 2 345555554 4556789
Q ss_pred EEEccCCCCh
Q 008238 420 VYEFVPNKSL 429 (573)
Q Consensus 420 v~e~~~~gsL 429 (573)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.15 E-value=0.0011 Score=63.75 Aligned_cols=135 Identities=15% Similarity=0.111 Sum_probs=78.5
Q ss_pred eeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccc--eEE-----EEEEcCCeeEEEEEccCCCChhhh
Q 008238 360 GEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLV--RLL-----GFCLEGEEKILVYEFVPNKSLDYF 432 (573)
Q Consensus 360 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv--~l~-----~~~~~~~~~~lv~e~~~~gsL~~~ 432 (573)
-.||+++.++|+.+++|..+.. ....+++..|...+..+....+. ..+ .........+.++++++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999989999999997643 23456788899888887533321 111 122345667889999987544211
Q ss_pred ----cc--------------C--cCccCCCCH-------------------H---HHHHHHHHHHHHHHHH-HhCCCCCe
Q 008238 433 ----LY--------------E--PEKQQQLDW-------------------S---RRYKIIGGIARGILYL-HEDSRLRI 469 (573)
Q Consensus 433 ----l~--------------~--~~~~~~l~~-------------------~---~~~~i~~qia~~L~yL-H~~~~~~i 469 (573)
+. . ......+++ . .....+.++...+.-+ .+.....+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00 0 000011111 1 1122223333222222 12223468
Q ss_pred EeecCCCCCEEeCCCCCeEEeccCCccc
Q 008238 470 IHRDLKASNILLDAEMNPKISDFGMAKI 497 (573)
Q Consensus 470 vH~Dlkp~NILl~~~~~vkl~DfGla~~ 497 (573)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.46 E-value=0.0039 Score=61.54 Aligned_cols=74 Identities=16% Similarity=0.259 Sum_probs=49.4
Q ss_pred ccccccccceeEEEEecCCC--------CeeEEEEeccCCccchHHHHHHHHHHHhcCCCcc-ceEEEEEEcCCeeEEEE
Q 008238 351 DNKLGEGGFGEVYKGVLPSG--------QEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNL-VRLLGFCLEGEEKILVY 421 (573)
Q Consensus 351 ~~~LG~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 421 (573)
++.|+.|-.=.+|+...+++ +.|.+++.-. . .......+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35677777788999886432 4566666542 2 233456789999888864444 477777643 6899
Q ss_pred EccCCCChh
Q 008238 422 EFVPNKSLD 430 (573)
Q Consensus 422 e~~~~gsL~ 430 (573)
||+++..+.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999876553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.18 E-value=0.0071 Score=57.45 Aligned_cols=156 Identities=12% Similarity=0.033 Sum_probs=81.6
Q ss_pred hhHHHHHhCCCCcccc-----cccccceeEEEEecCCCCeeEEEEeccCCccchHHHHHHHHHHHhcCCCccc--eEE--
Q 008238 338 FETIEVATNNFSTDNK-----LGEGGFGEVYKGVLPSGQEIAVKRLSRSSGQGGQEFKNEVVLVAKLQHRNLV--RLL-- 408 (573)
Q Consensus 338 ~~~~~~~~~~~~~~~~-----LG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv--~l~-- 408 (573)
.++++....+|.+.+. |..|---+.|+.+.++| .+++|+..... ..+++..|++++..+...++. ..+
T Consensus 5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccccee
Confidence 3455555666766443 34555577899987555 58999886432 234556677777777533321 111
Q ss_pred ----EEEEcCCeeEEEEEccCCCChhhhccC--------------------cCccCCC------------------CHHH
Q 008238 409 ----GFCLEGEEKILVYEFVPNKSLDYFLYE--------------------PEKQQQL------------------DWSR 446 (573)
Q Consensus 409 ----~~~~~~~~~~lv~e~~~~gsL~~~l~~--------------------~~~~~~l------------------~~~~ 446 (573)
.+.........++.+..+......... ....... ....
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 012223456677777766443211100 0000000 0111
Q ss_pred HHHHHHHHHHHHHHHHh-CCCCCeEeecCCCCCEEeCCCCCeEEeccCCcc
Q 008238 447 RYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDAEMNPKISDFGMAK 496 (573)
Q Consensus 447 ~~~i~~qia~~L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~vkl~DfGla~ 496 (573)
....+..+...+.-.+. .-+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11222222222222222 122359999999999999988777899999875
|